<SEC-DOCUMENT>0001493152-22-007862.txt : 20220328
<SEC-HEADER>0001493152-22-007862.hdr.sgml : 20220328
<ACCEPTANCE-DATETIME>20220328145715
ACCESSION NUMBER:		0001493152-22-007862
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		116
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220328
DATE AS OF CHANGE:		20220328

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Agape ATP Corp
		CENTRAL INDEX KEY:			0001713210
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				364838886
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-220144
		FILM NUMBER:		22775090

	BUSINESS ADDRESS:	
		STREET 1:		1705-1708 LEVEL 17, TOWER 2, FABER TOWER
		STREET 2:		JALAN DESA BAHAGIA, TAMAN DESA
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			58100
		BUSINESS PHONE:		(603) 27325716

	MAIL ADDRESS:	
		STREET 1:		1705-1708 LEVEL 17, TOWER 2, FABER TOWER
		STREET 2:		JALAN DESA BAHAGIA, TAMAN DESA
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			58100
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:AATP="http://agapeatp.com/20211231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_AATP_agapeatp.com_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20210101_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001713210 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_067_RM_0_iso4217%2D%2DMYR -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCentralIndexKey">0001713210</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0033" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0034" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0060" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl0116" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl0132" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0134" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0158" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31" id="xdx2ixbrl0159" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2020-12-31" id="xdx2ixbrl0209" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:RevenueFromRelatedParty" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0220" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0242" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0275" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0293" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0314" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0318" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0319" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0321" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0322" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0327" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0328" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0334" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0335" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0337" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0344" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0352" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ContributionsFromNoncontrollingInterestShareholders" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0356" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ContributionsFromNoncontrollingInterestShareholders" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ContributionsFromNoncontrollingInterestShareholders" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0358" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ContributionsFromNoncontrollingInterestShareholders" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0359" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0364" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0378" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0431" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfInvestmentProjects" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0524" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0527" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0613" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl0615" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_HealthAndWellnessServicesMember" id="xdx2ixbrl0721" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember" id="xdx2ixbrl0854" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember" id="xdx2ixbrl0857" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableGrossCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0974" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableRelatedPartiesCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0977" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableRelatedPartiesCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl0978" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:AccountsReceivableAndAccountsReceivableRelatedParties" contextRef="AsOf2021-12-31" id="xdx2ixbrl0980" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0992" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2020-12-31" id="xdx2ixbrl1008" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-12-31" id="xdx2ixbrl1015" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2019-12-31" id="xdx2ixbrl1016" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1019" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1021" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1022" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:AllowanceForDoubtfulAccountsReceivableExchangeRateEffect" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1025" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-12-31" id="xdx2ixbrl1028" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesGross" contextRef="AsOf2021-12-31_custom_DirectorsOfUnreservedInvestmentMember" id="xdx2ixbrl1163" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:SaleOfInvestmentInNonmarketableSecurities" contextRef="AsOf2021-12-31_custom_DirectorsOfUnreservedInvestmentMember" id="xdx2ixbrl1167" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:InvestmentInNonmarketableSecuritiesNet" contextRef="AsOf2021-12-31_custom_DirectorsOfUnreservedInvestmentMember" id="xdx2ixbrl1171" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:InvestmentInNonmarketableSecuritiesNet" contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember" id="xdx2ixbrl1173" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2021-12-31_custom_THThreeTechnologySdnBhdMember" id="xdx2ixbrl1241" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2021-12-31_custom_AgapeSuperiorLivingPtyLtdMember" id="xdx2ixbrl1252" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl1256" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" id="xdx2ixbrl1268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember" id="xdx2ixbrl1282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" contextRef="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember" id="xdx2ixbrl1301" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1305" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:NonControllingInterestPaidinCapital" contextRef="AsOf2020-12-31" id="xdx2ixbrl1384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:NonControllingInterestAccumulatedDeficit" contextRef="AsOf2020-12-31" id="xdx2ixbrl1387" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:NonControllingInterestAccumulatedOtherComprehensiveIncome" contextRef="AsOf2020-12-31" id="xdx2ixbrl1390" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:NonControllingInterestNonControllingInterestGross" contextRef="AsOf2020-12-31" id="xdx2ixbrl1393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:NonControllingInterestAsl" contextRef="AsOf2021-12-31" id="xdx2ixbrl1395" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:NonControllingInterestAsl" contextRef="AsOf2020-12-31" id="xdx2ixbrl1396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2020-12-31" id="xdx2ixbrl1399" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2020-12-31_country_US" id="xdx2ixbrl1519" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31" id="xdx2ixbrl1528" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2021-12-31" id="xdx2ixbrl1587" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="aatp-20211231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AgapeATPInternationalHoldingLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AgapeATPInternationalHoldingLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-07</xbrli:startDate>
        <xbrli:endDate>2020-05-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_custom_SubsidiaryCompanyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-11_custom_SubsidiaryCompanyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubsidiaryCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubsidiaryCompanyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubsidiaryCompanyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubsidiaryCompanyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubsidiaryCompanyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HealthAndWellnessProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:HealthAndWellnessProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HealthAndWellnessServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:HealthAndWellnessServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_HealthAndWellnessServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:HealthAndWellnessServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SocialSecurityOrganizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SocialSecurityOrganizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember_custom_MYRCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SocialSecurityOrganizationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EmployeesProvidentFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmployeesProvidentFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EmploymentInsuranceSystemMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmploymentInsuranceSystemMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EmploymentInsuranceSystemMember_custom_MYRCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmploymentInsuranceSystemMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HumanResourceDevelopmentFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:HumanResourceDevelopmentFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SurvivorSelectMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SurvivorSelectMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EnergizedMineralConcentrateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EnergizedMineralConcentrateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_IonizedCalMagMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IonizedCalMagMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OmegaBlendMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_OmegaBlendMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_BetaMaxxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_BetaMaxxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_VegeFruitFiberMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_VegeFruitFiberMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_IronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_YoungFormulaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_YoungFormulaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OrganicYouthCareCleansingBarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_OrganicYouthCareCleansingBarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_MitogizeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MitogizeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_NoOneMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_NoOneMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EnergetiqueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EnergetiqueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_TrimPlusMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TrimPlusMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PeriodEndMYRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndMYRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PeriodEndMYRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndMYRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PeriodEndHKDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndHKDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PeriodEndHKDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndHKDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PeriodAverageMYRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_PeriodAverageMYRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PeriodAverageHKDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_PeriodAverageHKDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubsidiaryCompanyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-292020-07-02_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-29</xbrli:startDate>
        <xbrli:endDate>2020-07-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ComputerAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ComputerAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_VehicleMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:VehicleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_VehicleMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:VehicleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-05-17_custom_GreenproCapitalCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-05-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-07-30_custom_GreenproCapitalCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-16_custom_GreenproCapitalCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-03_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-09_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-27_custom_SEATechVenturesCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SEATechVenturesCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-10_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-10_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-03_custom_UnreservedSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:UnreservedSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_MrHowKokChoongMember351695203">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-03_custom_PhoenixPlusCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-03_us-gaap_CommonStockMember_custom_PhoenixPlusCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_DirectorsOfUnreservedInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:DirectorsOfUnreservedInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:DirectorsOfUnreservedInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PhoenixPlusCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PhoenixPlusCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AgapeATPAsiaLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AgapeATPAsiaLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AgapeATPAsiaLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HostastaySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_HostastaySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_HostastaySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_HostastaySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_THThreeTechnologySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_THThreeTechnologySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_THThreeTechnologySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_VettonsSdnBhdOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:VettonsSdnBhdOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_VettonsSdnBhdOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:VettonsSdnBhdOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HowKokChoongMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:DSYWellnessAndLongevityCenterSdnBhdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:DSYWellnessAndLongevityCenterSdnBhdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:DSYWellnessAndLongevityCenterSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:DSYWellnessAndLongevityCenterSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_HowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-012020-05-31_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-292020-07-31_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-29</xbrli:startDate>
        <xbrli:endDate>2020-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HowKokChoongTalentLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongTalentLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HowKokChoongTalentLimitedMember_custom_ShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongTalentLimitedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:ShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HKCHoldingsSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HKCHoldingsSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_country_HK">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_country_HK">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-282019-01-02_custom_LabuanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">AATP:LabuanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-28</xbrli:startDate>
        <xbrli:endDate>2019-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_UnutilizedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AATP:UnutilizedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_UnutilizedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AATP:UnutilizedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AATPHKMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AATPHKMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AATPLBASLSEAWATPAndDSYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AATPLBASLSEAWATPAndDSYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AATPHKMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AATPHKMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AATPLBASLSEAAndWATPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AATPLBASLSEAAndWATPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:NoCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:NoCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember_us-gaap_CustomerConcentrationRiskMember_custom_VendorOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:ECommerceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_VendorTwoMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_VendorTwoMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-31_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-30_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_VendorOneMember_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_AccountsPayableMember_custom_OneVendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:OneVendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_OneSalesDistributorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:OneSalesDistributorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_NoSalesDistributorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:NoSalesDistributorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-01_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-302021-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-30</xbrli:startDate>
        <xbrli:endDate>2021-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-302021-05-31_custom_TrainingCenterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:TrainingCenterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-30</xbrli:startDate>
        <xbrli:endDate>2021-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-31_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_COVIDNineteenImpactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">AATP:COVIDNineteenImpactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-01-20_us-gaap_SubsequentEventMember_custom_MrHowKokChoongMember_custom_ShareForfeitureAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="RM">
      <xbrli:measure>iso4217:MYR</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001272" toRefs="Footnote001287"></ix:relationship>
  <ix:relationship fromRefs="Fact001274" toRefs="Footnote001287"></ix:relationship>
  <ix:relationship fromRefs="Fact001276" toRefs="Footnote001287"></ix:relationship>
  <ix:relationship fromRefs="Fact001278" toRefs="Footnote001287"></ix:relationship>
  <ix:relationship fromRefs="Fact001280" toRefs="Footnote001287"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1282" toRefs="Footnote001287"></ix:relationship>
  <ix:relationship fromRefs="Fact001489" toRefs="Footnote001494"></ix:relationship>
  <ix:relationship fromRefs="Fact001490" toRefs="Footnote001503"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_908_edei--DocumentType_c20210101__20211231_zmp1gxTFJhN6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--DocumentAnnualReport_c20210101__20211231_zLFMath4NQU5"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
The Fiscal Year Ended <span id="xdx_907_edei--DocumentPeriodEndDate_c20210101__20211231_zZJCfMNcNmn2"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_90E_edei--CurrentFiscalYearEndDate_c20210101__20211231_zm4vsrVTvXX6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, <span id="xdx_907_edei--DocumentFiscalYearFocus_c20210101__20211231_zM34hNEQgpQa"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric></span></ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--DocumentTransitionReport_c20210101__20211231_zeWy0iuuqlyl"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the transition period from _____________________________</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
File Number <span id="xdx_906_edei--EntityFileNumber_c20210101__20211231_zfNFNba7ULkj"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityFileNumber">333-220144</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20210101__20211231_zsixsyXCiZu2"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityRegistrantName">AGAPE ATP CORPORATION</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant issuer as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20210101__20211231_zXbXshR3kE39"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20210101__20211231_zmXSfy3wmZEg"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityTaxIdentificationNumber">36-4838886</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1705
&#8211; 1708, Level 17, <span id="xdx_907_edei--EntityAddressAddressLine1_c20210101__20211231_zb7sFp5RrWZk"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine1">Tower 2</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressAddressLine2_c20210101__20211231_z8k0FFjQbnU6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine2">Faber Towers</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine3_c20210101__20211231_zhtonFRkDmE4"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine3">Jalan Desa Bahagia</ix:nonNumeric></span>,</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taman
Desa, <span id="xdx_904_edei--EntityAddressPostalZipCode_c20210101__20211231_zKE3y977adi6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressPostalZipCode">58100</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressCityOrTown_c20210101__20211231_zwuOisBZg0E7"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressCityOrTown">Kuala Lumpur</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressCountry_c20210101__20211231_zbO86XDIyi31"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Malaysia</ix:nonNumeric></span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices, including zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
phone number, including area code</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--CityAreaCode_c20210101__20211231_zUOuzJtkVyx7"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:CityAreaCode">(60)</ix:nonNumeric></span>
<span id="xdx_907_edei--LocalPhoneNumber_c20210101__20211231_zTeFeEMWWLdl"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:LocalPhoneNumber">192230099</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Securities Exchange Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_907_edei--Security12bTitle_c20210101__20211231_zM1XR5fu5q38"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:Security12bTitle">Common
Stock, $0.0001 par value</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title
of Class)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">The
OTC Market &#8211; Pink Sheets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of exchange on which registered)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(g) of the Securities Exchange Act: <b><span style="text-decoration: underline">None</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <span id="xdx_909_edei--EntityWellKnownSeasonedIssuer_c20210101__20211231_zLVccnKRxFwh"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744; <span id="xdx_903_edei--EntityVoluntaryFilers_c20210101__20211231_zPEUlsAvfoS6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_90D_edei--EntityCurrentReportingStatus_c20210101__20211231_zGjMpq6tjOn4"><span style="-sec-ix-hidden: xdx2ixbrl0033">YES</span></span> &#9746;  NO &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was
required to submit and post such files). <span id="xdx_90B_edei--EntityInteractiveDataCurrent_c20210101__20211231_zCOWo60waVok"><span style="-sec-ix-hidden: xdx2ixbrl0034">YES</span></span> &#9746;  NO &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (&#167; 229.405 of this chapter) is not contained
herein, and will not be contained, to the best of registrant&#8217;s knowledge, in definitive proxy or information statements incorporated
by reference in Part III of this Form 10-K or any amendment to this Form 10-K. &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221;
in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
Accelerated Filer &#9744;   Accelerated Filer &#9744;   <span id="xdx_908_edei--EntityFilerCategory_c20210101__20211231_zwgLIgB77kYf"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated Filer</ix:nonNumeric></span> &#9746;  Smaller reporting company <span id="xdx_909_edei--EntitySmallBusiness_c20210101__20211231_zubvdOKJtgo5"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; <span id="xdx_904_edei--EntityShellCompany_c20210101__20211231_zmOCqVzc4A8c"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span>
&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth Company <span id="xdx_909_edei--EntityEmergingGrowthCompany_c20210101__20211231_z3Rib1z9FVxd"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_908_edei--EntityExTransitionPeriod_c20210101__20211231_zLNfbPnJyHaf"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of the Company&#8217;s common stock held by non-affiliates computed by reference to the closing bid price of the
Company&#8217;s common stock, as of the last business day of the registrant&#8217;s most recently completed second fiscal quarter:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">$<span id="xdx_908_edei--EntityPublicFloat_iI_pdp0_c20210630_zFiHdzC4zTQ6"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">914,950,575</ix:nonFraction></span></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
    at March 23, 2022</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, $0.0001 par value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityCommonStockSharesOutstanding_iI_pid_c20220323_z23xrlbxpAD"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-03-23" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">75,452,012</ix:nonFraction></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
10-K</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the Fiscal Year Ended December 31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Index</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
    #</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">PART I</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">Business</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_032">Risk Factors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">Unresolved Staff Comments</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">Properties</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">Legal Proceedings</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">Mine Safety Disclosure</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">PART II</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009">Selected Financial Data</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011">Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012">Financial Statements and Supplementary Data</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014">Controls and Procedures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_015">Other Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016">PART III</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    10.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017">Directors, Executive Officers and Corporate Governance</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    11.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018">Executive Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    12.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    13.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020">Certain Relationships and Related Transactions, and Director Independence</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    14.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021">Principal Accounting Fees and Services</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022">PART IV</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    15.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_023">Exhibits, Financial Statement Schedules</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024">SIGNATURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
Annual Report on Form 10-K contains forward-looking statements. These forward-looking statements are not historical facts but rather
are based on current expectations, estimates and projections. We may use words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221;
&#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;foresee,&#8221; &#8220;estimate&#8221; and variations of these
words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are
subject to certain risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict and could cause
actual results to differ materially from those expressed or forecasted. These risks and uncertainties include the following:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
    availability and adequacy of our cash flow to meet our requirements;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Economic,
    competitive, demographic, business and other conditions in our local and regional markets;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes
    or developments in laws, regulations or taxes in our industry;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Actions
    taken or omitted to be taken by third parties including our suppliers and competitors, as well as legislative, regulatory, judicial
    and other governmental authorities;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Competition
    in our industry;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
    loss of or failure to obtain any license or permit necessary or desirable in the operation of our business;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes
    in our business strategy, capital improvements or development plans;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
    availability of additional capital to support capital improvements and development; and</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
    risks identified in this report and in our other filings with the Securities and Exchange Commission or the SEC.</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
report should be read completely and with the understanding that actual future results may be materially different from what we expect.
The forward-looking statements included in this report are made as of the date of this report and should be evaluated with consideration
of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change
in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events
or otherwise.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Defined Terms</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise indicated by the context, references in this Report to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our,&#8221; &#8220;Agape&#8221; are references to Agape ATP
    Corporation, a Nevada corporation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Common
    Stock&#8221; refers to the common stock, par value $0.0001, of the Company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Malaysia&#8221;
    is Malaysia;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;U.S.
    dollar,&#8221; &#8220;$&#8221; and &#8220;US$&#8221; refer to the legal currency of the United States;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RM&#8221;
    and &#8220;Ringgit&#8221; are to the legal currency of Malaysia;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Securities
    Act&#8221; refers to the Securities Act of 1933, as amended; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Exchange
    Act&#8221; refers to the Securities Exchange Act of 1934, as amended.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="a_001"></span>PART
I</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>ITEM
1. BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
ORGANIZATION AND BUSINESS BACKGROUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation, a Nevada corporation (&#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on June 1, 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape
Superior Living Sdn. Bhd. (&#8220;ASL&#8221;), a company incorporated in Malaysia. .</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd.,
a network marketing entity incorporated in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (&#8220;WATP&#8221;), a wholly owned subsidiary
under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services
that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (&#8220;DSY Wellness&#8221;)
with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing
complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to
supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation,
anti-aging and products designed to improve the overall health system of the human body and various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements reflect the activities of the Company, AATP LB, AATP HK, WATP, ASL and its variable interest
entity (&#8220;VIE&#8221;), Agape S.E.A. Sdn. Bhd. (&#8220;SEA&#8221;) (See Note 3), and DSY Wellness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the Company&#8217;s subsidiaries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subsidiary
    company name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place
    and date of incorporation</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Particulars
    of issued capital</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
    activities</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proportional
    of ownership interest and voting power held</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
    ATP Corporation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labuan,
    <br />
    March 6, 2017</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
    shares of ordinary share of US$1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    holding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
    ATP International Holding Limited</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong,<br />
    June 1, 2017</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000
    shares of ordinary share of HK$1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wholesaling
    of health and wellness products; and health solution advisory services</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
    Superior Living Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malaysia,
    <br />
    August 8, 2003</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,590,598
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    and wellness products and health solution advisory services via network marketing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.99</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
    S.E.A. Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malaysia,
    <br />
    March 4, 2004</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE
    of Agape Superior Living Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wellness
    ATP International Holdings Sdn, Bhd</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malaysia,
    <br />
    September 11, 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events
    and campaigns</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSY
    Wellness International Sdn Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malaysia,
    <br />
    November 11, 2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision
    of complementary health therapies</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company
primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#8220;ATP Zeta Health Program&#8221;,
which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy
lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of
modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to strengthen the Company&#8217;s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99% of ASL,
with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years.
ASL has been offering the Company&#8217;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy
in the Company&#8217;s operation by boosting the Company&#8217;s retail and marketing capabilities. The newly acquired subsidiary allows
the Company to fulfill its mission of &#8220;helping people to create health and wealth&#8221; by providing a financially rewarding business
opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via
ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#201;NERG&#201;TIQUE
and BEAUNIQUE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused
by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity
through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and
distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&#201;NERG&#201;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series
is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
BEAUNIQUE product series focuses on the research of our diet&#8217;s impact on modifying gene expressions in order to address genetic
variations and deliver a nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution
advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various
wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">To
further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity,
DSY Wellness International Sdn. Bhd. (&#8220;DSY Wellness&#8221;) with an independent third party which Agape ATP Corporation (Labuan)
owns 60% of the equity interest, to pursue the business of providing complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Products</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">ATP1s
Survivor Select</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATP1s
Survivor Select contains various essential nutrients required by the human body to maintain the normal metabolism, which includes productions
of biological energy (ATP). Effective production of ATP enhances both physical as well as mental health, and helps the body to build
up resistance to diseases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_001.jpg" alt="" style="height: 175pt; width: 121.4pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stimulate
    instant bio-energy production at the cellular level to ensure sufficient supply of bio energy for body cell.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promote
    better metabolism at the cellular level.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promote
    healthy and optimal growth of bones system, teeth structure and muscle tissue of children.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improve
    the digestion and nutrient absorption powers of body cell.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promote
    cell detoxification and repair capabilities in order to enhance cell self-healing ability.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">ATP2
Energized Mineral Concentrate</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ATP2 is a nutritional supplement made from the finest plant substances and also is a proprietary formulation of a super-energized colloidal
concentrate developed from a dibase solution. Its formula supports and enhances nutritional biochemical activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_002.jpg" alt="" style="height: 175.2pt; width: 77.65pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
    and enhance nutritional biochemical activities (nutrient absorption and waste metabolism). </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Break
    down or oxidised toxins and waste material to promote cellular detoxification and improve blood circulation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    cellular respiration and energy production to reduce fatigue and maintain energy level.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    oxygen level in body cells to create a high oxygen environment in the body, which possibly help to prevent the growth of harmful
    pathogens that contribute to diseases.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
    sufficient antioxidants that act as a superior scavenger of free radicals, to strengthen the body cells resistance against oxidative
    damages.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">ATP3
Ionized Cal-Mag</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATP3
Ionized Cal-Mag is a specialized calcium and magnesium minerals supplement that is designed to transform into ionic form completely before
entering the body. This is compatible to the cellular ion channel theory, that all cellular metabolisms are dependent on ionic transmission
to achieve the highest absorption rate. This product was tested for its nanoparticle by the National Measurement Institute of Australian
Government, with proven content of nanosized calcium and magnesium that has better absorption and bio-availability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_003.jpg" alt="" style="height: 175pt; width: 97.1pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strengthen
    the bone system and promote better bone development.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strengthen
    the teeth structure and prevent teeth damages.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
    abundant of ionic calcium and magnesium to prevent chronic diseases through better blood circulation and acid-base regulation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promote
    better relaxing of nervous system and regulations of neurotransmitters which helps to enhance sleep quality.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promote
    better relaxing of muscle to prevent muscle soreness and cramps.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">ATP4
Omega Blend</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATP4
Omega Blend is a proprietary oil blend that is rich in undamaged polyunsaturated essential fatty acid, which is fully extracted from
plant-based ingredients. It provides a bio-effective balance of both essential fatty acids, Omega 3 and Omega 6 which are the important
structural components of cell membranes that cannot be synthesized by humans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_004.jpg" alt="" style="height: 192.2pt; width: 84.75pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulate
    cholesterol and triglycerides levels to promote better blood circulation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulate
    inflammation, the unifying component of many diseases, and enhance cell repairing activities. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulate
    hormones production and functions in the body through supplies of the balanced ratio of Omega 3 and Omega 6.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promote
    healthy functioning of the brain through the maintenance of healthy impulse transmission in brain cells that is crucial for memory
    and learning ability.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">ATP5
BetaMaxx</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATP5
BetaMaxx is derived from the cell wall of premium food-grade baker&#8217;s yeast and is a medical breakthrough result of more than 50
years of intensive research and studies by scientists and physicians. This product combines the immunostimulatory properties of perfectly
molecularly structured beta 1-3, 1-6-D-glucan with other immunomodulating compounds that work in perfect synergy to make ATP5 a unique
and effective natural product. It is a 100% natural immune enhancer, safe and does not cause any allergic reactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_005.jpg" alt="" style="height: 195.9pt; width: 101.3pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strengthen
    the function of immune cells to build up a better immune response of body for external and internal protections</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promote
    better cell repairing and regulate inflammatory responses in wound healing. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhance
    the function of immune cell against damages caused by radiation. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Helps
    to normalize blood sugar levels. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">AGN-Vege
Fruit Fiber</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGN-Vege
Fruit Fiber is the special nutrition-based formula for intestines and stomach. It consists of four most essential components for gastrointestinal
health effects such as fiber, probiotic the &#8220;friendly bacteria&#8221;, prebiotic fructooligosaccharides (FOS) as well as digestive
enzymes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_006.jpg" alt="" style="height: 203.45pt; width: 136.45pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promote
    better bowel movement and prevent low-fiber diet-induced constipation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintain
    bowel health. FOS helps increase intestinal bifidobacteria and helps maintain a good intestinal environment.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slow
    the absorption of sugar and lipid into the bloodstream which helps improve blood sugar and cholesterol level.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Induce
    better satiety, which results in reduced total food intake and helps in achieving an ideal weight management.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">AGP1-Iron</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGP1-Iron
is the purest and most advanced Colloidal Iron that is sourced from the remains of an ancient rainforest which contains the most active
plant-based element from nature. The colloidal nanosized iron provides high zeta potential promotes better absorptivity and cellular
iron uptake through the ion channel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_007.jpg" alt="" style="height: 190.9pt; width: 86.25pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promote
    better hemoglobin production to improve iron deficiency anemia.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iron
    is a component of hemoglobin in red blood cell which carries oxygen to all part of the body. Therefore, it helps to improve blood
    circulation and prevent some oxygen deficiency symptoms through enhancement of oxygen delivery and nutrient circulation as well as
    toxins excretion.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iron
    is a factor in red blood cell formation. It promotes hemoglobin production hence is suitable especially for women and individual
    who experienced accidental bleedings.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">YFA-Young
Formula</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">YFA-Young
Formula is a 100% natural unique formula, a combination of amino acid, vitamins, and minerals and is the best anti-aging and youthful
maintenance supplement. It stimulates the pituitary gland to release endocrine hormones such as human growth hormone (HGH) to stimulate
synergies thus achieving the efficacy of anti-ageing through the promotion of cells vitality and strengthening of organ function.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_008.jpg" alt="" style="height: 195.9pt; width: 177.5pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhance
    the production of bio-energy ATP and metabolism, which aids in reducing body fat accumulation and promote strong muscles building.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stimulate
    the production of collagen to restore skin elasticity and reduce wrinkles.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduce
    pigmentation and dark spots on face caused by hormonal imbalances.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HGH
    builds and repairs tissues and thus has an effect on hair cells at the hair root to promote healthy hair growth. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhance
    memory and cardiovascular function and prevent various chronic diseases due to HGH deficiency.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BEAUNIQUE
Mito+</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
BEAUNIQUE Mito+ is a strong antioxidant drink with great flavor and taste. The preeminence of BEAUNIQUE Mito+ is its ability to further
protect and stimulate mitochondria (the powerhouse of cells) in cellular energy (ATP) production with the added advantage of less total
sugars and calories. The formula comprises 11 Superfood including potent mangosteen skin extract. Backed by advanced scientific research
and tested on 88 nutrigenomic profile, the formulation revealed enhanced antioxidant properties. 96.34% DPPH Radical Scavenging activity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_009.jpg" alt="" style="height: 226.75pt; width: 63.5pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
Promotes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cellular
    health</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    antioxidants to protect from cellular oxidative damages.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Immune
    health</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhance
    adaptive immune response.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anti-inflammatory.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strengthen
    immunity against bacteria and viruses.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Metabolic
    health</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduce
    risk of obesity.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduce
    risk of vascular diseases.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduce
    risk of Type II Diabetic.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Brain
    health</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduce
    risk of neurodegenerative diseases.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Skin
    health</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Systemic
    photoprotection.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduce
    dark spot formation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alleviates
    skin wrinkle and inflammation induced by UV-B irradiation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">ORYC-Organic
Youth Care Cleansing Bar</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ORYC-Organic
Youth Care Cleansing Bar is a natural, organic cleansing soap for skin. It contains pure Australian-accredited natural and organic plant
oils acting as a high quality and natural skin lubricant. It maintains the softness of the skin while promoting skin beauty and radiance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_010.jpg" alt="" style="height: 179.4pt; width: 248.55pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
    its biodynamic avocado oil and vanilla extract, remove impurities, leaving skin clear, fresh and clean.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
    its biodynamic, coconut, almond and olive oil, moisturize and texturize the skin to prevent skin drying.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    acting as natural anti-bacterial and anti-inflammatory agents, reduce the risks of skin infections and allergies. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*References
alluding to the efficacy and effects of our products are based on client testimonials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Beauty
Products</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ENERGETIQUE series aim to provide a total dermal solution for a healthy skin beginning from the cellular level. The series
is comprised of Energy Mask, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ENERGY
MASK SERIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Energetique Mask Series is formulated with triple action natural ingredients and advanced technologies. The innovative
combination of award-winning patented liposome encapsulating the customized fast acting patented essence, produces micro-particle liposome
which, combined with collagen peptide Tencel film, creates an effective formulation that benefits the skin at the cellular level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are three types of face masks in the Energetique Mask Series, each to suit a different skin requirement. They are: N&#176;1 Med-Hydration;
N&#176;2 Med-Whitening; N&#176;3 Med-Firming. Advanced genetic analysis and clinical trials conducted revealed the benefits and efficacies
of the patented functional essence. The Energetique Mask Series has clinically shown deep penetration of liposomal essence into deep
skin layers within 5 minutes of the application to deliver immediate, deep-reaching and long-lasting benefit of skin hydration, whitening,
and firming.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>N&#176;1
Med-Hydration</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formulated
with the patented Sea Grape (Caulerpa lentillifera) extract, the <span style="background-color: white"><b>N&#176;1 Med-Hydration </b></span>enhances
skin moisture and luminosity. This treatment effectively improves the moisture content of the inner skin layer and rejuvenate the skin
barrier function to avoid moisture loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_011.jpg" alt="" style="height: 190.2pt; width: 144.3pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">locking
    the skin moisture and nutrients, strengthening the skin barrier function and boosting the skin&#8217;s moisture level.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    increase the skin&#8217;s natural moisturizing factor (PCA) and skin layer glycoprotein connectivity to maintain the skin&#8217;s
    moisture.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    effectively retain water, provides moisturization, restores skin elasticity, and promotes the growth of fibroblasts for moisturization,
    removes dryness, regains skin&#8217;s elasticity and smoothness.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">immensely
    in delivering an instant boost of skin moisture content up to 45.7% in just 5 minutes of application and synergistically ensuring
    a profound and long-lasting skin moisturization and hydration.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N&#176;2
Med-Whitening</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formulated
with patented Peach Blossom Stem Cell Extract, the <b>N&#176;2 Med-Whitening</b> has clinically shown its efficacy in inhibiting the melanin
synthesis, down-regulating the melanin synthesis gene, boosting skin moisture level and protecting skin against UV radiation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_012.jpg" alt="" style="height: 229.6pt; width: 166.7pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    suppressing melanin production and fight against UV radiation to protect skin cells and result in whitening effect.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    stimulate interstitial hyperplasia cell and helps in increasing the moisturizing ceramide by 7.4 times in order to remove skin roughness
    and smoothing skin.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    enhance the skin brightness up to 6.3% in just 5 minutes of application and synergistically rejuvenate a profound and long-lasting
    skin ability in anti-UV damage.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>N&#176;3
Med-Firming</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formulated
with the patented Djulis (Chenopodium formosanum Koidz) Seed Extract, the native cereal plant in Taiwan and traditionally called &#8220;ruby
of cereals.&#8221; The formulation is clinically proven to be effective in stimulation of collagen secretion and anti-advances glycation
end-products (AGEs) reducing the glycation of skin collagen, provide protection and maintenance of the basal skin collagen production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_013.jpg" alt="" style="height: 207.5pt; width: 165pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    suppress the skin collagen glycation process, reduces collagen loss, and enhancing collagen secretion.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">repairing
    the dead skin tissue, smooth wrinkles to restore the smoothness and health of the skin.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preventing
    wrinkles formation and providing the essential skin moisture content.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    boost skin elasticity by up to 14.4%. and improve sagging skin by 135 in just 5 minutes of application.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#201;NERG&#201;TIQUE
Hyaluronic Acid (HA) Serum</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Formulated
with four functional hyaluronic acid and a unique peptide, this scientifically advanced and intensive quintuple action serum proven to
deliver 5Rs dermal benefits. Filled in an innovative yet convenient and hygienics syringe packaging, this HA serum also ensure consumer-perceivable
benefits for every skin type.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_014.jpg" alt="" style="height: 215.7pt; width: 259.65pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REBALANCE
    - Hydrate the skin surface by forming a protection layer and keep skin moisturized even after cleansing</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECOVER
    &#8211; Repair the out-balanced lamellar layer to act as barrier to prevent skin moisture from evaporation</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGENERATE
    - Promote the production of Type I pro-collagen and boost skin&#8217;s own production of Hyaluronic Acid up to 3 times</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REHYDRATE
    - Nano-sized particles with high capacity of water-holding allow deep penetration and bestows moisture from inside the skin. Long-lasting
    moisture retention up to 72 hours</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REMODELLING
    - Proven to increase skin firmness +200% (cheek, under-eye and neck). Enhance skin viscoelasticity to improves skin roughness</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#201;NERG&#201;TIQUE
Mousse Facial Cleanser</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Formulated
with the mildest surface-active agents available on the market, this facial cleanser was designed to deliver a distinct A to E cleansing
benefits to consumers. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unique mousse like-foam delivers
a comfortable and soft feeling of the skin during and after use without compromising the moisturizing level <span style="background-color: white">and
viscoelastic properties of the skin.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_015.jpg" alt="" style="height: 207.8pt; width: 197.85pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
    Skin Type</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hypoallergenic</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-comedogenic</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pH-balanced
    formula with buffer capacity at pH 5.5 of the skin.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Comfortable</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mild
    to skin and eyes without irritating or drying your skin</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comfortable
    and soft feeling <b>&#8211; </b>prolonged comfortable to skin before and after use. Accidental consuming would not be harmful to
    your body.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dense</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mousse-like
    foam very fine porous foam and smooth skin-feel during use</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effortlessly</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Easily
    remove light makeup, dirt and impurities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Easy
    to rinse with no residual.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Unique
Characteristics via Nutrigenomic</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s BEAUNIQUE product series focuses on the research of diet&#8217;s impact on modifying gene expressions to address genetic
variations and deliver a personalized nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trim+:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trim+
is the first product launched under this series, utilizes the advanced technology to extract the patented active ingredients in foods.
Trim+ has scientifically proven to be effective in inhibiting the activities of carbohydrates digestive enzymes, which results in a reduction
of the breakdown and absorption of sugars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_016.jpg" alt="" style="height: 251.15pt; width: 261.05pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduce
    total carbohydrates calories intake with the scientifically proven effect on weight management.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulate
    blood sugar levels with scientifically proven efficacy.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improve
    cellular uptake of sugars for bioenergy ATP production. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintain
    insulin hormone balance, helps prevent diabetes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improve
    blood lipids composition, helps prevent cardiovascular disease.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Future
Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at the date of this report, the number of COVID-19 cases have hit over 447 million worldwide with approximately 6.0 million lives lost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
has been approximately 2 years since the declaration of the COVID-19 pandemic, the lethargy brought about by the pandemic to the world
populace, countries and governments is immense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of March 2022, Malaysia stands at position 26 as the country with the highest COVID-19 cases as recorded under the coronavirus statistics
of the &#8220;worldometer&#8221;. Total COVID-19 cases in Malaysia hit approximately 3.6 million and associated fatality of 33, 228.
These figures are huge relative to the small size economy of the country. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are witnessing the adverse impact on <span style="background-color: white">the purchasing power of consumers in Malaysia</span>, where
our products are mainly sold as a direct result of the prolonged pandemic. Revenue of ASL, our subsidiary that is principally involved
in network marketing decreased significantly <span style="background-color: white">for the year ended December 31, 2021 as compared to
the same period in 2020</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
immediate plans will be: (i) to bring the operational activities of ASL to pre-pandemic levels, to record higher revenue and profits.
As businesses continues to be digitized, we will further capitalize on the e-commerce trading platform provided by Vettons Sdn. Bhd.
to perform e-marketing and e-trading of our products to members, as well as online e-recruitment of new members; and (ii) to activate
WATP whose principal activity is in promoting wellness and wellbeing lifestyle of the community by providing services that includes online
editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle. We will focus on developing customer centric
programs, prioritizing high level engagements for a speedier and more tangible outcome.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (&#8220;DSY Wellness&#8221;)
with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing
complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The establishment of
DSY Wellness is a further expansion of our business into the health and wellness industry. The <span style="background-color: white">independent
third party readily owns 33 proprietary formulas for treating non-communicable disease which he has agreed to bring into the company
for joint commercialization. </span>The <span style="background-color: white">independent third party also has existing clients receiving
traditional complimentary medicine or &#8220;TCM&#8221; in Indonesia and Thailand. </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the COVID-19 pandemic subsists, we will concentrate our resources in developing our businesses in Malaysia where most of our activities
are concentrated. DSY Wellness will expand its businesses in the state of Penang and Johor in the short term. At time opportune, when
the pandemic has subsided or is over and restrictions on travelling between nations are uplifted, service centers will be set up in Indonesia
and Thailand. Together with ASL and WATP, this has the potential for the development of wellness tourism. As the products and services
offerings of the Company widens beyond the sale of health products via network marketing, any overseas expansion could generate multiplier
effect to the Company&#8217;s income and profitability, which the Company will capitalize. It is the Company&#8217;s ultimate aim to
partake in all the lucrative areas of the health and wellness ecosystem as far as possible, to carve a niche in the health and wellness
industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Marketing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
on information technology, we will continue to build our brand image to create brand awareness to penetrate the marketplace and attract
customers. For the Company&#8217;s network marketing business, we have a corporate website which introduces and promotes our products
and services, enable e-trading and e-recruitment of members. Going forward, we will use our corporate website more extensively to market
all our products and services. We will utilize marketing related search engines to attract potential clients to our website. In financial
year 2020, we have also synched-up with Vettons Sdn. Bhd, an e-merchant to further our reach through e-commerce. <span style="background-color: white">On
February 1, 2021, </span>Mr. How Kok Choong, the CEO and director of the Company, was appointed as the non-executive Chairman of <span style="background-color: white">Vettons
Sdn Bhd. Vettons Sdn. Bhd became our related party since then.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we will explore other online methods to enhance brand awareness that are impactful for community building for our other ventures in the
health and wellness industry such as referral programs, develop contents for guest publishing, social media contests, etc. We will be
social focus in the selection of social networks for our social media marketing, and where appropriate infographics will be used and
influence marketing will be employed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the incorporation of DSY Wellness, much cross-selling and up-selling will be deployed for a more comprehensive products and services
offerings to our customers. As discussed above, the multiplier effect of a wide products and services offerings to the Company&#8217;s
revenue stream and bottom line is huge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
health and wellness industry, with a focus on health supplements in particular in Malaysia, where we operate, is rather competitive.
Our focus is on the mature group of customers, i.e. adults ranging in age from 18-65 years old. We face competition from various retail
health supplement providers, pharmacies, and Multi-Level Marketing Companies which supply health supplement products, such as Bio-Life
Marketing Sdn Bhd, Elken Group, Usana Group, BMS Organics, NHF Group and their respective affiliates. These competitors are generating
significant traffic to their marketing websites; and have established brand recognition and financial resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the principal competitive factors in our type of market include the quality of health supplements, the efficacies of the
health supplements, strength and depth of relationships with clients, the ability to identify the changing needs and requirements of
prospective clients, and the scope of services. Through utilizing our competitive strengths, we believe that we have a competitive edge
over other competitors due to the breadth of our product offerings, one stop convenience, pricing, our services, our reputation and product
safety. As discussed, the prolonged pandemic has eroded much of the purchasing power of the Malaysian community. The last year has seen
consumers shifting to more affordable goods and services. As nations start to accept COVID-19 as endemic, we will target our resources
to regain our operational activities to pre-pandemic level. Next, we will develop and enlarge our market share in the Malaysian market
and potentially further into the overseas market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s latest investment in TCM is comparatively a less competitive health and wellness segment, especially at a time when non-communicable
disease is on the rise. The independent third party whom we joint venture with is an accredited practitioner in TCM in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customer base from our network marketing sales channel stood at 128,235 members as at December 31, 2021. We will rework our product-mix
and pricing to help our distributors and members to strengthen and widen their sales network. We will also capitalize the existing customer
base to build the wellness and wellbeing lifestyle community to enhance WATP&#8217;s business, and for our TCM products and services
offerings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the number of employees by function as of the date of this annual report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Function</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>employees</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Senior Management</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">3</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Business Development Department</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Corporate Affairs Department</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Finance Department</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Human Resources Department</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operations Department</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Product Development Department</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Sales &amp; Marketing Department</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">36</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, our products are predominately sold in Malaysia. As the contents and combination of the main ingredients in our ATP Zeta Health
Program and BEAUNIQUE series are categorized as health food rather than medicines or drugs, all of our products require authorization
from the Food Safety and Quality Division of the Ministry of Health, Malaysia according to the Food Act 1983 (ACT 281) &amp; Regulations
in order to be sold in the country. Accordingly, we have obtained the appropriate authorizations from the Food Safety and Quality Division
of the Ministry of Health, Malaysia for all products in our ATP Zeta Health Program and BEAUNIQUE series.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
&#201;NERG&#201;TIQUE series is regulated under the Control of Drugs and Cosmetics Regulations 1984, the Ministry of Health, Malaysia.
We have also obtained the appropriate authorizations for distribution and sale of the products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_032"></span>ITEM
1A. RISK FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
are exposed to concentration risk of heavy reliance on our major supplier for the supply of our products, and any shortage of, or delay
in, the supply may significantly impact on our business and results of operation.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2021, we purchased $28,969 and $27,707 from two of our major suppliers, represented approximately 47.3% and
45.2%, respectively, of our total purchases. Our business, financial condition and operating results depend on the continuous supply
of products from our major suppliers and our continuous supplier-customer relationships with them. Our heavy reliance on our major suppliers
for the supply of our products will have significant impact on our business and results of operation in the event of any shortage of,
or delay in the supply.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
is customary in distribution arrangements of this type, the distribution agreement with our major suppliers are terminable by either
party by giving notice. There is no assurance that our major suppliers will not terminate the distribution agreement. In the event that
they terminate the distribution agreements, we will have to source products from other suppliers and we may not be able to secure supply
of products with quantity and quality required to support our business or at all. Such termination may therefore have a material adverse
impact on our business, financial condition and operating results if we fail to engage any other suppliers before the termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no assurance that our major suppliers will continue to supply their products in the quantities and timeframes required by us to meet
the needs of our customers or comply with their supply agreements with us. Our product supply may also be disrupted by potential labor
disputes, strike action, natural disasters or other accidents, epidemic and pandemic affecting the supplier. If our major suppliers do
not supply products to us in a timely manner or in sufficient quantities, our business, financial condition and operating results may
be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
in the event of any delay in delivery of the products to us, our cash flow or working capital may be materially and adversely affected
as a result of the corresponding delay in delivery of our products to our customers, and hence the delay in our receipt of payment from
our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
major suppliers may change their existing sales or marketing strategy in respect of the products supplied to us by changing their export
strategy, reducing its sales or production volume or changing its selling prices. Consequently, there are no assurances that our major
suppliers will not appoint other dealers or distributors which may compete with us in the market where we operate. Furthermore, any significant
increase in the selling prices of the products which we source from our suppliers will increase our costs and may adversely affect our
profit margin if we are not able to pass the increased costs on to our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no assurances that there will be no deterioration in our relationships with our major suppliers which could affect our ability to
secure sufficient supply of products for our business. In the event that our major suppliers change their sales or marketing strategy
or otherwise appoint other dealers or distributors who may compete with us, our business, financial condition and operating results may
be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
could be adversely affected by a change in consumer preferences, perception and spending habits and failure to develop or enrich our
product offering or gain market acceptance of our new products could have a negative effect on our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market we operate is subject to changes in consumer preference, perception and spending habits. Our performance depends significantly
on factors which may affect the level and pattern of consumer spending in the market we operate. Such factors include consumer preference,
consumer confidence, consumer income and consumer perception of the safety and quality of our products. Media coverage regarding the
safety or quality of, or diet or health issues relating to, our products or the raw materials, ingredients or processes involved in their
manufacturing, may damage consumer confidence in our products. A general decline in the consumption of our products could occur as a
result of change in consumer preference, perception and spending habits at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure to adapt our product offering to respond to such changes may result in a decrease in our sales if such changes are related to
certain of our products. Any changes in consumer preference could result in lower sales of our products, put pressure on pricing or lead
to increased levels of selling and promotional expenses. In any event a decrease in customer demand on our products may also result in
lower sales and slow down the consumption of our inventory to a low inventory turnover level. Any of these changes could result in a
material adverse effect on our business, financial conditions or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of our products depends on a number of factors including our ability to accurately anticipate changes in market demand and consumer
preferences, our ability to differentiate the quality of our products from those of our competitors, and the effectiveness of our marketing
and advertising campaigns for our products. We may not be successful in identifying trends in consumer preferences and developing products
that respond to such trends in a timely manner. We also may not be able to effectively promote our products by our marketing and advertising
campaigns and gain market acceptance. If our products fail to gain market acceptance, are restricted by regulatory requirements, or have
quality problems, we may not be able to fully recover our costs and expenses incurred in our operation, and our business prospects, financial
condition or results of operations may be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we fail to maintain quality products and value, our sales are likely to be negatively affected.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends on the safety and quality of products that we obtain from our suppliers for our customers. Our future customers will
identify our brand name with a certain level of quality and value. If we cannot meet this perceived value or level of quality, we may
be negatively affected and our operating results may suffer. In addition, any failure on the part of our suppliers to maintain the quality
of their products, will in turn substantially harm the results of our business operations, potentially forcing us to identify other suppliers
or alter our business strategy significantly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we are unable to create brand influence, we may not be able to maintain current or attract new users and customers for our products.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operational and financial performance is highly dependent on the strength of our brand. We believe brand familiarity and preference will
continue to have a significant role in winning customers as the decision to buy our products and services. In order to further expand
our customer base, we may need to substantially increase our marketing expenditures to enhance brand awareness through various online
and offline means. Moreover, negative coverage in the media of our company could threaten the perception of our brand, and we cannot
assure you that we will be able to defuse negative press coverage about our company to the satisfaction of our investors, customers and
suppliers. If we are unable to defuse negative press coverage about our company, our brand may suffer in the marketplace, our operational
and financial performance may be negatively impacted and the price of our shares may decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
we sell our products, with or without customization, under our brand name &#8220;ATP&#8221;, to domestic customers in Malaysia and to
overseas customers. However, if our competitors initiate a lawsuit against us for infringing their trademark, we may be forced to adopt
a new brand name for our products. As a result, we may incur additional marketing cost to raise awareness of such new brand name. We
may also be ordered to pay a significant amount of damages, and our business, results of operations and financial condition could be
materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may incur losses resulting from product liability claims or product recalls.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may incur losses resulting from product liability claims with respect to our products supplied by our supplier. We may face claims or
liabilities which may arise if there exist any defects in quality of these products or any of these products are deemed or proven to
be unsafe, defective or contaminated. In the event that the use or misuse of any product distributed by us results in personal injury
or death, product liability and/or indemnity claims may be brought against us, in addition to our product recalls, and the relevant regulatory
authorities in the market we operate may close down some of our related operations and take administrative actions against us. If we
experience any business disruption and litigation, we may incur additional costs and have to divert our management&#8217;s attention
and resources on such matters, which may adversely affect our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
operate in a heavily regulated industry.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is principally regulated by various laws and regulations in the market we operate, such as in Malaysia the Food Act of 1983
(Act 281) and Regulations, Control of Drugs and Cosmetics Regulations 1984 mandate authorization from the Food Safety and Quality Division
and National Pharmaceutical Regulatory Agency of the Ministry of Health for our Company&#8217;s products to be sold in the country. Various
registrations, certificates and/or licenses for the conduct of our business are required under the above laws, which also contain provisions
for requirements on the storage, labelling, advertising and importation of some of our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on our experience, some of the laws and regulations of the place where we operate our business are subject to amendments, uncertainty
in interpretation and administrative actions from time to time. Therefore, we cannot assure you that, for the implementation of our business
plans and the introduction of any new product, we will be able to obtain all the necessary registrations, certificates and/or licenses.
Any failure to comply with the above laws and regulations may give rise to fines, administrative penalties and/or prosecution against
us, which may adversely affect our reputation, financial condition or results of operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being disseminated
to the public.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over our financial reporting. As defined in Exchange
Act Rule 13a-15(f), internal control over financial reporting is a process designed by, or under the supervision of, the principal executive
and principal financial officer and effected by the board of directors, management and other personnel, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles and includes those policies and procedures that: pertain to the maintenance of records in reasonable
detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; provide reasonable assurance that
transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and/or
directors of the Company; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use
or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the audit of our consolidated financial statements as of December 31, 2021, we and our independent registered public
accounting firms identified six &#8220;material weaknesses&#8221;, and other control deficiencies including significant deficiencies
in our internal control over financial reporting. A &#8220;material weakness&#8221; is a deficiency, or a combination of deficiencies,
in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s
annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses identified related
to the Company were: (i) insufficient full-time personnel with appropriate levels of accounting knowledge and experience to monitor the
daily recording of transactions, address complex U.S. GAAP accounting issues and to prepare and review financial statements and related
disclosures under U.S. GAAP; (ii) lack of a functional internal audit department or personnel that monitors the consistencies of the
preventive internal control procedures and lack of adequate policies and procedures in internal audit function to ensure that the Company&#8217;s
policies and procedures have been carried out as planned; (iii) lack of adequate segregation of duties and effective risk assessment,
which in turn may cause the Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect
errors; (iv) we lack of proper procedures developed for system change management policies. Change management policies and procedures
have not been developed. Critical change management control processes and procedures, such as change request and approval, periodic status
reporting, user testing and acceptance, post-implementation review, etc., were either not performed or formally documented; (v) we lack
of the following internal control procedures in relation of Third-Party (Service Organization) Vendor Management &#8211; (a) service
evaluation and qualification assessment of third-party vendors were not performed for the year ended December 31, 2021 and (b) Management
was not able to provide evidence of their review of their service providers&#8217; SOC 1 and SOC 2, or ISO 27001 certificate reports
and therefore unable to provide evidence of their review of the physical security and environmental controls in place at IP Serverone
cloud server (which the Company&#8217;s financial system is hosted on; (vi) we lack of the following internal control procedures in relation
of User Account Management &#8211; (a) Evidence relating to the authorization of database administrator user accounts and access was
not preserved for the MLM System during the year ended December 31, 2021 and (b) Evidence relating to periodic recertification of MLM
and SQL Finance System end user are privileged accounts and related access rights were preserved during the year ended December 31, 2021;
(vii) we lack of the following internal control procedures in relation of Audit Logs and Segregation of Duty (&#8220;SOD&#8221;) Management
&#8211; (a) MLM-DB level system/audit logs were not preserved. Procedures for periodic review and analysis of application (&#8220;AP&#8221;),
operating system (&#8220;OS&#8221;), and database (&#8220;DB&#8221;) level audit logs were not established and performed and (b) An SOD
conflict was identified, where administrative rights to AP, OS and DB levels of the MLM system were assigned to the CTO and (viii) we
lack of qualified person to be able to provide the tax provision for the U.S. income taxes in connection with the Subpart F and GILTI
taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have taken measures and plan to continue to take measures to remedy these material weaknesses. The measures that we have taken and are
planning to take which includes, but not limited to, hired a chief financial officer who possesses U.S. GAAP and SEC reporting knowledge
and hiring more qualified accounting personnel with U.S. GAAP experiences. We are also seeking a U.S. tax professional to assist in the
preparation of the Subpart F and GILTI tax provisions. We also intend to form an internal audit function and have plans to hire internal
auditors to strengthen our overall governance. All internal auditors will be independent of our operations and will report directly to
the audit committee. The implementation of these measures may not fully address the material weaknesses in our internal control over
financial reporting, and we cannot conclude that they have been fully remedied. Our failure to correct theses material weaknesses or
our failure to discover and address any other material weaknesses could result in inaccuracies in our financial statements and could
also impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, we will become subject to the Sarbanes-Oxley Act of 2002. Section 404 of the Sarbanes-Oxley Act, or SOX 404, will require
that we include a report from management on the effectiveness of our internal control over financial reporting in our annual report on
Form 10-K and in our quarterly report on Form 10-Q if we are qualified as an accelerated filer. Our management may conclude that our
internal control over financial reporting is not effective. Moreover, even if our management concludes that our internal control over
financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing, may
issue a report that is qualified if it is not satisfied with our internal controls or the level at which our controls are documented,
designed, operated or reviewed, or if it interprets the relevant requirements differently from us. In addition, after we become a public
company, our reporting obligations may place a significant strain on our management, operational and financial resources and systems
for the foreseeable future. We may be unable to timely complete our evaluation testing and any required remediation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the course of documenting and testing our internal control procedures, in order to satisfy the requirements of SOX 404, we may identify
other weaknesses and deficiencies in our internal control over financial reporting. In addition, if we fail to maintain the adequacy
of our internal control over financial reporting, as these standards are modified, supplemented or amended from time to time, we may
not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with SOX 404.
If we fail to achieve and maintain an effective internal control environment, we could suffer material misstatements in our financial
statements and fail to meet our reporting obligations, which would likely cause investors to lose confidence in our reported financial
information. This could in turn limit our access to capital markets, harm our results of operations, and lead to a decline in the trading
price of our shares. Additionally, ineffective internal control over financial reporting could expose us to increased risk of fraud or
misuse of corporate assets and subject us to potential delisting from the stock exchange on which we list, regulatory investigations
and civil or criminal sanctions. We may also be required to restate our financial statements from prior periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
disputes or proceedings could expose us to liability, divert our management&#8217;s attention and negatively impact our reputation.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may at times be involved in potential legal disputes or proceedings during the ordinary course of business operations relating to product
or other types of liability, employees&#8217; claims, labor disputes or contract disputes that could have a material and adverse effect
on our reputation, operation and financial condition. If we become involved in material or protracted legal proceedings or other legal
disputes in the future, the outcome of such proceedings could be uncertain and could result in settlements or outcomes which adversely
affect our financial condition. In addition, any litigation or legal proceedings could incur substantial legal expenses as well as significant
time and attention of our management, diverting their attention from our business and operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we are unable to successfully develop and timely introduce new products or services or enhance existing products or services, our business,
financial condition and results of operations may be materially and adversely affected.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
must continually source, develop and introduce new products and services as well as improve and enhance our existing products and services
to maintain or increase our sales. The success of new or enhanced products or services may depend on a number of factors including, anticipating
and effectively addressing user preferences and demand, the success of our sales and marketing efforts, effective forecasting and management
of products and services demands, purchase commitments, and the quality of or defects in our products. The risk of not meeting our customers&#8217;
preferences and demands through our products and services may result in a shift in market shares, as customers instead choose products
and services offered by our competitors. This may result in lower sales revenue, materially and adversely affecting our business, financial
condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fluctuations
in foreign currency exchange rates could have a material adverse effect on our financial results.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
earn revenues, pay expenses, own assets and incur liabilities in countries using currencies other than the U.S. dollar, including Australian
Dollar, Malaysian Ringgit and the Hong Kong Dollar. Because our consolidated financial statements are presented in U.S. dollars, we must
translate revenues, income and expenses, as well as assets and liabilities, into U.S. dollars at exchange rates in effect during or at
the end of each reporting period. Therefore, increases or decreases in the value of the U.S. dollar against other currencies affect our
net operating revenues, operating income and the value of balance sheet items denominated in foreign currencies. We cannot assure you
that fluctuations in foreign currency exchange rates, particularly the strengthening of the U.S. dollar against major currencies would
not materially affect our financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
business depends on the continued contributions made by Mr. How Kok Choong, as our key executive officer, the loss of who may result
in a severe impediment to our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success is dependent upon the continued contributions made by our CEO and President, Mr. How Kok Choong. We rely on his expertise in
business operations when we are developing our business. We have no &#8220;Key Man&#8221; insurance to cover the resulting losses in
the event that any of our officer or directors should die or resign.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Mr. How Kok Choong cannot serve the Company or is no longer willing to do so, the Company may not be able to find alternatives in a timely
manner or at all. This would likely result in a severe damage to our business operations and would have an adverse material impact on
our financial position and operating results. To continue as a viable operation, the Company may have to recruit and train replacement
personnel at a higher cost. Additionally, if Mr. How Kok Choong joins our competitors or develops similar businesses that are in competition
with our Company, our business may also be negatively impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future success depends on our ability to attract and retain qualified long-term staff to fill management, technology, sales, marketing,
and customer services positions. We have a great need for qualified talent, but we may not be successful in attracting, hiring, developing,
and retaining the talent required for our success.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we are not able to achieve our overall long-term growth objectives, the value of an investment in our Company could be negatively affected.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established and publicly announced certain long-term growth objectives. These objectives were based on, among other things, our
evaluation of our growth prospects, which are generally driven by the sales potential of many product types, some of which are more profitable
than others, and on an assessment of the potential price and product mix. There can be no assurance that we will realize the sales potential
and the price and product mix necessary to achieve our long-term growth objectives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
face risks related to health epidemics, severe weather conditions and other outbreaks.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years, there have been outbreaks of epidemics in various countries, including Malaysia. Recently, there was an outbreak of a novel
strain of coronavirus (COVID-19), which has spread rapidly to many parts of the world, including Malaysia. In March 2020, the World Health
Organization declared the COVID-19 a pandemic. The epidemic has resulted in quarantines, travel restrictions, and the temporary closure
of stores and facilities in Malaysia for prolong periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially,
affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact
to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and
severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact,
almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">t</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">emporary
    closure of offices, travel restrictions, financial impact of our customers or suspension supplies may negatively affected, and could
    continue to negatively affect, the demand for our products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">our
    customer may require additional time to pay us or fail to pay us at all, which could significantly increase the amount of accounts
    receivable and require us to record additional allowances for doubtful accounts. We may have to provide significant sales incentives
    to our sole customer during the outbreak, which may in turn materially adversely affect our financial condition and operating results;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">a</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ny
    disruption of our supply chain, logistics providers or customers could adversely impact our business and results of operations, including
    causing us or our suppliers to cease manufacturing for a period of time or materially delay delivery to our customers, which may
    also lead to loss of our customers; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">t</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
    global stock markets have experienced, and may continue to experience, significant decline from the COVID-19 outbreak and the marketable
    securities that we have invested in could be materially adversely affected, which may lead to significant impairment in the fair
    values of our investments and in turn materially adversely affect our financial condition and operating results.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the coronavirus
cannot be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar level year
over year in the fiscal year 2022. We may have to record downward adjustments or impairment in the fair value of investments in the fiscal
year 2022, if conditions have not been significantly improved and global stock markets have not recovered from recent declines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
general, our business could be adversely affected by the effects of epidemics, including, but not limited to, the COVID-19, avian influenza,
severe acute respiratory syndrome (SARS), the influenza A virus, Ebola virus, severe weather conditions such as flood or hazardous air
pollution, or other outbreaks. In response to an epidemic, severe weather conditions, or other outbreaks, government and other organizations
may adopt regulations and policies that could lead to severe disruption to our daily operations, including temporary closure of our offices
and other facilities. These severe conditions may cause us and/or our partners to make internal adjustments, including but not limited
to, temporarily closing down business, limiting business hours, and setting restrictions on travel and/or visits with clients and partners
for a prolonged period of time. Various impact arising from a severe condition may cause business disruption, resulting in material,
adverse impact to our financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
business and reputation may be affected by product liability claims, litigation, customer complaints, product tampering, food safety
issues, food-borne illnesses, health threats, quality control concerns or adverse publicity relating to our products. Product liability
insurance of our supplier may not cover our liability sufficiently or at all.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Like
other consumer product manufacturers, sale of our products involves an inherent risk of our products being found to be unfit for consumption
or cause illness. Products may be rendered unfit for consumption due to raw materials or product contamination or degeneration, presence
of microbials, illegal tampering of products by unauthorized third parties or other problems arising during the various stages of the
procurement, production, transportation and storage processes. The occurrence of such problems may result in customer complaints, fines,
penalties or adverse publicity causing serious damage to our reputation and brand, as well as product liability claims, other legal disputes
and loss of revenues. Under certain circumstances, we may be required to recall our products. Even if a situation does not necessitate
a product recall, we cannot assure you that product liability claims or other legal disputes will not be asserted against us as a result.
Product liability insurance of our supplier may not cover our liability sufficiently or at all and will not cover liability that arises
out of our default such as mishandling, poor storage condition and/or contamination of the products by us. As a result, a product liability
or other judgment against us, or a product recall, could have a material adverse effect on our business, financial condition or results
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is susceptible to food-borne illnesses. We cannot assure you that we are able to effectively prevent all diseases or illnesses
caused by our products or contamination of our products. Furthermore, our reliance on third-party product suppliers means that food-borne
illness incidents could be caused by our suppliers outside of our control. New illnesses may develop in the future, or diseases with
long incubation periods could arise that could give rise to claims or allegations on a retroactive basis. Reports in the media of instances
of food-borne illnesses or health threats of our products or any of their major ingredients could adversely and significantly affect
our sales, and have significant negative impact on our results of operations. This risk exists even if it were later determined that
the illness or health threat in fact was not caused by our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, adverse publicity about health and safety concerns, whether unfounded or not, may discourage consumers from buying our products.
Even if a product liability claim is unsuccessful or is not fully pursued, the negative publicity surrounding any assertion that our
products caused personal injury or illness could adversely affect our reputation and our corporate and brand image. If consumers were
to lose confidence in our brand and reputation, we could suffer long-term or even permanent declines in our sales and results of operation.
The amount of negative news, customers complaints and claims against us may also be very costly and may divert our management&#8217;s
attention from our business operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Increased
competition and capabilities in the marketplace could hurt our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market where we operate is highly competitive. We compete with other companies that operate in multiple geographic areas, as well as
numerous companies that are primarily regional or local in operation. Our ability to gain or maintain share of sales in the market where
we operate or in various local markets may be limited as a result of actions by competitors. If we do not continue to strengthen our
capabilities in marketing and innovation to maintain our brand loyalty and market share while we selectively expand into other product
categories, our business could be negatively affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
market price of our shares is likely to be highly volatile and subject to wide fluctuations in response to factors such as:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
    in our actual and perceived operating results, especially during this time when the COVID-19 pandemic poses a threat;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">news
    regarding gains or losses of customers or suppliers by us or our competitors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">news
    regarding gains or losses of key personnel by us or our competitors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    of competitive developments, acquisitions or strategic alliances in our industry by us or our competitors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in earnings estimates or buy/sell recommendations by financial analysts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    litigation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    imposition of fines or penalties related to our activities in the market where we operate and failure to comply with applicable rules
    and regulations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    market conditions or other developments affecting us or our industry; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    operating and stock price performance of other companies, other industries and other events or factors beyond our control.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the securities markets have from time-to-time experienced significant price and volume fluctuations that are not related to
the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price
of the shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may never be able to pay dividends and are unlikely to do so.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have not paid, nor do we intend to pay in the foreseeable future, dividends on our common stock, even if we become profitable.
Earnings, if any, are expected to be used to advance our activities and for working capital and general corporate purposes, rather than
to make distributions to stockholders. Since we are not in a financial position to pay dividends on our common stock and future dividends
are not presently being contemplated, investors are advised that return on investment in our common stock is restricted to an appreciation
in the share price. The potential or likelihood of an increase in share price is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under Nevada law, we may only pay dividends subject to our ability to service our debts as they become due and provided that
our assets will exceed our liabilities after the dividend. Our ability to pay dividends will therefore depend on our ability to generate
sufficient profits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholders
may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wherever
possible, our board of directors will attempt to use non-cash consideration to satisfy obligations. In many instances, we believe that
the non-cash consideration will consist of shares of our common stock, warrants to purchase shares of our common stock or other securities.
Our board of directors has authority, without action or vote of the shareholders, to issue all or part of the authorized but unissued
shares of common stock or warrants to purchase such shares of common stock. In addition, we may attempt to raise capital by selling shares
of our common stock, possibly at a discount to market in the future. These actions will result in dilution of the ownership interests
of existing shareholders and may further dilute common stock book value, and that dilution may be material. Such issuances may also serve
to enhance existing management&#8217;s ability to maintain control of us, because the shares may be issued to parties or entities committed
to supporting existing management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>ITEM
1B. UNRESOLVED STAFF COMMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>ITEM
2. PROPERTIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
support services are rendered from:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    principal executive office at</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1705
    &#8211; 1708, Level 17, Tower 2,</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Faber
    Towers, Jalan Desa Bahagia,</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taman
    Desa, 58100 Kuala Lumpur, Malaysia.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Room
    2708-9, 2F,</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Metropolis Tower,</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    Metropolis Drive, Hunghom,</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kowloon,
    Hong Kong.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>ITEM
3. LEGAL PROCEEDINGS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation
is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.
There are currently no pending legal proceedings or claims that we believe will have a material adverse effect on our business, financial
condition or operating results. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or
has a material interest adverse to our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>ITEM
4. MINE SAFETY DISCLOSURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="a_007"></span>PART
II</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_008"></span>ITEM
5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is currently listed on the OTC Markets &#8211; Pink Sheets under the trading symbol &#8220;ATTP.&#8221; There is no active
trading market in the Company&#8217;s securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, we had 290,460,047 shares of our Common Stock par value, $0.0001 issued and outstanding. There were 1,220 record
holders of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
transfer agent is VStock Transfer, LLC, with an address at 18, Lafayette Place, Woodmere, New York 11598 and telephone number is +1 (212)
828-843.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend
Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
future determination as to the declaration and payment of dividends on shares of our Common Stock will be made at the discretion of our
board of directors out of funds legally available for such purpose. We are under no contractual obligations or restrictions to declare
or pay dividends on our shares of Common Stock. In addition, we currently have no plans to pay such dividends. Our board of directors
currently intends to retain all earnings for use in the business for the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
there are no equity compensation plan in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
Sales of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchases
of Equity Securities by the Registrant and Affiliated Purchasers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not repurchased any shares of our common stock during the twelve months ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_009"></span>ITEM
6. SELECTED FINANCIAL DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth selected financial data as of December 31, 2021 and 2020 and for the years ended December 31, 2021 and 2020.
This selected financial data should be read in conjunction with the consolidated financial statements and related notes included in Item
15 of this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; padding-bottom: 2.5pt">Revenue</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">1,016,962</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">3,452,621</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss) attributable to Agape ATP Corporation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,524,244</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">354,766</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss) per share &#8211; (basic and diluted)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">4,724,535</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">7,210,607</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,312,841</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,285,773</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_010"></span>ITEM
7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated
financial statements and the notes to those financial statements appearing elsewhere in this Report.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain
statements in this Report constitute forward-looking statements. These forward-looking statements include statements, which involve risks
and uncertainties, regarding, among other things, (a) our projected sales, profitability, and cash flows, (b) our growth strategy, (c)
anticipated trends in our industry, (d) our future financing plans, and (e) our anticipated needs for, and use of, working capital. They
are generally identifiable by use of the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;anticipate,&#8221;
&#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;continuing,&#8221; &#8220;ongoing,&#8221;
&#8220;expects,&#8221; &#8220;management believes,&#8221; &#8220;we believe,&#8221; &#8220;we intend,&#8221; or the negative of these
words or other variations on these words or comparable terminology. In light of these risks and uncertainties, there can be no assurance
that the forward-looking statements contained in this filing will in fact occur. You should not place undue reliance on these forward-looking
statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities
laws, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date on which
the statements are made or to reflect the occurrence of unanticipated events.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Overview</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation, a Nevada corporation (&#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on June 1, 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape
Superior Living Sdn. Bhd. (&#8220;ASL&#8221;), a company incorporated in Malaysia. .</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd.,
a network marketing entity incorporated in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (&#8220;WATP&#8221;), a wholly owned subsidiary
under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services
that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (&#8220;DSY Wellness&#8221;)
with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing
complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to
supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation,
anti-aging and products designed to improve the overall health system of the human body and various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company
primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#8220;ATP Zeta Health Program&#8221;,
which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy
lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of
modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to strengthen the Company&#8217;s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99% of ASL,
with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years.
ASL has been offering the Company&#8217;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy
in the Company&#8217;s operation by boosting the Company&#8217;s retail and marketing capabilities. The newly acquired subsidiary allows
the Company to fulfill its mission of &#8220;helping people to create health and wealth&#8221; by providing a financially rewarding business
opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via
ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#201;NERG&#201;TIQUE
and BEAUNIQUE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused
by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity
through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and
distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&#201;NERG&#201;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series
is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
BEAUNIQUE product series focuses on the research of our diet&#8217;s impact on modifying gene expressions in order to address genetic
variations and deliver a nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution
advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various
wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">To
further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity,
DSY Wellness International Sdn. Bhd. (&#8220;DSY Wellness&#8221;) with an independent third party which Agape ATP Corporation (Labuan)
owns 60% of the equity interest, to pursue the business of providing complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Results
of Operation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">For
the years ended December 31, 2021 and 2020</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generated revenue of $1,016,962 for the year ended December 31, 2021 as compared to $3,452,621 for the year ended December 31, 2020,
representing a significant decrease of $2,435,659 or approximately 70.5%. <span style="background-color: white">It is to be noted that
as between the two fiscal years, ASL, with its large group of customers in an established network marketing sales channel that has been
in established in Malaysia for the past 15 years, contributed revenue throughout the entire year ended
December 31, 2021, whereas ASL&#8217;s revenue contribution to us only began from April 1, 2020 to December 31, 2020, after its acquisition
on May 8, 2020. For the period from January 1, 2020 to March 31, 2020, we were only making sales to our related party on wholesale basis
when ASL placed the purchase orders.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Despite
a full year revenue contribution from ASL for the year ended December 31, 2021, the Company&#8217;s revenue decreased significantly due
to the COVID-19 situation in Malaysia. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the date
of declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO to the date of this report, Malaysia
has been put through intermittent lockdowns of various degree of seriousness such as (1) full movement control orders (&#8220;MCO&#8221;),
under which, quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia were made mandatory, (2)
MCO were eased to a Conditional Movement Control Order (&#8220;CMCO&#8221;) where most business sectors were allowed to operate under
strict rules and Standard Operating Procedures mandated by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement
Control Order (&#8220;RMCO&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
lockdowns disrupted much of our operational activities, which led to the significant decrease in revenue for the year ended December
31, 2021 as compared to the same period in 2020. As of March 2022, Malaysia stands at position 26 as the country with the highest COVID-19
cases as recorded under the coronavirus statistics of the &#8220;worldometer&#8221;. Total COVID-19 cases of the country hit approximately
3.6 million and associated fatality of 33, 228. These figures are large relative to the small size economy of the country. The prolonged
pandemic has adversely affected the purchasing power of consumers in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cost
of Revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue for the year ended December 31, 2021 amounted to $297,333 as compared to $775,855 for the year ended December 31, 2020, representing
a significant decrease of $478,522 or approximately 61.7%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of revenue comprised of freight-in, cost of goods purchased, and packing materials. The significant decrease in cost of revenue
for the year ended December 31, 2021 as compared to the same period in 2020, was in line with the significant decrease in our revenues.
<span style="background-color: white">As explained in the above</span>, <span style="background-color: white">much of our operational
activities was disrupted as a result of the resurgence of COVID-19 infection and movement control orders imposed in Malaysia</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Gross
Profit</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit for the year ended December 31, 2021 amounted to $719,629 as compared to $2,676,766 for the year ended December 31, 2020. Gross
margin for the year ended December 31, 2021 was approximately 70.8% as compared to approximately 77.5% for the year ended December 31,
2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
view of the significant drop in revenue, the Company offered promotional discounts to our customers with the aim to promote sales, which
reduced the g</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ross margin for the year ended December
31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Operating
Expenses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operating expenses consist of selling expenses, commission expenses, general and administrative expenses and provision for doubtful accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Selling
expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
expenses for the year ended December 31, 2021 amounted to $394,682 as compared to $376,582 for the year ended December 31, 2020, an increase
of $18,100 or approximately 4.8%. <span style="background-color: white">The increase was mainly due to selling expenses incurred by ASL
for the year ended </span>December 31<span style="background-color: white">, 2021 for the entire year, whereas selling expenses for the
corresponding period last year in connection to ASL&#8217;s network marketing activities only began from April 1, 2020 to </span>December
31<span style="background-color: white">, 2020 after its acquisition. The Company incurred higher salaries and benefits expenses for
the current year, as it represented a full year from January 1, 2021 to </span>December 31<span style="background-color: white">, 2021,
but lower other selling expenses, such as credit card processing fees, promotional expenses, events expenses, and travelling expenses
from our sales team, as compared to the corresponding period last year for 9 months only from April 1, 2020 to </span>December 31, <span style="background-color: white">2020.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Commission
expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
expenses were $316,267 and $830,659 for the years ended December 31, 2021 and 2020, respectively, representing a significant decrease
of $514,392 or approximately 61.9%. The significant decrease in commission expenses was in line with the significant decrease in revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
and administrative expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses for the year ended December 31, 2021 amounted to $1,745,734, as compared to $1,627,660 for the year ended
December 31, 2020, representing an increase of $118,074 or approximately 7.3%. <span style="background-color: white">The increase was
mainly due to </span>general and administrative <span style="background-color: white">expenses incurred by ASL for the year ended </span>December
31<span style="background-color: white">, 2021 for the entire year, whereas </span>general and administrative <span style="background-color: white">expenses
for the corresponding period last year in connection to ASL&#8217;s network marketing activities only began from April 1, 2020 to </span>December
31<span style="background-color: white">, 2020 after its acquisition. The Company incurred higher salaries and benefits expenses for
the current year, as it represented a full year from January 1, 2021 to </span>December 31<span style="background-color: white">, 2021,
but lower other </span>general and administrative <span style="background-color: white">expenses, such as professional expenses and office
expenses, as compared to the corresponding period of last year for 9 months only from April 1, 2020 to </span>December 31, <span style="background-color: white">2020.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other
(Expenses) Income</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2021, we recorded an amount of $529,045 as other expenses, net as compared to $674,482 other income, net
for the year ended December 31, 2020, representing a change of $1,203,527, or approximately 178.4%, in other income. The net other expenses
of $529,405 incurred during the year ended December 31, 2021 comprised of other expense of $42,753, unrealized holding loss on marketable
securities of $505,231 and dividend income from marketable securities of $18,939. The net other income of $674,482 incurred during the
year ended December 31, 2020 comprised of other income of $164,283, unrealized holding gain on marketable securities of $350,137 and
dividend income from marketable securities of $160,062.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Provision
for Income Taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had a provision for income taxes of $137,067 and a provision for income taxes of $161,581 for the years ended December 31, 2021 and 2020,
respectively. During the year ended December 31, 2021, we had provision for income taxes of $114,862 due to certain permanent items required
for the income taxes provision in Malaysia jurisdiction after our Malaysia local tax audit and had provision for income taxes of $22,205
on U.S. GILTI taxes provision. On the other hand, during the year ended December 31, 2020, we generated taxable income in ASL that was
subjected to a unified 24% income tax rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Net
(Loss) Income</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred a net loss of $2,524,680 for the year ended December 31, 2021, from a net income of $354,766 for the year ended December 31,
2020, a change of $2,879,446, predominately due to reasons as discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Liquidity
and Capital Resources</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2020, the World Health Organization or WHO declared the corona virus or COVID-19 a pandemic. To help counter the transmission
of COVID-19, the government of Malaysia initiated movement control orders (&#8220;MCO&#8221;), the first effective March 18, 2020. The
MCO had resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia. The first MCO was
extended three times, each for a two-weeks period, until May 12, 2020. On May 13, 2020, the MCO was eased to a Conditional Movement Control
Order (&#8220;CMCO&#8221;) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated
by the government of Malaysia. The CMCO was further relaxed, and on June 8, 2020, Malaysia moved into the Recovery Movement Control Order
(&#8220;RMCO&#8221;). Due to a resurgence of COVID-19, CMCO was reimposed in the state of Sabah, Selangor, Kuala Lumpur and Putrajaya
effective October 14, 2020. On November 7, 2020, the CMCO was extended to a wider geographical area to include another six states in
the country. Effectively, ten of thirteen states in Malaysia were
placed under CMCO with the exceptions of Perlis, Pahang and Kelantan. On January 1, 2021, the Government of Malaysia extended the Recovery
Movement Control Order (&#8220;RMCO&#8221;) through March 31, 2021. On January 12, 2021, the Malaysian government declared a state of
emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the country.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 5, 2021, lockdowns in most part of the country was eased to a CMCO, nevertheless, COVID-19 cases in the country continue to rise.
On May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of
the country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian
population is fully vaccinated. The country is administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full
lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one
dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter
of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases
hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced
Movement Control Order (&#8220;EMCO&#8221;) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament
met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunization Plan, fast inoculating
its residents. COVID-19 infection started to drop below the 10,000 mark daily since beginning October 3, 2021. Effective October 11,
2021, interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the
country achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19
phase where it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country&#8217;s population have
been fully vaccinated, with a further 46.0% having received booster shot.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially,
affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact
to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and
severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact,
almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">temporary
    closure of offices, travel restrictions, disruption or suspension of supplies, our customers may be negatively impacted financially
    resulting in which the demand for our products may be adversely affected</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">we
    may have to provide significant sales incentives to our customers during the outbreak, which may in turn materially adversely affect
    our financial condition and operating results</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    disruption of our supply chain, logistics providers or customers could adversely impact our business and results of operations, including
    causing us or our suppliers to cease manufacturing for a period of time or materially delay delivery to our customers, which may
    also lead to loss of our customers.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
some of the countries from which our products are sourced are experiencing lockdowns, industries involve in the provision of food especially
health products and pharmaceuticals are normally exempted. We may experience slight delay in products delivery lead time but barring
unforeseen circumstances, the setback should be temporary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently operating primarily in Malaysia and anticipate expanding into the Asian markets in the future, with a particular focus,
at least initially, on expanding into Thailand, Indonesia and Taiwan. We will explore expansion via e-commerce. When the pandemic has
subsided or is over and restrictions on travelling between nations are uplifted, we will set up offices in the countries in which we
operate to better service our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot
be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar level year over
year in 2022</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, we had working capital of $2,599,281 consisting of cash in bank of $554,864 and time deposits of $1,975,347 as
compared to working capital of $4,645,729 consisting of cash in bank of $1,112,147 and time deposits of $2,391,182 as of December 31,
2020. The company had a net loss 2,524,680 for the year end December 31, 2021 and accumulated deficit of $3,258,687 as of December 31,
2021 as compared to net income of $354,766 for the year ended December 31, 2021 and accumulated deficit of $734,443 as of December 31,
2020. In assessing our liquidity and going concern, management is projecting that the company&#8217;s revenue will revert to pre-pandemic
level, generating sufficient cash therefrom to cover our operating expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to generate sufficient cash flow within the normal operating cycle of a twelve-month period to pay for its future payment
obligations, we may have to consider supplementing our available sources of funds through the following sources:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    available sources of financing from Malaysia banks and other financial institutions; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
    support from our related parties and shareholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the above initiatives, management is of the opinion that the company shall have sufficient funds to meet its working capital requirements
and debt obligations as they become due in the foreseeable future from the date of issuance of this Form 10-K. However, there is no assurance
that management will be successful in its plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summarizes the key components of our cash flows for the years ended December 31, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Net cash used in operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(845,842</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(557,951</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash (used in) provided by investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,959</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,276,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash used in financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,061</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(22,091</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Effect of exchange rate on cash and cash equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(50,890</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,985</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net change in cash and cash equivalents</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(919,752</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">773,143</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities for the year ended December 31, 2021 was $845,842 and were mainly comprised of the net loss of $2,524,680,
<span style="background-color: white">dividend income from marketable securities of $18,939,</span> the increase in prepayments and deposits
of $128,363, and the payment of operating lease liabilities of $138,143. The net cash used in operating activities was mainly offset
by the non-cash depreciation and amortization expense of $77,758, amortization of operating right-of-use assets of $139,451, the unrealized
holding loss on marketable securities of $505,231, the non-cash deferred tax expense of $10,127, inventories write-down of $36,241, provision
for doubtful accounts of $121,514, the decrease of accounts receivables of $167,566, the decrease in inventories of $192,713, the refund
in prepaid taxes of $430,062, the increase in customer deposits of $52,981, the increase in income tax payables of $3,988, and the increase
in other payables and accrued liabilities of $226,651.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Net
cash used in operating activities for the year ended December 31, 2020 was $557,951 and were mainly comprised of the non-cash income
on unrealized holding gain on marketable securities of $350,137 and dividend income from marketable securities of $160,062, the increase
of accounts receivables of $165,149, the decrease of customer deposits of $1,421,886 and the payment of operating lease liabilities of
$105,009. The net cash used in operating activities was mainly offset by the net income of $354,766, the non-cash depreciation and amortization
expense of $56,912, amortization of operating right-of-use assets of $106,561, deferred tax provision of $178,329, the decrease in inventories
of $78,674, the decrease in prepaid taxes of $184,985, the decrease in prepayments and deposits, including related party of $352,577,
and the increase in other payables and accrued liabilities of $336,709.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investing
activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities for the year ended December 31, 2021 was $3,959, the amount entirely for the purchase of equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Net
cash provided by investing activities for the year ended December 31, 2020 was $1,276,200, which were in respect of cash and cash equivalents
acquired through acquisition of ASL of $1,210,818, partial proceeds collected from the sale of our non-marketable securities of $70,173
and proceeds from sale of investment in marketable securities of $121, offset by purchase of equipment and intangible assets of $4,912.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing
activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in financing activities for the year ended December 31, 2021 was $19,061, mainly comprised of payment of deferred offering
cost of $15,210 and advances to related parties of $3,851.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Net
cash used in financing activities for the year ended December 31, 2020 was $22,091 which were mainly comprised of payment of deferred
offering cost of $249,525 offset by repayments from related parties of $227,434.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Credit
Facilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any credit facilities or other access to bank credit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Off-Balance
Sheet Arrangements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future
effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital
expenditures or capital resources that are material to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Critical
Accounting Polices</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates
reflected in the Company&#8217;s consolidated financial statements include allowance for doubtful accounts, allowance for inventories
obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for
deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment
in non-marketable securities. Actual results could differ from these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using
the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to
retained earnings upon adoption of this new guidance as the Company&#8217;s revenue was recognized based on the amount of consideration
expected to receive in exchange for satisfying the performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer
of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange.
This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a
point in time or over time, based on when control of goods and services transfers to a customer. The Company&#8217;s revenue streams
are recognized at a point in time for the Company&#8217;s sale of health and wellness products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company
(i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate
the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies
the performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment
terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of Health and Wellness products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>-
Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness
products are transferred to its customer at the Company&#8217;s office or shipment of the goods. The revenue is recorded net of estimated
discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were
insignificant sales returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value
of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds
resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and
wellness products transaction price upon such sales transactions occurred. The Company&#8217;s coupons have a validity period of six
months. If the Company&#8217;s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of
the originated sales value of the coupons as net revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of Health and Wellness services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company carries out its Wellness program, where the Company&#8217;s products are bundled with health screening test and a health camp
program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver
the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that
the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend
the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test
reports are completed and delivered to its customers during the consultation section in person. The Company also separately derives its
revenues from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final
day of the health camp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
value of financial instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and
requires disclosure of the fair value of financial instruments held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance
disclosure requirements for fair value measures. The three levels are defined as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that
    are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost,
which approximate fair value because of the short period of time between the origination of such instruments and their expected realization
and their current market rates of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent
accounting pronouncements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of
such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic
326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement
of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments
in Update 2016-13 added Topic 326, Financial Instruments&#8212;Credit Losses, and made several consequential amendments to the Codification.
Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses
when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments&#8212; Credit Losses&#8212;Available-for-Sale
Debt Securities. The amendments in this Update address those stakeholders&#8217; concerns by providing an option to irrevocably elect
the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition
relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar
financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments
in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued
ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain
smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for
fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning
January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05
may have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments
accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options
accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should
consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement
alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts
or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity
should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing
investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance
with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted,
including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-08, &#8220;Codification Improvements to Subtopic 310-20, Receivables&#8212;Nonrefundable Fees
and Other Costs&#8221;. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification
easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the
Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply
the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable
debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021
did not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-10, &#8220;Codification Improvements&#8221;. The amendments in this Update represent changes to
clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current
accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety
of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is
effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments
in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on
its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_011"></span>ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
exchange risk</i>. Substantially most of our revenues are denominated in the U.S. dollar while most of our expenses are denominated in
Malaysian Ringgit and Hong Kong Dollar. We do not believe that we currently have any significant direct foreign exchange risk and have
not hedged exposures denominated in foreign currencies or any other derivative financial instruments. Although in general, our exposure
to foreign exchange risks should be limited, the value of an investment in our Common Stock may be affected by the foreign exchange rate
between U.S. dollar and Malaysian Ringgit; and U.S. dollar and Hong Kong Dollar because the value of our business is effectively denominated
in Malaysian Ringgit and Hong Kong Dollar, while the Common Stock is traded in U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Credit
risk</i>. Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes
the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively
short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance
for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_012"></span>ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements required by this item are located in PART IV of this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_013"></span>ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_014"></span>ITEM
9A. CONTROLS AND PROCEDURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Disclosure
Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Disclosures
Control and Procedures</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over
financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the
supervision of, the company&#8217;s principal executive and principal financial officers and effected by the company&#8217;s board of
directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America
and includes those policies and procedures that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pertain
    to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets
    of the company;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
    reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with
    accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being
    made only in accordance with authorizations of management and directors of the company; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
    reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company&#8217;s
    assets that could have a material effect on the financial statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed,
have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect
to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material
misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent
limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to
reduce, though not eliminate, this risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, management assessed the effectiveness of our internal control over financial reporting based on the criteria for
effective internal control over financial reporting established in Internal Control&#8212;Integrated Framework issued by the Committee
of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;) and SEC guidance on conducting such assessments. Based on
such evaluation, the Company&#8217;s management concluded that, during the period covered by this Report, internal controls and procedures
over financial reporting were not effective. This was due to deficiencies that existed in the design or operation of our internal controls
over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Identified
Material Weakness</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness in internal control over financial reporting is a control deficiency, or combination of control deficiencies, that
results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
identified the following material weakness during its assessment of internal controls over financial reporting as of December 31, 2021,:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
insufficient full-time personnel with appropriate levels of accounting knowledge and experience to monitor the daily recording of transactions,
address complex U.S. GAAP accounting issues and to prepare and review financial statements and related disclosures under U.S. GAAP; (ii)
lack of a functional internal audit department or personnel that monitors the consistencies of the preventive internal control procedures
and lack of adequate policies and procedures in internal audit function to ensure that the Company&#8217;s policies and procedures have
been carried out as planned; (iii) lack of adequate segregation of duties and effective risk assessment, which in turn may cause the
Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect errors; (iv) we lack of proper
procedures developed for system change management policies. Change management policies and procedures have not been developed. Critical
change management control processes and procedures, such as change request and approval, periodic status reporting, user testing and
acceptance, post-implementation review, etc., were either not performed or formally documented; (v) we lack of the following internal
control procedures in relation of Third-Party (Service Organization) Vendor Management &#8211; (a) service evaluation and qualification
assessment of third-party vendors were not performed for the year ended December 31, 2021 and (b) Management was not able to provide
evidence of their review of their service providers&#8217; SOC 1 and SOC 2, or ISO 27001 certificate reports and therefore unable to
provide evidence of their review of the physical security and environmental controls in place at IP Serverone cloud server (which the
Company&#8217;s financial system is hosted on; (vi) we lack of the following internal control procedures in relation of User Account
Management &#8211; (a) Evidence relating to the authorization of database administrator user accounts and access was not preserved for
the MLM System during the year ended December 31, 2021 and (b) Evidence relating to periodic recertification of MLM and SQL Finance System
end user are privileged accounts and related access rights were preserved during the year ended December 31, 2021; (vii) we lack of the
following internal control procedures in relation of Audit Logs and Segregation of Duty (&#8220;SOD&#8221;) Management &#8211; (a) MLM-DB
level system/audit logs were not preserved. Procedures for periodic review and analysis of application (&#8220;AP&#8221;), operating
system (&#8220;OS&#8221;), and database (&#8220;DB&#8221;) level audit logs were not established and performed and (b) An SOD conflict
was identified, where administrative rights to AP, OS and DB levels of the MLM system were assigned to the CTO and (viii) we lack of
qualified person to be able to provide the tax provision for the U.S. income taxes in connection with the Subpart F and GILTI taxable
income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual
or interim financial statements will not be prevented or detected on a timely basis by the company&#8217;s internal controls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control
over financial reporting as of December 31, 2021 based on criteria established in Internal Control&#8212;Integrated Framework issued
by COSO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Management&#8217;s
Remediation Initiatives</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we will prepare written
policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC
guidelines, to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including
equity and debt transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
further strengthen the Company&#8217;s internal controls, we plan to initiate the following measures going forward:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    intend to establish an internal audit function with assessment of Sarbanes-Oxley compliance requirements and improvement of overall
    internal control.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
    we hire additional employees, we intend to initiate a comprehensive training program and development plan to provide ongoing company-wide
    trainings regarding internal control and requirements of U.S. GAAP financial statements and related disclosures, with particular
    emphasis on our accounting staff.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are seeking a U.S. tax professional to assist in the preparation of the Subpart F and GILTI tax provisions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that these initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Changes
in internal controls over financial reporting</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no significant changes in our internal controls over financial reporting that occurred during the period covered by this Report,
which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report does not include an attestation report of the Company&#8217;s registered independent public accounting firm regarding internal
control over financial reporting. Management&#8217;s report was not subject to attestation by the Company&#8217;s registered independent
public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management&#8217;s
report in this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_015"></span>ITEM
9B. OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="a_016"></span>PART
III</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_017"></span>ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officer&#8217;s and director&#8217;s and their respective ages as of the date hereof are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAME</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGE</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POSITION</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How
    Kok Choong</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President, Secretary, Treasurer, Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mohd
    Shaharuddin Bin Abdullah</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Lee Kam Fan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is a brief description of the background and business experience of our executive officer and director for the past five
years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">How
Kok Choong - President, Chief Executive Officer, Secretary, Treasurer, Director</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
How is primarily responsible for overall development and business strategies, financial, administrative and human resources affairs of
the Company. Mr. How has more than 20 years of experience in the senior management roles in the health and wellness industry. From 1987
to 2016, Mr. How was with the San Hin Group of Companies and his last position held was the group chief executive officer for the group.
Since August 2003, Mr. How began to work for AGAPE Superior Living International Group as the global president, and continues to hold
this position. Further, since September 2009, Mr. How has been serving as president for TH3 Holdings Sdn Bhd, company specialized in
IT, academics, online education, mobile Apps, e-Commerce and digital marketing. Mr. How obtained a master&#8217;s degree and a doctorate
degree in Business Administrative from Newport University, USA in December 1997 and December 2000, respectively. In Malaysia, Mr. How
Kok Choong was recognized by the Junior Chamber Malaysia (JCM) as an Outstanding Young Malaysian 2003, and was awarded the title of Justice
of Peace of Malaysia since 2005. Mr. How Kok Choong received the Outstanding Asian Community Contribution Award in 2011, Malaysia Top
Team 50 Enterprise Award in 2011 and 2016, The Contributor Award (Medical and Health Research) in 2012, &#8220;Man of The Year&#8221;
in Worldwide Excellence Award in 2015, &#8220;Man of The Year&#8221; in McMillan Global Award in 2016, The Distinguished Asia Pacific
Outstanding Entrepreneur Lifetime Achievement Award in 2019, World Outstanding Chinese Entrepreneur Lifetime Award in 2019 and Certified
Professional Trainer of The International Professional Managers Association in 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Mohd
Shaharuddin Bin Abdullah- Director</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mohd
Shaharuddin Bin Abdullah, was appointed as an executive director of the Board on January 12, 2021. Prior to joining the Company, Mr.
Shaharuddin has approximately 24 years of banking industry background and approximately 8 years of accounting and finance related experience.
From October 2013 to October 2016, Mr. Shaharuddin served as the assistant director and the head of consumer credit management at Kuwait
Finance House (M) Berhad. From April 2010 to October 2012, Mr. Shaharuddin served as the associate director head of special projects
at Danajamin Nasional Berhad, and was later seconded to head the corporate debt restructuring committee, a unit incorporated by Bank
Negara Malaysia. From January 2006 to April 2010, Mr. Shaharuddin served as the first vice president and the head of the corporate loans
and special assets management division at AffinBank Berhad. From January 2002 to December 2005, Mr. Shaharuddin served as an assistant
general manager of operations department at Pengurusan Danaharta Nasional Berhad. From January 1984 to December 2001, Mr. Shaharuddin
served as the internal auditor, a branch manager, a regional manager at Interfinance Berhad, which was merged with RHB Bank Bhd. in 2000
and Mr. Abdullah served as the head of monitoring and collection division post-merger. From January 1980 to December 1983, Mr. Shaharuddin
served as an investment officer and subsequently an assistant project accountant at Permodalan Bumiputra Sabah Berhad. From October 1976
to December 1979, Mr. Shaharuddin served as an executive officer at Bank Negara Malaysia. Mr. Shaharuddin has been an associate member
of the Asian Institute of Chartered Bankers since April 1998. Mr. Shaharuddin received his diploma in accountancy at Universiti Teknoloji
Mara in 1976, his diploma in banking and finance and Certified Credit Professional I from the Asian Institute of Chartered Bankers in
1992 and 2001, respectively, and his master&#8217;s degree in business administration from MBA-USA (Off Campus) in 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Andrew
Lee Kam Fan</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lee
Kam Fan, Andrew, age 59, was appointed as the chief financial officer of the Company on January 12, 2021. Prior to joining the Company,
Mr. Lee has approximately 38 years of accounting and finance related experience. Since July 2014, Mr. Lee has been the proprietor of
Andrew Lee &amp; Company. Since June 2010, Mr. Lee served as an adjunct lecturer of the HKICPA Processional Examinations Preparatory
Programme at HKU Space. From January 2011 to October 2015, Mr. Lee served as the managing director at ANSA CPA Limited. From September
2010 to October 2012, Mr. Lee served as an independent non-executive director at Sunrise (China) Technology Group Limited (currently
referred to as KOALA Financial Group Limited (Hong Kong stock code: 08226)). From March 2006 to April 2017, Mr. Lee was in cooperation
with Friedman LLP to oversee financial statements are prepared in accordance with U.S. GAAP. From October 2000 to December 2010, Mr.
Lee served as an audit manager and subsequently a partner at Clodick &amp; Company. From April 1998 to September 2000, Mr. Lee served
as a director at Nitwell Business Services Limited. From August 1994 to April 1998, Mr. Lee was an assistant audit manager at Cheng,
Kwok &amp; Chang. From July 1990 to July 1994, Mr. Lee served as an accountant at K.C. Manufacturing Company. From April 1989 to July
1990, Mr. Lee served as an accountant at Haldane, Midgley &amp; Booth. From January 1987 to April 1989, Mr. Lee served as an audit senior
at RSM Nelson Wheeler. From October 1985 to December 1986, Mr. Lee served as an audit assistant at Andrew Ma &amp; Company. From April
1983 to September 1985, Mr. Lee served as an audit Clerk at Anthony Y.T. Tse &amp; Company. Mr. Lee is an associate member of the Institute
of Chartered Accountants in England and Wales since April 2019, a certified public accountant (practicing) of the Hong Kong Institute
of Certified Public Accountants since May 2010, a fellow member of the Association of International Accountants since December 2006,
and an associate member and certified tax advisor of the Tax Institute of Hong Kong since July 2010. Mr. Lee received his bachelor&#8217;s
degree in business administration at the Open University of Hong Kong in June 2004 and his master&#8217;s degree in professional accounting
from the Hong Kong Polytechnic University in November 2010.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Corporate
Governance</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company promotes accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely and understandable
disclosure in reports and documents that the Company files with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and in
other public communications made by the Company; and strives to be compliant with applicable governmental laws, rules and regulations.
The Company has not formally adopted a written code of business conduct and ethics that governs the Company&#8217;s employees, officers
and Directors as the Company is not required to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
lieu of an Audit Committee, the Company&#8217;s Board of Directors, is responsible for reviewing and making recommendations concerning
the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of the Company&#8217;s financial
statements and other services provided by the Company&#8217;s independent public accountants. The Board of Directors and the Chief Executive
Officer of the Company review the Company&#8217;s internal accounting controls, practices and policies with advice from third party consultants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Committees
of the Board</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Company currently does not have nominating, compensation, or audit committees or committees performing similar functions nor does our
Company have a written nominating, compensation or audit committee charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Committee Financial Expert</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has determined that we do not have a board member that qualifies as an &#8220;audit committee financial expert&#8221;
as defined in Item 407(D)(5) of Regulation S-K, nor do we have a Board member that qualifies as &#8220;independent&#8221; as the term
is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Securities Exchange Act of 1934, as amended, and as defined by Rule 4200(a)(14)
of the FINRA Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to maintain good corporate governance and in view of the Company&#8217;s planned expansion, the Company plans to establish a full
board comprising the nominating, compensation, and audit committees during the year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Involvement
in Certain Legal Proceedings</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Directors and our Executive officers have not been involved in any of the following events during the past ten years:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bankruptcy
    petition filed by or against any business of which such person was a general partner or executive officer either at the time of the
    bankruptcy or within two years prior to that time;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor
    offenses);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Being
    subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction,
    permanently or temporarily enjoining, barring, suspending or otherwise limiting his/her involvement in any type of business, securities
    or banking activities; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Being
    found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have
    violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
    person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State
    securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended,
    or vacated;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
    person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated
    any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not
    been subsequently reversed, suspended or vacated;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
    person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not
    subsequently reversed, suspended or vacated, relating to an alleged violation of:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    Federal or State securities or commodities law or regulation; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent
    injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal
    or prohibition order; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
    person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory
    organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section
    1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that
    has disciplinary authority over its members or persons associated with a member.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Code
of Ethics</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not adopted a formal Code of Ethics. The Board of Directors evaluated the business of the Company and the number of employees and
determined that since the business is operated by a small number of persons, general rules of fiduciary duty and federal and state criminal,
business conduct and securities laws are adequate ethical guidelines. In the event our operations, employees and/or Directors expand
in the future, we may take actions to adopt a formal Code of Ethics.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
Proposals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Company does not have any defined policy or procedural requirements for shareholders to submit recommendations or nominations for Directors.
The Board of Directors believes that, given the stage of our development, a specific nominating policy would be premature and of little
assistance until our business operations develop to a more advanced level. Our Company does not currently have any specific or minimum
criteria for the election of nominees to the Board of Directors and we do not have any specific process or procedure for evaluating such
nominees. The Board of Directors will assess all candidates, whether submitted by management or shareholders, and make recommendations
for election or appointment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
shareholder who wishes to communicate with our Board of Directors may do so by directing a written request addressed to our President,
at the address appearing on the first page of this Information Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_018"></span>ITEM
11. EXECUTIVE COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
How Kok Choong, the Chief Executive Officer, President, Secretary, Treasurer, Director of the Group received $275,210 and $203,431 as
total salaries for the year ended December 31, 2021, and 2020 respectively. Mr. How Kok Choong had not received any (i) Stock compensation;
(ii) Option awards, (iii) Non-equity incentive plan compensation, (iv) Non-qualified deferred compensation earnings and (v) Any other
compensations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Mohd Shaharuddin Bin Abdullah was appointed and entered into an employment agreement with the Company on January 12, 2021 and the employment
agreement will take effect on the listing of our stock on NASDAQ Capital Market / New York Stock Exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Andrew Lee Kam Fan was appointed and entered into an employment agreement with the Company on January 12, 2021. For the financial year
ended December 31, 2021, Mr. Andrew Lee Kam Fan received $46,988 as total salary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Stock
Option Grants</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not granted any stock options to our executive officers since our incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Employment
Agreements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
except for Mr. Mohd Shaharuddin Bin Abdullah and Mr. Andrew Lee Kam Fan, we do not have an employment or consulting agreement with any
officers or Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Discussion and Analysis</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Chief Executive Officer, President, Secretary, Treasurer, Director of the Group, Mr. How Kok Choong is paid a monthly salary of $22,934
(RM 95,000). His salary shall accrue on a day-to-day basis, payable in arrears on the last day of each calendar month, provided that
if his employment is terminated prior to the end of a calendar month, his compensation for the month shall be pro-rated to reflect his
period of service up to the date of termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
executive director of the Company, Mr. Mohd Shaharuddin Bin Abdullah will be paid a monthly salary of $3,000. He is also entitled to
receive a stock-based compensation of $60,000 per annum. His compensation, i.e., salary and stock-based compensation shall accrue on
a day-to-day basis, payable in arrears on the last day of each calendar month, provided that if his employment is terminated prior to
the end of a calendar month, his compensation for the month shall be pro-rated to reflect his period of service up to the date of termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Chief Financial Officer of the Company, Mr. Andrew Lee Kam Fan is paid a monthly salary of $3,870. His salary shall accrue on a day-to-day
basis, payable in arrears on the last day of each calendar month, provided that if his employment is terminated prior to the end of a
calendar month, his compensation for the month shall be pro-rated to reflect his period of service up to the date of termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Compensation Philosophy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors determines the compensation given to our executive officers in their sole determination. Our Board of Directors reserves
the right to pay our executive or any future executives a salary, and/or issue them shares of common stock in consideration for services
rendered and/or to award incentive bonuses which are linked to our performance, as well as to the individual executive officer&#8217;s
performance. This package may also include long-term stock-based compensation to certain executives, which is intended to align the performance
of our executives with our long-term business strategies. Additionally, while our Board of Directors has not granted any performance
base stock options to date, the Board of Directors reserves the right to grant such options in the future, if the Board in its sole determination
believes such grants would be in the best interests of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive
Bonus</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors may grant incentive bonuses to our executive officer and/or future executive officers in its sole discretion, if the
Board of Directors believes such bonuses are in the Company&#8217;s best interest, after analyzing our current business objectives and
growth, if any, and the amount of revenue we are able to generate each month, which revenue is a direct result of the actions and ability
of such executives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-term,
Stock Based Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to attract, retain and motivate executive talent necessary to support the Company&#8217;s long-term business strategy we may award
our executive and any future executives with long-term, stock-based compensation in the future, at the sole discretion of our Board of
Directors, which we do not currently have any immediate plans to award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_019"></span>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, the Company has 290,460,047 shares of common stock issued and outstanding, which number of issued and outstanding
shares of common stock have been used throughout this report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name and Address of<br />
 Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares of Common Stock Beneficially Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock Voting Percentage Beneficially Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Voting <br />
Shares of Preferred Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Preferred Stock Voting Percentage Beneficially Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total <br /> Voting Percentage Beneficially Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Executive Officers and Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left">How Kok Choong, President, Chief Executive Officer, Secretary, Treasurer and Director; collectively this includes HKC Holdings Sdn. Bhd.*</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">243,216,637</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">83.73</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">83.73</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Mohd Shaharuddin Bin Abdullah</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Andrew Lee Kam Fan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed to
be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares).
In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares (for example, upon
exercise of a<span style="background-color: white">n option or warrant) within 60 days of the date as of which the information is provided.
In computing the percentage ownership of any person, the amount of shares is deemed to include the amount of shares beneficially owned
by such person by reason of such acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the
following table does not necessarily reflect the person&#8217;s actual voting power at any particular date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_020"></span>ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2016, Mr. How Kok Choong was appointed as CEO, President, Secretary, Treasurer and a member of our Board of Directors. Additionally,
on June 1, 2016, the Company issued 100,000 shares of restricted common stock, each with a par value of $0.0001 per share, to Mr. How
Kok Choong for initial working capital of $10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 5, 2017, the Company acquired Agape ATP Corporation, a company incorporated in Labuan, Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 10, 2017, the Company issued 245,000,000 and 70,000,000 shares of restricted common stock to Mr. How Kok Choong and HKC Holdings
Sdn Bhd respectively, each with a par value of $0.0001 per share, for total additional working capital of $31,500.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 1, 2020, the Company issued 176,547 shares of restricted common stock to Mr. How Kok Choong, with a par value of $0.0001 per share,
for total consideration payable by shares by the Company for the acquisition of 99.99% of the equity interest in ASL from Mr. How.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vettons
Sdn Bhd <span style="background-color: white">(&#8220;Vettons&#8221;) </span>is an e-commerce company through which ASL conducts some
of its distribution activities to its members. <span style="background-color: white">On February 1, 2021, </span>Mr. How Kok Choong,
our CEO and director, was appointed as the non-executive Chairman of <span style="background-color: white">Vettons</span>. As of December
31, 2020, the Company has accounts receivable of $172,757 from Vettons, representing 100% of our accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2021, there were share forfeiture agreements (the &#8220;Share Forfeiture Agreements&#8221;) between the Company and (i) HKC
Talent Limited; (ii) various shareholders of the Company (the &#8220;Forfeiting Shareholders&#8221;), pursuant to which: (i) HKC Talent
Limited had agreed to forfeiture of 41,750,000 shares of common stock of the Company, and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the Forfeiting Shareholders had agreed to forfeiture, in aggregate, 44,242,000 shares of common stock of the Company. Included in (ii)
is 11,242,000 shares forfeited from HKC Holdings Sdn. Bhd, a company in which Mr. How Kok Choong, the CEO and director of the Company,
is a shareholder. As a result, the outstanding shares was reduced by 85,992,000 shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
share forfeiture agreement (the &#8220;Share Forfeiture Agreement&#8221;) dated January 20, 2022, between the Company and Mr. How Kok
Choong, the CEO and director of the Company, pursuant to which Mr. How Kok Choong agreed to forfeit 215,008,035 shares of common stock
of the Company.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*HKC
Holdings Sdn. Bhd. is owned and controlled by How Kok Choong who is our CEO and Director. As such, HKC Holdings Sdn Bhd is regarded a
related party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regards to all of the above transactions we claim an exemption from registration afforded by Section 4a(2) and/or Regulation S of the
Securities Act of 1933, as amended (&#8220;Regulation S&#8221;) due to the fact that all sales of stock were made to non-U.S. persons
(as defined under Rule 902 section (k)(2)(i) of Regulation S), pursuant to offshore transactions, and no directed selling efforts were
made in the United States by the issuer, a distributor, any of their respective affiliates, or any person acting on behalf of any of
the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Company&#8217;s related party list and relationship are as follows:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
    parties</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relationships</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Agape
    S.E.A. Sdn Bhd</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">VIE
    of Agape Superior Living Sdn Bhd, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of
    Agape S.E.A. Sdn Bhd</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Agape
    Superior Living Pty Ltd</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Mr.
    How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
    parties</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relationships</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Agape
    ATP (Asia) Limited</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Mr.
    How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Hostastay
    Sdn. Bhd.</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Mr.
    How Kok Choong, the CEO and director of the Company is also a director of Hostastay Sdn. Bhd.</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Redboy
    Picture Sdn Bhd</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Mr.
    How Kok Choong, the CEO and director of the Company is also a director of Redboy Picture Sdn Bhd.</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Vettons
    Sdn Bhd</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021.</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
party balances as of December 31, 2021 and 2020 are as per table below:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
due from related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 37%; text-align: left">Agape ATP (Asia) Limited (&#8220;AATP Asia&#8221;)</td><td style="width: 2%">&#160;</td>
    <td style="width: 23%; text-align: left">Expenses paid for AATP Asia</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,214</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,227</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left">Hostastay Sdn. Bhd. (&#8220;Hostastay&#8221;)</td><td>&#160;</td>
    <td style="text-align: left">Sublease rent due from Hostastay</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">996</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">TH3 Technology Sdn Bhd</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Expenses paid for TH3 Technology</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,004</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
due to a Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 37%; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 23%; text-align: left; padding-bottom: 1.5pt">ATP Label Printing Fees</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right">455</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">455</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
party transactions for years ended December 31, 2021 and 2020, are as per table below:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related
party transactions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left">Agape Superior Living Pty Ltd (&#8220;ASLPL&#8221;)</td><td style="width: 2%">&#160;</td>
    <td style="width: 23%">Sales of products</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">18,060</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Vettons Sdn Bhd*</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Sales of products made through its platform</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,625</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,625</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,060</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>*
</b>During the year ended December 31, 2021, we had sales of $6,625 through the online platform owned by Vettons Sdn Bhd (&#8220;Vettons&#8221;).
Vettons is a related party since Mr. How Kok Choong, our CEO and director, is appointed as the non-executive Chairman of Vettons Sdn
Bhd on February 1, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchase</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left; padding-bottom: 1.5pt">DSY Wellness &amp; Longevity Center Sdn Bhd</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt">Dato&#8217; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp; Longevity Center Sdn Bhd.</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt">Purchase</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">718</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">718</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left; padding-bottom: 1.5pt">Mr. How Kok Choong*</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 23%; text-align: left; padding-bottom: 1.5pt">Commission expense</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right">12,758</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right">10,740</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,758</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,740</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Mr. How Kok Choong is the CEO and director of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 37%; text-align: left; padding-bottom: 1.5pt">Hostastay Sdn. Bhd.</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 23%; text-align: left; padding-bottom: 1.5pt">Sublease rental income due from Hostastay</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right">4,345</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right">2,881</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,345</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,881</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Review,
Approval and Ratification of Related Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification
of transactions, such as those described above, with our executive officer(s), Director(s) and significant stockholders. We intend to
establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional Directors, so
that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee
thereof. Until formal policies and procedures are put in place, our Directors will continue to approve any related party transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_021"></span>ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Friedman
LLP is our independent auditor and tax accountant for the year ended December 31, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is the aggregate amount of fees billed for professional services rendered by our principal accountants with respect to our last two fiscal
years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Audit fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">395,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">245,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Tax fees</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">411,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">273,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
category of &#8220;Audit fees&#8221; includes fees for our annual audit, quarterly reviews and services rendered in connection with regulatory
filings with the SEC, such as the issuance of comfort letters and consents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
category of &#8220;Tax fees&#8221; includes professional services rendered by our principal accountant for tax compliance, tax advice,
and tax planning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the professional services rendered by principal accountants for the audit of our annual financial statements that are normally provided
by the accountant in connection with statutory and regulatory filings or engagements for last two fiscal years were approved by our board
of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="a_022"></span>PART
IV</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_023"></span>ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are filed as part of this report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
Statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following financial statements of AGAPE ATP Corporation. and Report of Independent Registered Public Accounting Firm are presented in
the &#8220;F&#8221; pages of this Report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_025">Index</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ajz_001">Reports of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Financial Statements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_027">Consolidated Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_028">Consolidated Statements of Operations and Comprehensive Income (Loss)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_029">Consolidated Statements of Changes in Stockholders&#8217; Equity</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_030">Consolidated Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_031">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7
    &#8211; F-34</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are filed or &#8220;furnished&#8221; herewith:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1713210/000169082417000101/certofinc.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Incorporation**</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1713210/000169082417000101/bylaws.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws**</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-1.htm">Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer and principal financial officer*</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex32-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 1350 Certification of principal executive officer and principal financial officer*</span></a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Document*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Label Linkbase Document*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">104</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cover Page Interactive Data File (embedded within the Inline XBRL document)*</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Filed herewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**
As filed in the Registrant&#8217;s Registration Statement on Form S-1 Amendment No.2 (File No. 333-220144) on October 26, 2017.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_024"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAPE
    ATP CORPORATION.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Registrant)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 28, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>/s/
    How Kok Choong</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOW
    KOK CHOONG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President, Secretary, Treasurer, Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 28, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Andrew Lee Kam Fan</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEE
    KAM FAN</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_025"></span>INDEX
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ajz_001">Report of Independent Registered Public Accounting Firm</a> (PCAOB Name: <span id="xdx_907_edei--AuditorName_c20210101__20211231_zrPAR0u7W2f5"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorName">Friedman LLP</ix:nonNumeric></span> and PCAOB ID: <span id="xdx_906_edei--AuditorFirmId_c20210101__20211231_zqJx5k8YNoN"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorFirmId">711</ix:nonNumeric></span>)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_027">Consolidated Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_028">Consolidated Statements of Operations and Comprehensive Income (Loss)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_029">Consolidated Statements of Changes in Stockholders&#8217; Equity</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_030">Consolidated Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_031">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7
    - F-34</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="report_001.jpg" alt="" style="height: 72px; width: 383px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ajz_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
of Agape ATP Corporation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Agape ATP Corporation (the &#8220;Company&#8221;) as of December 31, 2021
and 2020, and the related consolidated statements of operations and comprehensive income (loss), changes in stockholders&#8217; equity
and cash flows&#160;for the years ended December 31, 2021 and 2020, and the related notes (collectively referred to as the consolidated
financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial
position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years ended December
31, 2021 and 2020, in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on the Company&#8217;s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
<span id="xdx_907_edei--AuditorName_c20210101__20211231_zcO9BG56vV4f"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorName">Friedman LLP</ix:nonNumeric></span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_90A_edei--AuditorLocation_c20210101__20211231_zp0gy25aAimg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorLocation">New
York, New York</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
28, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="report_002.jpg" alt="" style="height: 77px; width: 670px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_027"></span>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_111_zBG2ZmVcz7T2" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20211231_zYluZXbDLgPb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center">2021</td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20201231_zgarj8Oz2cib" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center">2020</td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CURRENT ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pp0p0_maACzplH_zh7VcDvqLR74" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Cash and cash equivalents (Included $<span id="xdx_90C_ecustom--VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_iI_pp0p0_c20211231_zOpbG3hECaNb" title="VIE consolidated amount of cash and cash equivalents"><ix:nonFraction name="AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,493</ix:nonFraction></span> and $<span id="xdx_909_ecustom--VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_iI_pp0p0_c20201231_zjtb89aNMfk3" title="VIE consolidated amount of cash and cash equivalents"><ix:nonFraction name="AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,387</ix:nonFraction></span> in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,597,848</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,517,600</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AccountsReceivableNetCurrent_i02I_pp0p0_maACzplH_zT9RrRk6jNjd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0060">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,757</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NotesReceivableRelatedPartiesCurrent_i02I_pp0p0_maACzplH_ztnyvxNF1fnl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amount due from related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesReceivableRelatedPartiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,004</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesReceivableRelatedPartiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,235</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryNet_i02I_pp0p0_maACzplH_zcFvA1EyWigh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">375,535</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">589,814</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidTaxes_i02I_pp0p0_maACzplH_z7RjpjeTI3Oc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepaid taxes (Included $<span id="xdx_901_ecustom--VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_iI_pp0p0_c20211231_z9eBtwWftMJf" title="VIE consolidated amount of prepaid taxes"><ix:nonFraction name="AATP:VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,357</ix:nonFraction></span> and $<span id="xdx_908_ecustom--VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_c20201231_pp0p0" title="VIE consolidated amount of prepaid taxes"><ix:nonFraction name="AATP:VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,330</ix:nonFraction></span> in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidTaxes" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">636,218</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidTaxes" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,104,495</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pp0p0_maACzplH_zqFJJjWIsV69" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepayments and deposits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">295,517</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">296,370</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsCurrent_i02TI_pp0p0_mtACzplH_maAzAou_zkXCbBrV1rD3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Current Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,912,122</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,684,271</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAssetsAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">OTHER ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_i02I_pp0p0_maOAzazH_zxTqleUWQ414" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,799</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">298,309</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i02I_pp0p0_maOAzazH_zp5QSW7xwaz2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,660</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,826</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_pp0p0_maOAzazH_zbcRk03pdoBf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">237,718</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">394,141</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--MarketableSecuritiesNoncurrent_i02I_pp0p0_maOAzazH_zbtMOd10RN7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Investment in marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,001</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">577,035</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_i02I_pp0p0_maOAzazH_z4RktEEKO7Z9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Investment in non-marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredOfferingCosts_i02I_pp0p0_maOAzazH_ziaiqkZkZLLg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Deferred offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">264,735</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">249,525</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherAssets_i02TI_pp0p0_mtOAzazH_maAzAou_zGJNNB0YfIc6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">812,413</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,526,336</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Assets_i01TI_pp0p0_mtAzAou_zhcIXFZl8bq6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,724,535</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,210,607</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableTradeCurrent_i02I_pp0p0_maLCzT5n_zkIgclrQbQ08" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,715</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0116">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_pp0p0_maLCzT5n_zn0jtNxwH1Bj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">279,689</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">236,134</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_pp0p0_maLCzT5n_zZwmQ3qFqVB9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">157,094</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">154,276</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_i02I_pp0p0_maLCzT5n_zw5oBQzvzVAj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Other payables and accrued liabilities ($<span id="xdx_90C_ecustom--VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_iI_pp0p0_c20211231_zW7p7ola2Hv2" title="VIE consolidated amount of other payables and accrued liabilities"><ix:nonFraction name="AATP:VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,548</ix:nonFraction></span> and $<span id="xdx_901_ecustom--VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_c20201231_pp0p0" title="VIE consolidated amount of other payables and accrued liabilities"><ix:nonFraction name="AATP:VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,904</ix:nonFraction></span> are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2021 and 2020, respectively.)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">858,355</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">647,677</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--TaxesPayableCurrent_i02I_pp0p0_maLCzT5n_zMyMUX3G3wob" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,988</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0132">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DueToRelatedPartiesCurrent_i02I_pp0p0_maLCzT5n_zAqpxv2LcdFc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Amount due to a related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0134">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">455</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesCurrent_i02TI_pp0p0_mtLCzT5n_maLzz14_zX31WZjCXSa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Current Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,312,841</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,038,542</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesNoncurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NON-CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_pp0p0_maLNz1IR_zGyNG8k26812" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,484</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">241,488</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i02I_pp0p0_maLNz1IR_zwhNlznId9x7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,574</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,743</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrent_i02TI_pp0p0_mtLNz1IR_maLzz14_zksf9m3rAEL8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Non-current Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">99,058</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">247,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Liabilities_i01I_pp0p0_mtLzz14_maLASEzFyq_zaHH2OJimOli" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,411,899</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,285,773</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PreferredStockValue_i02I_pp0p0_maSEzHmT_zTv7yLQtFXKg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Preferred stock, $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231_zEtp1ly2H7r8" title="Preferred stock, par value"><span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_c20201231_pdd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zBUcXcyzHrc9" title="Preferred stock, shares authorized"><span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_c20201231_pdd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_dn_c20211231_zcloOaQsf1H7" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20211231_zjKYRlQkOiBf" title="Preferred stock, shares outstanding"><span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_dn_c20201231_zlPe0iMfGvkl" title="Preferred stock, shares issued"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20201231_zNzM6yVKrDxc" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">None</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0158">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0159">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CommonStockValue_i02I_pp0p0_maSEzHmT_zhuM1BF8Kqc6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Common Stock, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231_z949eE812Hwc" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_c20201231_pdd" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_zuDyd60W4OA7" title="Common Stock, Shares Authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20201231_pdd" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20211231_zMDuvw5ZbRzd" title="Common stock, shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zg9N9px6Rxxe" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">290,460,047</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_c20201231_zrmRCaip87g2" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20201231_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2021 and 2020, respectively.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,046</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,645</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AdditionalPaidInCapital_i02I_pp0p0_maSEzHmT_zx359wktvCNh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional paid in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,449,215</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,440,616</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pp0p0_maSEzHmT_zPi4UskBubX2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,258,687</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">734,443</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_pp0p0_maSEzHmT_zBMyBr5NvAH" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated other comprehensive income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">93,398</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">181,016</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_pp0p0_mtSEzHmT_maSEIPAzVn8_zWmd8FR0a6Ha" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">TOTAL AGAPE CORPORATION STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,312,972</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,924,834</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--MinorityInterest_i01I_maSEIPAzVn8_zITfpl6AWpal" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">NON-CONTROLLING INTERESTS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">336</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0209">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_mtSEIPAzVn8_maLASEzFyq_zGSn4Jta0B9i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL EQUITY</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,312,636</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,924,834</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_mtLASEzFyq_zXzPINnKCvcg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,724,535</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,210,607</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_028"></span>CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_305_113_z6GHDAgIbmW8" summary="xdx: Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20210101__20211231_zqrjUWIbSO7d" style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200101__20201231_z3ZU4txAMEb4" style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maRzaLh_zxhYCMDJKqW" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUE</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,962</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,434,561</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--RevenueFromRelatedParty_maRzaLh_zlT6vx6moT0j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUE
    &#8211; RELATED PARTY</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0220">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AATP:RevenueFromRelatedParty" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,060</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_iT_pp0p0_mtRzaLh_maGPzxne_zSGMx7y0VUFe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    REVENUE</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,016,962</ix:nonFraction></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,452,621</ix:nonFraction></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--CostOfGoodsAndServicesSold_iN_pp0p0_di_msGPzxne_zkCBMvyMcb3c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST
    OF REVENUE</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">297,333</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">775,855</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--GrossProfit_iT_pp0p0_mtGPzxne_maOILzEpM_z3zzyY6bzyzf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GROSS
    PROFIT</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">719,629</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,676,766</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--SellingExpense_iN_pp0p0_di_maOEzZTL_zlfQLelbwNH7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELLING</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">394,682</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">376,582</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--SalesCommissionsAndFees_iN_pp0p0_di_maOEzZTL_zqGK3ajgXk74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMISSION</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SalesCommissionsAndFees" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,267</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SalesCommissionsAndFees" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">830,659</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--GeneralAndAdministrativeExpense_iN_pp0p0_di_maOEzZTL_zK1bbNkoKKjl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL
    AND ADMINISTRATIVE</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,745,734</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,627,660</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ProvisionForDoubtfulAccounts_iN_pp0p0_di_maOEzZTL_zGZNcgAUfHT2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROVISION
    FOR DOUBTFUL ACCOUNTS</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">121,514</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0242">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingExpenses_iNT_pp0p0_di_mtOEzZTL_msOILzEpM_zrmZqnsQgN16" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    OPERATING EXPENSES</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,578,197</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,834,901</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OperatingIncomeLoss_pp0p0_mtOILzEpM_maILFCOz6tX_zvgA8R972Sz8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    FROM OPERATIONS</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,858,568</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">158,135</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
    (EXPENSES) INCOME</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherNonoperatingIncomeExpense_i01_pp0p0_maNIEzaf6_z9JwPrP2vuZ" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    (Expenses) Income, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">42,753</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">164,283</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_i01_pp0p0_maNIEzaf6_z01g1IQdk0R5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized
    holding (loss) gain on marketable securities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">505,231</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">350,137</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--PreferredStockDividendIncomeStatementImpact_i01N_pp0p0_di_msNIEzaf6_zmG8tWiQ9TE6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    income from marketable securities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">18,939</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">160,062</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NonoperatingIncomeExpense_i01T_pp0p0_mtNIEzaf6_maILFCOz6tX_z9CFNVwJ0HNj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    OTHER (EXPENSES) INCOME, NET</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">529,045</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">674,482</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOz6tX_maPLzwk5_zNO4fROlNdjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(LOSS)
    INCOME BEFORE INCOME TAXES</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,387,613</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">516,347</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_msPLzwk5_zWoRr1EhYjM" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROVISION
    FOR INCOME TAXES</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,067</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">161,581</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_iT_pp0p0_mtPLzwk5_maNILzNnt_zHBT5lOXPcwg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    (LOSS) INCOME</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,524,680</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">354,766</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_msNILzNnt_zBChBssZgVIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">436</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0275">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLoss_iT_mtNILzNnt_zC1H2pQxY1ni" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,524,244</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,766</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_maCINOTzPlr_zpFGQHiipfqj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    (LOSS) INCOME</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,524,680</ix:nonFraction></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">354,766</ix:nonFraction></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
    COMPREHENSIVE (LOSS) INCOME</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_i01_pp0p0_maCINOTzPlr_zCyBzLaPril9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    currency translation adjustment</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">87,615</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">171,231</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_i01T_pp0p0_mtCINOTzPlr_maCINOTziBH_zzAiwz00VW" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    COMPREHENSIVE (LOSS) INCOME</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,612,295</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">525,997</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_msCINOTziBH_z6Cejq14x814" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    Comprehensive loss attributable to non-controlling interests</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">433</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0293">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--ComprehensiveIncomeNetOfTax_mtCINOTziBH_zzdc7qPps70f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPREHENSIVE
    (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,611,862</ix:nonFraction></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">525,997</ix:nonFraction></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(LOSS)
    EARNINGS PER SHARE</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--EarningsPerShareBasicAndDiluted_i01_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WEIGHTED
    AVERAGE NUMBER OF COMMON SHARES OUTSTANDING</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_i01_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,216,452</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,387,778</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_029"></span>CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_114_zWxO3sCl4ZG3" summary="xdx: Statement - Consolidated Statements of Changes in Stockholders&apos; Equity" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 8pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; text-align: center; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">Number
                                            of shares</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"></p></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; padding-bottom: 1.5pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; text-align: center; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zdoZAcPKMTMk" style="border-bottom: Black 1.5pt solid; display: none; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">Par
    value</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; display: none; padding-bottom: 1.5pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; text-align: center; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; display: none; padding-bottom: 1.5pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; text-align: center; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zkTF5YIa4z41" style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none"><br /></b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"><b style="display: none">ADDITIONAL PAID <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt">IN
    CAPITAL</span></b></p></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; padding-bottom: 1.5pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; text-align: center; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zpui8zgrndj5" style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">ACCUMULATED<br />
    DEFICIT</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; padding-bottom: 1.5pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; text-align: center; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zhyXgW0Td10d" style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">ACCUMULATED</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">OTHER</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">COMPREHENSIVE</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">INCOME
    </b></span></p></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; padding-bottom: 1.5pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; text-align: center; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zm46fYtofAf4" style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">NON-</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: center; margin-top: 0; margin-bottom: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">CONTROLLING
    INTERESTS</b></span></p></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; padding-bottom: 1.5pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td>&#160;</td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; display: none; text-align: center; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">&#160;</b></span></td>
    <td id="xdx_4B0_zNn5VTIhYkRa" style="border-bottom: Black 1.5pt solid; display: none; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 8pt"><b style="display: none">TOTAL
    <br />
    STOCKHOLDERS&#8217;<br />
 EQUITY</b></span></td></tr>
<tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>COMMON
    STOCK</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Number
                                            of shares</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></p></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Par
    value</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><br /></b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>ADDITIONAL PAID <span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">IN
    CAPITAL</span></b></p></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>ACCUMULATED<br />
    DEFICIT</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>ACCUMULATED</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>OTHER</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>COMPREHENSIVE</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>INCOME
    </b></span></p></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>NON-</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>CONTROLLING
    INTERESTS</b></span></p></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td>&#160;</td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>TOTAL
    <br />
    STOCKHOLDERS&#8217;<br />
 EQUITY</b></span></td></tr>
  <tr id="xdx_432_c20200101__20201231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zwk4pt38hVDb" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    as of December 31, 2019</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zObBIxOcNw1a" style="font: 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,275,500</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,628</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,293,082</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,089,209</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,785</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0314">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right; width: 4%"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,251,286</ix:nonFraction></span></td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zkEM6kpHKCu9" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    income</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0318">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0319">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,766</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0321">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0322">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,766</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zcan57ksZnVf" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issuance
    of common stock in connection with acquisition of Agape Superior Living Sdn Bhd</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zETfhu5V8LV2" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">176,547</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,147,534</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0327">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0328">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0329">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,147,551</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_z4xSvHGwopmc" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign
    currency translation adjustment</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0333">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0334">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0335">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">171,231</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0337">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">171,231</ix:nonFraction></span></td></tr>
  <tr id="xdx_435_c20210101__20211231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zLumCllZSime" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    as of December 31, 2020</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJBANYtPk70l" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,645</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,440,616</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">734,443</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">181,016</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0344">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,924,834</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_zC7ZbCP6rqDd" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Forfeiture
    of common stock</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvxgO7ijoiR4" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,992,000</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,599</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,599</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0350">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0351">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0352">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0353">-</span></span></td></tr>
  <tr id="xdx_403_ecustom--ContributionsFromNoncontrollingInterestShareholders_zVKucGUZOZq3" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Contributions
    from non-controlling interest shareholders</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0356">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0357">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0358">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0359">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="AATP:ContributionsFromNoncontrollingInterestShareholders" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="AATP:ContributionsFromNoncontrollingInterestShareholders" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zIHt5FvTvui9" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    loss</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">-<span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0363">&#160;</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0364">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,524,244</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0366">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">436</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td>&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,524,680</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zVACzqiOmGJ5" style="font: 8pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    income (loss)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,524,244</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">436</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td>&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,524,680</ix:nonFraction>)</span></td></tr>
<tr id="xdx_40D_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zrsa3YZr3XUl" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign
    currency translation adjustment</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0377">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0378">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0379">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,618</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,615</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43D_c20210101__20211231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zO2UAMPqq0s5" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    as of December 31, 2021</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znVk20mnHRD8" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">290,460,047</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,046</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,449,215</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,258,687</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,398</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">336</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">$</td>
    <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,312,636</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_030"></span>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_112_zvj4ZlnClbd7" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49E_20210101__20211231_zNFV0OYXSp9j" style="display: none; text-align: center">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_495_20200101__20201231_zJ613tiKNfAh" style="display: none; text-align: center">&#160;</td><td style="display: none">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pp0p0_maNCPBUzrvR_zQpCL1UesBGd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Net (loss) income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,524,680</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">354,766</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net (loss) income to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Depreciation_i02_pp0p0_maNCPBUzrvR_zjgirclk3Bo9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,797</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,407</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CostOfGoodsAndServicesSoldAmortization_i02_pp0p0_maNCPBUzrvR_zbgyChFJquPg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldAmortization" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,961</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldAmortization" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,505</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_pp0p0_maNCPBUzrvR_zdLDkgHYEjp3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amortization of operating right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">139,451</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,561</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_i02N_pp0p0_di_msNCPBUzrvR_z6VUD7p0qDVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized holding loss (gain) on marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">505,231</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">350,137</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--PreferredStockDividendIncomeStatementImpact_i02_pp0p0_maNCPBUzrvR_zERvewRS6EUb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Dividend income from marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">18,939</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">160,062</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_pp0p0_maNCPBUzrvR_z2K4u6owJbEg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deferred tax expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,127</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178,329</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryWriteDown_i02_pp0p0_maNCPBUzrvR_zI7UlcFMV5s" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Inventory write-down</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,241</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0420">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ProvisionForDoubtfulAccounts_i02_maNCPBUzrvR_zPHIOiN6n589" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Provision for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,514</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0423">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_pp0p0_di_msNCPBUzrvR_z98EsVzwx8Ti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">167,566</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">165,149</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_i03N_pp0p0_di_msNCPBUzrvR_z0yXmzeizYh8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amount due from a related party</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0431">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,417</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInInventories_i03N_pp0p0_di_msNCPBUzrvR_zv7nYfoJkPVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">192,713</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">78,674</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInPrepaidTaxes_i03N_pp0p0_di_msNCPBUzrvR_zxYGRwBul6K3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepaid taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidTaxes" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">430,062</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidTaxes" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">184,985</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_pp0p0_di_msNCPBUzrvR_zczH8kuzJWLi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepayments and deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">128,363</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">352,577</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInOtherAccountsPayable_i03_pp0p0_maNCPBUzrvR_zXITnnTQQOVa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0443">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,804</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_pp0p0_maNCPBUzrvR_zCMNXUWNKnL1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">52,981</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,421,886</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i03_pp0p0_maNCPBUzrvR_zORuBWxqWrj3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">226,651</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">336,709</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IncreaseDecreaseInOperatingLeaseLiabilities_i03_pp0p0_maNCPBUzrvR_zv8lmkgaBN44" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AATP:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">138,143</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AATP:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">105,009</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_pp0p0_maNCPBUzrvR_zJuVH3wBLWT" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Income tax payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,988</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0456">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i02T_pp0p0_mtNCPBUzrvR_maCCERCzPaW_z0eZOSRFr3jf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">845,842</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">557,951</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_pp0p0_di_msNCPBUzHoe_zM5kbbyfLFqb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Purchase of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,959</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,734</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_pp0p0_di_msNCPBUzHoe_z0XhvoAZv2ff" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Purchase of intangible assets</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0467">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--CashAcquiredFromAcquisition_i01_pp0p0_maNCPBUzHoe_zIyoAHFDzRh3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0470">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,210,818</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ProceedsFromSaleOfInvestmentProjects_i01_pp0p0_maNCPBUzHoe_z9wmY7NzMnn5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from sale of marketable securities</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfInvestmentProjects" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">121</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_i01_pp0p0_maNCPBUzHoe_zuIrIik35lGi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Proceeds from sale of non-marketable securities to a related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0476">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">70,173</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_mtNCPBUzHoe_maCCERCzPaW_z2ORaIDCPMod" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash (used in) provided by investing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,959</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,276,200</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PaymentsOfDebtIssuanceCosts_i01N_pp0p0_di_msNCPBUzKlO_zEdhBX8ovTl3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deferred offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,210</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">249,525</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_i01_pp0p0_maNCPBUzKlO_zs6bmIkKznd5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">(Advances to) Repayments from related parties</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,851</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">227,434</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUzKlO_maCCERCzPaW_zcZ1nIm6lUCk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">19,061</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">22,091</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_maCCERCzPaW_zuIyEBg3J5eg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">50,890</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,985</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzPaW_zdVHJfTHxq4c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">919,752</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">773,143</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">CASH AND CASH EQUIVALENTS, beginning of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,517,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,744,457</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0_zL9dnn8s0Zkd" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,597,848</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,517,600</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SupplementalCashFlowInformationAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">SUPPLEMENTAL CASH FLOWS INFORMATION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeTaxesPaidNet_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Income taxes paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">326,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">288,929</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestPaidNet_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Interest paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0512">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0513">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">SUPPLEMENTAL NON-CASH FLOWS INFORMATION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications_i01_z3E52g3PGD32" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Changes in right-of-use assets and lease liabilities due to lease modifications</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,250</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Initial recognition of right-of-use assets and lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0521">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">483,343</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Sale of non-marketable securities to a related party in exchange for acquisition payment of ASL</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0524">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">656,495</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Issuance of common stock in exchange for acquisition payment of ASL</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0527">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,147,551</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_031"></span>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_808_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zjryWW5VR6N1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
<span id="xdx_82D_zuTOrtJQ1rSi">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation, a Nevada corporation (&#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on June 1, 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape
Superior Living Sdn. Bhd. (&#8220;ASL&#8221;), a company incorporated in Malaysia. .</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zhzQsicOITE6" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-12-31_custom_AgapeATPInternationalHoldingLimitedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zFkZqBDvcHa1" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,590,596</ix:nonFraction></span> ordinary shares, no par value, equivalent to approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200508__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zZfcYS6QRELe" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-05-08_custom_SubsidiaryCompanyTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.99</ix:nonFraction></span>% of the equity interest in Agape Superior Living Sdn. Bhd.,
a network marketing entity incorporated in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (&#8220;WATP&#8221;), a wholly owned subsidiary
under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services
that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (&#8220;DSY Wellness&#8221;)
with an independent third party which Agape ATP Corporation (Labuan) owns <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211111__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zwxMW21cPNK6" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-11-11_custom_SubsidiaryCompanyFiveMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span>% of the equity interest, to pursue the business of providing
complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to
supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation,
anti-aging and products designed to improve the overall health system of the human body and various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements reflect the activities of the Company, AATP LB, AATP HK, WATP, ASL and its variable interest
entity (&#8220;VIE&#8221;), Agape S.E.A. Sdn. Bhd. (&#8220;SEA&#8221;) (See Note 3), and DSY Wellness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zwe7aFvThaG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the Company&#8217;s subsidiaries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zj3z0IqpFBQk" style="display: none">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Subsidiary company name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Place and date of incorporation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Particulars of issued capital</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Principal activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proportional of ownership interest and voting power held</td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 6%; vertical-align: top">1.</td>
    <td style="width: 2%">&#160;</td>
    <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zJXEvi6NRyUh" title="Subsidiary company name" style="vertical-align: top; width: 16%; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember" name="AATP:NameOftheCompany">Agape ATP Corporation</ix:nonNumeric></td><td style="width: 2%">&#160;</td>
    <td id="xdx_98B_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zzkn5rj3Uck" title="Place and date of incorporation" style="vertical-align: top; width: 16%; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember" name="AATP:PlaceAndDateOfIncorporation">Labuan, <br /> March 6, 2017</ix:nonNumeric></td><td style="width: 2%">&#160;</td>
    <td id="xdx_984_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsgpDyy2TMMl" title="Particulars of issued capital" style="vertical-align: top; width: 16%; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember" name="AATP:ParticularsOfIssuedCapital">100 shares of ordinary share of US$1 each</ix:nonNumeric></td><td style="width: 2%">&#160;</td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zoZtxcXvENgf" title="Principal activities" style="vertical-align: top; width: 16%; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember" name="AATP:PrincipalActivities">Investment holding</ix:nonNumeric></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zicZ1wjT3AE4" title="Proportional of ownership interest and voting power held" style="vertical-align: top; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="vertical-align: top; width: 1%; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">2.</td>
    <td>&#160;</td>
    <td id="xdx_98C_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zaubThxHYBVh" title="Subsidiary company name" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember" name="AATP:NameOftheCompany">Agape ATP International Holding Limited</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_989_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zuC7GgYsCeD7" title="Place and date of incorporation" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember" name="AATP:PlaceAndDateOfIncorporation">Hong Kong,<br /> June 1, 2017</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_98E_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zdSzsaNpIea4" title="Particulars of issued capital" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember" name="AATP:ParticularsOfIssuedCapital">1,000,000 shares of ordinary share of HK$1 each</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zocye911l2qg" title="Principal activities" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember" name="AATP:PrincipalActivities">Wholesaling of health and wellness products; and health solution advisory services</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z1c7ZCaUNV1f" title="Proportional of ownership interest and voting power held" style="vertical-align: top; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="vertical-align: top; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">3.</td>
    <td>&#160;</td>
    <td id="xdx_985_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zRcFlMWvqJ7l" title="Subsidiary company name" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember" name="AATP:NameOftheCompany">Agape Superior Living Sdn. Bhd.</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_984_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zcs7sN0Nu5q7" title="Place and date of incorporation" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember" name="AATP:PlaceAndDateOfIncorporation">Malaysia, <br /> August 8, 2003</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_986_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z5dnt8C8MCpe" title="Particulars of issued capital" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember" name="AATP:ParticularsOfIssuedCapital">9,590,598 shares of ordinary share of RM1 each</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zpruVcSAlxS2" title="Principal activities" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember" name="AATP:PrincipalActivities">Health and wellness products and health solution advisory services via network marketing</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z8X5TglxoRU1" title="Proportional of ownership interest and voting power held" style="vertical-align: top; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.99</ix:nonFraction></td><td style="vertical-align: top; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">4.</td>
    <td>&#160;</td>
    <td id="xdx_986_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zOSA8SvcFSe8" title="Subsidiary company name" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember" name="AATP:NameOftheCompany">Agape S.E.A. Sdn. Bhd.</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_986_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_z5D1tm2kmR9j" title="Place and date of incorporation" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember" name="AATP:PlaceAndDateOfIncorporation">Malaysia, <br /> March 4, 2004</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_985_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zKXQYjcIaqj4" title="Particulars of issued capital" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember" name="AATP:ParticularsOfIssuedCapital">2 shares of ordinary share of RM1 each</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zycxkWzXgPB5" title="Principal activities" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember" name="AATP:PrincipalActivities">VIE of Agape Superior Living Sdn. Bhd.</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE</span></td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">5.</td>
    <td>&#160;</td>
    <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zlD30iy2ipI8" title="Subsidiary company name" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember" name="AATP:NameOftheCompany">Wellness ATP International Holdings Sdn, Bhd</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_98E_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zQBdLUuSkqZi" title="Place and date of incorporation" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember" name="AATP:PlaceAndDateOfIncorporation">Malaysia, <br /> September 11, 2020</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z7oHDCHRFsp5" title="Particulars of issued capital" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember" name="AATP:ParticularsOfIssuedCapital">100 shares of ordinary share of RM1 each</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zIVr6Myj4za4" title="Principal activities" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember" name="AATP:PrincipalActivities">The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zuZTuMiA4XY6" title="Proportional of ownership interest and voting power held" style="vertical-align: top; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyFourMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="vertical-align: top; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">6.</td>
    <td>&#160;</td>
    <td id="xdx_989_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zTc8c6JIi7r7" title="Subsidiary company name" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember" name="AATP:NameOftheCompany">DSY Wellness International Sdn Bhd.</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zKS9tx910Yg9" title="Place and date of incorporation" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember" name="AATP:PlaceAndDateOfIncorporation">Malaysia, <br /> November 11, 2021</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_z1CtNu8Ndnue" title="Particulars of issued capital" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember" name="AATP:ParticularsOfIssuedCapital">1,000 shares of ordinary share of RM1 each</ix:nonNumeric></td><td>&#160;</td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zJKc7Z8ErKth" title="Principal activities" style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember" name="AATP:PrincipalActivities">Provision of complementary health therapies</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zolorxDKUq1i" title="Proportional of ownership interest and voting power held" style="vertical-align: top; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyFiveMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></td><td style="vertical-align: top; text-align: right">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zX77UpgzHdI7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
ORGANIZATION AND BUSINESS BACKGROUND (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company
primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#8220;ATP Zeta Health Program&#8221;,
which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy
lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of
modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to strengthen the Company&#8217;s supply chain, on May 8, 2020, the Company has successfully acquired approximately <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zNAp4MKs5WLe"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.99</ix:nonFraction></span>% of ASL,
with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years.
ASL has been offering the Company&#8217;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy
in the Company&#8217;s operation by boosting the Company&#8217;s retail and marketing capabilities. The newly acquired subsidiary allows
the Company to fulfill its mission of &#8220;helping people to create health and wealth&#8221; by providing a financially rewarding business
opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via
ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#201;NERG&#201;TIQUE
and BEAUNIQUE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused
by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity
through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and
distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&#201;NERG&#201;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series
is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
BEAUNIQUE product series focuses on the research of our diet&#8217;s impact on modifying gene expressions in order to address genetic
variations and deliver a nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution
advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various
wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">To
further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity,
DSY Wellness International Sdn. Bhd. (&#8220;DSY Wellness&#8221;) with an independent third party which Agape ATP Corporation (Labuan)
owns 60% of the equity interest, to pursue the business of providing complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zuQiQKgWfU4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<span id="xdx_829_zm1kCRUSRHuc">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zeDlPoyXheKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#8220;U.S. GAAP&#8221;) for information pursuant to the rules and regulations of the Securities Exchange Commission
(&#8220;SEC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company
exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary.
All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zIzk1snyltAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principles
of consolidation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to
govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a
majority of votes at the meeting of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without
additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such
as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of
the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary
and must consolidate the VIE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_843_eus-gaap--UseOfEstimates_zJNbiMqwRbCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use
of estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates
reflected in the Company&#8217;s consolidated financial statements include allowance for doubtful accounts, allowance for inventories
obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for
deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment
in non-marketable securities. Actual results could differ from these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z3rzciRsd7ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
and cash equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.</span></p>

</ix:nonNumeric><p id="xdx_85A_z7h8mKQ3Eo71" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zfLkXh3OhBMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
receivable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due
on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the
Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis,
using historical collection trends and aging of receivables. Management also periodically evaluates individual customer&#8217;s financial
condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary.
Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. The Company&#8217;s management continues to evaluate the reasonableness of the valuation allowance policy and update
it if necessary. As of December 31, 2021 and 2020, <span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20211231_zZpkZXBfDhF1" title="Accounts receivable, allowance for credit loss::XDX::-"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20201231_z2gRSfBQ4YQh" title="Accounts receivable, allowance for credit loss::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0613"><span style="-sec-ix-hidden: xdx2ixbrl0615">no</span></span></span></span> allowance of doubtful accounts was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zdaWn6gJJjD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Inventories</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life
of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net
realizable value. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021,
and 2020, the company recorded $<span id="xdx_90A_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zz2wt2LAgfC5" title="Inventories write-down"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,241</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--InventoryWriteDown_pp0p0_dxL_c20200101__20201231_zB3vozrYmlpa" title="Inventories write-down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0621">0</span></span> write-downs for inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:PrepaidTaxesPolicyTextBlock"><p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zdZoMb8wzNHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepaid
taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Prepaid
taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:PrepaymentsAndDepositsPolicyTextBlock"><p id="xdx_849_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zqkBitGlXc97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepayments
and deposits</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services.
This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not
be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management
reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary.
Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood
of collection is not probable. The Company&#8217;s management continues to evaluate the reasonableness of the valuation allowance policy
and update it if necessary. As of December 31, 2021 and 2020, there was $<span id="xdx_902_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20211231_zOfQcpaErBJ1" title="Allowance for doubtful accounts"><ix:nonFraction name="AATP:AllowanceForDoubtfulAccountsReceivablesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">121,514</ix:nonFraction></span> and $<span id="xdx_906_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zdfQOpCLD4Ne" title="Allowance for doubtful accounts"><ix:nonFraction name="AATP:AllowanceForDoubtfulAccountsReceivablesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> allowance for the doubtful accounts recorded.</span></p>

</ix:nonNumeric><p id="xdx_851_zmKlSpfnevK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7cYcWhlN8v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property
and equipment, net</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock"><p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zSzEw3lfeing" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    and office equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">6</ix:nonNumeric></span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> years</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_LeaseholdImprovementsMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">Lease
    Term</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_VehiclesMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>
    years</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A9_zEFPE25M0ylf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is
included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings
as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The
Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates
of useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zHEzuq48QgQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intangible
assets, net</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock"><p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the
estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zvU7SXf61uW4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonNumeric></span>
    years</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A7_zorLQNME5Hh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z5qzlK0tNytk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment
for long-lived assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes
in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that
the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted
future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows
expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying
value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value
based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and
2020, <span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20210101__20211231_zrSWi5qIbct2" title="Impairment of long-lived assets"><span id="xdx_902_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zLQgENYYhvLc" title="Impairment of long-lived assets"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="From2021-01-01to2021-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="From2020-01-012020-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> impairment of long-lived assets was recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock"><p id="xdx_84B_eus-gaap--DeferredChargesPolicyTextBlock_z36dlBRJQxUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred
offering costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
offering costs represents costs associated with the Company&#8217;s current offering which will be netted against the proceeds from the
Company&#8217;s current offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:MarketableSecuritiesPolicy"><p id="xdx_849_eus-gaap--MarketableSecuritiesPolicy_zgB7vO5Vnsi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment
in marketable equity securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company follows the provisions of ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair value
with changes in fair value recognized in the Company&#8217;s unaudited condensed consolidated statements of operations and comprehensive
loss in the caption of &#8220;unrealized holding gain loss on marketable securities&#8221; in each reporting period</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

</ix:nonNumeric><p id="xdx_854_zmZq0CFspjHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:NonMarketableSecuritiesPolicyTextBlock"><p id="xdx_84E_ecustom--NonMarketableSecuritiesPolicyTextBlock_z3ijwap9sP65" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment
in non-marketable equity securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Due to the Company&#8217;s non-marketable equity securities (non-current) does not
qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its
investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from
observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment
is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance,
credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or
technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical
area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed
auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that
raise significant concerns about the investee&#8217;s ability to continue as a going concern, such as negative cash flows from operations,
working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators
indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment
loss equal to the difference between the fair value of the investment and its carrying amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zTvWJ7as6POh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Customer
deposits</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced
when the related sale is recognized in accordance with the Company&#8217;s revenue recognition policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zMrTajC1AXKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue
recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core
principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods
and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange.
This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a
point in time or over time, based on when control of goods and services transfers to a customer. The Company&#8217;s revenue streams
are recognized at a point in time for the Company&#8217;s sale of health and wellness products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company
(i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate
the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies
the performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment
terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of Health and Wellness products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness
products are transferred to its customer at the Company&#8217;s office or shipment of the goods. The revenue is recorded net of estimated
discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were
insignificant sales returns</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value
of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds
resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and
wellness products transaction price upon such sales transactions occurred. The Company&#8217;s coupons have a validity period of six
months. If the Company&#8217;s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of
the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $<span id="xdx_906_ecustom--ForfeitedCouponIncome_pp0p0_c20210101__20211231_zh7G9r61F1ta"><ix:nonFraction name="AATP:ForfeitedCouponIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,209</ix:nonFraction></span>
and $<span id="xdx_908_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zkpNQLzrUHHf" title="Forfeited coupon income"><ix:nonFraction name="AATP:ForfeitedCouponIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">170,431</ix:nonFraction></span> as forfeited coupon income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_za2TyjvrR2mg" title="Revenue from sales"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_HealthAndWellnessProductsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">183,816</ix:nonFraction></span> which it is expected
to fulfill within 12 months from December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of Health and Wellness services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company carries out its Wellness program, where the Company&#8217;s products are bundled with health screening test and a health camp
program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver
the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that
the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend
the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test
reports are completed and delivered to its customers during the consultation section in person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp
program was completed in the final day of the health camp</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zHfubZZIitA3"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_HealthAndWellnessServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,543</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zqmC0FnEsRM2"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_HealthAndWellnessServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock"><p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated
information of revenues by products and services are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Survivor Select</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_SurvivorSelectMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,904</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_SurvivorSelectMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">149,897</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Energized Mineral Concentrate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_EnergizedMineralConcentrateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,047</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_EnergizedMineralConcentrateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,481</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ionized Cal-Mag</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_IonizedCalMagMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,527</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_IonizedCalMagMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">908,964</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Omega Blend</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_OmegaBlendMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">222,718</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_OmegaBlendMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">495,567</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">BetaMaxx</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_BetaMaxxMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">208,043</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_BetaMaxxMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,550</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vege Fruit Fiber</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_VegeFruitFiberMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,757</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_VegeFruitFiberMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,755</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Iron</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_IronMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,114</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_IronMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,389</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Young Formula</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_YoungFormulaMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,425</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_YoungFormulaMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">653,631</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organic Youth Care Cleansing Bar</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_OrganicYouthCareCleansingBarMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,137</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_OrganicYouthCareCleansingBarMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,127</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Mitogize</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_MitogizeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,800</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_MitogizeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,801</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">No. 1 MED</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_NoOneMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,331</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_NoOneMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,713</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Energetique</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_EnergetiqueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,574</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_EnergetiqueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">253,396</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trim+</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_TrimPlusMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,042</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_TrimPlusMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">365,350</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenues &#8211; products</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_us-gaap_ProductMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,009,419</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_us-gaap_ProductMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,452,621</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Health and Wellness
    services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_HealthAndWellnessServicesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,543</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0721">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenues</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,962</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,452,621</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zKKWWqhhjikh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock"><p id="xdx_840_eus-gaap--CostOfSalesPolicyTextBlock_z0ZV9KzHWuv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cost
of revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Cost
of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue
amounted to $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231_zQDKOqYEwgwe" title="Cost of revenue"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">297,333</ix:nonFraction></span> (including inventory write-downs of $<span id="xdx_907_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zAnOlYDliz7l" title="Inventories write-down"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,241</ix:nonFraction></span>) and $<span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20200101__20201231_z1I0GRSSjKHh" title="Cost of revenue"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">775,855</ix:nonFraction></span> for the years ended December 31, 2021 and 2020, respectively</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:ShippingAndHandlingPolicyTextBlock"><p id="xdx_847_ecustom--ShippingAndHandlingPolicyTextBlock_zHjEmh7vgPHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Shipping
and handling</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling charges amounted to $<span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z39I3F7j8mE9" title="Selling expenses"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,054</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zzZpeqTGyBZa" title="Selling expenses"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,315</ix:nonFraction></span> for the years ended December 31, 2021 and 2020, respectively. Shipping and handling
charges are expensed as incurred and included in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zOiXHeocTzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Advertising
costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
costs amounted to $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20210101__20211231_z2FuMLE61324" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,218</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zuyisFdiELCe" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,339</ix:nonFraction></span> for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as
incurred and included in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CommissionsExpensePolicyPolicyTextBlock"><p id="xdx_848_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zbeXzIh9K1Xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Commission
expenses </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
expenses are the Company&#8217;s most significant expenses. As with all companies in the network marketing industry, the Company&#8217;s
sales channel is external to the Company. The Company&#8217;s &#8220;external sales force&#8221; is stratified into two levels based
on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly,
are referred to as &#8220;sales network members&#8221;. The Company pays commission to every sales distributor based on purchases made
by its sales network members which includes the independent</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">direct
sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy
benefits such as maintaining a certain amount of the Company&#8217;s inventory on their store premises. The stockists shall account to
the Company for all products sales from their store premises as monitored through the Company&#8217;s centralized stock tracking system.
The Company pays a separate commission to stockists based on revenue generated from the stockists&#8217; physical stores. Commission
expenses amounted to $<span id="xdx_909_ecustom--SalesCommissionsAndFees1_pp0p0_c20210101__20211231_z6ZNeK45NC3j" title="Commission expenses"><ix:nonFraction name="AATP:SalesCommissionsAndFees1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,267</ix:nonFraction></span> and $<span id="xdx_900_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zSxc8j1L6f32" title="Commission expenses"><ix:nonFraction name="AATP:SalesCommissionsAndFees1" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">830,659</ix:nonFraction></span> for the years ended December 31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:DefinedContributionPlanPolicyTextBlock"><p id="xdx_846_ecustom--DefinedContributionPlanPolicyTextBlock_zkZvS1Yq0XF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span style="text-decoration: underline">Defined
contribution plan</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue
and pay for these benefits based on certain percentages of the employees&#8217; respective salaries, subject to certain ceilings, in
accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Total expenses for the plans were $<span id="xdx_900_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20210101__20211231_zgJgN31MZHD5" title="Defined contribution plan expense"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">99,488</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_z5f6ZzaKecgf" title="Defined contribution plan expense"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,802</ix:nonFraction></span> for the years ended December 31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
related contribution plans include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Social
    Security Organization (&#8220;SOSCO&#8221;) &#8211; <span id="xdx_90E_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_ze4TdFb1Fj2" title="Salary percentage"><ix:nonFraction name="AATP:SalaryPercentage" contextRef="From2021-01-012021-12-31_custom_SocialSecurityOrganizationMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.75</ix:nonFraction></span>% based on employee&#8217;s monthly salary capped of RM <span id="xdx_90C_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zUmbVWZyicu9" title="Monthly salary"><ix:nonFraction name="AATP:MonthlySalary" contextRef="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember_custom_MYRCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="RM">4,000</ix:nonFraction></span>;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
    Provident Fund (&#8220;EPF&#8221;) &#8211; <span id="xdx_905_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_zVn7Eiyly6O8" title="Salary percentage"><ix:nonFraction name="AATP:SalaryPercentage" contextRef="From2021-01-012021-12-31_custom_EmployeesProvidentFundMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% based on employee&#8217;s monthly salary;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Insurance System (&#8220;EIS&#8221;) &#8211; <span id="xdx_906_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zhFZHd7oCLi1" title="Salary percentage"><ix:nonFraction name="AATP:SalaryPercentage" contextRef="From2021-01-012021-12-31_custom_EmploymentInsuranceSystemMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span>% based on employee&#8217;s monthly salary capped of RM <span id="xdx_903_ecustom--MonthlySalary_pp0p0_uRM_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zavxrZi1P9Ul" title="Monthly salary"><ix:nonFraction name="AATP:MonthlySalary" contextRef="From2021-01-012021-12-31_custom_EmploymentInsuranceSystemMember_custom_MYRCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="RM">4,000</ix:nonFraction></span>;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Human
    Resource Development Fund (&#8220;HRDF&#8221;) &#8211; <span id="xdx_900_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zt0N8oBqBNq" title="Salary percentage"><ix:nonFraction name="AATP:SalaryPercentage" contextRef="From2021-01-012021-12-31_custom_HumanResourceDevelopmentFundMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span>% based on employee&#8217;s monthly salary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z5jmFnxmDe13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income
taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for
the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted
or substantively enacted by the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the
carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation
of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences
can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the
liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged
directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
uncertain tax position is recognized as a benefit only if it is &#8220;more likely than not&#8221; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is <span id="xdx_907_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210101__20211231_zI0BK4zQ6X15" title="Income tax examination, likelihood of unfavorable settlement"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement">greater than 50%</ix:nonNumeric></span> likely of being realized on examination. For tax positions not meeting the &#8220;more likely than not&#8221; test,
no tax benefit is recorded. $<span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20210101__20211231_zhtHJHFt04F7" title="Income tax examination, penalties and interest expense"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">395</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20200101__20201231_zwgUz8si7Xxk" title="Income tax examination, penalties and interest expense"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> penalties and interest incurred related to underpayment of income tax for the years ended December
31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a
result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock"><p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zFmJhQqD6MOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comprehensive
income (loss)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss)
refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#8217; equity but are excluded
from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not
using the U.S. dollar as its functional currencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:NoncontrollingInterestPolicyTextBlock"><p id="xdx_843_ecustom--NoncontrollingInterestPolicyTextBlock_zvodLWm7yptb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-controlling
interest</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--MinorityInterestDescription_c20210101__20211231_z2jVyFk7GMzi" title="Noncontrolling interest, description"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="us-gaap:MinorityInterestDescription">Non-controlling
interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out
of 9,590,598 shares) of the equity interests of ASL held by two individuals</ix:nonNumeric></span>. The non-controlling interests are presented in the consolidated
balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the
Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods
between non-controlling interest holders and the shareholders of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zZGPhNuzFDjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Earnings
(loss) per share</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company computes earnings (loss) per share (&#8220;EPS&#8221;) in accordance with ASC 260, &#8220;Earnings per Share&#8221;. ASC 260
requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share
outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible
securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later.
Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are
excluded from the calculation of diluted EPS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. For the
years ended December 31, 2021 and 2020, there were <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20210101__20211231_z6oZ7p2bv9Mf" title="Potentially dilutive securities outstanding"><span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20200101__20201231_zVXiU2cpuCAc" title="Potentially dilutive securities outstanding"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-01to2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span> dilutive shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8AGmGK5QsX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
currencies translation and transaction</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing
at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated
into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded
in the consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have been expressed
in US$. The Company&#8217;s subsidiary in Labuan maintains its books and record in United States Dollars (&#8220;US$&#8221;) albeit its
functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit
(&#8220;MYR&#8221; or &#8220;RM&#8221;). The Company&#8217;s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars
(&#8220;HK$&#8221;), similar to its functional currency. The Company&#8217;s subsidiary and VIE in Malaysia conducts its businesses and
maintains its books and record in the local currency, Malaysian Ringgit (&#8220;MYR&#8221; or &#8220;RM&#8221;), as its functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into
US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate on the balance
sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation
of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the
statements of stockholders&#8217; equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts
reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance
sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end MYR : US$1 exchange
    rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" title="Foreign Currency Exchange Rate, Translation" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2021-12-31_custom_PeriodEndMYRMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.18</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" title="Foreign Currency Exchange Rate, Translation" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2020-12-31_custom_PeriodEndMYRMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.02</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" title="Foreign Currency Exchange Rate, Translation" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2021-12-31_custom_PeriodEndHKDMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.80</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" title="Foreign Currency Exchange Rate, Translation" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2020-12-31_custom_PeriodEndHKDMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.75</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average MYR : US$1 exchange
    rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" title="Foreign currency exchange rate period average" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2021-01-012021-12-31_custom_PeriodAverageMYRMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.14</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" title="Foreign currency exchange rate period average" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2020-01-012020-12-31_custom_PeriodAverageMYRMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.20</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" title="Foreign currency exchange rate period average" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2021-01-012021-12-31_custom_PeriodAverageHKDMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.77</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" title="Foreign currency exchange rate period average" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2020-01-012020-12-31_custom_PeriodAverageHKDMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.76</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zqNifIeILn8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:RelatedPartiesPolicyTextBlock"><p id="xdx_846_ecustom--RelatedPartiesPolicyTextBlock_zrQDAfgxw1sl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related
parties</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFEmgvJtixod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
value of financial instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and
requires disclosure of the fair value of financial instruments held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance
disclosure requirements for fair value measures. The three levels are defined as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that
    are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost,
which approximate fair value because of the short period of time between the origination of such instruments and their expected realization
and their current market rates of interest.</span></p>

</ix:nonNumeric><p id="xdx_854_zbiKkVXe0pQi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zZNdDkKBmvPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopts ASU 2016-02, &#8220;Leases&#8221; (Topic 842), and elected the practical expedients that does not require the Company
to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing
leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted
to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient
that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company&#8217;s leases
include one or more options to renew, which is typically at the Company&#8217;s sole discretion. The Company regularly evaluates the
renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications
result in re-measurement of the right of use (&#8220;ROU&#8221;) assets and lease liabilities. Operating ROU assets and lease liabilities
are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for
the Company&#8217;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available
at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that
the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment
and over a similar term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease,
as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers
the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected
the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve
months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives.
Lease expense is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews
the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the
asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset
from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount
of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future
pre-tax cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwRa40sJZ3q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent
accounting pronouncements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of
such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic
326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement
of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments
in Update 2016-13 added Topic 326, Financial Instruments&#8212;Credit Losses, and made several consequential amendments to the Codification.
Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses
when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments&#8212; Credit Losses&#8212;Available-for-Sale
Debt Securities. The amendments in this Update address those stakeholders&#8217; concerns by providing an option to irrevocably elect
the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition
relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar
financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments
in Update 2016-13 while still providing financial statement users with decision-useful information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit
organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date
for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim
reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating
the impact ASU 2019-05 may have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments
accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options
accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should
consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement
alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts
or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity
should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing
investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance
with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted,
including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-08, &#8220;Codification Improvements to Subtopic 310-20, Receivables&#8212;Nonrefundable Fees
and Other Costs&#8221;. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification
easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the
Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply
the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable
debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021
did not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-10, &#8220;Codification Improvements&#8221;. The amendments in this Update represent changes to
clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current
accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety
of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is
effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments
in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on
its consolidated financial statements.</span></p>

</ix:nonNumeric><p id="xdx_85B_z1wiGXOwYsl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:VariableInterestEntityDisclosureTextBlock"><p id="xdx_80E_eus-gaap--VariableInterestEntityDisclosureTextBlock_zgIAe8pTJwf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.<span id="xdx_826_zJTc7N756JKh">
VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEA
is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided majority of ASL&#8217;s purchases. Its equity
at risk was insufficient to finance its activities and <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zCTAPQB3ObJb" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of its business is transacted with ASL. Therefore, it was considered to be
a VIE and ASL is the primary beneficiary since it has both of the following characteristics:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the
    VIE that could potentially be significant to the VIE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the accounts of SEA is consolidated in the accompanying financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_ziGf9DSLZguk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of the VIE&#8217;s assets and liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_z3zsHjUhKgR2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF VARIABLE INTEREST ENTITY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zBBDeiE1qBYf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_z2TTLKve29le"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_iI_zG66KK7YK2o8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,850</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,717</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesCurrent_iNI_di_zPrH2WbQg587" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,272</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,573</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--StockholdersEquity_iI_zPkIAvNRIe8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">32,422</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,856</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zW698uRlRrVl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zWYlp147wSI9"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_zMxrxRs5Smr9" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,493</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,387</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidTaxes_iI_zRfWUPLsX9ga" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidTaxes" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,357</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidTaxes" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,330</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsCurrent_iI_zEyDHieHajs8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,850</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,717</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_z8jU9wyuZVP9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable &#8211; intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,724</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,669</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--OtherPayablesRelatedPartyCurrent_iI_z1TajavnLNl5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables and accrued
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:OtherPayablesRelatedPartyCurrent" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,548</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:OtherPayablesRelatedPartyCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,904</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iI_zNU60IeGzAIc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,272</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,573</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquity_iI_zbeklS8QD69c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">32,422</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,856</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
summarized operating results of the VIE&#8217;s are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_499_20210101__20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zi6p0xMmPGM2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zk2JEF1orUyc"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zJkAWrUJn7vg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    revenues</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">346,907</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--GrossProfit_z8WN2B2SZ4M4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,442</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_z7P4DubEetea" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss from operations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,966</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,752</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_z9kg1Cro03Zj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,966</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,014</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_z9XMfeKjRbje" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_807_eus-gaap--BusinessCombinationDisclosureTextBlock_zHKYl8jArZKf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
<span id="xdx_82E_znKBt4nMZKba">BUSINESS COMBINATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 8, 2020, the Company entered into a Share Exchange Agreement (&#8220;SPA&#8221;) with Mr. How Kok Choong, CEO and director of the
Company to acquire <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zpoIx15294x9" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,590,596</ix:nonFraction></span> ordinary shares, <span id="xdx_903_eus-gaap--CommonStockNoParValue_iI_pid_do_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zusXLrQtxMGg" title="Ordinary shares no par value"><ix:nonFraction name="us-gaap:CommonStockNoParValue" contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares">no</ix:nonFraction></span> par value, equivalent to approximately <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_znvYx7HfnLQh" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.99</ix:nonFraction></span>% of the equity interest in ASL, an entity
incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration of $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200629__20200702__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zDegVsPKsyCi" title="Purchase consideration value"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2020-06-292020-07-02_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,804,046</ix:nonFraction></span>,
which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration shall be satisfied
by (i) the offset of the Consideration whereby the Company has a loan receivable of $<span id="xdx_906_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_pp0p0_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zqnnhV1u2Yrl" title="Loan payable"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">656,495</ix:nonFraction></span> as of March 31, 2020 due from Mr. How; and
(ii) allotment and issuance of common stock of the Company. The Company shall allot and issue <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z1n36MvAuTgd" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">176,547</ix:nonFraction></span> shares of the Company&#8217;s common
stock, par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zweck9JWKzxa" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>, representing approximately <span id="xdx_90F_ecustom--PercentageOfCommonStockIssuedAndOutstanding_pid_dp_uPure_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_ztBialGaIA75" title="Percentage of common stock issued and outstanding"><ix:nonFraction name="AATP:PercentageOfCommonStockIssuedAndOutstanding" contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0469</ix:nonFraction></span>% of the total issued and outstanding shares in the Company after the issuance
of the Shares, which is valued at $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zcDFdmnq1Mob" title="Stock issued during period, value, acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,147,551</ix:nonFraction></span> based on the closing price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20200331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zweSXWsFrjuc" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-03-31_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.50</ix:nonFraction></span> of the Company as quoted on the OTC Market on March
31, 2020. As of December 31, 2020, the Company has issued all <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zOYczuv65Dse" title="Issuance of common stock shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-01-012020-12-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">176,547</ix:nonFraction></span> shares of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated
the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020
as ASL was under the common control of Mr. How.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z9hQbHfHjE47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which
represents the net purchase price allocation on the date of the acquisition of ASL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BF_zZ9ze4vUt6Xf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20211231_zi5gZGfDW912" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Carry
    Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zFootoo6DkQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 80%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,206,493</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zPCfRzzCqFe2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,210</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_iI_zvU4mN9Vlab4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables - related
    parties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">219,121</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_z4KcdNuvJtvf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Inventories</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">616,880</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_iI_zIZKzHM3w2W" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,206,821</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zUn3enkZbJpk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepayments
    and other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">318,267</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zKz3awcUZDTd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,600,792</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_ztkI3wRKXP4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment,
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">325,648</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zLClQ04mPaFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,686</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_z5dLrc78mnxc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    taxes asset, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,250</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_zBZrA7c0ltt3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">504,584</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zPuB2iDXZjri" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,105,376</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES AND SHAREHOLDERS&#8217;
    EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zT38U9zsO3Kf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable - related
    party</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">491,628</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_zhCBrTvOaBml" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Customer deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,600,606</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_z9N5VJeANSV8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    payables and accrued liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,096</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_zCmXdCjZO6z7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,301,330</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zQvCrxEVwmn1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,301,330</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zq2ThSccWRP9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    net assets acquired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,804,046</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zv4jqD0Ky8K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
BUSINESS COMBINATION (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited pro forma combined results of operations presents the Company&#8217;s financial results as if the acquisition of
ASL had been completed on January 1, 2020. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings
which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily
indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2020. Future
results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other
factors.</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock"><p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zseqpulCa5J1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B9_zZVcZYoKTnPc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE
OF PRO FORMA BUSINESS COMBINATION</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200101__20201231_zuUagwDfcb66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the year ended December 31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaRevenue_zuz6pejZgaNh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,693,873</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_zhoMOdVTbnj8" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaCostOfRevenue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">875,708</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_406_ecustom--BusinessAcquisitionsProFormaGrossProfit_zEF3eZHqnGUj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaGrossProfit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,818,165</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_zXatwYMBeZoa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaOperatingExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,839,184</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zBEyIiiyyL8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;Loss from operations</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,019</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_zWFdgUfqokuj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other income (expense),
    net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">267,633</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_z7tgSGvyyUyh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income before income taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">246,614</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_zGrdUgLWVzZ6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income
    taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">212,414</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBg35qlM6qO3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,200</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_zX5mlxsNMQ4h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income per common
    share - basic and diluted</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_zq1dvEl2L7o7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number
    of common shares outstanding - basic and diluted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zbm6HAfwykq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsDisclosureTextBlock"><p id="xdx_800_eus-gaap--CashAndCashEquivalentsDisclosureTextBlock_zN9IiYDlrq18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.<span id="xdx_821_zPrw6JX8HjPe">
CASH AND CASH EQUIVALENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of December 31, 2021 and 2020 the Company had $<span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20211231_zAF6iYXW4g7d" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,597,848</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20201231_zFh1Og884st3" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,517,600</ix:nonFraction></span>, respectively, of cash and cash equivalents, which consists of
$<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20211231_zvcHm0WlQDP8" title="Cash in bank"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">554,864</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20201231_zyxICel5xP62" title="Cash in bank"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,112,147</ix:nonFraction></span>, respectively, of cash in banks and </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_eus-gaap--TimeDeposits_iI_pp0p0_c20211231_zWVS7j9hfk68" title="Time deposits"><ix:nonFraction name="us-gaap:TimeDeposits" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,975,347</ix:nonFraction>
</span><span style="background-color: white">and $</span><span id="xdx_905_eus-gaap--TimeDeposits_iI_pp0p0_c20201231_zaqEdjOZL1ua" title="Time deposits"><ix:nonFraction name="us-gaap:TimeDeposits" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,391,182</ix:nonFraction></span><span style="background-color: white">, respectively, of time deposits placed
with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The
effective interest rate for the time deposits ranges between <span id="xdx_90D_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pid_dp_uPure_c20211231__srt--RangeAxis__srt--MinimumMember_zuytjcggSXAi" title="Percentage of Interest rate for time deposits"><ix:nonFraction name="us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" contextRef="AsOf2021-12-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.10</ix:nonFraction></span>% to <span id="xdx_905_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pid_dp_uPure_c20211231__srt--RangeAxis__srt--MaximumMember_zTHpOlCuwpM7" title="Percentage of Interest rate for time deposits"><ix:nonFraction name="us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" contextRef="AsOf2021-12-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.25</ix:nonFraction></span>% per annum.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_802_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zANB6XTXVI5g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>6.
<span id="xdx_82C_zYmOLmtj2Z9j">ACCOUNTS RECEIVABLE </span></b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zHmyEyZzWE14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BC_ze0iPUfvtWL5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF ACCOUNTS RECEIVABLES - RELATED PARTY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_49F_20211231_z9PPc3k8pk4f" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_490_20201231_zpm43E1b5fV" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zQm67i8MAm51" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts receivable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableGrossCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,757</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_z7wtfqwZytyb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance for doubtful
    accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zPkkNTIE1sq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0980">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:AccountsReceivableAndAccountsReceivableRelatedParties" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,757</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_z5OUP4FoMg1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zWQmZCymz9Tf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
<span id="xdx_82C_zeqCj0uim1ai">INVENTORIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zruvM8S4PaXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zGTxmw5qLZR1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF INVENTORIES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20211231_ztBtShzWBIic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20201231_zNoSlNQMm9L6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_zBWMRwP1vewa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Finished
    goods</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">375,535</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">589,814</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zUGBK5Y1QI1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2021 and 2020, the Company recognized $<span id="xdx_90F_eus-gaap--InventoryWriteDown_c20210101__20211231_z979lnJ6UNTe" title="Inventory write-down"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,241</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--InventoryWriteDown_dxL_c20200101__20201231_zzWgX0JuZkbf" title="Inventory write-down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0992">0</span></span> inventory write-down, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:PrepaymentsAndDepositsTextBlock"><p id="xdx_800_ecustom--PrepaymentsAndDepositsTextBlock_zi54yOr6XXOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>8.<span id="xdx_828_zvy7XAm3hLm9">
PREPAYMENTS AND DEPOSITS</span></b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock"><p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zAtd04mFJGJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B8_zF59P1dp47df" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;SCHEDULE
OF PREPAID EXPENSES AND DEPOSITS</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_494_20211231_ziMwpEOwIyHf" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_499_20201231_zDrpQH6b7sf8" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zH01auAciTqf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Receivables from sales distributors</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:ReceivablesFromSalesDistributors" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">115,379</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:ReceivablesFromSalesDistributors" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,302</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zE6hh4Mu4raj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deposits to suppliers</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:DepositsToSupplier" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">301,233</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:DepositsToSupplier" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">261,068</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--PrepaidExpensesGross_iTI_pp0p0_mtPEGzE1e_maPEAOAzys7_z6VlCHZfPes6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:PrepaidExpensesGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">416,612</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:PrepaidExpensesGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">296,370</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iNI_di_msPEAOAzys7_zq8mIhkKa9yd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Provision for
    doubtful accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,095</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzys7_z2yGv6cu952d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">295,517</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">296,370</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zFsIeNl1R1Hk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock"><p id="xdx_89C_ecustom--ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_zZ1SZcciBJrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Movements
of allowance for doubtful accounts are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zOtTmiuBvtG2">SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zZywmLOnsVpa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20200101__20201231_zsnq60MWSzPj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_z4xFzw1tofAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1015">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zMeD0XKlg3s3" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Addition</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,514</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1019">&#160;</span></span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_zegPRvqut4vb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Write off</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1021">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1022">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_zpM2sAxNIGX1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:AllowanceForDoubtfulAccountsReceivableExchangeRateEffect" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">419</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1025">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_zFnjY6bhglQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,095</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zl57uYqJW8je" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zdFbnLwIqJU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
<span id="xdx_823_zFwRIn243Otd">PROPERTY AND EQUIPMENT, NET</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zEBQDGv1UhV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment, net consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_z6ieX65Jn6Ue" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20211231_z69fX0OmVDf5" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20201231_zRECSdxyxbj9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z1Gff565WJv3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer and office equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_ComputerAndOfficeEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">82,298</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_custom_ComputerAndOfficeEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,437</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zo9mxKzC7fRe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture &amp; fixtures</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">122,185</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,966</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zzUJMFAELrt3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,570</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">210,496</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zwHzILui9WXb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vehicle</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_VehicleMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,702</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_custom_VehicleMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,564</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENz5ZB_zFJIlVBSdyEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505,755</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">521,463</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENz5ZB_ztuoRLZe8B4l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">289,956</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">223,154</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENz5ZB_zinKGvSYnjR3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">215,799</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">298,309</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zJqojgI1LHf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for the years ended December 31, 2021 and 2020 amounted to $<span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20210101__20211231_zJNO1NybsZH9" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,797</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--Depreciation_pp0p0_c20200101__20201231_z0ECCJVEMrdg" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,407</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80B_eus-gaap--IntangibleAssetsDisclosureTextBlock_zGFkmRZ9XRW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.
<span id="xdx_827_zTIa8dhIaRyj">INTANGIBLE ASSETS, NET</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zc9eZtE2O7pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets, net, consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zvNaeIFuni2l" style="display: none">SCHEDULE OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20211231_zlsQm9npWeH9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_zQQB9ihbGkUb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzvmN_zYwict1pvqZf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer software</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,453</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,801</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzvmN_zOdvLeC8fWvk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,793</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,975</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzvmN_zOsuj2cfJOZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,660</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,826</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zaBwp2p2Umjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the years ended December 31, 2021 and 2020 amounted to $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_zDu4asXu3k5g" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,961</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200101__20201231_zwHERLSxH47b" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,505</ix:nonFraction></span>, respectively.</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:InvestmentInMarketableSecuritiesTextBlock"><p id="xdx_801_ecustom--InvestmentInMarketableSecuritiesTextBlock_z0AE31WvZSt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.
<span id="xdx_829_z7a3r8822GN1">INVESTMENT IN MARKETABLE SECURITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    May 17, 2018, the Company purchased <span id="xdx_907_eus-gaap--InvestmentOwnedBalanceShares_iI_pid_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zW7uOLKzpNUd" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,333</ix:nonFraction></span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90E_eus-gaap--InvestmentOwnedAtCost_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,000</ix:nonFraction></span> at a purchase price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zvq8oNqx3jSf" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6</ix:nonFraction></span>
    per share.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    July 30, 2018, the Company disposed <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pdd" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90D_eus-gaap--InvestmentOwnedAtCost_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125</ix:nonFraction></span> at a purchase price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_ztkqpm5Y2GG2" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.2613</ix:nonFraction></span> per
    share.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 16, 2018, the Company purchased <span id="xdx_907_eus-gaap--InvestmentOwnedBalanceShares_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pdd" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,333</ix:nonFraction></span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90B_eus-gaap--InvestmentOwnedAtCost_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000</ix:nonFraction></span> at a purchase price of
    $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zHz9zDfeYGA5" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per share.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    November 3, 2020, the Company received dividend of <span id="xdx_900_eus-gaap--InvestmentOwnedBalanceShares_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2020-11-03_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,667</ix:nonFraction></span> shares of common stock in DSwiss, Inc. for $<span id="xdx_902_eus-gaap--InvestmentOwnedAtCost_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_pp0p0" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-11-03_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">76,671</ix:nonFraction></span> at fair value of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_ztuzYabimIV3" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-11-03_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span>
    per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#8217;s shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 9, 2020, the Company received dividend of <span id="xdx_909_eus-gaap--InvestmentOwnedBalanceShares_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2020-12-09_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,663</ix:nonFraction></span> shares of common stock in DSwiss, Inc. for $<span id="xdx_904_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zQYdItS6YA95" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-12-09_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,315</ix:nonFraction></span> at fair value of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-09_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5</ix:nonFraction></span>
    per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#8217;s shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 27, 2021, the Company received dividend of <span id="xdx_90A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_zWxOSeW7TGKc" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2021-09-27_custom_SEATechVenturesCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,665</ix:nonFraction></span> shares of common stock in SEATech Ventures Corp. for $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_zFB6M57yUM7h" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2021-09-27_custom_SEATechVenturesCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,874</ix:nonFraction></span> at fair
    value of $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_z7ktyxfuiRa9" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-09-27_custom_SEATechVenturesCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.62</ix:nonFraction></span> per share from Greenpro Capital Corp as a dividend income since Greenpro Capital Corp previously owned these shares.</span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:MarketableSecuritiesTextBlock"><p id="xdx_895_eus-gaap--MarketableSecuritiesTextBlock_zFEm35wnJK17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zsAchnQKts4f" style="display: none">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20211231_zOIHppVaOEHj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20201231_zzMhWcyrOVu3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_maMSNzd9C_zg0L5qKThXZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">577,035</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,484</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--InvestmentsIncomeDividend_iNI_pp0p0_di_msMSNzd9C_zsGc1FQujud7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend income from Greenpro Capital Corp.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:InvestmentsIncomeDividend" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">18,939</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:InvestmentsIncomeDividend" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">160,062</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingGainLoss_iNI_pp0p0_di_msMSNzd9C_zVxQoo2AjMif" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized holding (loss) gain</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:MarketableSecuritiesUnrealizedHoldingGainLoss" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">505,231</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:MarketableSecuritiesUnrealizedHoldingGainLoss" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">350,137</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maMSNzd9C_zePn8dcJ0vrh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,742</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">352</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzd9C_z7o7Scdcq463" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in marketable
    securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,001</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">577,035</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zNnaIx5tgoTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:InvestmentInNonMarketableSecuritiesTextBlock"><p id="xdx_803_ecustom--InvestmentInNonMarketableSecuritiesTextBlock_zKKN32Sk8rPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
<span id="xdx_82B_zFhzKN0NPudl">INVESTMENT IN NON-MARKETABLE SECURITIES</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company invested in Unreserved Sdn Bhd with the investment amount of $<span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_zOzj0LJ5N4hf" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2021-12-31_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">863,592</ix:nonFraction></span> (RM <span id="xdx_90C_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_uRM_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_za2jMxdkzOql" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2021-12-31_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="RM">3,500,000</ix:nonFraction></span>), which approximated <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_z1zlrHooYPvc" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-12-31_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% of the equity interest
of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019, Unreserved Sdn Bhd issued additional
common stock for working capital. As the Company did not subscribe for the additional common stock, the Company&#8217;s equity interest
in investee company was diluted from approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190310__srt--RangeAxis__srt--MaximumMember_zljfcnZ7avah" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-03-10_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.0</ix:nonFraction></span>% to approximately <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190310__srt--RangeAxis__srt--MinimumMember_zGiCNJfyafw3" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-03-10_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17.86</ix:nonFraction></span>%. Effective from March 10, 2019, the Company discontinued
equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date.
Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unreserved
Sdn Bhd was incorporated in Malaysia with <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zhdFQ9osSjyf" title="Ordinary shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500,000</ix:nonFraction></span> ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim
and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April
30, 2018 to March 27, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 3, 2020, the Company agreed to sell the <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200303__srt--TitleOfIndividualAxis__custom--UnreservedSdnBhdMember_zaojmIJ84KR8" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-03-03_custom_UnreservedSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17.86</ix:nonFraction></span>% ownership interest in Unreserved Sdn Bhd at the December 31, 2019 carrying value
of $<span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z4ELyUEMCqE6" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2019-12-31_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">730,637</ix:nonFraction></span> to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $<span id="xdx_901_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_pp0p0_c20200101__20200331_zPNqRIEKcNS" title="Proceeds from investments"><ix:nonFraction name="AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" contextRef="From2020-01-012020-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">70,173</ix:nonFraction></span>, and had an amount due
from director of $<span id="xdx_900_eus-gaap--DueFromOfficersOrStockholdersCurrent_iI_pp0p0_c20200331__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zenllgMTtRwd" title="Amount due from director"><ix:nonFraction name="us-gaap:DueFromOfficersOrStockholdersCurrent" contextRef="AsOf2020-03-31_custom_MrHowKokChoongMember351695203" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">660,464</ix:nonFraction></span> at March 31, 2020. In May 2020, the entire outstanding balance was settled as part of the consideration in
a transaction which the Company had acquired the CEO&#8217;s ownership interest of Agape Superior Living Sdn. Bhd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 3, 2019, the Company purchased a <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zxu1gkHqNZ41" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>% of stock or <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pid_c20190403__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z7xvZX5Hj17d" title="Shares purchased during period"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2019-04-03_us-gaap_CommonStockMember_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000,000</ix:nonFraction></span> shares of common stock in Phoenix Plus Corp. for $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zJOhCu4LBiZ2" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></span> at purchase
price of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zr5Q9hljmw52" title="Shares Issued, Price Per Share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share.</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:NonMarketableSecuritiesTableTextBlock"><p id="xdx_89A_ecustom--NonMarketableSecuritiesTableTextBlock_zkOWturFo6n8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zfbB1nvQU2N9" style="display: none">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Unreserved Sdn Bhd</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable securities</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zf4RgvPstRU5" title="Investment in non-marketable securities" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1163">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--InvestmentInNonMarketableSecuritiesGross_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" title="Investment in non-marketable securities" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesGross" contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">730,637</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less:
    Sale of investment in non-marketable securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zQs5QiPliqOi" title="Less: Sale of investment in non-marketable securities" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1167">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" title="Less: Sale of investment in non-marketable securities" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:SaleOfInvestmentInNonmarketableSecurities" contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">730,637</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable
    securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zgdeHJqreulj" title="Investment in non-marketable securities" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--InvestmentInNonmarketableSecuritiesNet_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" title="Investment in non-marketable securities" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Phoenix Plus
    Corporation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zgS1H7OUcv5i" title="Cost of investment" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2021-12-31_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" title="Cost of investment" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-12-31_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total investment in
    non-marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z4dw6o4mr5x8" title="Total investment in non-marketable securities" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesNoncurrent" contextRef="AsOf2021-12-31_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" title="Total investment in non-marketable securities" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zdXgg29CBYk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:OtherLiabilitiesDisclosureTextBlock"><p id="xdx_80B_eus-gaap--OtherLiabilitiesDisclosureTextBlock_z13zBm5NrVYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
<span id="xdx_828_zttG9nD8Dwia">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock"><p id="xdx_898_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zRfJrGJiy5X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B1_zQzlwQRdDWch" style="display: none">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20211231_zEx06MSFkNDg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_z914hOdXEpA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">436,541</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">297,636</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AccruedPromotionExpenses_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Promotion expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:AccruedPromotionExpenses" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,024</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:AccruedPromotionExpenses" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,433</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Payroll</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,669</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,976</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Commission</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">219,721</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">224,711</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">143,400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,921</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--OtherAccountPayableAndAccruedLiabilities_iTIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:OtherAccountPayableAndAccruedLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">858,355</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:OtherAccountPayableAndAccruedLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">647,677</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_z5O1v57TAlQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zy6L4RvrFZF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
<span id="xdx_827_zRgcik2Js4A6">RELATED PARTY BALANCES AND TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related
party balances</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
due from related parties</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zcAQ3zTAOKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z8lWSWKWUU0c" style="display: none">SCHEDULE OF RELATED PARTIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name
    of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December
    31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape ATP
    (Asia) Limited (&#8220;AATP Asia&#8221;)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zFh7IyxtMaig" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zrYM4jVMEh4i" title="Relationship"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AgapeATPAsiaLimitedMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zT5TKVhB1k1h" title="Nature"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zuDhF7hq7hH3" title="Nature"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AgapeATPAsiaLimitedMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember" name="AATP:RelatedPartiesNatureDescription">Expenses
    paid for AATP Asia</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zBPYNcd3xTze" title="Amount due from related parties" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2021-12-31_custom_AgapeATPAsiaLimitedMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,214</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zWkTG45rUsf" title="Amount due from related parties" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2020-12-31_custom_AgapeATPAsiaLimitedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,227</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Hostastay Sdn. Bhd.</span></p>
                                                      <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#8220;Hostastay&#8221;&#160;</span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoHMJVFDgqqg" title="Relationship"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zj7Cls3LGfj1" title="Relationship"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr. How Kok Choong,
    the CEO and director of the Company is also the director of Hostastay</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_z96bkEc6Hqk9" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zOKpJukAbQx8" title="Nature"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdMember" name="AATP:RelatedPartiesNatureDescription">Sublease rent due from
    Hostastay</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zIRfbce6jjj6" title="Amount due from related parties" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2021-12-31_custom_HostastaySdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,790</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zf4Uas6lnH9a" title="Amount due from related parties" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2020-12-31_custom_HostastaySdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">996</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">TH3 Technology Sdn Bhd</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#8220;TH3&#160;</span>Technology&#8221;</p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdMAMDlv2nHd" title="Relationship"><span id="xdx_90C_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zRRw54uNEw4h" title="Relationship"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_THThreeTechnologySdnBhdMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zF0Z2g5QwuVc" title="Nature"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zOLs3a1wFca1" title="Nature"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_THThreeTechnologySdnBhdMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember" name="AATP:RelatedPartiesNatureDescription">Expenses
    paid for TH3 Technology</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zBS833tKI6Ca" title="Amount due from related parties" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdoHLYF8dUGb" title="Amount due from related parties" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2020-12-31_custom_THThreeTechnologySdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231_zXf0bP8Tyebk" title="Amount due from related parties" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,004</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_z1apLzBjnaN1" title="Amount due from related parties" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,235</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
due to a Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December
    31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape
    Superior Living Pty Ltd</span> &#8220;ASLPL&#8221;</td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zjaffT4I6jli" title="Relationship" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr.
    How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 1.5pt; width: 18%; text-align: center"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zTcNtnTuIgMj" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember" name="AATP:RelatedPartiesNatureDescription">ATP
    Label Printing Fees</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zGltgxrHs6Fk" title="Amount due from related parties" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zfnwEeWUjRli" title="Amount due from related parties" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2020-12-31_custom_AgapeSuperiorLivingPtyLtdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">455</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zO3PaOw8ZMM9" title="Amount due from related parties" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zonoooHgiBe8" title="Amount due from related parties" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">455</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
RELATED PARTY BALANCES AND TRANSACTIONS (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related
party transactions </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">For the years
    ended December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape Superior
    Living Pty Ltd (&#8220;ASLPL&#8221;)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zcC2giDupOh6" title="Relationship"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zW9HzqMSxgMb" title="Relationship"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; width: 18%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z4Lv347M7n3e" title="Nature"><span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zH9KjlqHYSA1" title="Nature"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" name="AATP:RelatedPartiesNatureDescription">Sales of
    products</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zGbEXE87uPu9" title="Revenue" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zLj2DGzHvADi" title="Revenue" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,060</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><span id="xdx_F4C_zm8QfSbpOFne" style="font-family: Times New Roman, Times, Serif">Vettons
    Sdn Bhd*</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zugLfroRtprc" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zZvVq3EoCVc1" title="Relationship"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_VettonsSdnBhdOneMember" id="Fact001272" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_VettonsSdnBhdOneMember" id="Fact001274" name="AATP:RelatedPartiesRelationshipsDescription">Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zuQtzdRYWHvj" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zb7z4MtJu9pk" title="Nature"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_VettonsSdnBhdOneMember" id="Fact001276" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_VettonsSdnBhdOneMember" id="Fact001278" name="AATP:RelatedPartiesNatureDescription">Sales
    of products made through its platform</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____z2oh2awX7Fzd" title="Revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2021-01-012021-12-31_custom_VettonsSdnBhdOneMember" id="Fact001280" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,625</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_fKg_____zvzZZ9Lr1X8e" title="Revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231_zZMNas14GZie" title="Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,625</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zbXwpniv32xe" title="Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,060</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b id="xdx_F07_z3qCnTQjHwmg">*</b></span></td>
  <td style="text-align: justify"><span id="xdx_F1F_zurIKlX1VP8l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001287" xml:lang="en-US">During the year ended December 31, 2021, the Company had sales
of $<span id="xdx_90F_eus-gaap--RevenueFromRelatedParties_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_za0RKbuWThr6" title="Revenue"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2021-01-012021-12-31_custom_HowKokChoongMember_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,625</ix:nonFraction></span> through the online platform owned by Vettons Sdn Bhd (&#8220;Vettons&#8221;). Vettons is a related party since Mr. How Kok
Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.</ix:footnote></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchase</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left; padding-bottom: 1.5pt">DSY Wellness &amp; Longevity Center Sdn Bhd</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zztjihGbEJi" title="Relationship"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKgGDN0XOXqi" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember_srt_ChiefExecutiveOfficerMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember_srt_ChiefExecutiveOfficerMember" name="AATP:RelatedPartiesRelationshipsDescription">Dato&#8217; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp; Longevity Center Sdn Bhd</ix:nonNumeric></ix:nonNumeric></span></span>.</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z4AK4a2VPoge" title="Nature"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zd3zORUqsxXh" title="Nature"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember" name="AATP:RelatedPartiesNatureDescription">Purchase</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z0MaSzrnIaGf" title="Purchase" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" contextRef="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">718</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zcp8pULpTfJd" title="Purchase" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1301">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231_zxjPSxdzQeW2" title="Purchase" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">718</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231_zWmsGiHMPUr3" title="Purchase" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1305">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold"></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years
    ended December 31, </b></span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name
    of Related Party</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mr.
    How Kok Choong</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zS3c71XRkOpc" title="Relationship"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKe4t3D9pIBh" title="Relationship"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember_srt_ChiefExecutiveOfficerMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember_srt_ChiefExecutiveOfficerMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr.
    How Kok Choong, the CEO and director of the Company</ix:nonNumeric></ix:nonNumeric></span></span>.</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zGlq7z43t2vb" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zpnZEXPuCsjk" title="Nature"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HowKokChoongMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HowKokChoongMember" name="AATP:RelatedPartiesNatureDescription">Commission
    expense</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zVewcRjCItP4" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:SalesCommissionsAndFee" contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,758</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_z6srxupaaap9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:SalesCommissionsAndFee" contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,740</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SalesCommissionsAndFee_pdp0_c20210101__20211231_zMp01UdDmLWb" title="Commission expense" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:SalesCommissionsAndFee" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,758</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SalesCommissionsAndFee_pp0p0_c20200101__20201231_zIjLrUletGIk" title="Commission expense" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:SalesCommissionsAndFee" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,740</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td rowspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Related Party</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the years ended December 31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hostastay
    Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQlgHq1wqYgl" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zdoJWj8m3jsi" title="Relationship"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember_srt_ChiefExecutiveOfficerMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember_srt_ChiefExecutiveOfficerMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Hostastay</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zZNbTceC974g" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zhxZicsFyDNg" title="Nature"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember" name="AATP:RelatedPartiesNatureDescription">Sublease
    rental income due from Hostastay</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--OtherIncome_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zutdgJUpW8Cf" title="Other income" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,345</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eus-gaap--OtherIncome_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zvIxFJm9Nj04" title="Other income" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,881</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20210101__20211231_zid26QmKtftg" title="Other income" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,345</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zjuv3Lyf9VN9" title="Other income" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,881</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zcO7cQRA7zP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:exclude><!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z1EoTOmM1nR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.
<span id="xdx_825_zWGqCJHetoAe">STOCKHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Preferred
stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 and 2020, there were <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zzJK3vpWjnfd" title="Preferred stock, shares authorized"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_zZTCjEPkdvyc" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> preferred stocks authorized but <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_dn_c20211231_zeqmFolebPa9" title="Preferred stock, shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20211231_zlgRdq6m3g6k" title="Preferred stock, shares outstanding"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_dn_c20201231_zScliMtehWfh" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20201231_zwdvKtJIUPNb" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Common
stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 and 2020, there were <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_z22kJHDEj365" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20201231_znNHnqB3ZfWf" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></ix:nonFraction></span></span> common stocks authorized, <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20211231_zmGeXMXqDgp7" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zKb4SWubZpV8" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">290,460,047</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20201231_zgegkGXH9Sq7" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20201231_zmPjVDc0StK9" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2020, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200501__20200531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zKsJrx6OXHpk" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-05-012020-05-31_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">162,694</ix:nonFraction></span> shares of the Company&#8217;s common stock in connection with the acquisition of ASL as part of
the acquisition payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased
by $<span id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_c20210630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zInmgVQjYzad" title="Business combination, recognized identifiable assets acquired and liabilities assumed, assets"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2021-06-30_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,043</ix:nonFraction></span>, which required the issuance of an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z4q91pPPvi19" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2021-01-012021-06-30_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,853</ix:nonFraction></span> shares of the Company&#8217;s common stock to fully satisfy the acquisition
payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200629__20200731__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zBR0sNWMhk1a" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-06-292020-07-31_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,853</ix:nonFraction></span> additional shares were issued in July 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2021, there were share forfeiture agreements (the &#8220;<b>Share Forfeiture Agreements</b>&#8221;) between the Company and
(i) HKC Talent Limited; (ii) various shareholders of the Company (the &#8220;<b>Forfeiting Shareholders</b>&#8221;), pursuant to which:
(i) HKC Talent Limited had agreed to forfeiture of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongTalentLimitedMember_zjZh4vmwzQ37"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HowKokChoongTalentLimitedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">41,750,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company, and (ii)
the Forfeiting Shareholders had agreed to forfeiture, in aggregate, <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongTalentLimitedMember__srt--TitleOfIndividualAxis__custom--ShareholdersMember_zEG1iaTobXDh"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HowKokChoongTalentLimitedMember_custom_ShareholdersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">44,242,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company. Included
in (ii) is <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HKCHoldingsSdnBhdMember_z7s7tathq1Bi"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HKCHoldingsSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,242,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares forfeited from HKC Holdings Sdn. Bhd,
a company in which <span style="background-color: white">Mr. How Kok Choong, </span>the CEO and director of the Company, is a shareholder.
As a result, the outstanding shares was reduced by <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember_zRAYMhCL1ktc"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,992,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20210101__20211231_z5AQ422mtOye" title="Potentially dilutive securities outstanding"><span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20200101__20201231_zFHH6aethW6" title="Potentially dilutive securities outstanding"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-01to2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span> stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:MinorityInterestDisclosureTextBlock"><p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zDBeMDPckdHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.
<span id="xdx_822_zrFQDIpLMPz7">NON-CONTROLLING INTEREST</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="AATP:ScheduleOfNonControllingInterestTableTextBlock"><p id="xdx_89F_ecustom--ScheduleOfNonControllingInterestTableTextBlock_zZBI5QjC7oDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s non-controlling interest consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zwxpd85H2Q5j" style="display: none">SCHEDULE
OF NON CONTROLLING INTEREST</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20211231_zwr96En8RGd1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20201231_z2Eht72PAx95" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">As of December
    31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">DSY Wellness:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--NonControllingInterestPaidinCapital_iI_zcfm1r481Hek" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paid-in capital</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:NonControllingInterestPaidinCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--NonControllingInterestAccumulatedDeficit_iI_zIssv5YTi0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:NonControllingInterestAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">436</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1387">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--NonControllingInterestAccumulatedOtherComprehensiveIncome_iI_zF3o95vL91Vk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive
    income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="AATP:NonControllingInterestAccumulatedOtherComprehensiveIncome" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1390">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--NonControllingInterestNonControllingInterestGross_iI_zDeVDEDJx5b8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="display: none; font-size: 10pt">Non Controlling interest Gross</span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:NonControllingInterestNonControllingInterestGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">336</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1393">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--NonControllingInterestAsl_iI_zFpZKA8KAfQ5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">ASL</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1395">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1396">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--MinorityInterest_iI_zW9WYiMyfzZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">336</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8AF_zikBXzqt0zpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zx1vaESLje23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
<span id="xdx_825_zIseJE7OXP2i">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zJ7stTvKpSRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
United States and foreign components of (loss) income before income taxes were comprised of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BC_zTWxPdCJiCud" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20210101__20211231_zrZAXd34Xik3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20200101__20201231_zfXKIGzf6yU7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax jurisdictions from:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zAlLrtxOUl7e" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Local &#8211; United States</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">706,659</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">735,159</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--MY_zEclGmfB1wAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign &#8211; Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2021-01-012021-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,064,314</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2020-01-012020-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,070,806</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--HK_zhAbaLKDIFKc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign &#8211; Hong
    Kong</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2021-01-012021-12-31_country_HK" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">616,640</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2020-01-012020-12-31_country_HK" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,700</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zWJCB0DdrB88" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zwsoXAMvtkTi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">(Loss) income before
    income tax</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,387,613</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">516,347</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zQwZHDkY8Q04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zPwBaAA1nP6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
(provision for) benefit of income taxes consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BE_zbupPTnAP3g2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF PROVISION FOR INCOME TAX</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20210101__20211231_zwjEcbQqFP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20200101__20201231_zSSX7rLf21y8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Current:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_iN_di_maITEBzB5L_zh20qlTxQ03d" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,205</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CurrentForeignTaxExpenseBenefit_iN_di_maITEBzB5L_zverS48xQVVi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,735</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,748</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Deferred:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_zFpxBWlN3REh" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1428">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1429">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_z2R5c2TT0h88" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,127</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">178,329</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBzB5L_zOZ0Dm8bu8Jl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income
    taxes</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,067</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">161,581</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zhWYBUgr16K4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad
range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan)
and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United
States of America</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a corporate
tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zr4IRO9K2cXa" title="Tax percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-012021-12-31_us-gaap_StateAndLocalJurisdictionMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% on its taxable income. Agape ATP Corporation also subject to controlled foreign corporations Subpart F income (&#8220;Subpart
F&#8221;) tax, which is a tax primarily on passive income from controlled foreign corporations with a tax rate of <span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z04iJ8TfDm6c" title="Tax percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-012021-12-31_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35</ix:nonFraction></span>%. <span id="xdx_909_eus-gaap--TaxCutsAndJobsActOf2017OtherTaxEffectDescription_c20210101__20211231_zq9p5RQTNMfe" title="Tax rate description"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="us-gaap:TaxCutsAndJobsActOf2017OtherTaxEffectDescription">In addition, the
Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#8220;GILTI&#8221;) tax, which is a tax on certain off-shore earnings
at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign
tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are
applied</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2021 and 2020, the Company&#8217;s foreign subsidiaries did not generate any income that are subject to
Subpart F tax and GILTI tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
INCOME TAXES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2021, the Company re-visited its fiscal 2020 U.S. income taxes and determined its stock dividend from Greenpro
Capital Corp as a result of its Spin-off of DSwiss Inc.&#8217;s shares in 2020 were subject to Subpart F and GILTI taxes. As a result,
the Company incurred additional income taxes expenses of $<span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zdqT2ffrpzXb" title="Income tax expense benefit"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,205</ix:nonFraction></span>, including interest and penalty of $<span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20210101__20211231_zJzyKKFFpTmi" title="Income tax  examination penalties and interest expense"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">395</ix:nonFraction></span>, for the year ended December
31, 2021, after utilizing its estimated cumulative net operating losses (&#8220;NOL&#8221;) of $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_c20201231_zeijZGafqpS5" title="Cumulative net operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">312,608</ix:nonFraction></span> as of December 31, 2020. As a
result, the Company&#8217;s deferred tax assets of estimated NOL of $<span id="xdx_904_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20211231_z5ngiqBIt3Pl" title="Deferred tax assets operating loss carryforwards"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,648</ix:nonFraction></span> were fully utilized and reduced to $<span id="xdx_901_ecustom--DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_iI_c20211231_zhTUhZUCdzcb" title="Cumulative net operating losses"><ix:nonFraction name="AATP:DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 and 2020, the operations in the United States of America incurred approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_ziRZzDY5u6oc" title="Operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">729,000</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zIL3DbXUwtg8" title="Operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span>, respectively, of
cumulative net operating losses (&#8220;NOL&#8221;) which can be carried forward to offset future taxable income or Subpart F and GILTI
taxes. These balance can be carried forward indefinitely. The deferred tax valuation allowance as of December 31, 2021 and 2020 were
approximately $<span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_zVzqt9niPNK6" title="Deferred tax valuation allowance"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">153,000</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_z1ArW8tk0za1" title="Deferred tax valuation allowance"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Malaysia</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies
incorporated in Labuan to satisfy the &#8220;substantial activity requirements&#8221; to qualify for the preferential tax rate of <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zruGRczcdzU" title="Tax percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2018-12-282019-01-02_custom_LabuanMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3</ix:nonFraction></span>%
on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to the &#8220;substantial activity requirements&#8221;
was issued. As Agape ATP Corporation did not maintain a permanent establishment in Labuan, and therefore did not satisfy the said requirements,
the company was subjected to tax at <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zWXtzm0GkKIe" title="Taxp percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2018-12-282019-01-02_custom_LabuanMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction></span>% on its net audited profit. On June 11, 2021, Agape ATP Corporation made an irrevocable election
to be taxed under the Malaysian Income Tax Act 1967 as the elected tax regime is more tax efficient to the entity compare to LBATA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
Superior Living Sdn Bhd, Agape S.E.A Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of
Malaysia and the income taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable
income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia,
enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential tax rates,
tax holidays and even tax exemption may be granted on case-by-case basis. <span id="xdx_903_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--MY_zMBjQTPtIlL7" title="Income tax examination, description"><ix:nonNumeric contextRef="From2021-01-012021-12-31_country_MY" name="us-gaap:IncomeTaxExaminationDescription">The tax rate for small and medium sized companies (generally
companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231__srt--StatementGeographicalAxis__country--MY_zC5zcFsPH3Hh" title="Tax percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-012021-12-31_country_MY" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17</ix:nonFraction></span>% for the first RM 600,000 (or approximately $150,000)
for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 and 2020, the operations in the Malaysia incurred approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--MY_zp1K6Soyryma"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">946,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zVmjPSCCLqIi"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">261,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, of cumulative net operating losses (&#8220;NOL&#8221;) which can be carried forward to offset future taxable income. Approximately
$<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_c20211231__srt--StatementScenarioAxis__custom--UnutilizedMember_zrQFP7JnakLe" title="Net operating loss carryforward"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31_custom_UnutilizedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">685,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_c20201231__srt--StatementScenarioAxis__custom--UnutilizedMember_zPSOKkOKBiY8"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31_custom_UnutilizedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">261,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the net operating loss carry forwards will
expire in 2028 and 2027, respectively, if unutilized. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately
$<span id="xdx_907_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--MY_z29Vtxjgn5qh"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">217,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zkaVl3EJUUUa"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong
Kong</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of <span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231__srt--StatementGeographicalAxis__country--HK_z7Hvvs9O4ON2" title="Tax percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-012021-12-31_country_HK" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16.5</ix:nonFraction></span>% on
its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative
Region is not subject to Hong Kong Profits Tax or deduction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
INCOME TAXES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zh8ZLrOPYINk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles the local (United States) statutory rates to the Company&#8217;s effective tax rate for the periods indicated
below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B6_zC5lQXfhDLsc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF EFFECTIVE INCOME TAX RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20210101__20211231_zHodPO8OlDVc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20200101__20201231_zIF4l0FDdfkl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zsEs0VSP47W2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">U.S. statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zTUSVlHzwV1b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">17.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">4.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zLMg3hNPRqq6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Differential tax rate in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zm9NRd88iKhh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Permanent difference</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2021-01-01to2021-12-31" id="Fact001489" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">12.7</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F2F_zxSNVakO0EU2" style="font-family: Times New Roman, Times, Serif">)%(1)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2020-01-012020-12-31" id="Fact001490" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.3</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F27_zzkQrrHwK2g8" style="font-family: Times New Roman, Times, Serif">%(2)</span></td></tr>
  <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zWHBlQpZ9SX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effective tax rate</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">5.7</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">31.3</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount comprised:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p id="xdx_F03_z9Nlra0fsGci" style="display: none; margin-top: 0; margin-bottom: 0">(1)</p></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zYdaYzTyVkc3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001494" xml:lang="en-US">&#160;The
    amount comprised: <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zkx8Ftrs7L89" class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" title="Non-deductible tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2021-01-012021-12-31_custom_AATPHKMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.2</ix:nonFraction></span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_z7zr0BljaQM3" class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" title="Non-deductible tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2021-01-012021-12-31_custom_AATPLBASLSEAWATPAndDSYMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.7</ix:nonFraction></span>%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_za3LDb8OY7Ml" title="Tax percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2021-01-012021-12-31_custom_AATPHKMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.2</ix:nonFraction></span>%
    being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_zJiKLXcUTRUk" title="Tax percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2021-01-012021-12-31_custom_AATPLBASLSEAWATPAndDSYMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.7</ix:nonFraction></span>%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount comprised:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td id="xdx_F06_z335a6X6xzjc" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify">(2)</td>
    <td colspan="2" id="xdx_F18_zVtSsVaotcc4" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"><ix:footnote id="Footnote001503" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231_zv1NMsh9HgPd"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.2</ix:nonFraction>%
being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; </span></span><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zyI1Oi1dqqbe" class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" title="Non-deductible tax rate" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2020-01-012020-12-31_custom_AATPHKMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction>%
being income derived in AATP HK that were not taxable in the Malaysia tax returns; and </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zAbCSjiqlxJf" class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" title="Non-deductible tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2020-01-012020-12-31_custom_AATPLBASLSEAAndWATPMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.3</ix:nonFraction></span>%
being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z809m78MTHpj" title="Tax percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.2</ix:nonFraction></span>%
    being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zmVeWeVqoWCj" title="Tax percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2020-01-012020-12-31_custom_AATPHKMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span>%
                                            being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zN2k4pv648T2" title="Tax percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2020-01-012020-12-31_custom_AATPLBASLSEAAndWATPMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.3</ix:nonFraction></span>%
    being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A5_zRf8gZITjCH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTgDaFWwPnw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B6_z6PE7E8dFond" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF DEFERRED TAX ASSETS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20211231_zbi55i6TjUyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20201231_z9HNpNIBftu7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    </tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--US_zdlrLW0iyXZk" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards
    in U.S.</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">153,061</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1519">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--MY_zTYHWbFloxwf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2021-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227,106</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2020-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,678</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zNxv9yYvsNDg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net operating loss carry forwards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less: valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20211231_zGKJemF1HSjc" title="Less: valuation allowance" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">380,167</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20201231_zhbZnY4zYwHl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1528">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iI_zHyYEH4A3upj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:DeferredTaxLiabilitiesDepreciation" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,574</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="AATP:DeferredTaxLiabilitiesDepreciation" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">68,421</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    </tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_di_zOrcgklJh9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,574</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,743</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    </tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zkxctfdEx5Kf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Uncertain
tax positions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical
merits, and measure the unrecognized benefits associated with the tax positions</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
As of December 31, 2021 and 2020, the Company did not have any significant unrecognized uncertain tax positions. The Company did not
incur interest and penalties tax for the years ended December 31, 2020 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zppyeLFDtlc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.
<span id="xdx_820_zzEoSomjbVI4">CONCENTRATIONS OF RISKS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Major customers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2021 and 2020, no customer accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zZ7wcEon2T32" title="Concentrations of risk percentage"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsbNNSoACeck" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></ix:nonFraction></span></span>% or more of the Company&#8217;s total revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no accounts receivable balance as of December 31, 2021. As of December 31, 2020, receivables from a third-party e-commerce company
accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zqs9F210iL0g" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember_us-gaap_CustomerConcentrationRiskMember_custom_VendorOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.0</ix:nonFraction></span>% of the total balance of accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Major vendors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2021, two vendors accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zifQOunHx8X4"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">47.3</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zbnvccvXJhJ6"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_VendorTwoMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.2</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the Company&#8217;s total purchases, respectively. For the year ended December 31, 2020, two vendors accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zqi8p3G09a0g"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">74.1</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zl7EPVu4Wdga"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_VendorTwoMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25.9</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the Company&#8217;s total purchases. In November and December 2020, the Company received dividend of <span id="xdx_905_ecustom--DividendShareForCommonStock_pid_c20201201__20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zdhCwhkcasw6"><ix:nonFraction name="AATP:DividendShareForCommonStock" contextRef="From2020-12-012020-12-31_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,330</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of DSwiss, Inc., represents
approximately <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zw6R8eDBrN83"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-11-30_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.01</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
ownership that the Company accounted for as investment in marketable securities (See Note 11). DSwiss, Inc.&#8217;s wholly owned subsidiary
is the vendor that accounted for the Company&#8217;s total purchases of approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--VendorOneMember__dei--LegalEntityAxis__custom--DSwissIncMember_z5XgWCTZ2QHe"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_VendorOneMember_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">47.3</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__dei--LegalEntityAxis__custom--DSwissIncMember_zg8t0GgGDGZf"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">74.1</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
for the years ended December 31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, one vendor accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--OneVendorMember_zTe2C8rp2Ttd" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_AccountsPayableMember_custom_OneVendorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total balance of accounts payable. There are no accounts payable balance as
of December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Commission Expenses to Sales Distributors and Stockists</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2021, one sales distributor accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--OneSalesDistributorMember_zKKo21123UW9" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_OneSalesDistributorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17.9</ix:nonFraction></span>% of the Company&#8217;s total commission expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2020, no sales distributor accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--NoSalesDistributorMember_zjvXG0OU1Tma"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_NoSalesDistributorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span>% of the Company&#8217;s total commission expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Credit risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of December
31, 2021 and 2020, $<span id="xdx_90A_eus-gaap--Deposits_iI_pp0p0_c20211231_ztTFsOM43Hc6" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">554,864</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--Deposits_iI_pp0p0_c20201231_zP2NpPQh02g1" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,112,147</ix:nonFraction></span> were deposited with financial institutions, respectively, $<span id="xdx_905_ecustom--DepositForInsurance_iI_pp0p0_c20211231_zUuFnX1Pw8Bd" title="Deposit for insurance"><ix:nonFraction name="AATP:DepositForInsurance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">295,761</ix:nonFraction></span> and $<span id="xdx_908_ecustom--DepositForInsurance_iI_pp0p0_c20201231_z7hIHHO8Zb2j" title="Deposit for insurance"><ix:nonFraction name="AATP:DepositForInsurance" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">563,788</ix:nonFraction></span> of these balances
are not covered by deposit insurance. While management believes that these financial institutions are of high credit quality, it also
continually monitors their credit worthiness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration
of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection
terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful
accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically,
the Company did not have any bad debt on its account receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.
CONCENTRATIONS OF RISKS (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Exchange rate risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could
post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower
profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes
in political and economic environments without notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zikBWEXc7Rr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.
<span id="xdx_824_zqFHuwr8qXXa">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Lease
commitments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2020, the Company adopted ASC 842 for ASL&#8217;s office space lease and sales and training center as the lease commencement
date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20200401__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_ztm1zkup7YVb" title="Operating lease liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-04-01_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">490,000</ix:nonFraction></span>, with a corresponding right-of-use
(&#8220;ROU&#8221;) asset in the same amount based on the present value of the future minimum rental payments of the lease, using an
effective interest rate of <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20200401__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zY9XWuKi7CWk" title="Operating lease effective interest rate"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2020-04-01_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.5</ix:nonFraction></span>%, which was determined using the Company&#8217;s estimated incremental borrowing rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 31, 2021, the Company entered into two separate two-year leases extension with the modified lease expiring <span id="xdx_90C_ecustom--LeaseExpirationTerm_dd_c20210530__20210531_zg0t1LRbg2ml" title="Lease expiration term"><ix:nonNumeric contextRef="From2021-05-302021-05-31" format="ixt:datemonthdayyearen" name="AATP:LeaseExpirationTerm">May 31, 2023</ix:nonNumeric></span> for its office
space and expiring <span id="xdx_90A_ecustom--LeaseExpirationTerm_dd_c20210530__20210531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TrainingCenterMember_zHbo9BMQZEYk" title="Lease expiration term"><ix:nonNumeric contextRef="From2021-05-302021-05-31_custom_TrainingCenterMember" format="ixt:datemonthdayyearen" name="AATP:LeaseExpirationTerm">August 31, 2023</ix:nonNumeric></span> for its training center. The lease modification required the Company to re-measure the ROU assets
and lease liabilities based on the modified leases. The Company recognized a reduction of $<span id="xdx_90E_ecustom--IncreaseDecreaseInROUAssetsAndLiabilities_iI_c20210531_zIq3NCDGKYMc" title="Reduction in ROU assets and liabilities"><ix:nonFraction name="AATP:IncreaseDecreaseInROUAssetsAndLiabilities" contextRef="AsOf2021-05-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,250</ix:nonFraction></span> in ROU assets and lease liabilities
upon lease modifications based on the present value of the future minimum rental payments of the lease, using an effective interest rate
of <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20210531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zkrbAxBZJ3S4" title="Operating lease effective interest rate"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-05-31_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.5</ix:nonFraction></span>%, which was determined using the Company&#8217;s estimated incremental borrowing rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of December 31, 2021, the weighted remaining term of the lease is approximately <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zLuEApcD1dr2" title="Operating lease, weighted average remaining lease term"><ix:nonNumeric contextRef="AsOf2021-12-31_custom_AgapeSuperiorLivingMember" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">1.64</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zLwSIOUdEDJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
five-year maturity of the Company&#8217;s operating lease liabilities is as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BB_z5HQRQCGEsN1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF LEASE COMMITMENTS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Twelve Months
    Ending December 31,</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_499_20211231_zrSpkKZ0riRb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzA1T_z29WVvrhY7u3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,426</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzA1T_zFb9TaYVqEpi" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">84,915</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzA1T_zgoP2DMVzy8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1587">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_zO7qR3PO3eAe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">251,341</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zSNfOKjtmRf5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,763</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">240,578</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zXefQuQgchwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent
expense for the years ended December 31, 2021 and 2020 was $<span id="xdx_90F_eus-gaap--OperatingLeaseExpense_pp0p0_c20210101__20211231_z4zUzdOiLlIk" title="Operating lease, rent expenses"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">179,562</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_pp0p0_c20200101__20201231_zlihFIIH9S6h" title="Operating lease, rent expenses"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,716</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contingencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued,
as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed
to be material to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.
COMMITMENTS AND CONTINGENCIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COVID-19</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO, Malaysia has been put through
various stages of lockdowns such as (1) full movement control orders (&#8220;MCO&#8221;), under which, quarantines, travel restrictions,
and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to a Conditional Movement Control
Order (&#8220;CMCO&#8221;) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated
by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement Control Order (&#8220;RMCO&#8221;). On January 12,
2021, due to a resurgence of COVID-19 cases, the Malaysian government declared a state of emergency nationwide to combat COVID-19. Intermittent
lockdowns were imposed in various states and districts in the country. February 2021 marked a significant month for Malaysia as all frontline
staff of the country, which comprised those in healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department
of Malaysia and civil defense sectors were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that
a National COVID-19 Immunisation Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will
be vaccinated to achieve herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO, nevertheless,
COVID-19 cases in the country continue to rise. <span id="xdx_90A_eus-gaap--UnusualRiskOrUncertaintyImpact_c20210101__20211231__us-gaap--UnusualRiskOrUncertaintyByNatureAxis__custom--COVIDNineteenImpactMember_zcGtXlDQGj5f" title="COVID-19 impact description"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_COVIDNineteenImpactMember" name="us-gaap:UnusualRiskOrUncertaintyImpact">On
May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the
country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian
population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full
lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one
dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter
of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases
hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced
Movement Control Order (&#8220;EMCO&#8221;) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament
met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating
its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021,
interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country
achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where
it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country&#8217;s population have been fully
vaccinated, with a further 46.0% having received booster shot</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially,
affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact
to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and
severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact,
almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">temporary
    closure of offices, travel restrictions, financial impact of the Company&#8217;s customers or suspension supplies may be negatively
    affected, and could continue to negatively affect the demand for the Company&#8217;s product;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely
    affect its financial condition and operating results; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    disruption of the Company&#8217;s supply chain, logistics providers or customers could adversely impact its business and results
    of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery
    to its customers, which may also lead to loss of its customers.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot
be reasonably estimated at this time. There is no guarantee that the Company&#8217;s total revenues will grow or remain at the similar
level year over year in 2021 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_znAil92WMLS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.
<span id="xdx_825_ztm6LAGqhyCc">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Forfeiture
of Common Stock</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A
share forfeiture agreement (the &#8220;Share Forfeiture Agreement&#8221;) dated January 20, 2022, between the Company and Mr. How Kok
Choong, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the CEO and director of the Company<span style="background-color: white">,
pursuant to which Mr. How Kok Choong agreed to forfeit <span id="xdx_904_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20220101__20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementMember_zvhF4E0oB6R4" title="Company share forfeiture"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited" contextRef="From2022-01-012022-01-20_us-gaap_SubsequentEventMember_custom_MrHowKokChoongMember_custom_ShareForfeitureAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">215,008,035</ix:nonFraction></span> shares of common stock of the Company.</span></span></p>

</ix:nonNumeric><p id="xdx_810_zAopj96j9du" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 86; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
HOW KOK CHOONG, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this annual report on Form 10-K of Agape ATP Corporation (the &ldquo;Company&rdquo;) for the year ended December 31,
2021;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide
    reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
    in accordance with generally accepted accounting principles.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
    the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
    or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 28, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    How Kok Choong</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOW
    KOK CHOONG</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Director, Secretary, Treasurer</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer and Principal Financial Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
ANDREW LEE KAM FAN, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this annual report on Form 10-K of Agape ATP Corporation (the &ldquo;Company&rdquo;) for the year ended December 31,
2021;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide
    reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
    in accordance with generally accepted accounting principles.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
    the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
    or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 28, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Andrew Lee Kam Fan</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEE
    KAM FAN</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer,</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO<BR>
18 U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report of Agape ATP Corporation (the &ldquo;Company&rdquo;) on Form 10-K for the year ended December 31, 2021
as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), The undersigned hereby certifies,
pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge
and belief:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 28, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    How Kok Choong</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOW
    KOK CHOONG</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Director, Secretary, Treasurer</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting
the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and
will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff
upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>EXHIBIT 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO<BR>
18 U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report of Agape ATP Corporation (the &ldquo;Company&rdquo;) on Form 10-K for the year ended December 31, 2021
as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), The undersigned hereby certifies,
pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge
and belief:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 28, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Andrew Lee Kam Fan</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEE
    KAM FAN</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting
the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and
will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff
upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (6 7,# 2(  A$! Q$!_\0
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MIVG_ #U/_?#?X4 6Z*KK?6K#(GC'^\<?SJ1)XI/]7*C?[K T 24444 %%%%
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MVL=Q&.KKQ5VR\?6$Q"74;VS_ .T,BB[ZCNCVJBN$T[Q*[H'MKP2Q\<%MP_\
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M_ D?AFNR>.&YA:&XB26)OO(ZA@?J#7.7W@#3+ES+922V4W52IW*#G.<'G\B
M*=Q6L>=W^C7>EW"I>1LL)8#SHUW*?ITY]CBHXH86B7S[B7RLG8L:JQ_X%EAL
M^I!KT(Z5XCTZ,P_9[75;=B5(,S+(X]6WDJ/H,UA7NCZ;.<W-E<Z/,2=SL,0
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MH 5C\BTK?>6AON+2M]Y: #_EI^%*OWC2?\M/PI5'S&@!!]PTO8?6@?=-+V%
M!W%'<T=Q2]S0 G:E[BD[4O<4 )_":#U/TH/W6I3U/TH 8>1_P&@]3^%+CC_@
M-!X/Y4 1,.GT_P :LZ9TE'N#^E5V_I_C4VG-BXG4GDJI _/_ .M5(#1HHHIB
M"BBB@ HHHH **** "BBB@ HHHH **** "LSQ"<:'<>IVX_[Z%:=8WB;=_9/R
M@D>8NXCL.>OXXH Y6$Y6K:]#]#5) 0015I&RI[?*?YU RSCA_P#@-2M]V?ZB
MHLYW_P"\HJ5C\LW^\*!DP_U[_P"Y2+_J[?ZTO_+63_<H7[EO]:0$B_ZV?Z4A
M_P"/6+_>%.7_ %D_TI/^76+ZB@"4_P#'XO\ NT1YQ-CKFE_Y?%_W:(_^6U !
MD?90<8&>13I/^6>*:/\ CT_&GR=(J ''_CX'TI4_USTA_P"/D'VIR_ZYZ8A(
M_NO]:!_J#2Q]'^M"_P"H- Q6_P!6M*W5:1O]6OUIS=5H$'_+3\*4??-&/G'T
MI1]\T -'W32_PBA?NFE_@_&@8'M2_P 1H/:C^(T"$[4O<4?PF@<;>_'6@!.Q
MI>Y^E)V:E_B_"@!OI]*0_P"%+_=^E-)P/P% #&Z&H[,L=4C*G ((/N,?XXIT
MAI--&_42<'"H>?3D?_7IH#:HHHJA!1110 4444 %%%% !1110 4444 %%%%
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M#.CP?K5E#BJBU9C:I&6DP:E5 :@0BIU-("01TX1"A6J16H :(J<(JD!%/&*
M(A'[4\1^U2C%.H B$8]*<(Q4E/ % $0B%*(A4HQ3@!0!$(A3A&*D %. %,"(
M1BE"#TJ4!:.,4 ,"#TI=OM3PPQ1N% #=OM2[:7=06H -M&VDW4FZ@!V!2<4F
M:2@!<TTFBDS0 AIAI],- $;56FZ&K+&JLO2@#?M^+:+_ '!_*I*C@_X]X_\
M='\JDJA!1110 4444 %%%% !1110 4444 %%%% !7G_C.]2S\5VB2G:D]JJ!
MCT#!VQ_,_I7H%>2_%U?^)A9G'_+#'_CQH$]#32K"5YYH7C(V@%MJ>YXAPLX&
M67_>'?Z]?K7>VMS!=PK-;RI+&W1D8$5(XR3V+B&IT8U E2KTH&6%:I5:JZU*
MM R<&I :@4U(#2$2@T\&H5)[U(#0!(#3LTP&G"F X4X4T4HH =S2\T@Q3N*
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M>\+BI55<=!1:Y/L>S/$8_$.MJJHFM:DB#HJ7<B@?D:T;3QKXELEVPZO<L/\
MILPE/YOFO5)=$TJX.Z;3;21O5X5)_E4<GAC0YEVMI=J!_L1!?Y8IV%[*721Y
MXOQ%\6$<ZLPX_P"?:'_XBK,?Q&\3JHSJ"N?]J!/Z"NQ/@/PXYR;!@3Z3R#^3
M4\>!/#H&!9,/^V\A_P#9J5GW!TZO21R*_$[Q(IR9;=O8PBGGXI^(Q_SZ=<_Z
MK_Z]=4? .@-_R[R#Z2M_C2?\*]T GF*;_OZ:+2[AR5NYR+_%#Q,YXFMT]EA'
M]::?B/XHD'&HJG^[!'_537:)\/O#PZVLC?69O\:E'@'PYWL6_P"_\@_]FI\L
MNX<E7N<4OQ \4?\ 05)^MO%_\14=UXQ\07B[)=5N%'_3$B(_FF*[Z/P+X=B;
M<M@<_P"U/(W\VJ^GAK1$7 TNT(_VH5;^8I<DNY/L:K^T>4_V]JYC*-JU^X(P
M0]R[9_,UF8:\N0$1I93R=HW,:]R@T?3+5@UOI]K$P[QPJI_05<VJ!P!1[+NQ
M?5F]Y'A<?A_6KN8+'I=X">[PLH_,X%;EIX)\03+L>V2#'1I95P?^^<UZS@4M
M/V:*6%AU/+D^%=W<2>9=ZI%$2>5BB+Y'U)'\JVK3X7>'[<DS_:KO/:27:!]-
MFT_K7;-25:BD:QI0CLC.L-"TK2\&RT^V@8#;O2,!B/=NI_&K_%+FFFJ-!#3#
M3B:833 C:H)1E#]*G:H7QB@#N1THHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\U^+O\ QY:>?>3_ -EKTJO-_BZ/^)?I_P#O2?\ LM ,\5EZFJS8)JQ/
MU-5<Y:LV<DMSH]5M9=3\.:9?VJ-(+:+R9E7EEQ@9QZ<'\Q5;P9=SP>(K>*%V
M\N?*R(#PP )R?IU_/UJOH?B&?0[APJ^;;N?GB)QSZCT/\ZZY/&FAQHURD$HN
M2,%?* <_CG'ZT:;E+E;4KV8[3K=++Q#K4$8(03)(,_[:[C^IK<0\5R7AF_DU
M+4=4NYN'E=&P.PY 'X  ?A75(:QD]36+3V+:G@5@>+-6^PPVZPDF=)XY2N#C
M;\W4].2N,?6MQ3P*XKQ-J5G=+=6MJC7EVQ$NZ/E8D0<Y/IR?^^O7BNK!Q4JJ
MNKI&6(DU!I;L[?\ M:QCCB>6[AB65 Z&1PN0>_-.37=-9_+BO(YI,$[(3YC8
M'LN37 :%H2^)=-S=:C/YUL=BQ9RB*<8XZ^HZ]JS],T1[_4Y-/A=$:,-@L"!P
M<?A7;'!46Y)RLX[Z'/+%U$HM1O?8]>BG\R-7"-@C(W#!_(\BIM\F!L53_O-C
M_&O-XO!.M6S;X+NW0CH4E93_ .@T^31_%\?W;FZD Z;;OC]34?5*3^&JOG<K
MZU57Q4F>BB2[W#]S#CU\T_\ Q-5=/N]5DUF\@N[-([-%4P3*W+D]<CZY^F/<
M&N:\&^)+N]NFTZ_?S'"EHY&&&XZJ?7U_.NY!YK"M3=&;A)'30JQJPYHD@-/!
MJ(&G@USFQ(#3@:C!IP-,"0&G \5'FG TP'YI<TS-+FF [-&:;FEH #3<TI-,
MI@+FD-&:;0 AIIIKRJ#M'S-Z"FX9N7/']T=*8#6;=]WIZU%+@(?I4S5!,0$.
M>E '>4444 %%%% !1110 4444 %%%% !1110 4444 %>=?%L9TRQ_P!Y_P#V
M6O1:\[^+0SI=E_O/_P"RT SP^XZFJG?BK=QUJK_$:S9R3.SM+G2?#VB63W=J
M9I;Q2[%4#$C@\Y/09%4KKP]'J7BW4[&U*6WEPK)$J@!=VU."!V.3T[^O=R6+
M>)/#-NELR_;; E?+8XW*>G\ACZ&I[NRU _$**>WMY_+\V(F4(=NP*H;GITR*
M9H]4M--"OX.1X;K4895*21LBLIZ@@N"/SKLHSQ6*FU?%^M[<#_4$CWV&M:-L
MUS3TD5%6T,;Q5KZZ?:&UMV/VJ08.WJH/]3V__55[PSH*:7I96X56NKD9N"<$
M#C[GT ./S/>J3^&XI/$=M? ?Z.@:5@6))E!^4\]N2?J*ZA2..:ZIUH1I1IT_
M5^I$8-R<I?+T.&\,3-I'B>:PD;Y)&:$GH"0?E/\ GUJ?PT<>-;D>IE'ZU9UO
MPY?7.L'4;!X@WRMAFPP8>G&.PI=!T?4[?Q*][<VOE0N7)/F*V,\]C7J^VI3I
MRGS*[C9KS1YWLZD9QA9V4KKT'^*_$E]::G]BLIO*5%&\JH)+'GO[8Z>M4QJ/
MC&.,?)=X(_Y]@?\ V6I-<TZ\E\7I<1VD\D.^(EUC)4 8SSC%=?>:E/8B0_9/
M-C55*LK\DG< ,8X^8*O4_>!. #63K4Z-*FHP4KK6YJJ4ZU6=Y-6>ASW@S0+N
M#4#J-[$\(12(U<89B>"2.N,9_.N_!Z5 IRH(J4&N'$8B5:?/([:%&-&'+$E!
MIU1@TX&L3<D'6G@U$IYIXI@/!IPJ,&G"@"3-+3,TM,!V:6F]Z"RK]X@4P%--
MIK2,>$7\6IAC+_ZQBWMT%, :902$!=O0=/SJ,K))_K&P/[J_XU+@#@ 8I,T[
MB$"JHPHP/:D-*332:!C&J&7&TYZ5*QJ&490@T =[1113 **** "BBB@ HHHH
M **** "BBB@ HHHH *\]^+ _XE5I]7_]EKT*O/\ XJKG2;4^A?\ ]EH \,N.
MIJUH6F0:M<S6\TQA?9F,@CDY]#UJM/DMCO53)5L@X/J*AG-)V9T#Z-KOA^Y%
MU:!I%7^.$;LCT*]:M)\1;A(MKZ=&TP&-XD(&?]W!_G5'3O&&HZ>0DI%U$/X9
M#\W_ 'U_CFMQ=9\+Z\0NI6R0S' +2C:?^^UZ#ZD4M.@TU]EV,SPO>37^HZG=
M7#;I93&6/_?7'T'2NFN(GN+.6%& ,B[<GL#P:P=)MK2RU[58;&3S+91$4;=N
M&"">HZ\DUT,;5S3?+.Y4=K,S8)]6M9/(5#.L852S+A<8'(/4DX/KUJWIFLW-
MV]NLEKM649\W[H^Z#P#R>21QZ9J^G3I4RD<5JZT9+6*N2H-/1A#?*5 ?[W<J
M.._Y]#5J*]A=RH?YAU&.G.*@V1R?> Z8Z5/';QC&%VX.0 <#/6N1>U75&FI/
M'<Q,H.]03C@L.,U-'*C]#GJ.GH<&JB6L2%64$;3\HSTXQ4@M5.?G?!)(''!)
MSZ>M6I5;:I#U+ZL*E!K,^PIR5.#MPO'(X(X/XU9M$:& (^,Y)PHP!S51J3YK
M20U<O TX$57+XI"[=<8'J>*T<QEM6YZT]36>+A%;YI%SZ#FG+J$*OMW9;T[_
M )4*K'J%S0'>G#.*JI=;QE5P.HSQ_P#7IWFYSEORJ^>/<98R .32AL]!57[0
MBCJ*>MPI'6A5(@3G<3UQ]* H!R!SZTT.#WIV:NX!FDS29H-.X@II-!-)FF $
MTTGB@FFDT -8U$_2I&J&3E2*8SOZ***8!1110 4444 %%%% !1110 4444 %
M%%% !7!_%$9T>W/N_P#(5WE</\31G18/]YOY4 >$?\O*_P"\*LW%E'/R/E?U
M JL>+E?]X5IU)AN7=+L=&TW1X[O58UE>=V RA? !(X'X=?>J>H^'8[OQ')9:
M6JQ+]F$ZAB<'VYZ9)%:4-NVI:,L<"AKBT=ODSRR-SQ^/\J6_W6_B&Q=,K>"*
M(*N<%NQ7'IUS2:*<5:QD>%D:&]OHI%*NNU64CD$%@<UUT9YJ"?3/^*GO9H?^
M6L4;,,=#R/Z5H0:;=2/@*H'J37+4@^;1"46M!J'M3PPSBM"+1F'^LF ]E%3K
MIEG$?G=F/^TW^%)4Y%6,Q)=I J_')P.YJ8_V?;C)2,#/5O\ Z]12:S:(-J$,
M1V4?Y%6H#)DCD89"FIU@('S,%K+.KR2@B&)SZ$]ORH5KV7#$B/\ 6JLEN%T;
M $2CER?H*BEOK:+.""1[Y_2J2VF\ RRO)STZ"I1!%']U #ZGDU,I)(=R.;5G
M.5BC;V(7 K/DN[J5LEE7(]235R=?052,;,]<5:L]D2R2VC:63YF=FQZ\5K0V
MP7C@=\"JMHFP^E7_ #"#T)K*#NKR+BA"#'D@XK/N;YX@<-5N7S9.@('M5">P
M=LY!K&K.7V+A*]M"G_:DA)))JS%J3\#)JJE@V>AJS'IYQTK"%2?0R2D7HM3;
M(YK0BOPYYK)2P8<\TI0HX SD<=:[J>)G'XBM4= DZL.#4F<C-9=FLAY-::J=
MHXKTZ4^=7* FFDU)L]328 K89'@T8]:D-,-,!C5"PW<5*U1$$LH'4L*8SO:*
M**8!1110 4444 %%%% !1110 4444 %%%% !7%_$D9T.$_\ 30_RKM*X[XCC
M.@1'_IM_[*: / G&+L8_OUJPPRW$R0PKND<X )P*:\2(Y(')/6M#0I5349''
M)2!FQ^5(R2U*JM=:5?M\ZQSQ'!*G*D$ X/3(K;@\8(T67M-\@X!B<%?QSR/U
MK*T+=K6NM)=@.JKYK @8)& !_7\*W+@Z+K=W+IQ&V[CRJ2A<'(Z@'OCT]J+#
M7D5M)U97O[JXN6 DFP=J\A0. /R_K6HVNJ#^[C)/OQ7+:=I<T6J3VTS!7BR#
MCOR,'\00?QKI(-/A0_,"Q]ZAN*>HU<=_:]U,=J_D.:/(O[DJ6DD0#T;;GZXJ
M]"B(N%4 >PJRM1SKHAV,^+0XMV9)7)/H:N1Z5 AX /\ O#-65ZU*AJ6[A9$*
M6S+P,8J18'QV_.IE-2(>*7*AV1"(7QT_6G&%_P"[5@=*D':AP3"QG26SG'R'
M\JB^R2;@=AK8P*=MYK&6&BV.Q1BMF##Y#5Q+?G)%2J.:E%7"C&)2(/L^#TJ)
MK8N2 ,"KN,TY5JG14M!E%=/!'(%3+9(!5L#%+51P\%T$5&MD Z5$+:)6SL&?
M>KS+FHF&6Q2E2BGL!'&OH,5-C H5<"@UK&-D2---I3335 (:::4TTTP&-4:Y
M,J =W'\Z>QI(<?:(L_WQ_.F@.ZHHHI@%%%% !1110 4444 %%%% !1110 44
M44 %<C\1A_Q3:'OYX_\ 06KKJY#XC_\ (LK_ -=Q_P"@M0!X)J=TXG$2\ 'D
MCO5W1KG[+JD4KY\HY5S[&LW4%_TD,>G6K<4T<B?(1]/2B]C)O4Z_2=+70H[Z
MZ>4.A&Y2.RC)_/FN=L69;VU?)\PSH3@\DEA_.HC/.UN(&GD,(Z1EN/\ ]5:^
M@7.EV?FS7BJ+A7W1L8RQ V@<8'UJ6[C;N:EX GBEP !NM58^YW$?R J\G)K#
MAO\ ^T=?EN0I5#%LC!'.T$=?Q)-;4?6L)_$.Y:3I4RFJZ587M4HHE7K4J]:C
M%2J*JP#UJ1>E,44]>E,9(.@J04P=*>*8$@[4\"FJ*D%.PQ0.:<& ('>H;FX6
MVA+MUZ >]8<]Z[DD-UK&K65/0+FY/>)"<;E_"B"]CF!VOR.U<J\TDCA1SD]Z
MVK#3Y\;B^T$5A"O.<O=0KMFBMR9)=D?)[^U/%T=Q7'(ZUF&7[).T8;+#@T?;
M(SPH+MZ#FJ5=K1O4=S3-QG&#^5!RY!!P:HJ7(!<[1_=[U,)U4X JU5O\0%\'
MY1333('+QY/K3FZ5UIW5Q#2>:8>E.-,/2@!#332DTTF@0QC20KNNH!_TT7^=
M#'FBW&;N ?\ 31?YBJ0SNZ***8!1110 4444 %%%% !1110 4444 %%%% !7
M(_$89\,J/^FZ_P#H+5UU<E\1/^1;3_KX'_H+4 >"ZLH!0_45CEV1@RL0?45N
M:LN8@?0U@R5$CFGN7;?5&0#ST)4G <"M2WN89Q^[=6]N_P"516A6[\'WEL(2
MTT$GFHVW^'(W8/J!U]JYP,0<CBDQ-M6._P!(.+T_[A_F*Z./@BO/_"MW<-J$
MJEFEVPL50GDG(XR:Z2V\3V7G>1=)/:RA@A66,XW'H,C(K*2;>AI&2L=+'5E.
MU5XZM(.!22-42H.14R+S34'2IU6M$AB*M/ IP6G!:=@ #BG@4!:>!18!0*D%
M- IXJDAF'K<V9DB[*,GZUE%B!S5_75*W@/8J#6:3GN*\G$-^T9+W%W[9 _IS
M6S9ZU)Y1!4$ <9K#?!!QBI+-\(P-9PJ2@[Q8B\C_ &AV:3!)))JPLRHNR,#Z
M**H+@+RW'I4@G;;MC7 ]0*2D]PN7<O@%F"BIH6$C;8R2U9;'',DGX UN:3!B
M+SV&-P^0>WK6U"+G*R&B^B;(POI0U*S 5"\N!Q7J[#%)J-F ')J-Y6SUQ4#,
M3U-2Y$W)GF'.*A,C$]::::32YF*Y/G<HI]L";VW _P">J_S%0QGY:FM<_;[;
M'_/5/YBM$4CNJ***H84444 %%%% !1110 4444 %%%% !1110 5R?Q#&?#:?
M]? _]!:NLKE/B%_R+:_]=U_]!:@#PO5%S;O[<USDG6NHO1NCD'M7+2=:B1A4
M-_PWXFCT5'MY[<R0N^XLIY!QCIWZ5N-HGAOQ)F33[E;>X/)6/C\T/],5A^&/
M#T&K)/<WLA2VB.W .,GKR?2K^H^"4-N;O1;HS%>?++ Y_P!UA1K8(\UNZ$T[
M1)= \3?9I)DE$EN75U!'&X#D?A3M1FMEU:6'^U)[-6DC:=1;EU+C:5PW\)P%
MK-\.W5U<:X!=32R-'$R#S"25&>G-:]Q,L6M3-#J%W:-M#2N8EDAX4'&.N<$&
MLOM!&S6AV4-7(ZI1'DU<C.:439%M!TJPHJNAJO<W$J,0K$8JYU%!78S1#&GA
MJ\UOM?URR)=)]R=.5!K.'C?56;YK@CVP*PCC(R5TOR,G62Z'KP:G@BO(D\;Z
MNAXF5A_M+5A/'VJ?Q",_08I_6E_*_P !?6(GK (IV17FMM\09U/[Z$$>U;5I
MX\LIW"2*RL?44UBZ?VDT4JT'U.CU.Q%[!P?WB\K[^U<)<ZW;VDSQ213AD;#+
MM&0?SKNK75K.Z \N9<GMFJFM^&;#78]\F8Y\86:/K^/J*SJTHUO?INY4KR7N
MLX9O%%GM.V&?/H0!_6IM%UUM4NI0+7RXH1EF9\?TJ"]^'6L0%VMIK>Y0<@$E
M6/X=/UK.\-:1?W\=]:VX5)MVUPY( QUS7)4I.,;6U.>]5-71H7/BMHY&%O C
M<\%B3FJ$WBK5)OEC:.+)X")G^>:WK;X97LN#>:JD8[I#%G]21_*NJT7P;I.B
MLLD<;3W _P"6TQW$?0=!6\,++JAJG5EN[&!X;\.ZI?R)>ZS<3K .4@SM+_[P
M'0>U=[@*H4# '04M-8UW4Z<::LC>,5%60QC5=SQ4CGK5=VXHDP8UCS49-*QY
MJ,GBLFR1Q-,)H)YII-.X%B/[GXU/:'_B86O_ %V3^8J!.$%369_XF-K_ -=D
M_F*VB6CNZ***L84444 %%%% !1110 4444 %%%% !1110 5RWQ &?#8]IU_D
MU=37,^/!GPRY])%/\Z /#KD9+"N4G7;*P]#767/WC7,7Z[;N0>^:F1C,V]*W
MW7@W5;6')E1UE*CNO&?Y&L;2-7NM'OEGMY#MR-\>>''H:FT75)M'O5O%1G@)
MV2#L1Z?6NOAT7PMK<JWD$H3)W/$LFW\U/3\,4MR4N9*SU&ZC9)!XJMK^W 5+
MVW9\?[0QD_D1^M9UQ;37<ZS7VGR3!3M>33IP=^.Q0\^WK6CJ>JVU[XILK2T=
M7CM8G!9>1DXX_ **PWTN^LRSBPE=HU/DR6LN?WN<ARO!YX!X-9NW,4]]#T.-
MN3GK5R(UGQGFKD3<"LXO4T3-%#TJO=H0Y).%8?K4D9J:2(31%#^!]*NI#GC8
MHX";8Y>,D]\ US=UH=TSL\2@@G. :ZB\LIENVBE7;(IQN'0CUJ5+8VK[99%+
M'^Z<BO"C.5)NQRN-]S@S:W,#XDC8?44]48G ZUV][#OMR5"D^XKFY+:1)N8P
M/3%=$,1S[HRG"Q<TO1!<8>=\+Z5TUO9Z59J 4!/TK*LDF,:KR!6K#:+P7R:X
MJE63EJ:TUV0R=[!F!C@<MV*U-;7FK0%39RN(Q_!*-P-7(S;18RGXXJ['/"P^
M4"G3;3O&5F:J%WN-@\53QDI>V8R!]Z,]?P/^-8VC3/IVJWEXBY^U2,[)Z9.:
MN7@5L[1S5)8I W%5/&5FU>6Q,KWW.KAUJ24?ZM15A-18D9 KFX'D7&:U-/!N
M)@I' ZUT4,96G)1OJ:J5S?W94'UJ-VIS<"H7->VV4R-VY/-5W;BI'/-0,>*Q
MDS-L0GFFDT9YI5B=NV![U.K$-)IR1EF]JF6W4=>:><#@5HH]RDAIJ2S/_$QM
M?^NR?^A"HB:EL<'4;7/_ #V3^8K5%([RBBBK&%%%% !1110 4444 %%%% !1
M110 4444 %<YXY&?"UQ[,A_6NCKGO&X_XI2[]BG_ *$* /"KG[QKGM57%P#Z
MBNAN>&-8>K+E$?T.*EF4]BQX=U"QB$^GZE&#:W.,N?X#V/\ ]>J^O>'9]&E$
MB$S6<AS',.<>Q]_YU'I6A7FM"7[*8QY>-V\XZUVN@:3K5E%]AOUMKG3W&"C.
M24'MD<CVI6N1&+:LT<7X9_Y#D6/[K?RKJD\01P3-%?6L]LR8+MM\Q%!Z<KG^
M517'AV'1/%-FULY,%P)"$/5"!R,]QS4>LK%]M=%FO(-\06YDBBWQA"3C=Z=^
M:QE%.5F-1<3JXO8U<B/>JD28 &2<#J3G-6H^E9+<T1>B;IS5N,^]48^U7(ZW
MB4C,UVREN;;SK90T\7\/]X=Q_45RHRZ^9*CC9Q]*[].M9NK:*;H&XLRJ7(ZJ
MWW9?8^A]ZY,5A/:>_#<B<+ZHX^#4+-8OL^H1SJ['((&1MJ[(EE=QJ]BA6,<%
M6)/XC-59I[>X\Y;A&MIHB%>(\,"2 !CIWJY!IWF(#9S(0 <H6&X'TXKRI)VY
M;69EJ]"2 +'P1BM"-T( XK#N'FM9"DR%3V(Y%+#?9_BK#E:U!3Y79F^8T;O4
MR0JBY[UE17BY&35B345"X!%--=313B1WDFQP!20SC(S67=WF^;@]*GL5DNGV
MKQCJ?2I<7N9<]Y:&W$PD(5>370:; D*=1O/6N=.ZRBQ"H,A_C<X K5T%&.7E
MF,CD\]A7?@H\M1-HWB];&V]0LI/:K9 ]*8PKW&B[%%H68GH*3[,H'))JV14;
M5#BB;(B"(O0"BGFF&F AIAIQ-,-,!I-267_(3LP/^>Z?S%1$U)8G.K68'_/9
M/YBFAG?T445H,**** "BBB@ HHHH **** "BBB@ HHHH *P/&HSX2OO;9_Z&
MM;]8'C7_ )%&_P#HG_H:T >$7/WC5"2WCN6CBE;:C. S#L,U>N?O$U1G7?$Z
M^HI,S9$D&KZ3=WT6DR2.D) D9%!)'8X_PJD_B?6R2&U"8>PP#4NC:S>Z-++/
M#'YL1P)0P/X<]JZ5-0\+^)0%O8EM;EOXF.TY_P!X<'\:GT,UKL[&%X>O;N_\
M16OVJYFFVAMOF.6QD=JW=>$'V\QD7\9$(^T2VP!41DG[P/T;D=.:2V\-Q:)X
MDTZ2WNC-#/O"Y R,+ZCK4>H)<M>O%JEI?KL3;]KL,GS$)/#CTQV_QJ;:W923
M2LSKX(T$2"/E-HV\]NU6D3BF6D<8M81""(MB[,]<8XJVD?%0X&J0L:]*M(*C
M1.E6%6K2&-4?,:G2HE')J915H#-UCPYIVNQ8NHL2@?+,G#K^/<>QK,MM-FT.
MW-LT#/;YS]IMU+$>I=,YS[C=^%=4M. S45*,*FZ!Q5[G!3LUU<745F8Y4B16
MWJX/F9'\/Y5S]RZH3(JNB$D#>N#GO7>Z[X0TK5V-R\9M[L<B>$[23_M#HWX\
M^]<3XAEGL=.;3Y;:!HP?W<UOE<<YY4Y_G7DUL*J<TEU.>K!I7*!OBF,-36U!
MVZM@5A+<L3S5_3[*ZU>Z6WM5RQ^\QZ*/4^U/ZNEN<FK=D:=H);R810KN8]2>
M@^M=M9PPZ;#LSOEZLW;-8MC#%8Q^3!@[/O-GDGU-6!(Q/)-9N"N=E.GRZO<N
MW$IF/6M;06*MMS6$AKH="A)^;%:4K\Z-%N=%BFD4ZD->P:$+"F,.*F(J-AQ4
MM$D)'-1FI2*B:I8AI/6F&G$]:8:!#&-+I;;M8M3_ --E_G5:YE"C:#R:FT8_
M\36T_P"NR_S%">M@OJ>CT445L6%%%% !1110 4444 %%%% !1110 4444 %8
M/C3_ )%&_P#HG_H:UO5@^-/^11O_ *)_Z&M '@MQUJJ1FK,V,U7I,S95TG4K
M?2]1N;>\B$EI<?))D9P.QI->\-G3U^W63>?I\G*NO.S/K[>].70;C6+Z1+=X
MT*H&.\D>U=-H&AZWI#&"22UN+%^'B9CP/4<5)/*WH]CDO"]T8=>M#+(WE(6(
M4G@9!'2NIUFXFN=2AO=*D:[$0VF*"890_-G*YYSD?3;4>J>&+33]=LIK;B&Y
M=E,1/"MM)X-9FH0PQ7OE"SAE(4N69S')UZ CJ?K6;ERRY6"3BK,])L!,;&W^
MTX^T>6OF8_O8Y_6KBJ*X2WUFZB@A>*9C&4&T-SQCC-:MIXFD'$T8(]14_6(7
MLS121U:K4RBLRSU:WN@,':?0UI*Z^HK6,XRU3+3N. &:>*@-Q$IY<?G3#?VZ
MG_6*?QH=2"W8%Y:<*KQ7,<H&U@:L YJHR4E=,"EJ4ICMVQZ5Y%XGOVDNS&3P
M*];U50;9OI7C/B:$I?,WK7EUM<4E+L<^(O9&7%+F0#/?FO4K*WL]+\/JENJ_
M;+P R8ZJ/3_/O7F&F(KWL>X95?F(]<?Y%>G^'K)KN3S9"=P^ZIJZBL]":$/M
M ;(1;((@9),;I".>?2I([!OO/A![]:Z!M.D!PI )[ <>YI'T>26/F0JP].*R
M]E-O8Z+,P6C$?W$W$=S5NWO;V!?W;!5],<5%=6MS8M\^&3/WO\:D@:9HC]PC
MVZU"YHOLR2Y'KMY&1YH1P>^VK]KKT4S!)5*,>,]JPY0%0L2>!D\5DP:C"EQ.
ML^YHVZ,!R*VIUZJ>]PNST576095@1Z@TC#BN&T_7$M;D?9W9HB?F5ACBNX21
M9HED0Y5AD&NZG551>92=R-A4#5-(ZKU-4)[L#[HS3FTMQ-V)'( ))JG-=J 0
MG)]:K33/)U--6/<,MTK!U')VB9\S>PQG+-DG-:>AG.K6O_75?YUGO#A=P!QZ
MUH:!@ZO:_P#705<$U+4<5J>D4445U&H4444 %%%% !1110 4444 %%%% !11
M10 5A>,_^12O_HG_ *&M;M8?C 9\*7X_V5_]"% '@,G.1[FH#UJ5R,O_ +QJ
M(]:3,V6;."69;IK>[>VFCB+*5[XZ@USC>(=8/_,1N/P?%=/I'V?^T5-Q*8EP
M0#G )]#5/6?!%U#(\^FXG@/(0'YE']:EW)DFUH9%CJ-Y=:G;_:+N:7:Q(\R0
MM@X/K5Z]GBN[SR/]&EVY++.2I)ST!K)LH9;;5HHYHWB<'E74@]*U)I2\\D7E
M27(3DQ21;OQ4CI^58M7G<B.VIK*C;5RH7@?*#POM^%3(N!4<&!''A"@V+A6&
M"HQT(]:F#]JXI[LT+=O*8FRIYJ^VLRQ@8-9*M4-Q+M'2I5P1BZAXGOC>3J)<
M .P _&J:^(KU6R9F/XUDWKDW\_\ UT;^=1*2:Z%0IVU1SR6NYW.C^,)4D59F
M_&N^T[Q)#.@!8=/6O"T8JV0>:U;35982"KD8K-T94WS4G8:J2AYGM%_J$<EN
M>:\O\3S0DLQ(SG%-/B.9H?F?@5E0QMJ]YYMPVV!3D^]8J,Y5/:5-+!.KSFUX
M'T@733ZC=C;;H0JY[]S_ $KT/3KXG4$$<8C@'R@8K,T2TBETQ%BXCR<*/R_I
M70V>FJC!N<U2G*I+F2.B%^56-W*\'@U7EF#2%>, >M4)KT6TK0/G*\CW%5'O
M<(6'>NFIB%L:.1K736US;E92H.,<]*XZX5K*5O*+O'GMSM]C5FZOF5<\M^E8
M=S<%#YS,3$_#C/3W%8SJ.K:Z)O<T&N9F^9!$%.-RR.!_]>LHPI<.P?8AW$EM
MV00/Z4[][\[X'E 9W=L5R#>)HSKQ1G=;%%9#MYW$C&>.U$(-IV)D^5&M>>(5
MT^\>TMO(G(&/,5LH,^A'6NS\!>()M3MKJRN60R6[90H, H:\BNY5M;V*2%E,
M;IO#*03M)(Y]#Q7HWP^2XMM5E581'9SQ;U8]2>"/?H<_C71&T&O,QC.3DKGH
M$U9TW>M*:LZ49.*NJC617  !=SA5YJA!--J^HK;6Y*P@Y=AW%0:_J AC,"-@
M 9;_  J7PEJ,-MI4]Q*1YKSB)1W.<8'ZTH+WN5&'.G/DZ&SK4BVC6D*#"L=M
M6-!0KKEL",'>#535E$VO62L,K&C.?TJ[H<AE\0V['^__ $K9_$="^)GHM%%%
M:F@4444 %%%% !1110 4444 %%%% !1110 5B^+!GPM?_P"X/_0A6U6/XI&?
M#&H?]<L_J* /GIC^]E'^U41IS'%U,#ZTTTF0R:ULI=0E,$)4-M)PW>J$>H>(
M/"\WEOY@B!X64;D(]C_A5J.1XI%>-RCCH0<&M&+Q@L,HL]7MEGA8?ZP*#^8[
MTB'8H:AXJBUV*TA>T\JX27<6!R",$?6HI+5ILXNG5>H'EJ=I]CU%7?$-CH5N
M+:YTXK'/(ZML4G#(0>0#_2LUY6A8,+R--W1)AQ^8K"I?FT#7JS3CS'&@W%B%
M +'@GWJ56![U C;HU)*DE0<J<C\#3D..]<<EKJ,MID@X%5YL$'-6[.58YTWC
M*$X/%3:YIK6:B>$%H&&<CM22&CSB^4"_G'_30_SJ$<4:A.#J$Y_VS4 D)KM2
M=C"2=R<M0),5'G R33X(C,^3]T46MN3HMRU;HUP?F)""K$UV(\11'"BH9IQ#
M'L7@U1#%FR:S4>;5[$I<VIZ7X8U"6+28"#G[W\S796>N@D*X -<!X=/_ !)[
M?K_%_,ULAL&N63<9.QU0TBK'1Z[<*WE7"$88;6K*$Y(P3^5.@;[3$;>0\&J+
MR>4[*W#*<&HE[SN5N/E<.^"Q P2/<U4N4S I)7:^< U;M],N+\.T:E8AU=CP
M/I6?J^EV^EP1>3=-*^-SX&<>@K2,1V./\07WE6'D#);<4!]5[URT5K--"TP0
MB)3@MVSZ5L^(VWBV7JY5F;\3_P#6K2@F\[P?!9VT*LZ>9+,0,D#N3Z# %=G-
MR15ENS.<K'++\\:1HAWY.6SUKU#X66]P-8NFFD=TA@VID\#)'0?A7G>D%8[]
M)9$W1@\U[KX-T;^SK:XNG=&DN2I(4YV #[I]^:IMN:C;0E7<TC>F[UFW$@BC
M>0]%!-:4]9MS92WT301L$+=2>PHFFWH:2OT/.M9NVDE;)R3\Q^M-T"*\&NZ=
M!.DJ1-,) K# /O7<6^BZ39ZU%"6%Q> &1@W(&!QQ2F5KS6-#:>%8Y\RN4'90
M,"E"FUJSBC0L^:3UN6+JZC3Q>D,I #6^T?7-:6B*$\30(O3?_2N>O[*6_P#&
M+.G"PHNXUOZ X?Q/"1R-Q_D:TOK\SL@W=W[GHU%%%:FH4444 %%%% !1110
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M9)/]/RKF_P"R9M8UYG\J1H2=H8#&X].M=A=:'J,VIWEE;QB*UF*2M*1@+QC
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M#W/O7I^D1YFEDYX 4?C_ /J%=<(\IU4X<JN]S6HHHK0L**** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!,4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.jpg
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (6 .T# 2(  A$! Q$!_\0
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M_*O.HJ +D?:K<=5(^U6X^U046$J=?ZU G2IU_K0!(M2"HU[5(* '"EI!3A0
M"G4@I: "D-+2&@"-A3<5(1FF$4 1RG$9JYH/_'I-_P!=C_Z"*SYR=I]*OZ"?
M]&G_ .NO]!5(3-:BBBF(**** "BBB@ HHHH **** "BBB@"&[_X\I_\ KFW\
MJ\ZAZBO1;O\ X\I_^N;?RKSF/K0!>C-6H^U58ZL1$\ U!1:3I4ZU G2IUZT
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MI1_XG,0_V6_E1*>*KZ1<H?$<< .7\MF(]!BF@.OHHHIB"BBB@ HHHH ****
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MHN\%_7YJQU'A>X6768H4TX67E1,3G.YQD<<UWZ'BO.?"1D&NH#?_ &I/+;:
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M\D8'85K>&A_Q-2?^F9K,<\5J>&>=5;_KF:3*1U]%%%24%%%% !1110 4444
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M#&,=J]^^(X)\*MC_ )ZK_6O"IX!\Q/4YKKPVQSU]-3"LE#2'<0HK36VC(&T
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M5KHN,W>S+)P>O-4KL@)DG!SP<5:W#/-5[E/,CP*F.C'+5%/4+R5+/_1US(_
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M2*D3&WZ=ZB(!?.![4ID*#:>N>U8VT-KZZC;J&=T#0E=P.<'@&J=W)/':'?M
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M$2KR,GUK"I)7.JE!<I&2",BMSPEC^TI_^N/]16 3M<Q^G>M_PC_R$I_^N/\
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MB.9?1OE-5)+?5+<J)K*8\=47>/\ QW-("Z #3P!5!+KUR#WR,5,MTOJ*!EL
M9Z4\*/2JPN5]:<+E?44 6,#-+@57^TIZBFFZ6@"W1FJRO/(,QV\SCU5":L+I
M^H2?\LUC]V8?THL A<"H)+E%..I/0"M"/0V;F>X)]D&*T+:PMK7F*)0W]X\G
M\Z!&/;Z==79#.##%ZL.3]!6W;6L-K'LB3'J3U/UJ:B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!&574JZA@>H(S47V.V_Y]XO\ O@5-
M10!7^PVO_/O'_P!\BG_9;?\ YX1?]\"I:* (OLMO_P \(O\ O@5( %&  ![4
MM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_003.jpg
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (6 2D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WXGD4M(1R
M*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ QGK3=B_W
M1^5.HH ,#THP/2BB@ HHHH 3'U_.@@'U_.EHH 0*!Z_G2T44 %%%% "$$]R/
MI0 1_$3]<4M% !^-%%% !1110 AZK]:6BB@ HHHH **** "BBB@ HHJK>:C:
MV"YN)0K$9"#EC^% %JBN7N?%<A)%K;A1_>E.2?P'3\ZRIM7U&<_/=R#V0[?Y
M4 =W))'$NZ1U1?5C@55DU;3XURUY"1_LMN_E7 DECDG)]310!VS>(M,49$Y;
MV$;?U%5_^$IL<_ZJX/\ P$?XUR5%(9U#^+(1_J[61O\ >8#_ !J/_A+?^G'_
M ,B__6KFQ1B@#I/^$M/_ #X_^1?_ *U)_P ):?\ GR_\B_\ UJYS%&* .D_X
M2W_IR_\ (O\ ]:I$\5PD_O+61?\ =8'_  KE\4E '7CQ38DC,<X]RH_QJPOB
M#3&_Y>-I]"C?X5Q%% 'H4=]:3$+'<PLQZ .,_E5BO-:EBNKBW&(9Y8P>H1R*
M8'HM%<9!XDOXC^\9)A_MKC^6*V+3Q-:3$+.C0-ZGYE_,<_I0(VZ*:DB2H'C=
M70]&4Y!IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <]KGB$V
M4IL[4 SX^:0]$_#N:Y@EI&+NS.[<EF.2:9,6N9Y+@CYW<L<>I.:<G(Q2&+BD
M(IV*3% !BDP*=10 F*,4M% "4=Z6B@"9$@(&Z1MQ[ =*BD"*V$);WI*,4 )1
M1BC% "8HQ3L48H ;BBG8HQ0 VBG8IRH6. ,T 6+"_N+&3= ^ >J'E3]179V-
M]'?VXD3Y6'#(>JFN/AM&ZL*V=(#V]V@S\KY!'X47 Z&BBBF(**** "BBB@ H
MHHH **:?]8OT/]*=0 4444 %%%% !110>!0!YG;N0*N*J/\ 7KQ_GZ_I5&'J
M*N0\8/T_G2&2^1VX_P __J/Y4&VSVIT;$X&>,=/P7_$U80[GVD<$_P V/^%(
M"F;5NU--O(/X:TTP^W/\0'ZDDTY0&7([@'\S@4 9!B<=5--*MZ5N;%R<]/F_
M(4[R0>"HSP/Q- &#M/I1BM[[.A'W1CG]*/LL?=!VH P<4;:WQ9Q$_<'7'2E%
MG%C_ %8Z9Z4 <_CVI<'TKH19Q9^XO7%.%K'V1: .<VD]J>()#T1ORKHA H_A
M%.$0]!0!SZV4S?P'\:F73)#]X@5N; *-HH RX]-0?>YJTEJB]% JW@4&@"$1
M*OX5+:_\?T/U/\J:W?\ SWIUK_Q_Q?4_R-,#;HHHIB"BBB@ HHHH **** #'
M.:*** "BBB@ HHHH *9,VV&1O12?TI]5]0;9IMT_]V%S^AH \YBSD5<C[8]?
MZBJ4)XJ[&.1]?ZBD,EB_A_#_ -DJU']\?A_[-5>-<;1VX_FM3I]Z,_[O\FI
M21#_ %7_  '^1J2/[J_[J?SID7'E_5?_ $$T^,_*O^ZG\Z )/X#_ +K_ ,ZE
M'W_^!C^51?P'_=;^=2C_ %G_  ,?RH  3L_X :DYW'ZK48_U8_W#3_XC_O#^
M5 #@>GU:ES\O_ 12#M_P*E_A_P" B@!W?\?Z4#I^%'?_ (%0.GX4 +WHHHH
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M?M(H^J__ %ZKB"0=)7_$U*L4V/\ 6'\J )-DO_/1/^^#_C2^7+_STC_[X/\
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M8H ;BC%.Q28H ;BDQ3Z2@!A%-(IYIII@0L*JSKE35MJJS_=- '36TAFM(96
M#.BL<>I%2U1TAB^E0$^A'Y$BKU42%%%% !1110 5YQJ7_(7O/^N[_P#H1KT>
MO-M1;.L7H])W'ZT#0Q:G2H4J9:0RPAJ=:K+4ZFD!.M2K4*FI%-("44X4P4\4
M /%.%-%.% #Q3@*:*>M #@M2!::#3MU,!0HI=HI-U+NXH =M%&T4@:G;J $V
MT;:7-&: &[:,4M(: $(I*6FYH *;2DTA- "&F&G&F,: (WJI.>#5E^E59_NF
M@#H-(0QZ5;@]UW?F<_UJ[573'$FDV;CHT"'_ ,=%6JHD**** "BD!R/QI: "
MO)=:U&&S\>:A8RL%6=E=&/3<5&1^->M5\]_%7CQC>>H"'_QT4TKC1W*5,M>9
M:!X^:TV6NK!I(QPMPO+*/]H=_KU^M>BV-]:ZA L]I/'-$>C(V?P^M*46MQEU
M:F6H5J9:D"9:D4U&M2+0!(#4@-1"I!0 \4\&F"G"@"0&G TP4X4 2 T[=48I
M10 _-+FF4HH ?FES3:* '[J7-,HH =NHS3:* %I#124 &:::6D- #3333C4;
MLJ*68@ #))[4 ,:N:\4:Y%I=H(5<&ZN/DC0'D#NWX5B>*/BCIFFA[;272_O.
MF]3F)/JP^]]!^8K@]&DOO$&NBYNY7FD)W2.W8>@]/852B]QI'TII2[-(LDQC
M;!&/_'15NHX$\NWC3^ZH'Z5)00%%%% "*,#\32T@Z?C2T %?/GQ6'_%8WOT3
M_P!!%?0=?/WQ5Y\7WWL$_P#0151W&CS.;K26FI7NEW GL;F6"0$9*-P<=B.A
M'L:6?K5-^AKI2NC1'?Z1\5KRW*QZK:)<)P#+#\C@=R1T)^FVNXTKX@^'-251
M_:"6TA&XI=?N\?\  C\I/T)KP(TTFH=&+V#E1]4Q2I*BNCJRL,@J<@BK"U\K
MV>HWNG.SV-Y<6S/PS0RE"WUP>:Z>Q^)WBBR(W7D=TBKM"3PJ1^)7#'\36;H2
MZ!R,^A!4@KQJR^--U'$BWVC12R9^:2&8H,>RD-_.NAM/C'X=FE2.>"_MP>LC
MQ*5'_?+$_I4.G)=">5GHXIPKD[7XD>$KJ7RX]9B!]98WC'YLH%:T'BGP_<.$
MAUS39'_NI=(3^6:AIH5F;(IPJ-'5D#*<J>A'0T\,/6@!XI::#3@10 HI:3-*
M"* %I:;GWI<CUH =12;A5:[U&QL$WWEY!;K_ 'II @_6@"U17/W/CCPO:0F6
M37K!E'413K*W_?*Y/Z5C7?Q;\)V\/F0W=Q=G/W(;=U;_ ,?"C]::BWLA\K['
M<TE>3:C\=+&%T%AHMS.IZF>98B/P4/FN5U'XV>)+I94M(+*S5C\CK&7D0?5C
MM/\ WS5>SEV'R,^@B16)K'BW0=!WKJ6JVT$B %HMVZ3!Z'8N6_2OFO4O&?B/
M5RXO=9O)%D7:\:R;(V'NBX7]*QX()[J98;>&265ONI&I8GZ 52I/J/D[GM6N
M?&ZSB#Q:)I\EP_($UR=B9[$*.6'U*FO--=\::]XD8C4+Y_()XMXODC'.>@ZX
M]3DU:TOX>:YJ&UYHELHC@[IC\V/]T<Y]CBNYTGX?Z1I6V293>SC^*8?*#[+T
M_/-.T8B]U' Z!X7U#67618S#:]YG'!_W?6O4-.TZVT>U$-NG ^\QZL?>M-D6
M- H XJ$#>X'8FDW<5[GK]%%%00%%%% !THHHH *\ ^*@_P"*PU#_ '(__05K
MW^O OB@N?&6HC_IFG_H JH[C1Y=-U-56JU-U-56KIB:H@;BFYR< 4YQ4^EB8
MZM9"V95G,Z"(L. ^X8S[9Q57&5C1BO1]9U_PV-1ELM5TH7<R?+/=0Q!&9QUQ
M\V['_ OSZU"?#O@[4[(WMEJLMDC,$ D?Y(FQG#;AGL>K8..#4>T[H.;N<]-X
M.U%0QCDMY,'A Q#'\QC]:H7'AS6+<*7L)&W=!$1(?_'2:]+GMIK7;)(T<D$W
M,5Q"<H^1^A/7N.G)I%8^M2IMD\[/)[BTN;-MMU;S0-Z2H5/ZU#GTKV-)2K @
MX/J*)K>VO6#7=M%.WK+&&_G3Y^X^<\<VJWWE!/N*TK;7=7LEV6NJ7T"^D5PZ
M#]#7ILFC:3-& VEV>/\ 8@5#^8 -,3P=X?8[FTX'V\Z0#]&HYHOH/G1Y^/%?
MB/\ Z&#5O_ V7_XJGKXO\2(.->U/\;MS_6O0V\&>'G'&F!/]V>4_S8U#_P *
M]T20@C[2OL)/\11S0ZH?/$X=?&WB=>FNW_XSL:&\:^)G/.O:A^$[#^M=N/AI
MHSG_ %]Z/HZ__$U,GPQT0'F>];ZR+_\ $TN:GV#G@>??\)9XC)S_ ,)!JOX7
ML@_K0?%7B$\-KVJ,/]J\D/\ 6O34^'GAVWB+26TLV!G]Y,P_]!(KE]%TC1]7
MNKLC2H5M5F*0%9I@Q4'J<N?:JBXO9![6*Z'%7%S/>.7N9GG<]6E8L3^)J,M@
M8%>Q6WAG0[>[=(M+@*J!_K5\S)_X%FK$^E:9$?-BTVQBD4@J\=NB$8]P*2JQ
MZ(MRMT/%8D>:0)$K.YZ*HR?RK5A\-:[<2)&FDWH+\@O"R+_WTP _6O3'OY'O
M[:*1V<%]H#'.#77!?E%$JKCT$YM'BL7PX\174FR2""V _BFF!'_CFZM:R^$L
MI"-?:HJG/S1P19X]F)'_ *#7J1% '%8NI)F;DV<C8_#?P]9D%X);I@V0UQ(3
MCVPN 1]173VNGVEA$8K2VAMXR<E8D"@GUP*L '.3T[4M3=O<S;&$ "H<$DDU
M(YW':.]-? &/2@16E-,@&ZXC7U84LGS' YJ6SC!O[5">6F0'\Q3&>K4445)(
M4444  Z44#H** "O!OB7\WC>^&.-B#_QQ:]YKPCXE<>-[[_<C_\ 0%JH[C1Y
M1.,,:JM5V\&)W'^T:IM73$U1"XR*6VFDM;F*XB.)(G#H<="#D4$TZUMWN[N&
MVBQYDTBQKGIDG _G5E';76DV/C<_VEI5W%;ZBRC[1:3'N,#((YQ[@$'CH<U8
MM_#+>&?#NMS:K=V["XMC%'%&2RE\$J>0/FSTXXYJ ^!-,:1[:+Q J7ENOF3A
ME!"J.^,C;V[FJ.K>!=>BMVNVN8;V*-201,2P3&<_,,?D37/=/1/0B_2YUL,@
M_L;Q$N0?)MO/1& (1P'(8>^4!_X"*BS@D9SBJS,P$J*[HLH"R!6P' .<$=#Z
M$]<<9QQ3U?'.?TIJ-B!E[=K9QQREP!YJJ?IW_3^5::," <X/K7(ZY-&[$O)A
MDPL:CG/<G_/I3(VU.\LOM,=QY,<*;"J.0W'.3VS@UU*@I03O;^M#DEB'&HU:
M_P#6IVT<@4<G]:EBO+<DH)XBX[!QFN!M$O[MFDB!G9""3+A\'MC=^/2M-;OQ
M$G)64_\ ;)2?T%-X.SMS*_J2L<FK\KMZ'9B[B!QB0G_90D?I^-*VK6MO)"DC
M,IE;8F4;D_EQQGD]<'%<C%XBU.RF3[9;@QGJ'C*DCVKM;8Q3I'<*,ADRK$<[
M3@_T%85J+IVOL_,VHUXU;I=/*Q?C[>]6$JM&<]ZL1US,V,_Q/?G3_#UY<+)L
M=8FV'T;&%_\ 'B*YWP?9"VTVV0CG&Y@?7_\ 74_Q!F8Z5;V:D'[1<)&R]]O+
M']56K6F@0V$C*,%8CCVXK6.E-ON)*\TB[9@.)9AT=RPS^51WC?NV]QC.:G@7
MR[9!G/'7UJO<GY3QQCFHC$Z9:S.9DEQKVE@GAKM 1GUKT;M7D^LW#6FHV,XZ
MPW*L2>V#7JT;K(BLIR&&01WIU>@IBGD\4G6G4F*R,V'>FN^*<QP,U" 9']A3
M('(.-WY5&P+?3UJ1Y5'"C<?;I^=5I"S#YCGV'2A 1R2*H^3!/K4NE8?6;(-T
M^T1_^A"JCFKFC?\ (9LA_P!/$?\ Z$*HH]4HHHJ" HHHH ;&<QJ?84ZD P /
M2EH *\(^)0_XK:^/^S'_ .@+7N]>$_$L?\5K?'_9C_\ 0%JH[C1Y;J(VW3^_
M-9[&M755Q.#ZK62W>NF.QHB,U)97+6=];W2C+0RK(!ZE2#_2HR:[31]&T#4/
M#$5Q/'.]TC%;A[4EGC&XX)3GC&.@/\Z<I**U*;L5-.U&PG\97ZB9EL=5CEMV
ME;Y2GF#/_H7%;'A[PIK=M_:6F7Y:#3YH&"RI,-OF9&UP <],YSC(X-90\):/
MJ/S:3XB@9G_U<%P,.?KT(_[YJU?Z!XUM=,>T^VFXM-AWK'<=% Z9;!QCMTK)
MV>B?WDZ="\9/,^<@KN^;#=1FJM_J*6<)(8>9C@'M[FK4QQ*3TR:SI]/2XN8I
M,G"MEP<G<.P_.MJ?+?WC&IS\MH;CM+T[_1GGN03-.I&#U53_ %/?_P"M5?3I
MC +RU?(WQL .OS '_P"O^5;2OQU_.LZXTEY;AY8I%4L<X-;TJJ?,IO<YJ]&4
M5%TU>WY,F\,G NSC(&S_ -FJ.+5=6O+AA:LW<A$48 _$5>T6PGLQ/O:,EPN-
MI)Z9Z\>],TK3[ZP-TXC0RF(^7D@@MV!]JTE4I\TYZ/:QSQI5>2G3U6][%>2R
MUK5)8TGC9MG 9@JA<]>G7I7=64(M[2* $D1H%R>I '_UJS;-KDRSB=8UC5ML
M1 P6&3SU/;:,<<@]B -.$\>O-<=:NZB4;62.VCAXTFY7;;[EV)L]ZMQ^]4H3
MGIWJVC "N9FQQ'B^43^)M-MQG=%&\I Z$$A1_P"@M6S$/^)7(H')9%_ MS^E
M<S?RO<^.+O<<^1''&GY;C^K&NNLX]UM@YY=?QQD_RK::M20Z3M51:8< >@Q5
M2X'R9YY_*K;8.>G'I56X&%+8[=,UG%FL=6>?^*XV8,P.=I&/;_)KT?PK?#4?
M#MG/N!8(%8>A%<5X@LWFMV; &!NRQ R/;U_"K?PZU**W:XTIIC(^XM&%&%/&
M>,X.>O;M6E17A<JH>B$4APHW,0![T?.>/E0>O4U%(J(-Q.3ZL<USV,&0RW)+
M;8HRQ_O-P/\ $U*D+% 96R?[HX4>V/\ &FVR>8Y<]*L.:!/L0/@<#BJLAJ>0
MU5D-- B%^N:O:&"=;L@/^>RG\CFL]C6OX93?X@M!Z,3^2DTV4>F4445! 444
M4 %%%% !7A7Q,'_%97OTC_\ 0%KW6O"?B6?^*TOA_LQ_^BUJH[C6YYMJP^16
M^HK$:M[5ES:@CLU8#'BNB&QJAAJ6TO+FPN5N+6=X9EZ,I_3W'M0+:5XQ(B%E
M]J[CPSK>GQZ!!IXN;2TOXV;+7D)*,"6/4,,=1U/;I3E*RVN-NQC-J6C>(5QJ
M\?\ 9]^?^7VW3*.>>73U]Q^8%5KS3==T"U+P74ITZ3I<64Y,+]N=I]\<_K78
MWNH^+[*/>FE:==PD A[5'<'_ (#NS^E<[>?$'69;6XL);.QA5T:-U$3AER,'
MJW!Y]*S3;V6A*N;$F6PQZXK/D@D\_P R*0J68%AG Q5\ME!SU J/;QQ6L96V
M(E%25F5X_MHX692!W;_/]:OK(P;@'&>_:J^"HS4L39/-353GL[>@1AR[,O6M
MS)YA C/3D\U;^TG;]QAD9 ((].,?C52V8"4#UJ^P*D8[]/>L/9S7VOR*:'1W
ML>U=RL <XSQTK2MY5= P'#?-[U6CM)90%\DE2.=PP#5J*#R4"NZ)CJN<D?@*
M(QDG[TK_ "$6X""!C/U-67;$39[C%5%GM8ER9=S#\*6\U$06LDR0_*BEF)'8
M#/?Z4VKDG!Z0KWVOZI<1*TBM<R$%?[N3C]*[ZSCV6:G(SO['J-IXXKSCPO+<
M3PKYMQ(V.@8DX'H*]%LHU^P\_-\X^]SSBMZR]U(4/CN2O(G5<M[XJO.Y"Y7"
M_3_&K+"JTRY!. :Q5C:.YSFI0&2)D)8Y%<O:2RZ/K=O>)D?-M.>!GMGVS_.N
MZD@#$G'%<WJNF[@Z8Z]ZZ:=GH55>AZ?;W*7-K'/&?D=0PS565C-+L7\:Y7PG
MK+?8S8S'#K]T'^]W'X]?SKK[.([3*W4]*Y9P<)69C%Z<Q80".,**8YH9MIJ-
MF!'%38D@D/6J[GFK+(6Z#\:9Y [FF,IM6UX4S_PD5K_P//\ WPU9<L. 2O:M
M7PH/^*AM?;?_ .@&A[#Z'I%%%%02%%%% !1110 5X/\ $P_\5M?#_9B_] 6O
M>*\&^)G_ "/-\/\ 8C_] 6JCN-' Z@-]K(/;-<V:ZB8;@0>AXKEY 58J>H.*
MWB:(V-,_X]1]35B6"*88DC5O<CFJVF'_ $4>F36XFB:F]G#=I;":*6,2 PMD
MJ",\@X.?89I-V8[E'3;;4;>[CBT6[N(978D1*XV,0"?NM\IX'>M$>([Z\MA#
MJ>E6.J*4(C<@(ZY'WN01GZ8J+3[Q=,UBVGGBEW1%BT.-LF"K#[K8]>]5[/*+
M'NZA0.:6["R;-4Q2* 2C<@<XJ=-+U"4@1V<O/.67:/S-=*==TV!$\OYN!PB8
MJK+XFE;BWMU'NQS_ (4TY/9&=S.A\,:G,FYQ%"<_=D?)_P#'<C]:M'PY:6C
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MNU:<S#8W8W]36A%+TK#AE!;K5^&0#WK2PR[J<G_$KFY]/YBN791(M;FJS?\
M$JFY]/\ T(5S\<P(Q3B58S;J$AB:I$XK;N$WK63/&5:M%V)DAMO<RV=REQ"Q
M61#D5Z?8WEOK^E">,CS0,2+W!KRJM30M8ET:_6523"QQ(GJ*)PNKK<E2L=4Z
M&&=,CD-SFMNRGPR\\5%?117UJE[:L&1L,"*JVC/N"*/F)P*S;NM32,=#H!(6
MW-V)_0?_ %_Y5?,AEA![_P!:R874H..",#Z5:LY>"M8.-M2G:2LNA8#YI'.3
M3A!*TGRHV#R#4R6,C$;B /UJKHRV*V.])M]JTUL$ ^9B?I4J6\2?=05/,@NC
M+2"1^BD^]6([(X^<@?2M#  I*ER)N0K"D:\#GUIRKFGD9H45+8AC\5U7@I +
M>\<=V4'\ ?\ &N0NYEAB9V./ZUU_@0E](N)#U:<_^@BD]@.IHHHJ1"-]QOI2
MT$9&** "BBB@ KYZ^+__ ".-U](__0%KZ%KYZ^+X_P"*QN?=8S_XX*J.XT<)
M:G]VP]ZFQ5:S;YG%6C6IHB*:/S8'0_Q*17-*I+A>Y.*ZG&:YR[3RKR11QSD5
M41H[A="\+0:K#H,WVV2_8*&G1@%5B,_YX-<N^GW]]J]SI-I+-<>3(XCC>3J%
M)'?C.*ZK0FL?$.LZ?J9NEM]5@*BXA?I/@8#*?7';_P#75W1_#%WI?BN\US4)
M(H+.)YI%8N#N#9Y]A@U%[;BN+ICG^SK/_KDG7Z"J(@N)$M; WSV\4.3!!<1%
M)"!_"K9VL,<;@,X)J:QN5,%OP%0HI7(X (XING0AKU#&E@GERAI$EN#.T8'=
M!LR&'/5C^%-C:,".62WF:&=2DBG!!]:U(+C..:T=5TR/4DSD)<+]R3U]C7,A
MIK.<P7"E'7J#6D9=R6G'<V-5ESI,V/0?S%<W%-BM/4+@-I4OT'\Q7/I+QUK5
M%)HUA-FHID#CWJO')[U.'SC-4ALSI$*M35%:$D0D%5&B*'!%:1,9(V_#NMOI
M\IMY26M)/O#/3WKM1:JT+W<)W)@!".Y/_P!;->9Q*23QVKUC1=FCV5C972_/
MY>]]W\+-SS^%8UE;5%4YV1+86$TL8,F8U]^I_"MFWMH;=AL3YNN3R<U,R KO
M3D'TIA/Z5SR?,"9<!#+3 <FF1/D4[(!]J@&2BBD4BG4B1IZ4TTXU&TJ#^*D
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M>=<PQ,",]"1R?R']*Z.[E^TW4DO/S,2/85<T:V6TT0@CYF78>.YY-5I8=K9
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MHHH$%%%% !1110 4444 %%&><44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 )_$3[4M)_$?I2T %%%% !S2'=V('U%%%  -W<C\!2T44 %%%% "'/8#\
MZ!GN!^=%% !S2T44 %(3BBB@ # TPS*#C!HHH >K!AD4M%% !1110 4444 %
C%%% !1110 4444 %%%% !1110 4444 %%%% !WS1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_004.jpg
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )+ 0,# 2(  A$! Q$!_\0
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MUR*Z:QU;3]33=97L$X_Z9N"?RH N4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<WXE\76V@CR443W9&=F>%]-Q_I725\TZYJ%T]W
M-=2L7E,SAF/L330%_P 3^*]7U>Y9;V\D%OU6&(E$_(=?QKFOM8C&$ 'TIO\
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MM1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S-JXR]X/\
MIJW\Z^F:^9]6_P!;>_\ 75_YFF@.0N4&S/'7\:HN@S6A<C]V3L/WOO?TJ@U
MB+##[KLOT-,.H7D+86>3CCK4C>PJJP_>'BD,T;*\U6^$@AF+[1E@S 8_.M"U
MLM?N@7A$;H#@L67&:YR%7$IV\9]*NE)(X#@D+GIF@#3EAUF.0H^P8ZE66MRW
M\/E;1;F\ULP!UW;%3)Q7&*S-*I8DX]ZW+6[D++'/(QC'J<XHN!?GMO#YB<-J
M%_)(/NM@<_A67<V,*+YD"7#Q8'SR# S756UQHD""4W$)D49"F+)S]<<50UC5
MK>^MMI$BD'*D'*FE<#EB #P,5-"=K ^G2EW0@Y(9OTI1(#]U0*8%_2S_ *?'
MCUKZC\*MO\+:<0,?N0,5\MZ3DZA']:^H_"?_ "*VG_\ 7+^II@;-%%%( HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ****  ]#7S/J_$EYQ_RU;^9KZ8
M/2OFC7AY-U=(W&9'Q^9IH#D;AOW97<?O9QVJ@U:$\C>2R97;NS[YK/;K0P&-
M59L>8:L-Q59O]8>*0$D#?O.!FKCEF@(9<<\55@^^.U7I5 M\]SU-("E&%$@)
M.>>E:,4B!\NN]>XSBLU.7%:*1J!DGBF!<-^B(1';PIG^(KDU0DG:8DLQ/UI9
M'&TJ ,&H$ZF@!6ZU)'49I\= &KHW_(2B],U]0>$CGPM8>T?]:^7M'XU&(GH*
M^G?!K;O"UG[+B@#>HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KYY^(>BWFE:E(T\9"2,61Q]UAGM^=?0U<+\3+"6YTJ"X2+?'#N#\9QG&
M/Y4T!\Y2,@@(9#YF[AL\8]*HL>:Z*\L8I7<*I4@$@+Z_2N:G;R7*NC#WZBAH
M0R1U'>H"V23VJ.=&D;<I&/K3@AV8X_.D,DA<YR!P*T&E$EJ<9XJA;YCD5G4,
M!_">E:\AB%F"$.\\D \4@,J,GS!6M%!).0J*3662#."J$#TKJ-*U(VSKY:1C
M(Y,B@TP(D\-:C+&'6,;6X&35:[T2ZT]0\^T!N@%=/)XJ-I\B26Y0\[0#@&N?
MU?Q$=0(1_*P.A"\TKL#(88-*E(&C=N2?P%:ED+4%0ML99"1C<<\_04P-;PIH
M.H:SJ<<5C;-*P(W-CY5'J3VKZ8T73%TC28+)7WF-?F;U/>N,^%=I.FG7-S-'
ML5MJ+QCGJ?RXKT*F 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&V-*)J-J'AR&,B+10S#H785SEW-:R3,T<21 G(4'.*V)/ EZD1>2<<#.,?\
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M3Q48-/%,!PIU,%.H >*6FTH- #J*2BF [M3:6FT@"FDTM--,!K&HF-2-434
M0O6CH/WKG_@/]:S7/.!UK1T'[US_ ,!_K30F;5%%%,04444 %%%% 'GWQ5_Y
M!EC_ -=&_E7C\G6O8?BM_P @NQ_ZZM_*O( P6=&;H&!/TKCQ&Y[F6NU,NK+K
M.C6Q>,211-SDJ&'Z]*V?"%Q+<QWL\SEY'E!)/TJ*;Q1-;:A-%);H]NIPJXP<
M>M:&AW5I>2W<]E#Y43,N4VA?FQR<"DE%.REMT)Q#J2I.4Z:5[.Z_4I^)VO+N
M\L],C5DAG;EP?O>OY"M/7--C'AE[>! %MT#(!V"__6S4MQ>I!>*)K=B@'R2[
M>A[\]NWUJW;:A97T95)48,""K#&1T/!ZBNU59146EHCQ'"+YDWJSA/MGVDZ5
MN.7BPA_!N*VO%;7-UKUK912E0T:[1G R2>?TK?\ ^$9TF202BV"."""C$#\N
ME2WF@0WNJV]^9662$   <$ D_P!:[/K=)S4ET3^]G+]6J<KBWNU]R.=/@W5Y
M0L;WL;QY_B=O\*[S2[-=/T^&U4Y$:XR>]4H;&>+4!.+MS <YA/([UJJ>:Y*N
M)G524MCIIT(4W>).M2 U$IIX-87-24&G@U$#3P:JX$@-.SQ3 :4&@1)VI<TS
M-.%,!V:*2B@!33:7--- !FFDT,ZH,L<5$9)'^ZNT>K4["'.P49)Q4#,7Z J/
M7O3_ "P#N8[F]32-3 A88K2T'[US_P !_K6:U:>@];D_[O\ 6A S9HHHIB"B
MBB@ HHHH \_^*O\ R";+_KJW\J\=DQNYZ5['\5?^039?]=6_E7C<O4UQXC<]
MS+?@.FGT6UUBW2;3[I?.5 K!CG.!CGN#4_ABQN-.2[M[E-CAPP&00016'/I5
M[IMBFH"783CA&(9<UM>%]1N-0^U/=2>9("HW8 X_"I;7-JK,*JFJ$E&?-#\5
MJ=)L208= V#W%$=A:HVY845L$9 ]>M*IJ935<[M8\IQN.6V'59''L#4JI*F<
M2Y&!@&D#?+3MW%82<%L'*/62Y!X",,GOVJW#*SQ@LNT^E4TDYY-3B0"LE72U
MN/D+BM3P]5%>I-^*M8I6N'(6U84\,*IK)4F^KCBDQ.!;4BG@U75N*>&K:-9,
MEQ)\TX&H0PQUIX<'I6RE<FQ)FC/K3,L?:@*._/UJ[B'&0=@3]*8P=N^T>W6I
M.U--,!@15.>I]:#2FFF@!IJ-JD-1M0!$U:F@_=N#[C^M93G@UK: /W$Q_P!L
M?RIH3->BBBF(**** "BBB@#@_BBH;3+ 'H9B/TKR"_LY+=R<%HST;'\Z]A^)
MW&DV1])_Z5YW(RX 897N<<?C7/65V>I@ZKA%6,Z^DG<Z@DCLRA$91NRN.,8_
M UNZ"L*PP/%$(VDM4+[1C)!(S]>*BC2QN;9K6\;R1MV+,"%^3.<9/ Q5VS:%
M[TQ6B_Z/! L:OV;D]/\ &H:ZW'5J7I\B5K?=LD:J&I0:A53Z5*(V(K"?-;1'
M'H2!N*<S82F"+ RS 4I: +AGSBO-J<^M]#16Z DGS5,I)-5/M=M&_K^-3+J"
MLI\M,X]!7&X]Y?<:_(N1[CV-6&4X!R!]:S%N+B3HF,^IJ=3(Z$/)CZ"B,X*Z
M?]?<)Q>Y9WHO);\JE$\> 1S^M9OEJO4D_4U=@V[.*5.O[UD.=.RN6!.YX5/Q
M-2*6)Y;\J@+;:D5L@5HL7)2L1R:%I0/_ -=2AJ@#844JO7I0Q-M#%Q+(-/!J
M!6IX:NZ%9-&;B2BFD\T;J:3FMU),FPI--)I:::M,0TU&U2$4QJ8$+_=-:^@?
M\>LO_73^@K(?H:U] _X])?\ KI_04T)FM1113$%%%% !1110!P_Q.&=$M?\
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MX[>U=] 8X(!' %"@54TW2;>QM$B 4D#+'U-719KL'EM_44TDCFG)L;&)V&T
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M5&^QI'"J+[G.ZO+K/F99Y2"<#;TJY-H%W8Z!-?W\Y9]HVQ]AFMJQ5[R^CB8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_005.jpg
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )6 38# 2(  A$! Q$!_\0
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MMSF0#GC J9=+C'5F([5H>E'\)H K+8PKGY<\8Y-2B)$!VJ!QZ5(>]![_ $H
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MM("5:>*8HJ0"@0\4\4P"G@4P'"G"F@4X T .I:04HH >G)ITJ;EP.M,YI>:
M)U "#-+\OJ*@YI<4 397UI-RU'BC% #RXII>DQ10 A8TAR:6D- #2*8:>34;
M$ 9)XH C>JLW(-66.1D=/6JLQP#C\Z -_1O^03#_ ,"_]"-7ZH:-_P @F#_@
M7_H1J_5DA1110 4444 %%%% !1110!Y;XN'_ !55Y_P#_P! 6LN,D&M7Q?\
M\C1=?1/_ $ 5DH*EE%Q"&'S#/OW_ #JTB_W7Q]1FJ<=6HZ0%M=X_@#>FT_XX
MJ=9 #@@CZ@@?G59#[U91R.](9/&ZL,J01Z@U.M5QM?&Y%;ZC-2A4.."/HQ%
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MD1AE64Y!%78\&H-BRE3I4"5.M(9,M3+4*]*E6@1,M2+40J1: )0:>#48IXH
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MCA6.>U6I*K.H=@A_B.* /4J***"0HHHH **** "BBB@ HHHH \A^-T1DDT?
MYV3G\MAKQ21VC8.C%64Y!'8U[O\ %XHM]X?WC*M]H0_B$']:\/N+.7[<]HBE
MY Y4 =ZT@SAQ,7>Z.ATR^^V^?<8(+NN1[[%!_45;N[>6=!+#(5DC5MH ZDC'
M^/YUG:9:/IWFVTC!F# DCIRH-;$3=JI::HV3;5I%1;[5+>1%,!E4Q!]N,DL
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M/6J4#].:N@\9%0T:)Z#A2$9H4\\T\U+&1XII%28IC4F(B8=:9CFI3@=\5&2
M.:$9L3H?:C)S5:2_M(SA[F%3Z&0"JLFOZ;'Q]H#$=E4G^E49N45NS5!]^:>&
M.*YJ7Q7;J/W,$KG_ &B /ZU1F\4W;@B)(XP>AZD?T_2G9F;KTUU.U5\=:BEU
M.TM\AYEW#L#DUY_+JEY<G][<2'U&<#\A1%,<U:AW,GC/Y4=L^N!^(4Q[M4/V
MF25\NQ)K"MY2<<UI0MS5.*6P1K3F]6:<#<UV/@C_ )"TO_7NW_H2UQ4!P>M=
MKX'/_$UE_P"O<_\ H2UC,]'#G>4445F=04444 %%%% !1110 4444 <A\3R5
M^'^HLI(*F(@C_KHM>)*MMX@L=DF%G0<D=5/K]*]N^)XS\.]5]A%_Z-2OFF.[
MFLKH30MM8?D1Z&JBKF-2:B]=B[!I-Q97TL,J]8R48=&P10QP1ZUJP:O#JDT!
M4%945MZGMTZ54OH0+IR@[]*I-WU)BHQ7N[$2,:O62>9,H-4T/^S6I8Q,@\UQ
MC(P!5N0I:EN2SW'*X'XU#=V;_8I\9)\MN_M5H2Y[TEQ+_H<V3_RS/\JFYBTC
MC5M)C_ :I,I21E/8ULQ7&'JKJ-OES.@R#]X>E4G9G-#0HI(R'@XJ_!J-R@&R
MYE7Z.15# /6GI'Z&M4T:,WH-6O5*L+F4_5LUOVFK7C6BL9FSZG!KGK%4DM"A
M W8./K6I92QO J#AE&"#0[,PG)QV9H?VO>YXF_\ '1_A4JZQ>L,>=R/]D5GL
MG-(X*G/>GRQ:V,'5J+JRS+J]^.EP?P452FU2_<\W4OX-C^5$CJRY'XU7.&)'
M%3RKL0ZL^XC7UX<YNIR#US(:HRNSDDL3]35B0 55;K4M(GF;W9&<Y_\ KT#/
M%/V@C-,Q4A:XN:0FD[TA%%RDARM@U81_?]:JCJ*D4X--,&C6MI3QS6K!(:Y^
M%MI'-:UL_%-FD&;=LQ)%=SX%'_$VE/\ T[M_Z$M<%:L,C-=_X%4_VE*W;R&'
M_CRUG,]7"G>T445D=@4444 %%%% !1110 4444 <E\3N?AWJOTB_]&I7SY>>
M'I#9)/;DN^W+(?Z5]"?$S_DGNJ_2+_T:E>(PZJL#3"<;8HMB@CMD=ZI7,YQB
M_B.;T &/5&# @A""#VY%:ZXFF<CKDFM#48[9)([J-$WLI&]>XQ532%&]G8@*
M%))-.]]3'V?*N4MVT431!O+7<.^*?(<57M;J%))(V?OP>U69 &&0012UZC^R
M)&C.K,.B\FH[IC]CF_W#_*E5BAR#BF7/S6<W ^X?Y5HCGD<N'Z&K4<V1@\]J
MHCIBI$//)Q3:.2Y::RAEY4[#^E/ATD%OFF&/85"DFVK$=P0:F[17.:45@D4.
M(3\W?/\ %520/"^_D,.N.HJS;7&>M7V@CNDP>&[,!TJHSL]2)PY]5N06EVLY
M"/A7[>AJZ\9(Q6'/;26\FUU[].WU%7K34E7$=P?EZ!_3ZUOTNC!._NRW%9=C
M\YP>M,>(CIT[&M)[=9!N4@CJ".:CV1(I21T![9-3*0>R=S*D0D55=<5LO'"P
MPLB'Z&J4MM@]*SN')8S\4H0L.*L-#CM2I%BDQ6U(%B)-(Z!>IJ[(HCB  ^9C
MQ4 LI&&2*:5R9SY"N$#=*-N#5N"T8R@ U/\ V5-*V%&?2FXM!&:DKHJ1'M6C
M;-@@9J2Y\/7EC'"[ -Y@Z#L?2KNGZ'<$AKC]VOIW-)Z'1"$F[6U+VG1M*PV@
M^YKTCP3%MNK@@<+$!^9_^M7(6T,<"!(UP!7:^">3>GVC_P#9JRD[GKT(<B.N
MHHHJ#H"BBB@ HHHH **** "BBB@#E/B4,_#[5?\ =C/_ )$6OGBY&^WO@!R8
MXW_E7T7\0UW> =7'_3)3_P"/K7SGI,HFU)H)CE98S%5(QJ=B--\UA9SY;Y=T
M+<^G(_0U:6<)9,@/S$\_05<N=.33])C@5]W[XMD_0UEC&<>M:Q2:",;6N21-
MDY[UHV<^U@C'Y3^E8R.T;<'!J>.4@BJ:30Y1.A:+TJ&=<6LO'\!_E5BVN(Y8
M$R?FQ@YI;J+_ $:3']T_RK)::'/)7V.(QS2XJ0KSTI=GM6IYUQJ\BI%/-(J<
MXQ4BQGL*A@7+1N16Y#*D4?F.=JCJ:QK6([AFI-59D2)?X3D_C4/<T6BN:-QJ
MUG.GEM;NZ^N<5G2P+(ADARRCKQ@CZ_XU2CE &*<UX]L&>-L,5*^O!K>-DCAE
M*=2I9B)JLULCPQR$+TQ_AZ5"DY=RS')/K6;,V,'VIT4]=-.,3U%0]W0U]X89
M'!JY979\U893E&Z'TK*$XD*[45 %"G!Z^Y]ZL(@ SU-.=--&4J?*;;QQ!SO=
M5 ZFKMM:V]Y!(ML,2*N0S=#65#I]U=E B'!&0>N:Z/3/#L\+J\DNT=QGK7"]
M#FIJI.6D=#G7MIS*ID_A...E75C+@**[I=(LY;?8Z;L=NE+%8V\!_=QJN/04
ME)+8Z%@9_:9RVF:--+<>:83M X+< UT5KI<4,@=\9'8"M)<;<+Q4,JLIH<FS
MJI86%-=PN%4Q8"C@YZ54*%E)QT%:!CVPC/IS5:XQ#:^A<U!TN/4J(>:[3P1_
MR_?]L_\ V:N)0UVO@<Y%]_VS_P#9J3+IG74444C0**** "BBB@ HHHH ****
M .=\>+O\#:N/^F&?R(KY@NE:RNHY(V(; <'T-?4_BY=_A'50?^?9S^0S7S/X
MBM'CE295_=% ,CL:J)A77NW(9]<FU.:")T"*F2<'J<=:,^]4[6QE\E+T$&/>
M4([@XJV@):MHM+85)R:O(E9%9O3-.2(]<UK6-K%<6A\Q<_-P1UJY;:=;1/N(
M+'T-0YEW9G0[HT'<5I0S+);2(Y .TXSWJL;=A.R0\@'H?2IIK!_LC-@;MIR!
M2O<YK.[9SPASD4];;/&*H17,UNVT\@=FJ\^K1)#E4(E]#T^M::G%9-DHM.>E
M2BU]NM<]+J%Q*_,K8^M6+?4[FV*D2>8O=6Y%-TY,U5(Z !8(R[G %4KB=[Z1
M45/E'08J$3SZI*-JGV4=!6Q:V:VJYQN<]2:P:=]3"7,W9:(R_P"R+Y7PL.X'
MH0<U=G\.SIHMQ<RM^]496-><#/.?PS6G'=;&'S8-:,%T'7#G(/4&FFT:QC"]
MV>:%=R%6/TJ (RFNGU?09(97EM$+PDYVCDK533=$NM38?(5B0_,Y'Z"NR,M+
MG33J="E9Q2W$@CB1G<] !77Z5X;+E/M;%F8C;&O]36QIFE1VD7E6UN0>A;N?
MJ:W;6R-O\[\N>PZ"HG6;5D:\B>Y(L,5M&(HD"JHP !49DPW6II<D$XJH3S7*
M#=MBW#.5/6K@,<PRIVOZ>M8X?;3A,5;@FFE<2G;1FI@H<D4X?O6RW%0V]V'
M5N#Z^M2,'9\J0,]Z9JFGL+<2# 4<C/-9EY<>;)P, <"M.1%2!F)R0*QG'S&D
MA3;$0\^U=MX%.1?CT\O_ -FKB5]*[?P*/W5\?=!_.DRJ9U]%%%2:A1110 44
M44 %%%% !1110!D^*!N\)ZP/^G*8_P#CAKY^MKJWN(ULYRK,R=&[U]!^)O\
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M+54.?F)9)"">:9(^[ZU6DN-\WRJQ!/R\'GVJ9'$T:LO*D9HC%6."<G<8K?.
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M<C;B/:M+&+-0.]1Q1 @%@O/M5GRV*KC[JFHJ/F6AC.JG9'#WL:RZB4.<!\$
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MO>:I<ZG*%.0A/"+2EW9O%J,>5&RU_)J=W%9VV=A8#C^(U]%^'+;[)X=L+?\
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M9R[BWT.ZYEQ][<<4RWL+^*0+'#+D'IC(IK73O(78 DG)Q6[9:[;1K&)5D!
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MB:8?\M7_ .^C4WVZ[Q_Q]3_]_#7M7_"N/#)_Y<&'_;=_\:!\-_#/_/D__?\
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MS_A6C%#' FR)%1?11BGT6"XBJ%4*H  Z 4M%%,04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %5I].LKF0R36D#R$8+M&-V/KUJS1
M0!EMX>T\H5C66(G^)96)'_?61^E1-X>C"XCNI@WJX!_D!6S10!AKH$H'-Z#_
M -LL?^S4U]&O%/[N6%A_M9']#6]10%S &D7_ /?M_P#OIO\ "G?V3??WH/\
MOH_X5NT4#N8/]DW_ &:W_P"^V_PIO]DZD3]ZV'_ V/\ [+7044!<Q!H=R1\U
MZH/H(L_UJ1=!0C]Y=SL?]G"C^5:]% B@FC6"$$P;R.[L6_0G%7(XHX5VQ1JB
M]<*,"GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
; %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_006.jpg
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )M :$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[Y;_ !H/B2_(^[ /HI_QK(HI :;:_J)Z2HOT04S^W-3S_P ?7_D-?\*S\T4
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MM"&W1;8>Q/\ X\:T:984444 %%%% !1110 4444 >4_% ?\ $]MC_P!.P_\
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M[?*C1#.T2'Y HZDCIZ]?2KO]GZ)?_N;5H89@"0("%/;)V]"/?%9AD:7PT$C
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MABUA'HB_RJ6F1#$*#T44^@H**** "BBB@ HHHH **** .'^*(SX<MV]+D?\
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MBTE%)3 <*=312TQ#A3A3!3Z8QPI],%*S*.I I@/-)3 Y/12?KQ2_,>I ^@H
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M2YD.Q9+<9J,'?*B^K"JUQ<"/;&#\W4U)9/YMY;C^\X_G33$>CT4450!1110
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MVDR^J,/TKY]<9!]ZQJZHRJE)>M2'!%1KUIS'TKP:AY[%BBFN)O+ABWL%+8R
M>"!W^M"RR6UQU>*7@G.48@=,^H^O%.@GEMIQ-"P#@%?F&00<?X5JKK5I<KY5
M_:_+G.=OF+QTXQG/X?C6^'C2E'2?++\#2"BUO9D/]LW1M9(9"DH>,IE_E.3W
M) ].VW\:V(Y5\H.N,%<BLN^TJ-;7[58R"2$?>&[< /4'Z]<_TJW9E7L8?4)B
MNRG*LIN%3731G32<^?ED5[Z57[;L9QNZ9^E5+:T9W#)Y<N\$A2P 4_GSCD=.
MM2W(65_(W,KMT9/Y>U02VK6L:,)&:-Y-HVG:<GU(X/3N*W.Y=A\UQ830B*>
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MG5&U'45AFVQR$90@\$UWT"PI 2I&_'S'TKR+PM!#=6D$UQYD]VLAE1L<QMG
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M+VW5T;'SQC((/?![?B:TIT:,X+G?*^_0N,8->]H.\/R,;R:VV;H9(B[YZ9!
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M H__ %TV:9I!\QS4DLP<Y"@#TS51S6*NSZ%J%"'LZ3T.M\$Z]::''?7-XKR
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M@.P;_P!!->;Z/&S7N<?(G?U->E^'!_Q-(/96_D:T3NSEJN[.THHHJC,****
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M:J3Z(VG54=+DWVE]N,\5"[L_!.?:F$T*<<U-C%U;Z,1[=",D#)JQ;6TH590
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MU@SC!9CR>V*KMR<@?A29.>3^%)5&M327O*QH_;"#CDU=BD:1 2O!Z53L[4L
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MCW/0PBEB)*GTZ^AR=Q*6FD<)@.Q;'IDTL(#,#MR0?PJSJ,RNRI^YRH 7RHP
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M/(S621AL9IK L^\C))H&<\FN7$5O;3YK6-8QY58F48&,9S56ZMU4JY'T-6T
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MY>?/3D8 _ ?UKS*6)K>62)I#N0D$]!U(_'_Z]=A+X4GC4_9[V10>JY(K O\
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MI7:9MQXJ^9+1 E?<?J!MKV/:XP>Q'6N?FE_L_P"5 9D]">16H\+,WO48B1)
M&4%O4]JF<U+H4[*-F<?K%I->ZFLUP9K:UBAW,7/'4GH1Z5GV&JLEPDP2&.U.
M%5"P)'N?>NB\7.KK("0%%N%QR.K8_EFN!N"TC@QQE8,\(>F>XKBJ1C)NYWY5
M0IR<IR7D>MZ9J=NT'[HJ#Z U7O+HW#[92<9XYQBO.],U&XL]HR<>E=-;:VTY
MV,O;^*L)U9I<O0[I8.$)<T32D9D3R5VD8QNSDBJ[:?YKD^:5.>/2IX)HY@-T
M7)_NU:2.(D8+XK&3YMR74]GL9TGARVNE!?:7_O 8IL?AYK4@(P9<^E=%%&@
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M<9QU[\U6M-&N_)@MKFU1HK2UF@ :3"W&[ &,<@;1SD9!/ -7>^X^=]C6GO\
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MK6UI';#Y1ER.6/4U.JA5"J  . !VI:[#4**** "BBB@ HHHH **** "BBB@
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M,/5LK_0UVPBN-Q'V>;C_ *9F@EDY92OKD8K"66X:7V?S(="F^APK>#=37D/
MWLKG^HJ)O"^KJ>+8-])%_P :] $@]:4.*Q>48=[7^\GZM \^_P"$;U<?\N9_
M[[4_UI#H&J+ULW_ @_UKT3?1OJ?['H=W^'^0OJT#SDZ%J7_/G+^5 T'4NUI)
M^5>C[J-]+^QJ/\S_  #ZK#N>>KX<U5AD6A_%@/ZT]?#6K?\ /K_Y$7_&O0-X
M]:-XJED]#N_Z^0?5H'$1>$]0<?.(T/H6S_*K">#;HM\]Q"!ZC)KL V>G-/\
M+E(R(I#_ ,!-:+*L,NC^\I8>F<K'X+C!'FWK,/14Q_4U;B\(Z:ARYFE]F? _
M3%="+:X89$1_'BGK8W#=0J_4_P"%;1P&&CM!%*C370R8="TJ 86RB/\ OC=_
M/-746.)0L:*JCH ,5<739"/GE53[#/\ A3AI2%</,^?50!_/-=,:<(?"DBTD
MMBB9 *9YNXE4#.PYVH"3^0K773K53DQ;CC'SDD?D>*LHBQH$10JC@ # %6,Q
MH[&ZE/*B)?5SSCZ#^N*N0Z5"A#2LTK>_"_E_CFKU% "*JHH50 HX  Z4M%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ! /45&8(6^]$A^JBI** (OLUO_P \
M(_\ O@4?9H/^>,?_ 'R*EHH B^S0?\\8_P#OD4?9X/\ GC'_ -\BI:* (Q!$
M.D2#Z**>% Z "EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_007.jpg
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )( 0@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>F,\K]/\*Z2*5)HUDC8,C<@BN)3-:NF73VD@!R8G(##T]Z8'24444""BBB@
MHHHH **** "BBB@ HHHH **** "JVH,5TZX(_P">9_E5FJ^H?\@ZZ_ZY/_(T
M <1&N.G /-6%#CI4*$]^M3Q,1UH8Q?,/<8IP<587:1R*>D$;Y)7%2!5W4NZK
M7V-#T)%)]A/9Z!E;-(2#]*L_8)/[P_*C[!+ZB@"MGBFD<U<_L^;VH_LV4^E
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M=34III% %<K385_TJ$_]-%_F*G*TU!B:+_KHG_H0IH#=HHHIB"BBB@ HHHH
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M10 4444 %%%% !4=P,VTH_V#_*I*;*,Q./\ 9- 'S[XDB#:K<,R@'!Q^!_\
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M7J1)^\8S7-Q6ZQ@,W+"NH\,G=J1;/_+,U[.'NU>6YYE5Z:'74445T',%%%%
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MUT*FH['CXF4I2UV6AB7#;Y2?>NA\)IMO,]]AKG2A\QCU7KFNE\+Y^V_\ /\
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MA98?.=CA4!QT[UT8>:LY/H8XM-N,(K<QOB'IPNM.M+G&/*E",WHK<?S IOQ
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M#WK:\,.3JS+Z1G^E<W#* -M=+X74?VFS=S&?Z5G&7,KG/-6.PHHHIF04444
M%%%% !1110 4444 %%%% 'BGQ(&/$5X/]T_^."N )RN?2O0/B5SXEO!_N?\
MH"UYX#\I^M:+8[J'PD4GW3]*]/\ #]U:S:9;"*5'*Q@'!Y!Q7F?>GH#'()(9
M'C<?Q(<&DXW-ZE+VD;7/4[O0=,U0$W5I$[G^,##?F.:YK6OA]806$]W:3S1F
M)&?8WS X&<>M9%OXNU?3(]SNEU&.JR#!_,5I7'Q$L[[2+FWFM9HII(F48P5R
M12]Y$0IXFDURO0AB&+>%@>B#^57[>3CT%5$3-E#_ +@_E3X]R@XSS7GS*FO>
M9K1R.-K1,0W4$5T5E>M-;C?@N.#VKE[1C_%TK5@!QG)!]<TH2<6931J33/CA
M:XJ\MKJXN9#M;ECUKIC/.@QN++VKD;F_D:>16<D%CWJ:M5=CIPS<;V)[1!IT
MZW GQ*O3;R?2KMQJ,M\N9'+$# W#.*Q/.YSR:T-.97G\MN-PXK&G6:FE;0V>
MLN9F-=_;(W\J21]A.1SQ6=-;GG;GZ5V=U:!@0Z@J:Q9;';(0G(ST-=JER.YK
M[1,P7B8]5.?<4^&SED.%7 [FNG&GS9 $)YJW!HTIQOP@_6O0C45C*51+<D\(
ME=*ED=5WRN,;O2NDN[F2>-Y'.<#@53M+%84VQK@=SZU-<L%A9>GRUSU)79P5
M+3GS(IVKEV[9KK_"[9U0K_TS/]*Y"R&",=*[#PLN-2)_Z9G^E%->Z8U]SL:*
M**HY@HHHH **** "BBB@ HHHH **** /$_B9QXDO/^ ?^@+7G08DL*]'^)8)
M\17GI\G_ * M>;D;7(/>M%L=M#X32AT*^FL4N[?$RMU0'!'^-4OFCD*2(R..
MJN,&NQ\,7\2:5''(P3:VW)[FN@GTZRU&+;<01R@]"1T_&ES6+6(<)6DM#S%T
M$D3+ZC%83*58KZ&O4;GP+#("UE=20MV5_F7_ !KEM7\$ZO8K+=;8I8E&YC&V
M,#Z&FI([J.*I2TN=%;+FPM^A'EKS^% C(;'7ZU:M(0=.MC@9\L?RIZVYW'BN
M":U.63U8ZSC/ *\"M!6V#@\BHH4")DXS]*56+,!6;5C)ZLL12CHW2N8O;(?:
M)"!U8XKI1'\I %8$VHV]M=B&Z;:9'*H<4K7LF=&'OS.QF-;L#\O6DA$L,J2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
F4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_008.jpg
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )6 AX# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BDI,T +FDS24F:!BYI,TE% "YI,T44 %%%% !1110 4444 %%%% !1110
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MUA01%VX'%=#X> &K./2 _P#H2T =11110 4444 %%%% !1110 4444 %%%%
M'EVH2?\ $XOL'(-Q)_Z$:%;<*J2R&2YF<G[SD_F:DC?'>FP+'>@]*%;<*#Q2
M$)1VH]*3I0 M%&:* $HI:2@!**6B@!M)3J3% Q**7%)0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%+0
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M C^S0?\ /-?RH^RP?\\U_*I*6@"/[-!_SR7\J7[/"/\ EFOY5)2T ,$$6/\
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MK#"@_*/04G*VA48WU/8M)_Y UC_U[Q_^@BKE5-+_ .019?\ 7!/_ $$5;JR
MHHHH **** "BBB@ HHHH *X;XJ_\BM;_ /7XO_H#UW-</\5?^16@_P"OQ?\
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MTLHEY(W'U/-3A O0 4M0T*6+R?J1$OMR:='8QJVY\NWJW-6\4&CE[A<8% '
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M\U,L:(,*H%/X%)D46 *,4FZFLX Y('UIB'4F:R;[Q)I&GY%Q?1;@<%$.YA^
MR:YN^^(MK&A6RM9)&YYD.T?XU$JD8[LI0D]D=P6K-U'7-/TM"UW=(A[+G+'\
M!S7EVH^,M9U'Y3.($/58/E_7K^M8+%Y)-S%G9CR2<DFLI5U]E&L:#ZG>:I\0
M7D/EZ9#L'_/60<_@*Y*YO;J^E,EU.\C$_P 1JYIGAG4;W#>488S_ !2<?I77
M:=X5LK,!YAY\H[L.!]!6?+4J;[&EZ=/8Y/3=!O-0((3RXCU=AC-=GIVC6VFQ
M@(NZ3NYK2 "_*H  '2@UO"E&!C.JY$357F^Z:L-5>7.TULC(]-C&(D'HHIU
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MQ(<DC+'TJ?&U0*& QNE5Y3A34[&H) ",>O%" ]0HHHH **** "BBB@ HHHH
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M*:30,C/I4E@ VJV8_P"FZ?\ H0J-JDT__D+67_7=/_0A5(3/2****8@HHHH
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MY*7XXI&<'(SG%5VE/ID4A+,^<$?C7FRK':H#@Y4@ #'_ -:K23@ DD?G55%
M!WD\=!BB%A+)AEV\UFIR37F-Q3)/.W$M^&,TX3#@XIWE1L"%(^4=J0Q@]N]-
M\_<+Q S DC!'TIPEX^O6D\H#!I1&.N.?6J3F+W1PE Z9)IXD!J,)SGO3A&>
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M!6ZCI37= W=69,KH>AJK=2?/@>E/"[22#5"ZD+3E1UJ*U7E@53@G(<27(7<
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M)QW.V%526A2!JY9/MN%]^*C\E2>.*5(V1P1V-0DTRF[HWTQC-2*?7@5!!*K
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M=E8RG%N39()!,<0S-$,]7;G\C5V95\N(-<,I XP?O5674K-^'7\UJ?[19S*
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M^ZI?-:]BDH<UKCH[R*5R@<\9YQQ6;(\%U,[1G.#@YJY_9DH+ ,$!4C@Y'/\
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M'6BTLY]3D(C^6('#2'H/8>IJY9:')/B2])1.HB!Y/U]/Y_2N@1%C0(BA5'
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MN)D$F?RVT:#,Q9,U*LE/D\,:S"6,<MI.HZ?,R,WX8QG\:JO8:Q A:;3)L?\
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M1ZQH$/YC!J#_ (1K2@"%MV'N)G_QK6HHN!AMX6LB<K/=(/17!_F#0/"]J/\
MEZN_Q9?_ (FMRBBX'/R>&,_ZJ]=?]] W\B*8/#-P/^8BO_?C_P"RKHZ*=P.=
M_P"$:G_Z""_]^/\ [*G?\(W-_P _Z_\ ?G_[*N@HHN!@?\(Y-_S_ (_[\_\
MV531^'D'^LNI&_W5 _QK9HHN!D_\(_;'_EO<?FO^%.30;1>KS/\ 5O\  5J4
M4@*!T73R,& G_MHW^-3)IUDB[1:Q$?[2AC^9JS10!''!%#_JHD3_ '5 J2BB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
-HH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_009.jpg
<TEXT>
begin 644 image_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "R #(# 2(  A$! Q$!_\0
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M:2^(+B#XA3ZW86\[6LK 21D8+(1C\^,TZ/5KR\\;_P!M7EM.L&'C1 .44J0
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@Y)JR,YR35D6Z***R,PHHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_010.jpg
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $_ ;H# 2(  A$! Q$!_\0
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M-7(^!B<77)//WO6NN;/89KLP\Y3IIRW+A+FC=C_,(.,FG>;+CY9&%01((XP
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M(FN[V""-"?F!.*\J+UT.5)MV.S\+6)LM+4L,/)\QK:)]*CB00Q*H[ "C<WS
M'FOHZ</9TU$[XJRL/Y(.#0">AZTPL?E((]Z.P)'(]*H8\G .3Q2BF[AG'<T
M$9[#M3 =P* <],$4PQJ2">H.:!UXQC/- #@"&)W9![>E1R6_FR!V=N#P >/Q
MJ44A!/0X_"BP#(T,:!"Y8YSD]:D'7BFF-3*)",L!@4[<!3 ,YXIBL =F\%@,
MGUI0<,W(YIC%Q(-L8/JV<4@)*0CWJO<7$D$\0\LM$YPS#^&K.01[4P$]NE+F
MCK1T^E B.93(NU7*'U%,@B:,89V8CHQ/)J;- H"X <<X-*2>U)GFFN"58!MN
M1U]* '[RO.X_G3EN' R'-0@@H#D,,=?6D^4 ODXQG% %E+Z;!(D;\:D75+@
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M19FBD@&,Y+XQ^=5.GA8PBVG[Q,95&W;H74\3:/<8V:LBGWX_G5^UGANAFUU
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MP>Q%+FH<[68%6V\?2F!+D'MD44W(4A0*20J%.[D4 .8@#DXI. *J[VF^>/+
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ML3Q'(&$4 QN/)KZ2K/ZOA[]E8Z9:(YIBSR-([%F;J343MSSTJXT?&WTJE/\
M*WTKYN+YF<DU8IS.<XP !5<R<]>O0U+-ECD]#3+.QN-3N?(@'R@@%L=*[:5-
MS?*C*,>9V1K^%)84U5IIG^ZN$ &237:!KN[8[!Y,9/WC][_ZU,TG0;33(%1(
M\OCYG/5C6L0=IVX![5[N'H^QA8[H0Y58I6ME#!*VY"TF,EVYS5WY6]Z4<+DC
M)[XIF!%D@84]@.];E$5[)]DLYKA(6F:-2PC7JWL*\*UCQMK-WK374<\ML(VP
MD0.-N.Q%>T:QK=IH=C+=71VA/NC^\?:O,?#OAC_A.M7O-:OBT-F9>$08,A]*
MF78RJ)MI(LZ?\6K@(L>H6BOCJ\9P?RKJ;;QWX?O8MS7/E$]GX(-5T^%>@I;2
M0N\[LS[EEW89!Z>]>8^*_#%SX;U-XMCO9L<PS$<$>A/K7-5I1F_>%>I!7/88
M]8TYF%U;7L)8XS\XPX_Q]ZV[.^M[^+S()%<9P<'.#7DO@C0]!U[3#'<0N;R%
MCYF)""P/0CVKT+1]'M=$98[*%88V;YOF)+>A)]:RP^(BI^PDW==S5<S7,=#3
M-V69<$8[^M-N9)(XBT47F/\ W0<4Y&+*"5V\=#VKK>XQHA4LK/AF7[I/:G\<
M\<TA8A>G--3S,L7((/3':@!W &3Q0#G!!R/6DW*X(X(I5"HH50 H["@ W8X/
M)]J7/.,'ZT@.6/'XTUPS%=K[0#SQU%,!6(SDD@"E.TC!Q4995B+/A@.>.:</
MW@5API&?0T -?S&;Y'  ZY%."COS2@@DCTIK+D@YP1Z4  (#$!<=\U1N-5M+
M2;RY)?G)Y]JO8 '/)]:HWFD6=ZP:9"2/0XS2=^@U;J%\SW-D(H6P9OEW==H[
M]*RO.U2"1HHXR[*@SM ([?CZUM20,L:1P,(T!Y&.HJ4D(<Y)ST%:0GRJS5R'
M&^QB1ZGJ#[,VH=6?!."H7G]:T#?F-W#QM@' -6T.X9V[?K37:/[KX&> #WJ:
MCYOAT!)HK#4(]R_NVW'K@9Q4J7<<C+A\>V.M-?9&R*(=P/&5'2FPVZEC+M*D
M]%/:LDI]PU)6F0?,I&2,G)[4X.6"X*D'KFH6LHSR2V?K41L]KH8VX!YS3;FN
M@%V/ !P,<]Z4, &(S30PR1GFD+8X K08;B6SCY<5$X#2(,X)(Q3MQ(Z8IJ#=
M<Q _WA2 BN/FU1QZ.!71R#_1V' &WDFN;;G6&]/-KIY #"P+;1CJ*R>QM'<B
MFR(8QUY4'-9>O'=;LG') K4E!VQA02"PSD]!6-KC,51<=70 _C7/B?X4BNAZ
M?&NV-5] !3J**Z#F*]__ ,@ZZ_ZXO_(UX]HMSYUG'_>""O8KT9L;@>L3?RKP
MV!CI]^L9/RLH(KSLP3M&147;4N:ME=KKP<\UQE^/+OY0O0G/YUU^K/OA#KR*
MY'5!\\<G=AS7)0EJX]S&MU1NVQ_<J<_PBFRGDC.!C--L29+6/G' J69 <KU)
MKSGI(:UB558NO'8UL>&X3)J$DC#[@XK)*E%':NA\-H51WP?F/!KLPD>>M%>8
MH+WCHLX')KEM2E,^IR$<A?E%=#<N(U:0L>%/'K7.6T9DG9B<Y;->AFU3W8TU
MUU-FKZ#7MV" D#FLF^7:V,<UU4H!P%7(%<YJL>UF]Z\:"U,ZT;(Q%CENKE;6
M!26?]*]#T#1H]+LE&!YK<L?>LOPMI@B5KF1<NW3([5U'+MW&/UKZ7 T5&GS]
M6%*%E<DS[TH/-1L/F%/KN-1U XZ\TTG&.:R/$.K)I6B7-VQY13M^O:DY)">B
MN>?^*)[CQ1X\M=(M5\RWMI 9!V !^8FO4X88;6%8H(TBC7@*@ %>3_#6UEOM
M<N];FE?<"4 [,3US7JC/D<D9%<TJZBV135U?N3L1BN8\;)!)X8OEN$W($R,=
MCV-:D]]L. 03Z"N%\?\ B(#31ID)WW%P0"J\D#TKCE65>:C#I8N;M%W,7X6Q
M%]9O7'"K"!GZFO4I(;=R!)DG(/7N*Y?P;X>N/#FCM)<Q#[1<$/(!U1<< _2K
M/B#Q/;:-IPN PE:3(C4<Y-<.*558Q."LWL.G:-/WCK;9RT9#$$@D<=Q4C9QU
MQ7.>&KVYFT2VNKHJ&N5,HVC 3/;\JQ=7\?R1:@UMI-B]\D/,[(I('KTKWT^:
M*D2Y)'>%LCG@=J!]W-9NDZQ9ZUIR7ELX:,CY@>J'N#[UFZKXWT32E99+E9)1
M_!'SS0#DEJ=$0& ]O>ESVKCF\=P6^A1:E>6S0M*_[N'=\S)V;VKJK>9+FVCF
MC)VR*&4^Q%*X*29.&R>M*[A8R?YU$K[?D)&[K]15?4=3M=,LVN;N14C4=^],
M;T)8F*;E;)([XX^M3[P<8/O7&Z!XYMM?\0/910.@$99')^]@^E=@W*XQUXH0
ME)/5#PV>]1L2'++SVQ38RV#N0+SQ@YIPZG@<T#!6<DA\8[8H& ,"BFJ",DG)
M)IB'=LTF,]?PIJJJEB,_,<GF@,<<T *Q/8T<'D@9%-SFLCQ#JATG1KB\6-Y"
M@P HS@^I]J!-VU-7S49RBNI8=0#R*?GBO!M(\4W%IXG75+J21T9CYB@]0:]C
MM=2_M"WMKJSR]M)]XD8(_"E<4)<Q=-[&+D098N?]G@?C4^\'I4)D11USCTYI
MY.13*'^]-+'G IAWG&#C':C=M&">: %(/7H:(&S?1+[YS42\%F+$@^O:EMI@
M+I&8@*#QB@:W(;(%M48LY;=,Q!/UZ5T]V0+63C/&*YC3"'U!6/3<37273'R2
M0V,XQ^=9,UCN$QS) /1OZ5DZT0+BT_VKF,'_ +Z%:\N?/A QC)S^58FHE9=8
MTV/^]?1*?^^UKGQ'\.WI^:&]CU2BBBN@YR.X&;:4>J'^5>'>(H?+%M.O90#7
MN<@S$X]C7C>M6ZS:1O'WE4&L<1#GI20-7BS)N9E:Q#9P,5S6HONBC/HQ%:J8
MGLRK$_+VK'OOE@P#P'%>+05IF,G<U=*<_9%YJZ[EL8ZUEZ0Y\DJ>1FM7<,<
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MYQR<CFL.XN[FWU&ZMA,1#M%R93SY:#[P'Y<?4U-_;T"*IGBDB+QK(@."64D
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M@UV4,&I+FFR]]S/CT>%&4L-Y[YJ\MO$@^5%'X4]6S2,WS  C-=\*-.'PQ&(
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MQ[#?UK'N=UZWVJ5T6')*;CT /0#U/K5<7MC-*46(Q*1G>Q[_ $Z46*.IR0O
MS4,D?FL@8E,<D ]ZHV1W(D)):)UWHV<?_JK49RJG",2.P[T@*-W=16L;K+*
M>, <G%3R(LD%NH :)XN3]32W444L1\R)6R.A%.C3 MPGRHL> O7-0]RHDMXA
M'D0G=Y*QKD;L \_SXJ%"K2.Z%CS@@]!BK5PI;4 ?EV)&%8$=>N*KH^ZWD.%
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M,DRCMFK$.O:C V6M X]!7MMQH>DW6?/TVU?/<Q#-9TW@?P_+R+'RCZQ2,O\
M6G%<NP'EP\6LG^NLG7Z5-'XJL6/SAU/N*[NX^'=@_P#J+Z[C]FVN/Y5F77PU
MF<YBOK:0>DD!7^1JN:0S!37=/D'RS*/K5M+^UE48E0_C4=S\-M47)2UM)?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !4,UI;7 Q/;Q2C_ &T!_G4U% &-<>$M N23+I-KD]U3:?TQ6=+\/M$8
MY@-W;'_IE.<?D<UU5% '''P*\>?(UB8CL)XE?]1BH6\):J@.VXM)?^^D/]:[
M>BG=A<\^E\-:OO"M:@@D#<D@('OV-=Q8V:6-JL*<D?>;U/K5FBANX!1112 *
**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_011.jpg
<TEXT>
begin 644 image_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &? 3L# 2(  A$! Q$!_\0
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M7_O\O^-%T%F7:*I?VOIO_00M?^_J_P"-+_:VG?\ /_;?]_5_QHN@LRY15/\
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MCUFC_G0)GS&[#>:3)/:G/@-[TW-9E@">XH- !]:3GKG-,!<Y&:3K[T<TG6D
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MM>6@\]*]3^! )\:W!["U;^8I ?1M%%%6(*X#XQ@'X>W.?^>T?\Z[^N!^,?\
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M:=F@ QWHP:,>E')[T##)HH'7DTH'%, 'O7L/P!Q_PD.I_P![[*/_ $(5X\,
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M -.Z_P#H5>.<5[)^S_SJ^K'_ *8+_P"A4"/>Z***H05P/QC_ .2>W/IYT?\
M.N^K@?C'_P D\NO^NL?\Z!,^8G//%,QGK3R.<TTXSS4%AT-(31GWI/E^M !P
M.];-B<^%]6Y_CA_]"-8I /0ULV( \-:J!W>'_P!"JH;D5-ON,;%.S[48.*!T
MJ2Q#TH!R:,<T4 (0*2G8I* "K.GQP37\*7,PA@+#>[9P!^'-5L4"@#KIM3M)
MKM9IKN$30-LADB!(6,C Z@9*\?F:A5;*0V=M=ZE:LBR[Y7225PP [[A@9Z8
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M]728FO'M+V^>\WD('@$:X).[D,Q/'THZAT,S3L?VG:?]=D_]"%2:V =;O?\
MKLW\ZCTW_D)VG_79/_0A4FM+G7+XC_GLW\ZT^R9_;^10 (H.:7!YHP3WJ"QN
M3]*7J:,9-+]V@!PX%>U_L_\ ^NUK_=C_ )M7B76O;?V?AB363_LQ_P!:.H'N
M-%%%62%<!\9/^2>7..OG1_SKOZX#XR_\D\N?^NT?\Z!,^9&!R<FF;?5J>P);
M/:F[?6LRPQQ@&@' Y%'RT#&>#3 4C XK8L ?^$9U7IC=%T_WJR,XK8L?^1:U
M7W>'_P!"-5#<B>WW&.N%8$C/L>]=/>>-I;_2;;3+G1M,>SMCF&/]^-O7N)<G
MJ>]<P13>U06:ESK27 LT&F6<5O:LSB!#*5<MC.XERW8="*;K&KG6;O[4]G;V
MTN K>07PV  ,[F;L!TQ6;THQB@#7O?$NHZCH-IH]TZ26]J^^)R#O'&-N<\@9
M],U=MO&5Q;>'CH?]EZ?)8LV]U?S<NW')(D'H.F!7-FC&.*+!<T[O6([FS6TA
MTRSM(O-$K>2926(&,$N[<<]L5H:AXON=0T.VTA]/LH[>UY@:/S0\9]02YR?K
MFN<HHL!T&J^+[S7-+@L]2M+.XDMUV1W3*XF'U(;!_$4P^*KFXL(+/4[2TU*.
MW&(6N5</&/[H9&4D?7-80''2@BBP&Y>>*KJZT)=%AM;2SL!)YIC@5SN;W+LQ
M_+%6;/QG=6GA[^PO[-L)K$DLZR>;N<^I(<?IBN8Q[TO/O3L%S2O-72YL?LD&
MF65G&7WLT'F%F/N7=N*N>'?%=WX;2Z6TM+24W*[)&G#D[?0885@]Z7B@+DK3
MHUX9_L\6TMN\G+;,>GWMV/QK7\0^*;OQ(+;[7:VD1MT\M&@#@[?0Y8BL*E/%
M '0)XG-]!9VFNVD>H6UN=J2DE)T3T# @'_@0-:GC'5M,N-.MK#0=2B728@"+
M%8I$</W9BPPWY_AWKBJ#2L%S;T;Q->Z+9W-FD<%S970Q-;7"%D;WX((/T-$N
MOJEK/;Z=I=G8+<*$E>,R.[+G.T%V. 3Z8Z5BBBBP&QX;\27/A>_>]L[>VEG9
M"FZ<,< XS@!AZ4]?$,22O/!H>G13NKKY@:<D;@02 9",X)[5AFG9XHL!9TX?
M\3.U/_39/YBGZUD:W>_]=F_G3-._Y"=I_P!=D_\ 0A4FMG_B=WN?^>S?SJ_L
MD?;^10R?2DSSTHQ2\CCK4EB8)-+M %'S=*-I/)H ,^E>V_L_??UKZ1?^S5XG
MMQSUKV[]G_[VLGU$?_LU'4#VZBBBK)"N ^,?_)/;C_KM'_.N_K@/C)_R3VY_
MZ[1_SH$SYF?[W%-V^M2-@$U&<L:@L/E!Z4F1Z&E"@'UI<#':D TD=N*VM/'_
M !3.J<_QP_SK'/(QZ5LV/'AG5,<?/%_Z$:N&Y$]ON,8BDZT[./K2?RJ"QASF
ME]Z7&:.M,!O4TN,4=J7&[G%(!/PHQ^%+1GG- " D5W/B_P "/IFFVNL:<I:S
MEA1IH^IB8J,GZ']*X@<FO5_$WB6?P]J&C?*+BQFT]$N;9ONR+@?D?>@:.#N-
M&M8O!=EJZO+]IGNGA9<C;M4<8&,Y_&NCT7P;I5W8:2MS'?S3ZFKM]H@(\NWQ
MTW#!_&I/&-OIEOX%TTZ1.9;.:\DE0'K'N7[I^E<3;:SJ=G:/:6VH7,-N^=T:
M2D*<]>*6X;!#;V=OK7D7[RM:1RE)&A WD XXSQ6]XY\.:=X?N-/&G/<-%=0>
M:?/8$CGCH!7*@>M=_P#%#&_0O:Q6F'0\]^E&*.]+Q^-,0GM112_3B@!*7K01
M2<=Z %H%';BB@"UIW_(4M/\ KLG_ *$*=K./[:O<'_ELW\Z33>=4M/\ KLG_
M *$*?K(SK-Y_UV;^=7]DC[?R* H(Q3L4=^:@L;@YX-*%/K1T-'&,9H  H[U[
M=\ ,?\3G'_3/_P!FKQ+CKFO;O@#@C6<?],_ZT=0/;****LD*X#XR?\D]N?\
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MM2XXK1_L+4_^?&;_ +YH_L/4_P#GQF_[YHY9=@YH]S.[\T5H?V'J9_Y<9O\
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M;!PO6@QL&VXYHY8=A\]3NSE/^$#T/_GC-_W]-)_P@.A_\\IO^_IKK/+89)'
M.#2!23@=3THY8=A.=1:7.4_X0+0^OE3?]_30/ 6A<?N9O^_IKJS&V"<=\'ZT
MIB8-@@@]*.6'8?-4[LY7_A ]#_YXR_\ ?PT?\(%H?_/&7_OX:ZLPNN[*_=Z^
MU(8V4$D< X-%H Y5.[.5_P"$"T/_ )XR_P#?PTG_  @6A_\ /*;/_74UU10[
M0V.#T-+Y+[@N.2,T<L.PN:IW9RO_  @6A@G]U+S_ --#2?\ "!Z'_P \I?\
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M>A8TGG2X(\UL8QU[5'12N%AV^0@*78J.V>*4SR''[QN.G)XIE!Q0%AYDD/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/%%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_012.jpg
<TEXT>
begin 644 image_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'V 6P# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HJ*YG6UM9KAPQ2)"[!>I &>*\L'QMMLG=I2A>Q^U#I_P!\TFTAI7/6
M**\J_P"%V6??3,?]O(_^)H_X7=8]M-S_ -O(_P#B:7.A\K/5:*\K_P"%V6&
M3IIY_P"G@?\ Q-(?C=IX(_XEI_&Y'_Q-'.@Y6>JT5Y8/C;IIS_Q+S_X$#_"G
M#XUZ9WT]O_ @?_$T<Z#E9ZC17E__  NO2\?\>#Y_Z[#_  I?^%U:5CFQ<?\
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M:;\PH.:0#@_O29SUIO3FE/- !C!ZTOS#O29(]Z,X[4 &6YYI0#CG-)N I"Q
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MJ:.,<"@!,@=J3=[4$^U+D4"%W#TH(!Z4F >E!!'2@ Y%.# CD<TFX4A0YXH
M7;BDW<G-&['6C@T## HQZ4$#'6CH*8CJOAQQ\0M#_P"OM/YU]<U\C_#<9^(F
MA_\ 7TO\Z^N*$#"BBBJ$%%%% #)O]1)_NG^5?%=P?WS\8^8U]J3<P2#_ &3_
M "KXLN.)6';)J9;C6Q%GUH)'>@GM1UI#$(ZT@..HHYS1UH 7@\D4G(/:DY'O
M2Y]10 A(QBD.#S2G''I2<"@0 #GGFCBCCL*7K0 @ZT%J.M)C'- P!]!FES[<
MTFX4N?3% "9/3%*<'ZT['M32F3Z4 *D+RN$C4N[' "C))J>;3;^UB,EQ97,2
M#J[PLH'XD5V=_*G@O0X+>TC4ZA<CYYR,X(QD_KP/Q^O'OJ6H7+[VO;EF'.XR
MMQ^O%:2BHZ/<RC-SU6Q2V]ZEAMKFY<K;6\LS 9*QH6./7BGR7$ID+,_FN&WF
M21=Q)XZD\G\?RI))9YX@&EDDCC ^4DG8/8=AG_/-1H::CYM.OK:,RW%C<PQ@
MX+R1,H_,BJF%KH-"\476GW<<=Q,TUFV%D21B=H]1Z8]._P"M2>,M(@TS54DM
MXQ%;W"[PHZ*V>0!V'0_C5.*:NC/G:ERR.:(6E&/2CZ#\Z,=ZDT'8[TA-!&1[
M497-(8T>PI=Q]*"1GDTHP1B@!H>@8-.('I32I[4Q"$&E##H:,\^U!4&@8;<]
M*,E5I.12YH$&0<9[4N!ZTG!-!"_E0 <>]+CTI!R:<..: .H^')Q\0]#_ .OM
M/YU]<U\C?#G_ )*'H>3_ ,O:?SKZYIH&%%%%,04444 -<9C8>H-?%ESCS6^I
M[U]J-]T_2OBNX $S_P"\:E[E+8A]>:3OTHXI/>D O4<TFTCO0#SS2]Z &YQ1
MD=Z=FMVPBTVV\//J%W8?:Y#=>2!YS1X&S/;_ #S2;L"5S .#QWHQSP*W/[2T
M(?\ ,O?^3C_X4O\ :>A?]"\?_ U_\*7-Y#MYF%MI<X&:VSJ>A]/^$>Q_V^/_
M (4G]IZ%D_\ %.Y'_7X_^%._D%O,PLDGBC8>YK=.J:$#_P BZ/\ P-?_  H&
MIZ&?^9>_\G7_ ,*5_(++N8048ZTF%'2M[^TM"_Z%[C_K\?\ PH_M+0<_\B[_
M .3K_P"%._D%C"SZ&E4\^AK;_M'0MV?^$>'T^VO6/)L:9VC3RT+$JF<[1V&>
M] F=5XZ'VB\L+M&S;SVX\L_CDG'T85G:!H;Z]=F!6,5G!AI7&-S$]/Q/..P'
MZV$?^U_";6I8&\T[,R=RT)^\,D]N#] N*ZSX8>4--N7,D:RQS%U5CC)VKM_7
M)_ UOHY79S:QI\JW-"#P]I%O"L:Z=;,H[R1AS^9R:QO$'@ZVN('N=-C6"[4$
M^6G"R#'3'8_3\>N1WS71A-R89R@E3<%1B 'W ''Y''M34U$Q0Q#<[_NB"OF8
M7)9L[ACG@BMG[RM8YXWB[\Q\^$(RY49.<$>E==\0;C=?V5KMR8XBY;_>./\
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M2@8H_2@_6C/7WI#Q0  XQ2G'2D_E2YY^E &C+<3Z7KDC12EI;27RT=NI"?*
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M% "<=:,BE/I2$&@ _"G#D8IO;BEZ9S0 $GMQ2$Y-36UK+>7"P0)ND;)QD
M9))/   ))/  )/ K5^P:!:R(EWK-Q<-D^8+"SWH.>@>1D.>_W2/<T: 8G\J3
M QC%=+;Z;X3O96'_  D%_8(!_P O6G;]Q]C&Y_458/P_U2Z3S=&N;#5XNK&T
MN%W1@]-ZM@@GTYZ&C0+,Y+/-)QFMJYTJRT:X>WU>2>2\C($EG;#9L..C2,"
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M^+1-1FUHZ/':LU^)3"8003N&<\],#!YZ8&>E>I6.E6UGJVO>)M(W:QJ]I>W
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MT3_Q1/\ W$?_ &G2ET&C"R?2C=@T$8Z&D)/7@U1(N[ X%)DFE##&<4!L"@!
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MQ^5 %+@YI@)^-&,FD-'>@ [&CK2\XI#UH ,_G1WI.M*!0 =:!CTH[T8]#UH
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M=V_QHU'H-_LG4>,V%UST_<M_A0=(U''_ "#KHCU\EO\ "E_M?5#_ ,Q*]_\
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M8X^(6BGM]H%?5]- PHHHJB0HHHH *^0/$(!\1:D?^GJ3_P!"-?7]?(/B!?\
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MTF_X_P"G=_\ "CF069FX]J,=ZTO[ UC(QI-_UQ_Q[/\ X4+X?UH_\PB^_P#
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MDF_(;.!M]#]:)8/+F,>2><9Q18+E?%*14IA*@L#E-NY3CKR!_6E,05T!< ,
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MNM,N6,;O(PW6SCJ>W;T'<>QI;33[^R1V\)ZJE]'(WE70F(/ER?\ /4>WY_\
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M<SG_ $/3",F!_P"(L.3QV_3/4.B?PK&_]MPAYI6;$.C]UG/7"^G [8].R@U
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M42!5!!SWY--+G;M&%4XR!WIM!(HNP $J0P/0Y%+YC;64' 8Y(Z4W/O1D'O0
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M/+=.VV'2>NR<]2!Z=,=AVYP!>I.A)%I6F2V3WT6KO'X99A+-9ECO$@Q^[/\
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M !)]J8"CH>M'/I2 D'VIW7UH&=1\.O\ DH.BYZ?:!7U77RE\//\ DH&B<_\
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M7_XW7T7119"/G3_A0_B__G_T3_O_ "__ !NC_A0_B_M?:)_W_E_^-U]%T46
M^<_^%#>+SUO]$_[_ ,O_ ,;H_P"%"^+O^?\ T7_O_+_\;KZ,HHL.Y\Z?\*&\
M6Y/^GZ+_ -_Y?_C=)_PH7Q;_ ,_^B_\ ?^7_ .-U]&44607/G/\ X4+XN_Y_
M]$_[_P O_P ;H_X4+XN/6_T3_O\ 2_\ QNOHRBBR%<^<_P#A0OB['_(0T7_O
M_+_\;H'P%\7?\_\ HG_?^7_XW7T9119#N?.7_"A?%^?^/_1/^_TO_P ;I?\
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_013.jpg
<TEXT>
begin 644 image_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '% 6@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"?\ T%/_ "#)_P#$U\K&YE(P9#3//?\ O-1=A9'U9_PLOPG_ -!3_P @2?\
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MR&+* ?[ _E7QGHW.MV';-PG_ *$*^S;48M(1_L#^52OB^0/8FHHHK0D****
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M"E!S0 ?>I.5/M05(-*#ZT +D?C0#2$ T8P:!%_1AG7;#_KXC_P#0A7V=;_\
M'M%_NBOC+1!G7M/S_P _,?\ Z$*^SH?]1'_NBDOB&]A]%%%:$A1110 4444
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MO.2??%91V*8'/7I1@'O2<=S0-N:H!0H]:,>E!7/2F@,/>@#I_"I_XE7B+/\
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MP36OWUN\_97P6QD$?? R20H)K;L-0M7L)+/1?$$&I(<)]AUSA0@X 4D<DD<
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M<TTK[TP'#(/!I2&I #ZT8YY- &OX8!_X2;33G_ENO\Z^R$_U:_05\;^&0?\
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M^$1_Q4EK_P "_P#036=;^%+T8X_$C$NB?M<W'5V_G4?!'-2W##[3*/\ ;/\
M.HL GK6D=D2)LYSF@KCO2X'KQ28'UI@ QGD\TX'% 6C.* -?PRQ_X2?3<?\
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M'_*O.\8KT3XQL#\09QZ01_RKSWC.364=BV-Q29I>#0>*8A/7%*!GB@9I0<4
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MX".GXUI:A(=.U6W72U46[VS"6Y1MS9$+;5)[#H?>H+>)G\-S7DUC"=69TD6
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MZ:+%OYV -VX9P3P&QG!/OWQ3[)4/B>S%YY!C%Q$)@FT(1D @]OJ>G6CV5/\
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M?X=X_P"$_P!'_P"N_P#0U]65\I_#OGX@:/\ ]=_Z&OJRG'=BD%%%%62%%%%
M!1110!\Q?%S_ )*1J?':+_T6M</7;?%T@?$C4\D=(NG_ %S6N%+CUK-%C\^]
M!QT-,R#WHR#WIB'^_>DZDT@((I.YYH 7'O2 <C- :DW4 /X!HS3-V>]+GWI
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M_ CPIG_CXU+_ +_+_P#$UZ?118+GEY^!'A7_ )^=3_[_ "__ !-'_"A_"O\
MS]:G_P!_E_\ B:]0HHL!Y</@/X6'_+UJ?_?Y?_B:#\!_"Q_Y>]3_ ._J?_$U
MZC12L!Y;_P *&\+?\_>J?]_4_P#B:/\ A0WA?_G]U0?]M4_^(KU*BBP7/+/^
M%"^%_P#G]U7_ +^I_P#$4?\ "A/"_P#S_:K_ -_4_P#B*]3HHL@/*_\ A0GA
MC/\ Q_ZM_P!_4_\ B*3_ (4'X8_Y_P#5O^_L?_Q%>JT46 \J_P"%!^&/^@AJ
MW_?V/_XBC_A0?AC_ *".K?\ ?V/_ .(KU6BBP'E/_"@O#/\ T$=7_P"_L?\
M\11_PH+PS_T$M7_[^Q__ !%>K446 \H/P \,_P#03UC_ +^Q_P#Q%)_PH#PU
M_P!!36/^_D7_ ,;KUBBG8#@/#7PA\/\ AG68M4AN+^ZGB!\L7,BE5)XSA5'/
MUKOZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_014.jpg
<TEXT>
begin 644 image_014.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" (F QH# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P!M+]D)!EOVI/AZ/KXRL?\ X[1R5.S^YA[2GW7WH].W#UH+ =Z\O_X;4_9
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FR':A-.I'&Y<4
M1//'#'YLLJJO4LS8 IR2*Z;TDS]&KP'_ (*0:GK.F_LZ3)HNH2VS7&H1QRM"
MY7<I1^#CMG!_"O%O^"5/[;-GXL@NOV;/B9KY;6M/NI6T&\NYV9KV/=DPY;^)
M.W/(..HKAEF%*..^KO=JY[%/):]3)WCX.Z3LUU2[GW2&SZTZHT9=U/WKZUW'
MCBT4 Y&:* "BDW?[)I0<]J "BDW8[&EH **** "BBB@ HHHH **** "BBB@
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M44 %%%% !1110 4$XZT4$9X- '@O_!1G2AJ/[.=U.9VC^RZA"Z[1]XD,N/\
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MK^!+FQOX)HY!F.2&8,K#V(ZU.&YYH*N.HHW#UIO!_C_6@!U%-RHYWT%E/ -
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M,V,<^E7'X6<R^%EB[E196)?[1-]?D7Z"EAN[MHU#WL<?'W12/;M&6"1L6[L
M/TS_ (4Y'>.-4:XEC/831@J?Q%7'H$?@+$273VWF%5D7=]Z/K_G\*:'CG?RW
MBCW?[29S_*I(%$?#A8)<Y61/N/4=U#ND+3021M_$T:[E-*/QF<?B%LR4#HLJ
MQ^OEP'=4\*,EON13"K-\TTOWFJG9^:BMLOI-H[JK#'YU-;H+F/.YF"MC<V3F
MNFY50GCD"IFSA5?^FDO4^_-3YNI-NZYA=O0XY_2FHCJ@ 24?[BJ?\:D+-*H
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MCZUZK:MMMUCW9V($7CGC_P"M7DVB72SI9Z5<Q?>U%FW*<*2%+=^_'ZUZ]-)
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M(Y55^\S-U^G2K5NT M_*ADA^]]TNPS^0 KI150L1XBC&Y67C^*W+?S-2%DF
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M3$=ZK#V?I31YB@+&MQ&N/NMM9?UJ1)' \I#EL9S@ "M(F4]B15D9]LDQ9O\
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MHH;I0 QT 7-?BM_P5^TY+#]K#6[AE^::Y)?Z&-2/T%?M5*>*_%[_ (+,(_\
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M*5V+4<9!]T'FE1]RX)J(XW\?>I%.&---B)_FW#'%-\PIU--8YV\4[YEZBDP
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MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?[//ABVFM8%\<:5+Y_BBUT<26?A\30[9HK>070D\['EXN5Z@'Y2#CG /V>+
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M!;?]OVKJ?_3=31^PWX%8G?\ \%!/@:WH?[1UC/Z:>*\;'S=:<!BLH^WAM/\
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M!G*KG/X5^9__  5WD\WXP-&"Q^6S!S_N"OTO*J(V^;-?F7_P5X22#XX0Y/\
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MF.7#=*6BF_N1\EV?QWMM.U3[=?Z)I]PL.EM9M#/)*J,WVB.7SA^Y^9O13\K
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MOI0=*^-S;_D95O\ $_S/K,H_Y%E'_"@HHHKSST@HHHH **** "BBB@ HHHH
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ME_#[QSJ%_=:/+?\ BN&7P'>V]KH;"639;^=(H\Y_)199&"A$\P(&8JQ'2?\
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M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *^??^"G: _L=^*',2LRK"8]W8[QS7T%7A/_  4FTJ+5OV+?'OFR,OV?
M1_.0K_>5AC^=>?FD>;+:J_NO\CU,EG[/-Z$NTX_F?SY?$-'705^UON>/>K_[
MV>:C^$MZ+3XO^&U ^22Q@55;/+&%LG'O_2K?Q1TV*PTN>QCFW>3-(@D/.>>M
M9_PJ$D7Q'\%S7<GS-&J1L1U4!\+]*_(UK!G].8A7HJW8]PUBX-UXFFC"LNU1
MSCKZUU>KK"-'LK6$L"J_O=@8 _+QU/)^G%<]J<!34I)&)5I&RNVNLE:*3PY;
MW2;FFC4"4>864#..1SMY'4D9["N6D^B/#Q"]Z#\SZI\(>&+BT\*^$&TME6/3
M]-C,T+.5$BR6XR<\\ACNZ5(FCV=QK$::=K]O'?02P0WD2ACYRQA7:-@>-P4A
MU8<@=<Y(JI^S[XRA\9_#'3Y]Q^T6,8M+A>NUD& ?Q7!_&NB@\&V$=WJ=[]I;
MS=2N5G+K@&%@B(=N/41C)Z\D=*_4L/'ZQ@Z<J>MTO\C^6,56JX#.L3#$MQE&
M4DM-7>3>O?1Z,S[3P?=V.E-I!U-&694CD?:5:-5E9\Q\\$@@?49J]+X<LKS2
MY-#>_P!T$GFE?*P&&]]YYYS@]..E6&\(:<TZ3R/,SJ[MNW=2S!B/P*C%6=/\
M.:?8.'MD8-Y83D_P@5V4\'S26AQU\XJ>S351W3OLEJCFOC#&+7X87T+W!);8
M-QX_Y:+Q],9KPP1-]]QS7JO[0_BB.*UMO"%K*I:1O/NOF^ZH^X#]<Y_"O+.3
M_P M#^-?GW$^(A5S+EA]E)'[OX;X2OA>'(RJJSG)R5][.R0JAU&-E*5.>!Q3
MV4_=- 5=V%[U\X??2O;8Z+P+X[TWPMIUSI6L>$(=4AN)EE99Y!A=H('!!YY/
MYUO^+?"W@[Q!X*;XC^#;%[%XW"W-GN&S)?!'?# GL0".U<II=GX2NK%1JFMW
MMG<HYW>79":-U[8^8$'KUXK3U[QMIL?A./P'X2MIEL?,\RZN[S;YEPV<YVCA
M1P.Y/%>MA\135*4*R35K+O?H?*YA@*TLPIU\%S1FYISU?*X?:36W:UNIS89B
M<BG(>=V.:8H8_,&[4Y3D,,_I7E6=D?4WZ(=N?H>E>Z?!/5(=5\"00I*IELF:
M&9=V,8.1^A_0UX3'\P^7^==1\*?%5]X8\7VL<,[?9[RX2&\CSPZDX!^H)KV,
MCQGU''1<EI+1_,^-XXR5YWD,HTW[].TE_P!NIW_ ]J@\)06T1BCNY$5E *H<
M @+M]3V/Z?6I#X:LV1O/FF;?NW;I/45I  )M)_"N3\9_%SPMX0\RT%R+R^C&
M/L<'\)_VFZ#C\?;O7Z;BJF!P='FJ.T4?SA@</G6=8MTL/%SF][;>K?1(I_&C
M7X_#W@<Z+:']]?XMXDSA@G\3?E\OU->/^('@1+.RMUA_<VX\QT49=CSU!YK9
MUW5M9UF^_P"$U\5%9&'RVMGYA7:H[# .,$\@X)ZUS%RYN;E[N1OF9MS=_P!:
M_,,YS#Z]B7..RT7H?TCP?D*R++8T&[ROS2?3F:L_5+H)(<)O4=C7YA_\%1RU
MS^U-I[2/G;J%FH_[YBK]/&.\<^E?F%_P4V!E_:IL8CT&L6HW?\!BKFR7_??^
MW9?D?2YA_N$_6/\ Z4C[]TLDZ-9A?^?6/_T$54U>%EAW,O7M5S2U":;;+YG_
M "Q3_P!!J:Z>W^S[9 #\M?&STG<^@E[K7R/S]^-;ZI9_M<^(M12W66WDDBM7
M\QR43-M'AB,]FYZ=N]>5_%'0=:TKXC1ZVY$EM)JC+%J4"E49G4E1R 5X4X!Q
M7?\ [605/VCM0CM%^RFXFAFF>.0_OBULA!/T  Q[$]Z[OX7^$O#WB_PU=:9X
MHTJ"_M9)(6:&X7<-X!(;V//45^JQQT*.#IR:O[J7X'Y2^'95L56E*?VF_O=S
MPF\O-<:>-;>XNLJ2?,CF)#<=:]+T2T^#>J+HD&K:SK%O'-H$2ZOJ5M?3'[/J
M;2QABZ[3NC1&8D+@X!V[B,'U-?V8/@1/&;N7P)#"5R?,BNI4Q[\-7$^(/A#\
M*(+UH/#%C?6T:N#NBU28;F P& W=AWZ\UG'.,+UB7/A[$3CI*QD6?AKX2ZA<
M0+-X]UBRA_LM)IYCJT9Q<^?&I@ :+(S&S$,P !')QDBE#X6\#1W=X;3XEZH]
MLNDR26(_M>VWW,@BMCC'ECR\O-*H!.<P'(P,GK+/X%^&3:*(_$_B*%GR6:/6
M']O7/H/RJIJ/P#T>Y=7'Q!\1%EE5U$EZDF&'0_,IZ#CZ5LL]P4M&K6\CD_U9
MS'F;4_Q.2TGPYX8UF*UMI/B]JNGFZTZSN[M[F2T=8Y)YVB: 8 ^95C#<\?O%
MR0,FJOB_PC-X;T2PU*'XFWLTUQ8K+J.F364/FZ;FQ2=8I2"<.7;RQ^'?*CL9
M/V<DFPX^)6J+B42?O+*WD^8$D=4Z<].AZ5!=?LXW-XRR)\4$9DD9_P#2_#-K
M)N))R&_O+R0 > ,   #%PSK+;ZR_!F/^KF:<V]_F>=_'F^U#X9_%?5O >F:K
M::A:Z?(UM'>0:6%2XV,R>8 S/][&>#C)XXYKD-(UNRO-65I_#.GMSGG2USFM
M_P ?? #5M)^+.B^ K?XDPSR:]L9KW^R]B6IDG\L957.0">Q&!78>-_\ @GK^
MT3\+/#&K>.F^+?A"YM=%LY+J98_M2RR1H,D*#%C<1C&2!S7H1S/+[17M$G):
M7TN>/BLBS:,G*5-R47JU9GG^A:=I=_XYU("")HXQ$T,:P@*@/+#;GCFOJC]B
M_P .Z1>>(7N[&728Y?M$:>5-;@LI5&(^G>OF7X/? 'XU?$'PG)\4M#O-"CM;
MBZEMV;4KXI(SQGYB$"$[>< YP<5Z[\)1XE^ GC_1/#/B.]T74-;O[>YFUEM/
MCD:"W22%C#&K'9N;RMK,<<%MO4&L<PQ%*5&<%)7VL=V3X#&>VA-P:CO?H??M
MKH]ZD*N9?#LAV_*K94U<CTR9AM?2_#<G_;PP_I7R&OQFUA';RM(LSR?N2SKC
M_P B5:@^.6LHRH^C1JW7Y=0N!_[.:^1M!+5'V_LZM_B/-_\ @LU874'C7P,L
M>EZ="ITF\REC-O#?O(^3GI7P7XNF\IHXI8N,?QKTKZD_;_\ &MUXU\0>';B_
ML6"VUG,N[[4\C+EEY&XG'2OF'QN/,BA$X::'9\LB_?3FOV;A_P#Y)VE;L_S9
M^)<1*2XDJI^7Y(S[01#:P6W4GN8VS_A5Y?WL@8+)<,/N[EVH*R["/RA_HFH+
MC^Z<J?RQ5^07!BS<73-[*QY_E6AB/FEA1LS$32],'[J^V.]>]? 9[A_V$_C8
M9451_P )-X0QMCQ_RWO:\%MK4JOF")CZ[5+8_(?UKWSX%B,?L*?&TK_T,_A#
M_ECM_P"6][^=9UOX;^7YH[LN_P![7H_R9S_[-_QSU_\ 9F^.?A?]H#PCX8T?
M5M:\'ZQ!JNBVNO+.UJMY"X>&1U@EB9MK@-MW[3C!!&17L'Q4_P""E&L?&'XS
M>(/VC/%_[(?PA/CWQ(UU+?\ BB&WUSS$N)[9K9ITA?5&MPXC8[<Q,H8!MN17
MS2O6G4'H<L7J>@7O[0>HWW[,NG?LNR?#CPZNF:7XGGU^WU]6O?[1-[-%'#(6
M_P!(\@H8HHX]HA& N00Q).R?VV?VA+C]C6;]@W5_%,6H_#O_ (2JW\0:=8ZA
M&TD^F742R*4MI-P\N%S*7:,@C>,C;N?=Y-10'+$^E=%_X*9^,K']CC0OV$?$
M?[,_PO\ $7P]\/\ B Z]9V6LQZT+B35&657NGFM]2B;+">7Y!A!NX48%<_X
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M/DK]LKRUUS0W6<QR?99<-_"?F'!KY\\9*P:-Q;LK;?O6[C!KZ=_;\2VL=?\
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M!"Y_A([K7TP.E?,?_!))B?V,=')_Z"-S_-:^G!TKXW-O^1E6_P 3_,^LR?\
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M5C9B:27)+%_+C9R.&R0O &<# KC;FR\<>$6DOO%GP4\06$,>!))=:++$B$G
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MD?5:^H!TKY'-O^1I6_Q/\SZS)_\ D5T?\*_)!1117GGI!1110 4444 %%%%
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M^5_QOF>+FU_8G]&/_!(1P_[%>CLHP/[4NL#\5KZD'2OEG_@C^5D_8ITCR_\
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MX?JE?8PZ5\QFG_(QJ_XG^9])E/\ R+*7^%?D@HHHK@/1"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FLI)IU(>#S0
M!^,G_!<C1[G3?VJ[R]N5W1WEC:S0LG\.(]N&]^":^#].GMH_&-NEW'NAF@N(
MW#>\+_UK]"/^"\<<D?[1MO(T?WM'MV42$C<F[:2..<$@=>Y]*_.V&(W?BRQM
M#N4-))\_I\A.?RS7Y#FD.7,JW^)G],\*\U3A[#_X4?3_ .S?-M\!&%!\JWK
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MFKCU)E\)([6HY_=_]_"U,5Q(V\[1GHO_ -85";J)G_>MQ_"HI6O5SAHI O\
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M/XI6!'Z4Y6+ON+>9)W;'RB@1.KD#;YTC?[0'%.::="%G/F+G\J@#!N<M(?\
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M&9/CI4FU$_H&_P"#<*3S?^"9NEOG_F;M3_\ 0HZ^]@<C-?#/_!OIX:E\&_\
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M6^'_ (F>!_A]\1KJW_9\\?ZE/XCMDO[W16O_ !#:FPFUB9Y!<8,:JLC1SO\
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M\/>'[>&-8XX]'TB&WPHZ#Y%!/XUU 2(<D5)UZBBM#38:H7=G IU%% !1110
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M^#7R59?^"5>F%3_S.VK?^AQU^B@Z5YV*_P!XEZG?A?\ =X^@4445@;A1110
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MRGFF]\L W^Z:&8CG.X?RJD@', >4^4^AH5V!^;/X&D/3Y2#]:500V?\ V:I
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MJ1).DP[ELCV%*)03D\_[U0B7CAOPI4.6RQIBY46;<DOEZZSPE, V#CKW%<A
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M=:_]*K:OPRO"''3_ .M7[E_\'N;#_A>WP#'_ %*.M?\ I5;5^&<R^;QFM?\
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M$MS6MH\VU\$UU47[QA6UB?U3?\&J<GF?\$F--<G_ )GS6/\ T**OTFK\T_\
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M10 4444 %%%% !1110 4444 %%%% !1110 4C_=YS^%+01GJ* /RU_X.1O\
M@B1\;_\ @JIX=\#_ !3_ &:O%VDQ^,/A_:7UI_PC>O7'V>#5K6X:)\13X(CF
M5H^ ^$8-@LFW)_&MO^#5G_@MH&('[,&D'W'Q"T;_ .2J_K=*JPP5'Y4NU1T6
MJ4FB7%,_DA_XA6O^"VO3_AF#2?\ PX>C?_)5'_$*S_P6T_Z->TG_ ,.%HW_R
M57];V!Z48SU%/G8<D3^2$_\ !JY_P6TS\W[+NDG_ +J%HW_R52?\0K?_  6S
M/'_#+ND_^'#T;_Y*K^M_IT%%'.PY$?R0?\0KG_!;5>1^R]I/_APM&_\ DJD/
M_!JY_P %MF_YM>TG_P .%HW_ ,E5_7!1@'J*7/(.2)_)"/\ @U:_X+9XP?V7
M=)_\.)HW_P E4'_@U<_X+: <?LO:3^'Q#T;_ .2J_K>HI\[#DB?R/C_@U;_X
M+9CI^RYI7U_X6'HW_P E4[_B%=_X+9X_Y-<TG_PX6C?_ "57];U%'.PY(G\C
MY_X-7/\ @MN>O[+^D_\ APM&_P#DJC_B%;_X+;?]&NZ3_P"'"T;_ .2J_K@P
M/2C /44<[#E1_)"/^#5S_@MKC_DUO2?_  X>C?\ R531_P &KG_!;8GG]E_2
M?_#A:-_\E5_7!1@>E'.PY3^2$_\ !JY_P6S!_P"37=)_\.'HW_R50/\ @U;_
M ."VAZ?LO:3_ .'"T;_Y*K^MZBCG8<J/Y'_^(5S_ (+;?]&NZ3_X<+1O_DJE
M7_@U<_X+:D_-^R[I/_APM&_^2J_K?HP!T%'.PY(G\D/_ !"M_P#!;/\ Z-=T
MG_PX>C?_ "51_P 0KO\ P6TZ?\,NZ3_X</1O_DJOZWJ*.=ARQ/Y(?^(5K_@M
MIG)_9>TG_P .'HW_ ,E4#_@U<_X+:#I^R[I/_APM&_\ DJOZWL =!1@'J*.=
MARQ/Y(1_P:M_\%M,Y_X9>TG_ ,.'HW_R52_\0KG_  6T_P"C7M)_\.)HW_R5
M7];M%'.PY(G\D1_X-7?^"VW;]E_2?_#AZ-_\E4G_ !"P_P#!;9#C_AEK2S[K
M\0M&_P#DJOZWL ]11CVHYV')$_DEC_X-9_\ @MH.1^RQIO\ X<'1O_DJM3PY
M_P &M'_!:.[U2&PU+]G+1=/AD<"2]O/'VE&.(>I$=P[8^BD^QK^L:@@'J*J-
M:<=B71BSY5_X(Y_L!>(O^":W["OAW]F7QIXOM-<UZ&^N]3UZ^TT-]E%U</N,
M<.Y58HBJJ[F +$$X&0!]5#IQ2;5QC:/RI:SE+FDVRXQ48V04444AA1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_015.jpg
<TEXT>
begin 644 image_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #G -P# 2(  A$! Q$!_\0
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MGEP/WC#\:>@M3ZW_ .%F>$?^@NO_ 'Z?_"C_ (69X2_Z"R_]^G_PKY+$TO\
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M$=M;1F1V/H.P]STKX]\6^)KKQ=XDNM7NB1YAVPQYXBC'W5'^>N:]:^*'B?\
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K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_016.jpg
<TEXT>
begin 644 image_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '> ?$# 2(  A$! Q$!_\0
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MS5J)7V#S H;OMZ4Z)90O[TJ6S_",<5)7FRDV]3I2ML-Q1BG8HJ1B8HQ3L44
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MJ8LURLCVK3;QV*$8_0G]*=HGB);G;:W3XF'RJ_9O_KTUI(=0FL]24C)B>VD
M_A9@"/U&/QKDG1HYW3D%3^5<U*BIQ<);HWK5'"2G'9GJ.X^IHR?4U6L9&EL+
M=W^\T8)S]*L5Y[5G8ZT[JXN3ZFC)]:**0Q:*2B@ S2TE+0 M%)10 M%%% !1
M110 M%)10 M%)10 M%)10 M%)2T %%%% !1110 4E%% !1110 4444 %%%%
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MYGW_ '9"0&(/(./QKM=#LH8M#CMP\S(VYF\ULL#GD9KEM.T\W4WEVD(3<=Q
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M ([>U/%Y 5!W$ H7R?0'%5WL&8.58+( OE/CH0,?E4,.G3M:Q),RJX@*,5Y
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MEA927$AX4<#U->=-+<^(-72,L296P/0"NF\;2,MA$@Z,W-4?!5LK7L\Q'*(
M/QKS9WK8CD>R."NW4JJGT.OLK.*PM$MX5PJC\SZU9HHKTMCN225D%)2UF:]J
M2Z5I4MP3\^,(/>HJ34(N3%*2BKLX[QWXB9V.EVCG /[TCO[572XN/#6CQ6-L
M/+N90))Y,<Y/;\!6;X;L7UOQ*C2_-&K>=(3WQ_\ 7KT;5M!AU"6.Y4*)XR"
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MUKUR^U.YN/AYJ-SJ%M##/('"AQM\['W6'OC^5>/^*8F;4C<12I);7!$B%?\
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M+1K?4Y8I)9)4>,$*8GVGFKT<<=O"L: )'&H '8 55LIY+R9[@$K;#Y8A_?\
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M#'2JCN)GA^KSO;^'[+2IMZ:,&P\D:8+R8S_,_I4VB^&8+C2VGL[F4N$W*A.
MQ'7-7/B7I,^E70FB<G2KQL[#R(I.O'IGK^=9FE:Z;#0VC2!AL_=M(K< GOBO
M=HR4H<T3BJIHOV>G6.J:>)KE,NHP"IY!!K9TP0QW2V?()C(4GGKQ68NDBVL8
M[RWE<(CAV!/&&X/ZU;29H[I#D+@#:PZUNUS)G->QH,I20@YR*MP*/XJHP3">
M9\-G!P3[UI1KD9QBL9Z:#B3CC%6%/&*C0 8)J0+R#7+(U1*.@QQ5B,&H4'Y5
M.G7VK&1HB=5I9YA;6SRG^$4J\XI9X%G@>)ONL,5EI?4TUMH<[I/B@WFKFQGC
MV%B1&W][ S73/RA%<[H_A.'3=6DU"2=IY2NR,$8"#V]ZZ-_N'%&)<&_<V'34
MDO>*Q6DVU)1Q7"= S91MJ2B@"/913\44 0XI,5+MHVT 18HQ4NVDV4P'KC8!
M5&_T^UOU"74"2JIR-PZ&KZ@;0.]1R"NNDVDFC":*OEK'&(T 50, #M43#-3L
M,"H&8%>""/45NC!D1'6HSS4I-1N>,5JB&1..QJ"49'7-6._K4;<YR*UBR69\
MBG'%4+J.5@AC."&!.>XK2E[]:K2 ;!BNB+,V9;IY,K3NQPH+8]*9I.JQ3:.\
M,F(Y-SDGU!/6FZNY-L8T!+/QQ6?;2I!>BU4*L<<)\]F]^WUK=JZNQ1*EE9?:
M[NTL/.AC#2/+YC#!&.@->A_#JWNAIYO6,4HO)'>:4'YL@X4?3 KSK7]06XQ=
M,H6)(_+B!&"Y]?I7I/PG\S_A#$\Q"!YK[2>XKS\:VH'=1U.ZQ2TE+7C'4%%%
M0SRM& $&6/K4RDHJ[$R:BF1N67YA@^U/IIJ2N@%HHHIC"BBB@04444 )12T4
M %)2T4#$HI:* $I:** $HI:* $HI:* $I#2T4"."^)]K:#PO>W$\I$A55B0M
MQN#=0/6O+M(M)KM_LH1"TD*OAGVC(/!]Z[WXOZ-=W5G;ZC$'D@A!611_#D]:
M\ZT"\69XX3((KN('R9#_ !#^Z:]G!.T%J<U9=CK;V>>;25MT^0.H8J#SQ5NP
M<7%M&[?> VFL3S;JZNHKJ%5#)E)H]W!'J*VK!0HROW3R*]#[)PO<T;6!(G)7
MC<<FM6'.*HVYW,,XK0AR#CK7)49<2=4.>M2ITIB\&I$&37-(T1,O(]!4Z#@&
MH4Z=*G7I6,C5$Z"I:K3.\=K(\:[G520/4U!HUW<WNG)/=0&&0D_*?3UK)Q;5
MS1/H:(%#\1F@=,BH('G>W_TA%63)X4Y&,\5G)>ZREN-I<T[;1MKF-AE+3MM&
M* &YHIV** '[*-M3[*-M $&RC94^VC;0!4D1F)7H,=:KP6XM;9( [,%X!8Y-
M7900PQ5>21-Y3(W =.]==-OEL83W*MQ'YL$D9)7>I&0>16=IE@^GV?D/,9<$
M_,:L:GJEMIJH9VP9#A0.IJ4.)(@Z=",BNJ/,H^3,':Y&PP*B/6I2N%]ZC8>U
M4B&0,#DD Y['/2F258;CO43@;:JG%1;:ZDV*$F>M5)3M']*LRS,'**N\@=*J
MNP.7;C'7)Z5M2K1D^2^J,F^AB:SJ-OIZ*\Q.6X '6J3I-=:=]H2 K$X^4!=S
M/CIFK%[9V;ZFEU=,TZGY4B R/PJ[H%K<7VJ_:)7:VTZ(X2%3@8':NMMQ5V7%
M(S-&\'ZCXEOXIM3;[/:H0%CQ\S#Z=J]OL;."PLXK6VC$<42A54=A6=I,/FS&
MZ,81,8C4#H/6MFO#Q55SE8[Z2TN%%%5[J]M[--\\@45QRDHJ[-6TE=CY)TC<
M)U8]!3+B%YU4QOL8<YQFN;O?$EL4=V0,.0H!YKGV\:ZQ;;$B@B:,'^('./2N
M+ZS"3<9;'++$PO9GI,,9C3#-N;N:?7)Z1XWMKMQ#?(+:4]#G*FNK5U=0RD,I
MZ$5UPE%KW=C>G4C->ZQU%8EYK@TG58[>^R(;E@MO(HS\W]TUM]:J,D]C1JP4
M444Q!1110,****!!1BBB@88HHHH$%%+24#"BBB@ HHHH$%%%% $<L4<\312H
MKQL,,K#((KROQ1\/-,MYWN(@]O&_*/'_ ,LS]/2O6*JW]LEU:/$X!!'?M6^'
MK.G+R(J1YHZ;GBD.F6]D@MI;^)I6!,4D>06],U!I^HZA8:F+35%VQR'"2$5T
M>K>&[> W"R-LQ\R?[)]JSIY3:Q02WY2:$)P^W)!STKWXM22:9YK?1HWH/E=2
M#\K5JP] >M<WH^NV6I3M#$Q61?X6&":Z2+CI7/4'%-%@<]ZD0<U6>Y@@=%ED
M5"YPNXXR:M+C=Q7-(U1.O.,5,HY%0QX(J;S%C&6( '<UBS1%E!Q3@1TS444\
M31&0.-@ZFN>@6^O?$J7EM.&T\9#L&X8CMBH4.:]]+%N5K6.I&.E+@8Q6?JTM
MW#I\LEE'OG ^5>N:M6!GDM86N$"3% 74=C64X^Y<N+UL2;*-E6-E&RN4V*^R
MDV59V4FR@"OL-%6-E% !BEQ110 8HQ2T4 5[C@#%8D>CBWUB?4!<.?- 'EGH
M*W;CA0:JR'BNJA)I:&-1&/JVDV^JQHLZG,;;D8'!!K.TR_N1;SI>0&+R"0#C
M@@=/K70M]*K31K*C(PR&&"*[(3TY6<\D9ME?FZ9@0 .QJVYVH6)X SFJ=C8?
MV<QV.60Y #=A5M^5QC-:2M?W3-7MJ9UAJL&HQEXL@9.,]\=ZQ9==N)O%,FG1
M;$B@4,P;J^?2MFWTRUL'D>"/9O))&:Y>VTJ75M7N-728Q;)/+10.&4>M:JVZ
M%T9MVUV&U&4LA5 < GH:Q/&QD%JH@9E$CA3LKH9O*/EIY)4#[Q]:K7-DKCG$
MT!X(/5:\:G4B\2IVMY&"E9W,S0?#>P1R)*TL@ .UVXS[5U,=M#;/%:;QA3F6
M3U)ZU%$!#&AMXS&OW1]:TKL+%##;1%#(>9,]:]AU7.VEO(W6JN=/9A?LZE.%
M(^7Z58JGI@8:="&Z[:LR2QQ+F1@H]S7C5-),]&+]U,29_*B9_05SEU82:[#(
MA8I%G&_N3[5HRZA'?2_9;8[S_$1T%:-O L$*QJ.!7-*"JO78RDE5=NAY/JG@
M_P 063M)9?Z3".FT_-^5<_-J&I6TGV>[B*LO&UUP17OF/:JUSIUE>'-Q:Q2G
M&,N@-0\*K&4L'%_">%1WZRMAT(/J*[CP3XC,=TNG3REHY/\ 5EC]T^E=8?"6
MA,<G380?88JS::!I5D^^WLH4;^]MR:*=!PE=$4\+.$E),S/$S)/J.C684/))
M<AQ[!>2:Z-G5%RS!0.I)KE[Z(6GC>PG* K+&T<>3P&Z_TK(\:SW[7RP"<QP
M9"@8#?6E*LJ:;MJV=V)J>R@F=RM]:.<+<Q$],!A5@$'H<UX7)--&<$LASPP-
M6;?Q9J^G K!=.RGKYG.*(8J^Z.&&-ONCVNBN2\+>-;7642UN7$=]CD=%?Z5U
MM=2::NCLA-35T%+244RPI:**!!24M% !1110 E%%% !112T#$HI:2@ IDKQH
MA,C!5]S2NZQKEB />LVZMENV\R:3;&.BUG4J*&Y$I66AS.L7<-Y<-&@5MORE
MA_%6:VG0I9_*<]PK?PUH7EI!%*S0'+*U$UNC!=W"L/F'I7=1QSLHO1'ER;<G
MS'$BQAM=;_M4RK'#&/G51G)K>L[ZTUU2;&_=7 ^ZAP1]:D73H5S"D8$!!R#W
MK/LM,LM+U,W-LOEG[IP>/RKLCB(NZO>PX.ZU,KQ3=$Z6L4@<W:R*%<]1CDGV
MKN+>:=]$ADA_>2&-3D'[W'-5I4CD):6.*17!&XKS@T[P]&UC8FUD;(1R$/\
ML]A2^LTZFJZ%1FMBWX>6^6Q;[<3O+L5#=0N>,UH:BI-DY4].V.M21$<8JP@!
M/-1*7O<QLE=6,C0K62XL[I+A66"4[5!X)'K6Q8:?!IEJ+>W7" D\G))/4U8C
M&.E28K*I4<FS6$;(!4L?WJCJ2+[U<\]C2.Y-1117.:A1110 4444 -HHQ2T
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MSG(1:Z\15CS1MU#$RC4C&4=QDOES( 1]X9%1Z=*D%T=Q [=:[;_A';*^L8'
M\MB@.5[UQWB+2X=*NEBBF\PMR1W%54BX:LQJ4)TUSO8T)V@G@;"JS#WK(D.$
M+1K@#M4&GL\=RK'.WN*M.RAV*@[2:X*JUN9-\VI3^ULF2C$'T-,DN'F![8ZU
M-)$LC9P!5:YMWBYVY'J*A<K)(!.5.!WJ*=SC<>M7(88)N"=K>]9NJ;[5OF!*
M]C6D;.5C2"NR7PH3)XYL$3KN)_#%>ZUY5\,]$DN-2EUN9"(E79"3W/<UZM7L
MTXV@D>O1C:(5#+*%^4=:9>7:6EN9&[=A6=!.+]A-&<J.N>H->9F6-=->SI[]
M^QK=7MU+F.OO5'59UM["3)^9A@"K]5GMDDG\R7YL?=!Z"OFDU>[-)J4HV1R(
MT2YO(QA=H/=JNP:7!IJ]-\O=CVKI3MV\5E7499CCFKGB)RTZ#PF"IPES/5D,
M"^8X*^M;T7" 5D6D90C)Q6LG2LD]3KQ _:&<!AD'@BO,?$&G-HVM2)@^1,=T
M?M7?7NKQ6$Z(ZLQ/I4&OV4.O:&9XA^\C&Y?7Z5[N7P<J$GV9XV+4:J:B]4<_
MX4U1=/O1!))^YF]>@-=[/,!;ED.21Q7D2R8487YUZ_6N]T_4GNO#PGD(WQ?*
M<5Z%&J^1Q^XYL+6M%P9+8SI')<,S?=.,FLK6+Y;MPD9^0=:RC>RRR2;3A">G
MK3XB#U[UC&-I7,I5G*/*B"[<1V^$ZYKIK"]=-)BPN^1_E -<W,#<,(HEYS78
M:59K<V$2NI41\ CN:VE#G2BD5AE)R=B3P] (H)=ZA9MWS@=!6S44%NENA5!U
MY)/4U+7=!-129Z5./+%(K7\0FLY%QVKB&4HQ SQQ7?L-RD>HKC+Y#'<NN .:
M]'!RWB88F.S,^- TZ!\!2PSFL?Q5H[WT'EVY 8$D =#6VXSZ<4QII1"RQ[1)
MM.PL.]>@F[W.5:%/P1:R6NE,DC9(8C&>E=)=W!M+5YMN=HSBN,T?44T_6I8)
MY5C#J'9"> QZXKL(;VSOD*I-%*IZ@,#6%6-I7>QJG<?I&H#4K);A5*@G&#6H
MG:JD"1P1A(E54'0#@5:5ZY9V;T-8ED<BGQCDUQ_B;Q%/IL$OV5@LL>" 1G?[
M5U6G3O<6<,LB['= Q7T)%8U:<HPN^II"2;+@%.Q2"G"N4W#%)BG48H ;BBGX
MHH 9124M !2444 %<;XRTN75+"6W@;$H8.H/0D=J[*L6^&+D^]=&&=IF57X3
MGM"BO(HV-T@CX "@UJECG-*>OM4;$ 'TKO;YG<Y-C/U?5XM+MQ(X+2,<(B]6
M/M7/M?:]=/OF,5I;MT7JU5[N[EU/Q+*EJBR2VXVIO^ZOO65)-KEWJ,UL[Q;8
MFVNR]JZJ=-*Q+N2:9=7%GK4RS1-/')(3'.%X!KK@Y9L\?6J-DB16RKCV%:DE
MN\!4.,!E!4^U7*RT(;;U'"0]N:Z+P\AS(Y'0 5SBYR!76Z%&$LMW]XYKCQ3M
M39K05YFK1117DG>(ZAT*D9!&*\MUFWDTG5949,Q.25XXYKU.LK7-%AU>T*,
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M4Y4UJ;J3>*J+:=T3**DK,\RB0VUWAEY!Y!K4F"7$)4\C%2^)+40W?FI@*_\
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MXVC5KJ ;.)7 =O2J2U=S1M-H[O0Y%;1[5@<KY8Q71V',9-<OI@2"QAB3A54
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MQ\J)1$H[4X*!VJ#[6?\ GC)^5'VH_P#/&3\JFX[%C%+5;[2W_/&3\J#<N/\
MEA)^5*X%FDJL;N0?\N\GY4IN9/\ GW>BX%BBJXN)#_RP>C[1+_S[O1<"Q15<
MSR_\^[TSS[C/-NV*=P+)/%9C$>9(Q]:GDN;C:=MJY_&LN>2^*,$LGR?>M:5C
M.H9EXXDN6(Z9JMN'F+ZT][/4RQQ9-SWS4(L-5# _8SQ[UZ<:D$K7.-PDWL5[
MU%%VY'?K2*?X14KZ9JTDI8VAY_VJ:=*U89(M.>QW5HJU.UKD^SE?8XWQ/,T6
MIL)",+&0O-<W=3JVAPJ#_%TKLM2\$:W?%V>,;W/)+=!5!OAMK31I'A=J^]$L
M536ESHA3:1PJ_>'UKZ(\*72W?A^S=1@+&%_*O-K7X6ZG),HE=8TSR>M>KZ)H
MSZ9IT%HI!$:X)]:X,35A**LS>*9?7K4RJ33T@V]:F"XKBN6-5:>%I0*=BD F
M**=BB@!F*0BG44 ,VTF*DQ2&@",KFFF)2.14M-S0!CW_ (>L+\YFB#'W%4!X
M.TE2/]''%=/C-)MJTVNHCGO^$4TK@_9ER.G%6$\.6*G*Q8)&,BMG&*44U*7<
M32,7_A&[+^ZWYTT^%M-8Y:#)]S6\!15<\NXN5&*GAG35Z6ZU*GAW3P>+=16N
M*44G)]PY44(]%LTZ0BK"Z?;#_EF*L4M0]1HC%I !Q&*7[)!_SS6I,T9I6&0F
MPML_ZM:/L-O_ ,\UJ;-&:+#N1BTMP/\ 5K^5+]EAQ_JU_*GT9I6%<:((5Z(/
MRIWE1_W!^5&:6G8!/*C_ +@_*E\N/^Z*,T$T6 78@_A%)M3^Z/RHS1FBP!M3
M^Z/RI=J_W129I*+!<7:G]T4;5_NBDS1FBP7%VKZ"C"^@I,T46"XN%]!2@#T%
M)29HL%QV!Z"CCT%)FBBP#N/04G'I29HS18!W'I1QZ4@HHL O'I2\>E-HH'<6
MEXIM%%@%X]*3BEHH :1FFE!Z4^B@1"8QZ4TQ#TJ>D-.X$!B'I33$,]*L48IW
M K&$>E)Y(]*LTF*5P(1&!VIX%.Q3@*&,;BEQ2XI0*D!,4H%+10 F**=10,__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>report_001.jpg
<TEXT>
begin 644 report_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !( 7\# 2(  A$! Q$!_\0
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M!)Y!DLH921/D#*X.#BO4*>-E!RCR/2PL'&48RY][A1117$=9YO\ %S[NF_\
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M=/NM*V=OT'2NCHHKDG.4W>3N=D(1@K15@HHHJ2@HHHH **** "BBB@ HHHH
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<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>report_002.jpg
<TEXT>
begin 644 report_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !< QX# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HI"RJ0&8 L<#/<TM !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !6-?PIJ.MQ:?<[C:I 9R@8@2MNQ@X
MZ@>GN*V:J7NGQ7PC9GEBFC.8YHFVLF>OM@XZ'B@#(GCCT"_7[ FV*:WE=X=Q
M**R $,!V]#CKD4^'6KR(V\E_% L%Q;/.HA)+)M4,0<\'(/;]:NQ:-"BW!EN+
MBXEGC,32S."P4]EP !^52'2K9OLH?<RVT30JK$$,K  [O7@4 9&G^(KNYO+9
M9(4>.X."L4,H:'/(+,PVL.Q(Q6AJ)/\ ;FCC)^_+_P"BS3[31X[22,B[NY8H
MO]5#))E4].V3@<#)-2W^FK?O!)]HG@D@8LCPD \C!Z@]J &:C,(KG35,2/YE
MSM!;JOR.<CWXQ^-8^F7M_9Z;#.T<+V/VEXF^8^9\TI4-Z8R0,>G?M6RFE@>0
M9KNYN&@F\Y&E*YSM*XX XY-00^'[:"2,B>Y:))#,(6DRA<DG<1CL3TZ<=,T
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MJO-H]K);74#[RMQ,9B=V"KG'*D=,8!%5SX=MY [3W-U/<';LG=QOCVG(VX
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M>M6=E\ZX%J[^8UH''E,>O3&<9YQG%6)+%X;:]%G(RSW,GF;BP^5B ...F%H
M@\3<^'KH9(SM&0<'[PJC=W$JQV]A<.3<6][ 0^?];&7&UOZ'W!]16Y?6<=_9
MO;2E@CXR5.#P0?Z5'>Z9;W\MM+,&$EM()(V4XY!S@^HXH PK?Q/<W$\4B1(]
MO+(%6)8)?,52<!BV-I]2/3O5AO$;Q1VJR0IYV]EO #Q$JL$+?3+ C/;-78-#
MAMY%$=S="V5MRVOF#RU/7CC.,\XSBI6T>T:XO)B&W7:!)!G@<8R/0]/R% "6
M-T=36\WQQFU$K0QD<^8!PQ/MG(_"LG[/=RW/_"/RRNULI\YIBWS-;YXC)ZYW
M#!/H/>M^SM8[&SAM8<^7$H4$]3[GW-(+.,:@U[EO-,0BQGC )/Y\T 8S:O?I
M92ZE%;VPTZ!V7RN?-**=I(.<#D' QT'6H=7O+RYT[6E;R4M;8F(;0WF$X5L^
MF.:T7\/6KR./.N1:O)YCV@<>4S=3QC."><9Q4\ND6\UM>P,TFR\??(01D' '
M''^R* &:3J,NJ>=<*J):!S'$ISYA(."6'\/TZ^M1^)1NT"X7+ ,T8)4X/+KT
MJ6?3F6Z>ZLY6BEE:/S5! 5@K#)(P><9'O5F]LX[^T:VE+!&*DE3@\$$?RH P
MKNXE"VMC<L3<V]]!\W_/6,M\K_T/N#2W,5Y:W3:-;R,+>^):&3/-N@_UBC\Q
MM]-WM6Q>Z9;7\]K-*&$EM()(V4XZ=CZBI);..6]M[IBWF0*ZJ >/FQG/Y"@!
M4MA;V0MK4B((FR,XSMXX..]<TWVBPL==7[7++,)HE,S'#?,J D8Z=3CTXKK*
MIMIEL_VT2!G6\(,JD\<*%X]. /QH P-6@CT [],!M_-M)]X#$@E5!5N?XAD\
MT_4;6'0/L]QIRF&1XY5D)8G?B)G!;/4Y4<_6M6#1($=VN)[B\+1&$?:'#;4/
M4# '7N>O%%MHD,$JO+<7-T$0I&MPX8(#P<<#/'&3DT 9;6<&E1:7>VJLEQ*X
M29V<DRAD).[UY -5;))4_LW4[FV:-KAX]UU'-F5B^,!UQC82<8!R!CIBMVVT
M."VFB<W%U,D&1#%,X9(\C''&3@<#)-$.A6\,\3">Y:&%MT5N\F8T/8@8SQVR
M3B@#4K(?4KQ([BY\J$VUO*R,,G>R@XR.P_K[5KUE0:5N>9IWE56N'D,0?Y'&
M[*DC\N/SJX<NO,1._0LZA9P7D*K=2,MNAWR)NVJX Z,?0=?PK,TZSD>*^&FS
MO:6,K+]G.W=C^^R ] >WTSWK2U+35U.!(7GFB57#_NB/FQT!R""/:GV5F]H'
M#WEQ<[L8\[;\OTV@5!9EZ19BZ\.BVDGF">?*'8/\SJ)6R">O/?&*=I%M!'JD
M\FF#9IWEA6"G*22YZK]!P2.#GVJW)H\+Z6^GK//'$[L[,C -\S%B,XZ9/Y46
M^EO;QN@U*\92FQ0VP;/=<** ,+5HI;N]U*6"VENQ$H19A(4-JX7)V#^(\AN,
M9/%&O:M%>:9+9V]\JHMIY\LA<*SY7*(!G.6ZGVX[UN3Z-'-<22QW5U;B7_71
MPN LAZ9.0<''&1CI4EQH]A<V;VK6T:HT7E!E0;E7&!@D<8% %&]M-+N+=+W4
M)/M$1C5(8]V5R?[@'5C^)XXJWIUI*VB16NH@RLR$.LAW'!/"D]R!@9[XJ.?0
MXY;F.>.\N;<Q1^6BQ;-JCV!4X)J[!;/#LW74\VU2I\PK\V3G)P!SVH YS[%:
M6\FJ:G8V\<"V,$D<)4?>D"DLQ]<<+_WU3YK.'2(M.O+-62XD;9*Y8GS08V8[
MO4Y -;UK80VEE]D7+QG=NW\EMQ).?7K56VT.&VFB=KFZG2$$0Q3.&6/(QQQS
MQQSGB@#)BLX;/3])U.$,+R>2'SIBQ)D\S&X-Z]?PP*CCMHH]!M-;4,-1=XI'
MGW'+;W 8'_9PV,?2MFWT&"WFB;[1<R0PL6AMY'!CC/;'&3C)QDG%":#;I,C>
M?<FW23S4M2X\I6Z],9P#R!G% &K1110 4444 %%%% !1110 4444 %%%% !1
M110!!>F06,YB8*X0D$]N*R-.^U6\-I;6Z6JM-"9G<JW/W1Z\GFMR1!+$\;9P
MP*G'O4$5E%#)"ZELPQ>2N3VXZ^_ K2,DHV9$HMNYDKJ\D<<4,*11,0[L3&[J
M/G8# 7GG!-68M2NKM8(X(DBG96>0RAL  XX'!.3TZ<5-_9,2!##-/"Z@C>C#
M)!).#D8/)J1]-C98]DLT<D8($JO\QSUSG(.:IRAV)49F;;75W'*\*1Q>;-=R
M*VYB0N%!R/;VJ8:C?+$\SQV_EPS>5(%+98[@,CTZCKFK<&EP6\B.C2$I(T@W
M-G)88.:<=/A,$T6Y]LLOFL<\YR#Q[<4.4&]@496*,^KRPW6TM;,HE"&)=S.
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M#_O]_P#6HY8?S?@'-/M^)MT5B?\ "-)_T$M0_P"_W_UJ/^$:3_H):A_W^_\
MK4<L/YOP#FGV_$VZ*Q/^$:3_ *"6H?\ ?[_ZU'_"-)_T$M0_[_?_ %J.6'\W
MX!S3[?B;=%8G_"-)_P!!+4/^_P!_]:C_ (1I/^@EJ'_?[_ZU'+#^;\ YI]OQ
M-NBL3_A&D_Z"6H?]_O\ ZU'_  C2?]!+4/\ O]_]:CEA_-^ <T^WXFW16)_P
MC2?]!+4/^_W_ -:C_A&D_P"@EJ'_ '^_^M1RP_F_ .:?;\3;HK$_X1I/^@EJ
M'_?[_P"M1_PC2?\ 02U#_O\ ?_6HY8?S?@'-/M^)MT5B?\(TG_02U#_O]_\
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MCEA_-^ <T^WXFW16)_PC2?\ 02U#_O\ ?_6H_P"$:3_H):A_W^_^M1RP_F_
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M '1QR1S('C=70Y 93D<<&G5D>&23H%N25)+29*]#^\;I[5KT %%%% !1110
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MUJL2P1>6L.[8JL<#<<GC_.*LT44 %%%% !1110 4444 %%%% !1110 4444
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3 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>22
<FILENAME>aatp-20211231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa6GCbP9z5Z8KekhvWB5bSk6zyEsYi6P3iKbY+x2Qb4J -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:AATP="http://agapeatp.com/20211231" elementFormDefault="qualified" targetNamespace="http://agapeatp.com/20211231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://agapeatp.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" id="StatementsOfOperationsAndComprehensiveIncomeLoss">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" id="StatementsOfChangesInStockholdersEquity">
	  <link:definition>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackground" id="OrganizationAndBusinessBackground">
	  <link:definition>00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/VariableInterestEntityVie" id="VariableInterestEntityVie">
	  <link:definition>00000009 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BusinessCombination" id="BusinessCombination">
	  <link:definition>00000010 - Disclosure - BUSINESS COMBINATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/CashAndCashEquivalents" id="CashAndCashEquivalents">
	  <link:definition>00000011 - Disclosure - CASH AND CASH EQUIVALENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/AccountsReceivable" id="AccountsReceivable">
	  <link:definition>00000012 - Disclosure - ACCOUNTS RECEIVABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/Inventories" id="Inventories">
	  <link:definition>00000013 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PrepaymentsAndDeposits" id="PrepaymentsAndDeposits">
	  <link:definition>00000014 - Disclosure - PREPAYMENTS AND DEPOSITS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
	  <link:definition>00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IntangibleAssetsNet" id="IntangibleAssetsNet">
	  <link:definition>00000016 - Disclosure - INTANGIBLE ASSETS, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInMarketableSecurities" id="InvestmentInMarketableSecurities">
	  <link:definition>00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" id="InvestmentInNon-marketableSecurities">
	  <link:definition>00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" id="OtherPayablesAndAccruedLiabilities">
	  <link:definition>00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" id="RelatedPartyBalancesAndTransactions">
	  <link:definition>00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StockholdersEquity" id="StockholdersEquity">
	  <link:definition>00000021 - Disclosure - STOCKHOLDERS&#8217; EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/Non-controllingInterest" id="Non-controllingInterest">
	  <link:definition>00000022 - Disclosure - NON-CONTROLLING INTEREST</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000023 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ConcentrationsOfRisks" id="ConcentrationsOfRisks">
	  <link:definition>00000024 - Disclosure - CONCENTRATIONS OF RISKS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000026 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" id="OrganizationAndBusinessBackgroundTables">
	  <link:definition>00000028 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/VariableInterestEntityVieTables" id="VariableInterestEntityVieTables">
	  <link:definition>00000030 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BusinessCombinationTables" id="BusinessCombinationTables">
	  <link:definition>00000031 - Disclosure - BUSINESS COMBINATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/AccountsReceivableTables" id="AccountsReceivableTables">
	  <link:definition>00000032 - Disclosure - ACCOUNTS RECEIVABLE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000033 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PrepaymentsAndDepositsTables" id="PrepaymentsAndDepositsTables">
	  <link:definition>00000034 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
	  <link:definition>00000035 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IntangibleAssetsNetTables" id="IntangibleAssetsNetTables">
	  <link:definition>00000036 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" id="InvestmentInMarketableSecuritiesTables">
	  <link:definition>00000037 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" id="InvestmentInNon-marketableSecuritiesTables">
	  <link:definition>00000038 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" id="OtherPayablesAndAccruedLiabilitiesTables">
	  <link:definition>00000039 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" id="RelatedPartyBalancesAndTransactionsTables">
	  <link:definition>00000040 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/Non-controllingInterestTables" id="Non-controllingInterestTables">
	  <link:definition>00000041 - Disclosure - NON-CONTROLLING INTEREST (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000042 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" id="ScheduleOfSubsidiariesAndAssociatesDetails">
	  <link:definition>00000044 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" id="OrganizationAndBusinessBackgroundDetailsNarrative">
	  <link:definition>00000045 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" id="ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails">
	  <link:definition>00000046 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" id="ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails">
	  <link:definition>00000047 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" id="ScheduleOfDis-aggregatedInformationOfRevenuesDetails">
	  <link:definition>00000048 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" id="ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails">
	  <link:definition>00000049 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" id="ScheduleOfVariableInterestEntityDetails">
	  <link:definition>00000051 - Disclosure -  SCHEDULE OF VARIABLE INTEREST ENTITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" id="VariableInterestEntityVieDetailsNarrative">
	  <link:definition>00000052 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" id="SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails">
	  <link:definition>00000053 - Disclosure -  SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" id="ScheduleOfProFormaBusinessCombinationDetails">
	  <link:definition>00000054 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BusinessCombinationDetailsNarrative" id="BusinessCombinationDetailsNarrative">
	  <link:definition>00000055 - Disclosure - BUSINESS COMBINATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" id="CashAndCashEquivalentsDetailsNarrative">
	  <link:definition>00000056 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" id="ScheduleOfAccountsReceivables-RelatedPartyDetails">
	  <link:definition>00000057 - Disclosure -  SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfInventoriesDetails" id="ScheduleOfInventoriesDetails">
	  <link:definition>00000058 - Disclosure -  SCHEDULE OF INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InventoriesDetailsNarrative" id="InventoriesDetailsNarrative">
	  <link:definition>00000059 - Disclosure - INVENTORIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" id="ScheduleOfPrepaidExpensesAndDepositsDetails">
	  <link:definition>00000060 - Disclosure -  SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" id="ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails">
	  <link:definition>00000061 - Disclosure - SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" id="ScheduleOfPropertyAndEquipmentNetDetails">
	  <link:definition>00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" id="PropertyAndEquipmentNetDetailsNarrative">
	  <link:definition>00000063 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" id="ScheduleOfIntangibleAssetsNetDetails">
	  <link:definition>00000064 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" id="IntangibleAssetsNetDetailsNarrative">
	  <link:definition>00000065 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" id="ScheduleOfInvestmentInMarketableSecuritiesDetails">
	  <link:definition>00000066 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" id="InvestmentInMarketableSecuritiesDetailsNarrative">
	  <link:definition>00000067 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" id="ScheduleOfInvestmentInNonMarketableSecuritiesDetails">
	  <link:definition>00000068 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" id="InvestmentInNon-marketableSecuritiesDetailsNarrative">
	  <link:definition>00000069 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" id="ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails">
	  <link:definition>00000070 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" id="ScheduleOfRelatedPartiesDetails">
	  <link:definition>00000071 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
	  <link:definition>00000072 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" id="ScheduleOfNonControllingInterestDetails">
	  <link:definition>00000073 - Disclosure - SCHEDULE OF NON CONTROLLING INTEREST (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" id="ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails">
	  <link:definition>00000074 - Disclosure -  SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" id="ScheduleOfProvisionForIncomeTaxDetails">
	  <link:definition>00000075 - Disclosure -  SCHEDULE OF PROVISION FOR INCOME TAX (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" id="ScheduleOfEffectiveIncomeTaxRateDetails">
	  <link:definition>00000076 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" id="ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical">
	  <link:definition>00000077 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" id="ScheduleOfDeferredTaxAssetsDetails">
	  <link:definition>00000078 - Disclosure -  SCHEDULE OF DEFERRED TAX ASSETS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000079 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" id="ConcentrationsOfRisksDetailsNarrative">
	  <link:definition>00000080 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" id="ScheduleOfLeaseCommitmentsDetails">
	  <link:definition>00000081 - Disclosure -  SCHEDULE OF LEASE COMMITMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000082 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000083 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="aatp-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="aatp-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="aatp-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="aatp-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="AATP_AgapeATPInternationalHoldingLimitedMember" name="AgapeATPInternationalHoldingLimitedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ShareExchangeAgreementMember" name="ShareExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MrHowKokChoongMember" name="MrHowKokChoongMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyTwoMember" name="SubsidiaryCompanyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyFiveMember" name="SubsidiaryCompanyFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyMember" name="SubsidiaryCompanyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyOneMember" name="SubsidiaryCompanyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyThreeMember" name="SubsidiaryCompanyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyFourMember" name="SubsidiaryCompanyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HealthAndWellnessProductsMember" name="HealthAndWellnessProductsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HealthAndWellnessServicesMember" name="HealthAndWellnessServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SocialSecurityOrganizationMember" name="SocialSecurityOrganizationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MYRCurrencyMember" name="MYRCurrencyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_EmployeesProvidentFundMember" name="EmployeesProvidentFundMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_EmploymentInsuranceSystemMember" name="EmploymentInsuranceSystemMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HumanResourceDevelopmentFundMember" name="HumanResourceDevelopmentFundMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SurvivorSelectMember" name="SurvivorSelectMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_EnergizedMineralConcentrateMember" name="EnergizedMineralConcentrateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IonizedCalMagMember" name="IonizedCalMagMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OmegaBlendMember" name="OmegaBlendMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BetaMaxxMember" name="BetaMaxxMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VegeFruitFiberMember" name="VegeFruitFiberMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IronMember" name="IronMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_YoungFormulaMember" name="YoungFormulaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OrganicYouthCareCleansingBarMember" name="OrganicYouthCareCleansingBarMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MitogizeMember" name="MitogizeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NoOneMEDMember" name="NoOneMEDMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_EnergetiqueMember" name="EnergetiqueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_TrimPlusMember" name="TrimPlusMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PeriodEndMYRMember" name="PeriodEndMYRMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PeriodEndHKDMember" name="PeriodEndHKDMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PeriodAverageMYRMember" name="PeriodAverageMYRMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PeriodAverageHKDMember" name="PeriodAverageHKDMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeSuperiorLivingSdnBhdMember" name="AgapeSuperiorLivingSdnBhdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ComputerAndOfficeEquipmentMember" name="ComputerAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VehicleMember" name="VehicleMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_GreenproCapitalCorpMember" name="GreenproCapitalCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DSwissIncMember" name="DSwissIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SEATechVenturesCorpMember" name="SEATechVenturesCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_UnreservedSdnBhdMember" name="UnreservedSdnBhdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PhoenixPlusCorpMember" name="PhoenixPlusCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DirectorsOfUnreservedInvestmentMember" name="DirectorsOfUnreservedInvestmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeATPAsiaLimitedMember" name="AgapeATPAsiaLimitedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HostastaySdnBhdMember" name="HostastaySdnBhdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_THThreeTechnologySdnBhdMember" name="THThreeTechnologySdnBhdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeSuperiorLivingPtyLtdMember" name="AgapeSuperiorLivingPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeSuperiorLivingPtyLtdASLPLMember" name="AgapeSuperiorLivingPtyLtdASLPLMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VettonsSdnBhdOneMember" name="VettonsSdnBhdOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HostastaySdnBhdOneMember" name="HostastaySdnBhdOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HowKokChoongMember" name="HowKokChoongMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DSYWellnessAndLongevityCenterSdnBhdMember" name="DSYWellnessAndLongevityCenterSdnBhdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeSuperiorLivingMember" name="AgapeSuperiorLivingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ShareForfeitureAgreementsMember" name="ShareForfeitureAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HowKokChoongTalentLimitedMember" name="HowKokChoongTalentLimitedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ShareholdersMember" name="ShareholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HKCHoldingsSdnBhdMember" name="HKCHoldingsSdnBhdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_LabuanMember" name="LabuanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_UnutilizedMember" name="UnutilizedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AATPHKMember" name="AATPHKMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AATPLBASLSEAWATPAndDSYMember" name="AATPLBASLSEAWATPAndDSYMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AATPLBASLSEAAndWATPMember" name="AATPLBASLSEAAndWATPMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NoCustomerMember" name="NoCustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ECommerceCompanyMember" name="ECommerceCompanyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VendorOneMember" name="VendorOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VendorTwoMember" name="VendorTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OneVendorMember" name="OneVendorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OneSalesDistributorMember" name="OneSalesDistributorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NoSalesDistributorMember" name="NoSalesDistributorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_TrainingCenterMember" name="TrainingCenterMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_COVIDNineteenImpactMember" name="COVIDNineteenImpactMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ShareForfeitureAgreementMember" name="ShareForfeitureAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" name="InvestmentInNonMarketableSecuritiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" name="VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" name="VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" name="VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_RevenueFromRelatedParty" name="RevenueFromRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PreferredStockDividendIncomeStatementImpact" name="PreferredStockDividendIncomeStatementImpact" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ContributionsFromNoncontrollingInterestShareholders" name="ContributionsFromNoncontrollingInterestShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" name="ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" name="ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" name="InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" name="SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" name="IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DisclosurePrepaymentsAndDepositsAbstract" name="DisclosurePrepaymentsAndDepositsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PrepaymentsAndDepositsTextBlock" name="PrepaymentsAndDepositsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" name="DisclosureInvestmentInMarketableSecuritiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInMarketableSecuritiesTextBlock" name="InvestmentInMarketableSecuritiesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" name="DisclosureInvestmentInNonmarketableSecuritiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInNonMarketableSecuritiesTextBlock" name="InvestmentInNonMarketableSecuritiesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PrepaidTaxesPolicyTextBlock" name="PrepaidTaxesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PrepaymentsAndDepositsPolicyTextBlock" name="PrepaymentsAndDepositsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NonMarketableSecuritiesPolicyTextBlock" name="NonMarketableSecuritiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ShippingAndHandlingPolicyTextBlock" name="ShippingAndHandlingPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DefinedContributionPlanPolicyTextBlock" name="DefinedContributionPlanPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NoncontrollingInterestPolicyTextBlock" name="NoncontrollingInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_RelatedPartiesPolicyTextBlock" name="RelatedPartiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" name="ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" name="ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" name="ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" name="ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock" name="ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NonMarketableSecuritiesTableTextBlock" name="NonMarketableSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" name="ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfNonControllingInterestTableTextBlock" name="ScheduleOfNonControllingInterestTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NameOftheCompany" name="NameOftheCompany" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PlaceAndDateOfIncorporation" name="PlaceAndDateOfIncorporation" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ParticularsOfIssuedCapital" name="ParticularsOfIssuedCapital" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PrincipalActivities" name="PrincipalActivities" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ForeignCurrencyExchangeRateAverage" name="ForeignCurrencyExchangeRateAverage" nillable="true" xbrli:periodType="duration" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" name="AllowanceForDoubtfulAccountsReceivablesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ForfeitedCouponIncome" name="ForfeitedCouponIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SalesCommissionsAndFees1" name="SalesCommissionsAndFees1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SalaryPercentage" name="SalaryPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MonthlySalary" name="MonthlySalary" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OtherPayablesRelatedPartyCurrent" name="OtherPayablesRelatedPartyCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaCostOfRevenue" name="BusinessAcquisitionsProFormaCostOfRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaGrossProfit" name="BusinessAcquisitionsProFormaGrossProfit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaOperatingExpenses" name="BusinessAcquisitionsProFormaOperatingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" name="BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" name="BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" name="BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" name="BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" name="BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PercentageOfCommonStockIssuedAndOutstanding" name="PercentageOfCommonStockIssuedAndOutstanding" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" name="AccountsReceivableAndAccountsReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ReceivablesFromSalesDistributors" name="ReceivablesFromSalesDistributors" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DepositsToSupplier" name="DepositsToSupplier" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PrepaidExpensesGross" name="PrepaidExpensesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect" name="AllowanceForDoubtfulAccountsReceivableExchangeRateEffect" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentsIncomeDividend" name="InvestmentsIncomeDividend" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss" name="MarketableSecuritiesUnrealizedHoldingGainLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" name="ExchangeRateEffectOnInvestmentInMarketableSecurites" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInNonMarketableSecuritiesGross" name="InvestmentInNonMarketableSecuritiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SaleOfInvestmentInNonmarketableSecurities" name="SaleOfInvestmentInNonmarketableSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInNonmarketableSecuritiesNet" name="InvestmentInNonmarketableSecuritiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AccruedPromotionExpenses" name="AccruedPromotionExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OtherAccountPayableAndAccruedLiabilities" name="OtherAccountPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_RelatedPartiesRelationshipsDescription" name="RelatedPartiesRelationshipsDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_RelatedPartiesNatureDescription" name="RelatedPartiesNatureDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SalesCommissionsAndFee" name="SalesCommissionsAndFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NonControllingInterestPaidinCapital" name="NonControllingInterestPaidinCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NonControllingInterestAccumulatedDeficit" name="NonControllingInterestAccumulatedDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome" name="NonControllingInterestAccumulatedOtherComprehensiveIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NonControllingInterestNonControllingInterestGross" name="NonControllingInterestNonControllingInterestGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NonControllingInterestAsl" name="NonControllingInterestAsl" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DeferredTaxLiabilitiesDepreciation" name="DeferredTaxLiabilitiesDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" name="DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DividendShareForCommonStock" name="DividendShareForCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DepositForInsurance" name="DepositForInsurance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_LeaseExpirationTerm" name="LeaseExpirationTerm" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IncreaseDecreaseInROUAssetsAndLiabilities" name="IncreaseDecreaseInROUAssetsAndLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>23
<FILENAME>aatp-20211231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://agapeatp.com/role/Cover" xlink:href="aatp-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheets" xlink:href="aatp-20211231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:href="aatp-20211231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:href="aatp-20211231.xsd#StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="aatp-20211231.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfCashFlows" xlink:href="aatp-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:href="aatp-20211231.xsd#OrganizationAndBusinessBackground" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVie" xlink:href="aatp-20211231.xsd#VariableInterestEntityVie" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusinessCombination" xlink:href="aatp-20211231.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CashAndCashEquivalents" xlink:href="aatp-20211231.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivable" xlink:href="aatp-20211231.xsd#AccountsReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Inventories" xlink:href="aatp-20211231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:href="aatp-20211231.xsd#PrepaymentsAndDeposits" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:href="aatp-20211231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNet" xlink:href="aatp-20211231.xsd#IntangibleAssetsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:href="aatp-20211231.xsd#InvestmentInMarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:href="aatp-20211231.xsd#InvestmentInNon-marketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:href="aatp-20211231.xsd#OtherPayablesAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:href="aatp-20211231.xsd#RelatedPartyBalancesAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquity" xlink:href="aatp-20211231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Non-controllingInterest" xlink:href="aatp-20211231.xsd#Non-controllingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxes" xlink:href="aatp-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:href="aatp-20211231.xsd#ConcentrationsOfRisks" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:href="aatp-20211231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEvents" xlink:href="aatp-20211231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:href="aatp-20211231.xsd#OrganizationAndBusinessBackgroundTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:href="aatp-20211231.xsd#VariableInterestEntityVieTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusinessCombinationTables" xlink:href="aatp-20211231.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivableTables" xlink:href="aatp-20211231.xsd#AccountsReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InventoriesTables" xlink:href="aatp-20211231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:href="aatp-20211231.xsd#PrepaymentsAndDepositsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:href="aatp-20211231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:href="aatp-20211231.xsd#IntangibleAssetsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:href="aatp-20211231.xsd#InvestmentInMarketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:href="aatp-20211231.xsd#InvestmentInNon-marketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:href="aatp-20211231.xsd#OtherPayablesAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:href="aatp-20211231.xsd#RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Non-controllingInterestTables" xlink:href="aatp-20211231.xsd#Non-controllingInterestTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesTables" xlink:href="aatp-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:href="aatp-20211231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfSubsidiariesAndAssociatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:href="aatp-20211231.xsd#OrganizationAndBusinessBackgroundDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="aatp-20211231.xsd#ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:href="aatp-20211231.xsd#ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:href="aatp-20211231.xsd#ScheduleOfVariableInterestEntityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:href="aatp-20211231.xsd#VariableInterestEntityVieDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="aatp-20211231.xsd#SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:href="aatp-20211231.xsd#ScheduleOfProFormaBusinessCombinationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusinessCombinationDetailsNarrative" xlink:href="aatp-20211231.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" xlink:href="aatp-20211231.xsd#CashAndCashEquivalentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:href="aatp-20211231.xsd#ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InventoriesDetailsNarrative" xlink:href="aatp-20211231.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:href="aatp-20211231.xsd#ScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="aatp-20211231.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:href="aatp-20211231.xsd#ScheduleOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:href="aatp-20211231.xsd#IntangibleAssetsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:href="aatp-20211231.xsd#InvestmentInMarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:href="aatp-20211231.xsd#InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:href="aatp-20211231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" xlink:href="aatp-20211231.xsd#ScheduleOfNonControllingInterestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:href="aatp-20211231.xsd#ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:href="aatp-20211231.xsd#ScheduleOfProvisionForIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:href="aatp-20211231.xsd#ScheduleOfEffectiveIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:href="aatp-20211231.xsd#ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:href="aatp-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:href="aatp-20211231.xsd#ConcentrationsOfRisksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfLeaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="aatp-20211231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:href="aatp-20211231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapNotesReceivableRelatedPartiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapNotesReceivableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RevenueFromRelatedParty" xlink:label="loc_AATPRevenueFromRelatedParty" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_AATPRevenueFromRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesCommissionsAndFees" xlink:label="loc_us-gaapSalesCommissionsAndFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSalesCommissionsAndFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="loc_AATPPreferredStockDividendIncomeStatementImpact" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_AATPPreferredStockDividendIncomeStatementImpact" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldAmortization" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="loc_AATPPreferredStockDividendIncomeStatementImpact" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_AATPPreferredStockDividendIncomeStatementImpact" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidTaxes" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_AATPIncreaseDecreaseInOperatingLeaseLiabilities" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_AATPIncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfInvestmentProjects" xlink:label="loc_us-gaapProceedsFromSaleOfInvestmentProjects" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfInvestmentProjects" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:title="00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVie" xlink:title="00000009 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusinessCombination" xlink:title="00000010 - Disclosure - BUSINESS COMBINATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CashAndCashEquivalents" xlink:title="00000011 - Disclosure - CASH AND CASH EQUIVALENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivable" xlink:title="00000012 - Disclosure - ACCOUNTS RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Inventories" xlink:title="00000013 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:title="00000014 - Disclosure - PREPAYMENTS AND DEPOSITS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:title="00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNet" xlink:title="00000016 - Disclosure - INTANGIBLE ASSETS, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:title="00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:title="00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:title="00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:title="00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquity" xlink:title="00000021 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Non-controllingInterest" xlink:title="00000022 - Disclosure - NON-CONTROLLING INTEREST" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:title="00000024 - Disclosure - CONCENTRATIONS OF RISKS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:title="00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEvents" xlink:title="00000026 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:title="00000028 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:title="00000030 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusinessCombinationTables" xlink:title="00000031 - Disclosure - BUSINESS COMBINATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivableTables" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InventoriesTables" xlink:title="00000033 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:title="00000034 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:title="00000035 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:title="00000036 - Disclosure - INTANGIBLE ASSETS, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:title="00000037 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:title="00000038 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:title="00000039 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:title="00000040 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Non-controllingInterestTables" xlink:title="00000041 - Disclosure - NON-CONTROLLING INTEREST (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesTables" xlink:title="00000042 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:title="00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:title="00000045 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:title="00000047 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:title="00000049 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:title="00000051 - Disclosure -  SCHEDULE OF VARIABLE INTEREST ENTITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:title="00000052 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000053 - Disclosure -  SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:title="00000054 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusinessCombinationDetailsNarrative" xlink:title="00000055 - Disclosure - BUSINESS COMBINATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="00000056 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:title="00000057 - Disclosure -  SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:label="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="loc_us-gaapAccountsReceivableGrossCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="loc_us-gaapAccountsReceivableGrossCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:title="00000058 - Disclosure -  SCHEDULE OF INVENTORIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InventoriesDetailsNarrative" xlink:title="00000059 - Disclosure - INVENTORIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:title="00000060 - Disclosure -  SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrepaidExpensesGross" xlink:label="loc_AATPPrepaidExpensesGross" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ReceivablesFromSalesDistributors" xlink:label="loc_AATPReceivablesFromSalesDistributors" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPPrepaidExpensesGross" xlink:to="loc_AATPReceivablesFromSalesDistributors" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DepositsToSupplier" xlink:label="loc_AATPDepositsToSupplier" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPPrepaidExpensesGross" xlink:to="loc_AATPDepositsToSupplier" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_AATPPrepaidExpensesGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" xlink:title="00000061 - Disclosure - SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:title="00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000063 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:title="00000064 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:title="00000065 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:title="00000066 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentsIncomeDividend" xlink:label="loc_AATPInvestmentsIncomeDividend" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:to="loc_AATPInvestmentsIncomeDividend" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MarketableSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_AATPMarketableSecuritiesUnrealizedHoldingGainLoss" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:to="loc_AATPMarketableSecuritiesUnrealizedHoldingGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:label="loc_AATPExchangeRateEffectOnInvestmentInMarketableSecurites" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:to="loc_AATPExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:title="00000067 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:title="00000068 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:title="00000069 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:title="00000070 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:title="00000071 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000072 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" xlink:title="00000073 - Disclosure - SCHEDULE OF NON CONTROLLING INTEREST (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:title="00000074 - Disclosure -  SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:title="00000075 - Disclosure -  SCHEDULE OF PROVISION FOR INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:title="00000076 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:title="00000077 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000078 - Disclosure -  SCHEDULE OF DEFERRED TAX ASSETS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000079 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:title="00000080 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:title="00000081 - Disclosure -  SCHEDULE OF LEASE COMMITMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000082 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000083 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>24
<FILENAME>aatp-20211231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://agapeatp.com/role/Cover" xlink:href="aatp-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheets" xlink:href="aatp-20211231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:href="aatp-20211231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:href="aatp-20211231.xsd#StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="aatp-20211231.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfCashFlows" xlink:href="aatp-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:href="aatp-20211231.xsd#OrganizationAndBusinessBackground" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVie" xlink:href="aatp-20211231.xsd#VariableInterestEntityVie" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusinessCombination" xlink:href="aatp-20211231.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CashAndCashEquivalents" xlink:href="aatp-20211231.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivable" xlink:href="aatp-20211231.xsd#AccountsReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Inventories" xlink:href="aatp-20211231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:href="aatp-20211231.xsd#PrepaymentsAndDeposits" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:href="aatp-20211231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNet" xlink:href="aatp-20211231.xsd#IntangibleAssetsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:href="aatp-20211231.xsd#InvestmentInMarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:href="aatp-20211231.xsd#InvestmentInNon-marketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:href="aatp-20211231.xsd#OtherPayablesAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:href="aatp-20211231.xsd#RelatedPartyBalancesAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquity" xlink:href="aatp-20211231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Non-controllingInterest" xlink:href="aatp-20211231.xsd#Non-controllingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxes" xlink:href="aatp-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:href="aatp-20211231.xsd#ConcentrationsOfRisks" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:href="aatp-20211231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEvents" xlink:href="aatp-20211231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:href="aatp-20211231.xsd#OrganizationAndBusinessBackgroundTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:href="aatp-20211231.xsd#VariableInterestEntityVieTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusinessCombinationTables" xlink:href="aatp-20211231.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivableTables" xlink:href="aatp-20211231.xsd#AccountsReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InventoriesTables" xlink:href="aatp-20211231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:href="aatp-20211231.xsd#PrepaymentsAndDepositsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:href="aatp-20211231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:href="aatp-20211231.xsd#IntangibleAssetsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:href="aatp-20211231.xsd#InvestmentInMarketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:href="aatp-20211231.xsd#InvestmentInNon-marketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:href="aatp-20211231.xsd#OtherPayablesAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:href="aatp-20211231.xsd#RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Non-controllingInterestTables" xlink:href="aatp-20211231.xsd#Non-controllingInterestTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesTables" xlink:href="aatp-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:href="aatp-20211231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfSubsidiariesAndAssociatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:href="aatp-20211231.xsd#OrganizationAndBusinessBackgroundDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="aatp-20211231.xsd#ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:href="aatp-20211231.xsd#ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:href="aatp-20211231.xsd#ScheduleOfVariableInterestEntityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:href="aatp-20211231.xsd#VariableInterestEntityVieDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="aatp-20211231.xsd#SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:href="aatp-20211231.xsd#ScheduleOfProFormaBusinessCombinationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusinessCombinationDetailsNarrative" xlink:href="aatp-20211231.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" xlink:href="aatp-20211231.xsd#CashAndCashEquivalentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:href="aatp-20211231.xsd#ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InventoriesDetailsNarrative" xlink:href="aatp-20211231.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:href="aatp-20211231.xsd#ScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="aatp-20211231.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:href="aatp-20211231.xsd#ScheduleOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:href="aatp-20211231.xsd#IntangibleAssetsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:href="aatp-20211231.xsd#InvestmentInMarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:href="aatp-20211231.xsd#InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:href="aatp-20211231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" xlink:href="aatp-20211231.xsd#ScheduleOfNonControllingInterestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:href="aatp-20211231.xsd#ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:href="aatp-20211231.xsd#ScheduleOfProvisionForIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:href="aatp-20211231.xsd#ScheduleOfEffectiveIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:href="aatp-20211231.xsd#ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:href="aatp-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:href="aatp-20211231.xsd#ConcentrationsOfRisksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfLeaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="aatp-20211231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:href="aatp-20211231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ContributionsFromNoncontrollingInterestShareholders" xlink:label="loc_AATPContributionsFromNoncontrollingInterestShareholders_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPContributionsFromNoncontrollingInterestShareholders_70" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:title="00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVie" xlink:title="00000009 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusinessCombination" xlink:title="00000010 - Disclosure - BUSINESS COMBINATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CashAndCashEquivalents" xlink:title="00000011 - Disclosure - CASH AND CASH EQUIVALENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivable" xlink:title="00000012 - Disclosure - ACCOUNTS RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Inventories" xlink:title="00000013 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:title="00000014 - Disclosure - PREPAYMENTS AND DEPOSITS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:title="00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNet" xlink:title="00000016 - Disclosure - INTANGIBLE ASSETS, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:title="00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:title="00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:title="00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:title="00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquity" xlink:title="00000021 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Non-controllingInterest" xlink:title="00000022 - Disclosure - NON-CONTROLLING INTEREST" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:title="00000024 - Disclosure - CONCENTRATIONS OF RISKS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:title="00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEvents" xlink:title="00000026 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:title="00000028 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:title="00000030 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusinessCombinationTables" xlink:title="00000031 - Disclosure - BUSINESS COMBINATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivableTables" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InventoriesTables" xlink:title="00000033 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:title="00000034 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:title="00000035 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:title="00000036 - Disclosure - INTANGIBLE ASSETS, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:title="00000037 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:title="00000038 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:title="00000039 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:title="00000040 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Non-controllingInterestTables" xlink:title="00000041 - Disclosure - NON-CONTROLLING INTEREST (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesTables" xlink:title="00000042 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:title="00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyMember" xlink:label="loc_AATPSubsidiaryCompanyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyOneMember" xlink:label="loc_AATPSubsidiaryCompanyOneMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyOneMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="loc_AATPSubsidiaryCompanyTwoMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyTwoMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="loc_AATPSubsidiaryCompanyThreeMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyThreeMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyFourMember" xlink:label="loc_AATPSubsidiaryCompanyFourMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyFourMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyFiveMember" xlink:label="loc_AATPSubsidiaryCompanyFiveMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyFiveMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NameOftheCompany" xlink:label="loc_AATPNameOftheCompany_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPNameOftheCompany_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PlaceAndDateOfIncorporation" xlink:label="loc_AATPPlaceAndDateOfIncorporation_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPPlaceAndDateOfIncorporation_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ParticularsOfIssuedCapital" xlink:label="loc_AATPParticularsOfIssuedCapital_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPParticularsOfIssuedCapital_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrincipalActivities" xlink:label="loc_AATPPrincipalActivities_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPPrincipalActivities_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:title="00000045 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeATPInternationalHoldingLimitedMember" xlink:label="loc_AATPAgapeATPInternationalHoldingLimitedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAgapeATPInternationalHoldingLimitedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="loc_AATPSubsidiaryCompanyTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyTwoMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyFiveMember" xlink:label="loc_AATPSubsidiaryCompanyFiveMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyFiveMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="loc_AATPShareExchangeAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareExchangeAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_70" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:title="00000047 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaapComputerSoftwareIntangibleAssetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapComputerSoftwareIntangibleAssetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SurvivorSelectMember" xlink:label="loc_AATPSurvivorSelectMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPSurvivorSelectMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EnergizedMineralConcentrateMember" xlink:label="loc_AATPEnergizedMineralConcentrateMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPEnergizedMineralConcentrateMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IonizedCalMagMember" xlink:label="loc_AATPIonizedCalMagMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPIonizedCalMagMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OmegaBlendMember" xlink:label="loc_AATPOmegaBlendMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPOmegaBlendMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BetaMaxxMember" xlink:label="loc_AATPBetaMaxxMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPBetaMaxxMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VegeFruitFiberMember" xlink:label="loc_AATPVegeFruitFiberMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPVegeFruitFiberMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IronMember" xlink:label="loc_AATPIronMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPIronMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_YoungFormulaMember" xlink:label="loc_AATPYoungFormulaMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPYoungFormulaMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OrganicYouthCareCleansingBarMember" xlink:label="loc_AATPOrganicYouthCareCleansingBarMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPOrganicYouthCareCleansingBarMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MitogizeMember" xlink:label="loc_AATPMitogizeMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPMitogizeMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoOneMEDMember" xlink:label="loc_AATPNoOneMEDMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPNoOneMEDMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EnergetiqueMember" xlink:label="loc_AATPEnergetiqueMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPEnergetiqueMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_TrimPlusMember" xlink:label="loc_AATPTrimPlusMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPTrimPlusMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HealthAndWellnessServicesMember" xlink:label="loc_AATPHealthAndWellnessServicesMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPHealthAndWellnessServicesMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenues_330" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:title="00000049 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaapVariableRateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapVariableRateAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodEndMYRMember" xlink:label="loc_AATPPeriodEndMYRMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodEndMYRMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodEndHKDMember" xlink:label="loc_AATPPeriodEndHKDMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodEndHKDMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodAverageMYRMember" xlink:label="loc_AATPPeriodAverageMYRMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodAverageMYRMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodAverageHKDMember" xlink:label="loc_AATPPeriodAverageHKDMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodAverageHKDMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateTranslation1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapForeignCurrencyExchangeRateTranslation1_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ForeignCurrencyExchangeRateAverage" xlink:label="loc_AATPForeignCurrencyExchangeRateAverage_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_AATPForeignCurrencyExchangeRateAverage_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HealthAndWellnessProductsMember" xlink:label="loc_AATPHealthAndWellnessProductsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPHealthAndWellnessProductsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HealthAndWellnessServicesMember" xlink:label="loc_AATPHealthAndWellnessServicesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPHealthAndWellnessServicesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SocialSecurityOrganizationMember" xlink:label="loc_AATPSocialSecurityOrganizationMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPSocialSecurityOrganizationMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EmployeesProvidentFundMember" xlink:label="loc_AATPEmployeesProvidentFundMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPEmployeesProvidentFundMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EmploymentInsuranceSystemMember" xlink:label="loc_AATPEmploymentInsuranceSystemMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPEmploymentInsuranceSystemMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HumanResourceDevelopmentFundMember" xlink:label="loc_AATPHumanResourceDevelopmentFundMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPHumanResourceDevelopmentFundMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MYRCurrencyMember" xlink:label="loc_AATPMYRCurrencyMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_AATPMYRCurrencyMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapInventoryWriteDown_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:label="loc_AATPAllowanceForDoubtfulAccountsReceivablesCurrent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPAllowanceForDoubtfulAccountsReceivablesCurrent_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ForfeitedCouponIncome" xlink:label="loc_AATPForfeitedCouponIncome_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPForfeitedCouponIncome_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSellingExpense_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SalesCommissionsAndFees1" xlink:label="loc_AATPSalesCommissionsAndFees1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPSalesCommissionsAndFees1_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaapDefinedContributionPlanEmployerDiscretionaryContributionAmount_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDefinedContributionPlanEmployerDiscretionaryContributionAmount_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SalaryPercentage" xlink:label="loc_AATPSalaryPercentage_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPSalaryPercentage_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MonthlySalary" xlink:label="loc_AATPMonthlySalary_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPMonthlySalary_160" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement_160" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense_160" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDescription" xlink:label="loc_us-gaapMinorityInterestDescription_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterestDescription_160" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_160" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:title="00000051 - Disclosure -  SCHEDULE OF VARIABLE INTEREST ENTITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivityGainsAndLossesLineItems" xlink:label="loc_us-gaapTradingActivityGainsAndLossesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivitiesGainLossByTypeTable" xlink:label="loc_us-gaapTradingActivitiesGainLossByTypeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapTradingActivitiesGainLossByTypeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivityByTypeAxis" xlink:label="loc_us-gaapTradingActivityByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapTradingActivitiesGainLossByTypeTable" xlink:to="loc_us-gaapTradingActivityByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivityByTypeDomain" xlink:label="loc_us-gaapTradingActivityByTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTradingActivityByTypeAxis" xlink:to="loc_us-gaapTradingActivityByTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivityByTypeDomain" xlink:label="loc_us-gaapTradingActivityByTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTradingActivityByTypeAxis" xlink:to="loc_us-gaapTradingActivityByTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableIncomeInterestRateMember" xlink:label="loc_us-gaapVariableIncomeInterestRateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityByTypeDomain" xlink:to="loc_us-gaapVariableIncomeInterestRateMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapAssetsCurrent_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapPrepaidTaxes_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OtherPayablesRelatedPartyCurrent" xlink:label="loc_AATPOtherPayablesRelatedPartyCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_AATPOtherPayablesRelatedPartyCurrent_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapGrossProfit_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:title="00000052 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="loc_AATPSubsidiaryCompanyThreeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyThreeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000053 - Disclosure -  SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:title="00000054 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusinessCombinationDetailsNarrative" xlink:title="00000055 - Disclosure - BUSINESS COMBINATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="loc_AATPShareExchangeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareExchangeAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingSdnBhdMember" xlink:label="loc_AATPAgapeSuperiorLivingSdnBhdMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingSdnBhdMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPMrHowKokChoongMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaapCommonStockNoParValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockNoParValue_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:label="loc_AATPPercentageOfCommonStockIssuedAndOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_AATPPercentageOfCommonStockIssuedAndOutstanding_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="00000056 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimeDeposits" xlink:label="loc_us-gaapTimeDeposits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTimeDeposits_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:label="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:title="00000057 - Disclosure -  SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:title="00000058 - Disclosure -  SCHEDULE OF INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InventoriesDetailsNarrative" xlink:title="00000059 - Disclosure - INVENTORIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:title="00000060 - Disclosure -  SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" xlink:title="00000061 - Disclosure - SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:title="00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ComputerAndOfficeEquipmentMember" xlink:label="loc_AATPComputerAndOfficeEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPComputerAndOfficeEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VehicleMember" xlink:label="loc_AATPVehicleMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPVehicleMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000063 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:title="00000064 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:title="00000065 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:title="00000066 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:title="00000067 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_GreenproCapitalCorpMember" xlink:label="loc_AATPGreenproCapitalCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPGreenproCapitalCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DSwissIncMember" xlink:label="loc_AATPDSwissIncMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPDSwissIncMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SEATechVenturesCorpMember" xlink:label="loc_AATPSEATechVenturesCorpMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPSEATechVenturesCorpMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:title="00000068 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DirectorsOfUnreservedInvestmentMember" xlink:label="loc_AATPDirectorsOfUnreservedInvestmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPDirectorsOfUnreservedInvestmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="loc_AATPPhoenixPlusCorpMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPPhoenixPlusCorpMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesGross" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesGross_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesGross_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:label="loc_AATPSaleOfInvestmentInNonmarketableSecurities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_AATPSaleOfInvestmentInNonmarketableSecurities_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonmarketableSecuritiesNet" xlink:label="loc_AATPInvestmentInNonmarketableSecuritiesNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonmarketableSecuritiesNet_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:title="00000069 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_UnreservedSdnBhdMember" xlink:label="loc_AATPUnreservedSdnBhdMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPUnreservedSdnBhdMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="loc_AATPPhoenixPlusCorpMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPPhoenixPlusCorpMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:label="loc_us-gaapDueFromOfficersOrStockholdersCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueFromOfficersOrStockholdersCurrent_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_110" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:title="00000070 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:title="00000071 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeATPAsiaLimitedMember" xlink:label="loc_AATPAgapeATPAsiaLimitedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeATPAsiaLimitedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HostastaySdnBhdMember" xlink:label="loc_AATPHostastaySdnBhdMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHostastaySdnBhdMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_THThreeTechnologySdnBhdMember" xlink:label="loc_AATPTHThreeTechnologySdnBhdMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPTHThreeTechnologySdnBhdMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingPtyLtdMember" xlink:label="loc_AATPAgapeSuperiorLivingPtyLtdMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingPtyLtdMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:label="loc_AATPAgapeSuperiorLivingPtyLtdASLPLMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingPtyLtdASLPLMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VettonsSdnBhdOneMember" xlink:label="loc_AATPVettonsSdnBhdOneMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPVettonsSdnBhdOneMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HostastaySdnBhdOneMember" xlink:label="loc_AATPHostastaySdnBhdOneMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHostastaySdnBhdOneMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HowKokChoongMember" xlink:label="loc_AATPHowKokChoongMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHowKokChoongMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DSYWellnessAndLongevityCenterSdnBhdMember" xlink:label="loc_AATPDSYWellnessAndLongevityCenterSdnBhdMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPDSYWellnessAndLongevityCenterSdnBhdMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RelatedPartiesRelationshipsDescription" xlink:label="loc_AATPRelatedPartiesRelationshipsDescription_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPRelatedPartiesRelationshipsDescription_370" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RelatedPartiesNatureDescription" xlink:label="loc_AATPRelatedPartiesNatureDescription_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPRelatedPartiesNatureDescription_370" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="loc_us-gaapDueFromRelatedParties_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueFromRelatedParties_370" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_370" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRevenueFromRelatedParties_370" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty_370" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SalesCommissionsAndFee" xlink:label="loc_AATPSalesCommissionsAndFee_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPSalesCommissionsAndFee_370" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherIncome_370" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000072 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="loc_AATPAgapeSuperiorLivingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_AATPAgapeSuperiorLivingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareForfeitureAgreementsMember" xlink:label="loc_AATPShareForfeitureAgreementsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareForfeitureAgreementsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HowKokChoongTalentLimitedMember" xlink:label="loc_AATPHowKokChoongTalentLimitedMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHowKokChoongTalentLimitedMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HKCHoldingsSdnBhdMember" xlink:label="loc_AATPHKCHoldingsSdnBhdMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHKCHoldingsSdnBhdMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareholdersMember" xlink:label="loc_AATPShareholdersMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPShareholdersMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_130" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" xlink:title="00000073 - Disclosure - SCHEDULE OF NON CONTROLLING INTEREST (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:title="00000074 - Disclosure -  SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY" xlink:label="loc_countryMY_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_HK" xlink:label="loc_countryHK_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryHK_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:title="00000075 - Disclosure -  SCHEDULE OF PROVISION FOR INCOME TAX (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:title="00000076 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:title="00000077 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AATPHKMember" xlink:label="loc_AATPAATPHKMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAATPHKMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AATPLBASLSEAWATPAndDSYMember" xlink:label="loc_AATPAATPLBASLSEAWATPAndDSYMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAATPLBASLSEAWATPAndDSYMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AATPLBASLSEAAndWATPMember" xlink:label="loc_AATPAATPLBASLSEAAndWATPMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAATPLBASLSEAAndWATPMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense_60" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000078 - Disclosure -  SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY" xlink:label="loc_countryMY_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_AATPDeferredTaxLiabilitiesDepreciation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPDeferredTaxLiabilitiesDepreciation_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000079 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_LabuanMember" xlink:label="loc_AATPLabuanMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_AATPLabuanMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY" xlink:label="loc_countryMY_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_HK" xlink:label="loc_countryHK_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryHK_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_UnutilizedMember" xlink:label="loc_AATPUnutilizedMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_AATPUnutilizedMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:label="loc_us-gaapTaxCutsAndJobsActOf2017OtherTaxEffectDescription_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapTaxCutsAndJobsActOf2017OtherTaxEffectDescription_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" xlink:label="loc_AATPDeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_AATPDeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription_160" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:title="00000080 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoCustomerMember" xlink:label="loc_AATPNoCustomerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPNoCustomerMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VendorOneMember" xlink:label="loc_AATPVendorOneMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPVendorOneMember_20" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VendorTwoMember" xlink:label="loc_AATPVendorTwoMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPVendorTwoMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OneVendorMember" xlink:label="loc_AATPOneVendorMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPOneVendorMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OneSalesDistributorMember" xlink:label="loc_AATPOneSalesDistributorMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPOneSalesDistributorMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoSalesDistributorMember" xlink:label="loc_AATPNoSalesDistributorMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPNoSalesDistributorMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsTotalMember" xlink:label="loc_us-gaapCostOfGoodsTotalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapCostOfGoodsTotalMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsPayableMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaapSupplierConcentrationRiskMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSupplierConcentrationRiskMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ECommerceCompanyMember" xlink:label="loc_AATPECommerceCompanyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPECommerceCompanyMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DSwissIncMember" xlink:label="loc_AATPDSwissIncMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPDSwissIncMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DividendShareForCommonStock" xlink:label="loc_AATPDividendShareForCommonStock_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_AATPDividendShareForCommonStock_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Deposits" xlink:label="loc_us-gaapDeposits_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapDeposits_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DepositForInsurance" xlink:label="loc_AATPDepositForInsurance_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_AATPDepositForInsurance_170" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:title="00000081 - Disclosure -  SCHEDULE OF LEASE COMMITMENTS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000082 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="loc_AATPAgapeSuperiorLivingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_AATPAgapeSuperiorLivingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_TrainingCenterMember" xlink:label="loc_AATPTrainingCenterMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPTrainingCenterMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:label="loc_us-gaapUnusualRiskOrUncertaintyByNatureAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapUnusualRiskOrUncertaintyByNatureAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:label="loc_us-gaapUnusualRiskOrUncertaintyNatureDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapUnusualRiskOrUncertaintyByNatureAxis" xlink:to="loc_us-gaapUnusualRiskOrUncertaintyNatureDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:label="loc_us-gaapUnusualRiskOrUncertaintyNatureDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapUnusualRiskOrUncertaintyByNatureAxis" xlink:to="loc_us-gaapUnusualRiskOrUncertaintyNatureDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_COVIDNineteenImpactMember" xlink:label="loc_AATPCOVIDNineteenImpactMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapUnusualRiskOrUncertaintyNatureDomain" xlink:to="loc_AATPCOVIDNineteenImpactMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_LeaseExpirationTerm" xlink:label="loc_AATPLeaseExpirationTerm_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_AATPLeaseExpirationTerm_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IncreaseDecreaseInROUAssetsAndLiabilities" xlink:label="loc_AATPIncreaseDecreaseInROUAssetsAndLiabilities_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_AATPIncreaseDecreaseInROUAssetsAndLiabilities_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyImpact" xlink:label="loc_us-gaapUnusualRiskOrUncertaintyImpact_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapUnusualRiskOrUncertaintyImpact_100" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000083 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareForfeitureAgreementMember" xlink:label="loc_AATPShareForfeitureAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareForfeitureAgreementMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited_20" xlink:type="arc" order="0" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>25
<FILENAME>aatp-20211231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeATPInternationalHoldingLimitedMember" xlink:label="AATP_AgapeATPInternationalHoldingLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeATPInternationalHoldingLimitedMember" xlink:to="AATP_AgapeATPInternationalHoldingLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeATPInternationalHoldingLimitedMember_lbl" xml:lang="en-US">Agape ATP International Holding Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="AATP_ShareExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareExchangeAgreementMember" xlink:to="AATP_ShareExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ShareExchangeAgreementMember_lbl" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="AATP_MrHowKokChoongMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MrHowKokChoongMember" xlink:to="AATP_MrHowKokChoongMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MrHowKokChoongMember_lbl" xml:lang="en-US">Mr.How Kok Choong [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="AATP_SubsidiaryCompanyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyTwoMember" xlink:to="AATP_SubsidiaryCompanyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyTwoMember_lbl" xml:lang="en-US">Subsidiary Company Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyFiveMember" xlink:label="AATP_SubsidiaryCompanyFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyFiveMember" xlink:to="AATP_SubsidiaryCompanyFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyFiveMember_lbl" xml:lang="en-US">Subsidiary Company Five [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyMember" xlink:label="AATP_SubsidiaryCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyMember" xlink:to="AATP_SubsidiaryCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyMember_lbl" xml:lang="en-US">Subsidiary Company [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyOneMember" xlink:label="AATP_SubsidiaryCompanyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyOneMember" xlink:to="AATP_SubsidiaryCompanyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyOneMember_lbl" xml:lang="en-US">Subsidiary Company One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="AATP_SubsidiaryCompanyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyThreeMember" xlink:to="AATP_SubsidiaryCompanyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyThreeMember_lbl" xml:lang="en-US">Subsidiary Company Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyFourMember" xlink:label="AATP_SubsidiaryCompanyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyFourMember" xlink:to="AATP_SubsidiaryCompanyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyFourMember_lbl" xml:lang="en-US">Subsidiary Company Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HealthAndWellnessProductsMember" xlink:label="AATP_HealthAndWellnessProductsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HealthAndWellnessProductsMember" xlink:to="AATP_HealthAndWellnessProductsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HealthAndWellnessProductsMember_lbl" xml:lang="en-US">Health and Wellness Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HealthAndWellnessServicesMember" xlink:label="AATP_HealthAndWellnessServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HealthAndWellnessServicesMember" xlink:to="AATP_HealthAndWellnessServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HealthAndWellnessServicesMember_lbl" xml:lang="en-US">Health And Wellness Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="us-gaap_ShippingAndHandlingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingMember" xlink:to="us-gaap_ShippingAndHandlingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingMember_lbl" xml:lang="en-US">Shipping and Handling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SocialSecurityOrganizationMember" xlink:label="AATP_SocialSecurityOrganizationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SocialSecurityOrganizationMember" xlink:to="AATP_SocialSecurityOrganizationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SocialSecurityOrganizationMember_lbl" xml:lang="en-US">Social Security Organization [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MYRCurrencyMember" xlink:label="AATP_MYRCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MYRCurrencyMember" xlink:to="AATP_MYRCurrencyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MYRCurrencyMember_lbl" xml:lang="en-US">MYR Currency [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EmployeesProvidentFundMember" xlink:label="AATP_EmployeesProvidentFundMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EmployeesProvidentFundMember" xlink:to="AATP_EmployeesProvidentFundMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_EmployeesProvidentFundMember_lbl" xml:lang="en-US">Employees Provident Fund [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EmploymentInsuranceSystemMember" xlink:label="AATP_EmploymentInsuranceSystemMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EmploymentInsuranceSystemMember" xlink:to="AATP_EmploymentInsuranceSystemMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_EmploymentInsuranceSystemMember_lbl" xml:lang="en-US">Employment Insurance System [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HumanResourceDevelopmentFundMember" xlink:label="AATP_HumanResourceDevelopmentFundMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HumanResourceDevelopmentFundMember" xlink:to="AATP_HumanResourceDevelopmentFundMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HumanResourceDevelopmentFundMember_lbl" xml:lang="en-US">Human Resource Development Fund [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SurvivorSelectMember" xlink:label="AATP_SurvivorSelectMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SurvivorSelectMember" xlink:to="AATP_SurvivorSelectMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SurvivorSelectMember_lbl" xml:lang="en-US">Survivor Select [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EnergizedMineralConcentrateMember" xlink:label="AATP_EnergizedMineralConcentrateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EnergizedMineralConcentrateMember" xlink:to="AATP_EnergizedMineralConcentrateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_EnergizedMineralConcentrateMember_lbl" xml:lang="en-US">Energized Mineral Concentrate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IonizedCalMagMember" xlink:label="AATP_IonizedCalMagMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IonizedCalMagMember" xlink:to="AATP_IonizedCalMagMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IonizedCalMagMember_lbl" xml:lang="en-US">Ionized Cal-Mag [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OmegaBlendMember" xlink:label="AATP_OmegaBlendMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OmegaBlendMember" xlink:to="AATP_OmegaBlendMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OmegaBlendMember_lbl" xml:lang="en-US">Omega Blend [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BetaMaxxMember" xlink:label="AATP_BetaMaxxMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BetaMaxxMember" xlink:to="AATP_BetaMaxxMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BetaMaxxMember_lbl" xml:lang="en-US">Beta Maxx [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VegeFruitFiberMember" xlink:label="AATP_VegeFruitFiberMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VegeFruitFiberMember" xlink:to="AATP_VegeFruitFiberMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VegeFruitFiberMember_lbl" xml:lang="en-US">Vege Fruit Fiber [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IronMember" xlink:label="AATP_IronMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IronMember" xlink:to="AATP_IronMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IronMember_lbl" xml:lang="en-US">Iron [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_YoungFormulaMember" xlink:label="AATP_YoungFormulaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_YoungFormulaMember" xlink:to="AATP_YoungFormulaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_YoungFormulaMember_lbl" xml:lang="en-US">Young Formula [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OrganicYouthCareCleansingBarMember" xlink:label="AATP_OrganicYouthCareCleansingBarMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OrganicYouthCareCleansingBarMember" xlink:to="AATP_OrganicYouthCareCleansingBarMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OrganicYouthCareCleansingBarMember_lbl" xml:lang="en-US">Organic Youth Care Cleansing Bar [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MitogizeMember" xlink:label="AATP_MitogizeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MitogizeMember" xlink:to="AATP_MitogizeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MitogizeMember_lbl" xml:lang="en-US">Mitogize [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoOneMEDMember" xlink:label="AATP_NoOneMEDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoOneMEDMember" xlink:to="AATP_NoOneMEDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NoOneMEDMember_lbl" xml:lang="en-US">No. 1 MED [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EnergetiqueMember" xlink:label="AATP_EnergetiqueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EnergetiqueMember" xlink:to="AATP_EnergetiqueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_EnergetiqueMember_lbl" xml:lang="en-US">Energetique [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_TrimPlusMember" xlink:label="AATP_TrimPlusMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_TrimPlusMember" xlink:to="AATP_TrimPlusMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_TrimPlusMember_lbl" xml:lang="en-US">Trim Plus [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductMember_lbl" xml:lang="en-US">Product [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US">Variable Rate [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodEndMYRMember" xlink:label="AATP_PeriodEndMYRMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodEndMYRMember" xlink:to="AATP_PeriodEndMYRMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PeriodEndMYRMember_lbl" xml:lang="en-US">Period-end MYR [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodEndHKDMember" xlink:label="AATP_PeriodEndHKDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodEndHKDMember" xlink:to="AATP_PeriodEndHKDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PeriodEndHKDMember_lbl" xml:lang="en-US">Period-end HKD [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodAverageMYRMember" xlink:label="AATP_PeriodAverageMYRMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodAverageMYRMember" xlink:to="AATP_PeriodAverageMYRMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PeriodAverageMYRMember_lbl" xml:lang="en-US">Period-average MYR [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodAverageHKDMember" xlink:label="AATP_PeriodAverageHKDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodAverageHKDMember" xlink:to="AATP_PeriodAverageHKDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PeriodAverageHKDMember_lbl" xml:lang="en-US">Period-average HKD [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivityByTypeAxis" xlink:label="us-gaap_TradingActivityByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingActivityByTypeAxis" xlink:to="us-gaap_TradingActivityByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingActivityByTypeAxis_lbl" xml:lang="en-US">Trading Activity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableIncomeInterestRateMember" xlink:label="us-gaap_VariableIncomeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableIncomeInterestRateMember" xlink:to="us-gaap_VariableIncomeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableIncomeInterestRateMember_lbl" xml:lang="en-US">Variable Income Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingSdnBhdMember" xlink:label="AATP_AgapeSuperiorLivingSdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingSdnBhdMember" xlink:to="AATP_AgapeSuperiorLivingSdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeSuperiorLivingSdnBhdMember_lbl" xml:lang="en-US">Agape Superior Living Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ComputerAndOfficeEquipmentMember" xlink:label="AATP_ComputerAndOfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ComputerAndOfficeEquipmentMember" xlink:to="AATP_ComputerAndOfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ComputerAndOfficeEquipmentMember_lbl" xml:lang="en-US">Computer And Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VehicleMember" xlink:label="AATP_VehicleMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VehicleMember" xlink:to="AATP_VehicleMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VehicleMember_lbl" xml:lang="en-US">Vehicle [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_GreenproCapitalCorpMember" xlink:label="AATP_GreenproCapitalCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_GreenproCapitalCorpMember" xlink:to="AATP_GreenproCapitalCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_GreenproCapitalCorpMember_lbl" xml:lang="en-US">Greenpro Capital Corp. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DSwissIncMember" xlink:label="AATP_DSwissIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DSwissIncMember" xlink:to="AATP_DSwissIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DSwissIncMember_lbl" xml:lang="en-US">DSwiss Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SEATechVenturesCorpMember" xlink:label="AATP_SEATechVenturesCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SEATechVenturesCorpMember" xlink:to="AATP_SEATechVenturesCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SEATechVenturesCorpMember_lbl" xml:lang="en-US">SEATech Ventures Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_UnreservedSdnBhdMember" xlink:label="AATP_UnreservedSdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_UnreservedSdnBhdMember" xlink:to="AATP_UnreservedSdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_UnreservedSdnBhdMember_lbl" xml:lang="en-US">Unreserved Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="AATP_PhoenixPlusCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PhoenixPlusCorpMember" xlink:to="AATP_PhoenixPlusCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PhoenixPlusCorpMember_lbl" xml:lang="en-US">Phoenix Plus Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DirectorsOfUnreservedInvestmentMember" xlink:label="AATP_DirectorsOfUnreservedInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DirectorsOfUnreservedInvestmentMember" xlink:to="AATP_DirectorsOfUnreservedInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DirectorsOfUnreservedInvestmentMember_lbl" xml:lang="en-US">Directors of Unreserved Investments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeATPAsiaLimitedMember" xlink:label="AATP_AgapeATPAsiaLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeATPAsiaLimitedMember" xlink:to="AATP_AgapeATPAsiaLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeATPAsiaLimitedMember_lbl" xml:lang="en-US">Agape ATP Asia Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HostastaySdnBhdMember" xlink:label="AATP_HostastaySdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HostastaySdnBhdMember" xlink:to="AATP_HostastaySdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HostastaySdnBhdMember_lbl" xml:lang="en-US">Hostastay Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_THThreeTechnologySdnBhdMember" xlink:label="AATP_THThreeTechnologySdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_THThreeTechnologySdnBhdMember" xlink:to="AATP_THThreeTechnologySdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_THThreeTechnologySdnBhdMember_lbl" xml:lang="en-US">TH3 Technology Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingPtyLtdMember" xlink:label="AATP_AgapeSuperiorLivingPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingPtyLtdMember" xlink:to="AATP_AgapeSuperiorLivingPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeSuperiorLivingPtyLtdMember_lbl" xml:lang="en-US">Agape Superior Living Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:label="AATP_AgapeSuperiorLivingPtyLtdASLPLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:to="AATP_AgapeSuperiorLivingPtyLtdASLPLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeSuperiorLivingPtyLtdASLPLMember_lbl" xml:lang="en-US">Agape Superior Living Pty Ltd ASLPL [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VettonsSdnBhdOneMember" xlink:label="AATP_VettonsSdnBhdOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VettonsSdnBhdOneMember" xlink:to="AATP_VettonsSdnBhdOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VettonsSdnBhdOneMember_lbl" xml:lang="en-US">Vettons Sdn Bhd One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HostastaySdnBhdOneMember" xlink:label="AATP_HostastaySdnBhdOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HostastaySdnBhdOneMember" xlink:to="AATP_HostastaySdnBhdOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HostastaySdnBhdOneMember_lbl" xml:lang="en-US">Hostastay Sdn. Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HowKokChoongMember" xlink:label="AATP_HowKokChoongMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HowKokChoongMember" xlink:to="AATP_HowKokChoongMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HowKokChoongMember_lbl" xml:lang="en-US">How Kok Choong [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DSYWellnessAndLongevityCenterSdnBhdMember" xlink:label="AATP_DSYWellnessAndLongevityCenterSdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DSYWellnessAndLongevityCenterSdnBhdMember" xlink:to="AATP_DSYWellnessAndLongevityCenterSdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DSYWellnessAndLongevityCenterSdnBhdMember_lbl" xml:lang="en-US">DSY Wellness &amp; Longevity Center Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="AATP_AgapeSuperiorLivingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingMember" xlink:to="AATP_AgapeSuperiorLivingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeSuperiorLivingMember_lbl" xml:lang="en-US">ASL [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareForfeitureAgreementsMember" xlink:label="AATP_ShareForfeitureAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareForfeitureAgreementsMember" xlink:to="AATP_ShareForfeitureAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ShareForfeitureAgreementsMember_lbl" xml:lang="en-US">Share Forfeiture Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HowKokChoongTalentLimitedMember" xlink:label="AATP_HowKokChoongTalentLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HowKokChoongTalentLimitedMember" xlink:to="AATP_HowKokChoongTalentLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HowKokChoongTalentLimitedMember_lbl" xml:lang="en-US">How Kok Choong Talent Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareholdersMember" xlink:label="AATP_ShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareholdersMember" xlink:to="AATP_ShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ShareholdersMember_lbl" xml:lang="en-US">Shareholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HKCHoldingsSdnBhdMember" xlink:label="AATP_HKCHoldingsSdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HKCHoldingsSdnBhdMember" xlink:to="AATP_HKCHoldingsSdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HKCHoldingsSdnBhdMember_lbl" xml:lang="en-US">HKC Holdings Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY" xlink:label="country_MY" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_MY" xlink:to="country_MY_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_MY_lbl" xml:lang="en-US">MALAYSIA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_HK" xlink:label="country_HK" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_HK_lbl" xml:lang="en-US">HONG KONG</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_LabuanMember" xlink:label="AATP_LabuanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_LabuanMember" xlink:to="AATP_LabuanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_LabuanMember_lbl" xml:lang="en-US">Labuan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_UnutilizedMember" xlink:label="AATP_UnutilizedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_UnutilizedMember" xlink:to="AATP_UnutilizedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_UnutilizedMember_lbl" xml:lang="en-US">Unutilized [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AATPHKMember" xlink:label="AATP_AATPHKMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AATPHKMember" xlink:to="AATP_AATPHKMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AATPHKMember_lbl" xml:lang="en-US">AATP HK [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AATPLBASLSEAWATPAndDSYMember" xlink:label="AATP_AATPLBASLSEAWATPAndDSYMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AATPLBASLSEAWATPAndDSYMember" xlink:to="AATP_AATPLBASLSEAWATPAndDSYMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AATPLBASLSEAWATPAndDSYMember_lbl" xml:lang="en-US">AATP LB, ASL, SEA, WATP, and DSY [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AATPLBASLSEAAndWATPMember" xlink:label="AATP_AATPLBASLSEAAndWATPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AATPLBASLSEAAndWATPMember" xlink:to="AATP_AATPLBASLSEAAndWATPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AATPLBASLSEAAndWATPMember_lbl" xml:lang="en-US">AATP LB, ASL, SEA and WATP [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoCustomerMember" xlink:label="AATP_NoCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoCustomerMember" xlink:to="AATP_NoCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NoCustomerMember_lbl" xml:lang="en-US">No Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerMember" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_lbl" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ECommerceCompanyMember" xlink:label="AATP_ECommerceCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ECommerceCompanyMember" xlink:to="AATP_ECommerceCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ECommerceCompanyMember_lbl" xml:lang="en-US">E-commerce [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VendorOneMember" xlink:label="AATP_VendorOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VendorOneMember" xlink:to="AATP_VendorOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VendorOneMember_lbl" xml:lang="en-US">Vendor One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsTotalMember" xlink:label="us-gaap_CostOfGoodsTotalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsTotalMember" xlink:to="us-gaap_CostOfGoodsTotalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsTotalMember_lbl" xml:lang="en-US">Cost of Goods and Service Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="us-gaap_SupplierConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplierConcentrationRiskMember" xlink:to="us-gaap_SupplierConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VendorTwoMember" xlink:label="AATP_VendorTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VendorTwoMember" xlink:to="AATP_VendorTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VendorTwoMember_lbl" xml:lang="en-US">Vendor Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OneVendorMember" xlink:label="AATP_OneVendorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OneVendorMember" xlink:to="AATP_OneVendorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OneVendorMember_lbl" xml:lang="en-US">One Vendor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OneSalesDistributorMember" xlink:label="AATP_OneSalesDistributorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OneSalesDistributorMember" xlink:to="AATP_OneSalesDistributorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OneSalesDistributorMember_lbl" xml:lang="en-US">One Sales Distributor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoSalesDistributorMember" xlink:label="AATP_NoSalesDistributorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoSalesDistributorMember" xlink:to="AATP_NoSalesDistributorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NoSalesDistributorMember_lbl" xml:lang="en-US">No Sales Distributor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_TrainingCenterMember" xlink:label="AATP_TrainingCenterMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_TrainingCenterMember" xlink:to="AATP_TrainingCenterMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_TrainingCenterMember_lbl" xml:lang="en-US">Training Center [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:label="us-gaap_UnusualRiskOrUncertaintyByNatureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:to="us-gaap_UnusualRiskOrUncertaintyByNatureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnusualRiskOrUncertaintyByNatureAxis_lbl" xml:lang="en-US">Unusual Risk or Uncertainty, Nature [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_COVIDNineteenImpactMember" xlink:label="AATP_COVIDNineteenImpactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_COVIDNineteenImpactMember" xlink:to="AATP_COVIDNineteenImpactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_COVIDNineteenImpactMember_lbl" xml:lang="en-US">COVID-19 Impact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareForfeitureAgreementMember" xlink:label="AATP_ShareForfeitureAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareForfeitureAgreementMember" xlink:to="AATP_ShareForfeitureAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ShareForfeitureAgreementMember_lbl" xml:lang="en-US">Share Forfeiture Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents (Included $17,493 and $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:label="us-gaap_NotesReceivableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:to="us-gaap_NotesReceivableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableRelatedPartiesCurrent_lbl" xml:lang="en-US">Amount due from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidTaxes_lbl" xml:lang="en-US">Prepaid taxes (Included $1,357 and $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepayments and deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl" xml:lang="en-US">OTHER ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xml:lang="en-US">Investment in marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:to="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_lbl" xml:lang="en-US">Investment in non-marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Total other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_OtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_OtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Other payables and accrued liabilities ($1,548 and $1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2021 and 2020, respectively.)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US">Income tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Amount due to a related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">NON-CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Non-current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 290,460,047 and 376,452,047 shares issued and outstanding as of December 31, 2021 and 2020, respectively.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL AGAPE CORPORATION STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">NON-CONTROLLING INTERESTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">TOTAL EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_lbl" xml:lang="en-US">VIE consolidated amount of cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_lbl" xml:lang="en-US">VIE consolidated amount of prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_lbl" xml:lang="en-US">VIE consolidated amount of other payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RevenueFromRelatedParty" xlink:label="AATP_RevenueFromRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RevenueFromRelatedParty" xlink:to="AATP_RevenueFromRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_RevenueFromRelatedParty_lbl" xml:lang="en-US">REVENUE &#8211; RELATED PARTY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">TOTAL REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">COST OF REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">GROSS PROFIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingExpense" xlink:label="us-gaap_SellingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingExpense" xlink:to="us-gaap_SellingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SellingExpense_lbl" xml:lang="en-US">SELLING</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesCommissionsAndFees" xlink:label="us-gaap_SalesCommissionsAndFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesCommissionsAndFees" xlink:to="us-gaap_SalesCommissionsAndFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SalesCommissionsAndFees_lbl" xml:lang="en-US">COMMISSION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">GENERAL AND ADMINISTRATIVE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">PROVISION FOR DOUBTFUL ACCOUNTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">TOTAL OPERATING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">LOSS FROM OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">OTHER (EXPENSES) INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other (Expenses) Income, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized holding (loss) gain on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="AATP_PreferredStockDividendIncomeStatementImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PreferredStockDividendIncomeStatementImpact" xlink:to="AATP_PreferredStockDividendIncomeStatementImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AATP_PreferredStockDividendIncomeStatementImpact_lbl" xml:lang="en-US">Dividend income from marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">TOTAL OTHER (EXPENSES) INCOME, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">(LOSS) INCOME BEFORE INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">PROVISION FOR INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">NET (LOSS) INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">NET (LOSS) INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">OTHER COMPREHENSIVE (LOSS) INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Foreign currency translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">TOTAL COMPREHENSIVE (LOSS) INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Less: Comprehensive loss attributable to non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">(LOSS) EARNINGS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Shares, Outstanding, Beginning Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xml:lang="en-US">Forfeiture of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ContributionsFromNoncontrollingInterestShareholders" xlink:label="AATP_ContributionsFromNoncontrollingInterestShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ContributionsFromNoncontrollingInterestShareholders" xlink:to="AATP_ContributionsFromNoncontrollingInterestShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ContributionsFromNoncontrollingInterestShareholders_lbl" xml:lang="en-US">Contributions from non-controlling interest shareholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Shares, Outstanding, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3_lbl" xml:lang="en-US">Net (loss) income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="us-gaap_CostOfGoodsAndServicesSoldAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAmortization_lbl" xml:lang="en-US">Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of operating right-of-use assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xml:lang="en-US">Unrealized holding loss (gain) on marketable securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PreferredStockDividendIncomeStatementImpact" xlink:to="AATP_PreferredStockDividendIncomeStatementImpact_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PreferredStockDividendIncomeStatementImpact_2_lbl" xml:lang="en-US">Dividend income from marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Inventory write-down</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_2_lbl" xml:lang="en-US">Provision for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_lbl" xml:lang="en-US">Amount due from a related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl" xml:lang="en-US">Prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepayments and deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Other payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income tax payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchase of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US">Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfInvestmentProjects" xlink:label="us-gaap_ProceedsFromSaleOfInvestmentProjects" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfInvestmentProjects" xlink:to="us-gaap_ProceedsFromSaleOfInvestmentProjects_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfInvestmentProjects_lbl" xml:lang="en-US">Proceeds from sale of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:to="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_lbl" xml:lang="en-US">Proceeds from sale of non-marketable securities to a related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">(Advances to) Repayments from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOWS INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL NON-CASH FLOWS INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" xlink:label="AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" xlink:to="AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications_lbl" xml:lang="en-US">Changes in right-of-use assets and lease liabilities due to lease modifications</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:label="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:to="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_lbl" xml:lang="en-US">Initial recognition of right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:label="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:to="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_lbl" xml:lang="en-US">Sale of non-marketable securities to a related party in exchange for acquisition payment of ASL</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:label="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:to="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_lbl" xml:lang="en-US">Issuance of common stock in exchange for acquisition payment of ASL</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">ORGANIZATION AND BUSINESS BACKGROUND</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl" xml:lang="en-US">VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">BUSINESS COMBINATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:label="AATP_DisclosurePrepaymentsAndDepositsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:to="AATP_DisclosurePrepaymentsAndDepositsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DisclosurePrepaymentsAndDepositsAbstract_lbl" xml:lang="en-US">Prepayments And Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrepaymentsAndDepositsTextBlock" xlink:label="AATP_PrepaymentsAndDepositsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaymentsAndDepositsTextBlock" xlink:to="AATP_PrepaymentsAndDepositsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PrepaymentsAndDepositsTextBlock_lbl" xml:lang="en-US">PREPAYMENTS AND DEPOSITS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">INTANGIBLE ASSETS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract_lbl" xml:lang="en-US">Investment In Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInMarketableSecuritiesTextBlock" xlink:label="AATP_InvestmentInMarketableSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInMarketableSecuritiesTextBlock" xlink:to="AATP_InvestmentInMarketableSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInMarketableSecuritiesTextBlock_lbl" xml:lang="en-US">INVESTMENT IN MARKETABLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract_lbl" xml:lang="en-US">Investment In Non-marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesTextBlock" xlink:label="AATP_InvestmentInNonMarketableSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesTextBlock" xlink:to="AATP_InvestmentInNonMarketableSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInNonMarketableSecuritiesTextBlock_lbl" xml:lang="en-US">INVESTMENT IN NON-MARKETABLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER PAYABLES AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY BALANCES AND TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US">NON-CONTROLLING INTEREST</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">CONCENTRATIONS OF RISKS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrepaidTaxesPolicyTextBlock" xlink:label="AATP_PrepaidTaxesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaidTaxesPolicyTextBlock" xlink:to="AATP_PrepaidTaxesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PrepaidTaxesPolicyTextBlock_lbl" xml:lang="en-US">Prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:label="AATP_PrepaymentsAndDepositsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:to="AATP_PrepaymentsAndDepositsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_PrepaymentsAndDepositsPolicyTextBlock_lbl" xml:lang="en-US">Prepayments and deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment for long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Investment in marketable equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonMarketableSecuritiesPolicyTextBlock" xlink:label="AATP_NonMarketableSecuritiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonMarketableSecuritiesPolicyTextBlock" xlink:to="AATP_NonMarketableSecuritiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NonMarketableSecuritiesPolicyTextBlock_lbl" xml:lang="en-US">Investment in non-marketable equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShippingAndHandlingPolicyTextBlock" xlink:label="AATP_ShippingAndHandlingPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShippingAndHandlingPolicyTextBlock" xlink:to="AATP_ShippingAndHandlingPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ShippingAndHandlingPolicyTextBlock_lbl" xml:lang="en-US">Shipping and handling</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:label="us-gaap_CommissionsExpensePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:to="us-gaap_CommissionsExpensePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommissionsExpensePolicyPolicyTextBlock_lbl" xml:lang="en-US">Commission expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DefinedContributionPlanPolicyTextBlock" xlink:label="AATP_DefinedContributionPlanPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DefinedContributionPlanPolicyTextBlock" xlink:to="AATP_DefinedContributionPlanPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DefinedContributionPlanPolicyTextBlock_lbl" xml:lang="en-US">Defined contribution plan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoncontrollingInterestPolicyTextBlock" xlink:label="AATP_NoncontrollingInterestPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoncontrollingInterestPolicyTextBlock" xlink:to="AATP_NoncontrollingInterestPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NoncontrollingInterestPolicyTextBlock_lbl" xml:lang="en-US">Non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign currencies translation and transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RelatedPartiesPolicyTextBlock" xlink:label="AATP_RelatedPartiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesPolicyTextBlock" xlink:to="AATP_RelatedPartiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_RelatedPartiesPolicyTextBlock_lbl" xml:lang="en-US">Related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value of financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:label="us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:to="us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_lbl" xml:lang="en-US">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:to="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" xlink:to="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" xlink:label="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" xlink:to="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:label="us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:to="us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl" xml:lang="en-US">SCHEDULE OF VARIABLE INTEREST ENTITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PRO FORMA BUSINESS COMBINATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" xlink:label="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" xlink:to="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock" xlink:label="AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock" xlink:to="AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INTANGIBLE ASSETS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonMarketableSecuritiesTableTextBlock" xlink:label="AATP_NonMarketableSecuritiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonMarketableSecuritiesTableTextBlock" xlink:to="AATP_NonMarketableSecuritiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NonMarketableSecuritiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" xlink:label="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" xlink:to="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RELATED PARTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfNonControllingInterestTableTextBlock" xlink:label="AATP_ScheduleOfNonControllingInterestTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfNonControllingInterestTableTextBlock" xlink:to="AATP_ScheduleOfNonControllingInterestTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfNonControllingInterestTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF NON CONTROLLING INTEREST</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROVISION FOR INCOME TAX</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF EFFECTIVE INCOME TAX RATE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEFERRED TAX ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF LEASE COMMITMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NameOftheCompany" xlink:label="AATP_NameOftheCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NameOftheCompany" xlink:to="AATP_NameOftheCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NameOftheCompany_lbl" xml:lang="en-US">Subsidiary company name</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PlaceAndDateOfIncorporation" xlink:label="AATP_PlaceAndDateOfIncorporation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PlaceAndDateOfIncorporation" xlink:to="AATP_PlaceAndDateOfIncorporation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PlaceAndDateOfIncorporation_lbl" xml:lang="en-US">Place and date of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ParticularsOfIssuedCapital" xlink:label="AATP_ParticularsOfIssuedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ParticularsOfIssuedCapital" xlink:to="AATP_ParticularsOfIssuedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ParticularsOfIssuedCapital_lbl" xml:lang="en-US">Particulars of issued capital</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrincipalActivities" xlink:label="AATP_PrincipalActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrincipalActivities" xlink:to="AATP_PrincipalActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PrincipalActivities_lbl" xml:lang="en-US">Principal activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Proportional of ownership interest and voting power held</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xml:lang="en-US">Ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Stock issued during period acquisitions, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated Useful Life of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xml:lang="en-US">Estimated Useful Lives of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated useful lives of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:to="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xml:lang="en-US">Foreign Currency Exchange Rate, Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ForeignCurrencyExchangeRateAverage" xlink:label="AATP_ForeignCurrencyExchangeRateAverage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ForeignCurrencyExchangeRateAverage" xlink:to="AATP_ForeignCurrencyExchangeRateAverage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ForeignCurrencyExchangeRateAverage_lbl" xml:lang="en-US">Foreign currency exchange rate period average</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Accounts receivable, allowance for credit loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryWriteDown_2_lbl" xml:lang="en-US">Inventories write-down</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:label="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:to="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ForfeitedCouponIncome" xlink:label="AATP_ForfeitedCouponIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ForfeitedCouponIncome" xlink:to="AATP_ForfeitedCouponIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ForfeitedCouponIncome_lbl" xml:lang="en-US">Forfeited coupon income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Revenue from sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingExpense" xlink:to="us-gaap_SellingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingExpense_2_lbl" xml:lang="en-US">Selling expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising costs</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SalesCommissionsAndFees1" xlink:label="AATP_SalesCommissionsAndFees1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalesCommissionsAndFees1" xlink:to="AATP_SalesCommissionsAndFees1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_SalesCommissionsAndFees1_lbl" xml:lang="en-US">Commission expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xml:lang="en-US">Defined contribution plan expense</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SalaryPercentage" xlink:label="AATP_SalaryPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalaryPercentage" xlink:to="AATP_SalaryPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SalaryPercentage_lbl" xml:lang="en-US">Salary percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MonthlySalary" xlink:label="AATP_MonthlySalary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MonthlySalary" xlink:to="AATP_MonthlySalary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MonthlySalary_lbl" xml:lang="en-US">Monthly salary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xml:lang="en-US">Income tax examination, likelihood of unfavorable settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Income tax examination, penalties and interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDescription" xlink:label="us-gaap_MinorityInterestDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDescription" xlink:to="us-gaap_MinorityInterestDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDescription_lbl" xml:lang="en-US">Noncontrolling interest, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Potentially dilutive securities outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivitiesGainLossByTypeTable" xlink:label="us-gaap_TradingActivitiesGainLossByTypeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingActivitiesGainLossByTypeTable" xlink:to="us-gaap_TradingActivitiesGainLossByTypeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingActivitiesGainLossByTypeTable_lbl" xml:lang="en-US">Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivityGainsAndLossesLineItems" xlink:label="us-gaap_TradingActivityGainsAndLossesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingActivityGainsAndLossesLineItems" xlink:to="us-gaap_TradingActivityGainsAndLossesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingActivityGainsAndLossesLineItems_lbl" xml:lang="en-US">Trading Activity, Gains and Losses, Net [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Net deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidTaxes_2_lbl" xml:lang="en-US">Prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable &#8211; intercompany</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OtherPayablesRelatedPartyCurrent" xlink:label="AATP_OtherPayablesRelatedPartyCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherPayablesRelatedPartyCurrent" xlink:to="AATP_OtherPayablesRelatedPartyCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_OtherPayablesRelatedPartyCurrent_lbl" xml:lang="en-US">Other payables and accrued liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_3_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xml:lang="en-US">Operating revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" xlink:to="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_lbl" xml:lang="en-US">Other receivables - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:to="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_lbl" xml:lang="en-US">Prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepayments and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_lbl" xml:lang="en-US">Deferred taxes asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xml:lang="en-US">Total other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accounts payable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl" xml:lang="en-US">Other payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Total net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:label="AATP_BusinessAcquisitionsProFormaCostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:to="AATP_BusinessAcquisitionsProFormaCostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_BusinessAcquisitionsProFormaCostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:label="AATP_BusinessAcquisitionsProFormaGrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:to="AATP_BusinessAcquisitionsProFormaGrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_BusinessAcquisitionsProFormaGrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaOperatingExpenses" xlink:label="AATP_BusinessAcquisitionsProFormaOperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaOperatingExpenses" xlink:to="AATP_BusinessAcquisitionsProFormaOperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaOperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:label="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:to="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_lbl" xml:lang="en-US">&#160;Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:label="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:to="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_lbl" xml:lang="en-US">Other income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:to="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:to="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:label="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:to="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_lbl" xml:lang="en-US">Net income per common share - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:label="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:to="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of common shares outstanding - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockNoParValue_lbl" xml:lang="en-US">Ordinary shares no par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Purchase consideration value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl" xml:lang="en-US">Loan payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:label="AATP_PercentageOfCommonStockIssuedAndOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:to="AATP_PercentageOfCommonStockIssuedAndOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PercentageOfCommonStockIssuedAndOutstanding_lbl" xml:lang="en-US">Percentage of common stock issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Stock issued during period, value, acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Purchased price per shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Issuance of common stock shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash in bank</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimeDeposits" xlink:label="us-gaap_TimeDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimeDeposits" xlink:to="us-gaap_TimeDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TimeDeposits_lbl" xml:lang="en-US">Time deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:label="us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:to="us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_lbl" xml:lang="en-US">Percentage of Interest rate for time deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="us-gaap_AccountsReceivableGrossCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableGrossCurrent" xlink:to="us-gaap_AccountsReceivableGrossCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableGrossCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:label="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:to="AATP_DisclosurePrepaymentsAndDepositsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_DisclosurePrepaymentsAndDepositsAbstract_2_lbl" xml:lang="en-US">Schedule Of Prepaid Expenses And Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ReceivablesFromSalesDistributors" xlink:label="AATP_ReceivablesFromSalesDistributors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ReceivablesFromSalesDistributors" xlink:to="AATP_ReceivablesFromSalesDistributors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ReceivablesFromSalesDistributors_lbl" xml:lang="en-US">Receivables from sales distributors</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DepositsToSupplier" xlink:label="AATP_DepositsToSupplier" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DepositsToSupplier" xlink:to="AATP_DepositsToSupplier_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DepositsToSupplier_lbl" xml:lang="en-US">Deposits to suppliers</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrepaidExpensesGross" xlink:label="AATP_PrepaidExpensesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaidExpensesGross" xlink:to="AATP_PrepaidExpensesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="AATP_PrepaidExpensesGross_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xml:lang="en-US">Less: Provision for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:to="AATP_DisclosurePrepaymentsAndDepositsAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="AATP_DisclosurePrepaymentsAndDepositsAbstract_3_lbl" xml:lang="en-US">Schedule Of Changes In Allowance For Doubtful Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_lbl" xml:lang="en-US">Addition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xml:lang="en-US">Write off</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect" xlink:label="AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect" xlink:to="AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_lbl" xml:lang="en-US">Exchange rate effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="us-gaap_CapitalizedComputerSoftwareGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareGross" xlink:to="us-gaap_CapitalizedComputerSoftwareGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareGross_lbl" xml:lang="en-US">Computer software</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract_2_lbl" xml:lang="en-US">Schedule Of Investment In Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="us-gaap_InvestmentOwnedAtCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtCost" xlink:to="us-gaap_InvestmentOwnedAtCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtCost_lbl" xml:lang="en-US">Cost of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentsIncomeDividend" xlink:label="AATP_InvestmentsIncomeDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentsIncomeDividend" xlink:to="AATP_InvestmentsIncomeDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AATP_InvestmentsIncomeDividend_lbl" xml:lang="en-US">Dividend income from Greenpro Capital Corp.</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MarketableSecuritiesUnrealizedHoldingGainLoss" xlink:label="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss" xlink:to="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss_lbl" xml:lang="en-US">Unrealized holding (loss) gain</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:label="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:to="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_lbl" xml:lang="en-US">Exchange rate effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_2_lbl" xml:lang="en-US">Investment in marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="us-gaap_InvestmentOwnedBalanceShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceShares" xlink:to="us-gaap_InvestmentOwnedBalanceShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalanceShares_lbl" xml:lang="en-US">Investment in securities, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtCost" xlink:to="us-gaap_InvestmentOwnedAtCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentOwnedAtCost_2_lbl" xml:lang="en-US">Investment amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesGross" xlink:label="AATP_InvestmentInNonMarketableSecuritiesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesGross" xlink:to="AATP_InvestmentInNonMarketableSecuritiesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_InvestmentInNonMarketableSecuritiesGross_lbl" xml:lang="en-US">Investment in non-marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:label="AATP_SaleOfInvestmentInNonmarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:to="AATP_SaleOfInvestmentInNonmarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SaleOfInvestmentInNonmarketableSecurities_lbl" xml:lang="en-US">Less: Sale of investment in non-marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonmarketableSecuritiesNet" xlink:label="AATP_InvestmentInNonmarketableSecuritiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonmarketableSecuritiesNet" xlink:to="AATP_InvestmentInNonmarketableSecuritiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_InvestmentInNonmarketableSecuritiesNet_lbl" xml:lang="en-US">Investment in non-marketable securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:to="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_2_lbl" xml:lang="en-US">Total investment in non-marketable securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_3_lbl" xml:lang="en-US">Equity interest percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Ordinary shares authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:to="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_2_lbl" xml:lang="en-US">Proceeds from investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:label="us-gaap_DueFromOfficersOrStockholdersCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:to="us-gaap_DueFromOfficersOrStockholdersCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromOfficersOrStockholdersCurrent_lbl" xml:lang="en-US">Amount due from director</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceShares" xlink:to="us-gaap_InvestmentOwnedBalanceShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentOwnedBalanceShares_2_lbl" xml:lang="en-US">Shares purchased during period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AccruedPromotionExpenses" xlink:label="AATP_AccruedPromotionExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccruedPromotionExpenses" xlink:to="AATP_AccruedPromotionExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AccruedPromotionExpenses_lbl" xml:lang="en-US">Promotion expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xml:lang="en-US">Payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="us-gaap_AccruedSalesCommissionCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalesCommissionCurrent" xlink:to="us-gaap_AccruedSalesCommissionCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalesCommissionCurrent_lbl" xml:lang="en-US">Commission</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilities_lbl" xml:lang="en-US">Others</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OtherAccountPayableAndAccruedLiabilities" xlink:label="AATP_OtherAccountPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherAccountPayableAndAccruedLiabilities" xlink:to="AATP_OtherAccountPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="AATP_OtherAccountPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RelatedPartiesRelationshipsDescription" xlink:label="AATP_RelatedPartiesRelationshipsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesRelationshipsDescription" xlink:to="AATP_RelatedPartiesRelationshipsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_RelatedPartiesRelationshipsDescription_lbl" xml:lang="en-US">Relationship</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RelatedPartiesNatureDescription" xlink:label="AATP_RelatedPartiesNatureDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesNatureDescription" xlink:to="AATP_RelatedPartiesNatureDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_RelatedPartiesNatureDescription_lbl" xml:lang="en-US">Nature</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="us-gaap_DueFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedParties" xlink:to="us-gaap_DueFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DueFromRelatedParties_lbl" xml:lang="en-US">Amount due from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Amount due from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="us-gaap_RevenueFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_RevenueFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromRelatedParties_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl" xml:lang="en-US">Purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SalesCommissionsAndFee" xlink:label="AATP_SalesCommissionsAndFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalesCommissionsAndFee" xlink:to="AATP_SalesCommissionsAndFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SalesCommissionsAndFee_lbl" xml:lang="en-US">Commission expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_3_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2_lbl" xml:lang="en-US">Business combination, recognized identifiable assets acquired and liabilities assumed, assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2_lbl" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestPaidinCapital" xlink:label="AATP_NonControllingInterestPaidinCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestPaidinCapital" xlink:to="AATP_NonControllingInterestPaidinCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NonControllingInterestPaidinCapital_lbl" xml:lang="en-US">Paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestAccumulatedDeficit" xlink:label="AATP_NonControllingInterestAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestAccumulatedDeficit" xlink:to="AATP_NonControllingInterestAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_NonControllingInterestAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome" xlink:label="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome" xlink:to="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestNonControllingInterestGross" xlink:label="AATP_NonControllingInterestNonControllingInterestGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestNonControllingInterestGross" xlink:to="AATP_NonControllingInterestNonControllingInterestGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NonControllingInterestNonControllingInterestGross_lbl" xml:lang="en-US">&#160;Non Controlling interest Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestAsl" xlink:label="AATP_NonControllingInterestAsl" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestAsl" xlink:to="AATP_NonControllingInterestAsl_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NonControllingInterestAsl_lbl" xml:lang="en-US">ASL</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MinorityInterest_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Local &#8211; United States</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">(Loss) income before income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">- Local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">- Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">- Local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">- Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">U.S. statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Differential tax rate in Malaysia</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Permanent difference</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Tax percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Net operating loss carry forwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DeferredTaxLiabilitiesDepreciation" xlink:label="AATP_DeferredTaxLiabilitiesDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DeferredTaxLiabilitiesDepreciation" xlink:to="AATP_DeferredTaxLiabilitiesDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_DeferredTaxLiabilitiesDepreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax liabilities, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xml:lang="en-US">Tax percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:label="us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:to="us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription_lbl" xml:lang="en-US">Tax rate description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income tax expense benefit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_2_lbl" xml:lang="en-US">Income tax examination penalties and interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Deferred tax assets operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" xlink:label="AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" xlink:to="AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_lbl" xml:lang="en-US">Cumulative net operating losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred tax valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xml:lang="en-US">Tax percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xml:lang="en-US">Income tax examination, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentrations of risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DividendShareForCommonStock" xlink:label="AATP_DividendShareForCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DividendShareForCommonStock" xlink:to="AATP_DividendShareForCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DividendShareForCommonStock_lbl" xml:lang="en-US">[custom:DividendShareForCommonStock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Deposits" xlink:label="us-gaap_Deposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="us-gaap_Deposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Deposits_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DepositForInsurance" xlink:label="AATP_DepositForInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DepositForInsurance" xlink:to="AATP_DepositForInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DepositForInsurance_lbl" xml:lang="en-US">Deposit for insurance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of lease liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Operating lease effective interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_LeaseExpirationTerm" xlink:label="AATP_LeaseExpirationTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_LeaseExpirationTerm" xlink:to="AATP_LeaseExpirationTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_LeaseExpirationTerm_lbl" xml:lang="en-US">Lease expiration term</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IncreaseDecreaseInROUAssetsAndLiabilities" xlink:label="AATP_IncreaseDecreaseInROUAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IncreaseDecreaseInROUAssetsAndLiabilities" xlink:to="AATP_IncreaseDecreaseInROUAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IncreaseDecreaseInROUAssetsAndLiabilities_lbl" xml:lang="en-US">Reduction in ROU assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating lease, weighted average remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating lease, rent expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyImpact" xlink:label="us-gaap_UnusualRiskOrUncertaintyImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnusualRiskOrUncertaintyImpact" xlink:to="us-gaap_UnusualRiskOrUncertaintyImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnusualRiskOrUncertaintyImpact_lbl" xml:lang="en-US">COVID-19 impact description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited_lbl" xml:lang="en-US">Company share forfeiture</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:to="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_doc" xml:lang="en-US">Investment in non-marketable securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_doc" xml:lang="en-US">VIE consolidated amount of cash and cash equivalents.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_doc" xml:lang="en-US">VIE consolidated amount of Prepaid taxes .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_doc" xml:lang="en-US">VIE consolidated amount of other payables and accrued liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PreferredStockDividendIncomeStatementImpact" xlink:to="AATP_PreferredStockDividendIncomeStatementImpact_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PreferredStockDividendIncomeStatementImpact_doc" xml:lang="en-US">The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_doc" xml:lang="en-US">Increase decrease in operating lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:to="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_doc" xml:lang="en-US">Proceeds from sale of non-marketable securities to a related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" xlink:to="AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications_doc" xml:lang="en-US">Changes in right of use asset and lease liabilities due to lease modifications.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:to="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_doc" xml:lang="en-US">Initial recognition of right-of-use assets and lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:to="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_doc" xml:lang="en-US">Sale of non-marketable securities to related party in exchange for acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:to="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_doc" xml:lang="en-US">Issuance of common stock in exchange for acquisition payment of acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeATPInternationalHoldingLimitedMember" xlink:to="AATP_AgapeATPInternationalHoldingLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeATPInternationalHoldingLimitedMember_doc" xml:lang="en-US">Agape ATP International Holding Limited [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareExchangeAgreementMember" xlink:to="AATP_ShareExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ShareExchangeAgreementMember_doc" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MrHowKokChoongMember" xlink:to="AATP_MrHowKokChoongMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MrHowKokChoongMember_doc" xml:lang="en-US">Mr.How Kok Choong [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyTwoMember" xlink:to="AATP_SubsidiaryCompanyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyTwoMember_doc" xml:lang="en-US">Subsidiary Company Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NameOftheCompany" xlink:to="AATP_NameOftheCompany_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NameOftheCompany_doc" xml:lang="en-US">Name of the company name.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyMember" xlink:to="AATP_SubsidiaryCompanyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyMember_doc" xml:lang="en-US">Subsidiary Company [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyOneMember" xlink:to="AATP_SubsidiaryCompanyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyOneMember_doc" xml:lang="en-US">Subsidiary Company One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyFiveMember" xlink:to="AATP_SubsidiaryCompanyFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyFiveMember_doc" xml:lang="en-US">Subsidiary Company Five [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyThreeMember" xlink:to="AATP_SubsidiaryCompanyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyThreeMember_doc" xml:lang="en-US">Subsidiary Company Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyFourMember" xlink:to="AATP_SubsidiaryCompanyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyFourMember_doc" xml:lang="en-US">Subsidiary Company Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PlaceAndDateOfIncorporation" xlink:to="AATP_PlaceAndDateOfIncorporation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PlaceAndDateOfIncorporation_doc" xml:lang="en-US">Place and date of incorporation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ParticularsOfIssuedCapital" xlink:to="AATP_ParticularsOfIssuedCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ParticularsOfIssuedCapital_doc" xml:lang="en-US">Particulars of issued capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrincipalActivities" xlink:to="AATP_PrincipalActivities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PrincipalActivities_doc" xml:lang="en-US">Principal activities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaidTaxesPolicyTextBlock" xlink:to="AATP_PrepaidTaxesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PrepaidTaxesPolicyTextBlock_doc" xml:lang="en-US">Prepaid Taxes [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:to="AATP_PrepaymentsAndDepositsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PrepaymentsAndDepositsPolicyTextBlock_doc" xml:lang="en-US">Prepayments And Deposits [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:to="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent_doc" xml:lang="en-US">Allowance for doubtful accounts,</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ComputerAndOfficeEquipmentMember" xlink:to="AATP_ComputerAndOfficeEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ComputerAndOfficeEquipmentMember_doc" xml:lang="en-US">Computer And Office Equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VehicleMember" xlink:to="AATP_VehicleMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VehicleMember_doc" xml:lang="en-US">Vehicle [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_GreenproCapitalCorpMember" xlink:to="AATP_GreenproCapitalCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_GreenproCapitalCorpMember_doc" xml:lang="en-US">Greenpro Capital Corp. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DSwissIncMember" xlink:to="AATP_DSwissIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DSwissIncMember_doc" xml:lang="en-US">DSwiss Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInMarketableSecuritiesTextBlock" xlink:to="AATP_InvestmentInMarketableSecuritiesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InvestmentInMarketableSecuritiesTextBlock_doc" xml:lang="en-US">Investment In Marketable Securities [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentsIncomeDividend" xlink:to="AATP_InvestmentsIncomeDividend_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InvestmentsIncomeDividend_doc" xml:lang="en-US">Dividend income .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss" xlink:to="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss_doc" xml:lang="en-US">Unrealized holding (loss) gain.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:to="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_doc" xml:lang="en-US">Exchange rate effect.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesTextBlock" xlink:to="AATP_InvestmentInNonMarketableSecuritiesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InvestmentInNonMarketableSecuritiesTextBlock_doc" xml:lang="en-US">Investment In Non Marketable Securities [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_UnreservedSdnBhdMember" xlink:to="AATP_UnreservedSdnBhdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_UnreservedSdnBhdMember_doc" xml:lang="en-US">Unreserved Sdn Bhd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PhoenixPlusCorpMember" xlink:to="AATP_PhoenixPlusCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PhoenixPlusCorpMember_doc" xml:lang="en-US">Phoenix Plus Corporation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonMarketableSecuritiesTableTextBlock" xlink:to="AATP_NonMarketableSecuritiesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NonMarketableSecuritiesTableTextBlock_doc" xml:lang="en-US">Non Marketable Securities [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesGross" xlink:to="AATP_InvestmentInNonMarketableSecuritiesGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InvestmentInNonMarketableSecuritiesGross_doc" xml:lang="en-US">Investment in non-marketable securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DirectorsOfUnreservedInvestmentMember" xlink:to="AATP_DirectorsOfUnreservedInvestmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DirectorsOfUnreservedInvestmentMember_doc" xml:lang="en-US">Directors of Unreserved Investments [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:to="AATP_SaleOfInvestmentInNonmarketableSecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SaleOfInvestmentInNonmarketableSecurities_doc" xml:lang="en-US">Sale of investment in non-marketable securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonmarketableSecuritiesNet" xlink:to="AATP_InvestmentInNonmarketableSecuritiesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InvestmentInNonmarketableSecuritiesNet_doc" xml:lang="en-US">Investment in non-marketable securities, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" xlink:to="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_doc" xml:lang="en-US">Schedule Of Other Payables And Accrued Liabilities [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccruedPromotionExpenses" xlink:to="AATP_AccruedPromotionExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AccruedPromotionExpenses_doc" xml:lang="en-US">Accrued promotion expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherAccountPayableAndAccruedLiabilities" xlink:to="AATP_OtherAccountPayableAndAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OtherAccountPayableAndAccruedLiabilities_doc" xml:lang="en-US">Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesRelationshipsDescription" xlink:to="AATP_RelatedPartiesRelationshipsDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_RelatedPartiesRelationshipsDescription_doc" xml:lang="en-US">Related parties, relationships, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeATPAsiaLimitedMember" xlink:to="AATP_AgapeATPAsiaLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeATPAsiaLimitedMember_doc" xml:lang="en-US">Agape ATP Asia Limited [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesNatureDescription" xlink:to="AATP_RelatedPartiesNatureDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_RelatedPartiesNatureDescription_doc" xml:lang="en-US">Related parties nature, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ContributionsFromNoncontrollingInterestShareholders" xlink:to="AATP_ContributionsFromNoncontrollingInterestShareholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ContributionsFromNoncontrollingInterestShareholders_doc" xml:lang="en-US">Contributions from non controlling interest shareholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HostastaySdnBhdMember" xlink:to="AATP_HostastaySdnBhdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HostastaySdnBhdMember_doc" xml:lang="en-US">Hostastay Sdn Bhd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_THThreeTechnologySdnBhdMember" xlink:to="AATP_THThreeTechnologySdnBhdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_THThreeTechnologySdnBhdMember_doc" xml:lang="en-US">TH3 Technology Sdn Bhd [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingPtyLtdMember" xlink:to="AATP_AgapeSuperiorLivingPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeSuperiorLivingPtyLtdMember_doc" xml:lang="en-US">Agape Superior Living Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:to="AATP_AgapeSuperiorLivingPtyLtdASLPLMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeSuperiorLivingPtyLtdASLPLMember_doc" xml:lang="en-US">Agape Superior Living Pty Ltd ASLPL [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HostastaySdnBhdOneMember" xlink:to="AATP_HostastaySdnBhdOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HostastaySdnBhdOneMember_doc" xml:lang="en-US">Hostastay Sdn. Bhd.[Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:to="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_doc" xml:lang="en-US">Schedule Of Estimated Useful Lives Of Property And Equipment [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" xlink:to="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_doc" xml:lang="en-US">Schedule Of Estimated Useful Lives Of Intangible Assets Net [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HowKokChoongMember" xlink:to="AATP_HowKokChoongMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HowKokChoongMember_doc" xml:lang="en-US">How Kok Choong [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonMarketableSecuritiesPolicyTextBlock" xlink:to="AATP_NonMarketableSecuritiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NonMarketableSecuritiesPolicyTextBlock_doc" xml:lang="en-US">Non Marketable Securities [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VettonsSdnBhdOneMember" xlink:to="AATP_VettonsSdnBhdOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VettonsSdnBhdOneMember_doc" xml:lang="en-US">Vettons Sdn Bhd One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ForfeitedCouponIncome" xlink:to="AATP_ForfeitedCouponIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ForfeitedCouponIncome_doc" xml:lang="en-US">Forfeited coupon income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HealthAndWellnessProductsMember" xlink:to="AATP_HealthAndWellnessProductsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HealthAndWellnessProductsMember_doc" xml:lang="en-US">Health and Wellness Products [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" xlink:to="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_doc" xml:lang="en-US">Schedule Of Disaggregated Information Of Revenues [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SurvivorSelectMember" xlink:to="AATP_SurvivorSelectMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SurvivorSelectMember_doc" xml:lang="en-US">Survivor Select [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EnergizedMineralConcentrateMember" xlink:to="AATP_EnergizedMineralConcentrateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_EnergizedMineralConcentrateMember_doc" xml:lang="en-US">Energized Mineral Concentrate [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IonizedCalMagMember" xlink:to="AATP_IonizedCalMagMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IonizedCalMagMember_doc" xml:lang="en-US">Ionized Cal-Mag [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OmegaBlendMember" xlink:to="AATP_OmegaBlendMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OmegaBlendMember_doc" xml:lang="en-US">Omega Blend [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BetaMaxxMember" xlink:to="AATP_BetaMaxxMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BetaMaxxMember_doc" xml:lang="en-US">Beta Maxx [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VegeFruitFiberMember" xlink:to="AATP_VegeFruitFiberMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VegeFruitFiberMember_doc" xml:lang="en-US">Vege Fruit Fiber [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IronMember" xlink:to="AATP_IronMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IronMember_doc" xml:lang="en-US">Iron [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_YoungFormulaMember" xlink:to="AATP_YoungFormulaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_YoungFormulaMember_doc" xml:lang="en-US">Young Formula [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OrganicYouthCareCleansingBarMember" xlink:to="AATP_OrganicYouthCareCleansingBarMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OrganicYouthCareCleansingBarMember_doc" xml:lang="en-US">Organic Youth Care Cleansing Bar [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MitogizeMember" xlink:to="AATP_MitogizeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MitogizeMember_doc" xml:lang="en-US">Mitogize [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoOneMEDMember" xlink:to="AATP_NoOneMEDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NoOneMEDMember_doc" xml:lang="en-US">No. 1 MED [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EnergetiqueMember" xlink:to="AATP_EnergetiqueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_EnergetiqueMember_doc" xml:lang="en-US">Energetique [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_TrimPlusMember" xlink:to="AATP_TrimPlusMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_TrimPlusMember_doc" xml:lang="en-US">Trim Plus [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HealthAndWellnessServicesMember" xlink:to="AATP_HealthAndWellnessServicesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HealthAndWellnessServicesMember_doc" xml:lang="en-US">Health And Wellness Services [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingMember" xlink:to="AATP_AgapeSuperiorLivingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeSuperiorLivingMember_doc" xml:lang="en-US">ASL [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShippingAndHandlingPolicyTextBlock" xlink:to="AATP_ShippingAndHandlingPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ShippingAndHandlingPolicyTextBlock_doc" xml:lang="en-US">Shipping and Handling [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalesCommissionsAndFees1" xlink:to="AATP_SalesCommissionsAndFees1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SalesCommissionsAndFees1_doc" xml:lang="en-US">Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DefinedContributionPlanPolicyTextBlock" xlink:to="AATP_DefinedContributionPlanPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DefinedContributionPlanPolicyTextBlock_doc" xml:lang="en-US">Defined Contribution Plan [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalaryPercentage" xlink:to="AATP_SalaryPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SalaryPercentage_doc" xml:lang="en-US">Salary percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SocialSecurityOrganizationMember" xlink:to="AATP_SocialSecurityOrganizationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SocialSecurityOrganizationMember_doc" xml:lang="en-US">Social Security Organization [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MonthlySalary" xlink:to="AATP_MonthlySalary_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MonthlySalary_doc" xml:lang="en-US">Monthly salary.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MYRCurrencyMember" xlink:to="AATP_MYRCurrencyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MYRCurrencyMember_doc" xml:lang="en-US">MYR Currency [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EmployeesProvidentFundMember" xlink:to="AATP_EmployeesProvidentFundMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_EmployeesProvidentFundMember_doc" xml:lang="en-US">Employees Provident Fund [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EmploymentInsuranceSystemMember" xlink:to="AATP_EmploymentInsuranceSystemMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_EmploymentInsuranceSystemMember_doc" xml:lang="en-US">Employment Insurance System [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HumanResourceDevelopmentFundMember" xlink:to="AATP_HumanResourceDevelopmentFundMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HumanResourceDevelopmentFundMember_doc" xml:lang="en-US">Human Resource Development Fund [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoncontrollingInterestPolicyTextBlock" xlink:to="AATP_NoncontrollingInterestPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NoncontrollingInterestPolicyTextBlock_doc" xml:lang="en-US">Noncontrolling Interest [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodEndMYRMember" xlink:to="AATP_PeriodEndMYRMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PeriodEndMYRMember_doc" xml:lang="en-US">Period-end MYR [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodEndHKDMember" xlink:to="AATP_PeriodEndHKDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PeriodEndHKDMember_doc" xml:lang="en-US">Period-end HKD [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ForeignCurrencyExchangeRateAverage" xlink:to="AATP_ForeignCurrencyExchangeRateAverage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ForeignCurrencyExchangeRateAverage_doc" xml:lang="en-US">Foreign currency exchange rate period average.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodAverageMYRMember" xlink:to="AATP_PeriodAverageMYRMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PeriodAverageMYRMember_doc" xml:lang="en-US">Period-average MYR [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodAverageHKDMember" xlink:to="AATP_PeriodAverageHKDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PeriodAverageHKDMember_doc" xml:lang="en-US">Period-average HKD [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesPolicyTextBlock" xlink:to="AATP_RelatedPartiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_RelatedPartiesPolicyTextBlock_doc" xml:lang="en-US">Related Parties [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareForfeitureAgreementsMember" xlink:to="AATP_ShareForfeitureAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ShareForfeitureAgreementsMember_doc" xml:lang="en-US">Share Forfeiture Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HowKokChoongTalentLimitedMember" xlink:to="AATP_HowKokChoongTalentLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HowKokChoongTalentLimitedMember_doc" xml:lang="en-US">How Kok Choong Talent Limited [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfNonControllingInterestTableTextBlock" xlink:to="AATP_ScheduleOfNonControllingInterestTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ScheduleOfNonControllingInterestTableTextBlock_doc" xml:lang="en-US">Schedule Of Non Controlling Interest [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestPaidinCapital" xlink:to="AATP_NonControllingInterestPaidinCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NonControllingInterestPaidinCapital_doc" xml:lang="en-US">Non controlling interest paid in capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestAccumulatedDeficit" xlink:to="AATP_NonControllingInterestAccumulatedDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NonControllingInterestAccumulatedDeficit_doc" xml:lang="en-US">Non controlling interest accumulated deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome" xlink:to="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome_doc" xml:lang="en-US">Non controlling interest accumulated other comprehensive income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestNonControllingInterestGross" xlink:to="AATP_NonControllingInterestNonControllingInterestGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NonControllingInterestNonControllingInterestGross_doc" xml:lang="en-US">Non controlling interest gross.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestAsl" xlink:to="AATP_NonControllingInterestAsl_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NonControllingInterestAsl_doc" xml:lang="en-US">Non controlling interest asl.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherPayablesRelatedPartyCurrent" xlink:to="AATP_OtherPayablesRelatedPartyCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OtherPayablesRelatedPartyCurrent_doc" xml:lang="en-US">Other payables - related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingSdnBhdMember" xlink:to="AATP_AgapeSuperiorLivingSdnBhdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeSuperiorLivingSdnBhdMember_doc" xml:lang="en-US">Agape Superior Living Sdn Bhd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:to="AATP_PercentageOfCommonStockIssuedAndOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PercentageOfCommonStockIssuedAndOutstanding_doc" xml:lang="en-US">Percentage of common stock issued and outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:to="AATP_BusinessAcquisitionsProFormaCostOfRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaCostOfRevenue_doc" xml:lang="en-US">Cost of revenue.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:to="AATP_BusinessAcquisitionsProFormaGrossProfit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaGrossProfit_doc" xml:lang="en-US">Gross profit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaOperatingExpenses" xlink:to="AATP_BusinessAcquisitionsProFormaOperatingExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaOperatingExpenses_doc" xml:lang="en-US">Total operating expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:to="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_doc" xml:lang="en-US">Business acquisitions pro-forma income loss before income taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:to="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_doc" xml:lang="en-US">Business acquisitions pro-forma income tax expense benefit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:to="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_doc" xml:lang="en-US">Business acquisition pro-forma earnings per share basic and diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:to="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_doc" xml:lang="en-US">Business acquisition pro-forma weighted average number of common shares outstanding basic snd diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" xlink:to="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed current assets receivables related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:to="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed current assets prepaid taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_doc" xml:lang="en-US">Accounts receivable and accounts receivable related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaymentsAndDepositsTextBlock" xlink:to="AATP_PrepaymentsAndDepositsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PrepaymentsAndDepositsTextBlock_doc" xml:lang="en-US">Prepayments and Deposits [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" xlink:to="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_doc" xml:lang="en-US">Schedule of Prepaid Expenses and Deposits [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ReceivablesFromSalesDistributors" xlink:to="AATP_ReceivablesFromSalesDistributors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ReceivablesFromSalesDistributors_doc" xml:lang="en-US">Receivables from sales distributors.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DepositsToSupplier" xlink:to="AATP_DepositsToSupplier_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DepositsToSupplier_doc" xml:lang="en-US">Deposits to supplier.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect" xlink:to="AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_doc" xml:lang="en-US">Allowance for doubtful accounts receivable exchange rate effect.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaidExpensesGross" xlink:to="AATP_PrepaidExpensesGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PrepaidExpensesGross_doc" xml:lang="en-US">Prepaid expenses gross.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_LabuanMember" xlink:to="AATP_LabuanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_LabuanMember_doc" xml:lang="en-US">Labuan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" xlink:to="AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_doc" xml:lang="en-US">Deferred tax assets operating loss carryforwards utilized and reduced.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DeferredTaxLiabilitiesDepreciation" xlink:to="AATP_DeferredTaxLiabilitiesDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DeferredTaxLiabilitiesDepreciation_doc" xml:lang="en-US">Deferred tax liabilities, depreciation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_UnutilizedMember" xlink:to="AATP_UnutilizedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_UnutilizedMember_doc" xml:lang="en-US">Unutilized [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoCustomerMember" xlink:to="AATP_NoCustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NoCustomerMember_doc" xml:lang="en-US">No Customer [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ECommerceCompanyMember" xlink:to="AATP_ECommerceCompanyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ECommerceCompanyMember_doc" xml:lang="en-US">E-commerce [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VendorOneMember" xlink:to="AATP_VendorOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VendorOneMember_doc" xml:lang="en-US">Vendor One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VendorTwoMember" xlink:to="AATP_VendorTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VendorTwoMember_doc" xml:lang="en-US">Vendor Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DepositForInsurance" xlink:to="AATP_DepositForInsurance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DepositForInsurance_doc" xml:lang="en-US">Deposit for insurance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_COVIDNineteenImpactMember" xlink:to="AATP_COVIDNineteenImpactMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_COVIDNineteenImpactMember_doc" xml:lang="en-US">COVID-19 Impact [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:to="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_doc" xml:lang="en-US">Other income (expense), net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock" xlink:to="AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_doc" xml:lang="en-US">Schedule of Changes in Allowance for Doubtful Accounts [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SEATechVenturesCorpMember" xlink:to="AATP_SEATechVenturesCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SEATechVenturesCorpMember_doc" xml:lang="en-US">SEATech Ventures Corp [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareholdersMember" xlink:to="AATP_ShareholdersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ShareholdersMember_doc" xml:lang="en-US">Shareholders [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HKCHoldingsSdnBhdMember" xlink:to="AATP_HKCHoldingsSdnBhdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HKCHoldingsSdnBhdMember_doc" xml:lang="en-US">HKC Holdings Sdn Bhd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalesCommissionsAndFee" xlink:to="AATP_SalesCommissionsAndFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SalesCommissionsAndFee_doc" xml:lang="en-US">Commission expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AATPHKMember" xlink:to="AATP_AATPHKMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AATPHKMember_doc" xml:lang="en-US">AATP HK [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AATPLBASLSEAWATPAndDSYMember" xlink:to="AATP_AATPLBASLSEAWATPAndDSYMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AATPLBASLSEAWATPAndDSYMember_doc" xml:lang="en-US">AATP LB, ASL, SEA, WATP, and DSY [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AATPLBASLSEAAndWATPMember" xlink:to="AATP_AATPLBASLSEAAndWATPMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AATPLBASLSEAAndWATPMember_doc" xml:lang="en-US">AATP LB, ASL, SEA and WATP [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DividendShareForCommonStock" xlink:to="AATP_DividendShareForCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DividendShareForCommonStock_doc" xml:lang="en-US">Dividend share for common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OneVendorMember" xlink:to="AATP_OneVendorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OneVendorMember_doc" xml:lang="en-US">One Vendor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OneSalesDistributorMember" xlink:to="AATP_OneSalesDistributorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OneSalesDistributorMember_doc" xml:lang="en-US">One Sales Distributor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoSalesDistributorMember" xlink:to="AATP_NoSalesDistributorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NoSalesDistributorMember_doc" xml:lang="en-US">No Sales Distributor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareForfeitureAgreementMember" xlink:to="AATP_ShareForfeitureAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ShareForfeitureAgreementMember_doc" xml:lang="en-US">Share Forfeiture Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_LeaseExpirationTerm" xlink:to="AATP_LeaseExpirationTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_LeaseExpirationTerm_doc" xml:lang="en-US">Lease expiration term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_TrainingCenterMember" xlink:to="AATP_TrainingCenterMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_TrainingCenterMember_doc" xml:lang="en-US">Training Center [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IncreaseDecreaseInROUAssetsAndLiabilities" xlink:to="AATP_IncreaseDecreaseInROUAssetsAndLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IncreaseDecreaseInROUAssetsAndLiabilities_doc" xml:lang="en-US">Reduction in ROU assets and liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RevenueFromRelatedParty" xlink:to="AATP_RevenueFromRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_RevenueFromRelatedParty_doc" xml:lang="en-US">Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DSYWellnessAndLongevityCenterSdnBhdMember" xlink:to="AATP_DSYWellnessAndLongevityCenterSdnBhdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DSYWellnessAndLongevityCenterSdnBhdMember_doc" xml:lang="en-US">DSY Wellness &amp; Longevity Center Sdn Bhd [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_2_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_3_lbl" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesCommissionsAndFees" xlink:to="us-gaap_SalesCommissionsAndFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesCommissionsAndFees_2_lbl" xml:lang="en-US">Sales Commissions and Fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_2_lbl" xml:lang="en-US">Increase (Decrease) in Due from Other Related Parties, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_3_lbl" xml:lang="en-US">IncreaseDecreaseInOperatingLeaseLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_2_lbl" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:to="AATP_PrepaymentsAndDepositsPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PrepaymentsAndDepositsPolicyTextBlock_3_lbl" xml:lang="en-US">PrepaymentsAndDepositsPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_2_lbl" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_2_lbl" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_2_lbl" xml:lang="en-US">Advertising Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalesCommissionsAndFees1" xlink:to="AATP_SalesCommissionsAndFees1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SalesCommissionsAndFees1_3_lbl" xml:lang="en-US">Commission expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherPayablesRelatedPartyCurrent" xlink:to="AATP_OtherPayablesRelatedPartyCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OtherPayablesRelatedPartyCurrent_3_lbl" xml:lang="en-US">OtherPayablesRelatedPartyCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:to="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:to="AATP_BusinessAcquisitionsProFormaCostOfRevenue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaCostOfRevenue_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaCostOfRevenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:to="AATP_BusinessAcquisitionsProFormaGrossProfit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaGrossProfit_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaGrossProfit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableGrossCurrent" xlink:to="us-gaap_AccountsReceivableGrossCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableGrossCurrent_2_lbl" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsReceivableRelatedPartiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent_2_lbl" xml:lang="en-US">Accounts Receivable, Related Parties, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_3_lbl" xml:lang="en-US">Accounts receivable and accounts receivable related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaidExpensesGross" xlink:to="AATP_PrepaidExpensesGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PrepaidExpensesGross_3_lbl" xml:lang="en-US">PrepaidExpensesGross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_2_lbl" xml:lang="en-US">Allowance for Doubtful Accounts, Premiums and Other Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentsIncomeDividend" xlink:to="AATP_InvestmentsIncomeDividend_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentsIncomeDividend_3_lbl" xml:lang="en-US">Dividend income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss" xlink:to="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MarketableSecuritiesUnrealizedHoldingGainLoss_3_lbl" xml:lang="en-US">Unrealized holding (loss) gain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:to="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_3_lbl" xml:lang="en-US">Exchange rate effect [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesGross" xlink:to="AATP_InvestmentInNonMarketableSecuritiesGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInNonMarketableSecuritiesGross_3_lbl" xml:lang="en-US">Investment in non-marketable securities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonmarketableSecuritiesNet" xlink:to="AATP_InvestmentInNonmarketableSecuritiesNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInNonmarketableSecuritiesNet_3_lbl" xml:lang="en-US">Investment in non-marketable securities, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherAccountPayableAndAccruedLiabilities" xlink:to="AATP_OtherAccountPayableAndAccruedLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OtherAccountPayableAndAccruedLiabilities_3_lbl" xml:lang="en-US">OtherAccountPayableAndAccruedLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedParties" xlink:to="us-gaap_DueFromRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromRelatedParties_2_lbl" xml:lang="en-US">Due from Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Due to Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_RevenueFromRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromRelatedParties_2_lbl" xml:lang="en-US">Revenue from Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestAccumulatedDeficit" xlink:to="AATP_NonControllingInterestAccumulatedDeficit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NonControllingInterestAccumulatedDeficit_3_lbl" xml:lang="en-US">NonControllingInterestAccumulatedDeficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome" xlink:to="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome_3_lbl" xml:lang="en-US">NonControllingInterestAccumulatedOtherComprehensiveIncome</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DeferredTaxLiabilitiesDepreciation" xlink:to="AATP_DeferredTaxLiabilitiesDepreciation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DeferredTaxLiabilitiesDepreciation_3_lbl" xml:lang="en-US">DeferredTaxLiabilitiesDepreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>26
<FILENAME>aatp-20211231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://agapeatp.com/role/Cover" xlink:href="aatp-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheets" xlink:href="aatp-20211231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:href="aatp-20211231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:href="aatp-20211231.xsd#StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="aatp-20211231.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfCashFlows" xlink:href="aatp-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:href="aatp-20211231.xsd#OrganizationAndBusinessBackground" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVie" xlink:href="aatp-20211231.xsd#VariableInterestEntityVie" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusinessCombination" xlink:href="aatp-20211231.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CashAndCashEquivalents" xlink:href="aatp-20211231.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivable" xlink:href="aatp-20211231.xsd#AccountsReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Inventories" xlink:href="aatp-20211231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:href="aatp-20211231.xsd#PrepaymentsAndDeposits" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:href="aatp-20211231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNet" xlink:href="aatp-20211231.xsd#IntangibleAssetsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:href="aatp-20211231.xsd#InvestmentInMarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:href="aatp-20211231.xsd#InvestmentInNon-marketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:href="aatp-20211231.xsd#OtherPayablesAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:href="aatp-20211231.xsd#RelatedPartyBalancesAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquity" xlink:href="aatp-20211231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Non-controllingInterest" xlink:href="aatp-20211231.xsd#Non-controllingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxes" xlink:href="aatp-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:href="aatp-20211231.xsd#ConcentrationsOfRisks" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:href="aatp-20211231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEvents" xlink:href="aatp-20211231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:href="aatp-20211231.xsd#OrganizationAndBusinessBackgroundTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:href="aatp-20211231.xsd#VariableInterestEntityVieTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusinessCombinationTables" xlink:href="aatp-20211231.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivableTables" xlink:href="aatp-20211231.xsd#AccountsReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InventoriesTables" xlink:href="aatp-20211231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:href="aatp-20211231.xsd#PrepaymentsAndDepositsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:href="aatp-20211231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:href="aatp-20211231.xsd#IntangibleAssetsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:href="aatp-20211231.xsd#InvestmentInMarketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:href="aatp-20211231.xsd#InvestmentInNon-marketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:href="aatp-20211231.xsd#OtherPayablesAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:href="aatp-20211231.xsd#RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Non-controllingInterestTables" xlink:href="aatp-20211231.xsd#Non-controllingInterestTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesTables" xlink:href="aatp-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:href="aatp-20211231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfSubsidiariesAndAssociatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:href="aatp-20211231.xsd#OrganizationAndBusinessBackgroundDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="aatp-20211231.xsd#ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:href="aatp-20211231.xsd#ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="aatp-20211231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:href="aatp-20211231.xsd#ScheduleOfVariableInterestEntityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:href="aatp-20211231.xsd#VariableInterestEntityVieDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="aatp-20211231.xsd#SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:href="aatp-20211231.xsd#ScheduleOfProFormaBusinessCombinationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusinessCombinationDetailsNarrative" xlink:href="aatp-20211231.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" xlink:href="aatp-20211231.xsd#CashAndCashEquivalentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:href="aatp-20211231.xsd#ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InventoriesDetailsNarrative" xlink:href="aatp-20211231.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:href="aatp-20211231.xsd#ScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="aatp-20211231.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:href="aatp-20211231.xsd#ScheduleOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:href="aatp-20211231.xsd#IntangibleAssetsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:href="aatp-20211231.xsd#InvestmentInMarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:href="aatp-20211231.xsd#InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:href="aatp-20211231.xsd#ScheduleOfRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:href="aatp-20211231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" xlink:href="aatp-20211231.xsd#ScheduleOfNonControllingInterestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:href="aatp-20211231.xsd#ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:href="aatp-20211231.xsd#ScheduleOfProvisionForIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:href="aatp-20211231.xsd#ScheduleOfEffectiveIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:href="aatp-20211231.xsd#ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:href="aatp-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:href="aatp-20211231.xsd#ConcentrationsOfRisksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:href="aatp-20211231.xsd#ScheduleOfLeaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="aatp-20211231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:href="aatp-20211231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapNotesReceivableRelatedPartiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapNotesReceivableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:label="loc_AATPVariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_AATPVariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:label="loc_AATPVariableInterestEntityConsolidatedAmountOfPrepaidTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_AATPVariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:label="loc_AATPVariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_AATPVariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RevenueFromRelatedParty" xlink:label="loc_AATPRevenueFromRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_AATPRevenueFromRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesCommissionsAndFees" xlink:label="loc_us-gaapSalesCommissionsAndFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSalesCommissionsAndFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="loc_AATPPreferredStockDividendIncomeStatementImpact" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_AATPPreferredStockDividendIncomeStatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ContributionsFromNoncontrollingInterestShareholders" xlink:label="loc_AATPContributionsFromNoncontrollingInterestShareholders" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPContributionsFromNoncontrollingInterestShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldAmortization" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="loc_AATPPreferredStockDividendIncomeStatementImpact" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_AATPPreferredStockDividendIncomeStatementImpact" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidTaxes" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_AATPIncreaseDecreaseInOperatingLeaseLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_AATPIncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfInvestmentProjects" xlink:label="loc_us-gaapProceedsFromSaleOfInvestmentProjects" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfInvestmentProjects" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" xlink:label="loc_AATPChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_AATPChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_AATPInitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_AATPInitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:label="loc_AATPSaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_AATPSaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:label="loc_AATPIssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_AATPIssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:title="00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVie" xlink:title="00000009 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="loc_us-gaapVariableInterestEntityDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapVariableInterestEntityDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusinessCombination" xlink:title="00000010 - Disclosure - BUSINESS COMBINATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CashAndCashEquivalents" xlink:title="00000011 - Disclosure - CASH AND CASH EQUIVALENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaapCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivable" xlink:title="00000012 - Disclosure - ACCOUNTS RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Inventories" xlink:title="00000013 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:title="00000014 - Disclosure - PREPAYMENTS AND DEPOSITS">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:label="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrepaymentsAndDepositsTextBlock" xlink:label="loc_AATPPrepaymentsAndDepositsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPPrepaymentsAndDepositsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:title="00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNet" xlink:title="00000016 - Disclosure - INTANGIBLE ASSETS, NET">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:title="00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInMarketableSecuritiesTextBlock" xlink:label="loc_AATPInvestmentInMarketableSecuritiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_AATPInvestmentInMarketableSecuritiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:title="00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesTextBlock" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:title="00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:title="00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquity" xlink:title="00000021 - Disclosure - STOCKHOLDERS&#8217; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Non-controllingInterest" xlink:title="00000022 - Disclosure - NON-CONTROLLING INTEREST">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaapMinorityInterestDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:title="00000024 - Disclosure - CONCENTRATIONS OF RISKS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:title="00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEvents" xlink:title="00000026 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrepaidTaxesPolicyTextBlock" xlink:label="loc_AATPPrepaidTaxesPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPPrepaidTaxesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:label="loc_AATPPrepaymentsAndDepositsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPPrepaymentsAndDepositsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="loc_us-gaapDeferredChargesPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDeferredChargesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonMarketableSecuritiesPolicyTextBlock" xlink:label="loc_AATPNonMarketableSecuritiesPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPNonMarketableSecuritiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaapCostOfSalesPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostOfSalesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShippingAndHandlingPolicyTextBlock" xlink:label="loc_AATPShippingAndHandlingPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPShippingAndHandlingPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:label="loc_us-gaapCommissionsExpensePolicyPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommissionsExpensePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DefinedContributionPlanPolicyTextBlock" xlink:label="loc_AATPDefinedContributionPlanPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPDefinedContributionPlanPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoncontrollingInterestPolicyTextBlock" xlink:label="loc_AATPNoncontrollingInterestPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPNoncontrollingInterestPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RelatedPartiesPolicyTextBlock" xlink:label="loc_AATPRelatedPartiesPolicyTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPRelatedPartiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:title="00000028 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:label="loc_us-gaapScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:label="loc_AATPScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" xlink:label="loc_AATPScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" xlink:label="loc_AATPScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:label="loc_us-gaapScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:title="00000030 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:label="loc_us-gaapScheduleOfVariableInterestEntitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusinessCombinationTables" xlink:title="00000031 - Disclosure - BUSINESS COMBINATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivableTables" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InventoriesTables" xlink:title="00000033 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:title="00000034 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:label="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" xlink:label="loc_AATPScheduleOfPrepaidExpensesAndDepositsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPScheduleOfPrepaidExpensesAndDepositsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock" xlink:label="loc_AATPScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:title="00000035 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:title="00000036 - Disclosure - INTANGIBLE ASSETS, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:title="00000037 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="loc_us-gaapMarketableSecuritiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:title="00000038 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonMarketableSecuritiesTableTextBlock" xlink:label="loc_AATPNonMarketableSecuritiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="loc_AATPNonMarketableSecuritiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:title="00000039 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_AATPScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_AATPScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:title="00000040 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Non-controllingInterestTables" xlink:title="00000041 - Disclosure - NON-CONTROLLING INTEREST (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ScheduleOfNonControllingInterestTableTextBlock" xlink:label="loc_AATPScheduleOfNonControllingInterestTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_AATPScheduleOfNonControllingInterestTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesTables" xlink:title="00000042 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:title="00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyMember" xlink:label="loc_AATPSubsidiaryCompanyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyOneMember" xlink:label="loc_AATPSubsidiaryCompanyOneMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="loc_AATPSubsidiaryCompanyTwoMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="loc_AATPSubsidiaryCompanyThreeMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyFourMember" xlink:label="loc_AATPSubsidiaryCompanyFourMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyFiveMember" xlink:label="loc_AATPSubsidiaryCompanyFiveMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NameOftheCompany" xlink:label="loc_AATPNameOftheCompany" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPNameOftheCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PlaceAndDateOfIncorporation" xlink:label="loc_AATPPlaceAndDateOfIncorporation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPPlaceAndDateOfIncorporation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ParticularsOfIssuedCapital" xlink:label="loc_AATPParticularsOfIssuedCapital" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPParticularsOfIssuedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrincipalActivities" xlink:label="loc_AATPPrincipalActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPPrincipalActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:title="00000045 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeATPInternationalHoldingLimitedMember" xlink:label="loc_AATPAgapeATPInternationalHoldingLimitedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAgapeATPInternationalHoldingLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="loc_AATPSubsidiaryCompanyTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyFiveMember" xlink:label="loc_AATPSubsidiaryCompanyFiveMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="loc_AATPShareExchangeAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:title="00000047 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaapComputerSoftwareIntangibleAssetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapComputerSoftwareIntangibleAssetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SurvivorSelectMember" xlink:label="loc_AATPSurvivorSelectMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPSurvivorSelectMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EnergizedMineralConcentrateMember" xlink:label="loc_AATPEnergizedMineralConcentrateMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPEnergizedMineralConcentrateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IonizedCalMagMember" xlink:label="loc_AATPIonizedCalMagMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPIonizedCalMagMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OmegaBlendMember" xlink:label="loc_AATPOmegaBlendMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPOmegaBlendMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BetaMaxxMember" xlink:label="loc_AATPBetaMaxxMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPBetaMaxxMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VegeFruitFiberMember" xlink:label="loc_AATPVegeFruitFiberMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPVegeFruitFiberMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IronMember" xlink:label="loc_AATPIronMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPIronMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_YoungFormulaMember" xlink:label="loc_AATPYoungFormulaMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPYoungFormulaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OrganicYouthCareCleansingBarMember" xlink:label="loc_AATPOrganicYouthCareCleansingBarMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPOrganicYouthCareCleansingBarMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MitogizeMember" xlink:label="loc_AATPMitogizeMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPMitogizeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoOneMEDMember" xlink:label="loc_AATPNoOneMEDMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPNoOneMEDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EnergetiqueMember" xlink:label="loc_AATPEnergetiqueMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPEnergetiqueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_TrimPlusMember" xlink:label="loc_AATPTrimPlusMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPTrimPlusMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HealthAndWellnessServicesMember" xlink:label="loc_AATPHealthAndWellnessServicesMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPHealthAndWellnessServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:title="00000049 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaapVariableRateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapVariableRateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodEndMYRMember" xlink:label="loc_AATPPeriodEndMYRMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodEndMYRMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodEndHKDMember" xlink:label="loc_AATPPeriodEndHKDMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodEndHKDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodAverageMYRMember" xlink:label="loc_AATPPeriodAverageMYRMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodAverageMYRMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PeriodAverageHKDMember" xlink:label="loc_AATPPeriodAverageHKDMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodAverageHKDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateTranslation1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapForeignCurrencyExchangeRateTranslation1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ForeignCurrencyExchangeRateAverage" xlink:label="loc_AATPForeignCurrencyExchangeRateAverage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_AATPForeignCurrencyExchangeRateAverage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HealthAndWellnessProductsMember" xlink:label="loc_AATPHealthAndWellnessProductsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPHealthAndWellnessProductsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HealthAndWellnessServicesMember" xlink:label="loc_AATPHealthAndWellnessServicesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPHealthAndWellnessServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SocialSecurityOrganizationMember" xlink:label="loc_AATPSocialSecurityOrganizationMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPSocialSecurityOrganizationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EmployeesProvidentFundMember" xlink:label="loc_AATPEmployeesProvidentFundMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPEmployeesProvidentFundMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_EmploymentInsuranceSystemMember" xlink:label="loc_AATPEmploymentInsuranceSystemMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPEmploymentInsuranceSystemMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HumanResourceDevelopmentFundMember" xlink:label="loc_AATPHumanResourceDevelopmentFundMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPHumanResourceDevelopmentFundMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MYRCurrencyMember" xlink:label="loc_AATPMYRCurrencyMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_AATPMYRCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:label="loc_AATPAllowanceForDoubtfulAccountsReceivablesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPAllowanceForDoubtfulAccountsReceivablesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ForfeitedCouponIncome" xlink:label="loc_AATPForfeitedCouponIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPForfeitedCouponIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSellingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SalesCommissionsAndFees1" xlink:label="loc_AATPSalesCommissionsAndFees1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPSalesCommissionsAndFees1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaapDefinedContributionPlanEmployerDiscretionaryContributionAmount" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SalaryPercentage" xlink:label="loc_AATPSalaryPercentage" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPSalaryPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MonthlySalary" xlink:label="loc_AATPMonthlySalary" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPMonthlySalary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDescription" xlink:label="loc_us-gaapMinorityInterestDescription" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterestDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:title="00000051 - Disclosure -  SCHEDULE OF VARIABLE INTEREST ENTITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivitiesGainLossByTypeTable" xlink:label="loc_us-gaapTradingActivitiesGainLossByTypeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapTradingActivitiesGainLossByTypeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivityGainsAndLossesLineItems" xlink:label="loc_us-gaapTradingActivityGainsAndLossesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivitiesGainLossByTypeTable" xlink:to="loc_us-gaapTradingActivityGainsAndLossesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivityByTypeAxis" xlink:label="loc_us-gaapTradingActivityByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivitiesGainLossByTypeTable" xlink:to="loc_us-gaapTradingActivityByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingActivityByTypeDomain" xlink:label="loc_us-gaapTradingActivityByTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityByTypeAxis" xlink:to="loc_us-gaapTradingActivityByTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableIncomeInterestRateMember" xlink:label="loc_us-gaapVariableIncomeInterestRateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityByTypeDomain" xlink:to="loc_us-gaapVariableIncomeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapPrepaidTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OtherPayablesRelatedPartyCurrent" xlink:label="loc_AATPOtherPayablesRelatedPartyCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_AATPOtherPayablesRelatedPartyCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:title="00000052 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="loc_AATPSubsidiaryCompanyThreeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000053 - Disclosure -  SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" xlink:label="loc_AATPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:label="loc_AATPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:title="00000054 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:label="loc_AATPBusinessAcquisitionsProFormaCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:label="loc_AATPBusinessAcquisitionsProFormaGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaOperatingExpenses" xlink:label="loc_AATPBusinessAcquisitionsProFormaOperatingExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaOperatingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:label="loc_AATPBusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:label="loc_AATPBusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:label="loc_AATPBusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:label="loc_AATPBusinessAcquisitionProFormaEarningsPerShareBasicDiluted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:label="loc_AATPBusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_AATPBusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusinessCombinationDetailsNarrative" xlink:title="00000055 - Disclosure - BUSINESS COMBINATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="loc_AATPShareExchangeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingSdnBhdMember" xlink:label="loc_AATPAgapeSuperiorLivingSdnBhdMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingSdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPMrHowKokChoongMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaapCommonStockNoParValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockNoParValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:label="loc_AATPPercentageOfCommonStockIssuedAndOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_AATPPercentageOfCommonStockIssuedAndOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="00000056 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaapCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimeDeposits" xlink:label="loc_us-gaapTimeDeposits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTimeDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:label="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:title="00000057 - Disclosure -  SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="loc_us-gaapAccountsReceivableGrossCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableGrossCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:label="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:title="00000058 - Disclosure -  SCHEDULE OF INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InventoriesDetailsNarrative" xlink:title="00000059 - Disclosure - INVENTORIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:title="00000060 - Disclosure -  SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:label="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ReceivablesFromSalesDistributors" xlink:label="loc_AATPReceivablesFromSalesDistributors" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPReceivablesFromSalesDistributors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DepositsToSupplier" xlink:label="loc_AATPDepositsToSupplier" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPDepositsToSupplier" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PrepaidExpensesGross" xlink:label="loc_AATPPrepaidExpensesGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPPrepaidExpensesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" xlink:title="00000061 - Disclosure - SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:label="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect" xlink:label="loc_AATPAllowanceForDoubtfulAccountsReceivableExchangeRateEffect" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPAllowanceForDoubtfulAccountsReceivableExchangeRateEffect" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:title="00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ComputerAndOfficeEquipmentMember" xlink:label="loc_AATPComputerAndOfficeEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPComputerAndOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VehicleMember" xlink:label="loc_AATPVehicleMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPVehicleMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000063 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:title="00000064 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:title="00000065 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:title="00000066 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentsIncomeDividend" xlink:label="loc_AATPInvestmentsIncomeDividend" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_AATPInvestmentsIncomeDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MarketableSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_AATPMarketableSecuritiesUnrealizedHoldingGainLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_AATPMarketableSecuritiesUnrealizedHoldingGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:label="loc_AATPExchangeRateEffectOnInvestmentInMarketableSecurites" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_AATPExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:title="00000067 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_GreenproCapitalCorpMember" xlink:label="loc_AATPGreenproCapitalCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPGreenproCapitalCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DSwissIncMember" xlink:label="loc_AATPDSwissIncMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPDSwissIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SEATechVenturesCorpMember" xlink:label="loc_AATPSEATechVenturesCorpMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPSEATechVenturesCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:title="00000068 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DirectorsOfUnreservedInvestmentMember" xlink:label="loc_AATPDirectorsOfUnreservedInvestmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPDirectorsOfUnreservedInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="loc_AATPPhoenixPlusCorpMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPPhoenixPlusCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesGross" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:label="loc_AATPSaleOfInvestmentInNonmarketableSecurities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_AATPSaleOfInvestmentInNonmarketableSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonmarketableSecuritiesNet" xlink:label="loc_AATPInvestmentInNonmarketableSecuritiesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonmarketableSecuritiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:title="00000069 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_UnreservedSdnBhdMember" xlink:label="loc_AATPUnreservedSdnBhdMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPUnreservedSdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="loc_AATPPhoenixPlusCorpMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPPhoenixPlusCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:label="loc_us-gaapDueFromOfficersOrStockholdersCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueFromOfficersOrStockholdersCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:title="00000070 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AccruedPromotionExpenses" xlink:label="loc_AATPAccruedPromotionExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_AATPAccruedPromotionExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OtherAccountPayableAndAccruedLiabilities" xlink:label="loc_AATPOtherAccountPayableAndAccruedLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_AATPOtherAccountPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:title="00000071 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeATPAsiaLimitedMember" xlink:label="loc_AATPAgapeATPAsiaLimitedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeATPAsiaLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HostastaySdnBhdMember" xlink:label="loc_AATPHostastaySdnBhdMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHostastaySdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_THThreeTechnologySdnBhdMember" xlink:label="loc_AATPTHThreeTechnologySdnBhdMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPTHThreeTechnologySdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingPtyLtdMember" xlink:label="loc_AATPAgapeSuperiorLivingPtyLtdMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:label="loc_AATPAgapeSuperiorLivingPtyLtdASLPLMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingPtyLtdASLPLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VettonsSdnBhdOneMember" xlink:label="loc_AATPVettonsSdnBhdOneMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPVettonsSdnBhdOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HostastaySdnBhdOneMember" xlink:label="loc_AATPHostastaySdnBhdOneMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHostastaySdnBhdOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HowKokChoongMember" xlink:label="loc_AATPHowKokChoongMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHowKokChoongMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DSYWellnessAndLongevityCenterSdnBhdMember" xlink:label="loc_AATPDSYWellnessAndLongevityCenterSdnBhdMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPDSYWellnessAndLongevityCenterSdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RelatedPartiesRelationshipsDescription" xlink:label="loc_AATPRelatedPartiesRelationshipsDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPRelatedPartiesRelationshipsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_RelatedPartiesNatureDescription" xlink:label="loc_AATPRelatedPartiesNatureDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPRelatedPartiesNatureDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="loc_us-gaapDueFromRelatedParties" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueFromRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRevenueFromRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_SalesCommissionsAndFee" xlink:label="loc_AATPSalesCommissionsAndFee" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPSalesCommissionsAndFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000072 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="loc_AATPAgapeSuperiorLivingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_AATPAgapeSuperiorLivingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareForfeitureAgreementsMember" xlink:label="loc_AATPShareForfeitureAgreementsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareForfeitureAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HowKokChoongTalentLimitedMember" xlink:label="loc_AATPHowKokChoongTalentLimitedMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHowKokChoongTalentLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_HKCHoldingsSdnBhdMember" xlink:label="loc_AATPHKCHoldingsSdnBhdMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHKCHoldingsSdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareholdersMember" xlink:label="loc_AATPShareholdersMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" xlink:title="00000073 - Disclosure - SCHEDULE OF NON CONTROLLING INTEREST (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestPaidinCapital" xlink:label="loc_AATPNonControllingInterestPaidinCapital" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_AATPNonControllingInterestPaidinCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestAccumulatedDeficit" xlink:label="loc_AATPNonControllingInterestAccumulatedDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_AATPNonControllingInterestAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome" xlink:label="loc_AATPNonControllingInterestAccumulatedOtherComprehensiveIncome" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_AATPNonControllingInterestAccumulatedOtherComprehensiveIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestNonControllingInterestGross" xlink:label="loc_AATPNonControllingInterestNonControllingInterestGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_AATPNonControllingInterestNonControllingInterestGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NonControllingInterestAsl" xlink:label="loc_AATPNonControllingInterestAsl" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_AATPNonControllingInterestAsl" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:title="00000074 - Disclosure -  SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY" xlink:label="loc_countryMY" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_HK" xlink:label="loc_countryHK" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryHK" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:title="00000075 - Disclosure -  SCHEDULE OF PROVISION FOR INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:title="00000076 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:title="00000077 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AATPHKMember" xlink:label="loc_AATPAATPHKMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAATPHKMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AATPLBASLSEAWATPAndDSYMember" xlink:label="loc_AATPAATPLBASLSEAWATPAndDSYMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAATPLBASLSEAWATPAndDSYMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AATPLBASLSEAAndWATPMember" xlink:label="loc_AATPAATPLBASLSEAAndWATPMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAATPLBASLSEAAndWATPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000078 - Disclosure -  SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY" xlink:label="loc_countryMY" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_AATPDeferredTaxLiabilitiesDepreciation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_AATPDeferredTaxLiabilitiesDepreciation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000079 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementGeographicalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_LabuanMember" xlink:label="loc_AATPLabuanMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_AATPLabuanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY" xlink:label="loc_countryMY" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_HK" xlink:label="loc_countryHK" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryHK" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementScenarioAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_UnutilizedMember" xlink:label="loc_AATPUnutilizedMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_AATPUnutilizedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:label="loc_us-gaapTaxCutsAndJobsActOf2017OtherTaxEffectDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapTaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" xlink:label="loc_AATPDeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_AATPDeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:title="00000080 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoCustomerMember" xlink:label="loc_AATPNoCustomerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPNoCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VendorOneMember" xlink:label="loc_AATPVendorOneMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPVendorOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_VendorTwoMember" xlink:label="loc_AATPVendorTwoMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPVendorTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OneVendorMember" xlink:label="loc_AATPOneVendorMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPOneVendorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_OneSalesDistributorMember" xlink:label="loc_AATPOneSalesDistributorMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPOneSalesDistributorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_NoSalesDistributorMember" xlink:label="loc_AATPNoSalesDistributorMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPNoSalesDistributorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsTotalMember" xlink:label="loc_us-gaapCostOfGoodsTotalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapCostOfGoodsTotalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaapSupplierConcentrationRiskMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSupplierConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ECommerceCompanyMember" xlink:label="loc_AATPECommerceCompanyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPECommerceCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DSwissIncMember" xlink:label="loc_AATPDSwissIncMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPDSwissIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DividendShareForCommonStock" xlink:label="loc_AATPDividendShareForCommonStock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_AATPDividendShareForCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Deposits" xlink:label="loc_us-gaapDeposits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_DepositForInsurance" xlink:label="loc_AATPDepositForInsurance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_AATPDepositForInsurance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:title="00000081 - Disclosure -  SCHEDULE OF LEASE COMMITMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000082 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="loc_AATPAgapeSuperiorLivingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_AATPAgapeSuperiorLivingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_TrainingCenterMember" xlink:label="loc_AATPTrainingCenterMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPTrainingCenterMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:label="loc_us-gaapUnusualRiskOrUncertaintyByNatureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapUnusualRiskOrUncertaintyByNatureAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:label="loc_us-gaapUnusualRiskOrUncertaintyNatureDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnusualRiskOrUncertaintyByNatureAxis" xlink:to="loc_us-gaapUnusualRiskOrUncertaintyNatureDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_COVIDNineteenImpactMember" xlink:label="loc_AATPCOVIDNineteenImpactMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnusualRiskOrUncertaintyNatureDomain" xlink:to="loc_AATPCOVIDNineteenImpactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_LeaseExpirationTerm" xlink:label="loc_AATPLeaseExpirationTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_AATPLeaseExpirationTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_IncreaseDecreaseInROUAssetsAndLiabilities" xlink:label="loc_AATPIncreaseDecreaseInROUAssetsAndLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_AATPIncreaseDecreaseInROUAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyImpact" xlink:label="loc_us-gaapUnusualRiskOrUncertaintyImpact" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapUnusualRiskOrUncertaintyImpact" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000083 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20211231.xsd#AATP_ShareForfeitureAgreementMember" xlink:label="loc_AATPShareForfeitureAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareForfeitureAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055400504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 23, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">333-220144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AGAPE ATP CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001713210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-4838886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Tower 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Faber Towers<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Jalan Desa Bahagia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kuala Lumpur<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">MY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">58100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">192230099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
Stock, $0.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 914,950,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,452,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Friedman LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New
York, New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843056641448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents (Included $17,493 and $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)</a></td>
<td class="nump">$ 2,597,848<span></span>
</td>
<td class="nump">$ 3,517,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">172,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedPartiesCurrent', window );">Amount due from related parties</a></td>
<td class="nump">7,004<span></span>
</td>
<td class="nump">3,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">375,535<span></span>
</td>
<td class="nump">589,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes (Included $1,357 and $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)</a></td>
<td class="nump">636,218<span></span>
</td>
<td class="nump">1,104,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and deposits</a></td>
<td class="nump">295,517<span></span>
</td>
<td class="nump">296,370<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">3,912,122<span></span>
</td>
<td class="nump">5,684,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">215,799<span></span>
</td>
<td class="nump">298,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">3,660<span></span>
</td>
<td class="nump">5,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right-of-use assets</a></td>
<td class="nump">237,718<span></span>
</td>
<td class="nump">394,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Investment in marketable securities</a></td>
<td class="nump">89,001<span></span>
</td>
<td class="nump">577,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent', window );">Investment in non-marketable securities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">264,735<span></span>
</td>
<td class="nump">249,525<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Total other assets</a></td>
<td class="nump">812,413<span></span>
</td>
<td class="nump">1,526,336<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,724,535<span></span>
</td>
<td class="nump">7,210,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">13,715<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Customer deposits</a></td>
<td class="nump">279,689<span></span>
</td>
<td class="nump">236,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">157,094<span></span>
</td>
<td class="nump">154,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Other payables and accrued liabilities ($1,548 and $1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2021 and 2020, respectively.)</a></td>
<td class="nump">858,355<span></span>
</td>
<td class="nump">647,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income tax payable</a></td>
<td class="nump">3,988<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Amount due to a related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">1,312,841<span></span>
</td>
<td class="nump">1,038,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>NON-CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">83,484<span></span>
</td>
<td class="nump">241,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">15,574<span></span>
</td>
<td class="nump">5,743<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Non-current Liabilities</a></td>
<td class="nump">99,058<span></span>
</td>
<td class="nump">247,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">1,411,899<span></span>
</td>
<td class="nump">1,285,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 290,460,047 and 376,452,047 shares issued and outstanding as of December 31, 2021 and 2020, respectively.</a></td>
<td class="nump">29,046<span></span>
</td>
<td class="nump">37,645<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">6,449,215<span></span>
</td>
<td class="nump">6,440,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(3,258,687)<span></span>
</td>
<td class="num">(734,443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">93,398<span></span>
</td>
<td class="nump">181,016<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL AGAPE CORPORATION STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">3,312,972<span></span>
</td>
<td class="nump">5,924,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">NON-CONTROLLING INTERESTS</a></td>
<td class="num">(336)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">TOTAL EQUITY</a></td>
<td class="nump">3,312,636<span></span>
</td>
<td class="nump">5,924,834<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 4,724,535<span></span>
</td>
<td class="nump">$ 7,210,607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonMarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843056600776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents', window );">VIE consolidated amount of cash and cash equivalents</a></td>
<td class="nump">$ 17,493<span></span>
</td>
<td class="nump">$ 37,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes', window );">VIE consolidated amount of prepaid taxes</a></td>
<td class="nump">1,357<span></span>
</td>
<td class="nump">11,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities', window );">VIE consolidated amount of other payables and accrued liabilities</a></td>
<td class="nump">$ 1,548<span></span>
</td>
<td class="nump">$ 1,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">290,460,047<span></span>
</td>
<td class="nump">376,452,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">290,460,047<span></span>
</td>
<td class="nump">376,452,047<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>VIE consolidated amount of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>VIE consolidated amount of other payables and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>VIE consolidated amount of Prepaid taxes .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055419288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">REVENUE</a></td>
<td class="nump">$ 1,016,962<span></span>
</td>
<td class="nump">$ 3,434,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RevenueFromRelatedParty', window );">REVENUE &#8211; RELATED PARTY</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,060<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUE</a></td>
<td class="nump">1,016,962<span></span>
</td>
<td class="nump">3,452,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">COST OF REVENUE</a></td>
<td class="num">(297,333)<span></span>
</td>
<td class="num">(775,855)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS PROFIT</a></td>
<td class="nump">719,629<span></span>
</td>
<td class="nump">2,676,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">SELLING</a></td>
<td class="num">(394,682)<span></span>
</td>
<td class="num">(376,582)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">COMMISSION</a></td>
<td class="num">(316,267)<span></span>
</td>
<td class="num">(830,659)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">GENERAL AND ADMINISTRATIVE</a></td>
<td class="num">(1,745,734)<span></span>
</td>
<td class="num">(1,627,660)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">PROVISION FOR DOUBTFUL ACCOUNTS</a></td>
<td class="num">(121,514)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">TOTAL OPERATING EXPENSES</a></td>
<td class="num">(2,578,197)<span></span>
</td>
<td class="num">(2,834,901)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">LOSS FROM OPERATIONS</a></td>
<td class="num">(1,858,568)<span></span>
</td>
<td class="num">(158,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER (EXPENSES) INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (Expenses) Income, net</a></td>
<td class="num">(42,753)<span></span>
</td>
<td class="nump">164,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized holding (loss) gain on marketable securities</a></td>
<td class="num">(505,231)<span></span>
</td>
<td class="nump">350,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PreferredStockDividendIncomeStatementImpact', window );">Dividend income from marketable securities</a></td>
<td class="nump">18,939<span></span>
</td>
<td class="nump">160,062<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">TOTAL OTHER (EXPENSES) INCOME, NET</a></td>
<td class="num">(529,045)<span></span>
</td>
<td class="nump">674,482<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(LOSS) INCOME BEFORE INCOME TAXES</a></td>
<td class="num">(2,387,613)<span></span>
</td>
<td class="nump">516,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">PROVISION FOR INCOME TAXES</a></td>
<td class="num">(137,067)<span></span>
</td>
<td class="num">(161,581)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET (LOSS) INCOME</a></td>
<td class="num">(2,524,680)<span></span>
</td>
<td class="nump">354,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS</a></td>
<td class="nump">436<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION</a></td>
<td class="num">(2,524,244)<span></span>
</td>
<td class="nump">354,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">NET (LOSS) INCOME</a></td>
<td class="num">(2,524,680)<span></span>
</td>
<td class="nump">354,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>OTHER COMPREHENSIVE (LOSS) INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(87,615)<span></span>
</td>
<td class="nump">171,231<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">TOTAL COMPREHENSIVE (LOSS) INCOME</a></td>
<td class="num">(2,612,295)<span></span>
</td>
<td class="nump">525,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive loss attributable to non-controlling interests</a></td>
<td class="num">(433)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION</a></td>
<td class="num">$ (2,611,862)<span></span>
</td>
<td class="nump">$ 525,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>(LOSS) EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="nump">376,216,452<span></span>
</td>
<td class="nump">376,387,778<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PreferredStockDividendIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PreferredStockDividendIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_RevenueFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_RevenueFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesCommissionsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesCommissionsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized in the period that are directly related to the selling and distribution of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055635768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 37,628<span></span>
</td>
<td class="nump">$ 5,293,082<span></span>
</td>
<td class="num">$ (1,089,209)<span></span>
</td>
<td class="nump">$ 9,785<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4,251,286<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">376,275,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">354,766<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">354,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">1,147,534<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,147,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">176,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">171,231<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">171,231<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 37,645<span></span>
</td>
<td class="nump">6,440,616<span></span>
</td>
<td class="num">(734,443)<span></span>
</td>
<td class="nump">181,016<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,924,834<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">376,452,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,524,244)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(436)<span></span>
</td>
<td class="num">(2,524,680)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(87,618)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(87,615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of common stock</a></td>
<td class="num">$ (8,599)<span></span>
</td>
<td class="nump">8,599<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</a></td>
<td class="num">(85,992,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ContributionsFromNoncontrollingInterestShareholders', window );">Contributions from non-controlling interest shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 29,046<span></span>
</td>
<td class="nump">$ 6,449,215<span></span>
</td>
<td class="num">$ (3,258,687)<span></span>
</td>
<td class="nump">$ 93,398<span></span>
</td>
<td class="num">$ (336)<span></span>
</td>
<td class="nump">$ 3,312,636<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">290,460,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ContributionsFromNoncontrollingInterestShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contributions from non controlling interest shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ContributionsFromNoncontrollingInterestShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055541896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income</a></td>
<td class="num">$ (2,524,680)<span></span>
</td>
<td class="nump">$ 354,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">75,797<span></span>
</td>
<td class="nump">55,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization</a></td>
<td class="nump">1,961<span></span>
</td>
<td class="nump">1,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating right-of-use assets</a></td>
<td class="nump">139,451<span></span>
</td>
<td class="nump">106,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized holding loss (gain) on marketable securities</a></td>
<td class="nump">505,231<span></span>
</td>
<td class="num">(350,137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PreferredStockDividendIncomeStatementImpact', window );">Dividend income from marketable securities</a></td>
<td class="num">(18,939)<span></span>
</td>
<td class="num">(160,062)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax expense</a></td>
<td class="nump">10,127<span></span>
</td>
<td class="nump">178,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">36,241<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">121,514<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivables</a></td>
<td class="nump">167,566<span></span>
</td>
<td class="num">(165,149)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent', window );">Amount due from a related party</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">192,713<span></span>
</td>
<td class="nump">78,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">430,062<span></span>
</td>
<td class="nump">184,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepayments and deposits</a></td>
<td class="num">(128,363)<span></span>
</td>
<td class="nump">352,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Accounts payable</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,804)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Customer deposits</a></td>
<td class="nump">52,981<span></span>
</td>
<td class="num">(1,421,886)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Other payables and accrued liabilities</a></td>
<td class="nump">226,651<span></span>
</td>
<td class="nump">336,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(138,143)<span></span>
</td>
<td class="num">(105,009)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payables</a></td>
<td class="nump">3,988<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(845,842)<span></span>
</td>
<td class="num">(557,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of equipment</a></td>
<td class="num">(3,959)<span></span>
</td>
<td class="num">(4,734)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(178)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,210,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfInvestmentProjects', window );">Proceeds from sale of marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty', window );">Proceeds from sale of non-marketable securities to a related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">70,173<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(3,959)<span></span>
</td>
<td class="nump">1,276,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Deferred offering costs</a></td>
<td class="num">(15,210)<span></span>
</td>
<td class="num">(249,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">(Advances to) Repayments from related parties</a></td>
<td class="num">(3,851)<span></span>
</td>
<td class="nump">227,434<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(19,061)<span></span>
</td>
<td class="num">(22,091)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(50,890)<span></span>
</td>
<td class="nump">76,985<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(919,752)<span></span>
</td>
<td class="nump">773,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS, beginning of year</a></td>
<td class="nump">3,517,600<span></span>
</td>
<td class="nump">2,744,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS, end of year</a></td>
<td class="nump">2,597,848<span></span>
</td>
<td class="nump">3,517,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL CASH FLOWS INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">326,838<span></span>
</td>
<td class="nump">288,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>SUPPLEMENTAL NON-CASH FLOWS INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications', window );">Changes in right-of-use assets and lease liabilities due to lease modifications</a></td>
<td class="nump">3,250<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities', window );">Initial recognition of right-of-use assets and lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">483,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition', window );">Sale of non-marketable securities to a related party in exchange for acquisition payment of ASL</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">656,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition', window );">Issuance of common stock in exchange for acquisition payment of ASL</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,147,551<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes in right of use asset and lease liabilities due to lease modifications.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial recognition of right-of-use assets and lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in exchange for acquisition payment of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PreferredStockDividendIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PreferredStockDividendIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of non-marketable securities to a related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of non-marketable securities to related party in exchange for acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in related party receivables classified as other, due within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfInvestmentProjects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of investment projects held by an entity in hopes of getting a future return or interest from it.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfInvestmentProjects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057494840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS BACKGROUND<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">ORGANIZATION AND BUSINESS BACKGROUND</a></td>
<td class="text"><p id="xdx_808_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zjryWW5VR6N1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
<span id="xdx_82D_zuTOrtJQ1rSi">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation, a Nevada corporation (&#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on June 1, 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape
Superior Living Sdn. Bhd. (&#8220;ASL&#8221;), a company incorporated in Malaysia. .</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zhzQsicOITE6" title="Ownership interest percentage">100</span>% equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zFkZqBDvcHa1" title="Stock issued during period acquisitions, shares">9,590,596</span> ordinary shares, no par value, equivalent to approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200508__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zZfcYS6QRELe" title="Ownership interest percentage">99.99</span>% of the equity interest in Agape Superior Living Sdn. Bhd.,
a network marketing entity incorporated in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (&#8220;WATP&#8221;), a wholly owned subsidiary
under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services
that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (&#8220;DSY Wellness&#8221;)
with an independent third party which Agape ATP Corporation (Labuan) owns <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211111__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zwxMW21cPNK6" title="Ownership interest percentage">60</span>% of the equity interest, to pursue the business of providing
complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to
supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation,
anti-aging and products designed to improve the overall health system of the human body and various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements reflect the activities of the Company, AATP LB, AATP HK, WATP, ASL and its variable interest
entity (&#8220;VIE&#8221;), Agape S.E.A. Sdn. Bhd. (&#8220;SEA&#8221;) (See Note 3), and DSY Wellness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zwe7aFvThaG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the Company&#8217;s subsidiaries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zj3z0IqpFBQk" style="display: none">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Subsidiary company name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Place and date of incorporation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Particulars of issued capital</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Principal activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proportional of ownership interest and voting power held</td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 6%; vertical-align: top">1.</td>
    <td style="width: 2%">&#160;</td>
    <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zJXEvi6NRyUh" style="vertical-align: top; width: 16%; text-align: center" title="Subsidiary company name">Agape ATP Corporation</td><td style="width: 2%">&#160;</td>
    <td id="xdx_98B_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zzkn5rj3Uck" style="vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation">Labuan, <br/> March 6, 2017</td><td style="width: 2%">&#160;</td>
    <td id="xdx_984_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsgpDyy2TMMl" style="vertical-align: top; width: 16%; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of US$1 each</td><td style="width: 2%">&#160;</td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zoZtxcXvENgf" style="vertical-align: top; width: 16%; text-align: center" title="Principal activities">Investment holding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zicZ1wjT3AE4" style="vertical-align: top; width: 18%; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; width: 1%; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">2.</td>
    <td>&#160;</td>
    <td id="xdx_98C_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zaubThxHYBVh" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape ATP International Holding Limited</td><td>&#160;</td>
    <td id="xdx_989_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zuC7GgYsCeD7" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Hong Kong,<br/> June 1, 2017</td><td>&#160;</td>
    <td id="xdx_98E_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zdSzsaNpIea4" style="vertical-align: top; text-align: center" title="Particulars of issued capital">1,000,000 shares of ordinary share of HK$1 each</td><td>&#160;</td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zocye911l2qg" style="vertical-align: top; text-align: center" title="Principal activities">Wholesaling of health and wellness products; and health solution advisory services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z1c7ZCaUNV1f" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">3.</td>
    <td>&#160;</td>
    <td id="xdx_985_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zRcFlMWvqJ7l" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape Superior Living Sdn. Bhd.</td><td>&#160;</td>
    <td id="xdx_984_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zcs7sN0Nu5q7" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> August 8, 2003</td><td>&#160;</td>
    <td id="xdx_986_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z5dnt8C8MCpe" style="vertical-align: top; text-align: center" title="Particulars of issued capital">9,590,598 shares of ordinary share of RM1 each</td><td>&#160;</td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zpruVcSAlxS2" style="vertical-align: top; text-align: center" title="Principal activities">Health and wellness products and health solution advisory services via network marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z8X5TglxoRU1" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">99.99</td><td style="vertical-align: top; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">4.</td>
    <td>&#160;</td>
    <td id="xdx_986_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zOSA8SvcFSe8" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape S.E.A. Sdn. Bhd.</td><td>&#160;</td>
    <td id="xdx_986_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_z5D1tm2kmR9j" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> March 4, 2004</td><td>&#160;</td>
    <td id="xdx_985_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zKXQYjcIaqj4" style="vertical-align: top; text-align: center" title="Particulars of issued capital">2 shares of ordinary share of RM1 each</td><td>&#160;</td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zycxkWzXgPB5" style="vertical-align: top; text-align: center" title="Principal activities">VIE of Agape Superior Living Sdn. Bhd.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE</span></td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">5.</td>
    <td>&#160;</td>
    <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zlD30iy2ipI8" style="vertical-align: top; text-align: center" title="Subsidiary company name">Wellness ATP International Holdings Sdn, Bhd</td><td>&#160;</td>
    <td id="xdx_98E_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zQBdLUuSkqZi" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> September 11, 2020</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z7oHDCHRFsp5" style="vertical-align: top; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of RM1 each</td><td>&#160;</td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zIVr6Myj4za4" style="vertical-align: top; text-align: center" title="Principal activities">The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zuZTuMiA4XY6" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">6.</td>
    <td>&#160;</td>
    <td id="xdx_989_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zTc8c6JIi7r7" style="vertical-align: top; text-align: center" title="Subsidiary company name">DSY Wellness International Sdn Bhd.</td><td>&#160;</td>
    <td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zKS9tx910Yg9" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> November 11, 2021</td><td>&#160;</td>
    <td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_z1CtNu8Ndnue" style="vertical-align: top; text-align: center" title="Particulars of issued capital">1,000 shares of ordinary share of RM1 each</td><td>&#160;</td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zJKc7Z8ErKth" style="vertical-align: top; text-align: center" title="Principal activities">Provision of complementary health therapies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zolorxDKUq1i" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">60</td><td style="vertical-align: top; text-align: right">%</td></tr>
  </table>

<p id="xdx_8AD_zX77UpgzHdI7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
ORGANIZATION AND BUSINESS BACKGROUND (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company
primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#8220;ATP Zeta Health Program&#8221;,
which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy
lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of
modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to strengthen the Company&#8217;s supply chain, on May 8, 2020, the Company has successfully acquired approximately <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zNAp4MKs5WLe">99.99</span>% of ASL,
with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years.
ASL has been offering the Company&#8217;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy
in the Company&#8217;s operation by boosting the Company&#8217;s retail and marketing capabilities. The newly acquired subsidiary allows
the Company to fulfill its mission of &#8220;helping people to create health and wealth&#8221; by providing a financially rewarding business
opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via
ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#201;NERG&#201;TIQUE
and BEAUNIQUE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused
by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity
through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and
distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&#201;NERG&#201;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series
is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
BEAUNIQUE product series focuses on the research of our diet&#8217;s impact on modifying gene expressions in order to address genetic
variations and deliver a nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution
advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various
wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">To
further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity,
DSY Wellness International Sdn. Bhd. (&#8220;DSY Wellness&#8221;) with an independent third party which Agape ATP Corporation (Labuan)
owns 60% of the equity interest, to pursue the business of providing complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054013976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zuQiQKgWfU4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<span id="xdx_829_zm1kCRUSRHuc">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zeDlPoyXheKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#8220;U.S. GAAP&#8221;) for information pursuant to the rules and regulations of the Securities Exchange Commission
(&#8220;SEC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company
exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary.
All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zIzk1snyltAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principles
of consolidation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to
govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a
majority of votes at the meeting of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without
additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such
as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of
the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary
and must consolidate the VIE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--UseOfEstimates_zJNbiMqwRbCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use
of estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates
reflected in the Company&#8217;s consolidated financial statements include allowance for doubtful accounts, allowance for inventories
obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for
deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment
in non-marketable securities. Actual results could differ from these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z3rzciRsd7ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
and cash equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.</span></p>

<p id="xdx_85A_z7h8mKQ3Eo71" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zfLkXh3OhBMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
receivable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due
on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the
Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis,
using historical collection trends and aging of receivables. Management also periodically evaluates individual customer&#8217;s financial
condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary.
Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. The Company&#8217;s management continues to evaluate the reasonableness of the valuation allowance policy and update
it if necessary. As of December 31, 2021 and 2020, <span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20211231_zZpkZXBfDhF1" title="Accounts receivable, allowance for credit loss::XDX::-"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20201231_z2gRSfBQ4YQh" title="Accounts receivable, allowance for credit loss::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0613"><span style="-sec-ix-hidden: xdx2ixbrl0615">no</span></span></span></span> allowance of doubtful accounts was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zdaWn6gJJjD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Inventories</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life
of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net
realizable value. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021,
and 2020, the company recorded $<span id="xdx_90A_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zz2wt2LAgfC5" title="Inventories write-down">36,241</span> and $<span id="xdx_908_eus-gaap--InventoryWriteDown_pp0p0_dxL_c20200101__20201231_zB3vozrYmlpa" title="Inventories write-down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0621">0</span></span> write-downs for inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zdZoMb8wzNHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepaid
taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Prepaid
taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zqkBitGlXc97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepayments
and deposits</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services.
This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not
be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management
reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary.
Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood
of collection is not probable. The Company&#8217;s management continues to evaluate the reasonableness of the valuation allowance policy
and update it if necessary. As of December 31, 2021 and 2020, there was $<span id="xdx_902_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20211231_zOfQcpaErBJ1" title="Allowance for doubtful accounts">121,514</span> and $<span id="xdx_906_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zdfQOpCLD4Ne" title="Allowance for doubtful accounts">0</span> allowance for the doubtful accounts recorded.</span></p>

<p id="xdx_851_zmKlSpfnevK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7cYcWhlN8v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property
and equipment, net</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zSzEw3lfeing" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    and office equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment">7</span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment">7</span> years</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment">Lease
    Term</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment">5</span>
    years</span></td></tr>
  </table>
<p id="xdx_8A9_zEFPE25M0ylf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is
included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings
as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The
Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates
of useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zHEzuq48QgQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intangible
assets, net</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the
estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zvU7SXf61uW4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets">5</span>
    years</span></td></tr>
  </table>
<p id="xdx_8A7_zorLQNME5Hh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z5qzlK0tNytk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment
for long-lived assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes
in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that
the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted
future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows
expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying
value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value
based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and
2020, <span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20210101__20211231_zrSWi5qIbct2" title="Impairment of long-lived assets"><span id="xdx_902_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zLQgENYYhvLc" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets was recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--DeferredChargesPolicyTextBlock_z36dlBRJQxUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred
offering costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
offering costs represents costs associated with the Company&#8217;s current offering which will be netted against the proceeds from the
Company&#8217;s current offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--MarketableSecuritiesPolicy_zgB7vO5Vnsi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment
in marketable equity securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company follows the provisions of ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair value
with changes in fair value recognized in the Company&#8217;s unaudited condensed consolidated statements of operations and comprehensive
loss in the caption of &#8220;unrealized holding gain loss on marketable securities&#8221; in each reporting period</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p id="xdx_854_zmZq0CFspjHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_ecustom--NonMarketableSecuritiesPolicyTextBlock_z3ijwap9sP65" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment
in non-marketable equity securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Due to the Company&#8217;s non-marketable equity securities (non-current) does not
qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its
investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from
observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment
is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance,
credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or
technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical
area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed
auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that
raise significant concerns about the investee&#8217;s ability to continue as a going concern, such as negative cash flows from operations,
working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators
indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment
loss equal to the difference between the fair value of the investment and its carrying amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zTvWJ7as6POh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Customer
deposits</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced
when the related sale is recognized in accordance with the Company&#8217;s revenue recognition policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zMrTajC1AXKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue
recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core
principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods
and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange.
This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a
point in time or over time, based on when control of goods and services transfers to a customer. The Company&#8217;s revenue streams
are recognized at a point in time for the Company&#8217;s sale of health and wellness products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company
(i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate
the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies
the performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment
terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of Health and Wellness products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness
products are transferred to its customer at the Company&#8217;s office or shipment of the goods. The revenue is recorded net of estimated
discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were
insignificant sales returns</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value
of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds
resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and
wellness products transaction price upon such sales transactions occurred. The Company&#8217;s coupons have a validity period of six
months. If the Company&#8217;s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of
the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $<span id="xdx_906_ecustom--ForfeitedCouponIncome_pp0p0_c20210101__20211231_zh7G9r61F1ta">15,209</span>
and $<span id="xdx_908_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zkpNQLzrUHHf" title="Forfeited coupon income">170,431</span> as forfeited coupon income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_za2TyjvrR2mg" title="Revenue from sales">183,816</span> which it is expected
to fulfill within 12 months from December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of Health and Wellness services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company carries out its Wellness program, where the Company&#8217;s products are bundled with health screening test and a health camp
program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver
the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that
the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend
the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test
reports are completed and delivered to its customers during the consultation section in person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp
program was completed in the final day of the health camp</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zHfubZZIitA3">7,543</span> and $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zqmC0FnEsRM2">0</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated
information of revenues by products and services are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Survivor Select</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,904</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,897</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Energized Mineral Concentrate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,481</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ionized Cal-Mag</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">39,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">908,964</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Omega Blend</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">222,718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">495,567</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">BetaMaxx</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,043</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,550</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vege Fruit Fiber</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">65,757</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Iron</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,114</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,389</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Young Formula</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">653,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organic Youth Care Cleansing Bar</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Mitogize</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">183,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,801</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">No. 1 MED</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Energetique</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,574</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">253,396</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trim+</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,042</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">365,350</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenues &#8211; products</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,009,419</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Health and Wellness
    services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,543</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0721">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenues</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,016,962</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A3_zKKWWqhhjikh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--CostOfSalesPolicyTextBlock_z0ZV9KzHWuv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cost
of revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Cost
of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue
amounted to $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231_zQDKOqYEwgwe" title="Cost of revenue">297,333</span> (including inventory write-downs of $<span id="xdx_907_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zAnOlYDliz7l" title="Inventories write-down">36,241</span>) and $<span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20200101__20201231_z1I0GRSSjKHh" title="Cost of revenue">775,855</span> for the years ended December 31, 2021 and 2020, respectively</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_ecustom--ShippingAndHandlingPolicyTextBlock_zHjEmh7vgPHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Shipping
and handling</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling charges amounted to $<span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z39I3F7j8mE9" title="Selling expenses">11,054</span> and $<span id="xdx_900_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zzZpeqTGyBZa" title="Selling expenses">9,315</span> for the years ended December 31, 2021 and 2020, respectively. Shipping and handling
charges are expensed as incurred and included in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zOiXHeocTzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Advertising
costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
costs amounted to $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20210101__20211231_z2FuMLE61324" title="Advertising costs">20,218</span> and $<span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zuyisFdiELCe" title="Advertising costs">14,339</span> for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as
incurred and included in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zbeXzIh9K1Xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Commission
expenses </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
expenses are the Company&#8217;s most significant expenses. As with all companies in the network marketing industry, the Company&#8217;s
sales channel is external to the Company. The Company&#8217;s &#8220;external sales force&#8221; is stratified into two levels based
on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly,
are referred to as &#8220;sales network members&#8221;. The Company pays commission to every sales distributor based on purchases made
by its sales network members which includes the independent</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">direct
sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy
benefits such as maintaining a certain amount of the Company&#8217;s inventory on their store premises. The stockists shall account to
the Company for all products sales from their store premises as monitored through the Company&#8217;s centralized stock tracking system.
The Company pays a separate commission to stockists based on revenue generated from the stockists&#8217; physical stores. Commission
expenses amounted to $<span id="xdx_909_ecustom--SalesCommissionsAndFees1_pp0p0_c20210101__20211231_z6ZNeK45NC3j" title="Commission expenses">316,267</span> and $<span id="xdx_900_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zSxc8j1L6f32" title="Commission expenses">830,659</span> for the years ended December 31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_ecustom--DefinedContributionPlanPolicyTextBlock_zkZvS1Yq0XF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span style="text-decoration: underline">Defined
contribution plan</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue
and pay for these benefits based on certain percentages of the employees&#8217; respective salaries, subject to certain ceilings, in
accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Total expenses for the plans were $<span id="xdx_900_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20210101__20211231_zgJgN31MZHD5" title="Defined contribution plan expense">99,488</span> and $<span id="xdx_90B_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_z5f6ZzaKecgf" title="Defined contribution plan expense">75,802</span> for the years ended December 31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
related contribution plans include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Social
    Security Organization (&#8220;SOSCO&#8221;) &#8211; <span id="xdx_90E_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_ze4TdFb1Fj2" title="Salary percentage">1.75</span>% based on employee&#8217;s monthly salary capped of RM <span id="xdx_90C_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zUmbVWZyicu9" title="Monthly salary">4,000</span>;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
    Provident Fund (&#8220;EPF&#8221;) &#8211; <span id="xdx_905_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_zVn7Eiyly6O8" title="Salary percentage">12</span>% based on employee&#8217;s monthly salary;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Insurance System (&#8220;EIS&#8221;) &#8211; <span id="xdx_906_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zhFZHd7oCLi1" title="Salary percentage">0.2</span>% based on employee&#8217;s monthly salary capped of RM <span id="xdx_903_ecustom--MonthlySalary_pp0p0_uRM_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zavxrZi1P9Ul" title="Monthly salary">4,000</span>;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Human
    Resource Development Fund (&#8220;HRDF&#8221;) &#8211; <span id="xdx_900_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zt0N8oBqBNq" title="Salary percentage">1</span>% based on employee&#8217;s monthly salary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z5jmFnxmDe13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income
taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for
the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted
or substantively enacted by the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the
carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation
of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences
can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the
liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged
directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
uncertain tax position is recognized as a benefit only if it is &#8220;more likely than not&#8221; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is <span id="xdx_907_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210101__20211231_zI0BK4zQ6X15" title="Income tax examination, likelihood of unfavorable settlement">greater than 50%</span> likely of being realized on examination. For tax positions not meeting the &#8220;more likely than not&#8221; test,
no tax benefit is recorded. $<span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20210101__20211231_zhtHJHFt04F7" title="Income tax examination, penalties and interest expense">395</span> and $<span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20200101__20201231_zwgUz8si7Xxk" title="Income tax examination, penalties and interest expense">0</span> penalties and interest incurred related to underpayment of income tax for the years ended December
31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a
result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zFmJhQqD6MOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comprehensive
income (loss)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss)
refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#8217; equity but are excluded
from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not
using the U.S. dollar as its functional currencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_ecustom--NoncontrollingInterestPolicyTextBlock_zvodLWm7yptb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-controlling
interest</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--MinorityInterestDescription_c20210101__20211231_z2jVyFk7GMzi" title="Noncontrolling interest, description">Non-controlling
interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out
of 9,590,598 shares) of the equity interests of ASL held by two individuals</span>. The non-controlling interests are presented in the consolidated
balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the
Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods
between non-controlling interest holders and the shareholders of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zZGPhNuzFDjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Earnings
(loss) per share</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company computes earnings (loss) per share (&#8220;EPS&#8221;) in accordance with ASC 260, &#8220;Earnings per Share&#8221;. ASC 260
requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share
outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible
securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later.
Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are
excluded from the calculation of diluted EPS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. For the
years ended December 31, 2021 and 2020, there were <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20210101__20211231_z6oZ7p2bv9Mf" title="Potentially dilutive securities outstanding"><span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20200101__20201231_zVXiU2cpuCAc" title="Potentially dilutive securities outstanding">no</span></span> dilutive shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8AGmGK5QsX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
currencies translation and transaction</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing
at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated
into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded
in the consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have been expressed
in US$. The Company&#8217;s subsidiary in Labuan maintains its books and record in United States Dollars (&#8220;US$&#8221;) albeit its
functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit
(&#8220;MYR&#8221; or &#8220;RM&#8221;). The Company&#8217;s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars
(&#8220;HK$&#8221;), similar to its functional currency. The Company&#8217;s subsidiary and VIE in Malaysia conducts its businesses and
maintains its books and record in the local currency, Malaysian Ringgit (&#8220;MYR&#8221; or &#8220;RM&#8221;), as its functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into
US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate on the balance
sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation
of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the
statements of stockholders&#8217; equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts
reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance
sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end MYR : US$1 exchange
    rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.02</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average MYR : US$1 exchange
    rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.20</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A5_zqNifIeILn8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_ecustom--RelatedPartiesPolicyTextBlock_zrQDAfgxw1sl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related
parties</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFEmgvJtixod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
value of financial instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and
requires disclosure of the fair value of financial instruments held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance
disclosure requirements for fair value measures. The three levels are defined as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that
    are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost,
which approximate fair value because of the short period of time between the origination of such instruments and their expected realization
and their current market rates of interest.</span></p>

<p id="xdx_854_zbiKkVXe0pQi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zZNdDkKBmvPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopts ASU 2016-02, &#8220;Leases&#8221; (Topic 842), and elected the practical expedients that does not require the Company
to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing
leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted
to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient
that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company&#8217;s leases
include one or more options to renew, which is typically at the Company&#8217;s sole discretion. The Company regularly evaluates the
renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications
result in re-measurement of the right of use (&#8220;ROU&#8221;) assets and lease liabilities. Operating ROU assets and lease liabilities
are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for
the Company&#8217;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available
at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that
the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment
and over a similar term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease,
as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers
the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected
the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve
months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives.
Lease expense is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews
the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the
asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset
from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount
of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future
pre-tax cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwRa40sJZ3q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent
accounting pronouncements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of
such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic
326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement
of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments
in Update 2016-13 added Topic 326, Financial Instruments&#8212;Credit Losses, and made several consequential amendments to the Codification.
Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses
when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments&#8212; Credit Losses&#8212;Available-for-Sale
Debt Securities. The amendments in this Update address those stakeholders&#8217; concerns by providing an option to irrevocably elect
the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition
relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar
financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments
in Update 2016-13 while still providing financial statement users with decision-useful information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit
organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date
for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim
reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating
the impact ASU 2019-05 may have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments
accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options
accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should
consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement
alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts
or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity
should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing
investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance
with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted,
including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-08, &#8220;Codification Improvements to Subtopic 310-20, Receivables&#8212;Nonrefundable Fees
and Other Costs&#8221;. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification
easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the
Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply
the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable
debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021
did not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-10, &#8220;Codification Improvements&#8221;. The amendments in this Update represent changes to
clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current
accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety
of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is
effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments
in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on
its consolidated financial statements.</span></p>

<p id="xdx_85B_z1wiGXOwYsl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843139586232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--VariableInterestEntityDisclosureTextBlock_zgIAe8pTJwf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.<span id="xdx_826_zJTc7N756JKh">
VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEA
is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided majority of ASL&#8217;s purchases. Its equity
at risk was insufficient to finance its activities and <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zCTAPQB3ObJb" title="Ownership interest percentage">100</span>% of its business is transacted with ASL. Therefore, it was considered to be
a VIE and ASL is the primary beneficiary since it has both of the following characteristics:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the
    VIE that could potentially be significant to the VIE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the accounts of SEA is consolidated in the accompanying financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_ziGf9DSLZguk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of the VIE&#8217;s assets and liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_z3zsHjUhKgR2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF VARIABLE INTEREST ENTITY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zBBDeiE1qBYf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_z2TTLKve29le"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_iI_zG66KK7YK2o8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,850</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesCurrent_iNI_di_zPrH2WbQg587" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(51,272</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(53,573</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--StockholdersEquity_iI_zPkIAvNRIe8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,856</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zW698uRlRrVl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zWYlp147wSI9"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_zMxrxRs5Smr9" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,387</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidTaxes_iI_zRfWUPLsX9ga" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,357</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsCurrent_iI_zEyDHieHajs8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,717</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_z8jU9wyuZVP9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable &#8211; intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">49,724</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--OtherPayablesRelatedPartyCurrent_iI_z1TajavnLNl5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables and accrued
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,548</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,904</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iI_zNU60IeGzAIc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,272</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">53,573</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquity_iI_zbeklS8QD69c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,856</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
summarized operating results of the VIE&#8217;s are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_499_20210101__20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zi6p0xMmPGM2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zk2JEF1orUyc"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zJkAWrUJn7vg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    revenues</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">346,907</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--GrossProfit_z8WN2B2SZ4M4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,442</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_z7P4DubEetea" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss from operations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,752</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_z9kg1Cro03Zj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(27,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,014</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p id="xdx_8A5_z9XMfeKjRbje" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057480344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATION</a></td>
<td class="text"><p id="xdx_807_eus-gaap--BusinessCombinationDisclosureTextBlock_zHKYl8jArZKf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
<span id="xdx_82E_znKBt4nMZKba">BUSINESS COMBINATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 8, 2020, the Company entered into a Share Exchange Agreement (&#8220;SPA&#8221;) with Mr. How Kok Choong, CEO and director of the
Company to acquire <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zpoIx15294x9" title="Stock issued during period acquisitions, shares">9,590,596</span> ordinary shares, <span id="xdx_903_eus-gaap--CommonStockNoParValue_iI_pid_do_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zusXLrQtxMGg" title="Ordinary shares no par value">no</span> par value, equivalent to approximately <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_znvYx7HfnLQh" title="Ownership interest percentage">99.99</span>% of the equity interest in ASL, an entity
incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration of $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200629__20200702__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zDegVsPKsyCi" title="Purchase consideration value">1,804,046</span>,
which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration shall be satisfied
by (i) the offset of the Consideration whereby the Company has a loan receivable of $<span id="xdx_906_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_pp0p0_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zqnnhV1u2Yrl" title="Loan payable">656,495</span> as of March 31, 2020 due from Mr. How; and
(ii) allotment and issuance of common stock of the Company. The Company shall allot and issue <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z1n36MvAuTgd" title="Stock issued during period acquisitions, shares">176,547</span> shares of the Company&#8217;s common
stock, par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zweck9JWKzxa" title="Common stock par value">0.0001</span>, representing approximately <span id="xdx_90F_ecustom--PercentageOfCommonStockIssuedAndOutstanding_pid_dp_uPure_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_ztBialGaIA75" title="Percentage of common stock issued and outstanding">0.0469</span>% of the total issued and outstanding shares in the Company after the issuance
of the Shares, which is valued at $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zcDFdmnq1Mob" title="Stock issued during period, value, acquisitions">1,147,551</span> based on the closing price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20200331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zweSXWsFrjuc" title="Purchased price per shares">6.50</span> of the Company as quoted on the OTC Market on March
31, 2020. As of December 31, 2020, the Company has issued all <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zOYczuv65Dse" title="Issuance of common stock shares">176,547</span> shares of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated
the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020
as ASL was under the common control of Mr. How.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z9hQbHfHjE47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which
represents the net purchase price allocation on the date of the acquisition of ASL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BF_zZ9ze4vUt6Xf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20211231_zi5gZGfDW912" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Carry
    Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zFootoo6DkQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 80%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,206,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zPCfRzzCqFe2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,210</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_iI_zvU4mN9Vlab4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables - related
    parties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,121</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_z4KcdNuvJtvf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Inventories</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">616,880</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_iI_zIZKzHM3w2W" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,206,821</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zUn3enkZbJpk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepayments
    and other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">318,267</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zKz3awcUZDTd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,600,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_ztkI3wRKXP4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment,
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">325,648</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zLClQ04mPaFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,686</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_z5dLrc78mnxc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    taxes asset, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,250</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_zBZrA7c0ltt3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">504,584</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zPuB2iDXZjri" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,105,376</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES AND SHAREHOLDERS&#8217;
    EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zT38U9zsO3Kf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable - related
    party</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">491,628</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_zhCBrTvOaBml" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Customer deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,600,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_z9N5VJeANSV8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    payables and accrued liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">209,096</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_zCmXdCjZO6z7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,301,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zQvCrxEVwmn1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,301,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zq2ThSccWRP9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    net assets acquired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,804,046</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A0_zv4jqD0Ky8K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
BUSINESS COMBINATION (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited pro forma combined results of operations presents the Company&#8217;s financial results as if the acquisition of
ASL had been completed on January 1, 2020. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings
which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily
indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2020. Future
results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other
factors.</span></p>

<p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zseqpulCa5J1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B9_zZVcZYoKTnPc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE
OF PRO FORMA BUSINESS COMBINATION</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200101__20201231_zuUagwDfcb66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the year ended December 31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaRevenue_zuz6pejZgaNh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,693,873</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_zhoMOdVTbnj8" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(875,708</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_406_ecustom--BusinessAcquisitionsProFormaGrossProfit_zEF3eZHqnGUj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,818,165</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_zXatwYMBeZoa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,839,184</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zBEyIiiyyL8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;Loss from operations</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,019</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_zWFdgUfqokuj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other income (expense),
    net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">267,633</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_z7tgSGvyyUyh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income before income taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">246,614</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_zGrdUgLWVzZ6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income
    taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(212,414</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBg35qlM6qO3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,200</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_zX5mlxsNMQ4h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income per common
    share - basic and diluted</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_zq1dvEl2L7o7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number
    of common shares outstanding - basic and diluted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">376,452,047</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AC_zbm6HAfwykq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057490120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH AND CASH EQUIVALENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock', window );">CASH AND CASH EQUIVALENTS</a></td>
<td class="text"><p id="xdx_800_eus-gaap--CashAndCashEquivalentsDisclosureTextBlock_zN9IiYDlrq18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.<span id="xdx_821_zPrw6JX8HjPe">
CASH AND CASH EQUIVALENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of December 31, 2021 and 2020 the Company had $<span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20211231_zAF6iYXW4g7d" title="Cash and cash equivalents">2,597,848</span> and $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20201231_zFh1Og884st3" title="Cash and cash equivalents">3,517,600</span>, respectively, of cash and cash equivalents, which consists of
$<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20211231_zvcHm0WlQDP8" title="Cash in bank">554,864</span> and $<span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20201231_zyxICel5xP62" title="Cash in bank">1,112,147</span>, respectively, of cash in banks and </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_eus-gaap--TimeDeposits_iI_pp0p0_c20211231_zWVS7j9hfk68" title="Time deposits">1,975,347
</span><span style="background-color: white">and $</span><span id="xdx_905_eus-gaap--TimeDeposits_iI_pp0p0_c20201231_zaqEdjOZL1ua" title="Time deposits">2,391,182</span><span style="background-color: white">, respectively, of time deposits placed
with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The
effective interest rate for the time deposits ranges between <span id="xdx_90D_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pid_dp_uPure_c20211231__srt--RangeAxis__srt--MinimumMember_zuytjcggSXAi" title="Percentage of Interest rate for time deposits">1.10</span>% to <span id="xdx_905_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pid_dp_uPure_c20211231__srt--RangeAxis__srt--MaximumMember_zTHpOlCuwpM7" title="Percentage of Interest rate for time deposits">1.25</span>% per annum.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057461624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text"><p id="xdx_802_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zANB6XTXVI5g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>6.
<span id="xdx_82C_zYmOLmtj2Z9j">ACCOUNTS RECEIVABLE </span></b></span></p>

<p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zHmyEyZzWE14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BC_ze0iPUfvtWL5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF ACCOUNTS RECEIVABLES - RELATED PARTY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_49F_20211231_z9PPc3k8pk4f" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_490_20201231_zpm43E1b5fV" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zQm67i8MAm51" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts receivable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,757</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_z7wtfqwZytyb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance for doubtful
    accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zPkkNTIE1sq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0980">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,757</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AE_z5OUP4FoMg1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843053965832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zWQmZCymz9Tf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
<span id="xdx_82C_zeqCj0uim1ai">INVENTORIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zruvM8S4PaXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zGTxmw5qLZR1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF INVENTORIES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20211231_ztBtShzWBIic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20201231_zNoSlNQMm9L6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_zBWMRwP1vewa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Finished
    goods</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">375,535</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">589,814</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A4_zUGBK5Y1QI1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2021 and 2020, the Company recognized $<span id="xdx_90F_eus-gaap--InventoryWriteDown_c20210101__20211231_z979lnJ6UNTe" title="Inventory write-down">36,241</span> and $<span id="xdx_900_eus-gaap--InventoryWriteDown_dxL_c20200101__20201231_zzWgX0JuZkbf" title="Inventory write-down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0992">0</span></span> inventory write-down, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054069784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAYMENTS AND DEPOSITS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosurePrepaymentsAndDepositsAbstract', window );"><strong>Prepayments And Deposits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrepaymentsAndDepositsTextBlock', window );">PREPAYMENTS AND DEPOSITS</a></td>
<td class="text"><p id="xdx_800_ecustom--PrepaymentsAndDepositsTextBlock_zi54yOr6XXOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>8.<span id="xdx_828_zvy7XAm3hLm9">
PREPAYMENTS AND DEPOSITS</span></b></span></p>

<p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zAtd04mFJGJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B8_zF59P1dp47df" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;SCHEDULE
OF PREPAID EXPENSES AND DEPOSITS</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_494_20211231_ziMwpEOwIyHf" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_499_20201231_zDrpQH6b7sf8" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zH01auAciTqf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Receivables from sales distributors</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,379</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,302</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zE6hh4Mu4raj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deposits to suppliers</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">301,233</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">261,068</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--PrepaidExpensesGross_iTI_pp0p0_mtPEGzE1e_maPEAOAzys7_z6VlCHZfPes6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">416,612</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">296,370</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iNI_di_msPEAOAzys7_zq8mIhkKa9yd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Provision for
    doubtful accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(121,095</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzys7_z2yGv6cu952d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">295,517</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">296,370</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AC_zFsIeNl1R1Hk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_ecustom--ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_zZ1SZcciBJrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Movements
of allowance for doubtful accounts are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zOtTmiuBvtG2">SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zZywmLOnsVpa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20200101__20201231_zsnq60MWSzPj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_z4xFzw1tofAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1015">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zMeD0XKlg3s3" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Addition</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">121,514</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1019">&#160;</span></span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_zegPRvqut4vb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Write off</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1021">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1022">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_zpM2sAxNIGX1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(419</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1025">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_zFnjY6bhglQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right">121,095</td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zl57uYqJW8je" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosurePrepaymentsAndDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosurePrepaymentsAndDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PrepaymentsAndDepositsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepayments and Deposits [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PrepaymentsAndDepositsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843053965832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text"><p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zdFbnLwIqJU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
<span id="xdx_823_zFwRIn243Otd">PROPERTY AND EQUIPMENT, NET</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zEBQDGv1UhV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment, net consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_z6ieX65Jn6Ue" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20211231_z69fX0OmVDf5" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20201231_zRECSdxyxbj9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z1Gff565WJv3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer and office equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">82,298</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,437</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zo9mxKzC7fRe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture &amp; fixtures</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122,185</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">126,966</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zzUJMFAELrt3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,570</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">210,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zwHzILui9WXb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vehicle</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,702</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,564</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENz5ZB_zFJIlVBSdyEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">505,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">521,463</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENz5ZB_ztuoRLZe8B4l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(289,956</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(223,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENz5ZB_zinKGvSYnjR3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">215,799</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">298,309</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zJqojgI1LHf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for the years ended December 31, 2021 and 2020 amounted to $<span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20210101__20211231_zJNO1NybsZH9" title="Depreciation">75,797</span> and $<span id="xdx_905_eus-gaap--Depreciation_pp0p0_c20200101__20201231_z0ECCJVEMrdg" title="Depreciation">55,407</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057457720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS, NET</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--IntangibleAssetsDisclosureTextBlock_zGFkmRZ9XRW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.
<span id="xdx_827_zTIa8dhIaRyj">INTANGIBLE ASSETS, NET</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zc9eZtE2O7pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets, net, consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zvNaeIFuni2l" style="display: none">SCHEDULE OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20211231_zlsQm9npWeH9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_zQQB9ihbGkUb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzvmN_zYwict1pvqZf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer software</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,453</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,801</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzvmN_zOdvLeC8fWvk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30,793</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(29,975</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzvmN_zOsuj2cfJOZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,660</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,826</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AE_zaBwp2p2Umjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the years ended December 31, 2021 and 2020 amounted to $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_zDu4asXu3k5g" title="Amortization expense">1,961</span> and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200101__20201231_zwHERLSxH47b" title="Amortization expense">1,505</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843053996376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN MARKETABLE SECURITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract', window );"><strong>Investment In Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInMarketableSecuritiesTextBlock', window );">INVESTMENT IN MARKETABLE SECURITIES</a></td>
<td class="text"><p id="xdx_801_ecustom--InvestmentInMarketableSecuritiesTextBlock_z0AE31WvZSt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.
<span id="xdx_829_z7a3r8822GN1">INVESTMENT IN MARKETABLE SECURITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    May 17, 2018, the Company purchased <span id="xdx_907_eus-gaap--InvestmentOwnedBalanceShares_iI_pid_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zW7uOLKzpNUd" title="Investment in securities, shares">83,333</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90E_eus-gaap--InvestmentOwnedAtCost_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount">500,000</span> at a purchase price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zvq8oNqx3jSf" title="Purchased price per shares">6</span>
    per share.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    July 30, 2018, the Company disposed <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pdd" title="Investment in securities, shares">20</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90D_eus-gaap--InvestmentOwnedAtCost_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount">125</span> at a purchase price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_ztkqpm5Y2GG2" title="Purchased price per shares">6.2613</span> per
    share.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 16, 2018, the Company purchased <span id="xdx_907_eus-gaap--InvestmentOwnedBalanceShares_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pdd" title="Investment in securities, shares">33,333</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90B_eus-gaap--InvestmentOwnedAtCost_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount">1,000</span> at a purchase price of
    $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zHz9zDfeYGA5" title="Purchased price per shares">0.03</span> per share.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    November 3, 2020, the Company received dividend of <span id="xdx_900_eus-gaap--InvestmentOwnedBalanceShares_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Investment in securities, shares">6,667</span> shares of common stock in DSwiss, Inc. for $<span id="xdx_902_eus-gaap--InvestmentOwnedAtCost_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_pp0p0" title="Investment amount">76,671</span> at fair value of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_ztuzYabimIV3" title="Purchased price per shares">11.50</span>
    per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#8217;s shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 9, 2020, the Company received dividend of <span id="xdx_909_eus-gaap--InvestmentOwnedBalanceShares_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Investment in securities, shares">16,663</span> shares of common stock in DSwiss, Inc. for $<span id="xdx_904_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zQYdItS6YA95" title="Investment amount">83,315</span> at fair value of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Purchased price per shares">5</span>
    per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#8217;s shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 27, 2021, the Company received dividend of <span id="xdx_90A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_zWxOSeW7TGKc" title="Investment in securities, shares">11,665</span> shares of common stock in SEATech Ventures Corp. for $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_zFB6M57yUM7h" title="Investment amount">18,874</span> at fair
    value of $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_z7ktyxfuiRa9" title="Purchased price per shares">1.62</span> per share from Greenpro Capital Corp as a dividend income since Greenpro Capital Corp previously owned these shares.</span></td></tr>
  </table>
<p id="xdx_895_eus-gaap--MarketableSecuritiesTextBlock_zFEm35wnJK17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zsAchnQKts4f" style="display: none">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20211231_zOIHppVaOEHj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20201231_zzMhWcyrOVu3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_maMSNzd9C_zg0L5qKThXZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">577,035</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,484</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--InvestmentsIncomeDividend_iNI_pp0p0_di_msMSNzd9C_zsGc1FQujud7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend income from Greenpro Capital Corp.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">160,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingGainLoss_iNI_pp0p0_di_msMSNzd9C_zVxQoo2AjMif" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized holding (loss) gain</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(505,231</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">350,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maMSNzd9C_zePn8dcJ0vrh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,742</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">352</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzd9C_z7o7Scdcq463" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in marketable
    securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">89,001</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">577,035</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A5_zNnaIx5tgoTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInMarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment In Marketable Securities [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054122232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN NON-MARKETABLE SECURITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract', window );"><strong>Investment In Non-marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesTextBlock', window );">INVESTMENT IN NON-MARKETABLE SECURITIES</a></td>
<td class="text"><p id="xdx_803_ecustom--InvestmentInNonMarketableSecuritiesTextBlock_zKKN32Sk8rPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
<span id="xdx_82B_zFhzKN0NPudl">INVESTMENT IN NON-MARKETABLE SECURITIES</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company invested in Unreserved Sdn Bhd with the investment amount of $<span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_zOzj0LJ5N4hf" title="Investment amount">863,592</span> (RM <span id="xdx_90C_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_uRM_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_za2jMxdkzOql" title="Investment amount">3,500,000</span>), which approximated <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_z1zlrHooYPvc" title="Equity interest percentage">20</span>% of the equity interest
of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019, Unreserved Sdn Bhd issued additional
common stock for working capital. As the Company did not subscribe for the additional common stock, the Company&#8217;s equity interest
in investee company was diluted from approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190310__srt--RangeAxis__srt--MaximumMember_zljfcnZ7avah" title="Equity interest percentage">20.0</span>% to approximately <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190310__srt--RangeAxis__srt--MinimumMember_zGiCNJfyafw3" title="Equity interest percentage">17.86</span>%. Effective from March 10, 2019, the Company discontinued
equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date.
Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unreserved
Sdn Bhd was incorporated in Malaysia with <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zhdFQ9osSjyf" title="Ordinary shares authorized">2,500,000</span> ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim
and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April
30, 2018 to March 27, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 3, 2020, the Company agreed to sell the <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200303__srt--TitleOfIndividualAxis__custom--UnreservedSdnBhdMember_zaojmIJ84KR8" title="Equity interest percentage">17.86</span>% ownership interest in Unreserved Sdn Bhd at the December 31, 2019 carrying value
of $<span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z4ELyUEMCqE6" title="Investment amount">730,637</span> to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $<span id="xdx_901_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_pp0p0_c20200101__20200331_zPNqRIEKcNS" title="Proceeds from investments">70,173</span>, and had an amount due
from director of $<span id="xdx_900_eus-gaap--DueFromOfficersOrStockholdersCurrent_iI_pp0p0_c20200331__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zenllgMTtRwd" title="Amount due from director">660,464</span> at March 31, 2020. In May 2020, the entire outstanding balance was settled as part of the consideration in
a transaction which the Company had acquired the CEO&#8217;s ownership interest of Agape Superior Living Sdn. Bhd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 3, 2019, the Company purchased a <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zxu1gkHqNZ41" title="Equity interest percentage">5</span>% of stock or <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pid_c20190403__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z7xvZX5Hj17d" title="Shares purchased during period">15,000,000</span> shares of common stock in Phoenix Plus Corp. for $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zJOhCu4LBiZ2" title="Investment amount">1,500</span> at purchase
price of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zr5Q9hljmw52" title="Shares Issued, Price Per Share">0.0001</span> per share.</span></p>

<p id="xdx_89A_ecustom--NonMarketableSecuritiesTableTextBlock_zkOWturFo6n8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zfbB1nvQU2N9" style="display: none">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Unreserved Sdn Bhd</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable securities</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zf4RgvPstRU5" style="width: 16%; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1163">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--InvestmentInNonMarketableSecuritiesGross_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">730,637</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less:
    Sale of investment in non-marketable securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zQs5QiPliqOi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1167">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">(730,637</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable
    securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zgdeHJqreulj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--InvestmentInNonmarketableSecuritiesNet_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Phoenix Plus
    Corporation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zgS1H7OUcv5i" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total investment in
    non-marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z4dw6o4mr5x8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AB_zdXgg29CBYk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment In Non Marketable Securities [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843053998408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER PAYABLES AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">OTHER PAYABLES AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--OtherLiabilitiesDisclosureTextBlock_z13zBm5NrVYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
<span id="xdx_828_zttG9nD8Dwia">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p>

<p id="xdx_898_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zRfJrGJiy5X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B1_zQzlwQRdDWch" style="display: none">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20211231_zEx06MSFkNDg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_z914hOdXEpA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">436,541</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">297,636</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AccruedPromotionExpenses_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Promotion expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,433</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Payroll</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,976</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Commission</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,721</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">224,711</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">143,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,921</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--OtherAccountPayableAndAccruedLiabilities_iTIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">858,355</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">647,677</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AC_z5O1v57TAlQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054116440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY BALANCES AND TRANSACTIONS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zy6L4RvrFZF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
<span id="xdx_827_zRgcik2Js4A6">RELATED PARTY BALANCES AND TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related
party balances</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
due from related parties</b></span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zcAQ3zTAOKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z8lWSWKWUU0c" style="display: none">SCHEDULE OF RELATED PARTIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name
    of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December
    31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape ATP
    (Asia) Limited (&#8220;AATP Asia&#8221;)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zFh7IyxtMaig" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zrYM4jVMEh4i" title="Relationship">Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zT5TKVhB1k1h" title="Nature"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zuDhF7hq7hH3" title="Nature">Expenses
    paid for AATP Asia</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zBPYNcd3xTze" style="width: 14%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">2,214</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zWkTG45rUsf" style="width: 12%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">2,227</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Hostastay Sdn. Bhd.</span></p>
                                                      <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#8220;Hostastay&#8221;&#160;</span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoHMJVFDgqqg" title="Relationship"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zj7Cls3LGfj1" title="Relationship">Mr. How Kok Choong,
    the CEO and director of the Company is also the director of Hostastay</span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_z96bkEc6Hqk9" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zOKpJukAbQx8" title="Nature">Sublease rent due from
    Hostastay</span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zIRfbce6jjj6" style="text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">4,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zf4Uas6lnH9a" style="text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">996</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">TH3 Technology Sdn Bhd</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#8220;TH3&#160;</span>Technology&#8221;</p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdMAMDlv2nHd" title="Relationship"><span id="xdx_90C_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zRRw54uNEw4h" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zF0Z2g5QwuVc" title="Nature"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zOLs3a1wFca1" title="Nature">Expenses
    paid for TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zBS833tKI6Ca" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdoHLYF8dUGb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231_zXf0bP8Tyebk" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">7,004</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_z1apLzBjnaN1" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">3,235</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
due to a Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December
    31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape
    Superior Living Pty Ltd</span> &#8220;ASLPL&#8221;</td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zjaffT4I6jli" style="font-family: Times New Roman, Times, Serif" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 1.5pt; width: 18%; text-align: center"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zTcNtnTuIgMj" style="font-family: Times New Roman, Times, Serif">ATP
    Label Printing Fees</span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zGltgxrHs6Fk" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zfnwEeWUjRli" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zO3PaOw8ZMM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zonoooHgiBe8" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
RELATED PARTY BALANCES AND TRANSACTIONS (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related
party transactions </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">For the years
    ended December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape Superior
    Living Pty Ltd (&#8220;ASLPL&#8221;)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zcC2giDupOh6" title="Relationship"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zW9HzqMSxgMb" title="Relationship">Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; width: 18%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z4Lv347M7n3e" title="Nature"><span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zH9KjlqHYSA1" title="Nature">Sales of
    products</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zGbEXE87uPu9" style="width: 14%; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zLj2DGzHvADi" style="width: 12%; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">18,060</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><span id="xdx_F4C_zm8QfSbpOFne" style="font-family: Times New Roman, Times, Serif">Vettons
    Sdn Bhd*</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zugLfroRtprc" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zZvVq3EoCVc1" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zuQtzdRYWHvj" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zb7z4MtJu9pk" title="Nature">Sales
    of products made through its platform</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____z2oh2awX7Fzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">6,625</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_fKg_____zvzZZ9Lr1X8e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231_zZMNas14GZie" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">6,625</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zbXwpniv32xe" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">18,060</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b id="xdx_F07_z3qCnTQjHwmg">*</b></span></td>
  <td style="text-align: justify"><span id="xdx_F1F_zurIKlX1VP8l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company had sales
of $<span id="xdx_90F_eus-gaap--RevenueFromRelatedParties_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_za0RKbuWThr6" title="Revenue">6,625</span> through the online platform owned by Vettons Sdn Bhd (&#8220;Vettons&#8221;). Vettons is a related party since Mr. How Kok
Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchase</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left; padding-bottom: 1.5pt">DSY Wellness &amp; Longevity Center Sdn Bhd</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zztjihGbEJi" title="Relationship"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKgGDN0XOXqi" title="Relationship">Dato&#8217; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp; Longevity Center Sdn Bhd</span></span>.</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z4AK4a2VPoge" title="Nature"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zd3zORUqsxXh" title="Nature">Purchase</span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z0MaSzrnIaGf" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Purchase">718</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zcp8pULpTfJd" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl1301">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231_zxjPSxdzQeW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">718</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231_zWmsGiHMPUr3" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl1305">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold"/><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years
    ended December 31, </b></span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name
    of Related Party</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mr.
    How Kok Choong</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zS3c71XRkOpc" title="Relationship"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKe4t3D9pIBh" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company</span></span>.</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zGlq7z43t2vb" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zpnZEXPuCsjk" title="Nature">Commission
    expense</span></span></span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zVewcRjCItP4" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,758</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_z6srxupaaap9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,740</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SalesCommissionsAndFee_pdp0_c20210101__20211231_zMp01UdDmLWb" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"><span style="font-family: Times New Roman, Times, Serif">12,758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SalesCommissionsAndFee_pp0p0_c20200101__20201231_zIjLrUletGIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"><span style="font-family: Times New Roman, Times, Serif">10,740</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td rowspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Related Party</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the years ended December 31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hostastay
    Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQlgHq1wqYgl" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zdoJWj8m3jsi" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zZNbTceC974g" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zhxZicsFyDNg" title="Nature">Sublease
    rental income due from Hostastay</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--OtherIncome_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zutdgJUpW8Cf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,345</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eus-gaap--OtherIncome_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zvIxFJm9Nj04" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,881</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20210101__20211231_zid26QmKtftg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,345</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zjuv3Lyf9VN9" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,881</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A5_zcO7cQRA7zP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057488136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z1EoTOmM1nR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.
<span id="xdx_825_zWGqCJHetoAe">STOCKHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Preferred
stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 and 2020, there were <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zzJK3vpWjnfd" title="Preferred stock, shares authorized"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_zZTCjEPkdvyc" title="Preferred stock, shares authorized">200,000,000</span></span> preferred stocks authorized but <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_dn_c20211231_zeqmFolebPa9" title="Preferred stock, shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20211231_zlgRdq6m3g6k" title="Preferred stock, shares outstanding"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_dn_c20201231_zScliMtehWfh" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20201231_zwdvKtJIUPNb" title="Preferred stock, shares outstanding">none</span></span></span></span> were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Common
stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 and 2020, there were <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_z22kJHDEj365" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20201231_znNHnqB3ZfWf" title="Common stock, shares authorized">1,000,000,000</span></span> common stocks authorized, <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20211231_zmGeXMXqDgp7" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zKb4SWubZpV8" title="Common stock, shares outstanding">290,460,047</span></span> and <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20201231_zgegkGXH9Sq7" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20201231_zmPjVDc0StK9" title="Common stock, shares outstanding">376,452,047</span></span> shares issued and outstanding,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2020, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200501__20200531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zKsJrx6OXHpk" title="Stock issued during period acquisitions, shares">162,694</span> shares of the Company&#8217;s common stock in connection with the acquisition of ASL as part of
the acquisition payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased
by $<span id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_c20210630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zInmgVQjYzad" title="Business combination, recognized identifiable assets acquired and liabilities assumed, assets">90,043</span>, which required the issuance of an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z4q91pPPvi19" title="Stock issued during period acquisitions, shares">13,853</span> shares of the Company&#8217;s common stock to fully satisfy the acquisition
payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200629__20200731__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zBR0sNWMhk1a" title="Stock issued during period acquisitions, shares">13,853</span> additional shares were issued in July 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2021, there were share forfeiture agreements (the &#8220;<b>Share Forfeiture Agreements</b>&#8221;) between the Company and
(i) HKC Talent Limited; (ii) various shareholders of the Company (the &#8220;<b>Forfeiting Shareholders</b>&#8221;), pursuant to which:
(i) HKC Talent Limited had agreed to forfeiture of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongTalentLimitedMember_zjZh4vmwzQ37">41,750,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company, and (ii)
the Forfeiting Shareholders had agreed to forfeiture, in aggregate, <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongTalentLimitedMember__srt--TitleOfIndividualAxis__custom--ShareholdersMember_zEG1iaTobXDh">44,242,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company. Included
in (ii) is <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HKCHoldingsSdnBhdMember_z7s7tathq1Bi">11,242,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares forfeited from HKC Holdings Sdn. Bhd,
a company in which <span style="background-color: white">Mr. How Kok Choong, </span>the CEO and director of the Company, is a shareholder.
As a result, the outstanding shares was reduced by <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember_zRAYMhCL1ktc">85,992,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20210101__20211231_z5AQ422mtOye" title="Potentially dilutive securities outstanding"><span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20200101__20201231_zFHH6aethW6" title="Potentially dilutive securities outstanding">no</span></span> stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054045464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NON-CONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">NON-CONTROLLING INTEREST</a></td>
<td class="text"><p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zDBeMDPckdHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.
<span id="xdx_822_zrFQDIpLMPz7">NON-CONTROLLING INTEREST</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_89F_ecustom--ScheduleOfNonControllingInterestTableTextBlock_zZBI5QjC7oDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s non-controlling interest consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zwxpd85H2Q5j" style="display: none">SCHEDULE
OF NON CONTROLLING INTEREST</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20211231_zwr96En8RGd1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20201231_z2Eht72PAx95" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">As of December
    31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">DSY Wellness:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--NonControllingInterestPaidinCapital_iI_zcfm1r481Hek" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paid-in capital</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">97</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--NonControllingInterestAccumulatedDeficit_iI_zIssv5YTi0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(436</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1387">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--NonControllingInterestAccumulatedOtherComprehensiveIncome_iI_zF3o95vL91Vk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive
    income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1390">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--NonControllingInterestNonControllingInterestGross_iI_zDeVDEDJx5b8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="display: none; font-size: 10pt">Non Controlling interest Gross</span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1393">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--NonControllingInterestAsl_iI_zFpZKA8KAfQ5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">ASL</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1395">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1396">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--MinorityInterest_iI_zW9WYiMyfzZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(336</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p id="xdx_8AF_zikBXzqt0zpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843053984056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zx1vaESLje23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
<span id="xdx_825_zIseJE7OXP2i">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zJ7stTvKpSRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
United States and foreign components of (loss) income before income taxes were comprised of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BC_zTWxPdCJiCud" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20210101__20211231_zrZAXd34Xik3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20200101__20201231_zfXKIGzf6yU7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax jurisdictions from:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zAlLrtxOUl7e" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Local &#8211; United States</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(706,659</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(735,159</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--MY_zEclGmfB1wAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign &#8211; Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,064,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,070,806</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--HK_zhAbaLKDIFKc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign &#8211; Hong
    Kong</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(616,640</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,700</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zWJCB0DdrB88" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zwsoXAMvtkTi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">(Loss) income before
    income tax</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,387,613</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">516,347</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AA_zQwZHDkY8Q04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zPwBaAA1nP6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
(provision for) benefit of income taxes consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BE_zbupPTnAP3g2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF PROVISION FOR INCOME TAX</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20210101__20211231_zwjEcbQqFP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20200101__20201231_zSSX7rLf21y8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Current:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_iN_di_maITEBzB5L_zh20qlTxQ03d" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(22,205</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CurrentForeignTaxExpenseBenefit_iN_di_maITEBzB5L_zverS48xQVVi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(104,735</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,748</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Deferred:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_zFpxBWlN3REh" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1428">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1429">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_z2R5c2TT0h88" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(178,329</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBzB5L_zOZ0Dm8bu8Jl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income
    taxes</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(137,067</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(161,581</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p id="xdx_8A8_zhWYBUgr16K4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad
range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan)
and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United
States of America</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a corporate
tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zr4IRO9K2cXa" title="Tax percentage">21</span>% on its taxable income. Agape ATP Corporation also subject to controlled foreign corporations Subpart F income (&#8220;Subpart
F&#8221;) tax, which is a tax primarily on passive income from controlled foreign corporations with a tax rate of <span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z04iJ8TfDm6c" title="Tax percentage">35</span>%. <span id="xdx_909_eus-gaap--TaxCutsAndJobsActOf2017OtherTaxEffectDescription_c20210101__20211231_zq9p5RQTNMfe" title="Tax rate description">In addition, the
Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#8220;GILTI&#8221;) tax, which is a tax on certain off-shore earnings
at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign
tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are
applied</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2021 and 2020, the Company&#8217;s foreign subsidiaries did not generate any income that are subject to
Subpart F tax and GILTI tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
INCOME TAXES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2021, the Company re-visited its fiscal 2020 U.S. income taxes and determined its stock dividend from Greenpro
Capital Corp as a result of its Spin-off of DSwiss Inc.&#8217;s shares in 2020 were subject to Subpart F and GILTI taxes. As a result,
the Company incurred additional income taxes expenses of $<span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zdqT2ffrpzXb" title="Income tax expense benefit">22,205</span>, including interest and penalty of $<span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20210101__20211231_zJzyKKFFpTmi" title="Income tax  examination penalties and interest expense">395</span>, for the year ended December
31, 2021, after utilizing its estimated cumulative net operating losses (&#8220;NOL&#8221;) of $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_c20201231_zeijZGafqpS5" title="Cumulative net operating loss">312,608</span> as of December 31, 2020. As a
result, the Company&#8217;s deferred tax assets of estimated NOL of $<span id="xdx_904_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20211231_z5ngiqBIt3Pl" title="Deferred tax assets operating loss carryforwards">65,648</span> were fully utilized and reduced to $<span id="xdx_901_ecustom--DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_iI_c20211231_zhTUhZUCdzcb" title="Cumulative net operating losses">0</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 and 2020, the operations in the United States of America incurred approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_ziRZzDY5u6oc" title="Operating loss">729,000</span> and $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zIL3DbXUwtg8" title="Operating loss">0</span>, respectively, of
cumulative net operating losses (&#8220;NOL&#8221;) which can be carried forward to offset future taxable income or Subpart F and GILTI
taxes. These balance can be carried forward indefinitely. The deferred tax valuation allowance as of December 31, 2021 and 2020 were
approximately $<span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_zVzqt9niPNK6" title="Deferred tax valuation allowance">153,000</span> and $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_z1ArW8tk0za1" title="Deferred tax valuation allowance">0</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Malaysia</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies
incorporated in Labuan to satisfy the &#8220;substantial activity requirements&#8221; to qualify for the preferential tax rate of <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zruGRczcdzU" title="Tax percentage">3</span>%
on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to the &#8220;substantial activity requirements&#8221;
was issued. As Agape ATP Corporation did not maintain a permanent establishment in Labuan, and therefore did not satisfy the said requirements,
the company was subjected to tax at <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zWXtzm0GkKIe" title="Taxp percentage">24</span>% on its net audited profit. On June 11, 2021, Agape ATP Corporation made an irrevocable election
to be taxed under the Malaysian Income Tax Act 1967 as the elected tax regime is more tax efficient to the entity compare to LBATA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
Superior Living Sdn Bhd, Agape S.E.A Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of
Malaysia and the income taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable
income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia,
enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential tax rates,
tax holidays and even tax exemption may be granted on case-by-case basis. <span id="xdx_903_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--MY_zMBjQTPtIlL7" title="Income tax examination, description">The tax rate for small and medium sized companies (generally
companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231__srt--StatementGeographicalAxis__country--MY_zC5zcFsPH3Hh" title="Tax percentage">17</span>% for the first RM 600,000 (or approximately $150,000)
for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 and 2020, the operations in the Malaysia incurred approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--MY_zp1K6Soyryma">946,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zVmjPSCCLqIi">261,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, of cumulative net operating losses (&#8220;NOL&#8221;) which can be carried forward to offset future taxable income. Approximately
$<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_c20211231__srt--StatementScenarioAxis__custom--UnutilizedMember_zrQFP7JnakLe" title="Net operating loss carryforward">685,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_c20201231__srt--StatementScenarioAxis__custom--UnutilizedMember_zPSOKkOKBiY8">261,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the net operating loss carry forwards will
expire in 2028 and 2027, respectively, if unutilized. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately
$<span id="xdx_907_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--MY_z29Vtxjgn5qh">217,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zkaVl3EJUUUa">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong
Kong</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape
ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of <span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231__srt--StatementGeographicalAxis__country--HK_z7Hvvs9O4ON2" title="Tax percentage">16.5</span>% on
its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative
Region is not subject to Hong Kong Profits Tax or deduction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
INCOME TAXES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zh8ZLrOPYINk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles the local (United States) statutory rates to the Company&#8217;s effective tax rate for the periods indicated
below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B6_zC5lQXfhDLsc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF EFFECTIVE INCOME TAX RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20210101__20211231_zHodPO8OlDVc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20200101__20201231_zIF4l0FDdfkl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zsEs0VSP47W2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">U.S. statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zTUSVlHzwV1b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zLMg3hNPRqq6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Differential tax rate in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zm9NRd88iKhh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Permanent difference</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(12.7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F2F_zxSNVakO0EU2" style="font-family: Times New Roman, Times, Serif">)%(1)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11.3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F27_zzkQrrHwK2g8" style="font-family: Times New Roman, Times, Serif">%(2)</span></td></tr>
  <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zWHBlQpZ9SX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effective tax rate</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount comprised:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p id="xdx_F03_z9Nlra0fsGci" style="display: none; margin-top: 0; margin-bottom: 0">(1)</p></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zYdaYzTyVkc3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;The
    amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zkx8Ftrs7L89" title="Non-deductible tax rate">6.2</span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_z7zr0BljaQM3" title="Non-deductible tax rate">6.7</span>%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_za3LDb8OY7Ml" title="Tax percentage">6.2</span>%
    being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_zJiKLXcUTRUk" title="Tax percentage">6.7</span>%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount comprised:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td id="xdx_F06_z335a6X6xzjc" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify">(2)</td>
    <td colspan="2" id="xdx_F18_zVtSsVaotcc4" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231_zv1NMsh9HgPd">10.2%
being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; </span></span><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zyI1Oi1dqqbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Non-deductible tax rate">0.2%
being income derived in AATP HK that were not taxable in the Malaysia tax returns; and </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zAbCSjiqlxJf" title="Non-deductible tax rate">1.3</span>%
being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z809m78MTHpj" title="Tax percentage">10.2</span>%
    being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zmVeWeVqoWCj" title="Tax percentage">0.2</span>%
                                            being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zN2k4pv648T2" title="Tax percentage">1.3</span>%
    being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p id="xdx_8A5_zRf8gZITjCH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTgDaFWwPnw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B6_z6PE7E8dFond" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF DEFERRED TAX ASSETS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20211231_zbi55i6TjUyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20201231_z9HNpNIBftu7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    </tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--US_zdlrLW0iyXZk" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards
    in U.S.</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">153,061</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1519">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--MY_zTYHWbFloxwf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">227,106</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,678</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zNxv9yYvsNDg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net operating loss carry forwards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less: valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20211231_zGKJemF1HSjc" style="text-align: right" title="Less: valuation allowance"><span style="font-family: Times New Roman, Times, Serif">(380,167</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20201231_zhbZnY4zYwHl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1528">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iI_zHyYEH4A3upj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,574</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,421</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    </tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_di_zOrcgklJh9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,574</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,743</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    </tr>
  </table>

<p id="xdx_8A7_zkxctfdEx5Kf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Uncertain
tax positions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical
merits, and measure the unrecognized benefits associated with the tax positions</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
As of December 31, 2021 and 2020, the Company did not have any significant unrecognized uncertain tax positions. The Company did not
incur interest and penalties tax for the years ended December 31, 2020 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054042200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS OF RISKS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CONCENTRATIONS OF RISKS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zppyeLFDtlc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.
<span id="xdx_820_zzEoSomjbVI4">CONCENTRATIONS OF RISKS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Major customers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2021 and 2020, no customer accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zZ7wcEon2T32" title="Concentrations of risk percentage"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsbNNSoACeck" title="Concentrations of risk percentage">10</span></span>% or more of the Company&#8217;s total revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no accounts receivable balance as of December 31, 2021. As of December 31, 2020, receivables from a third-party e-commerce company
accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zqs9F210iL0g" title="Concentrations of risk percentage">100.0</span>% of the total balance of accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Major vendors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2021, two vendors accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zifQOunHx8X4">47.3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zbnvccvXJhJ6">45.2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the Company&#8217;s total purchases, respectively. For the year ended December 31, 2020, two vendors accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zqi8p3G09a0g">74.1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zl7EPVu4Wdga">25.9</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the Company&#8217;s total purchases. In November and December 2020, the Company received dividend of <span id="xdx_905_ecustom--DividendShareForCommonStock_pid_c20201201__20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zdhCwhkcasw6">23,330
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of DSwiss, Inc., represents
approximately <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zw6R8eDBrN83">0.01</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
ownership that the Company accounted for as investment in marketable securities (See Note 11). DSwiss, Inc.&#8217;s wholly owned subsidiary
is the vendor that accounted for the Company&#8217;s total purchases of approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--VendorOneMember__dei--LegalEntityAxis__custom--DSwissIncMember_z5XgWCTZ2QHe">47.3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__dei--LegalEntityAxis__custom--DSwissIncMember_zg8t0GgGDGZf">74.1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
for the years ended December 31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, one vendor accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--OneVendorMember_zTe2C8rp2Ttd" title="Concentrations of risk percentage">100</span>% of the total balance of accounts payable. There are no accounts payable balance as
of December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Commission Expenses to Sales Distributors and Stockists</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2021, one sales distributor accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--OneSalesDistributorMember_zKKo21123UW9" title="Concentrations of risk percentage">17.9</span>% of the Company&#8217;s total commission expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2020, no sales distributor accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--NoSalesDistributorMember_zjvXG0OU1Tma">10.0</span>% of the Company&#8217;s total commission expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Credit risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of December
31, 2021 and 2020, $<span id="xdx_90A_eus-gaap--Deposits_iI_pp0p0_c20211231_ztTFsOM43Hc6" title="Deposits">554,864</span> and $<span id="xdx_90B_eus-gaap--Deposits_iI_pp0p0_c20201231_zP2NpPQh02g1" title="Deposits">1,112,147</span> were deposited with financial institutions, respectively, $<span id="xdx_905_ecustom--DepositForInsurance_iI_pp0p0_c20211231_zUuFnX1Pw8Bd" title="Deposit for insurance">295,761</span> and $<span id="xdx_908_ecustom--DepositForInsurance_iI_pp0p0_c20201231_z7hIHHO8Zb2j" title="Deposit for insurance">563,788</span> of these balances
are not covered by deposit insurance. While management believes that these financial institutions are of high credit quality, it also
continually monitors their credit worthiness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration
of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection
terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful
accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically,
the Company did not have any bad debt on its account receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.
CONCENTRATIONS OF RISKS (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Exchange rate risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could
post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower
profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes
in political and economic environments without notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843053969032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zikBWEXc7Rr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.
<span id="xdx_824_zqFHuwr8qXXa">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Lease
commitments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2020, the Company adopted ASC 842 for ASL&#8217;s office space lease and sales and training center as the lease commencement
date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20200401__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_ztm1zkup7YVb" title="Operating lease liability">490,000</span>, with a corresponding right-of-use
(&#8220;ROU&#8221;) asset in the same amount based on the present value of the future minimum rental payments of the lease, using an
effective interest rate of <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20200401__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zY9XWuKi7CWk" title="Operating lease effective interest rate">5.5</span>%, which was determined using the Company&#8217;s estimated incremental borrowing rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 31, 2021, the Company entered into two separate two-year leases extension with the modified lease expiring <span id="xdx_90C_ecustom--LeaseExpirationTerm_dd_c20210530__20210531_zg0t1LRbg2ml" title="Lease expiration term">May 31, 2023</span> for its office
space and expiring <span id="xdx_90A_ecustom--LeaseExpirationTerm_dd_c20210530__20210531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TrainingCenterMember_zHbo9BMQZEYk" title="Lease expiration term">August 31, 2023</span> for its training center. The lease modification required the Company to re-measure the ROU assets
and lease liabilities based on the modified leases. The Company recognized a reduction of $<span id="xdx_90E_ecustom--IncreaseDecreaseInROUAssetsAndLiabilities_iI_c20210531_zIq3NCDGKYMc" title="Reduction in ROU assets and liabilities">3,250</span> in ROU assets and lease liabilities
upon lease modifications based on the present value of the future minimum rental payments of the lease, using an effective interest rate
of <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20210531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zkrbAxBZJ3S4" title="Operating lease effective interest rate">5.5</span>%, which was determined using the Company&#8217;s estimated incremental borrowing rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of December 31, 2021, the weighted remaining term of the lease is approximately <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zLuEApcD1dr2" title="Operating lease, weighted average remaining lease term">1.64</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zLwSIOUdEDJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
five-year maturity of the Company&#8217;s operating lease liabilities is as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BB_z5HQRQCGEsN1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF LEASE COMMITMENTS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Twelve Months
    Ending December 31,</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_499_20211231_zrSpkKZ0riRb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzA1T_z29WVvrhY7u3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">166,426</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzA1T_zFb9TaYVqEpi" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">84,915</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzA1T_zgoP2DMVzy8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1587">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_zO7qR3PO3eAe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">251,341</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zSNfOKjtmRf5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,763</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">240,578</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A7_zXefQuQgchwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent
expense for the years ended December 31, 2021 and 2020 was $<span id="xdx_90F_eus-gaap--OperatingLeaseExpense_pp0p0_c20210101__20211231_z4zUzdOiLlIk" title="Operating lease, rent expenses">179,562</span> and $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_pp0p0_c20200101__20201231_zlihFIIH9S6h" title="Operating lease, rent expenses">156,716</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contingencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued,
as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed
to be material to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.
COMMITMENTS AND CONTINGENCIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COVID-19</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO, Malaysia has been put through
various stages of lockdowns such as (1) full movement control orders (&#8220;MCO&#8221;), under which, quarantines, travel restrictions,
and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to a Conditional Movement Control
Order (&#8220;CMCO&#8221;) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated
by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement Control Order (&#8220;RMCO&#8221;). On January 12,
2021, due to a resurgence of COVID-19 cases, the Malaysian government declared a state of emergency nationwide to combat COVID-19. Intermittent
lockdowns were imposed in various states and districts in the country. February 2021 marked a significant month for Malaysia as all frontline
staff of the country, which comprised those in healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department
of Malaysia and civil defense sectors were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that
a National COVID-19 Immunisation Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will
be vaccinated to achieve herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO, nevertheless,
COVID-19 cases in the country continue to rise. <span id="xdx_90A_eus-gaap--UnusualRiskOrUncertaintyImpact_c20210101__20211231__us-gaap--UnusualRiskOrUncertaintyByNatureAxis__custom--COVIDNineteenImpactMember_zcGtXlDQGj5f" title="COVID-19 impact description">On
May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the
country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian
population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full
lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one
dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter
of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases
hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced
Movement Control Order (&#8220;EMCO&#8221;) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament
met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating
its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021,
interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country
achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where
it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country&#8217;s population have been fully
vaccinated, with a further 46.0% having received booster shot</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially,
affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact
to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and
severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact,
almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">temporary
    closure of offices, travel restrictions, financial impact of the Company&#8217;s customers or suspension supplies may be negatively
    affected, and could continue to negatively affect the demand for the Company&#8217;s product;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely
    affect its financial condition and operating results; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    disruption of the Company&#8217;s supply chain, logistics providers or customers could adversely impact its business and results
    of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery
    to its customers, which may also lead to loss of its customers.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot
be reasonably estimated at this time. There is no guarantee that the Company&#8217;s total revenues will grow or remain at the similar
level year over year in 2021 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054059080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_znAil92WMLS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.
<span id="xdx_825_ztm6LAGqhyCc">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Forfeiture
of Common Stock</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A
share forfeiture agreement (the &#8220;Share Forfeiture Agreement&#8221;) dated January 20, 2022, between the Company and Mr. How Kok
Choong, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the CEO and director of the Company<span style="background-color: white">,
pursuant to which Mr. How Kok Choong agreed to forfeit <span id="xdx_904_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20220101__20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementMember_zvhF4E0oB6R4" title="Company share forfeiture">215,008,035</span> shares of common stock of the Company.</span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055673528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zeDlPoyXheKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#8220;U.S. GAAP&#8221;) for information pursuant to the rules and regulations of the Securities Exchange Commission
(&#8220;SEC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company
exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary.
All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zIzk1snyltAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principles
of consolidation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to
govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a
majority of votes at the meeting of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without
additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such
as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of
the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary
and must consolidate the VIE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><p id="xdx_843_eus-gaap--UseOfEstimates_zJNbiMqwRbCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use
of estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates
reflected in the Company&#8217;s consolidated financial statements include allowance for doubtful accounts, allowance for inventories
obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for
deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment
in non-marketable securities. Actual results could differ from these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z3rzciRsd7ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
and cash equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts receivable</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zfLkXh3OhBMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
receivable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due
on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the
Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis,
using historical collection trends and aging of receivables. Management also periodically evaluates individual customer&#8217;s financial
condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary.
Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. The Company&#8217;s management continues to evaluate the reasonableness of the valuation allowance policy and update
it if necessary. As of December 31, 2021 and 2020, <span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20211231_zZpkZXBfDhF1" title="Accounts receivable, allowance for credit loss::XDX::-"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20201231_z2gRSfBQ4YQh" title="Accounts receivable, allowance for credit loss::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0613"><span style="-sec-ix-hidden: xdx2ixbrl0615">no</span></span></span></span> allowance of doubtful accounts was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zdaWn6gJJjD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Inventories</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life
of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net
realizable value. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021,
and 2020, the company recorded $<span id="xdx_90A_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zz2wt2LAgfC5" title="Inventories write-down">36,241</span> and $<span id="xdx_908_eus-gaap--InventoryWriteDown_pp0p0_dxL_c20200101__20201231_zB3vozrYmlpa" title="Inventories write-down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0621">0</span></span> write-downs for inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrepaidTaxesPolicyTextBlock', window );">Prepaid taxes</a></td>
<td class="text"><p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zdZoMb8wzNHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepaid
taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Prepaid
taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrepaymentsAndDepositsPolicyTextBlock', window );">Prepayments and deposits</a></td>
<td class="text"><p id="xdx_849_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zqkBitGlXc97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepayments
and deposits</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services.
This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not
be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management
reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary.
Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood
of collection is not probable. The Company&#8217;s management continues to evaluate the reasonableness of the valuation allowance policy
and update it if necessary. As of December 31, 2021 and 2020, there was $<span id="xdx_902_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20211231_zOfQcpaErBJ1" title="Allowance for doubtful accounts">121,514</span> and $<span id="xdx_906_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zdfQOpCLD4Ne" title="Allowance for doubtful accounts">0</span> allowance for the doubtful accounts recorded.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment, net</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7cYcWhlN8v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property
and equipment, net</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zSzEw3lfeing" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    and office equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment">7</span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment">7</span> years</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment">Lease
    Term</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment">5</span>
    years</span></td></tr>
  </table>
<p id="xdx_8A9_zEFPE25M0ylf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is
included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings
as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The
Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates
of useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible assets, net</a></td>
<td class="text"><p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zHEzuq48QgQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intangible
assets, net</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the
estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zvU7SXf61uW4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets">5</span>
    years</span></td></tr>
  </table>
<p id="xdx_8A7_zorLQNME5Hh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment for long-lived assets</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z5qzlK0tNytk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment
for long-lived assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes
in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that
the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted
future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows
expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying
value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value
based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and
2020, <span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20210101__20211231_zrSWi5qIbct2" title="Impairment of long-lived assets"><span id="xdx_902_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zLQgENYYhvLc" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets was recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred offering costs</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--DeferredChargesPolicyTextBlock_z36dlBRJQxUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred
offering costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
offering costs represents costs associated with the Company&#8217;s current offering which will be netted against the proceeds from the
Company&#8217;s current offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investment in marketable equity securities</a></td>
<td class="text"><p id="xdx_849_eus-gaap--MarketableSecuritiesPolicy_zgB7vO5Vnsi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment
in marketable equity securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company follows the provisions of ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair value
with changes in fair value recognized in the Company&#8217;s unaudited condensed consolidated statements of operations and comprehensive
loss in the caption of &#8220;unrealized holding gain loss on marketable securities&#8221; in each reporting period</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NonMarketableSecuritiesPolicyTextBlock', window );">Investment in non-marketable equity securities</a></td>
<td class="text"><p id="xdx_84E_ecustom--NonMarketableSecuritiesPolicyTextBlock_z3ijwap9sP65" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment
in non-marketable equity securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Due to the Company&#8217;s non-marketable equity securities (non-current) does not
qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its
investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from
observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment
is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance,
credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or
technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical
area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed
auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that
raise significant concerns about the investee&#8217;s ability to continue as a going concern, such as negative cash flows from operations,
working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators
indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment
loss equal to the difference between the fair value of the investment and its carrying amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Customer deposits</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zTvWJ7as6POh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Customer
deposits</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced
when the related sale is recognized in accordance with the Company&#8217;s revenue recognition policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zMrTajC1AXKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue
recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core
principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods
and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange.
This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a
point in time or over time, based on when control of goods and services transfers to a customer. The Company&#8217;s revenue streams
are recognized at a point in time for the Company&#8217;s sale of health and wellness products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company
(i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate
the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies
the performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment
terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of Health and Wellness products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness
products are transferred to its customer at the Company&#8217;s office or shipment of the goods. The revenue is recorded net of estimated
discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were
insignificant sales returns</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value
of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds
resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and
wellness products transaction price upon such sales transactions occurred. The Company&#8217;s coupons have a validity period of six
months. If the Company&#8217;s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of
the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $<span id="xdx_906_ecustom--ForfeitedCouponIncome_pp0p0_c20210101__20211231_zh7G9r61F1ta">15,209</span>
and $<span id="xdx_908_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zkpNQLzrUHHf" title="Forfeited coupon income">170,431</span> as forfeited coupon income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_za2TyjvrR2mg" title="Revenue from sales">183,816</span> which it is expected
to fulfill within 12 months from December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of Health and Wellness services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company carries out its Wellness program, where the Company&#8217;s products are bundled with health screening test and a health camp
program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver
the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that
the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend
the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test
reports are completed and delivered to its customers during the consultation section in person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp
program was completed in the final day of the health camp</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zHfubZZIitA3">7,543</span> and $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zqmC0FnEsRM2">0</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated
information of revenues by products and services are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Survivor Select</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,904</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,897</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Energized Mineral Concentrate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,481</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ionized Cal-Mag</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">39,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">908,964</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Omega Blend</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">222,718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">495,567</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">BetaMaxx</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,043</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,550</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vege Fruit Fiber</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">65,757</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Iron</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,114</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,389</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Young Formula</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">653,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organic Youth Care Cleansing Bar</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Mitogize</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">183,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,801</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">No. 1 MED</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Energetique</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,574</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">253,396</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trim+</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,042</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">365,350</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenues &#8211; products</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,009,419</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Health and Wellness
    services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,543</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0721">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenues</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,016,962</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A3_zKKWWqhhjikh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of revenue</a></td>
<td class="text"><p id="xdx_840_eus-gaap--CostOfSalesPolicyTextBlock_z0ZV9KzHWuv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cost
of revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Cost
of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue
amounted to $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231_zQDKOqYEwgwe" title="Cost of revenue">297,333</span> (including inventory write-downs of $<span id="xdx_907_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zAnOlYDliz7l" title="Inventories write-down">36,241</span>) and $<span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20200101__20201231_z1I0GRSSjKHh" title="Cost of revenue">775,855</span> for the years ended December 31, 2021 and 2020, respectively</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ShippingAndHandlingPolicyTextBlock', window );">Shipping and handling</a></td>
<td class="text"><p id="xdx_847_ecustom--ShippingAndHandlingPolicyTextBlock_zHjEmh7vgPHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Shipping
and handling</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling charges amounted to $<span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z39I3F7j8mE9" title="Selling expenses">11,054</span> and $<span id="xdx_900_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zzZpeqTGyBZa" title="Selling expenses">9,315</span> for the years ended December 31, 2021 and 2020, respectively. Shipping and handling
charges are expensed as incurred and included in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising costs</a></td>
<td class="text"><p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zOiXHeocTzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Advertising
costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
costs amounted to $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20210101__20211231_z2FuMLE61324" title="Advertising costs">20,218</span> and $<span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zuyisFdiELCe" title="Advertising costs">14,339</span> for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as
incurred and included in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommissionsExpensePolicyPolicyTextBlock', window );">Commission expenses</a></td>
<td class="text"><p id="xdx_848_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zbeXzIh9K1Xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Commission
expenses </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
expenses are the Company&#8217;s most significant expenses. As with all companies in the network marketing industry, the Company&#8217;s
sales channel is external to the Company. The Company&#8217;s &#8220;external sales force&#8221; is stratified into two levels based
on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly,
are referred to as &#8220;sales network members&#8221;. The Company pays commission to every sales distributor based on purchases made
by its sales network members which includes the independent</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">direct
sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy
benefits such as maintaining a certain amount of the Company&#8217;s inventory on their store premises. The stockists shall account to
the Company for all products sales from their store premises as monitored through the Company&#8217;s centralized stock tracking system.
The Company pays a separate commission to stockists based on revenue generated from the stockists&#8217; physical stores. Commission
expenses amounted to $<span id="xdx_909_ecustom--SalesCommissionsAndFees1_pp0p0_c20210101__20211231_z6ZNeK45NC3j" title="Commission expenses">316,267</span> and $<span id="xdx_900_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zSxc8j1L6f32" title="Commission expenses">830,659</span> for the years ended December 31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DefinedContributionPlanPolicyTextBlock', window );">Defined contribution plan</a></td>
<td class="text"><p id="xdx_846_ecustom--DefinedContributionPlanPolicyTextBlock_zkZvS1Yq0XF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span style="text-decoration: underline">Defined
contribution plan</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue
and pay for these benefits based on certain percentages of the employees&#8217; respective salaries, subject to certain ceilings, in
accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Total expenses for the plans were $<span id="xdx_900_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20210101__20211231_zgJgN31MZHD5" title="Defined contribution plan expense">99,488</span> and $<span id="xdx_90B_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_z5f6ZzaKecgf" title="Defined contribution plan expense">75,802</span> for the years ended December 31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
related contribution plans include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Social
    Security Organization (&#8220;SOSCO&#8221;) &#8211; <span id="xdx_90E_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_ze4TdFb1Fj2" title="Salary percentage">1.75</span>% based on employee&#8217;s monthly salary capped of RM <span id="xdx_90C_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zUmbVWZyicu9" title="Monthly salary">4,000</span>;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
    Provident Fund (&#8220;EPF&#8221;) &#8211; <span id="xdx_905_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_zVn7Eiyly6O8" title="Salary percentage">12</span>% based on employee&#8217;s monthly salary;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Insurance System (&#8220;EIS&#8221;) &#8211; <span id="xdx_906_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zhFZHd7oCLi1" title="Salary percentage">0.2</span>% based on employee&#8217;s monthly salary capped of RM <span id="xdx_903_ecustom--MonthlySalary_pp0p0_uRM_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zavxrZi1P9Ul" title="Monthly salary">4,000</span>;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Human
    Resource Development Fund (&#8220;HRDF&#8221;) &#8211; <span id="xdx_900_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zt0N8oBqBNq" title="Salary percentage">1</span>% based on employee&#8217;s monthly salary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z5jmFnxmDe13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income
taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for
the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted
or substantively enacted by the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the
carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation
of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences
can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the
liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged
directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
uncertain tax position is recognized as a benefit only if it is &#8220;more likely than not&#8221; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is <span id="xdx_907_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210101__20211231_zI0BK4zQ6X15" title="Income tax examination, likelihood of unfavorable settlement">greater than 50%</span> likely of being realized on examination. For tax positions not meeting the &#8220;more likely than not&#8221; test,
no tax benefit is recorded. $<span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20210101__20211231_zhtHJHFt04F7" title="Income tax examination, penalties and interest expense">395</span> and $<span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20200101__20201231_zwgUz8si7Xxk" title="Income tax examination, penalties and interest expense">0</span> penalties and interest incurred related to underpayment of income tax for the years ended December
31, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a
result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive income (loss)</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zFmJhQqD6MOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comprehensive
income (loss)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss)
refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#8217; equity but are excluded
from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not
using the U.S. dollar as its functional currencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NoncontrollingInterestPolicyTextBlock', window );">Non-controlling interest</a></td>
<td class="text"><p id="xdx_843_ecustom--NoncontrollingInterestPolicyTextBlock_zvodLWm7yptb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-controlling
interest</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--MinorityInterestDescription_c20210101__20211231_z2jVyFk7GMzi" title="Noncontrolling interest, description">Non-controlling
interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out
of 9,590,598 shares) of the equity interests of ASL held by two individuals</span>. The non-controlling interests are presented in the consolidated
balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the
Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods
between non-controlling interest holders and the shareholders of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (loss) per share</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zZGPhNuzFDjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Earnings
(loss) per share</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company computes earnings (loss) per share (&#8220;EPS&#8221;) in accordance with ASC 260, &#8220;Earnings per Share&#8221;. ASC 260
requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share
outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible
securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later.
Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are
excluded from the calculation of diluted EPS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. For the
years ended December 31, 2021 and 2020, there were <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20210101__20211231_z6oZ7p2bv9Mf" title="Potentially dilutive securities outstanding"><span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20200101__20201231_zVXiU2cpuCAc" title="Potentially dilutive securities outstanding">no</span></span> dilutive shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currencies translation and transaction</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8AGmGK5QsX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
currencies translation and transaction</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing
at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated
into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded
in the consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have been expressed
in US$. The Company&#8217;s subsidiary in Labuan maintains its books and record in United States Dollars (&#8220;US$&#8221;) albeit its
functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit
(&#8220;MYR&#8221; or &#8220;RM&#8221;). The Company&#8217;s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars
(&#8220;HK$&#8221;), similar to its functional currency. The Company&#8217;s subsidiary and VIE in Malaysia conducts its businesses and
maintains its books and record in the local currency, Malaysian Ringgit (&#8220;MYR&#8221; or &#8220;RM&#8221;), as its functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into
US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate on the balance
sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation
of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the
statements of stockholders&#8217; equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts
reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance
sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end MYR : US$1 exchange
    rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.02</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average MYR : US$1 exchange
    rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.20</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A5_zqNifIeILn8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesPolicyTextBlock', window );">Related parties</a></td>
<td class="text"><p id="xdx_846_ecustom--RelatedPartiesPolicyTextBlock_zrQDAfgxw1sl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related
parties</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFEmgvJtixod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
value of financial instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and
requires disclosure of the fair value of financial instruments held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance
disclosure requirements for fair value measures. The three levels are defined as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that
    are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost,
which approximate fair value because of the short period of time between the origination of such instruments and their expected realization
and their current market rates of interest.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zZNdDkKBmvPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopts ASU 2016-02, &#8220;Leases&#8221; (Topic 842), and elected the practical expedients that does not require the Company
to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing
leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted
to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient
that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company&#8217;s leases
include one or more options to renew, which is typically at the Company&#8217;s sole discretion. The Company regularly evaluates the
renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications
result in re-measurement of the right of use (&#8220;ROU&#8221;) assets and lease liabilities. Operating ROU assets and lease liabilities
are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for
the Company&#8217;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available
at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that
the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment
and over a similar term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease,
as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers
the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected
the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve
months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives.
Lease expense is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews
the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the
asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset
from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount
of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future
pre-tax cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent accounting pronouncements</a></td>
<td class="text"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwRa40sJZ3q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent
accounting pronouncements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of
such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic
326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement
of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments
in Update 2016-13 added Topic 326, Financial Instruments&#8212;Credit Losses, and made several consequential amendments to the Codification.
Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses
when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments&#8212; Credit Losses&#8212;Available-for-Sale
Debt Securities. The amendments in this Update address those stakeholders&#8217; concerns by providing an option to irrevocably elect
the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition
relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar
financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments
in Update 2016-13 while still providing financial statement users with decision-useful information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit
organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date
for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim
reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating
the impact ASU 2019-05 may have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments
accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options
accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should
consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement
alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts
or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity
should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing
investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance
with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted,
including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-08, &#8220;Codification Improvements to Subtopic 310-20, Receivables&#8212;Nonrefundable Fees
and Other Costs&#8221;. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification
easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the
Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply
the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable
debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021
did not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-10, &#8220;Codification Improvements&#8221;. The amendments in this Update represent changes to
clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current
accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety
of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is
effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments
in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on
its consolidated financial statements.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DefinedContributionPlanPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DefinedContributionPlanPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NonMarketableSecuritiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non Marketable Securities [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NonMarketableSecuritiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NoncontrollingInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NoncontrollingInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PrepaidTaxesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Taxes [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PrepaidTaxesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PrepaymentsAndDepositsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepayments And Deposits [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PrepaymentsAndDepositsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_RelatedPartiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Parties [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_RelatedPartiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ShippingAndHandlingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shipping and Handling [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ShippingAndHandlingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommissionsExpensePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commissions incurred in relation to revenue generating activities or operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommissionsExpensePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054012232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS BACKGROUND (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock', window );">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zwe7aFvThaG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the Company&#8217;s subsidiaries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zj3z0IqpFBQk" style="display: none">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Subsidiary company name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Place and date of incorporation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Particulars of issued capital</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Principal activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proportional of ownership interest and voting power held</td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 6%; vertical-align: top">1.</td>
    <td style="width: 2%">&#160;</td>
    <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zJXEvi6NRyUh" style="vertical-align: top; width: 16%; text-align: center" title="Subsidiary company name">Agape ATP Corporation</td><td style="width: 2%">&#160;</td>
    <td id="xdx_98B_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zzkn5rj3Uck" style="vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation">Labuan, <br/> March 6, 2017</td><td style="width: 2%">&#160;</td>
    <td id="xdx_984_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsgpDyy2TMMl" style="vertical-align: top; width: 16%; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of US$1 each</td><td style="width: 2%">&#160;</td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zoZtxcXvENgf" style="vertical-align: top; width: 16%; text-align: center" title="Principal activities">Investment holding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zicZ1wjT3AE4" style="vertical-align: top; width: 18%; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; width: 1%; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">2.</td>
    <td>&#160;</td>
    <td id="xdx_98C_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zaubThxHYBVh" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape ATP International Holding Limited</td><td>&#160;</td>
    <td id="xdx_989_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zuC7GgYsCeD7" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Hong Kong,<br/> June 1, 2017</td><td>&#160;</td>
    <td id="xdx_98E_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zdSzsaNpIea4" style="vertical-align: top; text-align: center" title="Particulars of issued capital">1,000,000 shares of ordinary share of HK$1 each</td><td>&#160;</td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zocye911l2qg" style="vertical-align: top; text-align: center" title="Principal activities">Wholesaling of health and wellness products; and health solution advisory services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z1c7ZCaUNV1f" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">3.</td>
    <td>&#160;</td>
    <td id="xdx_985_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zRcFlMWvqJ7l" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape Superior Living Sdn. Bhd.</td><td>&#160;</td>
    <td id="xdx_984_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zcs7sN0Nu5q7" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> August 8, 2003</td><td>&#160;</td>
    <td id="xdx_986_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z5dnt8C8MCpe" style="vertical-align: top; text-align: center" title="Particulars of issued capital">9,590,598 shares of ordinary share of RM1 each</td><td>&#160;</td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zpruVcSAlxS2" style="vertical-align: top; text-align: center" title="Principal activities">Health and wellness products and health solution advisory services via network marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z8X5TglxoRU1" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">99.99</td><td style="vertical-align: top; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">4.</td>
    <td>&#160;</td>
    <td id="xdx_986_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zOSA8SvcFSe8" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape S.E.A. Sdn. Bhd.</td><td>&#160;</td>
    <td id="xdx_986_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_z5D1tm2kmR9j" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> March 4, 2004</td><td>&#160;</td>
    <td id="xdx_985_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zKXQYjcIaqj4" style="vertical-align: top; text-align: center" title="Particulars of issued capital">2 shares of ordinary share of RM1 each</td><td>&#160;</td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zycxkWzXgPB5" style="vertical-align: top; text-align: center" title="Principal activities">VIE of Agape Superior Living Sdn. Bhd.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE</span></td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">5.</td>
    <td>&#160;</td>
    <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zlD30iy2ipI8" style="vertical-align: top; text-align: center" title="Subsidiary company name">Wellness ATP International Holdings Sdn, Bhd</td><td>&#160;</td>
    <td id="xdx_98E_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zQBdLUuSkqZi" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> September 11, 2020</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z7oHDCHRFsp5" style="vertical-align: top; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of RM1 each</td><td>&#160;</td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zIVr6Myj4za4" style="vertical-align: top; text-align: center" title="Principal activities">The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zuZTuMiA4XY6" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">6.</td>
    <td>&#160;</td>
    <td id="xdx_989_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zTc8c6JIi7r7" style="vertical-align: top; text-align: center" title="Subsidiary company name">DSY Wellness International Sdn Bhd.</td><td>&#160;</td>
    <td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zKS9tx910Yg9" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> November 11, 2021</td><td>&#160;</td>
    <td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_z1CtNu8Ndnue" style="vertical-align: top; text-align: center" title="Particulars of issued capital">1,000 shares of ordinary share of RM1 each</td><td>&#160;</td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zJKc7Z8ErKth" style="vertical-align: top; text-align: center" title="Principal activities">Provision of complementary health therapies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zolorxDKUq1i" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">60</td><td style="vertical-align: top; text-align: right">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843053887880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock', window );">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zSzEw3lfeing" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    and office equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment">7</span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment">7</span> years</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment">Lease
    Term</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment">5</span>
    years</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock', window );">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</a></td>
<td class="text"><p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the
estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zvU7SXf61uW4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    Life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets">5</span>
    years</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock', window );">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</a></td>
<td class="text"><p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated
information of revenues by products and services are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Survivor Select</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,904</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,897</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Energized Mineral Concentrate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,481</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ionized Cal-Mag</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">39,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">908,964</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Omega Blend</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">222,718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">495,567</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">BetaMaxx</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,043</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,550</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vege Fruit Fiber</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">65,757</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Iron</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,114</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,389</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Young Formula</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">653,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organic Youth Care Cleansing Bar</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Mitogize</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">183,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,801</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">No. 1 MED</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Energetique</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,574</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">253,396</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trim+</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,042</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">365,350</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenues &#8211; products</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,009,419</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Health and Wellness
    services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,543</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0721">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenues</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,016,962</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock', window );">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end MYR : US$1 exchange
    rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.02</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average MYR : US$1 exchange
    rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.20</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Disaggregated Information Of Revenues [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Estimated Useful Lives Of Intangible Assets Net [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Estimated Useful Lives Of Property And Equipment [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057494840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">SCHEDULE OF VARIABLE INTEREST ENTITY</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_ziGf9DSLZguk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of the VIE&#8217;s assets and liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_z3zsHjUhKgR2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF VARIABLE INTEREST ENTITY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zBBDeiE1qBYf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_z2TTLKve29le"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_iI_zG66KK7YK2o8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,850</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesCurrent_iNI_di_zPrH2WbQg587" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(51,272</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(53,573</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--StockholdersEquity_iI_zPkIAvNRIe8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,856</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zW698uRlRrVl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zWYlp147wSI9"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_zMxrxRs5Smr9" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,387</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidTaxes_iI_zRfWUPLsX9ga" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,357</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsCurrent_iI_zEyDHieHajs8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,717</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_z8jU9wyuZVP9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable &#8211; intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">49,724</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--OtherPayablesRelatedPartyCurrent_iI_z1TajavnLNl5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables and accrued
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,548</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,904</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iI_zNU60IeGzAIc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,272</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">53,573</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquity_iI_zbeklS8QD69c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,856</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
summarized operating results of the VIE&#8217;s are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_499_20210101__20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zi6p0xMmPGM2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zk2JEF1orUyc"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zJkAWrUJn7vg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    revenues</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">346,907</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--GrossProfit_z8WN2B2SZ4M4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,442</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_z7P4DubEetea" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss from operations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,752</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_z9kg1Cro03Zj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(27,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,014</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054044904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z9hQbHfHjE47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which
represents the net purchase price allocation on the date of the acquisition of ASL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BF_zZ9ze4vUt6Xf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20211231_zi5gZGfDW912" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Carry
    Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zFootoo6DkQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 80%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,206,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zPCfRzzCqFe2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,210</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_iI_zvU4mN9Vlab4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables - related
    parties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,121</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_z4KcdNuvJtvf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Inventories</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">616,880</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_iI_zIZKzHM3w2W" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,206,821</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zUn3enkZbJpk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepayments
    and other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">318,267</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zKz3awcUZDTd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,600,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_ztkI3wRKXP4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment,
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">325,648</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zLClQ04mPaFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,686</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_z5dLrc78mnxc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    taxes asset, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,250</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_zBZrA7c0ltt3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">504,584</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zPuB2iDXZjri" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,105,376</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES AND SHAREHOLDERS&#8217;
    EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zT38U9zsO3Kf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable - related
    party</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">491,628</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_zhCBrTvOaBml" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Customer deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,600,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_z9N5VJeANSV8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    payables and accrued liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">209,096</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_zCmXdCjZO6z7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,301,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zQvCrxEVwmn1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,301,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zq2ThSccWRP9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    net assets acquired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,804,046</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">SCHEDULE OF PRO FORMA BUSINESS COMBINATION</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zseqpulCa5J1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B9_zZVcZYoKTnPc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE
OF PRO FORMA BUSINESS COMBINATION</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20200101__20201231_zuUagwDfcb66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the year ended December 31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaRevenue_zuz6pejZgaNh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,693,873</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_zhoMOdVTbnj8" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(875,708</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_406_ecustom--BusinessAcquisitionsProFormaGrossProfit_zEF3eZHqnGUj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,818,165</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_zXatwYMBeZoa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,839,184</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zBEyIiiyyL8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;Loss from operations</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,019</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_zWFdgUfqokuj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other income (expense),
    net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">267,633</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_z7tgSGvyyUyh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income before income taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">246,614</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_zGrdUgLWVzZ6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income
    taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(212,414</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBg35qlM6qO3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,200</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_zX5mlxsNMQ4h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income per common
    share - basic and diluted</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_zq1dvEl2L7o7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number
    of common shares outstanding - basic and diluted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">376,452,047</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054080760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zHmyEyZzWE14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BC_ze0iPUfvtWL5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF ACCOUNTS RECEIVABLES - RELATED PARTY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_49F_20211231_z9PPc3k8pk4f" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_490_20201231_zpm43E1b5fV" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zQm67i8MAm51" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts receivable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,757</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_z7wtfqwZytyb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance for doubtful
    accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zPkkNTIE1sq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0980">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,757</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054109592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">SCHEDULE OF INVENTORIES</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zruvM8S4PaXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zGTxmw5qLZR1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF INVENTORIES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20211231_ztBtShzWBIic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20201231_zNoSlNQMm9L6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_zBWMRwP1vewa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Finished
    goods</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">375,535</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">589,814</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054118936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAYMENTS AND DEPOSITS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosurePrepaymentsAndDepositsAbstract', window );"><strong>Prepayments And Deposits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock', window );">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</a></td>
<td class="text"><p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zAtd04mFJGJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B8_zF59P1dp47df" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;SCHEDULE
OF PREPAID EXPENSES AND DEPOSITS</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_494_20211231_ziMwpEOwIyHf" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_499_20201231_zDrpQH6b7sf8" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zH01auAciTqf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Receivables from sales distributors</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,379</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,302</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zE6hh4Mu4raj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deposits to suppliers</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">301,233</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">261,068</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--PrepaidExpensesGross_iTI_pp0p0_mtPEGzE1e_maPEAOAzys7_z6VlCHZfPes6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">416,612</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">296,370</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iNI_di_msPEAOAzys7_zq8mIhkKa9yd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Provision for
    doubtful accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(121,095</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzys7_z2yGv6cu952d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">295,517</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">296,370</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock', window );">SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS</a></td>
<td class="text"><p id="xdx_89C_ecustom--ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_zZ1SZcciBJrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Movements
of allowance for doubtful accounts are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zOtTmiuBvtG2">SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zZywmLOnsVpa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20200101__20201231_zsnq60MWSzPj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_z4xFzw1tofAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1015">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zMeD0XKlg3s3" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Addition</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">121,514</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1019">&#160;</span></span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_zegPRvqut4vb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Write off</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1021">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1022">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_zpM2sAxNIGX1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(419</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1025">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_zFnjY6bhglQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right">121,095</td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosurePrepaymentsAndDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosurePrepaymentsAndDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Changes in Allowance for Doubtful Accounts [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Prepaid Expenses and Deposits [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054122232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zEBQDGv1UhV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment, net consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_z6ieX65Jn6Ue" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20211231_z69fX0OmVDf5" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20201231_zRECSdxyxbj9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z1Gff565WJv3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer and office equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">82,298</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,437</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zo9mxKzC7fRe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture &amp; fixtures</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122,185</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">126,966</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zzUJMFAELrt3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,570</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">210,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zwHzILui9WXb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vehicle</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,702</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,564</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENz5ZB_zFJIlVBSdyEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">505,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">521,463</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENz5ZB_ztuoRLZe8B4l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(289,956</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(223,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENz5ZB_zinKGvSYnjR3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">215,799</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">298,309</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054004424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">SCHEDULE OF INTANGIBLE ASSETS, NET</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zc9eZtE2O7pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets, net, consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zvNaeIFuni2l" style="display: none">SCHEDULE OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20211231_zlsQm9npWeH9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_zQQB9ihbGkUb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzvmN_zYwict1pvqZf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer software</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,453</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,801</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzvmN_zOdvLeC8fWvk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30,793</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(29,975</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzvmN_zOsuj2cfJOZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,660</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,826</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054101240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN MARKETABLE SECURITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract', window );"><strong>Investment In Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</a></td>
<td class="text"><p id="xdx_895_eus-gaap--MarketableSecuritiesTextBlock_zFEm35wnJK17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zsAchnQKts4f" style="display: none">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20211231_zOIHppVaOEHj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20201231_zzMhWcyrOVu3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_maMSNzd9C_zg0L5qKThXZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">577,035</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,484</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--InvestmentsIncomeDividend_iNI_pp0p0_di_msMSNzd9C_zsGc1FQujud7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend income from Greenpro Capital Corp.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">160,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingGainLoss_iNI_pp0p0_di_msMSNzd9C_zVxQoo2AjMif" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized holding (loss) gain</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(505,231</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">350,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maMSNzd9C_zePn8dcJ0vrh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,742</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">352</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzd9C_z7o7Scdcq463" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in marketable
    securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">89,001</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">577,035</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInMarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843139534232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract', window );"><strong>Investment In Non-marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NonMarketableSecuritiesTableTextBlock', window );">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</a></td>
<td class="text"><p id="xdx_89A_ecustom--NonMarketableSecuritiesTableTextBlock_zkOWturFo6n8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zfbB1nvQU2N9" style="display: none">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Unreserved Sdn Bhd</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable securities</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zf4RgvPstRU5" style="width: 16%; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1163">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--InvestmentInNonMarketableSecuritiesGross_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">730,637</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less:
    Sale of investment in non-marketable securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zQs5QiPliqOi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1167">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">(730,637</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable
    securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zgdeHJqreulj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--InvestmentInNonmarketableSecuritiesNet_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Phoenix Plus
    Corporation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zgS1H7OUcv5i" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total investment in
    non-marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z4dw6o4mr5x8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NonMarketableSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non Marketable Securities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NonMarketableSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054006696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock', window );">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_898_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zRfJrGJiy5X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B1_zQzlwQRdDWch" style="display: none">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20211231_zEx06MSFkNDg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_z914hOdXEpA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">436,541</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">297,636</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AccruedPromotionExpenses_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Promotion expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,433</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Payroll</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,976</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Commission</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,721</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">224,711</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">143,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,921</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--OtherAccountPayableAndAccruedLiabilities_iTIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">858,355</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">647,677</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Other Payables And Accrued Liabilities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843053998408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">SCHEDULE OF RELATED PARTIES</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zcAQ3zTAOKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z8lWSWKWUU0c" style="display: none">SCHEDULE OF RELATED PARTIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name
    of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December
    31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape ATP
    (Asia) Limited (&#8220;AATP Asia&#8221;)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zFh7IyxtMaig" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zrYM4jVMEh4i" title="Relationship">Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zT5TKVhB1k1h" title="Nature"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zuDhF7hq7hH3" title="Nature">Expenses
    paid for AATP Asia</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zBPYNcd3xTze" style="width: 14%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">2,214</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zWkTG45rUsf" style="width: 12%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">2,227</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Hostastay Sdn. Bhd.</span></p>
                                                      <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#8220;Hostastay&#8221;&#160;</span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoHMJVFDgqqg" title="Relationship"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zj7Cls3LGfj1" title="Relationship">Mr. How Kok Choong,
    the CEO and director of the Company is also the director of Hostastay</span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_z96bkEc6Hqk9" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zOKpJukAbQx8" title="Nature">Sublease rent due from
    Hostastay</span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zIRfbce6jjj6" style="text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">4,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zf4Uas6lnH9a" style="text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">996</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">TH3 Technology Sdn Bhd</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#8220;TH3&#160;</span>Technology&#8221;</p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdMAMDlv2nHd" title="Relationship"><span id="xdx_90C_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zRRw54uNEw4h" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zF0Z2g5QwuVc" title="Nature"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zOLs3a1wFca1" title="Nature">Expenses
    paid for TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zBS833tKI6Ca" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdoHLYF8dUGb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231_zXf0bP8Tyebk" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">7,004</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_z1apLzBjnaN1" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">3,235</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
due to a Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December
    31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape
    Superior Living Pty Ltd</span> &#8220;ASLPL&#8221;</td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zjaffT4I6jli" style="font-family: Times New Roman, Times, Serif" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 1.5pt; width: 18%; text-align: center"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zTcNtnTuIgMj" style="font-family: Times New Roman, Times, Serif">ATP
    Label Printing Fees</span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zGltgxrHs6Fk" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zfnwEeWUjRli" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zO3PaOw8ZMM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zonoooHgiBe8" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
RELATED PARTY BALANCES AND TRANSACTIONS (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related
party transactions </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">For the years
    ended December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape Superior
    Living Pty Ltd (&#8220;ASLPL&#8221;)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zcC2giDupOh6" title="Relationship"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zW9HzqMSxgMb" title="Relationship">Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; width: 18%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z4Lv347M7n3e" title="Nature"><span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zH9KjlqHYSA1" title="Nature">Sales of
    products</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zGbEXE87uPu9" style="width: 14%; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zLj2DGzHvADi" style="width: 12%; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">18,060</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><span id="xdx_F4C_zm8QfSbpOFne" style="font-family: Times New Roman, Times, Serif">Vettons
    Sdn Bhd*</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zugLfroRtprc" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zZvVq3EoCVc1" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zuQtzdRYWHvj" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zb7z4MtJu9pk" title="Nature">Sales
    of products made through its platform</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____z2oh2awX7Fzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">6,625</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_fKg_____zvzZZ9Lr1X8e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231_zZMNas14GZie" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">6,625</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zbXwpniv32xe" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">18,060</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b id="xdx_F07_z3qCnTQjHwmg">*</b></span></td>
  <td style="text-align: justify"><span id="xdx_F1F_zurIKlX1VP8l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company had sales
of $<span id="xdx_90F_eus-gaap--RevenueFromRelatedParties_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_za0RKbuWThr6" title="Revenue">6,625</span> through the online platform owned by Vettons Sdn Bhd (&#8220;Vettons&#8221;). Vettons is a related party since Mr. How Kok
Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchase</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 22%; text-align: left; padding-bottom: 1.5pt">DSY Wellness &amp; Longevity Center Sdn Bhd</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zztjihGbEJi" title="Relationship"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKgGDN0XOXqi" title="Relationship">Dato&#8217; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp; Longevity Center Sdn Bhd</span></span>.</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z4AK4a2VPoge" title="Nature"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zd3zORUqsxXh" title="Nature">Purchase</span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z0MaSzrnIaGf" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Purchase">718</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zcp8pULpTfJd" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl1301">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231_zxjPSxdzQeW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">718</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231_zWmsGiHMPUr3" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl1305">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-weight: bold"/><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years
    ended December 31, </b></span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name
    of Related Party</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mr.
    How Kok Choong</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zS3c71XRkOpc" title="Relationship"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKe4t3D9pIBh" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company</span></span>.</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zGlq7z43t2vb" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zpnZEXPuCsjk" title="Nature">Commission
    expense</span></span></span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zVewcRjCItP4" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,758</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_z6srxupaaap9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,740</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SalesCommissionsAndFee_pdp0_c20210101__20211231_zMp01UdDmLWb" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"><span style="font-family: Times New Roman, Times, Serif">12,758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SalesCommissionsAndFee_pp0p0_c20200101__20201231_zIjLrUletGIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"><span style="font-family: Times New Roman, Times, Serif">10,740</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td rowspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Related Party</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the years ended December 31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hostastay
    Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQlgHq1wqYgl" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zdoJWj8m3jsi" title="Relationship">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zZNbTceC974g" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zhxZicsFyDNg" title="Nature">Sublease
    rental income due from Hostastay</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--OtherIncome_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zutdgJUpW8Cf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,345</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eus-gaap--OtherIncome_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zvIxFJm9Nj04" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,881</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20210101__20211231_zid26QmKtftg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,345</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zjuv3Lyf9VN9" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,881</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057493736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NON-CONTROLLING INTEREST (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfNonControllingInterestTableTextBlock', window );">SCHEDULE OF NON CONTROLLING INTEREST</a></td>
<td class="text"><p id="xdx_89F_ecustom--ScheduleOfNonControllingInterestTableTextBlock_zZBI5QjC7oDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s non-controlling interest consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zwxpd85H2Q5j" style="display: none">SCHEDULE
OF NON CONTROLLING INTEREST</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20211231_zwr96En8RGd1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20201231_z2Eht72PAx95" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">As of December
    31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">DSY Wellness:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--NonControllingInterestPaidinCapital_iI_zcfm1r481Hek" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paid-in capital</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">97</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--NonControllingInterestAccumulatedDeficit_iI_zIssv5YTi0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(436</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1387">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--NonControllingInterestAccumulatedOtherComprehensiveIncome_iI_zF3o95vL91Vk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive
    income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1390">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--NonControllingInterestNonControllingInterestGross_iI_zDeVDEDJx5b8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="display: none; font-size: 10pt">Non Controlling interest Gross</span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1393">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--NonControllingInterestAsl_iI_zFpZKA8KAfQ5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">ASL</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1395">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1396">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--MinorityInterest_iI_zW9WYiMyfzZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(336</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfNonControllingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Non Controlling Interest [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfNonControllingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843139613288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zJ7stTvKpSRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
United States and foreign components of (loss) income before income taxes were comprised of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BC_zTWxPdCJiCud" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20210101__20211231_zrZAXd34Xik3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20200101__20201231_zfXKIGzf6yU7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax jurisdictions from:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zAlLrtxOUl7e" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Local &#8211; United States</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(706,659</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(735,159</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--MY_zEclGmfB1wAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign &#8211; Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,064,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,070,806</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--HK_zhAbaLKDIFKc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign &#8211; Hong
    Kong</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(616,640</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,700</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zWJCB0DdrB88" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zwsoXAMvtkTi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">(Loss) income before
    income tax</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,387,613</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">516,347</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF PROVISION FOR INCOME TAX</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zPwBaAA1nP6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
(provision for) benefit of income taxes consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BE_zbupPTnAP3g2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF PROVISION FOR INCOME TAX</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20210101__20211231_zwjEcbQqFP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20200101__20201231_zSSX7rLf21y8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Current:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_iN_di_maITEBzB5L_zh20qlTxQ03d" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(22,205</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CurrentForeignTaxExpenseBenefit_iN_di_maITEBzB5L_zverS48xQVVi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(104,735</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,748</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Deferred:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_zFpxBWlN3REh" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1428">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1429">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_z2R5c2TT0h88" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(178,329</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBzB5L_zOZ0Dm8bu8Jl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income
    taxes</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(137,067</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(161,581</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">SCHEDULE OF EFFECTIVE INCOME TAX RATE</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zh8ZLrOPYINk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles the local (United States) statutory rates to the Company&#8217;s effective tax rate for the periods indicated
below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B6_zC5lQXfhDLsc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF EFFECTIVE INCOME TAX RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20210101__20211231_zHodPO8OlDVc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20200101__20201231_zIF4l0FDdfkl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zsEs0VSP47W2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">U.S. statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zTUSVlHzwV1b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zLMg3hNPRqq6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Differential tax rate in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zm9NRd88iKhh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Permanent difference</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(12.7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F2F_zxSNVakO0EU2" style="font-family: Times New Roman, Times, Serif">)%(1)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11.3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F27_zzkQrrHwK2g8" style="font-family: Times New Roman, Times, Serif">%(2)</span></td></tr>
  <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zWHBlQpZ9SX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effective tax rate</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount comprised:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p id="xdx_F03_z9Nlra0fsGci" style="display: none; margin-top: 0; margin-bottom: 0">(1)</p></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zYdaYzTyVkc3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;The
    amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zkx8Ftrs7L89" title="Non-deductible tax rate">6.2</span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_z7zr0BljaQM3" title="Non-deductible tax rate">6.7</span>%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_za3LDb8OY7Ml" title="Tax percentage">6.2</span>%
    being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_zJiKLXcUTRUk" title="Tax percentage">6.7</span>%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount comprised:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td id="xdx_F06_z335a6X6xzjc" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify">(2)</td>
    <td colspan="2" id="xdx_F18_zVtSsVaotcc4" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231_zv1NMsh9HgPd">10.2%
being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; </span></span><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zyI1Oi1dqqbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Non-deductible tax rate">0.2%
being income derived in AATP HK that were not taxable in the Malaysia tax returns; and </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zAbCSjiqlxJf" title="Non-deductible tax rate">1.3</span>%
being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z809m78MTHpj" title="Tax percentage">10.2</span>%
    being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zmVeWeVqoWCj" title="Tax percentage">0.2</span>%
                                            being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zN2k4pv648T2" title="Tax percentage">1.3</span>%
    being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF DEFERRED TAX ASSETS</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTgDaFWwPnw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B6_z6PE7E8dFond" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF DEFERRED TAX ASSETS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20211231_zbi55i6TjUyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20201231_z9HNpNIBftu7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    </tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--US_zdlrLW0iyXZk" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards
    in U.S.</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">153,061</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1519">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--MY_zTYHWbFloxwf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">227,106</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,678</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zNxv9yYvsNDg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net operating loss carry forwards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less: valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20211231_zGKJemF1HSjc" style="text-align: right" title="Less: valuation allowance"><span style="font-family: Times New Roman, Times, Serif">(380,167</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20201231_zhbZnY4zYwHl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1528">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iI_zHyYEH4A3upj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,574</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,421</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    </tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_di_zOrcgklJh9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,574</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,743</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    </tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054057400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">SCHEDULE OF LEASE COMMITMENTS</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zLwSIOUdEDJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
five-year maturity of the Company&#8217;s operating lease liabilities is as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BB_z5HQRQCGEsN1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF LEASE COMMITMENTS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Twelve Months
    Ending December 31,</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_499_20211231_zrSpkKZ0riRb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzA1T_z29WVvrhY7u3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">166,426</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzA1T_zFb9TaYVqEpi" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">84,915</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzA1T_zgoP2DMVzy8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1587">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_zO7qR3PO3eAe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">251,341</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zSNfOKjtmRf5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,763</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">240,578</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843051666872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 11, 2021</div></th>
<th class="th"><div>May 08, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyMember', window );">Subsidiary Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Agape ATP Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Labuan,  March 6, 2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">100 shares of ordinary share of US$1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Investment holding<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyOneMember', window );">Subsidiary Company One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Agape ATP International Holding Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Hong Kong, June 1, 2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">1,000,000 shares of ordinary share of HK$1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Wholesaling of health and wellness products; and health solution advisory services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember', window );">Subsidiary Company Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Agape Superior Living Sdn. Bhd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Malaysia,  August 8, 2003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">9,590,598 shares of ordinary share of RM1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Health and wellness products and health solution advisory services via network marketing<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember', window );">Subsidiary Company Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Agape S.E.A. Sdn. Bhd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Malaysia,  March 4, 2004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">2 shares of ordinary share of RM1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">VIE of Agape Superior Living Sdn. Bhd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFourMember', window );">Subsidiary Company Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Wellness ATP International Holdings Sdn, Bhd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Malaysia,  September 11, 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">100 shares of ordinary share of RM1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFiveMember', window );">Subsidiary Company Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">DSY Wellness International Sdn Bhd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Malaysia,  November 11, 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">1,000 shares of ordinary share of RM1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Provision of complementary health therapies<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NameOftheCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the company name.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NameOftheCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ParticularsOfIssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Particulars of issued capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ParticularsOfIssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PlaceAndDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Place and date of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PlaceAndDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PrincipalActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PrincipalActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055587032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) - shares<br></strong></div></th>
<th class="th"><div>May 08, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 11, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Mr.How Kok Choong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period acquisitions, shares</a></td>
<td class="nump">9,590,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_AgapeATPInternationalHoldingLimitedMember', window );">Agape ATP International Holding Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember', window );">Subsidiary Company Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="nump">99.99%<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFiveMember', window );">Subsidiary Company Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_AgapeATPInternationalHoldingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_AgapeATPInternationalHoldingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055361816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated Useful Lives of Property and Equipment</a></td>
<td class="text">Lease
    Term<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123364984&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843053955048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer Software, Intangible Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843051503624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 1,016,962<span></span>
</td>
<td class="nump">$ 3,452,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_SurvivorSelectMember', window );">Survivor Select [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">83,904<span></span>
</td>
<td class="nump">149,897<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_EnergizedMineralConcentrateMember', window );">Energized Mineral Concentrate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">52,047<span></span>
</td>
<td class="nump">81,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_IonizedCalMagMember', window );">Ionized Cal-Mag [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">39,527<span></span>
</td>
<td class="nump">908,964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_OmegaBlendMember', window );">Omega Blend [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">222,718<span></span>
</td>
<td class="nump">495,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_BetaMaxxMember', window );">Beta Maxx [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">208,043<span></span>
</td>
<td class="nump">156,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_VegeFruitFiberMember', window );">Vege Fruit Fiber [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">65,757<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_IronMember', window );">Iron [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">28,114<span></span>
</td>
<td class="nump">133,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_YoungFormulaMember', window );">Young Formula [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">52,425<span></span>
</td>
<td class="nump">653,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_OrganicYouthCareCleansingBarMember', window );">Organic Youth Care Cleansing Bar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">5,137<span></span>
</td>
<td class="nump">43,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_MitogizeMember', window );">Mitogize [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">183,800<span></span>
</td>
<td class="nump">162,801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_NoOneMEDMember', window );">No. 1 MED [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">15,331<span></span>
</td>
<td class="nump">46,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_EnergetiqueMember', window );">Energetique [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">25,574<span></span>
</td>
<td class="nump">253,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_TrimPlusMember', window );">Trim Plus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">27,042<span></span>
</td>
<td class="nump">365,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,009,419<span></span>
</td>
<td class="nump">3,452,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_HealthAndWellnessServicesMember', window );">Health And Wellness Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 7,543<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_SurvivorSelectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_SurvivorSelectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_EnergizedMineralConcentrateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_EnergizedMineralConcentrateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_IonizedCalMagMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_IonizedCalMagMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_OmegaBlendMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_OmegaBlendMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_BetaMaxxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_BetaMaxxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_VegeFruitFiberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_VegeFruitFiberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_IronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_IronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_YoungFormulaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_YoungFormulaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_OrganicYouthCareCleansingBarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_OrganicYouthCareCleansingBarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_MitogizeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_MitogizeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_NoOneMEDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_NoOneMEDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_EnergetiqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_EnergetiqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_TrimPlusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_TrimPlusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_HealthAndWellnessServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_HealthAndWellnessServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055595848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=AATP_PeriodEndMYRMember', window );">Period-end MYR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Foreign Currency Exchange Rate, Translation</a></td>
<td class="nump">4.18<span></span>
</td>
<td class="nump">4.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=AATP_PeriodEndHKDMember', window );">Period-end HKD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Foreign Currency Exchange Rate, Translation</a></td>
<td class="nump">7.80<span></span>
</td>
<td class="nump">7.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=AATP_PeriodAverageMYRMember', window );">Period-average MYR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ForeignCurrencyExchangeRateAverage', window );">Foreign currency exchange rate period average</a></td>
<td class="nump">4.14<span></span>
</td>
<td class="nump">4.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=AATP_PeriodAverageHKDMember', window );">Period-average HKD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ForeignCurrencyExchangeRateAverage', window );">Foreign currency exchange rate period average</a></td>
<td class="nump">7.77<span></span>
</td>
<td class="nump">7.76<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ForeignCurrencyExchangeRateAverage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign currency exchange rate period average.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ForeignCurrencyExchangeRateAverage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateTranslation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32618-110901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateTranslation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=AATP_PeriodEndMYRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=AATP_PeriodEndMYRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=AATP_PeriodEndHKDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=AATP_PeriodEndHKDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=AATP_PeriodAverageMYRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=AATP_PeriodAverageMYRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=AATP_PeriodAverageHKDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=AATP_PeriodAverageHKDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843052103240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>MYR (RM) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>MYR (RM) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for credit loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventories write-down</a></td>
<td class="nump">36,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_AllowanceForDoubtfulAccountsReceivablesCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">121,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ForfeitedCouponIncome', window );">Forfeited coupon income</a></td>
<td class="nump">15,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from sales</a></td>
<td class="nump">1,016,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,434,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">297,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Selling expenses</a></td>
<td class="nump">394,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">20,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalesCommissionsAndFees1', window );">Commission expenses</a></td>
<td class="nump">316,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">830,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined contribution plan expense</a></td>
<td class="nump">$ 99,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement', window );">Income tax examination, likelihood of unfavorable settlement</a></td>
<td class="text">greater than 50%<span></span>
</td>
<td class="text">greater than 50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax examination, penalties and interest expense</a></td>
<td class="nump">$ 395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDescription', window );">Noncontrolling interest, description</a></td>
<td class="text">Non-controlling
interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out
of 9,590,598 shares) of the equity interests of ASL held by two individuals<span></span>
</td>
<td class="text">Non-controlling
interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out
of 9,590,598 shares) of the equity interests of ASL held by two individuals<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_SocialSecurityOrganizationMember', window );">Social Security Organization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalaryPercentage', window );">Salary percentage</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_SocialSecurityOrganizationMember', window );">Social Security Organization [Member] | MYR Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_MonthlySalary', window );">Monthly salary | RM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">RM 4,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_EmployeesProvidentFundMember', window );">Employees Provident Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalaryPercentage', window );">Salary percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_EmploymentInsuranceSystemMember', window );">Employment Insurance System [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalaryPercentage', window );">Salary percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_EmploymentInsuranceSystemMember', window );">Employment Insurance System [Member] | MYR Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_MonthlySalary', window );">Monthly salary | RM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">RM 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_HumanResourceDevelopmentFundMember', window );">Human Resource Development Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalaryPercentage', window );">Salary percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_HealthAndWellnessProductsMember', window );">Health and Wellness Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from sales</a></td>
<td class="nump">$ 183,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_HealthAndWellnessServicesMember', window );">Health And Wellness Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from sales</a></td>
<td class="nump">7,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Selling expenses</a></td>
<td class="nump">$ 11,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_AllowanceForDoubtfulAccountsReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for doubtful accounts,</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_AllowanceForDoubtfulAccountsReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ForfeitedCouponIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forfeited coupon income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ForfeitedCouponIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_MonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly salary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_MonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_SalaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Salary percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_SalaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_SalesCommissionsAndFees1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_SalesCommissionsAndFees1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 15<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121825205&amp;loc=d3e27249-109313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized in the period that are directly related to the selling and distribution of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_SocialSecurityOrganizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_SocialSecurityOrganizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AATP_MYRCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AATP_MYRCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_EmployeesProvidentFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_EmployeesProvidentFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_EmploymentInsuranceSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_EmploymentInsuranceSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_HumanResourceDevelopmentFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_HumanResourceDevelopmentFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_HealthAndWellnessProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_HealthAndWellnessProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_HealthAndWellnessServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_HealthAndWellnessServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843056662696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF VARIABLE INTEREST ENTITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingActivityGainsAndLossesLineItems', window );"><strong>Trading Activity, Gains and Losses, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">$ 3,912,122<span></span>
</td>
<td class="nump">$ 5,684,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(1,312,841)<span></span>
</td>
<td class="num">(1,038,542)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Net deficit</a></td>
<td class="nump">3,312,972<span></span>
</td>
<td class="nump">5,924,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">2,597,848<span></span>
</td>
<td class="nump">3,517,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">636,218<span></span>
</td>
<td class="nump">1,104,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,312,841<span></span>
</td>
<td class="nump">1,038,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Operating revenues</a></td>
<td class="nump">1,016,962<span></span>
</td>
<td class="nump">3,434,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">719,629<span></span>
</td>
<td class="nump">2,676,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,858,568)<span></span>
</td>
<td class="num">(158,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(2,524,244)<span></span>
</td>
<td class="nump">354,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingActivityByTypeAxis=us-gaap_VariableIncomeInterestRateMember', window );">Variable Income Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingActivityGainsAndLossesLineItems', window );"><strong>Trading Activity, Gains and Losses, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">18,850<span></span>
</td>
<td class="nump">48,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(51,272)<span></span>
</td>
<td class="num">(53,573)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Net deficit</a></td>
<td class="num">(32,422)<span></span>
</td>
<td class="num">(4,856)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">17,493<span></span>
</td>
<td class="nump">37,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">1,357<span></span>
</td>
<td class="nump">11,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable &#8211; intercompany</a></td>
<td class="nump">49,724<span></span>
</td>
<td class="nump">51,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_OtherPayablesRelatedPartyCurrent', window );">Other payables and accrued liabilities</a></td>
<td class="nump">1,548<span></span>
</td>
<td class="nump">1,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">51,272<span></span>
</td>
<td class="nump">53,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Operating revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">346,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(21,966)<span></span>
</td>
<td class="num">(10,752)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (27,966)<span></span>
</td>
<td class="num">$ (24,014)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_OtherPayablesRelatedPartyCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other payables - related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_OtherPayablesRelatedPartyCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingActivityGainsAndLossesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingActivityGainsAndLossesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingActivityByTypeAxis=us-gaap_VariableIncomeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingActivityByTypeAxis=us-gaap_VariableIncomeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054080760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember', window );">Subsidiary Company Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843048501336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 1,206,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Other receivables</a></td>
<td class="nump">33,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties', window );">Other receivables - related parties</a></td>
<td class="nump">219,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">616,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">1,206,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepayments and other assets</a></td>
<td class="nump">318,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Total current assets</a></td>
<td class="nump">3,600,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">325,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">6,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred taxes asset, net</a></td>
<td class="nump">172,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total other assets</a></td>
<td class="nump">504,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">4,105,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable - related party</a></td>
<td class="nump">491,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Customer deposits</a></td>
<td class="nump">1,600,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other payables and accrued liabilities</a></td>
<td class="nump">209,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">2,301,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="nump">2,301,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total net assets acquired</a></td>
<td class="nump">$ 1,804,046<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current assets prepaid taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current assets receivables related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843051638616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 4,693,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaCostOfRevenue', window );">Cost of revenue</a></td>
<td class="num">(875,708)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaGrossProfit', window );">Gross profit</a></td>
<td class="nump">3,818,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaOperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(3,839,184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax', window );">&#160;Loss from operations</a></td>
<td class="num">(21,019)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet', window );">Other income (expense), net</a></td>
<td class="nump">267,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes', window );">Income before income taxes</a></td>
<td class="nump">246,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(212,414)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 34,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted', window );">Net income per common share - basic and diluted | $ / shares</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted', window );">Weighted average number of common shares outstanding - basic and diluted | shares</a></td>
<td class="nump">376,452,047<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition pro-forma earnings per share basic and diluted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition pro-forma weighted average number of common shares outstanding basic snd diluted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaCostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaCostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaGrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross profit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaGrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro-forma income loss before income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro-forma income tax expense benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other income (expense), net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843048335640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 02, 2020</div></th>
<th class="th"><div>May 08, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_MrHowKokChoongMember', window );">Mr.How Kok Choong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchased price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Mr.How Kok Choong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period acquisitions, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,590,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Mr.How Kok Choong [Member] | Agape Superior Living Sdn Bhd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period acquisitions, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Ordinary shares no par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration value</a></td>
<td class="nump">$ 1,804,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Loan payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 656,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PercentageOfCommonStockIssuedAndOutstanding', window );">Percentage of common stock issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0469%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock issued during period, value, acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,147,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PercentageOfCommonStockIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PercentageOfCommonStockIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingSdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingSdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057729608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CASH AND CASH EQUIVALENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,597,848<span></span>
</td>
<td class="nump">$ 3,517,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash in bank</a></td>
<td class="nump">554,864<span></span>
</td>
<td class="nump">1,112,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimeDeposits', window );">Time deposits</a></td>
<td class="nump">$ 1,975,347<span></span>
</td>
<td class="nump">$ 2,391,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits', window );">Percentage of Interest rate for time deposits</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits', window );">Percentage of Interest rate for time deposits</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of interest-bearing domestic time deposit liabilities to total deposit liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimeDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of time deposit liabilities, including certificates of deposit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116652737&amp;loc=d3e64164-112818<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimeDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055098664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 172,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_AccountsReceivableAndAccountsReceivableRelatedParties', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 172,757<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_AccountsReceivableAndAccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable and accounts receivable related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_AccountsReceivableAndAccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054086952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INVENTORIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 375,535<span></span>
</td>
<td class="nump">$ 589,814<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057479032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 36,241<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055493512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosurePrepaymentsAndDepositsAbstract', window );"><strong>Prepayments And Deposits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ReceivablesFromSalesDistributors', window );">Receivables from sales distributors</a></td>
<td class="nump">$ 115,379<span></span>
</td>
<td class="nump">$ 35,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DepositsToSupplier', window );">Deposits to suppliers</a></td>
<td class="nump">301,233<span></span>
</td>
<td class="nump">261,068<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrepaidExpensesGross', window );">Subtotal</a></td>
<td class="nump">416,612<span></span>
</td>
<td class="nump">296,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Less: Provision for doubtful accounts</a></td>
<td class="num">(121,095)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 295,517<span></span>
</td>
<td class="nump">$ 296,370<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DepositsToSupplier">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deposits to supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DepositsToSupplier</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosurePrepaymentsAndDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosurePrepaymentsAndDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PrepaidExpensesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PrepaidExpensesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ReceivablesFromSalesDistributors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables from sales distributors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ReceivablesFromSalesDistributors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055605448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosurePrepaymentsAndDepositsAbstract', window );"><strong>Prepayments And Deposits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease', window );">Addition</a></td>
<td class="nump">121,514<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write off</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect', window );">Exchange rate effect</a></td>
<td class="num">(419)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">$ 121,095<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for doubtful accounts receivable exchange rate effect.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosurePrepaymentsAndDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosurePrepaymentsAndDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843052085656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">$ 505,755<span></span>
</td>
<td class="nump">$ 521,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(289,956)<span></span>
</td>
<td class="num">(223,154)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">215,799<span></span>
</td>
<td class="nump">298,309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_ComputerAndOfficeEquipmentMember', window );">Computer And Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">82,298<span></span>
</td>
<td class="nump">81,437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">122,185<span></span>
</td>
<td class="nump">126,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">202,570<span></span>
</td>
<td class="nump">210,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_VehicleMember', window );">Vehicle [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">$ 98,702<span></span>
</td>
<td class="nump">$ 102,564<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_ComputerAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_ComputerAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_VehicleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_VehicleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843054029464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 75,797<span></span>
</td>
<td class="nump">$ 55,407<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843052533176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INTANGIBLE ASSETS, NET (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Computer software</a></td>
<td class="nump">$ 34,453<span></span>
</td>
<td class="nump">$ 35,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(30,793)<span></span>
</td>
<td class="num">(29,975)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 3,660<span></span>
</td>
<td class="nump">$ 5,826<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057495976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 1,961<span></span>
</td>
<td class="nump">$ 1,505<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843139637880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract', window );"><strong>Investment In Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">$ 577,035<span></span>
</td>
<td class="nump">$ 66,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentsIncomeDividend', window );">Dividend income from Greenpro Capital Corp.</a></td>
<td class="nump">18,939<span></span>
</td>
<td class="nump">160,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_MarketableSecuritiesUnrealizedHoldingGainLoss', window );">Unrealized holding (loss) gain</a></td>
<td class="num">(505,231)<span></span>
</td>
<td class="nump">350,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites', window );">Exchange rate effect</a></td>
<td class="num">(1,742)<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Investment in marketable securities</a></td>
<td class="nump">$ 89,001<span></span>
</td>
<td class="nump">$ 577,035<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInMarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange rate effect.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentsIncomeDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividend income .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentsIncomeDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_MarketableSecuritiesUnrealizedHoldingGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrealized holding (loss) gain.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_MarketableSecuritiesUnrealizedHoldingGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843048336104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 27, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 09, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Oct. 16, 2018</div></th>
<th class="th"><div>Jul. 30, 2018</div></th>
<th class="th"><div>May 17, 2018</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="nump">$ 577,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_GreenproCapitalCorpMember', window );">Greenpro Capital Corp. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment in securities, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,333<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">83,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchased price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 6.2613<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_DSwissIncMember', window );">DSwiss Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment in securities, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,663<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,315<span></span>
</td>
<td class="nump">$ 76,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchased price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_SEATechVenturesCorpMember', window );">SEATech Ventures Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment in securities, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchased price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_GreenproCapitalCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_GreenproCapitalCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_DSwissIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_DSwissIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_SEATechVenturesCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_SEATechVenturesCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843051427336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 03, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">$ 577,035<span></span>
</td>
<td class="nump">$ 66,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent', window );">Total investment in non-marketable securities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember', window );">Phoenix Plus Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent', window );">Total investment in non-marketable securities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AATP_DirectorsOfUnreservedInvestmentMember', window );">Directors of Unreserved Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesGross', window );">Investment in non-marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">730,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SaleOfInvestmentInNonmarketableSecurities', window );">Less: Sale of investment in non-marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(730,637)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonmarketableSecuritiesNet', window );">Investment in non-marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonMarketableSecuritiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonMarketableSecuritiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonMarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonmarketableSecuritiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in non-marketable securities, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonmarketableSecuritiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_SaleOfInvestmentInNonmarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_SaleOfInvestmentInNonmarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_DirectorsOfUnreservedInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_DirectorsOfUnreservedInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843052243656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>MYR (RM) </div>
<div>shares</div>
</th>
<th class="th"><div>Mar. 03, 2020</div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 03, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Mar. 10, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 577,035<span></span>
</td>
<td class="nump">$ 66,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty', window );">Proceeds from investments</a></td>
<td class="nump">$ 70,173<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 70,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember', window );">Phoenix Plus Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember', window );">Phoenix Plus Corporation [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Shares purchased during period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.86%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 863,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">RM 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember', window );">Mr.How Kok Choong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 730,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromOfficersOrStockholdersCurrent', window );">Amount due from director</a></td>
<td class="nump">$ 660,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AATP_UnreservedSdnBhdMember', window );">Unreserved Sdn Bhd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of non-marketable securities to a related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromOfficersOrStockholdersCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are usually due within 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39599-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromOfficersOrStockholdersCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_UnreservedSdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_UnreservedSdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057709272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">$ 436,541<span></span>
</td>
<td class="nump">$ 297,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_AccruedPromotionExpenses', window );">Promotion expenses</a></td>
<td class="nump">36,024<span></span>
</td>
<td class="nump">37,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Payroll</a></td>
<td class="nump">22,669<span></span>
</td>
<td class="nump">23,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commission</a></td>
<td class="nump">219,721<span></span>
</td>
<td class="nump">224,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities', window );">Others</a></td>
<td class="nump">143,400<span></span>
</td>
<td class="nump">63,921<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_OtherAccountPayableAndAccruedLiabilities', window );">Total</a></td>
<td class="nump">$ 858,355<span></span>
</td>
<td class="nump">$ 647,677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_AccruedPromotionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued promotion expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_AccruedPromotionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_OtherAccountPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_OtherAccountPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843051870952">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF RELATED PARTIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount due from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7,004<span></span>
</td>
<td class="nump">$ 3,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Amount due from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,625<span></span>
</td>
<td class="nump">18,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Purchase</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">718<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalesCommissionsAndFee', window );">Commission expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,758<span></span>
</td>
<td class="nump">10,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,345<span></span>
</td>
<td class="nump">$ 2,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeATPAsiaLimitedMember', window );">Agape ATP Asia Limited [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia<span></span>
</td>
<td class="text">Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Expenses
    paid for AATP Asia<span></span>
</td>
<td class="text">Expenses
    paid for AATP Asia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount due from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,214<span></span>
</td>
<td class="nump">$ 2,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdMember', window );">Hostastay Sdn Bhd [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr. How Kok Choong,
    the CEO and director of the Company is also the director of Hostastay<span></span>
</td>
<td class="text">Mr. How Kok Choong,
    the CEO and director of the Company is also the director of Hostastay<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Sublease rent due from
    Hostastay<span></span>
</td>
<td class="text">Sublease rent due from
    Hostastay<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount due from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,790<span></span>
</td>
<td class="nump">$ 996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_THThreeTechnologySdnBhdMember', window );">TH3 Technology Sdn Bhd [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology<span></span>
</td>
<td class="text">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Expenses
    paid for TH3 Technology<span></span>
</td>
<td class="text">Expenses
    paid for TH3 Technology<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount due from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdMember', window );">Agape Superior Living Pty Ltd [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mr.
    How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">ATP
    Label Printing Fees<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Amount due from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 455<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdASLPLMember', window );">Agape Superior Living Pty Ltd ASLPL [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL<span></span>
</td>
<td class="text">Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Sales of
    products<span></span>
</td>
<td class="text">Sales of
    products<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 18,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdASLPLMember', window );">Agape Superior Living Pty Ltd ASLPL [Member] | Chief Executive Officer [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr.
    How Kok Choong, the CEO and director of the Company<span></span>
</td>
<td class="text">Mr.
    How Kok Choong, the CEO and director of the Company<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_VettonsSdnBhdOneMember', window );">Vettons Sdn Bhd One [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021<span></span>
</td>
<td class="text">Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">Sales
    of products made through its platform<span></span>
</td>
<td class="text">Sales
    of products made through its platform<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 6,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdOneMember', window );">Hostastay Sdn. Bhd [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Sublease
    rental income due from Hostastay<span></span>
</td>
<td class="text">Sublease
    rental income due from Hostastay<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalesCommissionsAndFee', window );">Commission expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,758<span></span>
</td>
<td class="nump">10,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,345<span></span>
</td>
<td class="nump">$ 2,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdOneMember', window );">Hostastay Sdn. Bhd [Member] | Chief Executive Officer [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Hostastay<span></span>
</td>
<td class="text">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Hostastay<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HowKokChoongMember', window );">How Kok Choong [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Commission
    expense<span></span>
</td>
<td class="text">Commission
    expense<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HowKokChoongMember', window );">How Kok Choong [Member] | Chief Executive Officer [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_DSYWellnessAndLongevityCenterSdnBhdMember', window );">DSY Wellness &amp; Longevity Center Sdn Bhd [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Purchase<span></span>
</td>
<td class="text">Purchase<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Purchase</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 718<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_DSYWellnessAndLongevityCenterSdnBhdMember', window );">DSY Wellness &amp; Longevity Center Sdn Bhd [Member] | Chief Executive Officer [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Dato&#8217; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd<span></span>
</td>
<td class="text">Dato&#8217; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">During the year ended December 31, 2021, the Company had sales
of $<span id="xdx_90F_eus-gaap--RevenueFromRelatedParties_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_za0RKbuWThr6" title="Revenue">6,625</span> through the online platform owned by Vettons Sdn Bhd (&#8220;Vettons&#8221;). Vettons is a related party since Mr. How Kok
Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_RelatedPartiesNatureDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related parties nature, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_RelatedPartiesNatureDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_RelatedPartiesRelationshipsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related parties, relationships, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_RelatedPartiesRelationshipsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_SalesCommissionsAndFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_SalesCommissionsAndFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeATPAsiaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeATPAsiaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_THThreeTechnologySdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_THThreeTechnologySdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdASLPLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdASLPLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_VettonsSdnBhdOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_VettonsSdnBhdOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_DSYWellnessAndLongevityCenterSdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_DSYWellnessAndLongevityCenterSdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843052163128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,460,047<span></span>
</td>
<td class="nump">376,452,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,460,047<span></span>
</td>
<td class="nump">376,452,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business combination, recognized identifiable assets acquired and liabilities assumed, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,105,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareForfeitureAgreementsMember', window );">Share Forfeiture Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,992,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareForfeitureAgreementsMember', window );">Share Forfeiture Agreements [Member] | How Kok Choong Talent Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareForfeitureAgreementsMember', window );">Share Forfeiture Agreements [Member] | How Kok Choong Talent Limited [Member] | Shareholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareForfeitureAgreementsMember', window );">Share Forfeiture Agreements [Member] | HKC Holdings Sdn Bhd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember', window );">ASL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period acquisitions, shares</a></td>
<td class="nump">13,853<span></span>
</td>
<td class="nump">162,694<span></span>
</td>
<td class="nump">13,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business combination, recognized identifiable assets acquired and liabilities assumed, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AATP_ShareForfeitureAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AATP_ShareForfeitureAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HowKokChoongTalentLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HowKokChoongTalentLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_ShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_ShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HKCHoldingsSdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HKCHoldingsSdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843051672120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF NON CONTROLLING INTEREST (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NonControllingInterestPaidinCapital', window );">Paid-in capital</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NonControllingInterestAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(436)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome', window );">Accumulated other comprehensive income</a></td>
<td class="nump">3<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NonControllingInterestNonControllingInterestGross', window );">&#160;Non Controlling interest Gross</a></td>
<td class="num">(336)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NonControllingInterestAsl', window );">ASL</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Total</a></td>
<td class="num">$ (336)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NonControllingInterestAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non controlling interest accumulated deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NonControllingInterestAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non controlling interest accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NonControllingInterestAsl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non controlling interest asl.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NonControllingInterestAsl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NonControllingInterestNonControllingInterestGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non controlling interest gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NonControllingInterestNonControllingInterestGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NonControllingInterestPaidinCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non controlling interest paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NonControllingInterestPaidinCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055601784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Local &#8211; United States</a></td>
<td class="num">$ (706,659)<span></span>
</td>
<td class="num">$ (735,159)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before income tax</a></td>
<td class="num">(2,387,613)<span></span>
</td>
<td class="nump">516,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MY', window );">MALAYSIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(1,064,314)<span></span>
</td>
<td class="nump">1,070,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_HK', window );">HONG KONG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">$ (616,640)<span></span>
</td>
<td class="nump">$ 180,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055538792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF PROVISION FOR INCOME TAX (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">- Local</a></td>
<td class="num">$ (22,205)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">- Foreign</a></td>
<td class="num">(104,735)<span></span>
</td>
<td class="nump">16,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">- Local</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">- Foreign</a></td>
<td class="num">(10,127)<span></span>
</td>
<td class="num">(178,329)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">$ (137,067)<span></span>
</td>
<td class="num">$ (161,581)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057825816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(17.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Differential tax rate in Malaysia</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Permanent difference</a></td>
<td class="num">(12.70%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">11.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(5.70%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">31.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">&#160;The
    amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zkx8Ftrs7L89" title="Non-deductible tax rate">6.2</span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_z7zr0BljaQM3" title="Non-deductible tax rate">6.7</span>%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231_zv1NMsh9HgPd">10.2%
being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; </span></span><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zyI1Oi1dqqbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Non-deductible tax rate">0.2%
being income derived in AATP HK that were not taxable in the Malaysia tax returns; and </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zAbCSjiqlxJf" title="Non-deductible tax rate">1.3</span>%
being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843055234008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_AATPHKMember', window );">AATP HK [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Tax percentage</a></td>
<td class="nump">6.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_AATPLBASLSEAWATPAndDSYMember', window );">AATP LB, ASL, SEA, WATP, and DSY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Tax percentage</a></td>
<td class="nump">6.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_AATPLBASLSEAAndWATPMember', window );">AATP LB, ASL, SEA and WATP [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_AATPHKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_AATPHKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_AATPLBASLSEAWATPAndDSYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_AATPLBASLSEAWATPAndDSYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_AATPLBASLSEAAndWATPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_AATPLBASLSEAAndWATPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843051978952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">$ (380,167)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DeferredTaxLiabilitiesDepreciation', window );">Depreciation</a></td>
<td class="num">(15,574)<span></span>
</td>
<td class="num">(68,421)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax liabilities, net</a></td>
<td class="num">(15,574)<span></span>
</td>
<td class="num">(5,743)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Net operating loss carry forwards</a></td>
<td class="nump">153,061<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(153,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MY', window );">MALAYSIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Net operating loss carry forwards</a></td>
<td class="nump">227,106<span></span>
</td>
<td class="nump">62,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">$ (217,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DeferredTaxLiabilitiesDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities, depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DeferredTaxLiabilitiesDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843052358024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 02, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription', window );">Tax rate description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In addition, the
Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#8220;GILTI&#8221;) tax, which is a tax on certain off-shore earnings
at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign
tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are
applied<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137,067<span></span>
</td>
<td class="nump">$ 161,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax examination penalties and interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Deferred tax assets operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced', window );">Cumulative net operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 380,167<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.70%)<span></span>
</td>
<td class="nump">31.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=AATP_UnutilizedMember', window );">Unutilized [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 685,000<span></span>
</td>
<td class="nump">$ 261,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">729,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 153,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=AATP_LabuanMember', window );">Labuan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Tax percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MY', window );">MALAYSIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 946,000<span></span>
</td>
<td class="nump">261,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income tax examination, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The tax rate for small and medium sized companies (generally
companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000)
for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_HK', window );">HONG KONG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets operating loss carryforwards utilized and reduced.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of other income tax effect related to application of Tax Cuts and Jobs Act that are reclassified from accumulated other comprehensive income to retained earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL116659650-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659663-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=AATP_UnutilizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=AATP_UnutilizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=AATP_LabuanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=AATP_LabuanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843052151448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS OF RISKS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposits</a></td>
<td class="nump">$ 1,112,147<span></span>
</td>
<td class="nump">$ 554,864<span></span>
</td>
<td class="nump">$ 1,112,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DepositForInsurance', window );">Deposit for insurance</a></td>
<td class="nump">$ 563,788<span></span>
</td>
<td class="nump">$ 295,761<span></span>
</td>
<td class="nump">$ 563,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_DSwissIncMember', window );">DSwiss Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DividendShareForCommonStock', window );">[custom:DividendShareForCommonStock]</a></td>
<td class="nump">23,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_NoCustomerMember', window );">No Customer [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_VendorOneMember', window );">Vendor One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member] | E-commerce [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_VendorOneMember', window );">Vendor One [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47.30%<span></span>
</td>
<td class="nump">74.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_VendorOneMember', window );">Vendor One [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | DSwiss Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47.30%<span></span>
</td>
<td class="nump">74.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_VendorTwoMember', window );">Vendor Two [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.20%<span></span>
</td>
<td class="nump">25.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_OneVendorMember', window );">One Vendor [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_OneSalesDistributorMember', window );">One Sales Distributor [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_NoSalesDistributorMember', window );">No Sales Distributor [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DepositForInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deposit for insurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DepositForInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DividendShareForCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividend share for common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DividendShareForCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Deposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Deposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_DSwissIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_DSwissIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_NoCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_NoCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_VendorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_VendorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_ECommerceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_ECommerceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_VendorTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_VendorTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_OneVendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_OneVendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_OneSalesDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_OneSalesDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_NoSalesDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_NoSalesDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843056621368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF LEASE COMMITMENTS (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 166,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">84,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">251,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: interest</a></td>
<td class="num">(10,763)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 240,578<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843048270152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_LeaseExpirationTerm', window );">Lease expiration term</a></td>
<td class="text">May 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_IncreaseDecreaseInROUAssetsAndLiabilities', window );">Reduction in ROU assets and liabilities</a></td>
<td class="nump">$ 3,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease, rent expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179,562<span></span>
</td>
<td class="nump">$ 156,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualRiskOrUncertaintyByNatureAxis=AATP_COVIDNineteenImpactMember', window );">COVID-19 Impact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualRiskOrUncertaintyImpact', window );">COVID-19 impact description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On
May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the
country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian
population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full
lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one
dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter
of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases
hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced
Movement Control Order (&#8220;EMCO&#8221;) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament
met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating
its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021,
interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country
achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where
it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country&#8217;s population have been fully
vaccinated, with a further 46.0% having received booster shot<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_TrainingCenterMember', window );">Training Center [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_LeaseExpirationTerm', window );">Lease expiration term</a></td>
<td class="text">Aug. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember', window );">ASL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 490,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease effective interest rate</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_IncreaseDecreaseInROUAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in ROU assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_IncreaseDecreaseInROUAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_LeaseExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease expiration term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_LeaseExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRiskOrUncertaintyImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the potential impact of the occurrence of the defined risk or adverse resolution of an uncertainty on the entity's financial statements, including a range of potential loss if reasonably estimable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualRiskOrUncertaintyImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRiskOrUncertaintyByNatureAxis=AATP_COVIDNineteenImpactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualRiskOrUncertaintyByNatureAxis=AATP_COVIDNineteenImpactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_TrainingCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_TrainingCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139843057814968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Mr.How Kok Choong [Member] | Share Forfeiture Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited', window );">Company share forfeiture</a></td>
<td class="nump">$ 215,008,035<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AATP_ShareForfeitureAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AATP_ShareForfeitureAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>form10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:AATP="http://agapeatp.com/20211231"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aatp-20211231.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-03-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2022-03-23</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AgapeATPInternationalHoldingLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AgapeATPInternationalHoldingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-07</startDate>
            <endDate>2020-05-08</endDate>
        </period>
    </context>
    <context id="AsOf2020-05-08_custom_SubsidiaryCompanyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-08</instant>
        </period>
    </context>
    <context id="AsOf2021-11-11_custom_SubsidiaryCompanyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-11</instant>
        </period>
    </context>
    <context id="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-08</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SubsidiaryCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SubsidiaryCompanyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SubsidiaryCompanyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SubsidiaryCompanyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SubsidiaryCompanyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HealthAndWellnessProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:HealthAndWellnessProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HealthAndWellnessServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:HealthAndWellnessServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_HealthAndWellnessServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:HealthAndWellnessServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SocialSecurityOrganizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SocialSecurityOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember_custom_MYRCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SocialSecurityOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EmployeesProvidentFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmployeesProvidentFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EmploymentInsuranceSystemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmploymentInsuranceSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EmploymentInsuranceSystemMember_custom_MYRCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmploymentInsuranceSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HumanResourceDevelopmentFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:HumanResourceDevelopmentFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SurvivorSelectMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SurvivorSelectMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EnergizedMineralConcentrateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EnergizedMineralConcentrateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_IonizedCalMagMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IonizedCalMagMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OmegaBlendMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_OmegaBlendMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_BetaMaxxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_BetaMaxxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_VegeFruitFiberMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_VegeFruitFiberMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_IronMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IronMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_YoungFormulaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_YoungFormulaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OrganicYouthCareCleansingBarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_OrganicYouthCareCleansingBarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_MitogizeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_MitogizeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_NoOneMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_NoOneMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EnergetiqueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EnergetiqueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_TrimPlusMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TrimPlusMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PeriodEndMYRMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndMYRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PeriodEndMYRMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndMYRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PeriodEndHKDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndHKDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PeriodEndHKDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndHKDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PeriodAverageMYRMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_PeriodAverageMYRMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PeriodAverageHKDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_PeriodAverageHKDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SubsidiaryCompanyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-08</instant>
        </period>
    </context>
    <context id="From2020-06-292020-07-02_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-31_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ComputerAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ComputerAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_VehicleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:VehicleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_VehicleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:VehicleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-05-17_custom_GreenproCapitalCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-17</instant>
        </period>
    </context>
    <context id="AsOf2018-07-30_custom_GreenproCapitalCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-30</instant>
        </period>
    </context>
    <context id="AsOf2018-10-16_custom_GreenproCapitalCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-16</instant>
        </period>
    </context>
    <context id="AsOf2020-11-03_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="AsOf2020-12-09_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-09</instant>
        </period>
    </context>
    <context id="AsOf2021-09-27_custom_SEATechVenturesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SEATechVenturesCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-03-10_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-10</instant>
        </period>
    </context>
    <context id="AsOf2019-03-10_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-10</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-03_custom_UnreservedSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:UnreservedSdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-03</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-03-31_custom_MrHowKokChoongMember351695203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="AsOf2019-04-03_custom_PhoenixPlusCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-03</instant>
        </period>
    </context>
    <context id="AsOf2019-04-03_us-gaap_CommonStockMember_custom_PhoenixPlusCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-03</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_DirectorsOfUnreservedInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:DirectorsOfUnreservedInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:DirectorsOfUnreservedInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PhoenixPlusCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PhoenixPlusCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AgapeATPAsiaLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AgapeATPAsiaLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AgapeATPAsiaLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HostastaySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_HostastaySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_HostastaySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_HostastaySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_THThreeTechnologySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_THThreeTechnologySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_THThreeTechnologySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_VettonsSdnBhdOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:VettonsSdnBhdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_VettonsSdnBhdOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:VettonsSdnBhdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HowKokChoongMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:DSYWellnessAndLongevityCenterSdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:DSYWellnessAndLongevityCenterSdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:DSYWellnessAndLongevityCenterSdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:DSYWellnessAndLongevityCenterSdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_HowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-05-012020-05-31_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-06-292020-07-31_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HowKokChoongTalentLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongTalentLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HowKokChoongTalentLimitedMember_custom_ShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:ShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HowKokChoongTalentLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HKCHoldingsSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HKCHoldingsSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_country_HK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_country_HK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2018-12-282019-01-02_custom_LabuanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">AATP:LabuanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-28</startDate>
            <endDate>2019-01-02</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_UnutilizedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AATP:UnutilizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_UnutilizedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AATP:UnutilizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AATPHKMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AATPHKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AATPLBASLSEAWATPAndDSYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AATPLBASLSEAWATPAndDSYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AATPHKMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AATPHKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AATPLBASLSEAAndWATPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AATPLBASLSEAAndWATPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:NoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:NoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember_us-gaap_CustomerConcentrationRiskMember_custom_VendorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:ECommerceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_VendorTwoMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_VendorTwoMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-31_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-11-30_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_VendorOneMember_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_AccountsPayableMember_custom_OneVendorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:OneVendorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_OneSalesDistributorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:OneSalesDistributorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_NoSalesDistributorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:NoSalesDistributorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-04-01_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="From2021-05-302021-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <startDate>2021-05-30</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="From2021-05-302021-05-31_custom_TrainingCenterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:TrainingCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-30</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="AsOf2021-05-31_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_COVIDNineteenImpactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">AATP:COVIDNineteenImpactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-01-20_us-gaap_SubsequentEventMember_custom_MrHowKokChoongMember_custom_ShareForfeitureAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareForfeitureAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="RM">
        <measure>iso4217:MYR</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-12-31">0001713210</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-12-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0033">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0034">Yes</dei:EntityInteractiveDataCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0060"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TaxesPayableCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0132"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0134"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0158"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0159"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterest
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0209"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:RevenueFromRelatedParty
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0220"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0242"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0293"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0318"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0322"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0334"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0335"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0337"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0344"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0352"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0353"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ContributionsFromNoncontrollingInterestShareholders
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0356"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ContributionsFromNoncontrollingInterestShareholders
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ContributionsFromNoncontrollingInterestShareholders
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ContributionsFromNoncontrollingInterestShareholders
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0359"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0364"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0378"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InventoryWriteDown
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfInvestmentProjects
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0527"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0613"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InventoryWriteDown
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_HealthAndWellnessServicesMember"
      id="xdx2ixbrl0721"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember"
      id="xdx2ixbrl0854"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember"
      id="xdx2ixbrl0857"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0974"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0977"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0978"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:AccountsReceivableAndAccountsReceivableRelatedParties
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0980"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InventoryWriteDown
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0992"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1008"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1015"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1016"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1019"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl1021"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1022"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:AllowanceForDoubtfulAccountsReceivableExchangeRateEffect
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1025"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1028"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:InvestmentInNonMarketableSecuritiesGross
      contextRef="AsOf2021-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      id="xdx2ixbrl1163"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:SaleOfInvestmentInNonmarketableSecurities
      contextRef="AsOf2021-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      id="xdx2ixbrl1167"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:InvestmentInNonmarketableSecuritiesNet
      contextRef="AsOf2021-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      id="xdx2ixbrl1171"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:InvestmentInNonmarketableSecuritiesNet
      contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      id="xdx2ixbrl1173"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2021-12-31_custom_THThreeTechnologySdnBhdMember"
      id="xdx2ixbrl1241"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2021-12-31_custom_AgapeSuperiorLivingPtyLtdMember"
      id="xdx2ixbrl1252"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl1256"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember"
      id="xdx2ixbrl1268"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember"
      id="xdx2ixbrl1282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember"
      id="xdx2ixbrl1301"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1305"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:NonControllingInterestPaidinCapital
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1384"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:NonControllingInterestAccumulatedDeficit
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1387"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:NonControllingInterestAccumulatedOtherComprehensiveIncome
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1390"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:NonControllingInterestNonControllingInterestGross
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1393"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:NonControllingInterestAsl
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl1395"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:NonControllingInterestAsl
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1396"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterest
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1423"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl1428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2020-12-31_country_US"
      id="xdx2ixbrl1519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1528"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl1587"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-01-01to2021-12-31">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2021-01-01to2021-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-12-31">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-12-31">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2021-01-01to2021-12-31">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2021-01-01to2021-12-31">333-220144</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-12-31">AGAPE ATP CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-12-31">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-12-31">36-4838886</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-12-31">Tower 2</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-01-01to2021-12-31">Faber Towers</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2021-01-01to2021-12-31">Jalan Desa Bahagia</dei:EntityAddressAddressLine3>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-12-31">58100</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-12-31">Kuala Lumpur</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2021-01-01to2021-12-31">MY</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-12-31">(60)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-12-31">192230099</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2021-01-01to2021-12-31">Common Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2021-01-01to2021-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2021-01-01to2021-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityShellCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityShellCompany>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-12-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2021-01-01to2021-12-31">false</dei:EntityExTransitionPeriod>
    <dei:EntityPublicFloat contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">914950575</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-03-23" decimals="INF" unitRef="Shares">75452012</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName contextRef="From2021-01-01to2021-12-31">Friedman LLP</dei:AuditorName>
    <dei:AuditorFirmId contextRef="From2021-01-01to2021-12-31">711</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2021-01-01to2021-12-31">Friedman LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2021-01-01to2021-12-31">New York, New York</dei:AuditorLocation>
    <AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">17493</AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents>
    <AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">37387</AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2597848</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3517600</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">172757</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7004</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3235</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">375535</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">589814</us-gaap:InventoryNet>
    <AATP:VariableInterestEntityConsolidatedAmountOfPrepaidTaxes contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1357</AATP:VariableInterestEntityConsolidatedAmountOfPrepaidTaxes>
    <AATP:VariableInterestEntityConsolidatedAmountOfPrepaidTaxes contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11330</AATP:VariableInterestEntityConsolidatedAmountOfPrepaidTaxes>
    <us-gaap:PrepaidTaxes contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">636218</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1104495</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">295517</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">296370</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3912122</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5684271</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">215799</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">298309</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3660</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5826</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">237718</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">394141</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">89001</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">577035</us-gaap:MarketableSecuritiesNoncurrent>
    <AATP:InvestmentInNonMarketableSecuritiesNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1500</AATP:InvestmentInNonMarketableSecuritiesNoncurrent>
    <AATP:InvestmentInNonMarketableSecuritiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1500</AATP:InvestmentInNonMarketableSecuritiesNoncurrent>
    <us-gaap:DeferredOfferingCosts contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">264735</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">249525</us-gaap:DeferredOfferingCosts>
    <us-gaap:OtherAssets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">812413</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1526336</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4724535</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7210607</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">13715</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">279689</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">236134</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">157094</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">154276</us-gaap:OperatingLeaseLiabilityCurrent>
    <AATP:VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1548</AATP:VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities>
    <AATP:VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1904</AATP:VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">858355</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">647677</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3988</us-gaap:TaxesPayableCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">455</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1312841</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1038542</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">83484</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">241488</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">15574</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5743</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">99058</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">247231</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1411899</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1285773</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">290460047</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">290460047</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">376452047</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">376452047</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">29046</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">37645</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">6449215</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">6440616</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-3258687</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-734443</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">93398</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">181016</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3312972</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5924834</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-336</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3312636</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5924834</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4724535</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7210607</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1016962</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3434561</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <AATP:RevenueFromRelatedParty
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">18060</AATP:RevenueFromRelatedParty>
    <us-gaap:Revenues
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1016962</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3452621</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">297333</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">775855</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">719629</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2676766</us-gaap:GrossProfit>
    <us-gaap:SellingExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">394682</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">376582</us-gaap:SellingExpense>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">316267</us-gaap:SalesCommissionsAndFees>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">830659</us-gaap:SalesCommissionsAndFees>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1745734</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1627660</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">121514</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">2578197</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2834901</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-1858568</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-158135</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-42753</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">164283</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-505231</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">350137</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-18939</AATP:PreferredStockDividendIncomeStatementImpact>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-160062</AATP:PreferredStockDividendIncomeStatementImpact>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-529045</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">674482</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2387613</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">516347</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">137067</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">161581</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2524680</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">354766</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-436</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2524244</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">354766</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2524680</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">354766</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-87615</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">171231</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2612295</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">525997</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-433</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2611862</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">525997</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">376216452</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">376387778</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">376275500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">37628</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">5293082</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1089209</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">9785</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4251286</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">354766</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">354766</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">176547</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">17</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1147534</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1147551</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">171231</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">171231</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">376452047</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">37645</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">6440616</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-734443</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">181016</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5924834</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">85992000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">-8599</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">8599</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <AATP:ContributionsFromNoncontrollingInterestShareholders
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">97</AATP:ContributionsFromNoncontrollingInterestShareholders>
    <AATP:ContributionsFromNoncontrollingInterestShareholders
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">97</AATP:ContributionsFromNoncontrollingInterestShareholders>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-2524244</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-436</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2524680</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-2524244</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-436</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2524680</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-87618</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">3</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-87615</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">290460047</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">29046</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">6449215</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-3258687</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">93398</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-336</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3312636</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2524680</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">354766</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:Depreciation
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">75797</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">55407</us-gaap:Depreciation>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1961</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1505</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">139451</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">106561</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-505231</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">350137</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-18939</AATP:PreferredStockDividendIncomeStatementImpact>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-160062</AATP:PreferredStockDividendIncomeStatementImpact>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">10127</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">178329</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:InventoryWriteDown
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">36241</us-gaap:InventoryWriteDown>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">121514</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-167566</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">165149</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2417</us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-192713</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-78674</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-430062</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-184985</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">128363</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-352577</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-2804</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">52981</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-1421886</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">226651</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">336709</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <AATP:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-138143</AATP:IncreaseDecreaseInOperatingLeaseLiabilities>
    <AATP:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-105009</AATP:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">3988</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-845842</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-557951</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">3959</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">4734</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">178</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1210818</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:ProceedsFromSaleOfInvestmentProjects
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">121</us-gaap:ProceedsFromSaleOfInvestmentProjects>
    <AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">70173</AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-3959</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1276200</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">15210</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">249525</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-3851</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">227434</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-19061</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-22091</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-50890</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">76985</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-919752</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">773143</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3517600</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2744457</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2597848</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3517600</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">326838</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">288929</us-gaap:IncomeTaxesPaidNet>
    <AATP:ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">3250</AATP:ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications>
    <AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">483343</AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities>
    <AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">656495</AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition>
    <AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1147551</AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_808_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zjryWW5VR6N1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.
&lt;span id="xdx_82D_zuTOrtJQ1rSi"&gt;ORGANIZATION AND BUSINESS BACKGROUND&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agape
ATP Corporation, a Nevada corporation (&#x201c;the Company&#x201d;) was incorporated under the laws of the State of Nevada on June 1, 2016.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agape
ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape
Superior Living Sdn. Bhd. (&#x201c;ASL&#x201d;), a company incorporated in Malaysia. .&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zhzQsicOITE6" title="Ownership interest percentage"&gt;100&lt;/span&gt;% equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zFkZqBDvcHa1" title="Stock issued during period acquisitions, shares"&gt;9,590,596&lt;/span&gt; ordinary shares, no par value, equivalent to approximately &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200508__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zZfcYS6QRELe" title="Ownership interest percentage"&gt;99.99&lt;/span&gt;% of the equity interest in Agape Superior Living Sdn. Bhd.,
a network marketing entity incorporated in Malaysia.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agape
Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (&#x201c;WATP&#x201d;), a wholly owned subsidiary
under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services
that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (&#x201c;DSY Wellness&#x201d;)
with an independent third party which Agape ATP Corporation (Labuan) owns &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211111__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zwxMW21cPNK6" title="Ownership interest percentage"&gt;60&lt;/span&gt;% of the equity interest, to pursue the business of providing
complementary health therapies&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to
supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation,
anti-aging and products designed to improve the overall health system of the human body and various wellness programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements reflect the activities of the Company, AATP LB, AATP HK, WATP, ASL and its variable interest
entity (&#x201c;VIE&#x201d;), Agape S.E.A. Sdn. Bhd. (&#x201c;SEA&#x201d;) (See Note 3), and DSY Wellness.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zwe7aFvThaG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the Company&#x2019;s subsidiaries:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zj3z0IqpFBQk" style="display: none"&gt;SCHEDULE OF SUBSIDIARIES AND ASSOCIATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Subsidiary company name&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Place and date of incorporation&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Particulars of issued capital&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Principal activities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Proportional of ownership interest and voting power held&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 6%; vertical-align: top"&gt;1.&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zJXEvi6NRyUh" style="vertical-align: top; width: 16%; text-align: center" title="Subsidiary company name"&gt;Agape ATP Corporation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zzkn5rj3Uck" style="vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation"&gt;Labuan, &lt;br/&gt; March 6, 2017&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsgpDyy2TMMl" style="vertical-align: top; width: 16%; text-align: center" title="Particulars of issued capital"&gt;100 shares of ordinary share of US$1 each&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zoZtxcXvENgf" style="vertical-align: top; width: 16%; text-align: center" title="Principal activities"&gt;Investment holding&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zicZ1wjT3AE4" style="vertical-align: top; width: 18%; text-align: right" title="Proportional of ownership interest and voting power held"&gt;100&lt;/td&gt;&lt;td style="vertical-align: top; width: 1%; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;2.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zaubThxHYBVh" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;Agape ATP International Holding Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zuC7GgYsCeD7" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Hong Kong,&lt;br/&gt; June 1, 2017&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zdSzsaNpIea4" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;1,000,000 shares of ordinary share of HK$1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zocye911l2qg" style="vertical-align: top; text-align: center" title="Principal activities"&gt;Wholesaling of health and wellness products; and health solution advisory services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z1c7ZCaUNV1f" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;100&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;3.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zRcFlMWvqJ7l" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;Agape Superior Living Sdn. Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zcs7sN0Nu5q7" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Malaysia, &lt;br/&gt; August 8, 2003&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z5dnt8C8MCpe" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;9,590,598 shares of ordinary share of RM1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zpruVcSAlxS2" style="vertical-align: top; text-align: center" title="Principal activities"&gt;Health and wellness products and health solution advisory services via network marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z8X5TglxoRU1" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;99.99&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;4.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zOSA8SvcFSe8" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;Agape S.E.A. Sdn. Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_z5D1tm2kmR9j" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Malaysia, &lt;br/&gt; March 4, 2004&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zKXQYjcIaqj4" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;2 shares of ordinary share of RM1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zycxkWzXgPB5" style="vertical-align: top; text-align: center" title="Principal activities"&gt;VIE of Agape Superior Living Sdn. Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VIE&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;5.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zlD30iy2ipI8" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;Wellness ATP International Holdings Sdn, Bhd&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zQBdLUuSkqZi" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Malaysia, &lt;br/&gt; September 11, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z7oHDCHRFsp5" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;100 shares of ordinary share of RM1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zIVr6Myj4za4" style="vertical-align: top; text-align: center" title="Principal activities"&gt;The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zuZTuMiA4XY6" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;100&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;6.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zTc8c6JIi7r7" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;DSY Wellness International Sdn Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zKS9tx910Yg9" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Malaysia, &lt;br/&gt; November 11, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_z1CtNu8Ndnue" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;1,000 shares of ordinary share of RM1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zJKc7Z8ErKth" style="vertical-align: top; text-align: center" title="Principal activities"&gt;Provision of complementary health therapies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zolorxDKUq1i" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;60&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zX77UpgzHdI7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.
ORGANIZATION AND BUSINESS BACKGROUND (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Business
Overview&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company
primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#x201c;ATP Zeta Health Program&#x201d;,
which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy
lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of
modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to strengthen the Company&#x2019;s supply chain, on May 8, 2020, the Company has successfully acquired approximately &lt;span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zNAp4MKs5WLe"&gt;99.99&lt;/span&gt;% of ASL,
with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years.
ASL has been offering the Company&#x2019;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy
in the Company&#x2019;s operation by boosting the Company&#x2019;s retail and marketing capabilities. The newly acquired subsidiary allows
the Company to fulfill its mission of &#x201c;helping people to create health and wealth&#x201d; by providing a financially rewarding business
opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Via
ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#xc9;NERG&#xc9;TIQUE
and BEAUNIQUE.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused
by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity
through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and
distributors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
&#xc9;NERG&#xc9;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series
is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
BEAUNIQUE product series focuses on the research of our diet&#x2019;s impact on modifying gene expressions in order to address genetic
variations and deliver a nutrigenomic solution for every individual.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution
advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various
wellness programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;To
further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity,
DSY Wellness International Sdn. Bhd. (&#x201c;DSY Wellness&#x201d;) with an independent third party which Agape ATP Corporation (Labuan)
owns 60% of the equity interest, to pursue the business of providing complementary health therapies&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-12-31_custom_AgapeATPInternationalHoldingLimitedMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="Shares">9590596</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-05-08_custom_SubsidiaryCompanyTwoMember"
      decimals="INF"
      unitRef="Pure">0.9999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-11-11_custom_SubsidiaryCompanyFiveMember"
      decimals="INF"
      unitRef="Pure">0.60</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_899_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zwe7aFvThaG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the Company&#x2019;s subsidiaries:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zj3z0IqpFBQk" style="display: none"&gt;SCHEDULE OF SUBSIDIARIES AND ASSOCIATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Subsidiary company name&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Place and date of incorporation&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Particulars of issued capital&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Principal activities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Proportional of ownership interest and voting power held&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 6%; vertical-align: top"&gt;1.&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zJXEvi6NRyUh" style="vertical-align: top; width: 16%; text-align: center" title="Subsidiary company name"&gt;Agape ATP Corporation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zzkn5rj3Uck" style="vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation"&gt;Labuan, &lt;br/&gt; March 6, 2017&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsgpDyy2TMMl" style="vertical-align: top; width: 16%; text-align: center" title="Particulars of issued capital"&gt;100 shares of ordinary share of US$1 each&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zoZtxcXvENgf" style="vertical-align: top; width: 16%; text-align: center" title="Principal activities"&gt;Investment holding&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zicZ1wjT3AE4" style="vertical-align: top; width: 18%; text-align: right" title="Proportional of ownership interest and voting power held"&gt;100&lt;/td&gt;&lt;td style="vertical-align: top; width: 1%; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;2.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zaubThxHYBVh" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;Agape ATP International Holding Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zuC7GgYsCeD7" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Hong Kong,&lt;br/&gt; June 1, 2017&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zdSzsaNpIea4" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;1,000,000 shares of ordinary share of HK$1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zocye911l2qg" style="vertical-align: top; text-align: center" title="Principal activities"&gt;Wholesaling of health and wellness products; and health solution advisory services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z1c7ZCaUNV1f" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;100&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;3.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zRcFlMWvqJ7l" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;Agape Superior Living Sdn. Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zcs7sN0Nu5q7" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Malaysia, &lt;br/&gt; August 8, 2003&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z5dnt8C8MCpe" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;9,590,598 shares of ordinary share of RM1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zpruVcSAlxS2" style="vertical-align: top; text-align: center" title="Principal activities"&gt;Health and wellness products and health solution advisory services via network marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z8X5TglxoRU1" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;99.99&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;4.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zOSA8SvcFSe8" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;Agape S.E.A. Sdn. Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_z5D1tm2kmR9j" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Malaysia, &lt;br/&gt; March 4, 2004&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zKXQYjcIaqj4" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;2 shares of ordinary share of RM1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zycxkWzXgPB5" style="vertical-align: top; text-align: center" title="Principal activities"&gt;VIE of Agape Superior Living Sdn. Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VIE&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;5.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zlD30iy2ipI8" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;Wellness ATP International Holdings Sdn, Bhd&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zQBdLUuSkqZi" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Malaysia, &lt;br/&gt; September 11, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z7oHDCHRFsp5" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;100 shares of ordinary share of RM1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zIVr6Myj4za4" style="vertical-align: top; text-align: center" title="Principal activities"&gt;The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zuZTuMiA4XY6" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;100&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;6.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zTc8c6JIi7r7" style="vertical-align: top; text-align: center" title="Subsidiary company name"&gt;DSY Wellness International Sdn Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zKS9tx910Yg9" style="vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;Malaysia, &lt;br/&gt; November 11, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_z1CtNu8Ndnue" style="vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;1,000 shares of ordinary share of RM1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zJKc7Z8ErKth" style="vertical-align: top; text-align: center" title="Principal activities"&gt;Provision of complementary health therapies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zolorxDKUq1i" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;60&lt;/td&gt;&lt;td style="vertical-align: top; text-align: right"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock>
    <AATP:NameOftheCompany contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember">Agape ATP Corporation</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember">Labuan,  March 6, 2017</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember">100 shares of ordinary share of US$1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyMember">Investment holding</AATP:PrincipalActivities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <AATP:NameOftheCompany contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember">Agape ATP International Holding Limited</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember">Hong Kong, June 1, 2017</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember">1,000,000 shares of ordinary share of HK$1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyOneMember">Wholesaling of health and wellness products; and health solution advisory services</AATP:PrincipalActivities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyOneMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <AATP:NameOftheCompany contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember">Agape Superior Living Sdn. Bhd.</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember">Malaysia,  August 8, 2003</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember">9,590,598 shares of ordinary share of RM1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyTwoMember">Health and wellness products and health solution advisory services via network marketing</AATP:PrincipalActivities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyTwoMember"
      decimals="INF"
      unitRef="Pure">0.9999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <AATP:NameOftheCompany contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember">Agape S.E.A. Sdn. Bhd.</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember">Malaysia,  March 4, 2004</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember">2 shares of ordinary share of RM1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyThreeMember">VIE of Agape Superior Living Sdn. Bhd.</AATP:PrincipalActivities>
    <AATP:NameOftheCompany contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember">Wellness ATP International Holdings Sdn, Bhd</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember">Malaysia,  September 11, 2020</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember">100 shares of ordinary share of RM1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFourMember">The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns</AATP:PrincipalActivities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyFourMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <AATP:NameOftheCompany contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember">DSY Wellness International Sdn Bhd.</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember">Malaysia,  November 11, 2021</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember">1,000 shares of ordinary share of RM1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_SubsidiaryCompanyFiveMember">Provision of complementary health therapies</AATP:PrincipalActivities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyFiveMember"
      decimals="INF"
      unitRef="Pure">0.60</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="Pure">0.9999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zuQiQKgWfU4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
&lt;span id="xdx_829_zm1kCRUSRHuc"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zeDlPoyXheKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Basis
of presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#x201c;U.S. GAAP&#x201d;) for information pursuant to the rules and regulations of the Securities Exchange Commission
(&#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company
exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary.
All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zIzk1snyltAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Principles
of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to
govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a
majority of votes at the meeting of directors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without
additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such
as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of
the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary
and must consolidate the VIE.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--UseOfEstimates_zJNbiMqwRbCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Use
of estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates
reflected in the Company&#x2019;s consolidated financial statements include allowance for doubtful accounts, allowance for inventories
obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for
deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment
in non-marketable securities. Actual results could differ from these estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z3rzciRsd7ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_z7h8mKQ3Eo71" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zfLkXh3OhBMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Accounts
receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due
on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the
Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis,
using historical collection trends and aging of receivables. Management also periodically evaluates individual customer&#x2019;s financial
condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary.
Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. The Company&#x2019;s management continues to evaluate the reasonableness of the valuation allowance policy and update
it if necessary. As of December 31, 2021 and 2020, &lt;span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20211231_zZpkZXBfDhF1" title="Accounts receivable, allowance for credit loss::XDX::-"&gt;&lt;span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20201231_z2gRSfBQ4YQh" title="Accounts receivable, allowance for credit loss::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0613"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0615"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; allowance of doubtful accounts was recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zdaWn6gJJjD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life
of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net
realizable value. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the years ended December 31, 2021,
and 2020, the company recorded $&lt;span id="xdx_90A_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zz2wt2LAgfC5" title="Inventories write-down"&gt;36,241&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--InventoryWriteDown_pp0p0_dxL_c20200101__20201231_zB3vozrYmlpa" title="Inventories write-down::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0621"&gt;0&lt;/span&gt;&lt;/span&gt; write-downs for inventory.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zdZoMb8wzNHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Prepaid
taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Prepaid
taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zqkBitGlXc97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Prepayments
and deposits&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services.
This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not
be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management
reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary.
Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood
of collection is not probable. The Company&#x2019;s management continues to evaluate the reasonableness of the valuation allowance policy
and update it if necessary. As of December 31, 2021 and 2020, there was $&lt;span id="xdx_902_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20211231_zOfQcpaErBJ1" title="Allowance for doubtful accounts"&gt;121,514&lt;/span&gt; and $&lt;span id="xdx_906_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zdfQOpCLD4Ne" title="Allowance for doubtful accounts"&gt;0&lt;/span&gt; allowance for the doubtful accounts recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zmKlSpfnevK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7cYcWhlN8v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Property
and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets with no residual value. The estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zSzEw3lfeing" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful
    Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    and office equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt;-&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    &amp;amp; fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;
                                                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment"&gt;6&lt;/span&gt;-&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment"&gt;Lease
    Term&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicle&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_zEFPE25M0ylf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is
included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings
as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The
Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates
of useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zHEzuq48QgQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Intangible
assets, net&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the
estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zvU7SXf61uW4" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Classification&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful
    Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zorLQNME5Hh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z5qzlK0tNytk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Impairment
for long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes
in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that
the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted
future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows
expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying
value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value
based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and
2020, &lt;span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20210101__20211231_zrSWi5qIbct2" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_902_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zLQgENYYhvLc" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment of long-lived assets was recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--DeferredChargesPolicyTextBlock_z36dlBRJQxUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Deferred
offering costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
offering costs represents costs associated with the Company&#x2019;s current offering which will be netted against the proceeds from the
Company&#x2019;s current offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--MarketableSecuritiesPolicy_zgB7vO5Vnsi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Investment
in marketable equity securities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company follows the provisions of ASU 2016-01, &lt;i&gt;Financial Instruments &#x2013; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities&lt;/i&gt;. Investments in marketable equity securities (non-current) are reported at fair value
with changes in fair value recognized in the Company&#x2019;s unaudited condensed consolidated statements of operations and comprehensive
loss in the caption of &#x201c;unrealized holding gain loss on marketable securities&#x201d; in each reporting period&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zmZq0CFspjHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--NonMarketableSecuritiesPolicyTextBlock_z3ijwap9sP65" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Investment
in non-marketable equity securities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the provisions of ASU 2016-01, &lt;i&gt;Financial Instruments &#x2013; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities&lt;/i&gt;. Due to the Company&#x2019;s non-marketable equity securities (non-current) does not
qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its
investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from
observable price changes in orderly transactions for the identical or a similar investment of the same issue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment
is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance,
credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or
technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical
area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed
auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that
raise significant concerns about the investee&#x2019;s ability to continue as a going concern, such as negative cash flows from operations,
working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators
indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment
loss equal to the difference between the fair value of the investment and its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zTvWJ7as6POh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Customer
deposits&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced
when the related sale is recognized in accordance with the Company&#x2019;s revenue recognition policy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zMrTajC1AXKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Revenue
recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core
principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods
and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange.
This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a
point in time or over time, based on when control of goods and services transfers to a customer. The Company&#x2019;s revenue streams
are recognized at a point in time for the Company&#x2019;s sale of health and wellness products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company
(i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate
the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies
the performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment
terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sales
of Health and Wellness products&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-
&lt;i&gt;Performance obligations satisfied at a point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness
products are transferred to its customer at the Company&#x2019;s office or shipment of the goods. The revenue is recorded net of estimated
discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were
insignificant sales returns&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value
of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds
resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and
wellness products transaction price upon such sales transactions occurred. The Company&#x2019;s coupons have a validity period of six
months. If the Company&#x2019;s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of
the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $&lt;span id="xdx_906_ecustom--ForfeitedCouponIncome_pp0p0_c20210101__20211231_zh7G9r61F1ta"&gt;15,209&lt;/span&gt;
and $&lt;span id="xdx_908_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zkpNQLzrUHHf" title="Forfeited coupon income"&gt;170,431&lt;/span&gt; as forfeited coupon income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $&lt;span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_za2TyjvrR2mg" title="Revenue from sales"&gt;183,816&lt;/span&gt; which it is expected
to fulfill within 12 months from December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sales
of Health and Wellness services&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-
&lt;i&gt;Performance obligations satisfied at a point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company carries out its Wellness program, where the Company&#x2019;s products are bundled with health screening test and a health camp
program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver
the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that
the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend
the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test
reports are completed and delivered to its customers during the consultation section in person.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp
program was completed in the final day of the health camp&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $&lt;span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zHfubZZIitA3"&gt;7,543&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zqmC0FnEsRM2"&gt;0&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disaggregated
information of revenues by products and services are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none"&gt;SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Survivor Select&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;83,904&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;149,897&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Energized Mineral Concentrate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,047&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;81,481&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ionized Cal-Mag&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39,527&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;908,964&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Omega Blend&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;222,718&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;495,567&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;BetaMaxx&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;208,043&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;156,550&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vege Fruit Fiber&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;65,757&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,755&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Iron&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,114&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;133,389&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Young Formula&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,425&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;653,631&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Organic Youth Care Cleansing Bar&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,137&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,127&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mitogize&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;183,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;162,801&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;No. 1 MED&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,331&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;46,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Energetique&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,574&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;253,396&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trim+&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,042&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;365,350&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenues &#x2013; products&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,009,419&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,452,621&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Health and Wellness
    services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,543&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0721"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,016,962&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,452,621&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zKKWWqhhjikh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--CostOfSalesPolicyTextBlock_z0ZV9KzHWuv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Cost
of revenue&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Cost
of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue
amounted to $&lt;span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231_zQDKOqYEwgwe" title="Cost of revenue"&gt;297,333&lt;/span&gt; (including inventory write-downs of $&lt;span id="xdx_907_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zAnOlYDliz7l" title="Inventories write-down"&gt;36,241&lt;/span&gt;) and $&lt;span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20200101__20201231_z1I0GRSSjKHh" title="Cost of revenue"&gt;775,855&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--ShippingAndHandlingPolicyTextBlock_zHjEmh7vgPHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Shipping
and handling&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling charges amounted to $&lt;span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z39I3F7j8mE9" title="Selling expenses"&gt;11,054&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zzZpeqTGyBZa" title="Selling expenses"&gt;9,315&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively. Shipping and handling
charges are expensed as incurred and included in selling expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zOiXHeocTzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Advertising
costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advertising
costs amounted to $&lt;span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20210101__20211231_z2FuMLE61324" title="Advertising costs"&gt;20,218&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zuyisFdiELCe" title="Advertising costs"&gt;14,339&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as
incurred and included in selling expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zbeXzIh9K1Xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Commission
expenses &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commission
expenses are the Company&#x2019;s most significant expenses. As with all companies in the network marketing industry, the Company&#x2019;s
sales channel is external to the Company. The Company&#x2019;s &#x201c;external sales force&#x201d; is stratified into two levels based
on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly,
are referred to as &#x201c;sales network members&#x201d;. The Company pays commission to every sales distributor based on purchases made
by its sales network members which includes the independent&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;direct
sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy
benefits such as maintaining a certain amount of the Company&#x2019;s inventory on their store premises. The stockists shall account to
the Company for all products sales from their store premises as monitored through the Company&#x2019;s centralized stock tracking system.
The Company pays a separate commission to stockists based on revenue generated from the stockists&#x2019; physical stores. Commission
expenses amounted to $&lt;span id="xdx_909_ecustom--SalesCommissionsAndFees1_pp0p0_c20210101__20211231_z6ZNeK45NC3j" title="Commission expenses"&gt;316,267&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zSxc8j1L6f32" title="Commission expenses"&gt;830,659&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--DefinedContributionPlanPolicyTextBlock_zkZvS1Yq0XF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;span style="text-decoration: underline"&gt;Defined
contribution plan&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue
and pay for these benefits based on certain percentages of the employees&#x2019; respective salaries, subject to certain ceilings, in
accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
Total expenses for the plans were $&lt;span id="xdx_900_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20210101__20211231_zgJgN31MZHD5" title="Defined contribution plan expense"&gt;99,488&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_z5f6ZzaKecgf" title="Defined contribution plan expense"&gt;75,802&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
related contribution plans include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Social
    Security Organization (&#x201c;SOSCO&#x201d;) &#x2013; &lt;span id="xdx_90E_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_ze4TdFb1Fj2" title="Salary percentage"&gt;1.75&lt;/span&gt;% based on employee&#x2019;s monthly salary capped of RM &lt;span id="xdx_90C_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zUmbVWZyicu9" title="Monthly salary"&gt;4,000&lt;/span&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employees
    Provident Fund (&#x201c;EPF&#x201d;) &#x2013; &lt;span id="xdx_905_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_zVn7Eiyly6O8" title="Salary percentage"&gt;12&lt;/span&gt;% based on employee&#x2019;s monthly salary;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employment
    Insurance System (&#x201c;EIS&#x201d;) &#x2013; &lt;span id="xdx_906_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zhFZHd7oCLi1" title="Salary percentage"&gt;0.2&lt;/span&gt;% based on employee&#x2019;s monthly salary capped of RM &lt;span id="xdx_903_ecustom--MonthlySalary_pp0p0_uRM_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zavxrZi1P9Ul" title="Monthly salary"&gt;4,000&lt;/span&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Human
    Resource Development Fund (&#x201c;HRDF&#x201d;) &#x2013; &lt;span id="xdx_900_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zt0N8oBqBNq" title="Salary percentage"&gt;1&lt;/span&gt;% based on employee&#x2019;s monthly salary&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z5jmFnxmDe13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Income
taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for
the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted
or substantively enacted by the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the
carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation
of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences
can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the
liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged
directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
uncertain tax position is recognized as a benefit only if it is &#x201c;more likely than not&#x201d; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is &lt;span id="xdx_907_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210101__20211231_zI0BK4zQ6X15" title="Income tax examination, likelihood of unfavorable settlement"&gt;greater than 50%&lt;/span&gt; likely of being realized on examination. For tax positions not meeting the &#x201c;more likely than not&#x201d; test,
no tax benefit is recorded. $&lt;span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20210101__20211231_zhtHJHFt04F7" title="Income tax examination, penalties and interest expense"&gt;395&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20200101__20201231_zwgUz8si7Xxk" title="Income tax examination, penalties and interest expense"&gt;0&lt;/span&gt; penalties and interest incurred related to underpayment of income tax for the years ended December
31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a
result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zFmJhQqD6MOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Comprehensive
income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss)
refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#x2019; equity but are excluded
from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not
using the U.S. dollar as its functional currencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_ecustom--NoncontrollingInterestPolicyTextBlock_zvodLWm7yptb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Non-controlling
interest&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--MinorityInterestDescription_c20210101__20211231_z2jVyFk7GMzi" title="Noncontrolling interest, description"&gt;Non-controlling
interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out
of 9,590,598 shares) of the equity interests of ASL held by two individuals&lt;/span&gt;. The non-controlling interests are presented in the consolidated
balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the
Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods
between non-controlling interest holders and the shareholders of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zZGPhNuzFDjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Earnings
(loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company computes earnings (loss) per share (&#x201c;EPS&#x201d;) in accordance with ASC 260, &#x201c;Earnings per Share&#x201d;. ASC 260
requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share
outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible
securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later.
Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are
excluded from the calculation of diluted EPS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;. For the
years ended December 31, 2021 and 2020, there were &lt;span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20210101__20211231_z6oZ7p2bv9Mf" title="Potentially dilutive securities outstanding"&gt;&lt;span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20200101__20201231_zVXiU2cpuCAc" title="Potentially dilutive securities outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; dilutive shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8AGmGK5QsX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Foreign
currencies translation and transaction&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing
at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated
into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded
in the consolidated statements of operations and comprehensive income (loss).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reporting currency of the Company is United States Dollars (&#x201c;US$&#x201d;) and the accompanying financial statements have been expressed
in US$. The Company&#x2019;s subsidiary in Labuan maintains its books and record in United States Dollars (&#x201c;US$&#x201d;) albeit its
functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit
(&#x201c;MYR&#x201d; or &#x201c;RM&#x201d;). The Company&#x2019;s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars
(&#x201c;HK$&#x201d;), similar to its functional currency. The Company&#x2019;s subsidiary and VIE in Malaysia conducts its businesses and
maintains its books and record in the local currency, Malaysian Ringgit (&#x201c;MYR&#x201d; or &#x201c;RM&#x201d;), as its functional currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into
US$, in accordance with ASC Topic 830-30, &#x201c;&lt;i&gt;Translation of Financial Statement&#x201d;&lt;/i&gt;, using the exchange rate on the balance
sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation
of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the
statements of stockholders&#x2019; equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts
reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance
sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none"&gt;SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-end MYR : US$1 exchange
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.18&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.02&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-end HKD : US$1 exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-average MYR : US$1 exchange
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.20&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-average HKD : US$1 exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" style="text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.77&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" style="text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.76&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zqNifIeILn8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--RelatedPartiesPolicyTextBlock_zrQDAfgxw1sl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Related
parties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFEmgvJtixod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and
requires disclosure of the fair value of financial instruments held by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance
disclosure requirements for fair value measures. The three levels are defined as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that
    are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost,
which approximate fair value because of the short period of time between the origination of such instruments and their expected realization
and their current market rates of interest.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zbiKkVXe0pQi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zZNdDkKBmvPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopts ASU 2016-02, &#x201c;Leases&#x201d; (Topic 842), and elected the practical expedients that does not require the Company
to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing
leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted
to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient
that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company&#x2019;s leases
include one or more options to renew, which is typically at the Company&#x2019;s sole discretion. The Company regularly evaluates the
renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications
result in re-measurement of the right of use (&#x201c;ROU&#x201d;) assets and lease liabilities. Operating ROU assets and lease liabilities
are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for
the Company&#x2019;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available
at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that
the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment
and over a similar term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease,
as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers
the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected
the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve
months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives.
Lease expense is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews
the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the
asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset
from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount
of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future
pre-tax cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwRa40sJZ3q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Recent
accounting pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of
such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic
326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement
of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments
in Update 2016-13 added Topic 326, Financial Instruments&#x2014;Credit Losses, and made several consequential amendments to the Codification.
Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses
when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments&#x2014; Credit Losses&#x2014;Available-for-Sale
Debt Securities. The amendments in this Update address those stakeholders&#x2019; concerns by providing an option to irrevocably elect
the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition
relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar
financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments
in Update 2016-13 while still providing financial statement users with decision-useful information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit
organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date
for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim
reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating
the impact ASU 2019-05 may have on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments
accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options
accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should
consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement
alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts
or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity
should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing
investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance
with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted,
including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2020, the FASB issued ASU 2020-08, &#x201c;Codification Improvements to Subtopic 310-20, Receivables&#x2014;Nonrefundable Fees
and Other Costs&#x201d;. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification
easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the
Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply
the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable
debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021
did not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2020, the FASB issued ASU 2020-10, &#x201c;Codification Improvements&#x201d;. The amendments in this Update represent changes to
clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current
accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety
of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is
effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments
in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on
its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85B_z1wiGXOwYsl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zeDlPoyXheKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Basis
of presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#x201c;U.S. GAAP&#x201d;) for information pursuant to the rules and regulations of the Securities Exchange Commission
(&#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company
exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary.
All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zIzk1snyltAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Principles
of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to
govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a
majority of votes at the meeting of directors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without
additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such
as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of
the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary
and must consolidate the VIE.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_843_eus-gaap--UseOfEstimates_zJNbiMqwRbCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Use
of estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates
reflected in the Company&#x2019;s consolidated financial statements include allowance for doubtful accounts, allowance for inventories
obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for
deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment
in non-marketable securities. Actual results could differ from these estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z3rzciRsd7ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zfLkXh3OhBMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Accounts
receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due
on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the
Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis,
using historical collection trends and aging of receivables. Management also periodically evaluates individual customer&#x2019;s financial
condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary.
Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. The Company&#x2019;s management continues to evaluate the reasonableness of the valuation allowance policy and update
it if necessary. As of December 31, 2021 and 2020, &lt;span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20211231_zZpkZXBfDhF1" title="Accounts receivable, allowance for credit loss::XDX::-"&gt;&lt;span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20201231_z2gRSfBQ4YQh" title="Accounts receivable, allowance for credit loss::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0613"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0615"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; allowance of doubtful accounts was recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zdaWn6gJJjD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life
of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net
realizable value. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the years ended December 31, 2021,
and 2020, the company recorded $&lt;span id="xdx_90A_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zz2wt2LAgfC5" title="Inventories write-down"&gt;36,241&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--InventoryWriteDown_pp0p0_dxL_c20200101__20201231_zB3vozrYmlpa" title="Inventories write-down::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0621"&gt;0&lt;/span&gt;&lt;/span&gt; write-downs for inventory.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryWriteDown
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">36241</us-gaap:InventoryWriteDown>
    <AATP:PrepaidTaxesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zdZoMb8wzNHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Prepaid
taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Prepaid
taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:PrepaidTaxesPolicyTextBlock>
    <AATP:PrepaymentsAndDepositsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_849_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zqkBitGlXc97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Prepayments
and deposits&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services.
This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not
be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management
reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary.
Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood
of collection is not probable. The Company&#x2019;s management continues to evaluate the reasonableness of the valuation allowance policy
and update it if necessary. As of December 31, 2021 and 2020, there was $&lt;span id="xdx_902_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20211231_zOfQcpaErBJ1" title="Allowance for doubtful accounts"&gt;121,514&lt;/span&gt; and $&lt;span id="xdx_906_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zdfQOpCLD4Ne" title="Allowance for doubtful accounts"&gt;0&lt;/span&gt; allowance for the doubtful accounts recorded.&lt;/span&gt;&lt;/p&gt;

</AATP:PrepaymentsAndDepositsPolicyTextBlock>
    <AATP:AllowanceForDoubtfulAccountsReceivablesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">121514</AATP:AllowanceForDoubtfulAccountsReceivablesCurrent>
    <AATP:AllowanceForDoubtfulAccountsReceivablesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</AATP:AllowanceForDoubtfulAccountsReceivablesCurrent>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7cYcWhlN8v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Property
and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets with no residual value. The estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zSzEw3lfeing" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful
    Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    and office equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt;-&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    &amp;amp; fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;
                                                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment"&gt;6&lt;/span&gt;-&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment"&gt;Lease
    Term&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicle&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_zEFPE25M0ylf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is
included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings
as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The
Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates
of useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets with no residual value. The estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zSzEw3lfeing" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful
    Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    and office equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt;-&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    &amp;amp; fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;
                                                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment"&gt;6&lt;/span&gt;-&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment"&gt;Lease
    Term&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicle&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">P6Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2021-01-012021-12-31_us-gaap_LeaseholdImprovementsMember">Lease
    Term</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-01-012021-12-31_us-gaap_VehiclesMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zHEzuq48QgQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Intangible
assets, net&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the
estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zvU7SXf61uW4" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Classification&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful
    Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zorLQNME5Hh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the
estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zvU7SXf61uW4" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Classification&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful
    Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-01-012021-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z5qzlK0tNytk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Impairment
for long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes
in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that
the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted
future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows
expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying
value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value
based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and
2020, &lt;span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20210101__20211231_zrSWi5qIbct2" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_902_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zLQgENYYhvLc" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment of long-lived assets was recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84B_eus-gaap--DeferredChargesPolicyTextBlock_z36dlBRJQxUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Deferred
offering costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
offering costs represents costs associated with the Company&#x2019;s current offering which will be netted against the proceeds from the
Company&#x2019;s current offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_849_eus-gaap--MarketableSecuritiesPolicy_zgB7vO5Vnsi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Investment
in marketable equity securities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company follows the provisions of ASU 2016-01, &lt;i&gt;Financial Instruments &#x2013; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities&lt;/i&gt;. Investments in marketable equity securities (non-current) are reported at fair value
with changes in fair value recognized in the Company&#x2019;s unaudited condensed consolidated statements of operations and comprehensive
loss in the caption of &#x201c;unrealized holding gain loss on marketable securities&#x201d; in each reporting period&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

</us-gaap:MarketableSecuritiesPolicy>
    <AATP:NonMarketableSecuritiesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84E_ecustom--NonMarketableSecuritiesPolicyTextBlock_z3ijwap9sP65" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Investment
in non-marketable equity securities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the provisions of ASU 2016-01, &lt;i&gt;Financial Instruments &#x2013; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities&lt;/i&gt;. Due to the Company&#x2019;s non-marketable equity securities (non-current) does not
qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its
investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from
observable price changes in orderly transactions for the identical or a similar investment of the same issue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment
is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance,
credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or
technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical
area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed
auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that
raise significant concerns about the investee&#x2019;s ability to continue as a going concern, such as negative cash flows from operations,
working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators
indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment
loss equal to the difference between the fair value of the investment and its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:NonMarketableSecuritiesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zTvWJ7as6POh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Customer
deposits&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced
when the related sale is recognized in accordance with the Company&#x2019;s revenue recognition policy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zMrTajC1AXKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Revenue
recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core
principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods
and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange.
This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a
point in time or over time, based on when control of goods and services transfers to a customer. The Company&#x2019;s revenue streams
are recognized at a point in time for the Company&#x2019;s sale of health and wellness products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company
(i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate
the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies
the performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment
terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sales
of Health and Wellness products&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-
&lt;i&gt;Performance obligations satisfied at a point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness
products are transferred to its customer at the Company&#x2019;s office or shipment of the goods. The revenue is recorded net of estimated
discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were
insignificant sales returns&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value
of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds
resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and
wellness products transaction price upon such sales transactions occurred. The Company&#x2019;s coupons have a validity period of six
months. If the Company&#x2019;s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of
the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $&lt;span id="xdx_906_ecustom--ForfeitedCouponIncome_pp0p0_c20210101__20211231_zh7G9r61F1ta"&gt;15,209&lt;/span&gt;
and $&lt;span id="xdx_908_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zkpNQLzrUHHf" title="Forfeited coupon income"&gt;170,431&lt;/span&gt; as forfeited coupon income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $&lt;span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_za2TyjvrR2mg" title="Revenue from sales"&gt;183,816&lt;/span&gt; which it is expected
to fulfill within 12 months from December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sales
of Health and Wellness services&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-
&lt;i&gt;Performance obligations satisfied at a point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company carries out its Wellness program, where the Company&#x2019;s products are bundled with health screening test and a health camp
program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver
the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that
the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend
the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test
reports are completed and delivered to its customers during the consultation section in person.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp
program was completed in the final day of the health camp&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $&lt;span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zHfubZZIitA3"&gt;7,543&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zqmC0FnEsRM2"&gt;0&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disaggregated
information of revenues by products and services are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none"&gt;SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Survivor Select&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;83,904&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;149,897&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Energized Mineral Concentrate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,047&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;81,481&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ionized Cal-Mag&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39,527&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;908,964&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Omega Blend&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;222,718&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;495,567&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;BetaMaxx&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;208,043&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;156,550&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vege Fruit Fiber&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;65,757&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,755&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Iron&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,114&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;133,389&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Young Formula&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,425&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;653,631&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Organic Youth Care Cleansing Bar&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,137&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,127&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mitogize&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;183,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;162,801&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;No. 1 MED&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,331&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;46,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Energetique&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,574&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;253,396&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trim+&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,042&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;365,350&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenues &#x2013; products&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,009,419&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,452,621&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Health and Wellness
    services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,543&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0721"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,016,962&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,452,621&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zKKWWqhhjikh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <AATP:ForfeitedCouponIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">15209</AATP:ForfeitedCouponIncome>
    <AATP:ForfeitedCouponIncome
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">170431</AATP:ForfeitedCouponIncome>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_HealthAndWellnessProductsMember"
      decimals="0"
      unitRef="USD">183816</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_HealthAndWellnessServicesMember"
      decimals="0"
      unitRef="USD">7543</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_HealthAndWellnessServicesMember"
      decimals="0"
      unitRef="USD">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <AATP:ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disaggregated
information of revenues by products and services are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none"&gt;SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Survivor Select&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;83,904&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;149,897&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Energized Mineral Concentrate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,047&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;81,481&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ionized Cal-Mag&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39,527&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;908,964&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Omega Blend&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;222,718&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;495,567&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;BetaMaxx&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;208,043&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;156,550&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vege Fruit Fiber&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;65,757&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,755&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Iron&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,114&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;133,389&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Young Formula&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,425&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;653,631&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Organic Youth Care Cleansing Bar&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,137&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,127&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mitogize&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;183,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;162,801&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;No. 1 MED&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,331&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;46,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Energetique&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,574&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;253,396&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trim+&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,042&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;365,350&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenues &#x2013; products&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,009,419&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,452,621&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Health and Wellness
    services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,543&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0721"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,016,962&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,452,621&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AATP:ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_SurvivorSelectMember"
      decimals="0"
      unitRef="USD">83904</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_SurvivorSelectMember"
      decimals="0"
      unitRef="USD">149897</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_EnergizedMineralConcentrateMember"
      decimals="0"
      unitRef="USD">52047</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_EnergizedMineralConcentrateMember"
      decimals="0"
      unitRef="USD">81481</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_IonizedCalMagMember"
      decimals="0"
      unitRef="USD">39527</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_IonizedCalMagMember"
      decimals="0"
      unitRef="USD">908964</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_OmegaBlendMember"
      decimals="0"
      unitRef="USD">222718</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_OmegaBlendMember"
      decimals="0"
      unitRef="USD">495567</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_BetaMaxxMember"
      decimals="0"
      unitRef="USD">208043</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_BetaMaxxMember"
      decimals="0"
      unitRef="USD">156550</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_VegeFruitFiberMember"
      decimals="0"
      unitRef="USD">65757</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_VegeFruitFiberMember"
      decimals="0"
      unitRef="USD">1755</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_IronMember"
      decimals="0"
      unitRef="USD">28114</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_IronMember"
      decimals="0"
      unitRef="USD">133389</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_YoungFormulaMember"
      decimals="0"
      unitRef="USD">52425</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_YoungFormulaMember"
      decimals="0"
      unitRef="USD">653631</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_OrganicYouthCareCleansingBarMember"
      decimals="0"
      unitRef="USD">5137</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_OrganicYouthCareCleansingBarMember"
      decimals="0"
      unitRef="USD">43127</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_MitogizeMember"
      decimals="0"
      unitRef="USD">183800</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_MitogizeMember"
      decimals="0"
      unitRef="USD">162801</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_NoOneMEDMember"
      decimals="0"
      unitRef="USD">15331</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_NoOneMEDMember"
      decimals="0"
      unitRef="USD">46713</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_EnergetiqueMember"
      decimals="0"
      unitRef="USD">25574</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_EnergetiqueMember"
      decimals="0"
      unitRef="USD">253396</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_TrimPlusMember"
      decimals="0"
      unitRef="USD">27042</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_TrimPlusMember"
      decimals="0"
      unitRef="USD">365350</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_us-gaap_ProductMember"
      decimals="0"
      unitRef="USD">1009419</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_us-gaap_ProductMember"
      decimals="0"
      unitRef="USD">3452621</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_HealthAndWellnessServicesMember"
      decimals="0"
      unitRef="USD">7543</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1016962</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3452621</us-gaap:Revenues>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_840_eus-gaap--CostOfSalesPolicyTextBlock_z0ZV9KzHWuv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Cost
of revenue&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Cost
of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue
amounted to $&lt;span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231_zQDKOqYEwgwe" title="Cost of revenue"&gt;297,333&lt;/span&gt; (including inventory write-downs of $&lt;span id="xdx_907_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zAnOlYDliz7l" title="Inventories write-down"&gt;36,241&lt;/span&gt;) and $&lt;span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20200101__20201231_z1I0GRSSjKHh" title="Cost of revenue"&gt;775,855&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">297333</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InventoryWriteDown
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">36241</us-gaap:InventoryWriteDown>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">775855</us-gaap:CostOfGoodsAndServicesSold>
    <AATP:ShippingAndHandlingPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_847_ecustom--ShippingAndHandlingPolicyTextBlock_zHjEmh7vgPHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Shipping
and handling&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling charges amounted to $&lt;span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z39I3F7j8mE9" title="Selling expenses"&gt;11,054&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zzZpeqTGyBZa" title="Selling expenses"&gt;9,315&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively. Shipping and handling
charges are expensed as incurred and included in selling expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:ShippingAndHandlingPolicyTextBlock>
    <us-gaap:SellingExpense
      contextRef="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">11054</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">9315</us-gaap:SellingExpense>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zOiXHeocTzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Advertising
costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advertising
costs amounted to $&lt;span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20210101__20211231_z2FuMLE61324" title="Advertising costs"&gt;20,218&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zuyisFdiELCe" title="Advertising costs"&gt;14,339&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as
incurred and included in selling expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">20218</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">14339</us-gaap:AdvertisingExpense>
    <us-gaap:CommissionsExpensePolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_848_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zbeXzIh9K1Xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Commission
expenses &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commission
expenses are the Company&#x2019;s most significant expenses. As with all companies in the network marketing industry, the Company&#x2019;s
sales channel is external to the Company. The Company&#x2019;s &#x201c;external sales force&#x201d; is stratified into two levels based
on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly,
are referred to as &#x201c;sales network members&#x201d;. The Company pays commission to every sales distributor based on purchases made
by its sales network members which includes the independent&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;direct
sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy
benefits such as maintaining a certain amount of the Company&#x2019;s inventory on their store premises. The stockists shall account to
the Company for all products sales from their store premises as monitored through the Company&#x2019;s centralized stock tracking system.
The Company pays a separate commission to stockists based on revenue generated from the stockists&#x2019; physical stores. Commission
expenses amounted to $&lt;span id="xdx_909_ecustom--SalesCommissionsAndFees1_pp0p0_c20210101__20211231_z6ZNeK45NC3j" title="Commission expenses"&gt;316,267&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zSxc8j1L6f32" title="Commission expenses"&gt;830,659&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommissionsExpensePolicyPolicyTextBlock>
    <AATP:SalesCommissionsAndFees1
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">316267</AATP:SalesCommissionsAndFees1>
    <AATP:SalesCommissionsAndFees1
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">830659</AATP:SalesCommissionsAndFees1>
    <AATP:DefinedContributionPlanPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_ecustom--DefinedContributionPlanPolicyTextBlock_zkZvS1Yq0XF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;span style="text-decoration: underline"&gt;Defined
contribution plan&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue
and pay for these benefits based on certain percentages of the employees&#x2019; respective salaries, subject to certain ceilings, in
accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
Total expenses for the plans were $&lt;span id="xdx_900_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20210101__20211231_zgJgN31MZHD5" title="Defined contribution plan expense"&gt;99,488&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_z5f6ZzaKecgf" title="Defined contribution plan expense"&gt;75,802&lt;/span&gt; for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
related contribution plans include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Social
    Security Organization (&#x201c;SOSCO&#x201d;) &#x2013; &lt;span id="xdx_90E_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_ze4TdFb1Fj2" title="Salary percentage"&gt;1.75&lt;/span&gt;% based on employee&#x2019;s monthly salary capped of RM &lt;span id="xdx_90C_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zUmbVWZyicu9" title="Monthly salary"&gt;4,000&lt;/span&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employees
    Provident Fund (&#x201c;EPF&#x201d;) &#x2013; &lt;span id="xdx_905_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_zVn7Eiyly6O8" title="Salary percentage"&gt;12&lt;/span&gt;% based on employee&#x2019;s monthly salary;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employment
    Insurance System (&#x201c;EIS&#x201d;) &#x2013; &lt;span id="xdx_906_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zhFZHd7oCLi1" title="Salary percentage"&gt;0.2&lt;/span&gt;% based on employee&#x2019;s monthly salary capped of RM &lt;span id="xdx_903_ecustom--MonthlySalary_pp0p0_uRM_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zavxrZi1P9Ul" title="Monthly salary"&gt;4,000&lt;/span&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Human
    Resource Development Fund (&#x201c;HRDF&#x201d;) &#x2013; &lt;span id="xdx_900_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zt0N8oBqBNq" title="Salary percentage"&gt;1&lt;/span&gt;% based on employee&#x2019;s monthly salary&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:DefinedContributionPlanPolicyTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">99488</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">75802</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <AATP:SalaryPercentage
      contextRef="From2021-01-012021-12-31_custom_SocialSecurityOrganizationMember"
      decimals="INF"
      unitRef="Pure">0.0175</AATP:SalaryPercentage>
    <AATP:MonthlySalary
      contextRef="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember_custom_MYRCurrencyMember"
      decimals="0"
      unitRef="RM">4000</AATP:MonthlySalary>
    <AATP:SalaryPercentage
      contextRef="From2021-01-012021-12-31_custom_EmployeesProvidentFundMember"
      decimals="INF"
      unitRef="Pure">0.12</AATP:SalaryPercentage>
    <AATP:SalaryPercentage
      contextRef="From2021-01-012021-12-31_custom_EmploymentInsuranceSystemMember"
      decimals="INF"
      unitRef="Pure">0.002</AATP:SalaryPercentage>
    <AATP:MonthlySalary
      contextRef="From2021-01-012021-12-31_custom_EmploymentInsuranceSystemMember_custom_MYRCurrencyMember"
      decimals="0"
      unitRef="RM">4000</AATP:MonthlySalary>
    <AATP:SalaryPercentage
      contextRef="From2021-01-012021-12-31_custom_HumanResourceDevelopmentFundMember"
      decimals="INF"
      unitRef="Pure">0.01</AATP:SalaryPercentage>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z5jmFnxmDe13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Income
taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for
the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted
or substantively enacted by the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the
carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation
of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences
can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the
liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged
directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
uncertain tax position is recognized as a benefit only if it is &#x201c;more likely than not&#x201d; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is &lt;span id="xdx_907_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210101__20211231_zI0BK4zQ6X15" title="Income tax examination, likelihood of unfavorable settlement"&gt;greater than 50%&lt;/span&gt; likely of being realized on examination. For tax positions not meeting the &#x201c;more likely than not&#x201d; test,
no tax benefit is recorded. $&lt;span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20210101__20211231_zhtHJHFt04F7" title="Income tax examination, penalties and interest expense"&gt;395&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20200101__20201231_zwgUz8si7Xxk" title="Income tax examination, penalties and interest expense"&gt;0&lt;/span&gt; penalties and interest incurred related to underpayment of income tax for the years ended December
31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a
result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement contextRef="From2021-01-01to2021-12-31">greater than 50%</us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">395</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zFmJhQqD6MOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Comprehensive
income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss)
refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#x2019; equity but are excluded
from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not
using the U.S. dollar as its functional currencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <AATP:NoncontrollingInterestPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_843_ecustom--NoncontrollingInterestPolicyTextBlock_zvodLWm7yptb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Non-controlling
interest&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--MinorityInterestDescription_c20210101__20211231_z2jVyFk7GMzi" title="Noncontrolling interest, description"&gt;Non-controlling
interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out
of 9,590,598 shares) of the equity interests of ASL held by two individuals&lt;/span&gt;. The non-controlling interests are presented in the consolidated
balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the
Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods
between non-controlling interest holders and the shareholders of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:NoncontrollingInterestPolicyTextBlock>
    <us-gaap:MinorityInterestDescription contextRef="From2021-01-01to2021-12-31">Non-controlling
interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out
of 9,590,598 shares) of the equity interests of ASL held by two individuals</us-gaap:MinorityInterestDescription>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zZGPhNuzFDjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Earnings
(loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company computes earnings (loss) per share (&#x201c;EPS&#x201d;) in accordance with ASC 260, &#x201c;Earnings per Share&#x201d;. ASC 260
requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share
outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible
securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later.
Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are
excluded from the calculation of diluted EPS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;. For the
years ended December 31, 2021 and 2020, there were &lt;span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20210101__20211231_z6oZ7p2bv9Mf" title="Potentially dilutive securities outstanding"&gt;&lt;span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20200101__20201231_zVXiU2cpuCAc" title="Potentially dilutive securities outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; dilutive shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8AGmGK5QsX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Foreign
currencies translation and transaction&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing
at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated
into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded
in the consolidated statements of operations and comprehensive income (loss).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reporting currency of the Company is United States Dollars (&#x201c;US$&#x201d;) and the accompanying financial statements have been expressed
in US$. The Company&#x2019;s subsidiary in Labuan maintains its books and record in United States Dollars (&#x201c;US$&#x201d;) albeit its
functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit
(&#x201c;MYR&#x201d; or &#x201c;RM&#x201d;). The Company&#x2019;s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars
(&#x201c;HK$&#x201d;), similar to its functional currency. The Company&#x2019;s subsidiary and VIE in Malaysia conducts its businesses and
maintains its books and record in the local currency, Malaysian Ringgit (&#x201c;MYR&#x201d; or &#x201c;RM&#x201d;), as its functional currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into
US$, in accordance with ASC Topic 830-30, &#x201c;&lt;i&gt;Translation of Financial Statement&#x201d;&lt;/i&gt;, using the exchange rate on the balance
sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation
of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the
statements of stockholders&#x2019; equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts
reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance
sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none"&gt;SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-end MYR : US$1 exchange
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.18&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.02&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-end HKD : US$1 exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-average MYR : US$1 exchange
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.20&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-average HKD : US$1 exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" style="text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.77&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" style="text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.76&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zqNifIeILn8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none"&gt;SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-end MYR : US$1 exchange
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.18&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.02&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-end HKD : US$1 exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-average MYR : US$1 exchange
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.20&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period-average HKD : US$1 exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" style="text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.77&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" style="text-align: right" title="Foreign currency exchange rate period average"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.76&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2021-12-31_custom_PeriodEndMYRMember"
      decimals="INF"
      unitRef="Pure">4.18</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2020-12-31_custom_PeriodEndMYRMember"
      decimals="INF"
      unitRef="Pure">4.02</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2021-12-31_custom_PeriodEndHKDMember"
      decimals="INF"
      unitRef="Pure">7.80</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2020-12-31_custom_PeriodEndHKDMember"
      decimals="INF"
      unitRef="Pure">7.75</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2021-01-012021-12-31_custom_PeriodAverageMYRMember"
      decimals="INF"
      unitRef="Pure">4.14</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2020-01-012020-12-31_custom_PeriodAverageMYRMember"
      decimals="INF"
      unitRef="Pure">4.20</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2021-01-012021-12-31_custom_PeriodAverageHKDMember"
      decimals="INF"
      unitRef="Pure">7.77</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2020-01-012020-12-31_custom_PeriodAverageHKDMember"
      decimals="INF"
      unitRef="Pure">7.76</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:RelatedPartiesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_ecustom--RelatedPartiesPolicyTextBlock_zrQDAfgxw1sl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Related
parties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:RelatedPartiesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFEmgvJtixod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and
requires disclosure of the fair value of financial instruments held by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance
disclosure requirements for fair value measures. The three levels are defined as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that
    are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost,
which approximate fair value because of the short period of time between the origination of such instruments and their expected realization
and their current market rates of interest.&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zZNdDkKBmvPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopts ASU 2016-02, &#x201c;Leases&#x201d; (Topic 842), and elected the practical expedients that does not require the Company
to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing
leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted
to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient
that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company&#x2019;s leases
include one or more options to renew, which is typically at the Company&#x2019;s sole discretion. The Company regularly evaluates the
renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications
result in re-measurement of the right of use (&#x201c;ROU&#x201d;) assets and lease liabilities. Operating ROU assets and lease liabilities
are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for
the Company&#x2019;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available
at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that
the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment
and over a similar term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease,
as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers
the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected
the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve
months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives.
Lease expense is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews
the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the
asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset
from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount
of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future
pre-tax cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwRa40sJZ3q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Recent
accounting pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of
such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic
326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement
of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments
in Update 2016-13 added Topic 326, Financial Instruments&#x2014;Credit Losses, and made several consequential amendments to the Codification.
Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses
when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments&#x2014; Credit Losses&#x2014;Available-for-Sale
Debt Securities. The amendments in this Update address those stakeholders&#x2019; concerns by providing an option to irrevocably elect
the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition
relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar
financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments
in Update 2016-13 while still providing financial statement users with decision-useful information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit
organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date
for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim
reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating
the impact ASU 2019-05 may have on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments
accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options
accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should
consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement
alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts
or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity
should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing
investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance
with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted,
including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2020, the FASB issued ASU 2020-08, &#x201c;Codification Improvements to Subtopic 310-20, Receivables&#x2014;Nonrefundable Fees
and Other Costs&#x201d;. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification
easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the
Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply
the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable
debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021
did not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2020, the FASB issued ASU 2020-10, &#x201c;Codification Improvements&#x201d;. The amendments in this Update represent changes to
clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current
accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety
of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is
effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments
in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on
its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:VariableInterestEntityDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80E_eus-gaap--VariableInterestEntityDisclosureTextBlock_zgIAe8pTJwf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.&lt;span id="xdx_826_zJTc7N756JKh"&gt;
VARIABLE INTEREST ENTITY (&#x201c;VIE&#x201d;)&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SEA
is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided majority of ASL&#x2019;s purchases. Its equity
at risk was insufficient to finance its activities and &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zCTAPQB3ObJb" title="Ownership interest percentage"&gt;100&lt;/span&gt;% of its business is transacted with ASL. Therefore, it was considered to be
a VIE and ASL is the primary beneficiary since it has both of the following characteristics:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
    power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
    obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the
    VIE that could potentially be significant to the VIE&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
the accounts of SEA is consolidated in the accompanying financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_ziGf9DSLZguk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of the VIE&#x2019;s assets and liabilities were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BA_z3zsHjUhKgR2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF VARIABLE INTEREST ENTITY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zBBDeiE1qBYf" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_z2TTLKve29le"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsCurrent_iI_zG66KK7YK2o8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,850&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,717&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LiabilitiesCurrent_iNI_di_zPrH2WbQg587" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(51,272&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,573&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--StockholdersEquity_iI_zPkIAvNRIe8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,856&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zW698uRlRrVl" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zWYlp147wSI9"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_zMxrxRs5Smr9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,493&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,387&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PrepaidTaxes_iI_zRfWUPLsX9ga" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,357&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,330&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsCurrent_iI_zEyDHieHajs8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,850&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,717&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_z8jU9wyuZVP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable &#x2013; intercompany&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,724&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;51,669&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--OtherPayablesRelatedPartyCurrent_iI_z1TajavnLNl5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other payables and accrued
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,548&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,904&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iI_zNU60IeGzAIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;51,272&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;53,573&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--StockholdersEquity_iI_zbeklS8QD69c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,856&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
summarized operating results of the VIE&#x2019;s are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210101__20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zi6p0xMmPGM2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zk2JEF1orUyc"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zJkAWrUJn7vg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;346,907&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--GrossProfit_z8WN2B2SZ4M4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0857"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,442&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingIncomeLoss_z7P4DubEetea" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(21,966&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--NetIncomeLoss_z9kg1Cro03Zj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(27,966&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(24,014&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_z9XMfeKjRbje" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-12-31_custom_SubsidiaryCompanyThreeMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_ziGf9DSLZguk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of the VIE&#x2019;s assets and liabilities were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BA_z3zsHjUhKgR2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF VARIABLE INTEREST ENTITY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zBBDeiE1qBYf" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_z2TTLKve29le"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsCurrent_iI_zG66KK7YK2o8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,850&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,717&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LiabilitiesCurrent_iNI_di_zPrH2WbQg587" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(51,272&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,573&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--StockholdersEquity_iI_zPkIAvNRIe8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,856&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zW698uRlRrVl" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zWYlp147wSI9"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_zMxrxRs5Smr9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,493&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,387&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PrepaidTaxes_iI_zRfWUPLsX9ga" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,357&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,330&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsCurrent_iI_zEyDHieHajs8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,850&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,717&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_z8jU9wyuZVP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable &#x2013; intercompany&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,724&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;51,669&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--OtherPayablesRelatedPartyCurrent_iI_z1TajavnLNl5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other payables and accrued
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,548&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,904&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iI_zNU60IeGzAIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;51,272&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;53,573&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--StockholdersEquity_iI_zbeklS8QD69c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,856&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
summarized operating results of the VIE&#x2019;s are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210101__20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zi6p0xMmPGM2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zk2JEF1orUyc"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zJkAWrUJn7vg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;346,907&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--GrossProfit_z8WN2B2SZ4M4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0857"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,442&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingIncomeLoss_z7P4DubEetea" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(21,966&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--NetIncomeLoss_z9kg1Cro03Zj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(27,966&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(24,014&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">18850</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">48717</us-gaap:AssetsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">51272</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">53573</us-gaap:LiabilitiesCurrent>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-32422</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-4856</us-gaap:StockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">17493</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">37387</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidTaxes
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">1357</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">11330</us-gaap:PrepaidTaxes>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">18850</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">48717</us-gaap:AssetsCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">49724</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">51669</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <AATP:OtherPayablesRelatedPartyCurrent
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">1548</AATP:OtherPayablesRelatedPartyCurrent>
    <AATP:OtherPayablesRelatedPartyCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">1904</AATP:OtherPayablesRelatedPartyCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">51272</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">53573</us-gaap:LiabilitiesCurrent>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-32422</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-4856</us-gaap:StockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">346907</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">4442</us-gaap:GrossProfit>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-21966</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-10752</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-27966</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-24014</us-gaap:NetIncomeLoss>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_807_eus-gaap--BusinessCombinationDisclosureTextBlock_zHKYl8jArZKf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.
&lt;span id="xdx_82E_znKBt4nMZKba"&gt;BUSINESS COMBINATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 8, 2020, the Company entered into a Share Exchange Agreement (&#x201c;SPA&#x201d;) with Mr. How Kok Choong, CEO and director of the
Company to acquire &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zpoIx15294x9" title="Stock issued during period acquisitions, shares"&gt;9,590,596&lt;/span&gt; ordinary shares, &lt;span id="xdx_903_eus-gaap--CommonStockNoParValue_iI_pid_do_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zusXLrQtxMGg" title="Ordinary shares no par value"&gt;no&lt;/span&gt; par value, equivalent to approximately &lt;span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_znvYx7HfnLQh" title="Ownership interest percentage"&gt;99.99&lt;/span&gt;% of the equity interest in ASL, an entity
incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration of $&lt;span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200629__20200702__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zDegVsPKsyCi" title="Purchase consideration value"&gt;1,804,046&lt;/span&gt;,
which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration shall be satisfied
by (i) the offset of the Consideration whereby the Company has a loan receivable of $&lt;span id="xdx_906_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_pp0p0_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zqnnhV1u2Yrl" title="Loan payable"&gt;656,495&lt;/span&gt; as of March 31, 2020 due from Mr. How; and
(ii) allotment and issuance of common stock of the Company. The Company shall allot and issue &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z1n36MvAuTgd" title="Stock issued during period acquisitions, shares"&gt;176,547&lt;/span&gt; shares of the Company&#x2019;s common
stock, par value $&lt;span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zweck9JWKzxa" title="Common stock par value"&gt;0.0001&lt;/span&gt;, representing approximately &lt;span id="xdx_90F_ecustom--PercentageOfCommonStockIssuedAndOutstanding_pid_dp_uPure_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_ztBialGaIA75" title="Percentage of common stock issued and outstanding"&gt;0.0469&lt;/span&gt;% of the total issued and outstanding shares in the Company after the issuance
of the Shares, which is valued at $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zcDFdmnq1Mob" title="Stock issued during period, value, acquisitions"&gt;1,147,551&lt;/span&gt; based on the closing price of $&lt;span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20200331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zweSXWsFrjuc" title="Purchased price per shares"&gt;6.50&lt;/span&gt; of the Company as quoted on the OTC Market on March
31, 2020. As of December 31, 2020, the Company has issued all &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zOYczuv65Dse" title="Issuance of common stock shares"&gt;176,547&lt;/span&gt; shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated
the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020
as ASL was under the common control of Mr. How.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z9hQbHfHjE47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which
represents the net purchase price allocation on the date of the acquisition of ASL.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BF_zZ9ze4vUt6Xf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20211231_zi5gZGfDW912" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Carry
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zFootoo6DkQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 80%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,206,493&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zPCfRzzCqFe2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,210&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_iI_zvU4mN9Vlab4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other receivables - related
    parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;219,121&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_z4KcdNuvJtvf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;616,880&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_iI_zIZKzHM3w2W" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,206,821&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zUn3enkZbJpk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepayments
    and other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;318,267&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zKz3awcUZDTd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,600,792&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_ztkI3wRKXP4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment,
    net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;325,648&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zLClQ04mPaFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,686&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_z5dLrc78mnxc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    taxes asset, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;172,250&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_zBZrA7c0ltt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;504,584&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zPuB2iDXZjri" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,105,376&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;LIABILITIES AND SHAREHOLDERS&#x2019;
    EQUITY&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zT38U9zsO3Kf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable - related
    party&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;491,628&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_zhCBrTvOaBml" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Customer deposits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,600,606&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_z9N5VJeANSV8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    payables and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;209,096&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_zCmXdCjZO6z7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,301,330&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zQvCrxEVwmn1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,301,330&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zq2ThSccWRP9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,804,046&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zv4jqD0Ky8K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.
BUSINESS COMBINATION (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following unaudited pro forma combined results of operations presents the Company&#x2019;s financial results as if the acquisition of
ASL had been completed on January 1, 2020. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings
which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily
indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2020. Future
results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other
factors.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zseqpulCa5J1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B9_zZVcZYoKTnPc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SCHEDULE
OF PRO FORMA BUSINESS COMBINATION&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20200101__20201231_zuUagwDfcb66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaRevenue_zuz6pejZgaNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,693,873&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_zhoMOdVTbnj8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(875,708&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--BusinessAcquisitionsProFormaGrossProfit_zEF3eZHqnGUj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,818,165&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_zXatwYMBeZoa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,839,184&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zBEyIiiyyL8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(21,019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_zWFdgUfqokuj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other income (expense),
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;267,633&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_z7tgSGvyyUyh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;246,614&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_zGrdUgLWVzZ6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision for income
    taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(212,414&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBg35qlM6qO3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,200&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_zX5mlxsNMQ4h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net income per common
    share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_zq1dvEl2L7o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average number
    of common shares outstanding - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;376,452,047&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zbm6HAfwykq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="Shares">9590596</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockNoParValue
      contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:CommonStockNoParValue>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="Pure">0.9999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2020-06-292020-07-02_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="0"
      unitRef="USD">1804046</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="0"
      unitRef="USD">656495</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="Shares">176547</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <AATP:PercentageOfCommonStockIssuedAndOutstanding
      contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="Pure">0.000469</AATP:PercentageOfCommonStockIssuedAndOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="0"
      unitRef="USD">1147551</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-03-31_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="USDPShares">6.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-01-012020-12-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="Shares">176547</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z9hQbHfHjE47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which
represents the net purchase price allocation on the date of the acquisition of ASL.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BF_zZ9ze4vUt6Xf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20211231_zi5gZGfDW912" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Carry
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zFootoo6DkQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 80%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,206,493&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zPCfRzzCqFe2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,210&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_iI_zvU4mN9Vlab4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other receivables - related
    parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;219,121&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_z4KcdNuvJtvf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;616,880&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_iI_zIZKzHM3w2W" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,206,821&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zUn3enkZbJpk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepayments
    and other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;318,267&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zKz3awcUZDTd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,600,792&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_ztkI3wRKXP4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment,
    net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;325,648&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zLClQ04mPaFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,686&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_z5dLrc78mnxc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    taxes asset, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;172,250&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_zBZrA7c0ltt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;504,584&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zPuB2iDXZjri" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,105,376&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;LIABILITIES AND SHAREHOLDERS&#x2019;
    EQUITY&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zT38U9zsO3Kf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable - related
    party&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;491,628&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_zhCBrTvOaBml" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Customer deposits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,600,606&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_z9N5VJeANSV8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    payables and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;209,096&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_zCmXdCjZO6z7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,301,330&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zQvCrxEVwmn1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,301,330&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zq2ThSccWRP9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,804,046&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1206493</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">33210</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">219121</AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">616880</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1206821</AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">318267</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3600792</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">325648</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">6686</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">172250</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">504584</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4105376</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">491628</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1600606</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">209096</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2301330</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2301330</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1804046</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zseqpulCa5J1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B9_zZVcZYoKTnPc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SCHEDULE
OF PRO FORMA BUSINESS COMBINATION&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20200101__20201231_zuUagwDfcb66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaRevenue_zuz6pejZgaNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,693,873&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_zhoMOdVTbnj8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(875,708&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--BusinessAcquisitionsProFormaGrossProfit_zEF3eZHqnGUj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,818,165&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_zXatwYMBeZoa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,839,184&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zBEyIiiyyL8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(21,019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_zWFdgUfqokuj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other income (expense),
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;267,633&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_z7tgSGvyyUyh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;246,614&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_zGrdUgLWVzZ6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision for income
    taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(212,414&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBg35qlM6qO3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,200&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_zX5mlxsNMQ4h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net income per common
    share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_zq1dvEl2L7o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average number
    of common shares outstanding - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;376,452,047&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">4693873</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <AATP:BusinessAcquisitionsProFormaCostOfRevenue
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-875708</AATP:BusinessAcquisitionsProFormaCostOfRevenue>
    <AATP:BusinessAcquisitionsProFormaGrossProfit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3818165</AATP:BusinessAcquisitionsProFormaGrossProfit>
    <AATP:BusinessAcquisitionsProFormaOperatingExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-3839184</AATP:BusinessAcquisitionsProFormaOperatingExpenses>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-21019</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">267633</AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet>
    <AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">246614</AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes>
    <AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-212414</AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">34200</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00</AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted>
    <AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">376452047</AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted>
    <us-gaap:CashAndCashEquivalentsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_800_eus-gaap--CashAndCashEquivalentsDisclosureTextBlock_zN9IiYDlrq18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.&lt;span id="xdx_821_zPrw6JX8HjPe"&gt;
CASH AND CASH EQUIVALENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;As
of December 31, 2021 and 2020 the Company had $&lt;span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20211231_zAF6iYXW4g7d" title="Cash and cash equivalents"&gt;2,597,848&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20201231_zFh1Og884st3" title="Cash and cash equivalents"&gt;3,517,600&lt;/span&gt;, respectively, of cash and cash equivalents, which consists of
$&lt;span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20211231_zvcHm0WlQDP8" title="Cash in bank"&gt;554,864&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20201231_zyxICel5xP62" title="Cash in bank"&gt;1,112,147&lt;/span&gt;, respectively, of cash in banks and &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90C_eus-gaap--TimeDeposits_iI_pp0p0_c20211231_zWVS7j9hfk68" title="Time deposits"&gt;1,975,347
&lt;/span&gt;&lt;span style="background-color: white"&gt;and $&lt;/span&gt;&lt;span id="xdx_905_eus-gaap--TimeDeposits_iI_pp0p0_c20201231_zaqEdjOZL1ua" title="Time deposits"&gt;2,391,182&lt;/span&gt;&lt;span style="background-color: white"&gt;, respectively, of time deposits placed
with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The
effective interest rate for the time deposits ranges between &lt;span id="xdx_90D_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pid_dp_uPure_c20211231__srt--RangeAxis__srt--MinimumMember_zuytjcggSXAi" title="Percentage of Interest rate for time deposits"&gt;1.10&lt;/span&gt;% to &lt;span id="xdx_905_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pid_dp_uPure_c20211231__srt--RangeAxis__srt--MaximumMember_zTHpOlCuwpM7" title="Percentage of Interest rate for time deposits"&gt;1.25&lt;/span&gt;% per annum.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsDisclosureTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2597848</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3517600</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:Cash contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">554864</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1112147</us-gaap:Cash>
    <us-gaap:TimeDeposits contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1975347</us-gaap:TimeDeposits>
    <us-gaap:TimeDeposits contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2391182</us-gaap:TimeDeposits>
    <us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits
      contextRef="AsOf2021-12-31_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.0110</us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits>
    <us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits
      contextRef="AsOf2021-12-31_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.0125</us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zANB6XTXVI5g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;6.
&lt;span id="xdx_82C_zYmOLmtj2Z9j"&gt;ACCOUNTS RECEIVABLE &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zHmyEyZzWE14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8BC_ze0iPUfvtWL5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF ACCOUNTS RECEIVABLES - RELATED PARTY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20211231_z9PPc3k8pk4f" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20201231_zpm43E1b5fV" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zQm67i8MAm51" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;172,757&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_z7wtfqwZytyb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance for doubtful
    accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0978"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zPkkNTIE1sq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0980"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;172,757&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z5OUP4FoMg1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zHmyEyZzWE14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8BC_ze0iPUfvtWL5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF ACCOUNTS RECEIVABLES - RELATED PARTY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20211231_z9PPc3k8pk4f" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20201231_zpm43E1b5fV" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zQm67i8MAm51" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;172,757&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_z7wtfqwZytyb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance for doubtful
    accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0978"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zPkkNTIE1sq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0980"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;172,757&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">172757</us-gaap:AccountsReceivableGrossCurrent>
    <AATP:AccountsReceivableAndAccountsReceivableRelatedParties contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">172757</AATP:AccountsReceivableAndAccountsReceivableRelatedParties>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zWQmZCymz9Tf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.
&lt;span id="xdx_82C_zeqCj0uim1ai"&gt;INVENTORIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zruvM8S4PaXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories
consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zGTxmw5qLZR1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF INVENTORIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20211231_ztBtShzWBIic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20201231_zNoSlNQMm9L6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_zBWMRwP1vewa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;375,535&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;589,814&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zUGBK5Y1QI1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended December 31, 2021 and 2020, the Company recognized $&lt;span id="xdx_90F_eus-gaap--InventoryWriteDown_c20210101__20211231_z979lnJ6UNTe" title="Inventory write-down"&gt;36,241&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--InventoryWriteDown_dxL_c20200101__20201231_zzWgX0JuZkbf" title="Inventory write-down::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;0&lt;/span&gt;&lt;/span&gt; inventory write-down, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zruvM8S4PaXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories
consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zGTxmw5qLZR1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF INVENTORIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20211231_ztBtShzWBIic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20201231_zNoSlNQMm9L6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_zBWMRwP1vewa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;375,535&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;589,814&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">375535</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">589814</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWriteDown
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">36241</us-gaap:InventoryWriteDown>
    <AATP:PrepaymentsAndDepositsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_800_ecustom--PrepaymentsAndDepositsTextBlock_zi54yOr6XXOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;8.&lt;span id="xdx_828_zvy7XAm3hLm9"&gt;
PREPAYMENTS AND DEPOSITS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zAtd04mFJGJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8B8_zF59P1dp47df" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;SCHEDULE
OF PREPAID EXPENSES AND DEPOSITS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20211231_ziMwpEOwIyHf" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20201231_zDrpQH6b7sf8" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zH01auAciTqf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Receivables from sales distributors&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,379&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35,302&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zE6hh4Mu4raj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deposits to suppliers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;301,233&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;261,068&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PrepaidExpensesGross_iTI_pp0p0_mtPEGzE1e_maPEAOAzys7_z6VlCHZfPes6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;416,612&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;296,370&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iNI_di_msPEAOAzys7_zq8mIhkKa9yd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Provision for
    doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(121,095&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1008"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzys7_z2yGv6cu952d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;295,517&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;296,370&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zFsIeNl1R1Hk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_zZ1SZcciBJrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Movements
of allowance for doubtful accounts are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_zOtTmiuBvtG2"&gt;SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210101__20211231_zZywmLOnsVpa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20200101__20201231_zsnq60MWSzPj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_z4xFzw1tofAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1015"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1016"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zMeD0XKlg3s3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Addition&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,514&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1019"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_zegPRvqut4vb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Write off&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1021"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1022"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_zpM2sAxNIGX1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange rate effect&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_zFnjY6bhglQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;121,095&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1028"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zl57uYqJW8je" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:PrepaymentsAndDepositsTextBlock>
    <AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zAtd04mFJGJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8B8_zF59P1dp47df" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;SCHEDULE
OF PREPAID EXPENSES AND DEPOSITS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20211231_ziMwpEOwIyHf" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20201231_zDrpQH6b7sf8" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zH01auAciTqf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Receivables from sales distributors&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,379&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35,302&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zE6hh4Mu4raj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deposits to suppliers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;301,233&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;261,068&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PrepaidExpensesGross_iTI_pp0p0_mtPEGzE1e_maPEAOAzys7_z6VlCHZfPes6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;416,612&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;296,370&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iNI_di_msPEAOAzys7_zq8mIhkKa9yd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Provision for
    doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(121,095&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1008"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzys7_z2yGv6cu952d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;295,517&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;296,370&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock>
    <AATP:ReceivablesFromSalesDistributors contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">115379</AATP:ReceivablesFromSalesDistributors>
    <AATP:ReceivablesFromSalesDistributors contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">35302</AATP:ReceivablesFromSalesDistributors>
    <AATP:DepositsToSupplier contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">301233</AATP:DepositsToSupplier>
    <AATP:DepositsToSupplier contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">261068</AATP:DepositsToSupplier>
    <AATP:PrepaidExpensesGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">416612</AATP:PrepaidExpensesGross>
    <AATP:PrepaidExpensesGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">296370</AATP:PrepaidExpensesGross>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">121095</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">295517</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">296370</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <AATP:ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89C_ecustom--ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_zZ1SZcciBJrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Movements
of allowance for doubtful accounts are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_zOtTmiuBvtG2"&gt;SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210101__20211231_zZywmLOnsVpa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20200101__20201231_zsnq60MWSzPj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_z4xFzw1tofAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1015"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1016"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zMeD0XKlg3s3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Addition&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,514&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1019"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_zegPRvqut4vb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Write off&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1021"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1022"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_zpM2sAxNIGX1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange rate effect&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_zFnjY6bhglQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;121,095&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1028"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AATP:ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">121514</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <AATP:AllowanceForDoubtfulAccountsReceivableExchangeRateEffect
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-419</AATP:AllowanceForDoubtfulAccountsReceivableExchangeRateEffect>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">121095</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zdFbnLwIqJU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.
&lt;span id="xdx_823_zFwRIn243Otd"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zEBQDGv1UhV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment, net consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_z6ieX65Jn6Ue" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20211231_z69fX0OmVDf5" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20201231_zRECSdxyxbj9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z1Gff565WJv3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computer and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,298&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;81,437&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zo9mxKzC7fRe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture &amp;amp; fixtures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;122,185&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;126,966&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zzUJMFAELrt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;202,570&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;210,496&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zwHzILui9WXb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicle&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;98,702&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,564&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENz5ZB_zFJIlVBSdyEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;505,755&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;521,463&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENz5ZB_ztuoRLZe8B4l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(289,956&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(223,154&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENz5ZB_zinKGvSYnjR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,799&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;298,309&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zJqojgI1LHf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
expense for the years ended December 31, 2021 and 2020 amounted to $&lt;span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20210101__20211231_zJNO1NybsZH9" title="Depreciation"&gt;75,797&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--Depreciation_pp0p0_c20200101__20201231_z0ECCJVEMrdg" title="Depreciation"&gt;55,407&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zEBQDGv1UhV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment, net consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_z6ieX65Jn6Ue" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20211231_z69fX0OmVDf5" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20201231_zRECSdxyxbj9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z1Gff565WJv3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computer and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,298&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;81,437&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zo9mxKzC7fRe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture &amp;amp; fixtures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;122,185&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;126,966&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zzUJMFAELrt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;202,570&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;210,496&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zwHzILui9WXb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicle&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;98,702&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,564&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENz5ZB_zFJIlVBSdyEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;505,755&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;521,463&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENz5ZB_ztuoRLZe8B4l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(289,956&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(223,154&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENz5ZB_zinKGvSYnjR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,799&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;298,309&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_ComputerAndOfficeEquipmentMember"
      decimals="0"
      unitRef="USD">82298</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_custom_ComputerAndOfficeEquipmentMember"
      decimals="0"
      unitRef="USD">81437</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">122185</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">126966</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">202570</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">210496</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_VehicleMember"
      decimals="0"
      unitRef="USD">98702</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_custom_VehicleMember"
      decimals="0"
      unitRef="USD">102564</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">505755</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">521463</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">289956</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">223154</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">215799</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">298309</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">75797</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">55407</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80B_eus-gaap--IntangibleAssetsDisclosureTextBlock_zGFkmRZ9XRW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.
&lt;span id="xdx_827_zTIa8dhIaRyj"&gt;INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zc9eZtE2O7pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets, net, consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zvNaeIFuni2l" style="display: none"&gt;SCHEDULE OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20211231_zlsQm9npWeH9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231_zQQB9ihbGkUb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzvmN_zYwict1pvqZf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computer software&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,453&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35,801&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzvmN_zOdvLeC8fWvk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(30,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(29,975&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzvmN_zOsuj2cfJOZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,660&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,826&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zaBwp2p2Umjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
expense for the years ended December 31, 2021 and 2020 amounted to $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_zDu4asXu3k5g" title="Amortization expense"&gt;1,961&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200101__20201231_zwHERLSxH47b" title="Amortization expense"&gt;1,505&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zc9eZtE2O7pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets, net, consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zvNaeIFuni2l" style="display: none"&gt;SCHEDULE OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20211231_zlsQm9npWeH9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231_zQQB9ihbGkUb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzvmN_zYwict1pvqZf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computer software&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,453&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35,801&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzvmN_zOdvLeC8fWvk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(30,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(29,975&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzvmN_zOsuj2cfJOZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,660&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,826&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">34453</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">35801</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">30793</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">29975</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3660</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5826</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1961</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1505</us-gaap:AmortizationOfIntangibleAssets>
    <AATP:InvestmentInMarketableSecuritiesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_801_ecustom--InvestmentInMarketableSecuritiesTextBlock_z0AE31WvZSt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.
&lt;span id="xdx_829_z7a3r8822GN1"&gt;INVESTMENT IN MARKETABLE SECURITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    May 17, 2018, the Company purchased &lt;span id="xdx_907_eus-gaap--InvestmentOwnedBalanceShares_iI_pid_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zW7uOLKzpNUd" title="Investment in securities, shares"&gt;83,333&lt;/span&gt; shares of common stock in Greenpro Capital Corp. for $&lt;span id="xdx_90E_eus-gaap--InvestmentOwnedAtCost_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount"&gt;500,000&lt;/span&gt; at a purchase price of $&lt;span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zvq8oNqx3jSf" title="Purchased price per shares"&gt;6&lt;/span&gt;
    per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    July 30, 2018, the Company disposed &lt;span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pdd" title="Investment in securities, shares"&gt;20&lt;/span&gt; shares of common stock in Greenpro Capital Corp. for $&lt;span id="xdx_90D_eus-gaap--InvestmentOwnedAtCost_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount"&gt;125&lt;/span&gt; at a purchase price of $&lt;span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_ztkqpm5Y2GG2" title="Purchased price per shares"&gt;6.2613&lt;/span&gt; per
    share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    October 16, 2018, the Company purchased &lt;span id="xdx_907_eus-gaap--InvestmentOwnedBalanceShares_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pdd" title="Investment in securities, shares"&gt;33,333&lt;/span&gt; shares of common stock in Greenpro Capital Corp. for $&lt;span id="xdx_90B_eus-gaap--InvestmentOwnedAtCost_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount"&gt;1,000&lt;/span&gt; at a purchase price of
    $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zHz9zDfeYGA5" title="Purchased price per shares"&gt;0.03&lt;/span&gt; per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    November 3, 2020, the Company received dividend of &lt;span id="xdx_900_eus-gaap--InvestmentOwnedBalanceShares_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Investment in securities, shares"&gt;6,667&lt;/span&gt; shares of common stock in DSwiss, Inc. for $&lt;span id="xdx_902_eus-gaap--InvestmentOwnedAtCost_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_pp0p0" title="Investment amount"&gt;76,671&lt;/span&gt; at fair value of $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_ztuzYabimIV3" title="Purchased price per shares"&gt;11.50&lt;/span&gt;
    per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#x2019;s shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(v)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    December 9, 2020, the Company received dividend of &lt;span id="xdx_909_eus-gaap--InvestmentOwnedBalanceShares_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Investment in securities, shares"&gt;16,663&lt;/span&gt; shares of common stock in DSwiss, Inc. for $&lt;span id="xdx_904_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zQYdItS6YA95" title="Investment amount"&gt;83,315&lt;/span&gt; at fair value of $&lt;span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Purchased price per shares"&gt;5&lt;/span&gt;
    per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#x2019;s shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(vi)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    September 27, 2021, the Company received dividend of &lt;span id="xdx_90A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_zWxOSeW7TGKc" title="Investment in securities, shares"&gt;11,665&lt;/span&gt; shares of common stock in SEATech Ventures Corp. for $&lt;span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_zFB6M57yUM7h" title="Investment amount"&gt;18,874&lt;/span&gt; at fair
    value of $&lt;span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_z7ktyxfuiRa9" title="Purchased price per shares"&gt;1.62&lt;/span&gt; per share from Greenpro Capital Corp as a dividend income since Greenpro Capital Corp previously owned these shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_895_eus-gaap--MarketableSecuritiesTextBlock_zFEm35wnJK17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zsAchnQKts4f" style="display: none"&gt;SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20211231_zOIHppVaOEHj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20201231_zzMhWcyrOVu3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_maMSNzd9C_zg0L5qKThXZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of investment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;577,035&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66,484&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InvestmentsIncomeDividend_iNI_pp0p0_di_msMSNzd9C_zsGc1FQujud7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dividend income from Greenpro Capital Corp.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,939&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;160,062&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingGainLoss_iNI_pp0p0_di_msMSNzd9C_zVxQoo2AjMif" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unrealized holding (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(505,231&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;350,137&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maMSNzd9C_zePn8dcJ0vrh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange rate effect&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,742&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;352&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzd9C_z7o7Scdcq463" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment in marketable
    securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;89,001&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;577,035&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zNnaIx5tgoTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:InvestmentInMarketableSecuritiesTextBlock>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="Shares">83333</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember"
      decimals="0"
      unitRef="USD">500000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="USDPShares">6</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="Shares">20</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember"
      decimals="0"
      unitRef="USD">125</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="USDPShares">6.2613</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="Shares">33333</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember"
      decimals="0"
      unitRef="USD">1000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2020-11-03_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Shares">6667</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2020-11-03_custom_DSwissIncMember"
      decimals="0"
      unitRef="USD">76671</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-11-03_custom_DSwissIncMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2020-12-09_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Shares">16663</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2020-12-09_custom_DSwissIncMember"
      decimals="0"
      unitRef="USD">83315</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-09_custom_DSwissIncMember"
      decimals="INF"
      unitRef="USDPShares">5</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2021-09-27_custom_SEATechVenturesCorpMember"
      decimals="INF"
      unitRef="Shares">11665</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2021-09-27_custom_SEATechVenturesCorpMember"
      decimals="0"
      unitRef="USD">18874</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-09-27_custom_SEATechVenturesCorpMember"
      decimals="INF"
      unitRef="USDPShares">1.62</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_eus-gaap--MarketableSecuritiesTextBlock_zFEm35wnJK17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zsAchnQKts4f" style="display: none"&gt;SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20211231_zOIHppVaOEHj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20201231_zzMhWcyrOVu3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_maMSNzd9C_zg0L5qKThXZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of investment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;577,035&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66,484&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InvestmentsIncomeDividend_iNI_pp0p0_di_msMSNzd9C_zsGc1FQujud7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dividend income from Greenpro Capital Corp.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,939&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;160,062&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingGainLoss_iNI_pp0p0_di_msMSNzd9C_zVxQoo2AjMif" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unrealized holding (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(505,231&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;350,137&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maMSNzd9C_zePn8dcJ0vrh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange rate effect&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,742&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;352&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzd9C_z7o7Scdcq463" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment in marketable
    securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;89,001&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;577,035&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:InvestmentOwnedAtCost contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">577035</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">66484</us-gaap:InvestmentOwnedAtCost>
    <AATP:InvestmentsIncomeDividend contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-18939</AATP:InvestmentsIncomeDividend>
    <AATP:InvestmentsIncomeDividend contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-160062</AATP:InvestmentsIncomeDividend>
    <AATP:MarketableSecuritiesUnrealizedHoldingGainLoss contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">505231</AATP:MarketableSecuritiesUnrealizedHoldingGainLoss>
    <AATP:MarketableSecuritiesUnrealizedHoldingGainLoss contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-350137</AATP:MarketableSecuritiesUnrealizedHoldingGainLoss>
    <AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-1742</AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites>
    <AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">352</AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">89001</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">577035</us-gaap:MarketableSecuritiesNoncurrent>
    <AATP:InvestmentInNonMarketableSecuritiesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_803_ecustom--InvestmentInNonMarketableSecuritiesTextBlock_zKKN32Sk8rPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12.
&lt;span id="xdx_82B_zFhzKN0NPudl"&gt;INVESTMENT IN NON-MARKETABLE SECURITIES&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company invested in Unreserved Sdn Bhd with the investment amount of $&lt;span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_zOzj0LJ5N4hf" title="Investment amount"&gt;863,592&lt;/span&gt; (RM &lt;span id="xdx_90C_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_uRM_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_za2jMxdkzOql" title="Investment amount"&gt;3,500,000&lt;/span&gt;), which approximated &lt;span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_z1zlrHooYPvc" title="Equity interest percentage"&gt;20&lt;/span&gt;% of the equity interest
of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019, Unreserved Sdn Bhd issued additional
common stock for working capital. As the Company did not subscribe for the additional common stock, the Company&#x2019;s equity interest
in investee company was diluted from approximately &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190310__srt--RangeAxis__srt--MaximumMember_zljfcnZ7avah" title="Equity interest percentage"&gt;20.0&lt;/span&gt;% to approximately &lt;span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190310__srt--RangeAxis__srt--MinimumMember_zGiCNJfyafw3" title="Equity interest percentage"&gt;17.86&lt;/span&gt;%. Effective from March 10, 2019, the Company discontinued
equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date.
Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unreserved
Sdn Bhd was incorporated in Malaysia with &lt;span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zhdFQ9osSjyf" title="Ordinary shares authorized"&gt;2,500,000&lt;/span&gt; ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim
and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April
30, 2018 to March 27, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 3, 2020, the Company agreed to sell the &lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200303__srt--TitleOfIndividualAxis__custom--UnreservedSdnBhdMember_zaojmIJ84KR8" title="Equity interest percentage"&gt;17.86&lt;/span&gt;% ownership interest in Unreserved Sdn Bhd at the December 31, 2019 carrying value
of $&lt;span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z4ELyUEMCqE6" title="Investment amount"&gt;730,637&lt;/span&gt; to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $&lt;span id="xdx_901_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_pp0p0_c20200101__20200331_zPNqRIEKcNS" title="Proceeds from investments"&gt;70,173&lt;/span&gt;, and had an amount due
from director of $&lt;span id="xdx_900_eus-gaap--DueFromOfficersOrStockholdersCurrent_iI_pp0p0_c20200331__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zenllgMTtRwd" title="Amount due from director"&gt;660,464&lt;/span&gt; at March 31, 2020. In May 2020, the entire outstanding balance was settled as part of the consideration in
a transaction which the Company had acquired the CEO&#x2019;s ownership interest of Agape Superior Living Sdn. Bhd.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 3, 2019, the Company purchased a &lt;span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zxu1gkHqNZ41" title="Equity interest percentage"&gt;5&lt;/span&gt;% of stock or &lt;span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pid_c20190403__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z7xvZX5Hj17d" title="Shares purchased during period"&gt;15,000,000&lt;/span&gt; shares of common stock in Phoenix Plus Corp. for $&lt;span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zJOhCu4LBiZ2" title="Investment amount"&gt;1,500&lt;/span&gt; at purchase
price of $&lt;span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zr5Q9hljmw52" title="Shares Issued, Price Per Share"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--NonMarketableSecuritiesTableTextBlock_zkOWturFo6n8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zfbB1nvQU2N9" style="display: none"&gt;SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unreserved Sdn Bhd&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment in non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zf4RgvPstRU5" style="width: 16%; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1163"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InvestmentInNonMarketableSecuritiesGross_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;730,637&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:
    Sale of investment in non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zQs5QiPliqOi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1167"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(730,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment in non-marketable
    securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zgdeHJqreulj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1171"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentInNonmarketableSecuritiesNet_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1173"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Phoenix Plus
    Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of investment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zgS1H7OUcv5i" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total investment in
    non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z4dw6o4mr5x8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zdXgg29CBYk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:InvestmentInNonMarketableSecuritiesTextBlock>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2021-12-31_srt_DirectorMember"
      decimals="0"
      unitRef="USD">863592</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2021-12-31_srt_DirectorMember"
      decimals="0"
      unitRef="RM">3500000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-12-31_srt_DirectorMember"
      decimals="INF"
      unitRef="Pure">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-03-10_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.200</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-03-10_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.1786</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="Shares">2500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-03-03_custom_UnreservedSdnBhdMember"
      decimals="INF"
      unitRef="Pure">0.1786</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2019-12-31_custom_MrHowKokChoongMember"
      decimals="0"
      unitRef="USD">730637</us-gaap:InvestmentOwnedAtCost>
    <AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty
      contextRef="From2020-01-012020-03-31"
      decimals="0"
      unitRef="USD">70173</AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty>
    <us-gaap:DueFromOfficersOrStockholdersCurrent
      contextRef="AsOf2020-03-31_custom_MrHowKokChoongMember351695203"
      decimals="0"
      unitRef="USD">660464</us-gaap:DueFromOfficersOrStockholdersCurrent>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember"
      decimals="INF"
      unitRef="Pure">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2019-04-03_us-gaap_CommonStockMember_custom_PhoenixPlusCorpMember"
      decimals="INF"
      unitRef="Shares">15000000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">1500</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:SharesIssuedPricePerShare>
    <AATP:NonMarketableSecuritiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89A_ecustom--NonMarketableSecuritiesTableTextBlock_zkOWturFo6n8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zfbB1nvQU2N9" style="display: none"&gt;SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unreserved Sdn Bhd&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment in non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zf4RgvPstRU5" style="width: 16%; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1163"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InvestmentInNonMarketableSecuritiesGross_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;730,637&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:
    Sale of investment in non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zQs5QiPliqOi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1167"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(730,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment in non-marketable
    securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zgdeHJqreulj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1171"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentInNonmarketableSecuritiesNet_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1173"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Phoenix Plus
    Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of investment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zgS1H7OUcv5i" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total investment in
    non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z4dw6o4mr5x8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AATP:NonMarketableSecuritiesTableTextBlock>
    <AATP:InvestmentInNonMarketableSecuritiesGross
      contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      decimals="0"
      unitRef="USD">730637</AATP:InvestmentInNonMarketableSecuritiesGross>
    <AATP:SaleOfInvestmentInNonmarketableSecurities
      contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      decimals="0"
      unitRef="USD">-730637</AATP:SaleOfInvestmentInNonmarketableSecurities>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2021-12-31_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">1500</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2020-12-31_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">1500</us-gaap:InvestmentOwnedAtCost>
    <AATP:InvestmentInNonMarketableSecuritiesNoncurrent
      contextRef="AsOf2021-12-31_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">1500</AATP:InvestmentInNonMarketableSecuritiesNoncurrent>
    <AATP:InvestmentInNonMarketableSecuritiesNoncurrent
      contextRef="AsOf2020-12-31_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">1500</AATP:InvestmentInNonMarketableSecuritiesNoncurrent>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80B_eus-gaap--OtherLiabilitiesDisclosureTextBlock_z13zBm5NrVYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;13.
&lt;span id="xdx_828_zttG9nD8Dwia"&gt;OTHER PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zRfJrGJiy5X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B1_zQzlwQRdDWch" style="display: none"&gt;SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20211231_zEx06MSFkNDg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231_z914hOdXEpA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;436,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;297,636&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AccruedPromotionExpenses_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Promotion expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,433&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payroll&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,669&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,976&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Commission&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;219,721&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;224,711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;143,400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;63,921&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--OtherAccountPayableAndAccruedLiabilities_iTIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;858,355&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;647,677&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_z5O1v57TAlQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_898_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zRfJrGJiy5X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B1_zQzlwQRdDWch" style="display: none"&gt;SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20211231_zEx06MSFkNDg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231_z914hOdXEpA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;436,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;297,636&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AccruedPromotionExpenses_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Promotion expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,433&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payroll&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,669&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,976&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Commission&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;219,721&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;224,711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;143,400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;63,921&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--OtherAccountPayableAndAccruedLiabilities_iTIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;858,355&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;647,677&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">436541</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">297636</us-gaap:AccruedProfessionalFeesCurrent>
    <AATP:AccruedPromotionExpenses contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">36024</AATP:AccruedPromotionExpenses>
    <AATP:AccruedPromotionExpenses contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">37433</AATP:AccruedPromotionExpenses>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">22669</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">23976</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">219721</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">224711</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">143400</us-gaap:AccountsPayableAndOtherAccruedLiabilities>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">63921</us-gaap:AccountsPayableAndOtherAccruedLiabilities>
    <AATP:OtherAccountPayableAndAccruedLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">858355</AATP:OtherAccountPayableAndAccruedLiabilities>
    <AATP:OtherAccountPayableAndAccruedLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">647677</AATP:OtherAccountPayableAndAccruedLiabilities>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zy6L4RvrFZF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.
&lt;span id="xdx_827_zRgcik2Js4A6"&gt;RELATED PARTY BALANCES AND TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Related
party balances&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Amount
due from related parties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zcAQ3zTAOKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z8lWSWKWUU0c" style="display: none"&gt;SCHEDULE OF RELATED PARTIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name
    of Related&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nature&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agape ATP
    (Asia) Limited (&#x201c;AATP Asia&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zFh7IyxtMaig" title="Relationship"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zrYM4jVMEh4i" title="Relationship"&gt;Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zT5TKVhB1k1h" title="Nature"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zuDhF7hq7hH3" title="Nature"&gt;Expenses
    paid for AATP Asia&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zBPYNcd3xTze" style="width: 14%; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,214&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zWkTG45rUsf" style="width: 12%; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,227&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Hostastay Sdn. Bhd.&lt;/span&gt;&lt;/p&gt;
                                                      &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x201c;Hostastay&#x201d;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoHMJVFDgqqg" title="Relationship"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zj7Cls3LGfj1" title="Relationship"&gt;Mr. How Kok Choong,
    the CEO and director of the Company is also the director of Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_z96bkEc6Hqk9" title="Nature"&gt;&lt;span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zOKpJukAbQx8" title="Nature"&gt;Sublease rent due from
    Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zIRfbce6jjj6" style="text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,790&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zf4Uas6lnH9a" style="text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;TH3 Technology Sdn Bhd&lt;/span&gt;&lt;/p&gt;
                                                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x201c;TH3&#160;&lt;/span&gt;Technology&#x201d;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdMAMDlv2nHd" title="Relationship"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zRRw54uNEw4h" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zF0Z2g5QwuVc" title="Nature"&gt;&lt;span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zOLs3a1wFca1" title="Nature"&gt;Expenses
    paid for TH3 Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zBS833tKI6Ca" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdoHLYF8dUGb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231_zXf0bP8Tyebk" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,004&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_z1apLzBjnaN1" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Amount
due to a Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name of Related&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nature&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agape
    Superior Living Pty Ltd&lt;/span&gt; &#x201c;ASLPL&#x201d;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zjaffT4I6jli" style="font-family: Times New Roman, Times, Serif" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1.5pt; width: 18%; text-align: center"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zTcNtnTuIgMj" style="font-family: Times New Roman, Times, Serif"&gt;ATP
    Label Printing Fees&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zGltgxrHs6Fk" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1252"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zfnwEeWUjRli" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;455&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zO3PaOw8ZMM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zonoooHgiBe8" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;455&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.
RELATED PARTY BALANCES AND TRANSACTIONS (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Related
party transactions &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name of Related&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the years
    ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nature&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agape Superior
    Living Pty Ltd (&#x201c;ASLPL&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zcC2giDupOh6" title="Relationship"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zW9HzqMSxgMb" title="Relationship"&gt;Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 18%; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z4Lv347M7n3e" title="Nature"&gt;&lt;span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zH9KjlqHYSA1" title="Nature"&gt;Sales of
    products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zGbEXE87uPu9" style="width: 14%; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1268"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zLj2DGzHvADi" style="width: 12%; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,060&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"&gt;&lt;span id="xdx_F4C_zm8QfSbpOFne" style="font-family: Times New Roman, Times, Serif"&gt;Vettons
    Sdn Bhd*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zugLfroRtprc" title="Relationship"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zZvVq3EoCVc1" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zuQtzdRYWHvj" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zb7z4MtJu9pk" title="Nature"&gt;Sales
    of products made through its platform&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____z2oh2awX7Fzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_fKg_____zvzZZ9Lr1X8e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231_zZMNas14GZie" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zbXwpniv32xe" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,060&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify; width: 0.15in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b id="xdx_F07_z3qCnTQjHwmg"&gt;*&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zurIKlX1VP8l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2021, the Company had sales
of $&lt;span id="xdx_90F_eus-gaap--RevenueFromRelatedParties_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_za0RKbuWThr6" title="Revenue"&gt;6,625&lt;/span&gt; through the online platform owned by Vettons Sdn Bhd (&#x201c;Vettons&#x201d;). Vettons is a related party since Mr. How Kok
Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Purchase&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the years ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: left; padding-bottom: 1.5pt"&gt;DSY Wellness &amp;amp; Longevity Center Sdn Bhd&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zztjihGbEJi" title="Relationship"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKgGDN0XOXqi" title="Relationship"&gt;Dato&#x2019; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp;amp; Longevity Center Sdn Bhd&lt;/span&gt;&lt;/span&gt;.&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z4AK4a2VPoge" title="Nature"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zd3zORUqsxXh" title="Nature"&gt;Purchase&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z0MaSzrnIaGf" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Purchase"&gt;718&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zcp8pULpTfJd" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Purchase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1301"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231_zxjPSxdzQeW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"&gt;718&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231_zWmsGiHMPUr3" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1305"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Commission
expense&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; font-weight: bold"/&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the years
    ended December 31, &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name
    of Related Party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nature&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mr.
    How Kok Choong&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zS3c71XRkOpc" title="Relationship"&gt;&lt;span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKe4t3D9pIBh" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company&lt;/span&gt;&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 18%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zGlq7z43t2vb" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zpnZEXPuCsjk" title="Nature"&gt;Commission
    expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SalesCommissionsAndFee_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zVewcRjCItP4" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,758&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SalesCommissionsAndFee_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_z6srxupaaap9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,740&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SalesCommissionsAndFee_pdp0_c20210101__20211231_zMp01UdDmLWb" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,758&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SalesCommissionsAndFee_pp0p0_c20200101__20201231_zIjLrUletGIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,740&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Other
income&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td rowspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Name
    of Related Party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the years ended December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Relationship&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Nature&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 22%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Hostastay
    Sdn. Bhd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQlgHq1wqYgl" title="Relationship"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zdoJWj8m3jsi" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zZNbTceC974g" title="Nature"&gt;&lt;span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zhxZicsFyDNg" title="Nature"&gt;Sublease
    rental income due from Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--OtherIncome_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zutdgJUpW8Cf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: right" title="Other income"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,345&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--OtherIncome_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zvIxFJm9Nj04" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: right" title="Other income"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,881&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20210101__20211231_zid26QmKtftg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,345&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zjuv3Lyf9VN9" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,881&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zcO7cQRA7zP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zcAQ3zTAOKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z8lWSWKWUU0c" style="display: none"&gt;SCHEDULE OF RELATED PARTIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name
    of Related&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nature&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agape ATP
    (Asia) Limited (&#x201c;AATP Asia&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zFh7IyxtMaig" title="Relationship"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zrYM4jVMEh4i" title="Relationship"&gt;Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zT5TKVhB1k1h" title="Nature"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zuDhF7hq7hH3" title="Nature"&gt;Expenses
    paid for AATP Asia&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zBPYNcd3xTze" style="width: 14%; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,214&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zWkTG45rUsf" style="width: 12%; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,227&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Hostastay Sdn. Bhd.&lt;/span&gt;&lt;/p&gt;
                                                      &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x201c;Hostastay&#x201d;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoHMJVFDgqqg" title="Relationship"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zj7Cls3LGfj1" title="Relationship"&gt;Mr. How Kok Choong,
    the CEO and director of the Company is also the director of Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_z96bkEc6Hqk9" title="Nature"&gt;&lt;span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zOKpJukAbQx8" title="Nature"&gt;Sublease rent due from
    Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zIRfbce6jjj6" style="text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,790&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zf4Uas6lnH9a" style="text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;TH3 Technology Sdn Bhd&lt;/span&gt;&lt;/p&gt;
                                                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x201c;TH3&#160;&lt;/span&gt;Technology&#x201d;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdMAMDlv2nHd" title="Relationship"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zRRw54uNEw4h" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zF0Z2g5QwuVc" title="Nature"&gt;&lt;span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zOLs3a1wFca1" title="Nature"&gt;Expenses
    paid for TH3 Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zBS833tKI6Ca" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdoHLYF8dUGb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231_zXf0bP8Tyebk" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,004&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_z1apLzBjnaN1" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Amount
due to a Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name of Related&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nature&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agape
    Superior Living Pty Ltd&lt;/span&gt; &#x201c;ASLPL&#x201d;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zjaffT4I6jli" style="font-family: Times New Roman, Times, Serif" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1.5pt; width: 18%; text-align: center"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zTcNtnTuIgMj" style="font-family: Times New Roman, Times, Serif"&gt;ATP
    Label Printing Fees&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zGltgxrHs6Fk" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1252"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zfnwEeWUjRli" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;455&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zO3PaOw8ZMM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zonoooHgiBe8" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;455&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.
RELATED PARTY BALANCES AND TRANSACTIONS (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Related
party transactions &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name of Related&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the years
    ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nature&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agape Superior
    Living Pty Ltd (&#x201c;ASLPL&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zcC2giDupOh6" title="Relationship"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zW9HzqMSxgMb" title="Relationship"&gt;Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 18%; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z4Lv347M7n3e" title="Nature"&gt;&lt;span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zH9KjlqHYSA1" title="Nature"&gt;Sales of
    products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zGbEXE87uPu9" style="width: 14%; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1268"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zLj2DGzHvADi" style="width: 12%; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,060&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"&gt;&lt;span id="xdx_F4C_zm8QfSbpOFne" style="font-family: Times New Roman, Times, Serif"&gt;Vettons
    Sdn Bhd*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zugLfroRtprc" title="Relationship"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zZvVq3EoCVc1" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zuQtzdRYWHvj" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zb7z4MtJu9pk" title="Nature"&gt;Sales
    of products made through its platform&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____z2oh2awX7Fzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_fKg_____zvzZZ9Lr1X8e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231_zZMNas14GZie" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zbXwpniv32xe" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,060&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify; width: 0.15in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b id="xdx_F07_z3qCnTQjHwmg"&gt;*&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zurIKlX1VP8l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2021, the Company had sales
of $&lt;span id="xdx_90F_eus-gaap--RevenueFromRelatedParties_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_za0RKbuWThr6" title="Revenue"&gt;6,625&lt;/span&gt; through the online platform owned by Vettons Sdn Bhd (&#x201c;Vettons&#x201d;). Vettons is a related party since Mr. How Kok
Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Purchase&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the years ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: left; padding-bottom: 1.5pt"&gt;DSY Wellness &amp;amp; Longevity Center Sdn Bhd&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zztjihGbEJi" title="Relationship"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKgGDN0XOXqi" title="Relationship"&gt;Dato&#x2019; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp;amp; Longevity Center Sdn Bhd&lt;/span&gt;&lt;/span&gt;.&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z4AK4a2VPoge" title="Nature"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zd3zORUqsxXh" title="Nature"&gt;Purchase&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z0MaSzrnIaGf" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Purchase"&gt;718&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zcp8pULpTfJd" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Purchase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1301"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231_zxjPSxdzQeW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"&gt;718&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231_zWmsGiHMPUr3" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1305"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Commission
expense&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; font-weight: bold"/&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the years
    ended December 31, &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name
    of Related Party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nature&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mr.
    How Kok Choong&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zS3c71XRkOpc" title="Relationship"&gt;&lt;span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKe4t3D9pIBh" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company&lt;/span&gt;&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: top; width: 18%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zGlq7z43t2vb" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zpnZEXPuCsjk" title="Nature"&gt;Commission
    expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SalesCommissionsAndFee_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zVewcRjCItP4" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,758&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SalesCommissionsAndFee_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_z6srxupaaap9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,740&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SalesCommissionsAndFee_pdp0_c20210101__20211231_zMp01UdDmLWb" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,758&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SalesCommissionsAndFee_pp0p0_c20200101__20201231_zIjLrUletGIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,740&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Other
income&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td rowspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Name
    of Related Party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the years ended December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Relationship&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Nature&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 22%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Hostastay
    Sdn. Bhd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQlgHq1wqYgl" title="Relationship"&gt;&lt;span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zdoJWj8m3jsi" title="Relationship"&gt;Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zZNbTceC974g" title="Nature"&gt;&lt;span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zhxZicsFyDNg" title="Nature"&gt;Sublease
    rental income due from Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--OtherIncome_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zutdgJUpW8Cf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: right" title="Other income"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,345&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--OtherIncome_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zvIxFJm9Nj04" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: right" title="Other income"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,881&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20210101__20211231_zid26QmKtftg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,345&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zjuv3Lyf9VN9" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,881&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2021-01-012021-12-31_custom_AgapeATPAsiaLimitedMember">Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember">Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2021-01-012021-12-31_custom_AgapeATPAsiaLimitedMember">Expenses
    paid for AATP Asia</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember">Expenses
    paid for AATP Asia</AATP:RelatedPartiesNatureDescription>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2021-12-31_custom_AgapeATPAsiaLimitedMember"
      decimals="0"
      unitRef="USD">2214</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2020-12-31_custom_AgapeATPAsiaLimitedMember"
      decimals="0"
      unitRef="USD">2227</us-gaap:DueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdMember">Mr. How Kok Choong,
    the CEO and director of the Company is also the director of Hostastay</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdMember">Mr. How Kok Choong,
    the CEO and director of the Company is also the director of Hostastay</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdMember">Sublease rent due from
    Hostastay</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdMember">Sublease rent due from
    Hostastay</AATP:RelatedPartiesNatureDescription>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2021-12-31_custom_HostastaySdnBhdMember"
      decimals="0"
      unitRef="USD">4790</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2020-12-31_custom_HostastaySdnBhdMember"
      decimals="0"
      unitRef="USD">996</us-gaap:DueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2021-01-012021-12-31_custom_THThreeTechnologySdnBhdMember">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2021-01-012021-12-31_custom_THThreeTechnologySdnBhdMember">Expenses
    paid for TH3 Technology</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember">Expenses
    paid for TH3 Technology</AATP:RelatedPartiesNatureDescription>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2020-12-31_custom_THThreeTechnologySdnBhdMember"
      decimals="0"
      unitRef="USD">12</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7004</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3235</us-gaap:DueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">Mr.
    How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">ATP
    Label Printing Fees</AATP:RelatedPartiesNatureDescription>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2020-12-31_custom_AgapeSuperiorLivingPtyLtdMember"
      decimals="0"
      unitRef="USD">455</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">455</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">Sales of
    products</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">Sales of
    products</AATP:RelatedPartiesNatureDescription>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember"
      decimals="0"
      unitRef="USD">18060</us-gaap:RevenueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription
      contextRef="From2021-01-012021-12-31_custom_VettonsSdnBhdOneMember"
      id="Fact001272">Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription
      contextRef="From2020-01-012020-12-31_custom_VettonsSdnBhdOneMember"
      id="Fact001274">Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1,
    2021</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription
      contextRef="From2021-01-012021-12-31_custom_VettonsSdnBhdOneMember"
      id="Fact001276">Sales
    of products made through its platform</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription
      contextRef="From2020-01-012020-12-31_custom_VettonsSdnBhdOneMember"
      id="Fact001278">Sales
    of products made through its platform</AATP:RelatedPartiesNatureDescription>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2021-01-012021-12-31_custom_VettonsSdnBhdOneMember"
      decimals="0"
      id="Fact001280"
      unitRef="USD">6625</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">6625</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">18060</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2021-01-012021-12-31_custom_HowKokChoongMember_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">6625</us-gaap:RevenueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember_srt_ChiefExecutiveOfficerMember">Dato&#x2019; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp; Longevity Center Sdn Bhd</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember_srt_ChiefExecutiveOfficerMember">Dato&#x2019; Sri Yap Foo Ching @ Steve Yap,
    a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp; Longevity Center Sdn Bhd</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember">Purchase</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember">Purchase</AATP:RelatedPartiesNatureDescription>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="From2021-01-012021-12-31_custom_DSYWellnessAndLongevityCenterSdnBhdMember"
      decimals="0"
      unitRef="USD">718</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">718</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2021-01-012021-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember_srt_ChiefExecutiveOfficerMember">Mr.
    How Kok Choong, the CEO and director of the Company</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember_srt_ChiefExecutiveOfficerMember">Mr.
    How Kok Choong, the CEO and director of the Company</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2021-01-012021-12-31_custom_HowKokChoongMember">Commission
    expense</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_HowKokChoongMember">Commission
    expense</AATP:RelatedPartiesNatureDescription>
    <AATP:SalesCommissionsAndFee
      contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember"
      decimals="0"
      unitRef="USD">12758</AATP:SalesCommissionsAndFee>
    <AATP:SalesCommissionsAndFee
      contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember"
      decimals="0"
      unitRef="USD">10740</AATP:SalesCommissionsAndFee>
    <AATP:SalesCommissionsAndFee
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">12758</AATP:SalesCommissionsAndFee>
    <AATP:SalesCommissionsAndFee
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">10740</AATP:SalesCommissionsAndFee>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember_srt_ChiefExecutiveOfficerMember">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Hostastay</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember_srt_ChiefExecutiveOfficerMember">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Hostastay</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember">Sublease
    rental income due from Hostastay</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember">Sublease
    rental income due from Hostastay</AATP:RelatedPartiesNatureDescription>
    <us-gaap:OtherIncome
      contextRef="From2021-01-012021-12-31_custom_HostastaySdnBhdOneMember"
      decimals="0"
      unitRef="USD">4345</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember"
      decimals="0"
      unitRef="USD">2881</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">4345</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2881</us-gaap:OtherIncome>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z1EoTOmM1nR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;15.
&lt;span id="xdx_825_zWGqCJHetoAe"&gt;STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Preferred
stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021 and 2020, there were &lt;span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zzJK3vpWjnfd" title="Preferred stock, shares authorized"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_zZTCjEPkdvyc" title="Preferred stock, shares authorized"&gt;200,000,000&lt;/span&gt;&lt;/span&gt; preferred stocks authorized but &lt;span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_dn_c20211231_zeqmFolebPa9" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20211231_zlgRdq6m3g6k" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_dn_c20201231_zScliMtehWfh" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20201231_zwdvKtJIUPNb" title="Preferred stock, shares outstanding"&gt;none&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; were issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Common
stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021 and 2020, there were &lt;span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_z22kJHDEj365" title="Common stock, shares authorized"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20201231_znNHnqB3ZfWf" title="Common stock, shares authorized"&gt;1,000,000,000&lt;/span&gt;&lt;/span&gt; common stocks authorized, &lt;span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20211231_zmGeXMXqDgp7" title="Common stock, shares issued"&gt;&lt;span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zKb4SWubZpV8" title="Common stock, shares outstanding"&gt;290,460,047&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20201231_zgegkGXH9Sq7" title="Common stock, shares issued"&gt;&lt;span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20201231_zmPjVDc0StK9" title="Common stock, shares outstanding"&gt;376,452,047&lt;/span&gt;&lt;/span&gt; shares issued and outstanding,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2020, the Company issued &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200501__20200531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zKsJrx6OXHpk" title="Stock issued during period acquisitions, shares"&gt;162,694&lt;/span&gt; shares of the Company&#x2019;s common stock in connection with the acquisition of ASL as part of
the acquisition payment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased
by $&lt;span id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_c20210630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zInmgVQjYzad" title="Business combination, recognized identifiable assets acquired and liabilities assumed, assets"&gt;90,043&lt;/span&gt;, which required the issuance of an additional &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z4q91pPPvi19" title="Stock issued during period acquisitions, shares"&gt;13,853&lt;/span&gt; shares of the Company&#x2019;s common stock to fully satisfy the acquisition
payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200629__20200731__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zBR0sNWMhk1a" title="Stock issued during period acquisitions, shares"&gt;13,853&lt;/span&gt; additional shares were issued in July 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2021, there were share forfeiture agreements (the &#x201c;&lt;b&gt;Share Forfeiture Agreements&lt;/b&gt;&#x201d;) between the Company and
(i) HKC Talent Limited; (ii) various shareholders of the Company (the &#x201c;&lt;b&gt;Forfeiting Shareholders&lt;/b&gt;&#x201d;), pursuant to which:
(i) HKC Talent Limited had agreed to forfeiture of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongTalentLimitedMember_zjZh4vmwzQ37"&gt;41,750,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock of the Company, and (ii)
the Forfeiting Shareholders had agreed to forfeiture, in aggregate, &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongTalentLimitedMember__srt--TitleOfIndividualAxis__custom--ShareholdersMember_zEG1iaTobXDh"&gt;44,242,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock of the Company. Included
in (ii) is &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HKCHoldingsSdnBhdMember_z7s7tathq1Bi"&gt;11,242,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares forfeited from HKC Holdings Sdn. Bhd,
a company in which &lt;span style="background-color: white"&gt;Mr. How Kok Choong, &lt;/span&gt;the CEO and director of the Company, is a shareholder.
As a result, the outstanding shares was reduced by &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember_zRAYMhCL1ktc"&gt;85,992,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were &lt;span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20210101__20211231_z5AQ422mtOye" title="Potentially dilutive securities outstanding"&gt;&lt;span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20200101__20201231_zFHH6aethW6" title="Potentially dilutive securities outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">290460047</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">290460047</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">376452047</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">376452047</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-05-012020-05-31_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Shares">162694</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2021-06-30_custom_AgapeSuperiorLivingMember"
      decimals="0"
      unitRef="USD">90043</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2021-01-012021-06-30_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Shares">13853</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-06-292020-07-31_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Shares">13853</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HowKokChoongTalentLimitedMember"
      decimals="INF"
      unitRef="Shares">41750000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HowKokChoongTalentLimitedMember_custom_ShareholdersMember"
      decimals="INF"
      unitRef="Shares">44242000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember_custom_HKCHoldingsSdnBhdMember"
      decimals="INF"
      unitRef="Shares">11242000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember"
      decimals="INF"
      unitRef="Shares">85992000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zDBeMDPckdHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;16.
&lt;span id="xdx_822_zrFQDIpLMPz7"&gt;NON-CONTROLLING INTEREST&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfNonControllingInterestTableTextBlock_zZBI5QjC7oDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s non-controlling interest consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zwxpd85H2Q5j" style="display: none"&gt;SCHEDULE
OF NON CONTROLLING INTEREST&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20211231_zwr96En8RGd1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20201231_z2Eht72PAx95" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;DSY Wellness:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--NonControllingInterestPaidinCapital_iI_zcfm1r481Hek" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1384"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--NonControllingInterestAccumulatedDeficit_iI_zIssv5YTi0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(436&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1387"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NonControllingInterestAccumulatedOtherComprehensiveIncome_iI_zF3o95vL91Vk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated other comprehensive
    income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1390"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NonControllingInterestNonControllingInterestGross_iI_zDeVDEDJx5b8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="display: none; font-size: 10pt"&gt;Non Controlling interest Gross&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--NonControllingInterestAsl_iI_zFpZKA8KAfQ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;ASL&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1395"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1396"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--MinorityInterest_iI_zW9WYiMyfzZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(336&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1399"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p id="xdx_8AF_zikBXzqt0zpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MinorityInterestDisclosureTextBlock>
    <AATP:ScheduleOfNonControllingInterestTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89F_ecustom--ScheduleOfNonControllingInterestTableTextBlock_zZBI5QjC7oDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s non-controlling interest consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zwxpd85H2Q5j" style="display: none"&gt;SCHEDULE
OF NON CONTROLLING INTEREST&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20211231_zwr96En8RGd1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20201231_z2Eht72PAx95" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;DSY Wellness:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--NonControllingInterestPaidinCapital_iI_zcfm1r481Hek" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1384"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--NonControllingInterestAccumulatedDeficit_iI_zIssv5YTi0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(436&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1387"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NonControllingInterestAccumulatedOtherComprehensiveIncome_iI_zF3o95vL91Vk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated other comprehensive
    income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1390"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NonControllingInterestNonControllingInterestGross_iI_zDeVDEDJx5b8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="display: none; font-size: 10pt"&gt;Non Controlling interest Gross&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--NonControllingInterestAsl_iI_zFpZKA8KAfQ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;ASL&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1395"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1396"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--MinorityInterest_iI_zW9WYiMyfzZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(336&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1399"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

</AATP:ScheduleOfNonControllingInterestTableTextBlock>
    <AATP:NonControllingInterestPaidinCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">97</AATP:NonControllingInterestPaidinCapital>
    <AATP:NonControllingInterestAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-436</AATP:NonControllingInterestAccumulatedDeficit>
    <AATP:NonControllingInterestAccumulatedOtherComprehensiveIncome contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3</AATP:NonControllingInterestAccumulatedOtherComprehensiveIncome>
    <AATP:NonControllingInterestNonControllingInterestGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-336</AATP:NonControllingInterestNonControllingInterestGross>
    <us-gaap:MinorityInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-336</us-gaap:MinorityInterest>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zx1vaESLje23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;17.
&lt;span id="xdx_825_zIseJE7OXP2i"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zJ7stTvKpSRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
United States and foreign components of (loss) income before income taxes were comprised of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BC_zTWxPdCJiCud" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210101__20211231_zrZAXd34Xik3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20200101__20201231_zfXKIGzf6yU7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tax jurisdictions from:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zAlLrtxOUl7e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Local &#x2013; United States&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(706,659&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(735,159&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--MY_zEclGmfB1wAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign &#x2013; Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,064,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,070,806&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--HK_zhAbaLKDIFKc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign &#x2013; Hong
    Kong&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(616,640&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;180,700&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zWJCB0DdrB88" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zwsoXAMvtkTi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss) income before
    income tax&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,387,613&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;516,347&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zQwZHDkY8Q04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zPwBaAA1nP6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
(provision for) benefit of income taxes consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zbupPTnAP3g2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF PROVISION FOR INCOME TAX&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210101__20211231_zwjEcbQqFP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20200101__20201231_zSSX7rLf21y8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_iN_di_maITEBzB5L_zh20qlTxQ03d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Local&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(22,205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1423"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CurrentForeignTaxExpenseBenefit_iN_di_maITEBzB5L_zverS48xQVVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Foreign&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(104,735&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,748&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_zFpxBWlN3REh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Local&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1428"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1429"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_z2R5c2TT0h88" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Foreign&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,127&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(178,329&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBzB5L_zOZ0Dm8bu8Jl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision for income
    taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(137,067&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(161,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zhWYBUgr16K4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad
range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan)
and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;United
States of America&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agape
ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a corporate
tax rate of &lt;span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zr4IRO9K2cXa" title="Tax percentage"&gt;21&lt;/span&gt;% on its taxable income. Agape ATP Corporation also subject to controlled foreign corporations Subpart F income (&#x201c;Subpart
F&#x201d;) tax, which is a tax primarily on passive income from controlled foreign corporations with a tax rate of &lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z04iJ8TfDm6c" title="Tax percentage"&gt;35&lt;/span&gt;%. &lt;span id="xdx_909_eus-gaap--TaxCutsAndJobsActOf2017OtherTaxEffectDescription_c20210101__20211231_zq9p5RQTNMfe" title="Tax rate description"&gt;In addition, the
Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#x201c;GILTI&#x201d;) tax, which is a tax on certain off-shore earnings
at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign
tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are
applied&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended December 31, 2021 and 2020, the Company&#x2019;s foreign subsidiaries did not generate any income that are subject to
Subpart F tax and GILTI tax.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;17.
INCOME TAXES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the year ended December 31, 2021, the Company re-visited its fiscal 2020 U.S. income taxes and determined its stock dividend from Greenpro
Capital Corp as a result of its Spin-off of DSwiss Inc.&#x2019;s shares in 2020 were subject to Subpart F and GILTI taxes. As a result,
the Company incurred additional income taxes expenses of $&lt;span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zdqT2ffrpzXb" title="Income tax expense benefit"&gt;22,205&lt;/span&gt;, including interest and penalty of $&lt;span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20210101__20211231_zJzyKKFFpTmi" title="Income tax  examination penalties and interest expense"&gt;395&lt;/span&gt;, for the year ended December
31, 2021, after utilizing its estimated cumulative net operating losses (&#x201c;NOL&#x201d;) of $&lt;span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_c20201231_zeijZGafqpS5" title="Cumulative net operating loss"&gt;312,608&lt;/span&gt; as of December 31, 2020. As a
result, the Company&#x2019;s deferred tax assets of estimated NOL of $&lt;span id="xdx_904_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20211231_z5ngiqBIt3Pl" title="Deferred tax assets operating loss carryforwards"&gt;65,648&lt;/span&gt; were fully utilized and reduced to $&lt;span id="xdx_901_ecustom--DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_iI_c20211231_zhTUhZUCdzcb" title="Cumulative net operating losses"&gt;0&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021 and 2020, the operations in the United States of America incurred approximately $&lt;span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_ziRZzDY5u6oc" title="Operating loss"&gt;729,000&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zIL3DbXUwtg8" title="Operating loss"&gt;0&lt;/span&gt;, respectively, of
cumulative net operating losses (&#x201c;NOL&#x201d;) which can be carried forward to offset future taxable income or Subpart F and GILTI
taxes. These balance can be carried forward indefinitely. The deferred tax valuation allowance as of December 31, 2021 and 2020 were
approximately $&lt;span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_zVzqt9niPNK6" title="Deferred tax valuation allowance"&gt;153,000&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_z1ArW8tk0za1" title="Deferred tax valuation allowance"&gt;0&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Malaysia&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes
to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies
incorporated in Labuan to satisfy the &#x201c;substantial activity requirements&#x201d; to qualify for the preferential tax rate of &lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zruGRczcdzU" title="Tax percentage"&gt;3&lt;/span&gt;%
on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to the &#x201c;substantial activity requirements&#x201d;
was issued. As Agape ATP Corporation did not maintain a permanent establishment in Labuan, and therefore did not satisfy the said requirements,
the company was subjected to tax at &lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zWXtzm0GkKIe" title="Taxp percentage"&gt;24&lt;/span&gt;% on its net audited profit. On June 11, 2021, Agape ATP Corporation made an irrevocable election
to be taxed under the Malaysian Income Tax Act 1967 as the elected tax regime is more tax efficient to the entity compare to LBATA.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agape
Superior Living Sdn Bhd, Agape S.E.A Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of
Malaysia and the income taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable
income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia,
enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential tax rates,
tax holidays and even tax exemption may be granted on case-by-case basis. &lt;span id="xdx_903_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--MY_zMBjQTPtIlL7" title="Income tax examination, description"&gt;The tax rate for small and medium sized companies (generally
companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is &lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231__srt--StatementGeographicalAxis__country--MY_zC5zcFsPH3Hh" title="Tax percentage"&gt;17&lt;/span&gt;% for the first RM 600,000 (or approximately $150,000)
for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021 and 2020, the operations in the Malaysia incurred approximately $&lt;span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--MY_zp1K6Soyryma"&gt;946,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zVmjPSCCLqIi"&gt;261,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively, of cumulative net operating losses (&#x201c;NOL&#x201d;) which can be carried forward to offset future taxable income. Approximately
$&lt;span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_c20211231__srt--StatementScenarioAxis__custom--UnutilizedMember_zrQFP7JnakLe" title="Net operating loss carryforward"&gt;685,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_c20201231__srt--StatementScenarioAxis__custom--UnutilizedMember_zPSOKkOKBiY8"&gt;261,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of the net operating loss carry forwards will
expire in 2028 and 2027, respectively, if unutilized. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately
$&lt;span id="xdx_907_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--MY_z29Vtxjgn5qh"&gt;217,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_90F_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zkaVl3EJUUUa"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Hong
Kong&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agape
ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of &lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231__srt--StatementGeographicalAxis__country--HK_z7Hvvs9O4ON2" title="Tax percentage"&gt;16.5&lt;/span&gt;% on
its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative
Region is not subject to Hong Kong Profits Tax or deduction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;17.
INCOME TAXES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zh8ZLrOPYINk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reconciles the local (United States) statutory rates to the Company&#x2019;s effective tax rate for the periods indicated
below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8B6_zC5lQXfhDLsc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF EFFECTIVE INCOME TAX RATE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20210101__20211231_zHodPO8OlDVc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20200101__20201231_zIF4l0FDdfkl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zsEs0VSP47W2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S. statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zTUSVlHzwV1b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zLMg3hNPRqq6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Differential tax rate in Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zm9NRd88iKhh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Permanent difference&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(12.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span id="xdx_F2F_zxSNVakO0EU2" style="font-family: Times New Roman, Times, Serif"&gt;)%(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span id="xdx_F27_zzkQrrHwK2g8" style="font-family: Times New Roman, Times, Serif"&gt;%(2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zWHBlQpZ9SX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    amount comprised:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p id="xdx_F03_z9Nlra0fsGci" style="display: none; margin-top: 0; margin-bottom: 0"&gt;(1)&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zYdaYzTyVkc3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;The
    amount comprised: &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zkx8Ftrs7L89" title="Non-deductible tax rate"&gt;6.2&lt;/span&gt;% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_z7zr0BljaQM3" title="Non-deductible tax rate"&gt;6.7&lt;/span&gt;%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_za3LDb8OY7Ml" title="Tax percentage"&gt;6.2&lt;/span&gt;%
    being income derived in AATP HK that were not taxable in the Malaysia tax returns; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_zJiKLXcUTRUk" title="Tax percentage"&gt;6.7&lt;/span&gt;%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    amount comprised:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F06_z335a6X6xzjc" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"&gt;(2)&lt;/td&gt;
    &lt;td colspan="2" id="xdx_F18_zVtSsVaotcc4" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amount comprised: &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231_zv1NMsh9HgPd"&gt;10.2%
being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; &lt;/span&gt;&lt;/span&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zyI1Oi1dqqbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Non-deductible tax rate"&gt;0.2%
being income derived in AATP HK that were not taxable in the Malaysia tax returns; and &lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zAbCSjiqlxJf" title="Non-deductible tax rate"&gt;1.3&lt;/span&gt;%
being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z809m78MTHpj" title="Tax percentage"&gt;10.2&lt;/span&gt;%
    being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zmVeWeVqoWCj" title="Tax percentage"&gt;0.2&lt;/span&gt;%
                                            being income derived in AATP HK that were not taxable in the Malaysia tax returns; and&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.35pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zN2k4pv648T2" title="Tax percentage"&gt;1.3&lt;/span&gt;%
    being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p id="xdx_8A5_zRf8gZITjCH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTgDaFWwPnw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_z6PE7E8dFond" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20211231_zbi55i6TjUyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20201231_z9HNpNIBftu7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--US_zdlrLW0iyXZk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating loss carry forwards
    in U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;153,061&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1519"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--MY_zTYHWbFloxwf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating loss carry forwards in Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;227,106&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,678&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zNxv9yYvsNDg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net operating loss carry forwards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20211231_zGKJemF1HSjc" style="text-align: right" title="Less: valuation allowance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(380,167&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20201231_zhbZnY4zYwHl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1528"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iI_zHyYEH4A3upj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,574&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(68,421&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_di_zOrcgklJh9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax liabilities,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,574&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,743&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zkxctfdEx5Kf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Uncertain
tax positions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical
merits, and measure the unrecognized benefits associated with the tax positions&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
As of December 31, 2021 and 2020, the Company did not have any significant unrecognized uncertain tax positions. The Company did not
incur interest and penalties tax for the years ended December 31, 2020 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zJ7stTvKpSRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
United States and foreign components of (loss) income before income taxes were comprised of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BC_zTWxPdCJiCud" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210101__20211231_zrZAXd34Xik3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20200101__20201231_zfXKIGzf6yU7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tax jurisdictions from:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zAlLrtxOUl7e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Local &#x2013; United States&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(706,659&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(735,159&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--MY_zEclGmfB1wAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign &#x2013; Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,064,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,070,806&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--HK_zhAbaLKDIFKc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign &#x2013; Hong
    Kong&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(616,640&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;180,700&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zWJCB0DdrB88" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zwsoXAMvtkTi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss) income before
    income tax&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,387,613&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;516,347&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-706659</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-735159</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2021-01-012021-12-31_country_MY"
      decimals="0"
      unitRef="USD">-1064314</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2020-01-012020-12-31_country_MY"
      decimals="0"
      unitRef="USD">1070806</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2021-01-012021-12-31_country_HK"
      decimals="0"
      unitRef="USD">-616640</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2020-01-012020-12-31_country_HK"
      decimals="0"
      unitRef="USD">180700</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2387613</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">516347</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zPwBaAA1nP6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
(provision for) benefit of income taxes consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zbupPTnAP3g2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF PROVISION FOR INCOME TAX&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210101__20211231_zwjEcbQqFP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20200101__20201231_zSSX7rLf21y8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_iN_di_maITEBzB5L_zh20qlTxQ03d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Local&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(22,205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1423"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CurrentForeignTaxExpenseBenefit_iN_di_maITEBzB5L_zverS48xQVVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Foreign&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(104,735&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,748&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_zFpxBWlN3REh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Local&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1428"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1429"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_z2R5c2TT0h88" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Foreign&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,127&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(178,329&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBzB5L_zOZ0Dm8bu8Jl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision for income
    taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(137,067&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(161,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">22205</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">104735</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-16748</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">10127</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">178329</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">137067</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">161581</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-012021-12-31_us-gaap_StateAndLocalJurisdictionMember"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-012021-12-31_us-gaap_ForeignCountryMember"
      decimals="INF"
      unitRef="Pure">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:TaxCutsAndJobsActOf2017OtherTaxEffectDescription contextRef="From2021-01-01to2021-12-31">In addition, the
Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#x201c;GILTI&#x201d;) tax, which is a tax on certain off-shore earnings
at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign
tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are
applied</us-gaap:TaxCutsAndJobsActOf2017OtherTaxEffectDescription>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31_us-gaap_DomesticCountryMember"
      decimals="0"
      unitRef="USD">22205</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">395</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">312608</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">65648</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <AATP:DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</AATP:DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31_country_US"
      decimals="0"
      unitRef="USD">729000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2020-12-31_country_US"
      decimals="0"
      unitRef="USD">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2021-12-31_country_US"
      decimals="0"
      unitRef="USD">153000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2020-12-31_country_US"
      decimals="0"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2018-12-282019-01-02_custom_LabuanMember"
      decimals="INF"
      unitRef="Pure">0.03</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2018-12-282019-01-02_custom_LabuanMember"
      decimals="INF"
      unitRef="Pure">0.24</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxExaminationDescription contextRef="From2021-01-012021-12-31_country_MY">The tax rate for small and medium sized companies (generally
companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000)
for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-012021-12-31_country_MY"
      decimals="INF"
      unitRef="Pure">0.17</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31_country_MY"
      decimals="0"
      unitRef="USD">946000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2020-12-31_country_MY"
      decimals="0"
      unitRef="USD">261000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31_custom_UnutilizedMember"
      decimals="0"
      unitRef="USD">685000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2020-12-31_custom_UnutilizedMember"
      decimals="0"
      unitRef="USD">261000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2021-12-31_country_MY"
      decimals="0"
      unitRef="USD">217000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2020-12-31_country_MY"
      decimals="0"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-012021-12-31_country_HK"
      decimals="INF"
      unitRef="Pure">0.165</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zh8ZLrOPYINk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reconciles the local (United States) statutory rates to the Company&#x2019;s effective tax rate for the periods indicated
below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8B6_zC5lQXfhDLsc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF EFFECTIVE INCOME TAX RATE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20210101__20211231_zHodPO8OlDVc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20200101__20201231_zIF4l0FDdfkl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zsEs0VSP47W2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S. statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zTUSVlHzwV1b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zLMg3hNPRqq6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Differential tax rate in Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zm9NRd88iKhh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Permanent difference&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(12.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span id="xdx_F2F_zxSNVakO0EU2" style="font-family: Times New Roman, Times, Serif"&gt;)%(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span id="xdx_F27_zzkQrrHwK2g8" style="font-family: Times New Roman, Times, Serif"&gt;%(2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zWHBlQpZ9SX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    amount comprised:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p id="xdx_F03_z9Nlra0fsGci" style="display: none; margin-top: 0; margin-bottom: 0"&gt;(1)&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zYdaYzTyVkc3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;The
    amount comprised: &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zkx8Ftrs7L89" title="Non-deductible tax rate"&gt;6.2&lt;/span&gt;% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_z7zr0BljaQM3" title="Non-deductible tax rate"&gt;6.7&lt;/span&gt;%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_za3LDb8OY7Ml" title="Tax percentage"&gt;6.2&lt;/span&gt;%
    being income derived in AATP HK that were not taxable in the Malaysia tax returns; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_zJiKLXcUTRUk" title="Tax percentage"&gt;6.7&lt;/span&gt;%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    amount comprised:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F06_z335a6X6xzjc" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"&gt;(2)&lt;/td&gt;
    &lt;td colspan="2" id="xdx_F18_zVtSsVaotcc4" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amount comprised: &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231_zv1NMsh9HgPd"&gt;10.2%
being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; &lt;/span&gt;&lt;/span&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zyI1Oi1dqqbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Non-deductible tax rate"&gt;0.2%
being income derived in AATP HK that were not taxable in the Malaysia tax returns; and &lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zAbCSjiqlxJf" title="Non-deductible tax rate"&gt;1.3&lt;/span&gt;%
being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z809m78MTHpj" title="Tax percentage"&gt;10.2&lt;/span&gt;%
    being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zmVeWeVqoWCj" title="Tax percentage"&gt;0.2&lt;/span&gt;%
                                            being income derived in AATP HK that were not taxable in the Malaysia tax returns; and&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.35pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zN2k4pv648T2" title="Tax percentage"&gt;1.3&lt;/span&gt;%
    being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">-0.170</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">-0.040</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.030</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.030</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact001489"
      unitRef="Pure">-0.127</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      id="Fact001490"
      unitRef="Pure">0.113</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">-0.057</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.313</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2021-01-012021-12-31_custom_AATPHKMember"
      decimals="INF"
      unitRef="Pure">0.062</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2021-01-012021-12-31_custom_AATPLBASLSEAWATPAndDSYMember"
      decimals="INF"
      unitRef="Pure">0.067</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2021-01-012021-12-31_custom_AATPHKMember"
      decimals="INF"
      unitRef="Pure">0.062</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2021-01-012021-12-31_custom_AATPLBASLSEAWATPAndDSYMember"
      decimals="INF"
      unitRef="Pure">0.067</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.102</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2020-01-012020-12-31_custom_AATPHKMember"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2020-01-012020-12-31_custom_AATPLBASLSEAAndWATPMember"
      decimals="INF"
      unitRef="Pure">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.102</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2020-01-012020-12-31_custom_AATPHKMember"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2020-01-012020-12-31_custom_AATPLBASLSEAAndWATPMember"
      decimals="INF"
      unitRef="Pure">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTgDaFWwPnw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_z6PE7E8dFond" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20211231_zbi55i6TjUyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20201231_z9HNpNIBftu7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--US_zdlrLW0iyXZk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating loss carry forwards
    in U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;153,061&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1519"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--MY_zTYHWbFloxwf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating loss carry forwards in Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;227,106&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,678&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zNxv9yYvsNDg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net operating loss carry forwards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20211231_zGKJemF1HSjc" style="text-align: right" title="Less: valuation allowance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(380,167&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20201231_zhbZnY4zYwHl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1528"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iI_zHyYEH4A3upj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,574&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(68,421&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_di_zOrcgklJh9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax liabilities,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,574&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,743&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2021-12-31_country_US"
      decimals="0"
      unitRef="USD">153061</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2021-12-31_country_MY"
      decimals="0"
      unitRef="USD">227106</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2020-12-31_country_MY"
      decimals="0"
      unitRef="USD">62678</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">380167</us-gaap:DeferredTaxAssetsValuationAllowance>
    <AATP:DeferredTaxLiabilitiesDepreciation contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-15574</AATP:DeferredTaxLiabilitiesDepreciation>
    <AATP:DeferredTaxLiabilitiesDepreciation contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-68421</AATP:DeferredTaxLiabilitiesDepreciation>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">15574</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5743</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zppyeLFDtlc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;18.
&lt;span id="xdx_820_zzEoSomjbVI4"&gt;CONCENTRATIONS OF RISKS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)
Major customers&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended December 31, 2021 and 2020, no customer accounted for &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zZ7wcEon2T32" title="Concentrations of risk percentage"&gt;&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsbNNSoACeck" title="Concentrations of risk percentage"&gt;10&lt;/span&gt;&lt;/span&gt;% or more of the Company&#x2019;s total revenues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
are no accounts receivable balance as of December 31, 2021. As of December 31, 2020, receivables from a third-party e-commerce company
accounted for approximately &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zqs9F210iL0g" title="Concentrations of risk percentage"&gt;100.0&lt;/span&gt;% of the total balance of accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)
Major vendors&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the year ended December 31, 2021, two vendors accounted for approximately &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zifQOunHx8X4"&gt;47.3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
and &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zbnvccvXJhJ6"&gt;45.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the Company&#x2019;s total purchases, respectively. For the year ended December 31, 2020, two vendors accounted for approximately &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zqi8p3G09a0g"&gt;74.1&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
and &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zl7EPVu4Wdga"&gt;25.9&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the Company&#x2019;s total purchases. In November and December 2020, the Company received dividend of &lt;span id="xdx_905_ecustom--DividendShareForCommonStock_pid_c20201201__20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zdhCwhkcasw6"&gt;23,330
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock of DSwiss, Inc., represents
approximately &lt;span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zw6R8eDBrN83"&gt;0.01&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
ownership that the Company accounted for as investment in marketable securities (See Note 11). DSwiss, Inc.&#x2019;s wholly owned subsidiary
is the vendor that accounted for the Company&#x2019;s total purchases of approximately &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--VendorOneMember__dei--LegalEntityAxis__custom--DSwissIncMember_z5XgWCTZ2QHe"&gt;47.3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__dei--LegalEntityAxis__custom--DSwissIncMember_zg8t0GgGDGZf"&gt;74.1&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021, one vendor accounted for &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--OneVendorMember_zTe2C8rp2Ttd" title="Concentrations of risk percentage"&gt;100&lt;/span&gt;% of the total balance of accounts payable. There are no accounts payable balance as
of December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)
Commission Expenses to Sales Distributors and Stockists&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the year ended December 31, 2021, one sales distributor accounted for &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--OneSalesDistributorMember_zKKo21123UW9" title="Concentrations of risk percentage"&gt;17.9&lt;/span&gt;% of the Company&#x2019;s total commission expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the year ended December 31, 2020, no sales distributor accounted for &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--NoSalesDistributorMember_zjvXG0OU1Tma"&gt;10.0&lt;/span&gt;% of the Company&#x2019;s total commission expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)
Credit risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of December
31, 2021 and 2020, $&lt;span id="xdx_90A_eus-gaap--Deposits_iI_pp0p0_c20211231_ztTFsOM43Hc6" title="Deposits"&gt;554,864&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--Deposits_iI_pp0p0_c20201231_zP2NpPQh02g1" title="Deposits"&gt;1,112,147&lt;/span&gt; were deposited with financial institutions, respectively, $&lt;span id="xdx_905_ecustom--DepositForInsurance_iI_pp0p0_c20211231_zUuFnX1Pw8Bd" title="Deposit for insurance"&gt;295,761&lt;/span&gt; and $&lt;span id="xdx_908_ecustom--DepositForInsurance_iI_pp0p0_c20201231_z7hIHHO8Zb2j" title="Deposit for insurance"&gt;563,788&lt;/span&gt; of these balances
are not covered by deposit insurance. While management believes that these financial institutions are of high credit quality, it also
continually monitors their credit worthiness.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration
of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection
terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful
accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically,
the Company did not have any bad debt on its account receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;18.
CONCENTRATIONS OF RISKS (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e)
Exchange rate risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could
post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower
profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes
in political and economic environments without notice.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember_us-gaap_CustomerConcentrationRiskMember_custom_VendorOneMember"
      decimals="INF"
      unitRef="Pure">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.473</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_VendorTwoMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.452</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.741</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_VendorTwoMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.259</us-gaap:ConcentrationRiskPercentage1>
    <AATP:DividendShareForCommonStock
      contextRef="From2020-12-012020-12-31_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Shares">23330</AATP:DividendShareForCommonStock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-11-30_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Pure">0.0001</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_VendorOneMember_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Pure">0.473</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_VendorOneMember_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Pure">0.741</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_AccountsPayableMember_custom_OneVendorMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_OneSalesDistributorMember"
      decimals="INF"
      unitRef="Pure">0.179</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_us-gaap_CostOfGoodsTotalMember_custom_NoSalesDistributorMember"
      decimals="INF"
      unitRef="Pure">0.100</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Deposits contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">554864</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1112147</us-gaap:Deposits>
    <AATP:DepositForInsurance contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">295761</AATP:DepositForInsurance>
    <AATP:DepositForInsurance contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">563788</AATP:DepositForInsurance>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zikBWEXc7Rr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;19.
&lt;span id="xdx_824_zqFHuwr8qXXa"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Lease
commitments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2020, the Company adopted ASC 842 for ASL&#x2019;s office space lease and sales and training center as the lease commencement
date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $&lt;span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20200401__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_ztm1zkup7YVb" title="Operating lease liability"&gt;490,000&lt;/span&gt;, with a corresponding right-of-use
(&#x201c;ROU&#x201d;) asset in the same amount based on the present value of the future minimum rental payments of the lease, using an
effective interest rate of &lt;span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20200401__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zY9XWuKi7CWk" title="Operating lease effective interest rate"&gt;5.5&lt;/span&gt;%, which was determined using the Company&#x2019;s estimated incremental borrowing rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 31, 2021, the Company entered into two separate two-year leases extension with the modified lease expiring &lt;span id="xdx_90C_ecustom--LeaseExpirationTerm_dd_c20210530__20210531_zg0t1LRbg2ml" title="Lease expiration term"&gt;May 31, 2023&lt;/span&gt; for its office
space and expiring &lt;span id="xdx_90A_ecustom--LeaseExpirationTerm_dd_c20210530__20210531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TrainingCenterMember_zHbo9BMQZEYk" title="Lease expiration term"&gt;August 31, 2023&lt;/span&gt; for its training center. The lease modification required the Company to re-measure the ROU assets
and lease liabilities based on the modified leases. The Company recognized a reduction of $&lt;span id="xdx_90E_ecustom--IncreaseDecreaseInROUAssetsAndLiabilities_iI_c20210531_zIq3NCDGKYMc" title="Reduction in ROU assets and liabilities"&gt;3,250&lt;/span&gt; in ROU assets and lease liabilities
upon lease modifications based on the present value of the future minimum rental payments of the lease, using an effective interest rate
of &lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20210531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zkrbAxBZJ3S4" title="Operating lease effective interest rate"&gt;5.5&lt;/span&gt;%, which was determined using the Company&#x2019;s estimated incremental borrowing rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;As
of December 31, 2021, the weighted remaining term of the lease is approximately &lt;span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zLuEApcD1dr2" title="Operating lease, weighted average remaining lease term"&gt;1.64&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zLwSIOUdEDJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
five-year maturity of the Company&#x2019;s operating lease liabilities is as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BB_z5HQRQCGEsN1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF LEASE COMMITMENTS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Twelve Months
    Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20211231_zrSpkKZ0riRb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzA1T_z29WVvrhY7u3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: bottom; width: 78%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;166,426&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzA1T_zFb9TaYVqEpi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;84,915&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzA1T_zgoP2DMVzy8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1587"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_zO7qR3PO3eAe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;251,341&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zSNfOKjtmRf5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,763&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;240,578&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zXefQuQgchwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rent
expense for the years ended December 31, 2021 and 2020 was $&lt;span id="xdx_90F_eus-gaap--OperatingLeaseExpense_pp0p0_c20210101__20211231_z4zUzdOiLlIk" title="Operating lease, rent expenses"&gt;179,562&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--OperatingLeaseExpense_pp0p0_c20200101__20201231_zlihFIIH9S6h" title="Operating lease, rent expenses"&gt;156,716&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Legal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued,
as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed
to be material to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;19.
COMMITMENTS AND CONTINGENCIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;COVID-19&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO, Malaysia has been put through
various stages of lockdowns such as (1) full movement control orders (&#x201c;MCO&#x201d;), under which, quarantines, travel restrictions,
and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to a Conditional Movement Control
Order (&#x201c;CMCO&#x201d;) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated
by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement Control Order (&#x201c;RMCO&#x201d;). On January 12,
2021, due to a resurgence of COVID-19 cases, the Malaysian government declared a state of emergency nationwide to combat COVID-19. Intermittent
lockdowns were imposed in various states and districts in the country. February 2021 marked a significant month for Malaysia as all frontline
staff of the country, which comprised those in healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department
of Malaysia and civil defense sectors were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that
a National COVID-19 Immunisation Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will
be vaccinated to achieve herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO, nevertheless,
COVID-19 cases in the country continue to rise. &lt;span id="xdx_90A_eus-gaap--UnusualRiskOrUncertaintyImpact_c20210101__20211231__us-gaap--UnusualRiskOrUncertaintyByNatureAxis__custom--COVIDNineteenImpactMember_zcGtXlDQGj5f" title="COVID-19 impact description"&gt;On
May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the
country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian
population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full
lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one
dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter
of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases
hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced
Movement Control Order (&#x201c;EMCO&#x201d;) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament
met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating
its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021,
interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country
achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where
it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country&#x2019;s population have been fully
vaccinated, with a further 46.0% having received booster shot&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially,
affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact
to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and
severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact,
almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;temporary
    closure of offices, travel restrictions, financial impact of the Company&#x2019;s customers or suspension supplies may be negatively
    affected, and could continue to negatively affect the demand for the Company&#x2019;s product;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely
    affect its financial condition and operating results; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;any
    disruption of the Company&#x2019;s supply chain, logistics providers or customers could adversely impact its business and results
    of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery
    to its customers, which may also lead to loss of its customers.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot
be reasonably estimated at this time. There is no guarantee that the Company&#x2019;s total revenues will grow or remain at the similar
level year over year in 2021 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2020-04-01_custom_AgapeSuperiorLivingMember"
      decimals="0"
      unitRef="USD">490000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2020-04-01_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Pure">0.055</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <AATP:LeaseExpirationTerm contextRef="From2021-05-302021-05-31">2023-05-31</AATP:LeaseExpirationTerm>
    <AATP:LeaseExpirationTerm contextRef="From2021-05-302021-05-31_custom_TrainingCenterMember">2023-08-31</AATP:LeaseExpirationTerm>
    <AATP:IncreaseDecreaseInROUAssetsAndLiabilities contextRef="AsOf2021-05-31" decimals="0" unitRef="USD">3250</AATP:IncreaseDecreaseInROUAssetsAndLiabilities>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2021-05-31_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Pure">0.055</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2021-12-31_custom_AgapeSuperiorLivingMember">P1Y7M20D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zLwSIOUdEDJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
five-year maturity of the Company&#x2019;s operating lease liabilities is as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BB_z5HQRQCGEsN1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;SCHEDULE
OF LEASE COMMITMENTS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Twelve Months
    Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20211231_zrSpkKZ0riRb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzA1T_z29WVvrhY7u3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: bottom; width: 78%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;166,426&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzA1T_zFb9TaYVqEpi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;84,915&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzA1T_zgoP2DMVzy8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1587"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_zO7qR3PO3eAe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;251,341&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zSNfOKjtmRf5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,763&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;240,578&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">166426</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">84915</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">251341</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">10763</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">240578</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">179562</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">156716</us-gaap:OperatingLeaseExpense>
    <us-gaap:UnusualRiskOrUncertaintyImpact contextRef="From2021-01-012021-12-31_custom_COVIDNineteenImpactMember">On
May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the
country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian
population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full
lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one
dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter
of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases
hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced
Movement Control Order (&#x201c;EMCO&#x201d;) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament
met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating
its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021,
interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country
achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where
it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country&#x2019;s population have been fully
vaccinated, with a further 46.0% having received booster shot</us-gaap:UnusualRiskOrUncertaintyImpact>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_znAil92WMLS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;20.
&lt;span id="xdx_825_ztm6LAGqhyCc"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Forfeiture
of Common Stock&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;A
share forfeiture agreement (the &#x201c;Share Forfeiture Agreement&#x201d;) dated January 20, 2022, between the Company and Mr. How Kok
Choong, &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the CEO and director of the Company&lt;span style="background-color: white"&gt;,
pursuant to which Mr. How Kok Choong agreed to forfeit &lt;span id="xdx_904_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20220101__20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementMember_zvhF4E0oB6R4" title="Company share forfeiture"&gt;215,008,035&lt;/span&gt; shares of common stock of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited
      contextRef="From2022-01-012022-01-20_us-gaap_SubsequentEventMember_custom_MrHowKokChoongMember_custom_ShareForfeitureAgreementMember"
      decimals="0"
      unitRef="USD">215008035</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001272"
          xlink:label="Fact001272"
          xlink:type="locator"/>
        <link:footnote id="Footnote001287" xlink:label="Footnote001287" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During the year ended December 31, 2021, the Company had sales
of $<xhtml:span id="xdx_90F_eus-gaap--RevenueFromRelatedParties_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_za0RKbuWThr6" title="Revenue">6,625</xhtml:span> through the online platform owned by Vettons Sdn Bhd (&#x201c;Vettons&#x201d;). Vettons is a related party since Mr. How Kok
Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001272"
          xlink:to="Footnote001287"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001274"
          xlink:label="Fact001274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001274"
          xlink:to="Footnote001287"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001276"
          xlink:label="Fact001276"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001276"
          xlink:to="Footnote001287"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001278"
          xlink:label="Fact001278"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001278"
          xlink:to="Footnote001287"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001280"
          xlink:label="Fact001280"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001280"
          xlink:to="Footnote001287"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1282"
          xlink:label="xdx2ixbrl1282"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1282"
          xlink:to="Footnote001287"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001489"
          xlink:label="Fact001489"
          xlink:type="locator"/>
        <link:footnote id="Footnote001494" xlink:label="Footnote001494" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#160;The
    amount comprised: <xhtml:span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zkx8Ftrs7L89" title="Non-deductible tax rate">6.2</xhtml:span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and <xhtml:span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_z7zr0BljaQM3" title="Non-deductible tax rate">6.7</xhtml:span>%
    being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001489"
          xlink:to="Footnote001494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001490"
          xlink:label="Fact001490"
          xlink:type="locator"/>
        <link:footnote id="Footnote001503" xlink:label="Footnote001503" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount comprised: <xhtml:span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231_zv1NMsh9HgPd">10.2%
being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; </xhtml:span></xhtml:span><xhtml:span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zyI1Oi1dqqbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Non-deductible tax rate">0.2%
being income derived in AATP HK that were not taxable in the Malaysia tax returns; and </xhtml:span> <xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><xhtml:span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zAbCSjiqlxJf" title="Non-deductible tax rate">1.3</xhtml:span>%
being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001490"
          xlink:to="Footnote001503"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>111
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MWPA1H)_;),UO>YNBV'T>#/)H([8\OY8[D<(W:YEM>0&WV?,@WV6"KZI!VV1
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MO(E3-8V+(H-O8QA7W(UDFLLD7O%"K-!7GO T$FBAU.7H"GU?W*-?/OWM9E#
MH]2 0=2H_5JK)1UJ[T5TC2CN(^(0;!@^NGRX<SQ\  [NO21[+TFECW9Y^7T^
M'T^7:+A8C)<+BT*Z5T@KA:Q+(<\WB*<K%*D+\4<9O_!$I!"T7R9IE)0KB.8G
M[/=92"NQ3]3OT\!'<8J*C4#18=1_GXSA0UZ KA0]"53F\*%,DS=42)2+HD@$
MDD])_,S5PL^17)MU\.HK")W8/HEL'_WJ^2J.?=AV^4Y4^R9YNS;.:NVU6WFM
M,L#+'7%#/V#!S>#E</IT.>IBWW.<O=Q16-D^K,P:UF$4R5)%,0,O(*1/B3!9
M:56B$M_G?,<C<=N#S):+[$7T[I!I$=9ZO ,OL$]\US<[X>Z=<.U.;)4/:%4*
MM,[D%GQ)JCG:\:R(16YRR-4,\1V'G<1<%Z*$NF9;O;VMGM762?H"JU9F'79Y
M^B-]USUX:&V9+N8&88"9V39_;YMOM>TQ$SL>KU#!?XKC?=6GKE]O*PS7U/F_
MWU:^%B"/>@2?[BI=#&.'L;!CDH-]((/S@7S;5NE)6;T2.YG'A7'& \T$$KJP
MM4\L-8EYU._8_N'>T-!JZ%(6/$&C,LO 5C3,89:,1H;ZL@PQP82<6*G+N5[
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M(Y<ZLHQF+I?(05/GP>MP1DTW4,TWBXP?&M+D7UXU;FBZ2K(UN$C+6G#-SPZ
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MDF>N4OMD\:#E57N_NF'TI>R0/U'&Z+:\W)!X17(AP-\_4\K>;\0$AX\LP_\
M4$L#!!0    ( "1W?%2,&>J9E04  )@9   8    >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&ULM5EMC^(V$/XK%JK4J[0<L?.^8I%V"="5>G>KI==^J/K!2PRX
ME\2<[2RW_[YVR ;(BW=1TR^0D)EGQO-,QC-FO&?\F]@2(L&/-,G$S6 KY>YZ
M-!*K+4FQ^,AV)%-/UHRG6*I;OAF)'2<X+I329(0LRQNEF&:#R;CX[8%/QBR7
M"<W( P<B3U/,7^Y(PO8W SAX_>&1;K92_S":C'=X0Y9$?MT]<'4WJE!BFI),
M4)8!3M8W@UMXO8">5B@D_J!D+TZN@5[*$V/?],U]?#.PM$<D(2NI(;#Z>B93
MDB0:2?GQO00=5#:UXNGU*_J\6+Q:S!,69,J2/VDLMS>#8 !BLL9Y(A_9_E=2
M+LC5>"N6B.(3[$M9:P!6N9 L+965!RG-#M_X1QF($P6$.A10J8!J"K;7H6"7
M"G;=@M^AX)0*3MU"EX);*KAU!;M#P2L5O)H"[%+P2P6_(.L0W8*:"$L\&7.V
M!UQ+*S1]4?!;:"M&:*93<2FY>DJ5GIQ,62980F,L20R64GVI/),"L#68;G&V
M(0+03#U@JV];EL2$BY_!['M.Y0L8@J_+"'SXZ9?Q2"I/--YH55J].UA%G5;3
ME)6PX*]/)'TB_.\6F*D9YC:.J4YHG( '3..A\G2*=U2J>P-H9 9])%*]P2H:
M,\PSFFV$"6OVAH-?IO?@5DI.GW*)GQ(")%.N<A5B$^K<C/J992N62<X2]60#
M[C-).!%&Q(49\7>F8G:N-E*)5&43JK()%3A.!\X=V=!,!TV5AP1G*W(%GG&2
M$X EB,CJ([#A%4 6#-M2Y@#M%M"Z@CY/;-]#P7CT?)H132D7A;85H'.YJ"DW
MA%80(BL\%YPU!4,_<,^%YL9EZ^WB6NSPBMP,U'X@"'\F@PEHHZ%IS$$N1(%7
MV3N+NUW%W3;&?;E5.26NP)=<"HFS6#%P!8YDW!W(>!<+!T->C07?=2VKW4>G
M\M$Q^OA9[:M4)6Y*P(>$"=%:-HP0[X_SM"><R&E&PW5\SZOE4$_FYCWA+-YT
M^XQ!MV+0-3)X+T1>Y)':'%:'"BZ*"J[JKBI(6=E=[*G<JA9#;1*BJ,Y:_':#
M=P0L\QWAE''P&WW6>;F,,W"WC=L2P6V\*-"O50*WL4@('=^UG5HE,"[J_4&=
M]80S[PEGT;%^%[:S[%4L>^9:4E"JN59[8)1S3=2#IBV^ J]UYK-J,0L)T<:=
MUW3,]U3^M?OE5W[Y1K]4YZGZ2I5I.5?[Y^H%2(XSD>!#1QO_HWHEW;JT.60$
MOJ"J](03]80S\UL"#9$-:YM73^86;YH[XS6H> V,O,Z*[<K<,""KC=:@K6%P
M:EOW-&AX[3F.Y<%:#8^:<D/?=AS'KM7ZIAP,H%6'FQL7?4'0F^;<$#G!294[
MBWI813V\O&,HJ6AO%]HY"-O:!<=%5M?K#JWC9&+]]X;!C''!N]T74%0"G242
M<I&#G-K&-.O+Y+S-I&/7,G+1Y9@7='1V\&2(A/]7;38C7T)@3T!17T"S$N@L
MX('OP=I(,V^1L^O<=4"Y'<P=!S9HGM@4<VM"9<X;75TK62U35>"&M9%J6HJ=
M>MN4BLR>71+GGH#F?0$M>@ ZY_,X",+W3()E^W9LV(KOH3ZSB\$#?M$O([CE
M7!_PZ.LK4.8!:6W&87,H+&A'5M=0"(]3(32/A5-]DJ&/1U2I$&#-60HRE@U/
M#SCHZP&'T*LHCZ%:_>QK?.P+*.H+:-87T!PV9\/0KU<;H\PYT<?A$9JGQW?U
M>;"5UN8PB$++\>I5IRFF.KT00;=>>)J"0QNY@1?X]1VZ*1G:=M@HX&V S?VW
M*67;$'EVQU@.CQ,;?&-DN[R9:P]T<W(K FTUN[G1R9&S_L_B$^8;JE[@A*R5
MKO715\ODA[\!#C>2[8I3Z"<F)4N+RRW!ZDW6 NKYFC'Y>J,/MJL_8R;_ E!+
M P04    "  D=WQ44Q229:X(   S)0  &    'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;*U:W7+B.!-]%16U%TG5,E@__DLEJ6((V:$J@7PAF?UN'5N =XS%
MVH8D^_3;,@X&6U)@=FX2V[2DTZWN/MVR+U]%]B-?<%Z@MV62YE>=15&L+GJ]
M/%SP99!_$2N>PB\SD2V# FZS>2]?93R(RD'+I$<LR^DM@SCM7%^6SQZRZTNQ
M+I(XY0\9RM?+99"]?^6)>+WJX,['@\=XOBCD@][UY2J8\RDOGE</&=SU=K-$
M\9*G>2Q2E/'95:>/+P;,DP-*B>\Q?\WWKI%4Y46('_)F%%UU+(F()SPLY!0!
M_-OP 4\2.1/@^+N:M+-;4P[<O_Z8_;94'I1Y"7(^$,F?<50LKCI>!T5\%JR3
MXE&\?N.50K:<+Q1)7OY%KY6LU4'A.B_$LAH,")9QNOT?O%6&V!N '<T 4@T@
MS0%,,X!6 VBIZ!99J=9-4 37EYEX19F4AMGD16F;<C1H$Z=R&Z=%!K_&,*ZX
M'H@T%TD<!06/T+2 ?[!'18[$# V"?(%N89]SU$7/TQMT]MOY9:^ 1>707E@M
M\'6[ -$L@ FZ%VFQR-$PC7AT.$$/T.X@DP_(7XEQQAL>?D$4_XZ(1; "T.#X
MX98!#MU9D);S49T%^]-OZ/9N\N<4W3Y.[M'D8?C8?QJ-_T#]P=/H^^AI-)Q>
M&-9ANW58N0[3K#.&F#Y+1)Z?HS@-Q9*K]F([A5U.(2-X<]TE-F&.!YIN]FW4
M%J0V<QUG)W: T=YAM(VVZ$=_@<MN/:@0$.:A2,,XX2AM@I<_RX>A=+)U#LX7
MIPB24Q84<3K?1G=<Q#PWF<[9P7*,IKOAD.+".)")0V6U[6AGSQBN[?INPV1M
M*=MFEJNVF+N#YAJA]9<B*^)_M-#<UJ+8=W #F4+(MFPU,&\'S#L:F,P&]=YD
M,C-VQ:P+VX:"/.=%KD+NM4%1G]E-[ HQR['W5#Q [^_0^T;TSREP6A+_ WZU
M$$DD84OO0V=S8+9S!"H!:?W@1? "SIGS<)V5SJ;2PV]ONV43VM2C+=:EMH6I
MQC^P52=HR^R\$ @13Z./P)EE8GD\^FKR US8\ZG?@*^4<Z 6(!K\>P2#/PF^
M&<\RV(@B>$/\#>J/7)FZJFD./0&39A2JQ%R/$E^#D]0XB1'G*-U WA+9.WH%
M<_)N)%Z5$5E-LP^ .H0U_<&\FJS.+O)5$/*K#N2FG&<;WKE&AER':S["U*C(
M0R8V<5EF096'(K%^*6;K!%)J*-:I.E:K&0^,2K"-65,IX\H_H51-?IB96781
MI'.>-UBB3#XH@.!(XN E3CYE#%PS&;;-^:\RER0Q'F]DJ*E-9[=-Y[CV'I-6
MIFO+08"!B76.6Y,;-K,;9&H BJ)UE1L"@)R4]=PJR(IW)6CCC$?M8Z55FQ2[
M$ NZI%>S(C;3XD<PZK*:BA:)BVG3Z&TYUW-<IH%7<R,VD^-#QE=!7*8T#< V
MK3%ZD$TK@ KZ\YCO:<@;U_R'S018(GS?5F(R/B*^$GFLB7X%=V'B4:=ESK8@
MM8GM:K:;U!Q'S!RW"S; +"--A=(\Q0D^2Q141SQ+XQ2D)CIB)KI!V:WQS&AK
MTJ8OF_A>DST48EW,"/8\385.:IXC9IZ;% O 6!EZZQQ #=F:'R11)?8V\Q'B
M.*V23B%'J>-:FDQ':F8C9F:;[#)_PJ%U_Q1OF]6ZF'J8-?U:*6C9EA9Q35O$
MW+2-JF8'2I\/BRN1LK;%?,]KPC2N=3K[DIH,B9D,Q\=T:DK%%*SG,=MCS42H
M$K2A";,UC0"IZ9$X)_7GH_'WX?2$_IS4I$7,I/6PSL*%]$MHE_C?ZW@ETZ_2
M*FU:ZE+?;M;D*C'F4EVBJMF+?,)>>SCCM(#"*I:-A+Z5,\]W2NIMTUT7JG>-
M0C79$3/9E2=5,I&5/BI-OPD2L#TX)UR7O<<B$^OY8OL <G/5U/;GP8JCZ1J\
M.89:^0X\&5QZ&J7HZR)26L((Y!1+M*D4*F[+PQICT)I+J9E+H?P/.8_R;3&8
M@R&DID<WC.;93]"0MFD6$TTTTYIDJ9EDU=JE(NTJ-93'3$?4P^9%3U&ZS=NN
MA5VJ4;LF;6HF[5T"/JLR\#E:R38O@IN7=[C?\/R(=$S;S*Q*/ HQ:,0=8ED:
M/?;.2D\[++T=C?OCP?')F-;,2\W,NSMV$#.XD*8)1:Y.;[3-OEUL0S0VS:*0
M(\R'"EACEII?J9E?S_K1)DC#TE_/T6-=NI=>ON^^NHU5T"?U6I690HP0E^DH
MA=8D2\T]:*M F,4I*'2$1RH:2.Q;K2-.E1PAEJ]+*#5I4S-I#V]OAX,G-+E%
MP_\/OO7'?PS18_]IB"9C5#IK?WRSO1C^[WGTO7\W'#]-E8HHR-JV/+_E1(J6
MU-$V?+0F=6HF];.;X>!QV)\.SZ'"V5[!Q8DZ*.C9Q[YK-ZLUA:#KTOW"^E"+
MFLGI)TRN@_L[>N'S.$VE1T'"?^=!IM1 U:%BU[%:V] 6A$!@S-;TLJSF7V;F
M7X,*\A37 )ZU&9/8ONNQ9B.@$&QJ>0B^IE>&C?EY^OSP<#>\![C].[27K$?C
MV\GC??]I-!F;7F75?,8^.VS]Z(NX;/IC9;'%%'TD<3S:,H>B+_4\7W<DS&JV
M8N9^<Y06'/B^T"/\[^>AE0J_^&"5[;U5-!^L'NSX>#+NGK[K-<TQ,\WM'>(J
M7B)MSW&;C7UYK@E5W/:'I8CB61R6;Z64?,+:#$>)W7K[:<3Y$^:NB9*9B7*4
M@E9!4KX:G:>[1N1H<RAU_E6GN:Q-LLRC5)?664VRS$RRTY^HTZ67\+>P=)GR
M3<9^[U852&4/-[U3&L6(Z!2CM G;L1TH^S1&J1F;F1E[E.=K6?1))2 ;+D&M
MO!#AC_^J^*]JUJN)]K\1P)BY=NM(IK?W^<F29_/RJYP<E4>ZV\\Z=D]W7_[T
MR^]=&L^_XHO!]ON=>IKMYT3W00;LGT,\S&!*ZXL+J++M%SK;FT*LRH]<7D11
MB&5YN>!!Q#,I +_/A"@^;N0"N^^DKO\%4$L#!!0    ( "1W?%1/\M:ID H
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MX#8,. PF%RFM /16SM&1Q!26*2.IE.ZJ6"MF'3%6RQT_=/<$*WOIH/^*$;^
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MW$_UE1:_\'K;>SQ8&U#07.DZ1Z%$S:1JV6UV.AWZ>W3[\Z_5]M^QJ3"(6$C
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MML&T^^SE;G*5V4]-,Y6#&MI+6!$I@R;@^5RAF)0WM$'][?'D?U!+ P04
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M%!"<I$R4^'F>E#,XD+I@:85(!83BTOL&N3,G!,G?X=95Y]9QGGWP%>;!9+5
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MG?A]?@?H#8S%[D!F<F4XH)T*QW8-6D1]= I12!G8?,"K7:2KSNERX=:0MA;
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M8]9])!:!U5@S?0=++9/*M<[^_/N=-6& /<B7=Y\;[;2?09A7CI_'F7]6\.4
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M#<K\W,#3FTD4@/V5  JI/]# Z3%__Q=02P,$%     @ )'=\5  S(][B @
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MFFHZ6W>"-.4E4U+/UZ%!<*819]!H^Q?MJ[834#VWA*4(>@- QLN%6I;4(8?
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MU3M>.F<OG<I+Y_]-[KN@IDMO5!DG.+"I#17* ]I#QEK6![Q9C>P*YMQZB%^
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M\'$\6DW','^ 7W-Q3.U- P(G58[8 C:%56NL(S;FZG(AQ98I,[BTA"W#VMY
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M?B:- =YOA="O!Q/@\E_2_Q]02P,$%     @ )'=\5'36.<B=!0  W0\  !D
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M@<4SLZ\QWK^9-!MP_58(70V,@?I&?_8O4$L#!!0    ( "1W?%0HQ.[]B@,
M ,8'   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;*U5;6_C-@S^GE]!
M>,-P XSX)<Y;+PF0ICVTZQ77-;T-P[ /BLW86FTI)\G-Y=^/DA,G-RS!,.R#
M+4HB'SXD)6JRE>I5%X@&OE:ET%.O,&9S%00Z+;!BNBLW*&AG+57%#$U5'NB-
M0I8YHZH,XC <!!7CPIM-W-J3FDUD;4HN\$F!KJN*J=TUEG([]2+OL/#,\\+8
MA6 VV; <EV@^;YX4S8(6)>,5"LVE (7KJ3>/KJX3J^\4?N&XU2<RV$A64K[:
MR7TV]4)+"$M,C45@-+SA LO2 A&-+WM,KW5I#4_E _H'%SO%LF(:%[+\E6>F
MF'HC#S)<L[HTSW)[A_MX^A8OE:5V?]@VNC%Y3&MM9+4WIGG%13.RK_L\G!B,
MPC,&\=X@=KP;1X[E#3-L-E%R"\IJ$YH57*C.FLAQ88NR-(IV.=F9V?+ET^+A
M[M/'F]OGY0_?C>)H^!YN?_Y\__+;)#"$;[6"=(]UW6#%9["B&!ZE,(6&6Y%A
M]BU 0,1:=O&!W75\$?$&TR[T(A_B,(XNX/7::'L.KW<&[_9+S<T.?I^OM%%T
M(/ZX@)FTF(G#3/Z7#%[$LC?P2F]8BE./KIA&]8;>+.IW.^>=P!,=8U0*LPX=
MEO05YKHCUT"9PVJ%JLT>,)%9(?3!%*@0MO9'=]</FP^$% @+6552_!>HZ #D
MP.)QZ"<#DI,A](8#/^G'3KX7G4>V.UI;AQLF=L"UKC&#:!#[@W%B]7ZJ!>X5
MY\N/=.@SA!25H4X#+/N3[@8U!Z/!2. T/#*5%@>.(:RY8"+EK 1MF$&GVJ6(
M@%$OT71G&_>"^A[3&@D@94KMN,CAC94U A<I=3E->5WMX'L8VUAZ$/7\4;\=
MB&6;'9N9;Q*B"T9_ZIMKY*8FD>4*&R+PSOJVA8S#][!TBA^.BO.CXG[5TG)J
MA2PS5!J2R!_V7:H[SH\&JE3JB@=-\6A^DE_?%>T=YS]V[.HYV()E#<W,IO7(
MW0>;])QV<DJF#TGBQTG\[]UW*55I65-7Z!"0I4$%ARCZ.\K>([E?*UG!W<,"
M[H@:\=2PS$07KHO,[S#KJCDU K8%I[H_JBYI;N%!OL*BD%+D/HSZ_GA\B607
M7FRY.JY<0L(_=8/@I+=6J'+W@M!AD;4P39MM5]M':M[TYJ-Z\\+1"<VYT%#B
MFDS#[K#O@6I>C69BY,9UZI4TU/>=6-!#B\HJT/Y:2G.86 ?MTSW["U!+ P04
M    "  D=WQ4+FY <"L#  !L!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6RM55%OVD@0?O>O&/FJ4R*5& Q-4@)(#C@I$C$(.ZU.IWM8S(!7M7?=
MW75(_OW-VD!IE>2I+_;NSLPWWS?C'0]V4GW7&:*!YR(7>NAFQI1]S]-IA@73
M%[)$09:-5 4SM%5;3Y<*V;H.*G+/;[<OO8)QX8X&]=E"C0:R,CD7N%"@JZ)@
MZN46<[D;NAWW<+#DV\S8 V\T*-D68S2/Y4+1SCNBK'F!0G,I0.%FZ :=_FW/
M^M<.7SGN],D:K)*5E-_M9KH>NFU+"'-,C45@]'K",>:Y!2(:/_:8[C&E#3Q=
M']#O:NVD9<4TCF7^C:]--G2O75CCAE6Y6<K=%]SK^63Q4IGK^@F[QK?[R86T
MTD86^V!B4'#1O-GSO@XG =?M-P+\?8!?\VX2U2PGS+#10,D=*.M-:'912ZVC
MB1P7MBFQ463E%&=&T3QJC>=1LIS/9M/H'J91$B[#.!EXAM"MCY?ND6X;)/\-
MI(X/#U*83$,HUKC^%< C6D=N_H';K?\NX@33"^AV/H+?]COOX'6/6KLU7O<M
MK5*DQ%#)G"Q;F J#"K6!?X.5-HJ^C__>2=([)NG527I_H*#O(MGKV-<E2W'H
MTGW3J)[0'74N+YRW4D"2H3.61<G$R]]_7?N=JQL-0HK6J6I^4$V'FFNC06[
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ME31S_0+U9Z)?9-S#=+_,-Y>)IU!L;#"3W*"#J*L5O$!/>C4RM&#2K #HHMU
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MKU#ESFY!53:)DS"P,T!5!I@[U"X?13+W/FSM@V)W8BVVY)7DA/S[>UHV)F&
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MN_OAX.XJN/SVVP?N RO<II%*=!FDC=>'^%*LK4MH=WN(M85'NY[JA0ZM#>C
M5= [NR+X,05*@O1*6:/KKK=6/L-3DU6M$GA[Z0;?WWH=H926X0WH1%!Z_5!J
M9]MGYJ1^73TMK]^H5](NT71%3@ML'?0.\:JS];NO_N%-&=Y:<^-1MV&8011D
M>0&^+PRZ<_.#';2/[]/_ 5!+ P04    "  D=WQ4<T.G_&8-  "7'@  &0
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M216$,6\U]W4.@*5*0TA596TL6DO1UG!RN3<V5J.%3#LFJ];&/8,> +*,_E1
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MQ\1)H#Y:( $)WR..D. ]--(,::G@\^4!\CF'RN&F XRCXKS0*5/G-!-SWXK
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M!YBO\MS2/I  *2N.6Z5D/A*2V5N0&3R:<9K\BQ@( M9H/EIL6A9E=0#4R'^
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M98A(6\4Z,RL^!('R0I)0\DG0QE>8_T]OLU6.R?F4\\<9C1BZRC,"8.)3F=&
MK,GU;=]J1(S0]VEFN*<'=$5@8.B**>[)DZFLKAXX0Y]DHB_Q"9'DKW82X"QO
MZ-87K2I- /=V%>G2Z#1.;>XT)[]02&UFJD<,UI+5X13'YJEB)Z!D\;;HI%_)
M\'D:H_Y$C0L)E?<'3;XC3\,.K)S3??<;GQ1CT\=<P 0.HXWBD[M>PH,:8VN%
M3W83Q=K!KLXH2QMU[1RSFX%J=G8HQB<J^0M%JC=S0'9;8))$RS'1D8??I5I*
MWIM]DWD$N;W[<>4CU:/^4/7M[@2=V/J.F+4,K<*U-[QJBYS*"H):C2F8X(L8
MX[!?V*%OD_M!T7#%!*!P'!X,SR)MUTZLXP+34..Y]0Q<.$2_/)]>Z#O2.(Z'
MQUP; )@L,#E3,K[1&C5%NK7N["ZHTR$"'*+*$WM]R&Z&$W7ES!ZX$8A7!$8%
MOD()^$L.PU.LGMS,-J)%3-0M/LD"'B^#4=)BZ5RTJ*8XQ^-NV0";PJ7P',KR
M39G^B!L;J:B0P)^$S(AGMO<G%NZ6,WYC3L0+](L@Y=B&QMI>4 N6\IZXW,R$
M1R+&A').4D>9GK#D8S<=?(B\ST*B[UQ-8:&HFU 4(-/&8P?1[KB46U8%"L&:
M,_Q;"]/-A5GYW!Z)3CJLZ-[$:<4Y@X\@[ZU.)=D(> J0CEP^;^#6B$$Z/H)B
M\6 .0,9N]#I?F+1)7D5(]W9G#BL\_LX(P5PBOFR!RDO0L!QNA:IH),^6["01
M:W^-I_=1@(\BT&"1Z'*>*-Q9X&(4/(Z8 >L=@BX-?8?,.8^]\E4!Y(*QP4?^
MKNF]$Q<3@JX )+E L\[G(* CUNKP7*.,5ZVE:5J:*U8RI!JCJO#LO5ME:Q>)
M1,LO49<K7S5.7 ECE4M,\MD/Y5:8PD9XEJ)=AFCT9T [^>2>X*C>.JDD&1IC
MR&0BT'ZI(L%J$9@^2!I8X+CE>+A"Q$HHI>T-<S/=<WX/9AYRE<6,W:X22PKQ
M'&(4)I=',>,,\R)<Z'F@SW\Y_WRISN\^ZXN;V\\WM^=W5S?7^OKF[G*J[F[@
MR^OIS<>K]^2E_W!U?7Y]<77^44_OX L,_4WURPO2T>98K(6LNF0H- O=WL.,
MF/S@JMRF/UB1%%$2T(9U\JPFGQFN^!Y  5@=#]2?*<R$]=X)0WG_2D]CJ4CZ
MU;.4?[19BCY0G_>0HB6C3C864@]:N^A&9R5*TNV)Q7".Y[PI8$E]='**OG)O
MS0QEC'L.VF;82!(=+%*Y_5"-E;!PR00+)]1-%N;8K\1JT6"ZEVBMS$8B@CFC
M/7FBD%%B%7J/@^*-A;**H*U*Q"H;GWH (WT.E[H"R&6@7NA%O"TE'U+J<@HG
M8KVWSQ5&6(MQH']U>:SIUB4EP#]@=X1LC%%A!^^(4J)U65I%M0TV7AH9740,
M@;;+'"Y(M@@*-UI*+YH-&54N;OW3JOFTL"#2B$._Q"Y3I30P,9,]>AN)UF5C
M)#Q8,27QDB*'F['N5,6A@C#J;06R75=;M <TY71Y5$;3QFY8>;)FP.Z"FO2L
M=D1^Q[ZI3I)4,$FA#LLR22@YM]%N60JOBK)S8X1_LD#+DWU=!*#DF^($?&?A
M[CJ8+387@ "4A))>U]@X)P;!<)+/_[2M"HA?&@K\V\HR*1*PAE#925[L%J@<
M#WEFQF0SD:>1S2D8_D&/CJ+Q\$R/3H;1X62DSXF;[N9>-@:XCQ<!P_/>&*D_
M[5/O1%LG6R+'Z4\GT>GHN)^1.[WUOX"1<ZD(K+.NZ/2'TF)5Q&M;>]Q%%0T&
M/ .S*+6!#]ER.2^,R6AS1K)68OO;/%YOE$S"E+O_I>#$X&MV;9(0XA/(8X0-
ME=#MU;9X*AA@3576E'Z!$>%"57N7P YBMY(8,^;8%!?)$JZ-4A-D$<#SK&[#
M"8=!P@FF55I' [M@YI4/[5KT2/YEL"^'?,HDH:5;2_3)U9-((@_.0@KBW<%R
M!QPM(-J@:NVL&3S^;U< 2 # ^A6OW^):?*!B,M+V=R5^H]@/Z0/X/*N)I7$2
M!@BDW%&*62HZ[/V/[++C0%"*H=]LXDNW4]0:6E*$Z&Z@_BP/;&ZHBTLY6D/8
M_Z!/HJ/#B1[^M57H]TD9KU8%.IU!LPO[4(25I;-MP/U"5T)?FN'[J^G!^2^_
MW%[^0J"YNOYP<_N)@0>_WE[^=GG]!4!(:$(4(495'T:#1Z<U+. !P#&EKC>
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MNDMAJ&#Z8SP#CN7B7*Q*X>5=-GT> ?:G["^PY<'LI 16U85JMDF)A\H=$FV
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M=L"W PJEY;G6%;*,?#< >D_-64&%P]HB*;)#2M[1MXK?&$UNB[;!H^^M+CC
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M_=+(FTE#_5#\CX#ZWK@H;"TTK-B+O67@2A%? !<&52&;%1,O%N,\R).,!,I
MMWONW5'EU,ZH+1@K"K7&TCM,6!QTLAY]SZ/L!YJ'6@[5YI4$E]:?2"K8CFIG
M.O^*)=![H>B64'?1C:'9J%]MK^_;R*,)ZUF=%V1* ]H9\5:9[G;XGL(O*-:.
M]CM;GZQ+X>7>[TIJ2J.2"\?9'F5!EB7>![N_4++9<:1+;@-)*"W=;AM4' 5Y
M)]EV4VT-K$+^32')@BC.X/2U"QX>S.$&U=*]-AI<8=N1O-_=/VCC=HY_4V]?
MPX],+3G1JW%!IM%9WO%!M2],NS!RY:;Z7!IZ(YQ8T:.,RBK0^4)*LUM8!_MG
M?O0O4$L#!!0    ( "1W?%33<1YB( 4  /(*   9    >&PO=V]R:W-H965T
M<R]S:&5E=#,Q+GAM;(U66W/B-A1^UZ_0T$PG.Z,&WS!FFS#C -LP$T(*9'=V
M.GT0ML":VA8KR9#TU_=(-BQL">U+8IW[^<Z%<[L3\B^5,:;Q:Y&7ZJZ5:;WY
MV&ZK)&,%53=BPTK@K(0LJ(:G7+?51C*:6J4B;WN.$[8+RLM6_];2GF7_5E0Z
MYR5[EEA514'EVSW+Q>ZNY;;VA!E?9]H0VOW;#5VS.=,OFV<)K_;!2LH+5BHN
M2BS9ZJX5NQ_O.T;>"GSF;*>.OK')9"G$7^8Q3N]:C@F(Y2S1Q@*%?ULV8'EN
M#$$8WQJ;K8-+HWC\O;?^R>8.N2RI8@.1?^&ISNY:40NG;$6K7,_$[H$U^=@
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M/S,X2IDT L!?":'W#^/@<.;V_P%02P,$%     @ )'=\5(!J/ 9F @  (@4
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M!,A7T0+K!Y*V.PP[*#9M"Y4E3U*2]M]/DA,O!9I<;%(B'Q]I/@]W4KWJ$M'
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MEU<] JJ14^,86?L57DMC!>'-TOZ!4+D >Y]+:0Z.*]#^T\;_ %!+ P04
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M8*.R ;2?2VF.CB7H_P(6_P-02P,$%     @ )'=\5)M.1^VD @  =04  !D
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MTOFH^<[%N.4H=N52D1#Q/5/5Y-6O]=X:5^/Z;EXM/?W#[2B3D&&BH6ZKU[%
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M4WQZ,FDVX/J=$+H>& /-8_;\/U!+ P04    "  D=WQ4>B=S(KT"  #$!0
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M9*G4DQ/N5EV_Z@BAP-@Z!$:_9QR@$ Z(:/S98_I'E\[P]'Q OREBIUB6S.!
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MM&Y1.P5Z3Y2R!\$Y."[PWE]02P,$%     @ )'=\5,Z*4&/N!0  _AP  !D
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MZ 8:+5"!P>CE2;'D!>-(IZV#X&E#\-2)^Y2A& -$$Y @B0&; T+C?2541-V
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MM;)T;[NC;BM!@=;WH,?W#A<4#^*6H%1+A[[1D[Z+KC4RZ#&R0_7$@P?_JXY
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M!?7_G#&YN=$%-$>>5_\"4$L#!!0    ( "1W?%1U E9X] (   8)   9
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MN5Z@YM>,R=>.?MG*3Y_>;U!+ P04    "  D=WQ4]0Z,J",#  #%#   &0
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MD?G.0&D7F/FE$'K;L03EETOW-U!+ P04    "  D=WQ4I[&SHU0"   4!0
M&0   'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q]5-UOVC 0_U=.>=JDKH%0
MVJD")#["B@1=U4#W4.W!)!=BU1^9[33M?S_;@91IA9?$9]_OXY([#VJI7G2!
M:."-,Z&'06%,>1N&.BV0$WTI2Q3V))>*$V-#M0MUJ9!D'L19&'4ZUR$G5 2C
M@=][4*.!K RC A\4Z(ISHMXGR&0]#+K!8>.1[@KC-L+1H"0[3-!LR@=EH[!E
MR2A'H:D4H# ?!N/N[:3O\GW"$\5:'ZW!5;*5\L4%BVP8=)PA9)@:QT#LZQ6G
MR)@CLC;^[#F#5M(!C]<']KFOW=:R)1JGDOVBF2F&P?< ,LQ)Q<RCK.]P7X\W
MF$JF_1/J)O?&*J:5-I+OP3;F5#1O\K;_#D> [O4)0+0'1-YW(^1=SH@AHX&2
M-2B7;=G<PI?JT=8<%>ZG)$;94VIQ9I1,[^+99AG#SSG$R7JQ&J_C&6R2>+Y9
MPG+Q%"?N9'&_'M__6$QLWCA)XG5R ??Q&K[,T!#*]-=!:*P7QQBF>]U)HQN=
MT.U&L)+"%!IBD6'V+T%HBV@KB0Z53**SC#-,+Z'7O8"H$W7/\/7:+]/S?%<G
M^*:2EY5!!8G,34T47L!"&")V=,L0QEK;B7E>(=^B^GU&[JJ5N_)RO1-R<RJH
MP6]+VZ/9?T(:GI<V'Q8&N3ZGUF_5^F>+B[6AMJ6M5*4QKQ@PJZM!YD _I(F7
M_NS?GB?OPSL2I3^S&1YU*D>U\_.H(965,$W3MKOMR(^;3O](;^Z+%5$[*C0P
MS"VT<WEC3:EF!IO R-+W_58:.T5^6=AK"Y5+L.>YE.80.('V(AS]!5!+ P04
M    "  D=WQ4YJE44%,%   $&@  &0   'AL+W=O<FMS:&5E=',O<VAE970T
M."YX;6RUF=ENVS@4AE^%,.:B!::QN&@+' /QDM9 G01QTV)0S 5C,[90270I
MVDGGZ8>4%5'55@&&;F(M9^'Y(OWB(4<O7/Q(=HQ)\!J%<7(UV$FYOQP.D_6.
M132YX'L6JSO/7$14JE.Q'29[P>@F=8K"(;(L9QC1(!Z,1^FU>S$>\8,,@YC=
M"Y <HHB*7Q,6\I>K 1R\77@(MCNI+PS'HSW=LA63C_M[H<Z&>91-$+$X"7@,
M!'N^&ES#RRGQM4-J\35@+TGA&.A2GCC_H4\6FZN!I4?$0K:6.@15/T<V96&H
M(ZEQ_,R"#O*<VK%X_!;])BU>%?-$$S;EX;=@(W=7 V\ -NR9'D+YP%\^L:P@
M6\=;\S!)_X*7DZVK,JX/B>11YJS.HR ^_=+7#$3! 3H-#BAS0&4'TN" ,P><
M%GH:65K6C$HZ'@G^ H2V5M'T0<HF]5;5!+'^-ZZD4'<#Y2?'J^FG^>SQ\QS<
MW8#98O7A^N/'A_G'ZR_S&5C<WMP]+*^_+.YN]=V'^=?Y[>-\!=[-F*1!F+P'
M'\#C:@;>_?5^-)1J+#KB<)WEG9SRHH:\$($EC^4N ?-XPS:_!QBJ(O)*T%LE
M$]0:<<;6%P##OP&R$*P9T+2[N]4R')R#Q6D\W!#O7O#-82W!(CZ]:_J9_?Y9
M&8&%9%'R;TL*DJ<@:0K2D.(+ES14[]*1Q0>6U/T/3OYVZJ]?Z.,86M#Q'30:
M'HMHJG:8V,C1'(\U [3S =JM UP=Q#$X<@%6Z6L+OB]9],1$6^U.'MKI"Z^;
MIW#/Q'OR=PK8/.Q;I 2W:@6)[_EN/5LO'YW7.KIYS,0V^(]MP%+=$6JD4QZO
M62P%E:P+:3]/Y/=%&EI&A:PS66<!BAAM9!&W!+O&S(/$:WB084$F8>L %SQ.
M84]I^&%)MUT 0V2"H]X0&SV"^%S$N,(.^S:J(*Z:^9;G.Z2!L9$SV*YG=Q';
M4C )6;SIQ-?($+1[XVL$"3KG\G4JX!!"+O3*@*MVQ+=MIT$QH!$TV*YH$_7A
M!DOZ^MH)KU$BZ/6&UZ@0],_%ZU?Q6IY%<!EOU0[:CFU;]7B1$3'4+F)?V9:!
M&W$()+@)%-TNE)%1( 3[HHR,$B%T)N4L0)&>8[MV621JS*!KVPV(C8BA=A%;
M"%UU!ZQ&=!#I#:L1(-0^$>J U:X^O!Z$Y;E$C1G$&'M^ UBC7JA=O?[AAW@+
M=&=T"&DGPD9UD-L;8:-!J'TZU(&P5S.!(,@N$ZZ:.39V<,,, AD!0^T"=B>V
M- [60)&6.S6/$ Q,0T950ZS 3V@GM<!&B[#5%W1L) FW3XK^##T+\!MTB,MB
M46-%,$0-WSMLU RWJ]DRD%S/D3NA+31VO75VV,@2/K>WRP+\)@4>]BRK#+?&
MSD&>U?! 8R-JN%W4;OD%@& YGW7":Y0(]];98:-)^-S>#M>T;38NR$!&MVI&
M'!?B!KA&SW"']H[)X.>AV]-K9 CWULX1HS[DW':.5/LT9-MN^7M7:X:Q[]3S
M)4:ZR!^D2P01N \/21>ZQ"@.Z:V3(T: R+F='*FV:,BU2&79IZ;A4Q^[IIDP
M*2Q,M:O7&X8N;(W>D-ZZ.&+4AYS;Q9%J=P8MRR?0+].M&K:NJA&C7J1=O3XQ
M&JHYQ+7JD[^Q,(Q9DH 5$\=@S;H]ST:&2&^M'3&21,YM[;( Q05*UZXT=NUI
M](;(9;*G:W8UV N6*%YL, 9U%0P+Z^F1UF&]S9" M9HCR]."='XUW\JX3A?P
M2]<G\')ZVI P84[[(TLJMD&<@) ]JY#6A:MJ$Z<MA].)Y/MTU?Z)2\FC]'#'
MZ(8);:#N/W,NWTYT@GSC9_P_4$L#!!0    ( "1W?%2[H,#, 0,  /()   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;+56VV[B,!#]%2M/NU*WN1 N
MK0 )0KJ@+10%NA=5^V"2 :(F-FL;:/]^;2<$R@;$/O"2^#+G>.;8'D]S2]DK
M7P((])8FA+>,I1"K>]/DX1)2S&_I"HB<F5.68B&[;&'R%0,<:5":F(YEU<P4
MQ\1H-_78F+6;="V2F,"8(;Y.4\S>NY#0;<NPC=U $"^60@V8[>8*+V "XGDU
M9K)G%BQ1G +A,26(P;QE=.Q[SW850%M\CV'+#]I(A3*C]%5U!E'+L)1'D$ H
M% 66OPUXD"2*2?KQ)R<UBC45\+"]8W_0P<M@9IB#1Y,?<226+:-AH CF>)V(
M@&[[D =457PA3;C^HFUF6Y/&X9H+FN9@Z4$:D^R/WW(A#@!V[03 R0'.,< ]
M :CD@(H.-/-,A]7# K>;C&X14]:2336T-AHMHXF)VL:)8'(VECC1GGA]O_?\
MZ*.G!_3P%/B#KR/D/0>!/_(&_@1-@\YH\MB9#IY&R/_I]3NCKSX*.E,Y]:D'
M L<)_]PTA71$T9EAOF@W6]0YL:CMH"$E8LF13R*(/A*8,H(B#&<71M<YR]B#
M\!95[!OD6(Y=XI!W.=PZXTZE4+6B^=P3?&-@,8V^ (G0\%> 7H:0SH#]/L/L
M%LRN9JZ<]'0FT(!PP=;R,@GT\B@-T$! RL_15POZZEG'Y=60!Y\@;\T8D/ =
M^6_A$I,%H  +N$%3A@E/L+J!9=N>D=]I<I5 -FWWUFXTS<WA5I0964YA],'O
M6N%W[5+!^]]ZEPA>+YCKUQ"\4= WKBEXXQ\MZ[?'>I?9U*OE>M\5;M]=HC?>
M )/)_M)#;EO[K&1=0W7[(.W9%^D>[G2'G>Y,ZHY6.CZ4QU>:X>RRL^X>:5]J
M=>*LV\[>>>=_U+_PQ-O[[&57KJ+^/HG9[I75=\L.=?U8_5*KVI'\YL'KF0);
MZ**"HY"NB<A>H&*T*%PZ^KD^&N^J@D:_RGN:K!H:8K:("4<)S"6E):^?@5A6
M8&0=05?ZC9Y1(5]\W5S*H@R8,I#S<TK%KJ,6*,J\]E]02P,$%     @ )'=\
M5$5FT-\W!P  WA\  !D   !X;"]W;W)K<VAE971S+W-H965T-3 N>&UL[5EM
M;]LV$/Z^7T$8*] ":2Q1+[:+)$!BIZN!)@WB=44Q[ ,CT3912=1(RHZ'_?@=
M)57RBT0KW?QM'Q);\MWQN3OJN3OQ8LW%-[FD5*'G.$KD96^I5/JNWY?!DL9$
MGO.4)O#+G(N8*+@4B[Y,!25AKA1'?6Q9?C\F+.E=7>3W'L35!<]4Q!+Z()#,
MXIB(S0V-^/JR9_>^WWADBZ72-_I7%RE9T!E5G],' 5?]RDK(8II(QA,DZ/RR
M=VV_NW4]K9!+_,;H6FY]1]J5)\Z_Z8MI>-FS-"(:T4!I$P0^5G1,HTA; AQ_
MED9[U9I:<?O[=^OO<^?!F2<BZ9A'7UBHEI>]80^%=$ZR2#WR]0=:.I0##'@D
M\_]H7<CZ3@\%F50\+I4!0<R2XI,\EX'84AA:+0JX5,!=%9Q2P=E3P(,6!;=4
M</<5ABT*7JF0N]XO?,\#-R&*7%T(OD9"2X,U_26/?JX-\6*)WB@S)>!7!GKJ
M:O;Y[N[Z\2OZ]![-IK_<3]]/Q]?WOZ+K\?C3Y_M?I_>_H(=/'Z?CZ>T,O9Y0
M15@DT3T1@NC\OKGH*\"@+?6#<KV;8CW<LIZ-T1U/U%*BVR2DX:Z!/H"O/,#?
M/;C!1HL3&IPCQSY#V,+VY]D$O?[YC5P2064#NO$+;-U]?42O'^_:C4VZ&[..
M ;M]@2T3L)T0.M4F<'+K3HOU!\'#+%!HFA3,HY_@WS^"$)HJ&LL_#$NXU1)N
MOH3;LL1U$/ L41+():!L19XB>H9(!#Q%DH B6!<%@H9,H8C+I@#=&.UK/GTG
M4Q+0RQX0IJ1B17M7J"EI_][.3@"\*@">,0#39$43Q06C$JT%4_1MR-=)DZ.%
M'3^WHWE^=>7XV+4O^JMM-XRKO=P-OW+#-^=Q)V4ASY[4/(N [XOT-OGC'_AC
M8]NSW3V'#L6L2F('ZJ"".C!'/$X)$U#4%.)SV%;)XFT$I!4B(B5MACHP8"A0
MFB1V4 XKE$,C2BAW<PK;(400P10>/)8$/*9-Z(:'@?2P-=I#V" UL%S';H8Y
MJF".C# ?*6S?#+(N>(PDB1I)[&9TN+9E^R,?[V$\E'-<Q_7\%I"V55<SRPAS
MS&6>;5' ;:Q/UL'B>#1P'&</8X/<8. -/:\%XU;%M8T89] 5L62!Z#-T>[(Y
MD*6)G0B-7'^X'\@FN8'O;<GM@L0U2&Q^SL,5%8I)#32 H#:CQ(>AA,(YW =Y
M*&:[CC-JP5A7+=LYDNPX9C)O68VQ= YC9/O8'^S#/)0;.I;OM>&L2Y]MKGT3
M.H<[^@%/E&!/65Y?TXA4L!M1%S:]+32CD3L\B*U[N$N]H=66_[I:V<?*E68A
MI,@S@"30>.9=P1F*V#<:L27GH7[,LF1.5ESH:HZ 4U5$-=TVNF->;@%#CJ("
MJ25$Q;->-;5N_\K$;ACJ:F>;RUU;&"!M)%*ZEI,D!,J&A2DPCRF?_D$^G9&W
MG\U#H9;R8M=5T#:7P7N>Y!N/%ZSS'>L9C%,R$"S5#C4"/FKV[9;=GZH8P$W)
M@##T_G"M5_I#+2FB?V9,;:KE\Y\GLZ_H"[!A0J5$2QJ%Z&D# 06AD*U8F)$H
M#R])4\&?&32F--H@Z]RR7Z'7&'$10C[$!A5],((Q^"<P.CKS1A;\#<O[;TP(
MKF<?JX75FF^MW#@]_!^3]F>J;GAL<\?SP!60!(/F?X-"%F5ZD@3V"#+HBEF!
M62KP4>_6OU'KQ'1C'W8Z>]W:^+C(Y+C(K5%D-PAU.V6;^ZD9#R ":%:XO4&?
MQ((D[*]R]KJC\1,5IKD+URT1MDXUW.&ZI\%'>AH2Z5V74A% ;LFBD0*/V+#/
M!UXC\;]<;]>+NNG!YJ:G4U)@3^H!?)P)09-@TRE9=4N#3S:)X[H?P>9^)'\!
M P^?+)+V-WJ\:WPC45C1?7"U[UW+:MGZN&XML+E0W\9IQ#<4GG3P%HA%#VCO
M,^"T+I&L*S?V3Q;)NK9B,^%WV_9F&S8^MYH;GA]0W/6CIF1LIN0B)?FH/$UD
M)O(!?[:1$*E.6:EI#X].E16G9CS'/ 1VRLH1&]8Y;D[*R_5VO:@IU3'36I><
M_  7.34;.OADN=IZ\VB>X;IQT;BTTI&+G)H*'3,5?LABZ*T>J>09;!8TH2L:
M\31^"24Y-?$YWLD"6O.>8YY8NFU^LPV[C9%>KK?K14VLCIG;/E 8KY9YIULU
MPV7X9*>DU-3G#$^6E)KVG/_B[5EI9'OZLX?.T/:;=[E;$Z)K)J4RFM?;T9Q1
ML6(![11-MR8MUS[924)-3*ZY3>L63??PK=/ <_??\I52'29NM^8TU\QILR5+
M4SV]Z.W[ ?[E@W>7.&^=IK@GBW/-5ZZY4>ORHK(TL;-G;<O;?[G?(#9R[/U7
MJ?VM<\R8BD5^@"Q1?K10' A6=ZM#ZNO\:';O_HW][K8X:J[-%"??=T0L6")1
M1.=@TH+1H8=$<9A<7"B>YJ>E3UPI'N=?EY2$5&@!^'W.87PM+_0"U9'^U3]0
M2P,$%     @ )'=\5%\$W)8)!0  V!,  !D   !X;"]W;W)K<VAE971S+W-H
M965T-3$N>&ULO5AI;Z,X&/XK5G:UFI':@@^N;A(I33LSE7JIUVHUV@\N. D:
MP*QQFO;?KX$44C!.^V55J>%XC\?'^SPO'F^X^%6L&)/@)4VR8C):29D?6U81
MKEA*BR.>LTR]67"14JENQ=(J<L%H5#FEB85LV[52&F>CZ;AZ=B.F8[Z629RQ
M&P&*=9I2\7K"$KZ9C.#H[<%MO%S)\H$U'>=TR>Z8?,AOA+JSFBA1G+*LB'D&
M!%M,1C-X/$=>Z5!9/,9L4^Q<@W(H3YS_*F_.H\G(+A&QA(6R#$'5SS.;LR0I
M(RD<_VZ#CIJ<I>/N]5OT;]7@U6">:,'F//DKCN1J,O)'(&(+ND[D+=_\8-L!
M.66\D"=%]1]L:EO'&X%P74B>;IT5@C3.ZE_ZLIV('0?H#CB@K0/J.I !![QU
MP-5 :V35L$ZII-.QX!L@2FL5K;RHYJ;R5J.)LW(9[Z10;V/E)Z=W\Q]GIP\7
M9^#Z&WB<W9[/3M3U^=7]V>W9W3TXN[H_O_\;?#EEDL9)\14<@H>[4_#E]Z]C
M2ZKL90PKW&8ZJ3.A@4P0@4N>R54!SK*(1>\#6 IV@QV]83]!QHBG+#P"&!X
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M3X$2]3%2?2-Y7IW$/'$I>5I=KAB-F"@-U/L%Y_+MIDS0'.9-_P-02P,$%
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M(0ME(18DNCG09E&.*!UV] *I=8_T"U]1#[=JL71R#3_$WC#P.N!K'23]0EC
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M9$J5YZXKTPP*(GN\!*9WUEP41.FIV+BR%$!6%E3DKN]Y?;<@E#FC@5V;B]&
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M&"=^N[ZHT1=UZKNFC!;; OVZAF()XG?'X>DWE/U.RCF(5)\5W>407Z,94R!
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M<J5'Q!X+O<1 & -]O^-<'07CH%^+Z1M02P,$%     @ )'=\5'J4K#2^ @
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M,[ZYAZT?W_!EG,GZB39-;( ME*VDXL46K!44M&S>Y&-;ASV VSL!P%L _B[
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MP@3H_07G:C<QK;*]&:/_4$L#!!0    ( "1W?%1PXMHCRP(  '4(   9
M>&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;*5676_:,!3]*U:TAU9:&Q(^6P%2
M"+!6HH!*69_=Y(983>S,-M#^^]E.R(!!-M27Q%_GW'-LY]YTMXR_BQA HH\T
MH:)GQ5)F][8M@AA2+&Y9!E3-1(RG6*HN7]DBXX!# TH3VZW56G:*";7Z73,V
MY_TN6\N$4)AS)-9IBOGG !*V[5F.M1MX)JM8Z@&[W\WP"A8@E]F<JYY=LH0D
M!2H(HXA#U+,\Y][OZ/5FP4\"6['71MK)&V/ONO,8]JR:%@0)!%(S8/7:@ ])
MHHF4C%\%IU6&U,#]]HY];+PK+V]8@,^25Q+*N&=U+!1"A->)?&;;!RC\-#5?
MP!)AGFB;KVTW+12LA61I 58*4D+S-_XH]F$/X+3. -P"X!X#&F< ]0)0-T9S
M9<;6$$O<[W*V15RO5FRZ8?;&H)4;0O4I+B17LT3A9'_A/XR&R\D(S<;(?_"F
M/T8+]#A%WF0R>_6F_@B-9\]H.%L.7L;+"?)\?[:<OBS0U1 D)HFX1C=HN1BB
MJV_775LJ/9K5#HK8@SRV>R:VXZ(G1F4LT(B&$!X2V,I(Z<;=N1FXE8Q#"&Y1
MW?F.W)KKG!#D_S^\5B&G7FYNW?#5S_#-.63X4]UY*9!'0S2$C DB105UHZ1N
M&.K&&>H!K BEA*[4)4XP#>#4]E=2Z/QP+S(<0,]2"4  WX#51Z=V[>L\!QZ;
MI<=FI4<O#(G^UD]9RY$M@]29:J-ND]-T&EU[LZ^\,L#ERENE\E:E\E=.)" 6
M1:>D5T(O.)6O\QQX:Y?>VI7>1A]!C.D*$,?*(T212LBG;+;_.J&;AG-W=#Z5
MH2[WT"D]=*H]T/ ?GTZ.;Q[>K]I=\TA_99@+]-M[&3P%OC*%3:" K:G,TU\Y
M6M9.SY2,H_&!JJEY"?Q#DQ?D)\Q5RA H@4A1UFYU">-YD<L[DF6F3KPQJ:J.
M:<;JOP"X7J#F(\;DKJ,#E'\:_=]02P,$%     @ )'=\5+9KT]]+ P  80L
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MU"$9K&G%\5[4U]#ZL0)3P95]DKK)#4.'I)5"D;=@K2!G1?.FSVT?=@"#X1Z
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M$*N.G=D&NGWZV0F-* 34-\0/=__[W6&?AULN7F4!H-!;29D<6852U8UMR[2
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M=7#(&V1[KZV9)T7?S!5A$E'(M:/3B[2":-IT,U&\JCO=DBO=-^MAH5\V$,9
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MXHT*4QD@GA\(X:\->1JMWM&6_P-02P,$%     @ )'=\5 B<<ZUN P  D@P
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MV0KT8Z)T656*)BPA&Y*L,7V+Q@\Q72>$K5"48@%GIGL3-,7?3;A$F.D)ETJ
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M@8E,79#G:TK%?J,2U"-X^!M02P,$%     @ )'=\5""JQ$[A @  Y@@  !D
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M=L[FDHM,@4%V3]?R!#@A HRID)S.EG)7J9^\)DT%06<G$L\S#N_9-P]'B=?
M"7L-2\LSQ<&S^[':V_R/I/.,^7OH5-)M'?#8MP!'?>HV<![>H3A;!Y)J;[ H
M3H(%*#QN<T17/:U.FR^+,]:]YR-X/MZ<&1N:S1'V+>8+JC))R%Q1NNV>LEV^
M.17>W$B6%\>>,R;5/J:XC F."-<-U/LY8_+Y1@>HSN:'_P!02P,$%     @
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M248]?726?@=2CA%ANB8@U1!W]('[U?=&23C,37MN>I:[-#5D"NTQW0'B95<
M2O":4*+T 1_*DGXX@T'DQ:/T71;WJ$>8=KO 8DN8U(Q2"[W+D780;0MK)XHW
MMFVLN=)-R XKW?5!F 7Z><FY>IN83M3_C^3_ %!+ P04    "  D=WQ4Z<4T
M-0 '  #9$P  &0   'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6R]6%N3XC86
M?@Z_0L5N4C-5!&RN3?I2U:')+MFAZ>I+\I#:![4ML&ILR9%D&/Y]OB,;PTS3
MI*<J-2_@B\XYW[E].O+%1IN/-A'"L4]9JNQE,W$N_ZG3L5$B,F[;.A<*;Y;:
M9-SAUJPZ-C>"QUXH2SO=(!AV,BY5\^K"/[LS5Q>Z<*E4XLXP6V09-]N?1:HW
ME\VPN7MP+U>)HP>=JXN<K\2#<$_YG<%=I]82RTPH*[5B1BPOF]?A3]-P1 )^
MQ6]2;.S!-2-7GK7^2#>S^+(9$"*1BLB1"HZ_M9B(-"5-P/%GI;19VR3!P^N=
M]E^\\W#FF5LQT>GO,G;)9?.LR6*QY$7J[O7FOZ)R:$#Z(IU:_\LVY=IAT&11
M89W.*F$@R*0J__FG*A ' N'P%8%N)=#]0N#L-0N]2J#WI87^*P+]2J#_5H%!
M)>!=[Y2^^\#=<,>O+HS>,$.KH8TN?/2]-.(E%17*@S-X*R'GKB:+^7SV.)_>
M/CZPZ]L;-EG</LYN_S.]G<RF#^S=C7!<II;=<F,XI?0]^Y$]/=RP=_]^?]%Q
M $!J.E%E[.?26/<58W.^9;VPQ;I!-SPB/3DM?2.B]BGQF[>+!T?$IZ?%KW/3
M9L%1\0YB7@>^6P>^Z_7U7M%W+ZPS1>0*(]6*3;1UC*N8X;$P:\'^^(#U;.9$
M9O]_PEJOMM;SUOJO6%OD@O('2ZE 6[%4\F>92K<]EH92U<"K(J)97W7[P6!T
M=M%9'X'0KR'T3T+XX V+3[DD). ()TQVK(9.JZEJJ/'==TA$[T1H!C6NP4F%
M]R(N2M*2BMTOGABW5CCKL[$+DQ3V&-+!BT#UNH/@>)B&-9SAUV2J!396CL(&
M<CZ*8C)\@2(<C0?#;HVC[(XCRP;#43@\#G=4PQV=A#M9_#:[^3$<LUF6@_39
M'W.1/0MSJF;/:M5GWZ!#QK6U\=L<D:4CL;"1D3D5QK&@GU:V4 VJT[!;DE6+
MS7G*MU9RMN&HK!4V<)87CA4J%H9QMBS2E*4Z^ACKC6+*]P?V 62_4$ZFS"7H
M'&Y2B=5ZR=[)]RP&+V]9C3I"K5A4\++:@+$*0HU(0X'9LB6'@6<:"UB_%03!
M.71 B52.]GQ$\TE)QR;<P*0V;#9Y:@&JB2VSCAO'=%V5'%E@F8[I'CPBUB(]
M)Q'H@\(P^+XR7;NL&KG.B[3L>6F]KUNVYE$DX:B(V^P1JW= ?7QB;'32@A_(
MH%[#Z7X0$&P6:W(3%FK'2T5XZ /29@O%?BU@(!SM8D]@R&BC#C 9L2F-$%A(
M71:CZ5G8:X]?HF<'Z$GN2_B(DW0)*E-#S+ > I#P-0$W(A((;4PAHUY&%)5H
MD <[(Q7V,@*U1U:Z@N\(R1W$QB9Z W5*8\G*IY@_^Z2TV?\*X&4?BBPOC.^2
M!Y%RM4)>C*!Q$6*^AG(9@4Z$:50(X!BZ#(ZM/:BZ?BPP:<?3EP7V.:+"Y$27
MI7:XAQ$E30DZILZ/>%#FHCO8Y8*@E97K]3422>6$2&D3LP09(13=?FLP'I/T
M=;'"",2ZPU*^S6Z$S27JCLS%@BI$5W6Y#Y^#3V765U0[*B,"3>42R?H\3DNC
M,S95"5>1B!MS+/9+)QJ^81!;&&K.=S_\ZZS;#<ZG\\G"7X;G[QE/,),35!K<
MXR(5WC&!;BXCL>_@$@XMA7*S$BK:'C@6[ORZH^;F9+Z1X72  T!9MM)@E<-D
MCEOTSA8DL(]J'96:77!6\-F@6J6JE(Y&-\)RF,I9EA7HK[+&[E G+? #[$BE
M(U_J:M4@22B#!PH'D;WLGF$\,9"_FL5&YQ6[$.JP[%5? C[9+;Q<2:4H3XO(
MZ6=JE!WXZ=)K1 'N7H556%H-XB=31I "[&_5SA]G4+4IH71&EE7+-L*(7:Z7
MOOHK%]@FT6C,&$B$>M'$)24C!+6?Z/2#0F_P*)&">IGB L=72)+OESIB;%Q2
M'RW@* EW0!QE@Q]4(U*)5.7<$QP":!- )O<T_/1UE,EH#R9/:'3:@%\$$H/4
M@LS!-[15$9OX.MN1FV7 ">I85AUKI 7!7'O2G',3):PL&VQ-GEE'9P>L5[E+
M=1Z.SNTA]R5$$?O@-5XR(%X8SX']8?L("^*P2)1.+.9.[-=AL#^Y!"<WV4>#
MG/G6]Y3VEM$C/#@6A=]@^ CWIX&P^\],QW^C!\32?MM\'.[/#N'IP\/UPX<W
M!7=_$@C[WR*X^PD_/#WB?\WI9QJ^G.K[8_#9*W-]N!_LPZ^:[)FHB<_S&NW#
M-%,=3?IIS8/V(/C^J"]?+?>Y;_M30'CZ&/#BU++Q7VB(64$R?"6J.63O_2OU
M/?D;0V&Y!XXP@BJ76# 9MIBM/>9$Y^"K"'WT OMA$[*POX3JH#U"BDWY':F\
M<3KW'TJ>M7,Z\Y>TSPM#"_!^J;7;W="WE_IKWM5?4$L#!!0    ( "1W?%2,
M5C0D10(  /D$   9    >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;(U4WV^;
M,!#^5RRTAU:: B%AJRJ"E%]3NS555I;N8=J# P=8P3:U36BE_?&S#6%,6J(]
M8.[L^[[[#NX<-EP<9 &@T"LMF9PYA5+5K>O*I "*Y8A7P/1)Q@7%2KLB=V4E
M *<61$O7][P/+L6$.5%H][8B"GFM2L)@*Y"L*<7B;0$E;V;.V#EM/)&\4&;#
MC<(*YQ"#VE5;H3VW9TD)!28)9TA -G/FX]M%8.)MP#.!1@YL9"K9<WXPSGTZ
M<SPC"$I(E&' ^G6$)92E(=(R7CI.IT]I@$/[Q/[)UJYKV6,)2UY^)ZDJ9LZ-
M@U+(<%VJ)][<05>/%9CP4MH5-5VLYZ"DEHK3#JP54,+:-W[MOL, X(_/ /P.
MX%O=;2*K<H45CD+!&R1,M&8SABW5HK4XPLQ/B970IT3C5!3O%O'ZZV[]^ VM
MG_4:HZL5*$Q*B1ZQ$-A\L^O053J5 ;A)1[MH:?TSM&.TX4P5$JU9"NG?>%=+
M['7Z)YT+_R+A9\Q&R/?>Z\?W=_$*7;V[OD [Z<N?6-KIN?+KO827&IA"ZZ-9
M?VR [D'\1+_01HSN--L7?D#+@G.6#P_C @M NC$R(*K6YCP7 '1(<4'>M)<W
MM?(F_RWO04>@>P547N(/>O[@8OE+3BO,WI"TU61]-?_ZX2U38)G,J!\C?QQX
MWHTW"4+W.!3A#MJ1@LCMT$F4\)JIMC/[W7ZNYVT[_PEO+X4-%CEA$I60::@W
M^JCSBW;06D?QRC;WGBL]*M8L]-T$P@3H\XQS=7),@OZVBWX#4$L#!!0    (
M "1W?%1<.>?9) ,  "X2   -    >&PO<W1Y;&5S+GAM;-U844_;,!#^*Y&9
M)I FTC0C-*.IM%5"FC0F-'C8&W(;I[7DV)GCLI9?/U^<IJ'X$.-AZY:JQ+[/
M]]WGNPN..J[-1K";)6,F6)="UAE9&E-]",-ZOF0EK4]5Q:1%"J5+:NQ4+\*Z
MTHSF-3B5(AP.!DE84B[)9"Q7Y65IZF"N5M)DY'UG"MSM<YZ1*'E/ D<W53G+
MR-WQVQ\K92[>!.Y^].[H:'!W<K%O/VZ $Q)Z2<]>0'HZL!?*W* 8??(R^N?(
M,>IS/_6W*R0?'=!+2-AF?C(NE-P5(";.8./2D@7W5&1D2@6?:0Y>!2VYV#CS
M$ QS)90.C*V\%1*!I7YP<.1FT!0M3\FETDUL%\']G;7+]X#M# 1R(3J!0^(,
MDW%%C6%:7MI)L[@Q/H&"=GR[J:S"A::;:'A&=@[-S0:9*9TSW86)R-8T&0M6
M@!S-%TNX&U6% !JC2CO(.5TH21L-6X]V8&GG3(@;>&*^%X^XUT6OH@.HI^R&
M5E [=#1N OQ]-L?=IWT=;U#Q>V4^K>QV9#.'3F'7FA5\W<S712< 8X]P=EI5
M8O-1\(4LF=O\BP-.QG3K%RR5Y@\V&K3*W!J8)L$]TX;/^Y:?FE:W;&VV[;0N
M<,W#?U#SG\WS@DFFJ>B+MKU_R%E^M>+VB/D;FIM_*_N*O2+C\\/7V!ZKARXR
M.7R1<7KX&MM7D8,3&;9'8^_\?73Z=M8 WG(R\A7>IL0N:#!;<6&X;&=+GN=,
M/CF$+;VA,_LR_(C?KL]905?"W'9@1G;C*Y;S59EVJZXA$>VJW?@+;"]*NE<L
M&XO+G*U9/FVG>C%KAH$=V*CM!0[[R&5S^1',QV%^!# L#J8 \W%>6)S_:3\C
M=#\.P[2-O,@(]1FA/L[+ATR;#Q;'[Y/:R[_3-(WC),$R.IUZ%4RQO"4)?/UL
MF#;PP.) I-_+-5YMO$.>[P.LIL]U"+93O!.QG>*Y!L2?-_!(4W^UL3C@@54!
MZQV([X\#/>7WB6.H*J8->X)Q)$TQ!'K1WZ-)@F0G@8^_/MA3$L=IZD< \RN(
M8PR!IQ%', 6@ 4/BN#D']\ZC<'M.A;M?B":_ %!+ P04    "  D=WQ4EXJ[
M',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6
M!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV
M)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O
M@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=
MI7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    (
M "1W?%0 ;"#C? 8  / V   /    >&PO=V]R:V)O;VLN>&ULQ9O?<]HX$(#_
M%0U/N9GK$8Q_T$[3&6$$T01LSC)<<R\9!TSQU-@9VVGO^M>?9$B[)L[.O<@\
M!0PQ'Y)7W^[*?/R>%U\?\_PK^>>09N5-;U]53Q_Z_7*SCP]1^4?^%&?RE5U>
M'*)*/BV^],NG(HZVY3Z.JT/:-ZZO[?XA2K+>IX\OYUH6??@DK^)-E>29/*@.
MK)/X>_GK=?64?$O*Y#%)D^K?FU[].(U[Y)!DR2'Y$6]O>M<]4N[S[[=YD?S(
MLRI*Q:;(T_2F-SB^L(Z+*MF\.BP49!@]EO61*GH,(@ERT[.OY0EW25%6]3OJ
M\T>2\5LLWWQ\]ESETR2MXF(25?&LR)^?DNR+.HW\%GWP->IQ>/E[',0/Q?\9
MQGRW2S;Q)-\\'^*L.HYC$:<*,"OWR5/9(UETB&]Z;OXM+M3WD1_ M\?O5DDH
M,%+%AT2^4/!MC:<3)2OS--G*3]^2<91&V28F]1"6 -!  (V+ 9*K900@APCD
ML$-(H2#4/Y0DWQ'_J3'5)@)I7@S2W4<9@+002.MRD%&Y!Y V FGKA?2#&?7X
MWS3DOD>H-R'CE> >$X*,J7LW Y . NGHA12KQ8(&]\2?$L%G'I]REWHAH:[K
MK[R0 \@1 CG2"[FF :?C.2/<"UG 1$B89 OOR=7#FK,' /D>@7RO%_+G[+K^
M8LR]>MKAZGV-+=_7FN.%BMOZ$JP?L#]7?$WG<@P%!$3]HEDPI^M-D("Y3,+)
MR89HF%D&FM7"O;4<*3_@K#%:F$<&FD6R#-B2WB_4!-:S.F%+7_#F;&(*&6AV
MR#+PERR0\:G@U-6V5*R_$X^%$!$3R$"S0>1*0KT95XL*%8*%XA4=9HZ!9G6H
M:TZ$:M#DDD?D GW'PGH!%,Q=!7!5'F#N&&B61Q/3\[UW#52(B=ECH%D??GC+
M B(C1G$=(T:N-\&*3<A<>@5B8OX8:!9(P.8TE$Q+JD)G3.?4<T^X84"A2PS,
M)89FEXC0=^]N_?F$!>*ACN[P'K)A&C$T:T1=@J[OA8$_GW-O]C-?@'QHE:+=
M)3(Y8"2DGQLR,3"9&+JK$E]>9G+(ZH1%J$0PX.*N@8>YQ-!=C_B+!0]_N4Y-
MKYQ:YKE-(1N830S--A&KL9"1H!9"MC[+JPQ,)(9FD:#I_8,!,3&1&)I%@I9*
M34Q,)(9FD>"C.828F$@,S2)!RZ7&: XQD0PUBZ2M8")7820IRM\@)&:48?>%
M22LC9I5A=Q5**QO:\KI0J7("A9B898:7JU@4*<3$/#.\2-72.NF8=8:7+%^:
M"Q!FG>$ERY<F)F:=X27+ER8F9IWA)<N7!J:)6<?4;)VW2H37"Y*)><?4[!U8
M*;3%MXD)Q]2]VX+EY.0*8F+N,36[1[BW;+*2L:SR-9FA\PFGM23K$((YNHEN
MN&AV#Y[\PJS2Q-QCZJYQP&C*>.&+.MI7@DU7<[D004S,/:;NB@?#;"Y#F'M,
MW?LN '/"Q3LZFP5L5K-R;^I#3,P]INZ*!V!._8#)JH>XJR XA3K$Q-QC:G8/
M7IB9<-,2<X^ENW4&1K.E2(.8F'LLS>[!ZT>X(%F8A2S-%@*3?DR&Y7S+S#V0
M(:1648B)6<CJT$*RS%!AM*"_UGB(B5G(TFRA]FI\$E=1DI8$=I\M=.-?]\[_
M6SN91U:(B5G(ZM!"^-ZFA5G(ZM!"C2["<=XA)F8A2[.%6M#D)1D51:1NW8)I
ML859R-)MH4:DLR7E$\(^+YDGZIP3WI6"6<CNT$+N+95YNU#U+YW/_;]DS08Q
M,0O9FBUTMFZ>MV<@)F8A6[.%T,[1!-:3-F8ANT,+M721("9F(5NSA=YJ<)V"
M'F)B%K([K(5:FET0$[T![:)].)C(V9B%[(XMU.C)D4:D8Q:R.[#0V^W"QFAB
M%K([M%!+ZQ#>=HA9R.G00K!U>'(\Q,0LY.BV4,O=#NUIL8-9R-%="X'15$%S
MUN&$F)B%G XM).N,I>_5J7L=]_(YQ,0LY&BVT%GJL>9"%4.R<'N-B5G(Z;(C
M-YTR-^1K1GYVCB$F9B&GRX[<.6:C(^>@-T)WV9%C4Q:H1D)(/Y\2$8B)6<C1
M;B&X,?"J&(*8F(4<S19ZXZZBELIRA%EHU*&%YHP*1N#>!MS)&&$6&NG^_0VV
MX=((H1%FH9'VCMS9;5#-"Q1B8A8:U1;JUV\N/WW<QKLDB[>>_(A2'M]$Z699
M$/5'G6E@F):Z;7/WG*:N/.9G\SS:OOQ@Z^7'9I_^ U!+ P04    "  D=WQ4
M-$X[?7H"    ,0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=I-
M;J- $(;AJU@<(+BKJJO(*,YJ-MF.<@'DM'\4VUC :)+;C^4L[ _-8C81WPHU
MB.)=H$<(>/I5#NVX[T[#;G\>%A_'PVE85;MQ//^HZV&]*\=V>.C.Y70YLNGZ
M8SM>EOVV/K?K]W9;:EDNO>[O9U3/3_<S%Z^?Y_(_$[O-9K\N/[OU[V,YC?\8
M7/_I^O=A5\I8+5[;?EO&555_'&Z[A_JZ20^7R=7BY6U5]2]OJ:KG#A((DOF#
M%()T_B"#()L_*$-0GC_((<CG#PH(BOF#&@AJY@]ZA*#'^8/2$F5<$B1-L";0
M.B'7B<#KA& G K$3DIT(S$Z(=B)0.R';B<#MA' G KD3TIT([$Z(=R+06U!O
M(=!;4&\AT%LF#]L$>@OJ+01Z"^HM!'H+ZBT$>@OJ+01Z"^HM!'H+ZBT$>@OJ
M+01Z*^JM!'HKZJT$>BOJK01ZZ^1E"8'>BGHK@=Z*>BN!WHIZ*X'>BGHK@=Z*
M>BN!WHIZ*X'>AGH;@=Z&>AN!WH9Z&X'>AGH;@=XV>=E-H+>AWD:@MZ'>1J"W
MH=Y&H+>AWD:@MZ'>1J!W1KTS@=X9]<X$>F?4.Q/HG5'O3*!W1KTS@=YY\K&2
M0.^,>F<"O3/JG0GTSJAW)M [H]Z90&]'O9U ;T>]G4!O1[V=0&]'O9U ;T>]
MG4!O1[V=0&^?_&Q"H+>CWDZ@MZ/>3J"WH]Y.H'>@WD&@=Z#>0:!WH-Y!H'>@
MWD&@=Z#>0:!WH-Y!H'>@WD&@=TQ^%B30.U#O(- [4.\@T+M!O1L"O1O4NR'0
MNT&]&P*]&]2[^4Z]A_'S4(9;S]<:K_^=5(^7<\OM\M?EU\[)K7+%N;ZO&)[_
M E!+ P04    "  D=WQ4(' .V20"  "I+P  $P   %M#;VYT96YT7U1Y<&5S
M72YX;6S-VDUNVS 0!>"K&-H&%LU_M8BS:;MML^@%6&D<"Y9$@F12Y_:EY"1
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MT^ZH>V-VN=Z?/AZ6>22V/"Z_X]]G_%+_G7T(D#XD2!\*I \-TH<!Z<."]-&
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MY5F/KI^>\]GR#_V;7U!+ 0(4 Q0    ( "1W?%0'04UB@0   +$    0
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M965T,RYX;6Q02P$"% ,4    "  D=WQ4W8LT[L4&  !P&0  &
M    @($1&@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @
M)'=\5(P9ZIF5!0  F!D  !@              ("!#"$  'AL+W=O<FMS:&5E
M=',O<VAE970U+GAM;%!+ 0(4 Q0    ( "1W?%13%))EK@@  #,E   8
M          " @=<F  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M    "  D=WQ43_+6J9 *  "''   &               @(&[+P  >&PO=V]R
M:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ )'=\5!!LGVXM*P  -8<
M !@              ("!@3H  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+
M 0(4 Q0    ( "1W?%3[!\:[-@4  #8+   8              " @>1E  !X
M;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    "  D=WQ4Y?/BJ88'
M  #8#P  &0              @(%0:P  >&PO=V]R:W-H965T<R]S:&5E=#$P
M+GAM;%!+ 0(4 Q0    ( "1W?%0 ,R/>X@(  /8%   9              "
M@0US  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ )'=\
M5%)R^Q;- @  L@4  !D              ("!)G8  'AL+W=O<FMS:&5E=',O
M<VAE970Q,BYX;6Q02P$"% ,4    "  D=WQ4 5-T-7@"   K!0  &0
M        @($J>0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0
M   ( "1W?%353!]R/@,  )H&   9              " @=E[  !X;"]W;W)K
M<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ )'=\5)]#9RZ= P  & <
M !D              ("!3G\  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q0
M2P$"% ,4    "  D=WQ4@I^76<P"  #9!0  &0              @($B@P
M>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( "1W?%27QE+X
MYP,  "P(   9              " @26&  !X;"]W;W)K<VAE971S+W-H965T
M,3<N>&UL4$L! A0#%     @ )'=\5*PM,3L\ P  <P<  !D
M ("!0XH  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    "  D
M=WQ4O=PB=2D#  !7!@  &0              @(&VC0  >&PO=V]R:W-H965T
M<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( "1W?%1TUCG(G04  -T/   9
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M970R-"YX;6Q02P$"% ,4    "  D=WQ4<T.G_&8-  "7'@  &0
M    @(&YL   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (
M "1W?%0IT1%CAP(  &D%   9              " @5:^  !X;"]W;W)K<VAE
M971S+W-H965T,C8N>&UL4$L! A0#%     @ )'=\5-T,0+K +P  :)\  !D
M             ("!%,$  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"
M% ,4    "  D=WQ4J8G>XR,$  !1"0  &0              @($+\0  >&PO
M=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( "1W?%0MC+Y0'08
M  ,.   9              " @67U  !X;"]W;W)K<VAE971S+W-H965T,CDN
M>&UL4$L! A0#%     @ )'=\5$\0Y*RI P  \@<  !D              ("!
MN?L  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    "  D=WQ4
MTW$>8B %  #R"@  &0              @(&9_P  >&PO=V]R:W-H965T<R]S
M:&5E=#,Q+GAM;%!+ 0(4 Q0    ( "1W?%2 :CP&9@(  "(%   9
M      " @? $ 0!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%
M  @ )'=\5):^F[96 @  WP0  !D              ("!C0<! 'AL+W=O<FMS
M:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  D=WQ4@]G?)E4#  !9!P
M&0              @($:"@$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+
M 0(4 Q0    ( "1W?%2!A)A<! ,   X&   9              " @:8- 0!X
M;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ )'=\5)M.1^VD
M @  =04  !D              ("!X1 ! 'AL+W=O<FMS:&5E=',O<VAE970S
M-BYX;6Q02P$"% ,4    "  D=WQ4=+]%0\H"  #9!0  &0
M@(&\$P$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( "1W
M?%1YRY+VI0(  "$&   9              " @;T6 0!X;"]W;W)K<VAE971S
M+W-H965T,S@N>&UL4$L! A0#%     @ )'=\5&24]O6V @  H@4  !D
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M=#0S+GAM;%!+ 0(4 Q0    ( "1W?%3.BE!C[@4  /X<   9
M  " @3PN 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @
M)'=\5'4"5GCT @  !@D  !D              ("!830! 'AL+W=O<FMS:&5E
M=',O<VAE970T-2YX;6Q02P$"% ,4    "  D=WQ4]0Z,J",#  #%#   &0
M            @(&,-P$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4
M Q0    ( "1W?%2GL;.C5 (  !0%   9              " @>8Z 0!X;"]W
M;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ )'=\5.:I5%!3!0
M!!H  !D              ("!<3T! 'AL+W=O<FMS:&5E=',O<VAE970T."YX
M;6Q02P$"% ,4    "  D=WQ4NZ# S $#  #R"0  &0              @('[
M0@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( "1W?%1%
M9M#?-P<  -X?   9              " @3-& 0!X;"]W;W)K<VAE971S+W-H
M965T-3 N>&UL4$L! A0#%     @ )'=\5%\$W)8)!0  V!,  !D
M     ("!H4T! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "1W?%2U$()JEP(  $('   9              "
M@8=A 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ )'=\
M5(4U#XQ; @  . 8  !D              ("!560! 'AL+W=O<FMS:&5E=',O
M<VAE970U-RYX;6Q02P$"% ,4    "  D=WQ4][6+?@D"  !9!   &0
M        @('G9@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0
M   ( "1W?%2BE??7/0(  "(%   9              " @2=I 0!X;"]W;W)K
M<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ )'=\5'J4K#2^ @  )0<
M !D              ("!FVL! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q0
M2P$"% ,4    "  D=WQ4<.+:(\L"  !U"   &0              @(&0;@$
M>&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( "1W?%2V:]/?
M2P,  &$+   9              " @9)Q 0!X;"]W;W)K<VAE971S+W-H965T
M-C(N>&UL4$L! A0#%     @ )'=\5"LO4V]* @  $04  !D
M ("!%'4! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    "  D
M=WQ4@V,AJ&X"  "[!0  &0              @(&5=P$ >&PO=V]R:W-H965T
M<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( "1W?%2639'64 (  !X%   9
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M970V.2YX;6Q02P$"% ,4    "  D=WQ4U='@)\ "  !]!P  &0
M    @(%:C $ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    (
M "1W?%1,!$T@&P@  &4R   9              " @5&/ 0!X;"]W;W)K<VAE
M971S+W-H965T-S$N>&UL4$L! A0#%     @ )'=\5.R <N;H!   +!4  !D
M             ("!HY<! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"
M% ,4    "  D=WQ4SSX7J;P"  "1"   &0              @('"G $ >&PO
M=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( "1W?%2ICQWQQ@(
M $H'   9              " @;6? 0!X;"]W;W)K<VAE971S+W-H965T-S0N
M>&UL4$L! A0#%     @ )'=\5 #QG$K( @  X@<  !D              ("!
MLJ(! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    "  D=WQ4
M;R>379T#  "K"P  &0              @(&QI0$ >&PO=V]R:W-H965T<R]S
M:&5E=#<V+GAM;%!+ 0(4 Q0    ( "1W?%14C03=B0(  (X'   9
M      " @86I 0!X;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%
M  @ )'=\5""JQ$[A @  Y@@  !D              ("!1:P! 'AL+W=O<FMS
M:&5E=',O<VAE970W."YX;6Q02P$"% ,4    "  D=WQ40DW4::\&   B&P
M&0              @(%=KP$ >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+
M 0(4 Q0    ( "1W?%1[&Q*YS@0  *<7   9              " @4.V 0!X
M;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @ )'=\5/Z><)J2
M @  4P8  !D              ("!2+L! 'AL+W=O<FMS:&5E=',O<VAE970X
M,2YX;6Q02P$"% ,4    "  D=WQ4Z<4T-0 '  #9$P  &0
M@($1O@$ >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    ( "1W
M?%2,5C0D10(  /D$   9              " @4C% 0!X;"]W;W)K<VAE971S
M+W-H965T.#,N>&UL4$L! A0#%     @ )'=\5%PYY]DD P  +A(   T
M         ( !Q,<! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  D=WQ4EXJ[
M',     3 @  "P              @ $3RP$ 7W)E;',O+G)E;'-02P$"% ,4
M    "  D=WQ4 &P@XWP&  #P-@  #P              @ '\RP$ >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ )'=\5#1..WUZ @   #$  !H
M     ( !I=(! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ )'=\5"!P#MDD @  J2\  !,              ( !5]4! %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     %L 6P#T&   K-<!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>223</ContextCount>
  <ElementCount>372</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>102</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OrganizationAndBusinessBackground</Role>
      <ShortName>ORGANIZATION AND BUSINESS BACKGROUND</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/VariableInterestEntityVie</Role>
      <ShortName>VARIABLE INTEREST ENTITY (???VIE???)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - BUSINESS COMBINATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BusinessCombination</Role>
      <ShortName>BUSINESS COMBINATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - CASH AND CASH EQUIVALENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/CashAndCashEquivalents</Role>
      <ShortName>CASH AND CASH EQUIVALENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - ACCOUNTS RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/AccountsReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - PREPAYMENTS AND DEPOSITS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PrepaymentsAndDeposits</Role>
      <ShortName>PREPAYMENTS AND DEPOSITS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IntangibleAssetsNet</Role>
      <ShortName>INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInMarketableSecurities</Role>
      <ShortName>INVESTMENT IN MARKETABLE SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInNon-marketableSecurities</Role>
      <ShortName>INVESTMENT IN NON-MARKETABLE SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities</Role>
      <ShortName>OTHER PAYABLES AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/RelatedPartyBalancesAndTransactions</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - NON-CONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/Non-controllingInterest</Role>
      <ShortName>NON-CONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - CONCENTRATIONS OF RISKS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ConcentrationsOfRisks</Role>
      <ShortName>CONCENTRATIONS OF RISKS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables</Role>
      <ShortName>ORGANIZATION AND BUSINESS BACKGROUND (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/OrganizationAndBusinessBackground</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/VariableInterestEntityVieTables</Role>
      <ShortName>VARIABLE INTEREST ENTITY (???VIE???) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/VariableInterestEntityVie</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - BUSINESS COMBINATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BusinessCombinationTables</Role>
      <ShortName>BUSINESS COMBINATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/BusinessCombination</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - ACCOUNTS RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/AccountsReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/AccountsReceivable</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/Inventories</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PrepaymentsAndDepositsTables</Role>
      <ShortName>PREPAYMENTS AND DEPOSITS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/PrepaymentsAndDeposits</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/IntangibleAssetsNet</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables</Role>
      <ShortName>INVESTMENT IN MARKETABLE SECURITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/InvestmentInMarketableSecurities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables</Role>
      <ShortName>INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/InvestmentInNon-marketableSecurities</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables</Role>
      <ShortName>OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/RelatedPartyBalancesAndTransactions</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - NON-CONTROLLING INTEREST (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/Non-controllingInterestTables</Role>
      <ShortName>NON-CONTROLLING INTEREST (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/Non-controllingInterest</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/IncomeTaxes</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails</Role>
      <ShortName>SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative</Role>
      <ShortName>ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails</Role>
      <ShortName>SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails</Role>
      <ShortName>SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails</Role>
      <ShortName>SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails</Role>
      <ShortName>SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure -  SCHEDULE OF VARIABLE INTEREST ENTITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails</Role>
      <ShortName>SCHEDULE OF VARIABLE INTEREST ENTITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative</Role>
      <ShortName>VARIABLE INTEREST ENTITY (???VIE???) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/VariableInterestEntityVieTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure -  SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails</Role>
      <ShortName>SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - BUSINESS COMBINATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BusinessCombinationDetailsNarrative</Role>
      <ShortName>BUSINESS COMBINATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/BusinessCombinationTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative</Role>
      <ShortName>CASH AND CASH EQUIVALENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/CashAndCashEquivalents</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure -  SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails</Role>
      <ShortName>SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure -  SCHEDULE OF INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfInventoriesDetails</Role>
      <ShortName>SCHEDULE OF INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - INVENTORIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InventoriesDetailsNarrative</Role>
      <ShortName>INVENTORIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/InventoriesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure -  SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails</Role>
      <ShortName>SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails</Role>
      <ShortName>SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails</Role>
      <ShortName>SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails</Role>
      <ShortName>SCHEDULE OF INTANGIBLE ASSETS, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative</Role>
      <ShortName>INTANGIBLE ASSETS, NET (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/IntangibleAssetsNetTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails</Role>
      <ShortName>SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative</Role>
      <ShortName>INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails</Role>
      <ShortName>SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative</Role>
      <ShortName>INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails</Role>
      <ShortName>SCHEDULE OF RELATED PARTIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/StockholdersEquity</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - SCHEDULE OF NON CONTROLLING INTEREST (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails</Role>
      <ShortName>SCHEDULE OF NON CONTROLLING INTEREST (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure -  SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails</Role>
      <ShortName>SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure -  SCHEDULE OF PROVISION FOR INCOME TAX (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails</Role>
      <ShortName>SCHEDULE OF PROVISION FOR INCOME TAX (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails</Role>
      <ShortName>SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical</Role>
      <ShortName>SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure -  SCHEDULE OF DEFERRED TAX ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails</Role>
      <ShortName>SCHEDULE OF DEFERRED TAX ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/IncomeTaxesTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative</Role>
      <ShortName>CONCENTRATIONS OF RISKS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/ConcentrationsOfRisks</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure -  SCHEDULE OF LEASE COMMITMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails</Role>
      <ShortName>SCHEDULE OF LEASE COMMITMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/SubsequentEvents</ParentRole>
      <Position>83</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="form10-k.htm">form10-k.htm</File>
    <File>aatp-20211231.xsd</File>
    <File>aatp-20211231_cal.xml</File>
    <File>aatp-20211231_def.xml</File>
    <File>aatp-20211231_lab.xml</File>
    <File>aatp-20211231_pre.xml</File>
    <File>ex31-1.htm</File>
    <File>ex32-1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
    <File>image_007.jpg</File>
    <File>image_008.jpg</File>
    <File>image_009.jpg</File>
    <File>image_010.jpg</File>
    <File>image_011.jpg</File>
    <File>image_012.jpg</File>
    <File>image_013.jpg</File>
    <File>image_014.jpg</File>
    <File>image_015.jpg</File>
    <File>image_016.jpg</File>
    <File>report_001.jpg</File>
    <File>report_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="694">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>117
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form10-k.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "contextCount": 223,
   "dts": {
    "calculationLink": {
     "local": [
      "aatp-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aatp-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form10-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aatp-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aatp-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aatp-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 612,
   "entityCount": 1,
   "hidden": {
    "http://agapeatp.com/20211231": 22,
    "http://fasb.org/us-gaap/2021-01-31": 74,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 101
   },
   "keyCustom": 80,
   "keyStandard": 292,
   "memberCustom": 71,
   "memberStandard": 30,
   "nsprefix": "AATP",
   "nsuri": "http://agapeatp.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://agapeatp.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - BUSINESS COMBINATION",
     "role": "http://agapeatp.com/role/BusinessCombination",
     "shortName": "BUSINESS COMBINATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - CASH AND CASH EQUIVALENTS",
     "role": "http://agapeatp.com/role/CashAndCashEquivalents",
     "shortName": "CASH AND CASH EQUIVALENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - ACCOUNTS RECEIVABLE",
     "role": "http://agapeatp.com/role/AccountsReceivable",
     "shortName": "ACCOUNTS RECEIVABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - INVENTORIES",
     "role": "http://agapeatp.com/role/Inventories",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:PrepaymentsAndDepositsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - PREPAYMENTS AND DEPOSITS",
     "role": "http://agapeatp.com/role/PrepaymentsAndDeposits",
     "shortName": "PREPAYMENTS AND DEPOSITS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:PrepaymentsAndDepositsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET",
     "role": "http://agapeatp.com/role/PropertyAndEquipmentNet",
     "shortName": "PROPERTY AND EQUIPMENT, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - INTANGIBLE ASSETS, NET",
     "role": "http://agapeatp.com/role/IntangibleAssetsNet",
     "shortName": "INTANGIBLE ASSETS, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:InvestmentInMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES",
     "role": "http://agapeatp.com/role/InvestmentInMarketableSecurities",
     "shortName": "INVESTMENT IN MARKETABLE SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:InvestmentInMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES",
     "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecurities",
     "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES",
     "role": "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities",
     "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "role": "http://agapeatp.com/role/BalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS",
     "role": "http://agapeatp.com/role/RelatedPartyBalancesAndTransactions",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - STOCKHOLDERS\u2019 EQUITY",
     "role": "http://agapeatp.com/role/StockholdersEquity",
     "shortName": "STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - NON-CONTROLLING INTEREST",
     "role": "http://agapeatp.com/role/Non-controllingInterest",
     "shortName": "NON-CONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - INCOME TAXES",
     "role": "http://agapeatp.com/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - CONCENTRATIONS OF RISKS",
     "role": "http://agapeatp.com/role/ConcentrationsOfRisks",
     "shortName": "CONCENTRATIONS OF RISKS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://agapeatp.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://agapeatp.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)",
     "role": "http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables",
     "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://agapeatp.com/role/BalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Tables)",
     "role": "http://agapeatp.com/role/VariableInterestEntityVieTables",
     "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - BUSINESS COMBINATION (Tables)",
     "role": "http://agapeatp.com/role/BusinessCombinationTables",
     "shortName": "BUSINESS COMBINATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - ACCOUNTS RECEIVABLE (Tables)",
     "role": "http://agapeatp.com/role/AccountsReceivableTables",
     "shortName": "ACCOUNTS RECEIVABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - INVENTORIES (Tables)",
     "role": "http://agapeatp.com/role/InventoriesTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)",
     "role": "http://agapeatp.com/role/PrepaymentsAndDepositsTables",
     "shortName": "PREPAYMENTS AND DEPOSITS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)",
     "role": "http://agapeatp.com/role/PropertyAndEquipmentNetTables",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - INTANGIBLE ASSETS, NET (Tables)",
     "role": "http://agapeatp.com/role/IntangibleAssetsNetTables",
     "shortName": "INTANGIBLE ASSETS, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)",
     "role": "http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables",
     "shortName": "INVESTMENT IN MARKETABLE SECURITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:NonMarketableSecuritiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)",
     "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables",
     "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:NonMarketableSecuritiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)",
     "role": "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables",
     "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)",
     "role": "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "AATP:RevenueFromRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "role": "http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfNonControllingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - NON-CONTROLLING INTEREST (Tables)",
     "role": "http://agapeatp.com/role/Non-controllingInterestTables",
     "shortName": "NON-CONTROLLING INTEREST (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfNonControllingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://agapeatp.com/role/IncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://agapeatp.com/role/CommitmentsAndContingenciesTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_custom_SubsidiaryCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:NameOftheCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
     "shortName": "SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_custom_SubsidiaryCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:NameOftheCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)",
     "role": "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
     "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31_custom_AgapeATPInternationalHoldingLimitedMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
     "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails",
     "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
     "shortName": "SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_custom_SurvivorSelectMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31_custom_PeriodEndMYRMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails",
     "shortName": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31_custom_PeriodEndMYRMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity",
     "role": "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity",
     "shortName": "Consolidated Statements of Changes in Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryWriteDown",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "AATP:PrepaymentsAndDepositsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "AATP:AllowanceForDoubtfulAccountsReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure -  SCHEDULE OF VARIABLE INTEREST ENTITY (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
     "shortName": "SCHEDULE OF VARIABLE INTEREST ENTITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31_custom_SubsidiaryCompanyThreeMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Details Narrative)",
     "role": "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative",
     "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure -  SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)",
     "role": "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails",
     "shortName": "SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails",
     "shortName": "SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - BUSINESS COMBINATION (Details Narrative)",
     "role": "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
     "shortName": "BUSINESS COMBINATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-03-31_custom_MrHowKokChoongMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)",
     "role": "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative",
     "shortName": "CASH AND CASH EQUIVALENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure -  SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails",
     "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure -  SCHEDULE OF INVENTORIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfInventoriesDetails",
     "shortName": "SCHEDULE OF INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryWriteDown",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - INVENTORIES (Details Narrative)",
     "role": "http://agapeatp.com/role/InventoriesDetailsNarrative",
     "shortName": "INVENTORIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://agapeatp.com/role/StatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "AATP:ReceivablesFromSalesDistributors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure -  SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails",
     "shortName": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "AATP:ReceivablesFromSalesDistributors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock",
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails",
     "shortName": "SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock",
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails",
     "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)",
     "role": "http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CapitalizedComputerSoftwareGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails",
     "shortName": "SCHEDULE OF INTANGIBLE ASSETS, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CapitalizedComputerSoftwareGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)",
     "role": "http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative",
     "shortName": "INTANGIBLE ASSETS, NET (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtCost",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails",
     "shortName": "SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "AATP:InvestmentsIncomeDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtCost",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)",
     "role": "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
     "shortName": "INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2018-10-16_custom_GreenproCapitalCorpMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:InvestmentOwnedBalanceShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtCost",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
     "shortName": "SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:NonMarketableSecuritiesTableTextBlock",
       "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31_custom_PhoenixPlusCorpMember",
      "decimals": "0",
      "lang": null,
      "name": "AATP:InvestmentInNonMarketableSecuritiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtCost",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000069 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)",
     "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
     "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-04-03_custom_PhoenixPlusCorpMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND",
     "role": "http://agapeatp.com/role/OrganizationAndBusinessBackground",
     "shortName": "ORGANIZATION AND BUSINESS BACKGROUND",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000070 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails",
     "shortName": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000071 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails",
     "shortName": "SCHEDULE OF RELATED PARTIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000072 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "role": "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfNonControllingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "AATP:NonControllingInterestPaidinCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000073 - Disclosure - SCHEDULE OF NON CONTROLLING INTEREST (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails",
     "shortName": "SCHEDULE OF NON CONTROLLING INTEREST (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfNonControllingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "AATP:NonControllingInterestPaidinCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000074 - Disclosure -  SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
     "shortName": "SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000075 - Disclosure -  SCHEDULE OF PROVISION FOR INCOME TAX (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails",
     "shortName": "SCHEDULE OF PROVISION FOR INCOME TAX (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000076 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails",
     "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000077 - Disclosure -  SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)",
     "role": "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
     "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000078 - Disclosure -  SCHEDULE OF DEFERRED TAX ASSETS (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails",
     "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "AATP:DeferredTaxLiabilitiesDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000079 - Disclosure - INCOME TAXES (Details Narrative)",
     "role": "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:TaxCutsAndJobsActOf2017OtherTaxEffectDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Deposits",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000080 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)",
     "role": "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
     "shortName": "CONCENTRATIONS OF RISKS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Deposits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000081 - Disclosure -  SCHEDULE OF LEASE COMMITMENTS (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails",
     "shortName": "SCHEDULE OF LEASE COMMITMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000082 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-05-302021-05-31",
      "decimals": null,
      "lang": "en-US",
      "name": "AATP:LeaseExpirationTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-012022-01-20_us-gaap_SubsequentEventMember_custom_MrHowKokChoongMember_custom_ShareForfeitureAgreementMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000083 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "role": "http://agapeatp.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-012022-01-20_us-gaap_SubsequentEventMember_custom_MrHowKokChoongMember_custom_ShareForfeitureAgreementMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d)",
     "role": "http://agapeatp.com/role/VariableInterestEntityVie",
     "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 102,
   "tag": {
    "AATP_AATPHKMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AATP HK [Member]",
        "label": "AATP HK [Member]"
       }
      }
     },
     "localname": "AATPHKMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AATPLBASLSEAAndWATPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AATP LB, ASL, SEA and WATP [Member]",
        "label": "AATP LB, ASL, SEA and WATP [Member]"
       }
      }
     },
     "localname": "AATPLBASLSEAAndWATPMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AATPLBASLSEAWATPAndDSYMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AATP LB, ASL, SEA, WATP, and DSY [Member]",
        "label": "AATP LB, ASL, SEA, WATP, and DSY [Member]"
       }
      }
     },
     "localname": "AATPLBASLSEAWATPAndDSYMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AccountsReceivableAndAccountsReceivableRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable and accounts receivable related parties.",
        "label": "Accounts receivable and accounts receivable related parties",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsReceivableAndAccountsReceivableRelatedParties",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_AccruedPromotionExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued promotion expenses.",
        "label": "Promotion expenses"
       }
      }
     },
     "localname": "AccruedPromotionExpenses",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_AgapeATPAsiaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agape ATP Asia Limited [Member]",
        "label": "Agape ATP Asia Limited [Member]"
       }
      }
     },
     "localname": "AgapeATPAsiaLimitedMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeATPInternationalHoldingLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agape ATP International Holding Limited [Member]",
        "label": "Agape ATP International Holding Limited [Member]"
       }
      }
     },
     "localname": "AgapeATPInternationalHoldingLimitedMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeSuperiorLivingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASL [Member]",
        "label": "ASL [Member]"
       }
      }
     },
     "localname": "AgapeSuperiorLivingMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeSuperiorLivingPtyLtdASLPLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agape Superior Living Pty Ltd ASLPL [Member]",
        "label": "Agape Superior Living Pty Ltd ASLPL [Member]"
       }
      }
     },
     "localname": "AgapeSuperiorLivingPtyLtdASLPLMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeSuperiorLivingPtyLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agape Superior Living Pty Ltd [Member]",
        "label": "Agape Superior Living Pty Ltd [Member]"
       }
      }
     },
     "localname": "AgapeSuperiorLivingPtyLtdMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeSuperiorLivingSdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agape Superior Living Sdn Bhd [Member]",
        "label": "Agape Superior Living Sdn Bhd [Member]"
       }
      }
     },
     "localname": "AgapeSuperiorLivingSdnBhdMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for doubtful accounts receivable exchange rate effect.",
        "label": "Exchange rate effect"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableExchangeRateEffect",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_AllowanceForDoubtfulAccountsReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for doubtful accounts,",
        "label": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivablesCurrent",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BetaMaxxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beta Maxx [Member]",
        "label": "Beta Maxx [Member]"
       }
      }
     },
     "localname": "BetaMaxxMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition pro-forma earnings per share basic and diluted",
        "label": "Net income per common share - basic and diluted"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasicDiluted",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition pro-forma weighted average number of common shares outstanding basic snd diluted.",
        "label": "Weighted average number of common shares outstanding - basic and diluted"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "AATP_BusinessAcquisitionsProFormaCostOfRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of revenue.",
        "label": "BusinessAcquisitionsProFormaCostOfRevenue",
        "verboseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaCostOfRevenue",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaGrossProfit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross profit.",
        "label": "BusinessAcquisitionsProFormaGrossProfit",
        "verboseLabel": "Gross profit"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaGrossProfit",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisitions pro-forma income loss before income taxes.",
        "label": "Income before income taxes"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisitions pro-forma income tax expense benefit.",
        "label": "Provision for income taxes"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaOperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total operating expenses.",
        "label": "Total operating expenses"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaOperatingExpenses",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other income (expense), net.",
        "label": "Other income (expense), net"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current assets prepaid taxes.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes",
        "verboseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current assets receivables related parties.",
        "label": "Other receivables - related parties"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_COVIDNineteenImpactMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Impact [Member]",
        "label": "COVID-19 Impact [Member]"
       }
      }
     },
     "localname": "COVIDNineteenImpactMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes in right of use asset and lease liabilities due to lease modifications.",
        "label": "Changes in right-of-use assets and lease liabilities due to lease modifications"
       }
      }
     },
     "localname": "ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_ComputerAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer And Office Equipment [Member]",
        "label": "Computer And Office Equipment [Member]"
       }
      }
     },
     "localname": "ComputerAndOfficeEquipmentMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ContributionsFromNoncontrollingInterestShareholders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contributions from non controlling interest shareholders.",
        "label": "Contributions from non-controlling interest shareholders"
       }
      }
     },
     "localname": "ContributionsFromNoncontrollingInterestShareholders",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_DSYWellnessAndLongevityCenterSdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DSY Wellness &amp; Longevity Center Sdn Bhd [Member].",
        "label": "DSY Wellness &amp; Longevity Center Sdn Bhd [Member]"
       }
      }
     },
     "localname": "DSYWellnessAndLongevityCenterSdnBhdMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_DSwissIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DSwiss Inc [Member]",
        "label": "DSwiss Inc [Member]"
       }
      }
     },
     "localname": "DSwissIncMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets operating loss carryforwards utilized and reduced.",
        "label": "Cumulative net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_DeferredTaxLiabilitiesDepreciation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities, depreciation.",
        "label": "DeferredTaxLiabilitiesDepreciation",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciation",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_DefinedContributionPlanPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan [Policy Text Block]",
        "label": "Defined contribution plan"
       }
      }
     },
     "localname": "DefinedContributionPlanPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_DepositForInsurance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposit for insurance.",
        "label": "Deposit for insurance"
       }
      }
     },
     "localname": "DepositForInsurance",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_DepositsToSupplier": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": {
       "order": 2.0,
       "parentTag": "AATP_PrepaidExpensesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposits to supplier.",
        "label": "Deposits to suppliers"
       }
      }
     },
     "localname": "DepositsToSupplier",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_DirectorsOfUnreservedInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors of Unreserved Investments [Member]",
        "label": "Directors of Unreserved Investments [Member]"
       }
      }
     },
     "localname": "DirectorsOfUnreservedInvestmentMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_DisclosureInvestmentInMarketableSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Marketable Securities",
        "verboseLabel": "Schedule Of Investment In Marketable Securities"
       }
      }
     },
     "localname": "DisclosureInvestmentInMarketableSecuritiesAbstract",
     "nsuri": "http://agapeatp.com/20211231",
     "xbrltype": "stringItemType"
    },
    "AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Non-marketable Securities"
       }
      }
     },
     "localname": "DisclosureInvestmentInNonmarketableSecuritiesAbstract",
     "nsuri": "http://agapeatp.com/20211231",
     "xbrltype": "stringItemType"
    },
    "AATP_DisclosurePrepaymentsAndDepositsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments And Deposits",
        "terseLabel": "Schedule Of Changes In Allowance For Doubtful Accounts",
        "verboseLabel": "Schedule Of Prepaid Expenses And Deposits"
       }
      }
     },
     "localname": "DisclosurePrepaymentsAndDepositsAbstract",
     "nsuri": "http://agapeatp.com/20211231",
     "xbrltype": "stringItemType"
    },
    "AATP_DividendShareForCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend share for common stock.",
        "label": "[custom:DividendShareForCommonStock]"
       }
      }
     },
     "localname": "DividendShareForCommonStock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "AATP_ECommerceCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E-commerce [Member].",
        "label": "E-commerce [Member]"
       }
      }
     },
     "localname": "ECommerceCompanyMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_EmployeesProvidentFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees Provident Fund [Member]",
        "label": "Employees Provident Fund [Member]"
       }
      }
     },
     "localname": "EmployeesProvidentFundMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_EmploymentInsuranceSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment Insurance System [Member]",
        "label": "Employment Insurance System [Member]"
       }
      }
     },
     "localname": "EmploymentInsuranceSystemMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_EnergetiqueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Energetique [Member]",
        "label": "Energetique [Member]"
       }
      }
     },
     "localname": "EnergetiqueMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_EnergizedMineralConcentrateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Energized Mineral Concentrate [Member]",
        "label": "Energized Mineral Concentrate [Member]"
       }
      }
     },
     "localname": "EnergizedMineralConcentrateMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_MarketableSecuritiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange rate effect.",
        "label": "Exchange rate effect [Default Label]",
        "verboseLabel": "Exchange rate effect"
       }
      }
     },
     "localname": "ExchangeRateEffectOnInvestmentInMarketableSecurites",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_ForeignCurrencyExchangeRateAverage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign currency exchange rate period average.",
        "label": "Foreign currency exchange rate period average"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateAverage",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "AATP_ForfeitedCouponIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forfeited coupon income.",
        "label": "Forfeited coupon income"
       }
      }
     },
     "localname": "ForfeitedCouponIncome",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_GreenproCapitalCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Greenpro Capital Corp. [Member]",
        "label": "Greenpro Capital Corp. [Member]"
       }
      }
     },
     "localname": "GreenproCapitalCorpMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HKCHoldingsSdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HKC Holdings Sdn Bhd [Member]",
        "label": "HKC Holdings Sdn Bhd [Member]"
       }
      }
     },
     "localname": "HKCHoldingsSdnBhdMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HealthAndWellnessProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health and Wellness Products [Member]",
        "label": "Health and Wellness Products [Member]"
       }
      }
     },
     "localname": "HealthAndWellnessProductsMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HealthAndWellnessServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health And Wellness Services [Member]",
        "label": "Health And Wellness Services [Member]"
       }
      }
     },
     "localname": "HealthAndWellnessServicesMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HostastaySdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hostastay Sdn Bhd [Member]",
        "label": "Hostastay Sdn Bhd [Member]"
       }
      }
     },
     "localname": "HostastaySdnBhdMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HostastaySdnBhdOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hostastay Sdn. Bhd.[Member]",
        "label": "Hostastay Sdn. Bhd [Member]"
       }
      }
     },
     "localname": "HostastaySdnBhdOneMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HowKokChoongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "How Kok Choong [Member]",
        "label": "How Kok Choong [Member]"
       }
      }
     },
     "localname": "HowKokChoongMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HowKokChoongTalentLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "How Kok Choong Talent Limited [Member]",
        "label": "How Kok Choong Talent Limited [Member]"
       }
      }
     },
     "localname": "HowKokChoongTalentLimitedMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HumanResourceDevelopmentFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Human Resource Development Fund [Member]",
        "label": "Human Resource Development Fund [Member]"
       }
      }
     },
     "localname": "HumanResourceDevelopmentFundMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in operating lease liabilities.",
        "label": "IncreaseDecreaseInOperatingLeaseLiabilities",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_IncreaseDecreaseInROUAssetsAndLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in ROU assets and liabilities.",
        "label": "Reduction in ROU assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInROUAssetsAndLiabilities",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial recognition of right-of-use assets and lease liabilities.",
        "label": "Initial recognition of right-of-use assets and lease liabilities"
       }
      }
     },
     "localname": "InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InvestmentInMarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment In Marketable Securities [Text Block]",
        "label": "INVESTMENT IN MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "InvestmentInMarketableSecuritiesTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_InvestmentInNonMarketableSecuritiesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in non-marketable securities.",
        "label": "Investment in non-marketable securities [Default Label]",
        "verboseLabel": "Investment in non-marketable securities"
       }
      }
     },
     "localname": "InvestmentInNonMarketableSecuritiesGross",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InvestmentInNonMarketableSecuritiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in non-marketable securities.",
        "label": "Investment in non-marketable securities",
        "verboseLabel": "Total investment in non-marketable securities"
       }
      }
     },
     "localname": "InvestmentInNonMarketableSecuritiesNoncurrent",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InvestmentInNonMarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment In Non Marketable Securities [Text Block]",
        "label": "INVESTMENT IN NON-MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "InvestmentInNonMarketableSecuritiesTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_InvestmentInNonmarketableSecuritiesNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in non-marketable securities, net.",
        "label": "Investment in non-marketable securities, net",
        "verboseLabel": "Investment in non-marketable securities"
       }
      }
     },
     "localname": "InvestmentInNonmarketableSecuritiesNet",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InvestmentsIncomeDividend": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_MarketableSecuritiesNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend income .",
        "label": "Dividend income",
        "negatedLabel": "Dividend income from Greenpro Capital Corp."
       }
      }
     },
     "localname": "InvestmentsIncomeDividend",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_IonizedCalMagMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ionized Cal-Mag [Member]",
        "label": "Ionized Cal-Mag [Member]"
       }
      }
     },
     "localname": "IonizedCalMagMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_IronMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Iron [Member]",
        "label": "Iron [Member]"
       }
      }
     },
     "localname": "IronMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in exchange for acquisition payment of acquisition.",
        "label": "Issuance of common stock in exchange for acquisition payment of ASL"
       }
      }
     },
     "localname": "IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_LabuanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Labuan [Member]",
        "label": "Labuan [Member]"
       }
      }
     },
     "localname": "LabuanMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_LeaseExpirationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease expiration term.",
        "label": "Lease expiration term"
       }
      }
     },
     "localname": "LeaseExpirationTerm",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "AATP_MYRCurrencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MYR Currency [Member]",
        "label": "MYR Currency [Member]"
       }
      }
     },
     "localname": "MYRCurrencyMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_MarketableSecuritiesUnrealizedHoldingGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_MarketableSecuritiesNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized holding (loss) gain.",
        "label": "Unrealized holding (loss) gain",
        "negatedLabel": "Unrealized holding (loss) gain"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedHoldingGainLoss",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_MitogizeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mitogize [Member]",
        "label": "Mitogize [Member]"
       }
      }
     },
     "localname": "MitogizeMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_MonthlySalary": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly salary.",
        "label": "Monthly salary"
       }
      }
     },
     "localname": "MonthlySalary",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_MrHowKokChoongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mr.How Kok Choong [Member]",
        "label": "Mr.How Kok Choong [Member]"
       }
      }
     },
     "localname": "MrHowKokChoongMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_NameOftheCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the company name.",
        "label": "Subsidiary company name"
       }
      }
     },
     "localname": "NameOftheCompany",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_NoCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No Customer [Member].",
        "label": "No Customer [Member]"
       }
      }
     },
     "localname": "NoCustomerMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_NoOneMEDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No. 1 MED [Member]",
        "label": "No. 1 MED [Member]"
       }
      }
     },
     "localname": "NoOneMEDMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_NoSalesDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No Sales Distributor [Member]",
        "label": "No Sales Distributor [Member]"
       }
      }
     },
     "localname": "NoSalesDistributorMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_NonControllingInterestAccumulatedDeficit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non controlling interest accumulated deficit.",
        "label": "NonControllingInterestAccumulatedDeficit",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "NonControllingInterestAccumulatedDeficit",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non controlling interest accumulated other comprehensive income.",
        "label": "NonControllingInterestAccumulatedOtherComprehensiveIncome",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "NonControllingInterestAccumulatedOtherComprehensiveIncome",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_NonControllingInterestAsl": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non controlling interest asl.",
        "label": "ASL"
       }
      }
     },
     "localname": "NonControllingInterestAsl",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_NonControllingInterestNonControllingInterestGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non controlling interest gross.",
        "label": "Non Controlling interest Gross"
       }
      }
     },
     "localname": "NonControllingInterestNonControllingInterestGross",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_NonControllingInterestPaidinCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non controlling interest paid in capital.",
        "label": "Paid-in capital"
       }
      }
     },
     "localname": "NonControllingInterestPaidinCapital",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_NonMarketableSecuritiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Marketable Securities [Policy Text Block]",
        "label": "Investment in non-marketable equity securities"
       }
      }
     },
     "localname": "NonMarketableSecuritiesPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_NonMarketableSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Marketable Securities [Table Text Block]",
        "label": "SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "NonMarketableSecuritiesTableTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_NoncontrollingInterestPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest [Policy Text Block]",
        "label": "Non-controlling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_OmegaBlendMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Omega Blend [Member]",
        "label": "Omega Blend [Member]"
       }
      }
     },
     "localname": "OmegaBlendMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_OneSalesDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Sales Distributor [Member]",
        "label": "One Sales Distributor [Member]"
       }
      }
     },
     "localname": "OneSalesDistributorMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_OneVendorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Vendor [Member]",
        "label": "One Vendor [Member]"
       }
      }
     },
     "localname": "OneVendorMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_OrganicYouthCareCleansingBarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organic Youth Care Cleansing Bar [Member]",
        "label": "Organic Youth Care Cleansing Bar [Member]"
       }
      }
     },
     "localname": "OrganicYouthCareCleansingBarMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_OtherAccountPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "OtherAccountPayableAndAccruedLiabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherAccountPayableAndAccruedLiabilities",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_OtherPayablesRelatedPartyCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other payables - related party.",
        "label": "OtherPayablesRelatedPartyCurrent",
        "verboseLabel": "Other payables and accrued liabilities"
       }
      }
     },
     "localname": "OtherPayablesRelatedPartyCurrent",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_ParticularsOfIssuedCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Particulars of issued capital.",
        "label": "Particulars of issued capital"
       }
      }
     },
     "localname": "ParticularsOfIssuedCapital",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_PercentageOfCommonStockIssuedAndOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of common stock issued and outstanding.",
        "label": "Percentage of common stock issued and outstanding"
       }
      }
     },
     "localname": "PercentageOfCommonStockIssuedAndOutstanding",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "AATP_PeriodAverageHKDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period-average HKD [Member]",
        "label": "Period-average HKD [Member]"
       }
      }
     },
     "localname": "PeriodAverageHKDMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PeriodAverageMYRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period-average MYR [Member]",
        "label": "Period-average MYR [Member]"
       }
      }
     },
     "localname": "PeriodAverageMYRMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PeriodEndHKDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period-end HKD [Member]",
        "label": "Period-end HKD [Member]"
       }
      }
     },
     "localname": "PeriodEndHKDMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PeriodEndMYRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period-end MYR [Member]",
        "label": "Period-end MYR [Member]"
       }
      }
     },
     "localname": "PeriodEndMYRMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PhoenixPlusCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phoenix Plus Corporation [Member]",
        "label": "Phoenix Plus Corporation [Member]"
       }
      }
     },
     "localname": "PhoenixPlusCorpMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PlaceAndDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Place and date of incorporation.",
        "label": "Place and date of incorporation"
       }
      }
     },
     "localname": "PlaceAndDateOfIncorporation",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_PreferredStockDividendIncomeStatementImpact": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Dividend income from marketable securities",
        "negatedLabel": "Dividend income from marketable securities"
       }
      }
     },
     "localname": "PreferredStockDividendIncomeStatementImpact",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_PrepaidExpensesGross": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses gross.",
        "label": "PrepaidExpensesGross",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "PrepaidExpensesGross",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_PrepaidTaxesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Taxes [Policy Text Block]",
        "label": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxesPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_PrepaymentsAndDepositsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayments And Deposits [Policy Text Block]",
        "label": "PrepaymentsAndDepositsPolicyTextBlock",
        "verboseLabel": "Prepayments and deposits"
       }
      }
     },
     "localname": "PrepaymentsAndDepositsPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_PrepaymentsAndDepositsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayments and Deposits [Text Block]",
        "label": "PREPAYMENTS AND DEPOSITS"
       }
      }
     },
     "localname": "PrepaymentsAndDepositsTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/PrepaymentsAndDeposits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_PrincipalActivities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal activities.",
        "label": "Principal activities"
       }
      }
     },
     "localname": "PrincipalActivities",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of non-marketable securities to a related party.",
        "label": "Proceeds from sale of non-marketable securities to a related party",
        "verboseLabel": "Proceeds from investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_ReceivablesFromSalesDistributors": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": {
       "order": 1.0,
       "parentTag": "AATP_PrepaidExpensesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables from sales distributors.",
        "label": "Receivables from sales distributors"
       }
      }
     },
     "localname": "ReceivablesFromSalesDistributors",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_RelatedPartiesNatureDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties nature, description.",
        "label": "Nature"
       }
      }
     },
     "localname": "RelatedPartiesNatureDescription",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_RelatedPartiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Parties [Policy Text Block]",
        "label": "Related parties"
       }
      }
     },
     "localname": "RelatedPartiesPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_RelatedPartiesRelationshipsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties, relationships, description.",
        "label": "Relationship"
       }
      }
     },
     "localname": "RelatedPartiesRelationshipsDescription",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_RevenueFromRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "REVENUE \u2013 RELATED PARTY"
       }
      }
     },
     "localname": "RevenueFromRelatedParty",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_SEATechVenturesCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SEATech Ventures Corp [Member]",
        "label": "SEATech Ventures Corp [Member]"
       }
      }
     },
     "localname": "SEATechVenturesCorpMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SalaryPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Salary percentage.",
        "label": "Salary percentage"
       }
      }
     },
     "localname": "SalaryPercentage",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "AATP_SaleOfInvestmentInNonmarketableSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of investment in non-marketable securities.",
        "label": "Less: Sale of investment in non-marketable securities"
       }
      }
     },
     "localname": "SaleOfInvestmentInNonmarketableSecurities",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of non-marketable securities to related party in exchange for acquisition.",
        "label": "Sale of non-marketable securities to a related party in exchange for acquisition payment of ASL"
       }
      }
     },
     "localname": "SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_SalesCommissionsAndFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission expense.",
        "label": "Commission expense"
       }
      }
     },
     "localname": "SalesCommissionsAndFee",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_SalesCommissionsAndFees1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).",
        "label": "Commission expenses [Default Label]",
        "verboseLabel": "Commission expenses"
       }
      }
     },
     "localname": "SalesCommissionsAndFees1",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Changes in Allowance for Doubtful Accounts [Table Text Block]",
        "label": "SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/PrepaymentsAndDepositsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Disaggregated Information Of Revenues [Table Text Block]",
        "label": "SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES"
       }
      }
     },
     "localname": "ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Estimated Useful Lives Of Intangible Assets Net [Table Text Block]",
        "label": "SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Estimated Useful Lives Of Property And Equipment [Table Text Block]",
        "label": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfNonControllingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Non Controlling Interest [Table Text Block]",
        "label": "SCHEDULE OF NON CONTROLLING INTEREST"
       }
      }
     },
     "localname": "ScheduleOfNonControllingInterestTableTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/Non-controllingInterestTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Other Payables And Accrued Liabilities [Table Text Block]",
        "label": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES"
       }
      }
     },
     "localname": "ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Prepaid Expenses and Deposits [Table Text Block]",
        "label": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS"
       }
      }
     },
     "localname": "ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/PrepaymentsAndDepositsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ShareExchangeAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Exchange Agreement [Member]",
        "label": "Share Exchange Agreement [Member]"
       }
      }
     },
     "localname": "ShareExchangeAgreementMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ShareForfeitureAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Forfeiture Agreement [Member]",
        "label": "Share Forfeiture Agreement [Member]"
       }
      }
     },
     "localname": "ShareForfeitureAgreementMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ShareForfeitureAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Forfeiture Agreements [Member]",
        "label": "Share Forfeiture Agreements [Member]"
       }
      }
     },
     "localname": "ShareForfeitureAgreementsMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ShareholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholders [Member]",
        "label": "Shareholders [Member]"
       }
      }
     },
     "localname": "ShareholdersMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ShippingAndHandlingPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shipping and Handling [Policy Text Block]",
        "label": "Shipping and handling"
       }
      }
     },
     "localname": "ShippingAndHandlingPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_SocialSecurityOrganizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Social Security Organization [Member]",
        "label": "Social Security Organization [Member]"
       }
      }
     },
     "localname": "SocialSecurityOrganizationMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company Five [Member]",
        "label": "Subsidiary Company Five [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyFiveMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company Four [Member]",
        "label": "Subsidiary Company Four [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyFourMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company [Member]",
        "label": "Subsidiary Company [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company One [Member]",
        "label": "Subsidiary Company One [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyOneMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company Three [Member]",
        "label": "Subsidiary Company Three [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyThreeMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company Two [Member]",
        "label": "Subsidiary Company Two [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyTwoMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SurvivorSelectMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Survivor Select [Member]",
        "label": "Survivor Select [Member]"
       }
      }
     },
     "localname": "SurvivorSelectMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_THThreeTechnologySdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TH3 Technology Sdn Bhd [Member].",
        "label": "TH3 Technology Sdn Bhd [Member]"
       }
      }
     },
     "localname": "THThreeTechnologySdnBhdMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_TrainingCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Training Center [Member]",
        "label": "Training Center [Member]"
       }
      }
     },
     "localname": "TrainingCenterMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_TrimPlusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trim Plus [Member]",
        "label": "Trim Plus [Member]"
       }
      }
     },
     "localname": "TrimPlusMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_UnreservedSdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unreserved Sdn Bhd [Member]",
        "label": "Unreserved Sdn Bhd [Member]"
       }
      }
     },
     "localname": "UnreservedSdnBhdMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_UnutilizedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unutilized [Member]",
        "label": "Unutilized [Member]"
       }
      }
     },
     "localname": "UnutilizedMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VIE consolidated amount of cash and cash equivalents.",
        "label": "VIE consolidated amount of cash and cash equivalents"
       }
      }
     },
     "localname": "VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VIE consolidated amount of other payables and accrued liabilities.",
        "label": "VIE consolidated amount of other payables and accrued liabilities"
       }
      }
     },
     "localname": "VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VIE consolidated amount of Prepaid taxes .",
        "label": "VIE consolidated amount of prepaid taxes"
       }
      }
     },
     "localname": "VariableInterestEntityConsolidatedAmountOfPrepaidTaxes",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_VegeFruitFiberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vege Fruit Fiber [Member]",
        "label": "Vege Fruit Fiber [Member]"
       }
      }
     },
     "localname": "VegeFruitFiberMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VehicleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vehicle [Member]",
        "label": "Vehicle [Member]"
       }
      }
     },
     "localname": "VehicleMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VendorOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor One [Member]",
        "label": "Vendor One [Member]"
       }
      }
     },
     "localname": "VendorOneMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VendorTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor Two [Member]",
        "label": "Vendor Two [Member]"
       }
      }
     },
     "localname": "VendorTwoMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VettonsSdnBhdOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vettons Sdn Bhd One [Member]",
        "label": "Vettons Sdn Bhd One [Member]"
       }
      }
     },
     "localname": "VettonsSdnBhdOneMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_YoungFormulaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Young Formula [Member]",
        "label": "Young Formula [Member]"
       }
      }
     },
     "localname": "YoungFormulaMember",
     "nsuri": "http://agapeatp.com/20211231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_HK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "HONG KONG"
       }
      }
     },
     "localname": "HK",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_MY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MALAYSIA"
       }
      }
     },
     "localname": "MY",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r574",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r574",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r574",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r574",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r122",
      "r237",
      "r242",
      "r248",
      "r390",
      "r391",
      "r399",
      "r400",
      "r456",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r122",
      "r237",
      "r242",
      "r248",
      "r390",
      "r391",
      "r399",
      "r400",
      "r456",
      "r559"
     ],
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r177",
      "r304",
      "r308",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r253",
      "r274",
      "r316",
      "r319",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r526",
      "r530",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r253",
      "r274",
      "r316",
      "r319",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r526",
      "r530",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r177",
      "r304",
      "r308",
      "r529"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r174",
      "r304",
      "r306",
      "r476",
      "r525",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r174",
      "r304",
      "r306",
      "r476",
      "r525",
      "r527"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r253",
      "r274",
      "r313",
      "r316",
      "r319",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r526",
      "r530",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r253",
      "r274",
      "r313",
      "r316",
      "r319",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r526",
      "r530",
      "r560",
      "r561"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r132",
      "r136",
      "r317"
     ],
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r304",
      "r307",
      "r528",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r304",
      "r307",
      "r528",
      "r544",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r132",
      "r136",
      "r235",
      "r317",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r178",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.",
        "label": "Others"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts payable \u2013 intercompany"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableMember": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations incurred and payable to vendors for goods and services received.",
        "label": "Accounts Payable [Member]"
       }
      }
     },
     "localname": "AccountsPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r12",
      "r45"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r179",
      "r180"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": {
       "order": 1.0,
       "parentTag": "AATP_AccountsReceivableAndAccountsReceivableRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r26",
      "r179",
      "r180"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedPartiesCurrent": {
     "auth_ref": [
      "r53",
      "r121",
      "r450",
      "r453"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": {
       "order": 2.0,
       "parentTag": "AATP_AccountsReceivableAndAccountsReceivableRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.",
        "label": "Accounts Receivable, Related Parties, Current",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AccountsReceivableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "auth_ref": [
      "r12",
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Payroll"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Commission"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r43",
      "r221"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r63",
      "r65",
      "r66",
      "r511",
      "r535",
      "r536"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r62",
      "r66",
      "r74",
      "r75",
      "r76",
      "r124",
      "r125",
      "r126",
      "r397",
      "r531",
      "r532",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r329",
      "r459"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r326",
      "r327",
      "r328",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net (loss) income to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "verboseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "auth_ref": [
      "r185"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.",
        "label": "Allowance for Doubtful Accounts, Premiums and Other Receivables",
        "negatedLabel": "Less: Provision for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r185",
      "r193",
      "r194",
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r33",
      "r185",
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts receivable, allowance for credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.",
        "label": "Addition"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r196"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Write off"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r102",
      "r207",
      "r213"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Potentially dilutive securities outstanding"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r116",
      "r163",
      "r166",
      "r172",
      "r191",
      "r237",
      "r238",
      "r239",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r390",
      "r399",
      "r423",
      "r457",
      "r459",
      "r493",
      "r510"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r10",
      "r60",
      "r116",
      "r191",
      "r237",
      "r238",
      "r239",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r390",
      "r399",
      "r423",
      "r457",
      "r459"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Total current assets",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r321",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r315",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r315",
      "r318",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r370",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "SCHEDULE OF PRO FORMA BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": {
     "auth_ref": [
      "r370",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.",
        "label": "Loss from operations"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r370",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Net income"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r370",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r379",
      "r380",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Purchase consideration value"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Loan payable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombination"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Total assets",
        "verboseLabel": "Business combination, recognized identifiable assets acquired and liabilities assumed, assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "verboseLabel": "Total current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Prepayments and other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Other receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "verboseLabel": "Total current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Accounts payable - related party"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "verboseLabel": "Customer deposits"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "verboseLabel": "Other payables and accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Deferred taxes asset, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r374",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r374",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Total net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Total other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r374",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r3",
      "r123",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "ORGANIZATION AND BUSINESS BACKGROUND"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackground"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Computer software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r39",
      "r459",
      "r538",
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash in bank"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r39",
      "r104"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents (Included $17,493 and $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.",
        "label": "CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r18",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r98",
      "r104",
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of year",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r98",
      "r424"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommissionsExpensePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commissions incurred in relation to revenue generating activities or operations.",
        "label": "Commission expenses"
       }
      }
     },
     "localname": "CommissionsExpensePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r232",
      "r233",
      "r234",
      "r236",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Ordinary shares no par value"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "verboseLabel": "Ordinary shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r459"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 290,460,047 and 376,452,047 shares issued and outstanding as of December 31, 2021 and 2020, respectively."
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r68",
      "r70",
      "r71",
      "r82",
      "r503",
      "r521"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r68",
      "r70",
      "r81",
      "r388",
      "r389",
      "r408",
      "r502",
      "r520"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Less: Comprehensive loss attributable to non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r68",
      "r70",
      "r80",
      "r387",
      "r408",
      "r501",
      "r519"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "TOTAL COMPREHENSIVE (LOSS) INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r208",
      "r211",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r153",
      "r154",
      "r177",
      "r420",
      "r421",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r177",
      "r420",
      "r421",
      "r537",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r177",
      "r420",
      "r421",
      "r537",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "CONCENTRATIONS OF RISKS"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisks"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r153",
      "r154",
      "r177",
      "r420",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentrations of risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r151",
      "r153",
      "r154",
      "r155",
      "r420",
      "r422",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r153",
      "r154",
      "r177",
      "r420",
      "r421",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r398",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r293",
      "r294",
      "r305"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Customer deposits"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r88",
      "r476"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "COST OF REVENUE",
        "verboseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Amortization"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsTotalMember": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation.",
        "label": "Cost of Goods and Service Benchmark [Member]"
       }
      }
     },
     "localname": "CostOfGoodsTotalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r353"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "negatedLabel": "- Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r353",
      "r360"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "negatedLabel": "- Local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r152",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r51",
      "r115",
      "r122",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r287",
      "r288",
      "r289",
      "r290",
      "r434",
      "r435",
      "r436",
      "r437",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "verboseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r354",
      "r360"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "negatedLabel": "- Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r117",
      "r354",
      "r360",
      "r361",
      "r362"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred tax expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r335",
      "r336"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r59",
      "r205"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r354",
      "r360"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "negatedLabel": "- Local"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "negatedLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred tax assets operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Net operating loss carry forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred tax valuation allowance",
        "negatedLabel": "Less: valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined contribution plan expense"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Deposits": {
     "auth_ref": [
      "r497"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.",
        "label": "Deposits"
       }
      }
     },
     "localname": "Deposits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r102",
      "r219"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromOfficersOrStockholdersCurrent": {
     "auth_ref": [
      "r53",
      "r450",
      "r452"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are usually due within 1 year (or 1 business cycle).",
        "label": "Amount due from director"
       }
      }
     },
     "localname": "DueFromOfficersOrStockholdersCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueFromRelatedParties": {
     "auth_ref": [
      "r121",
      "r240",
      "r242",
      "r243",
      "r247",
      "r248",
      "r249",
      "r450",
      "r496",
      "r517"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.",
        "label": "Due from Related Parties",
        "verboseLabel": "Amount due from related parties"
       }
      }
     },
     "localname": "DueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r45",
      "r121",
      "r240",
      "r242",
      "r243",
      "r247",
      "r248",
      "r249",
      "r450"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Amount due to a related party"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r121",
      "r240",
      "r242",
      "r243",
      "r247",
      "r248",
      "r249",
      "r450",
      "r498",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to Related Parties",
        "verboseLabel": "Amount due from related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "(LOSS) EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings (loss) per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective tax rate",
        "verboseLabel": "Tax percentage"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r119",
      "r338",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "U.S. statutory rate",
        "verboseLabel": "Tax percentage"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r338",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r338",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Differential tax rate in Malaysia"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r338",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Tax percentage"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r338",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Permanent difference"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r74",
      "r75",
      "r76",
      "r124",
      "r125",
      "r126",
      "r128",
      "r133",
      "r135",
      "r146",
      "r192",
      "r286",
      "r291",
      "r326",
      "r327",
      "r328",
      "r356",
      "r357",
      "r416",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r531",
      "r532",
      "r533",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Proportional of ownership interest and voting power held",
        "terseLabel": "Equity interest percentage",
        "verboseLabel": "Ownership interest percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Estimated useful lives of intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r208",
      "r209",
      "r212",
      "r214",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r208",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r212",
      "r477"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyExchangeRateTranslation1": {
     "auth_ref": [
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.",
        "label": "Foreign Currency Exchange Rate, Translation"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateTranslation1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign currencies translation and transaction"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedLabel": "GENERAL AND ADMINISTRATIVE"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r87",
      "r116",
      "r163",
      "r165",
      "r168",
      "r171",
      "r173",
      "r191",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r423"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross profit",
        "totalLabel": "GROSS PROFIT"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r102",
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r216",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment for long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r118",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Local \u2013 United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r78",
      "r163",
      "r165",
      "r168",
      "r171",
      "r173",
      "r491",
      "r499",
      "r504",
      "r522"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "(Loss) income before income tax",
        "totalLabel": "(LOSS) INCOME BEFORE INCOME TAXES"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r118",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r119",
      "r339",
      "r343",
      "r348",
      "r358",
      "r365",
      "r367",
      "r368",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationDescription": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.",
        "label": "Income tax examination, description"
       }
      }
     },
     "localname": "IncomeTaxExaminationDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": {
     "auth_ref": [
      "r332",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.",
        "label": "Income tax examination, likelihood of unfavorable settlement"
       }
      }
     },
     "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income tax examination, penalties and interest expense",
        "verboseLabel": "Income tax examination penalties and interest expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r134",
      "r135",
      "r162",
      "r337",
      "r359",
      "r366",
      "r523"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income tax expense benefit",
        "negatedLabel": "PROVISION FOR INCOME TAXES",
        "negatedTotalLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r72",
      "r333",
      "r334",
      "r343",
      "r344",
      "r347",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Income tax payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r101",
      "r471"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "verboseLabel": "Customer deposits"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in related party receivables classified as other, due within one year or operating cycle, if longer.",
        "label": "Increase (Decrease) in Due from Other Related Parties, Current",
        "negatedLabel": "Amount due from a related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayable": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Increase (Decrease) in Other Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Other payables and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "negatedLabel": "Prepayments and deposits"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r110",
      "r211",
      "r473",
      "r474",
      "r475",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r206",
      "r210"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r96",
      "r99",
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r57",
      "r459"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r13",
      "r58",
      "r111",
      "r145",
      "r199",
      "r201",
      "r202",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r200"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory write-down",
        "verboseLabel": "Inventories write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InventoriesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtCost": {
     "auth_ref": [
      "r540"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_MarketableSecuritiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of the investment.",
        "label": "Cost of investment",
        "verboseLabel": "Investment amount"
       }
      }
     },
     "localname": "InvestmentOwnedAtCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "auth_ref": [
      "r541",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance held at close of period in number of shares.",
        "label": "Investment in securities, shares",
        "verboseLabel": "Shares purchased during period"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r47",
      "r116",
      "r167",
      "r191",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r391",
      "r399",
      "r400",
      "r423",
      "r457",
      "r458"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r116",
      "r191",
      "r423",
      "r459",
      "r495",
      "r514"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r50",
      "r116",
      "r191",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r391",
      "r399",
      "r400",
      "r423",
      "r457",
      "r458",
      "r459"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Total current liabilities",
        "negatedLabel": "Current liabilities",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r22",
      "r23",
      "r116",
      "r191",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r391",
      "r399",
      "r400",
      "r423",
      "r457",
      "r458"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Non-current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON-CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "ACCOUNTS RECEIVABLE"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/AccountsReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      },
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Investment in marketable securities",
        "totalLabel": "Investment in marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Investment in marketable equity securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Unrealized holding (loss) gain on marketable securities",
        "negatedLabel": "Unrealized holding loss (gain) on marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r55",
      "r116",
      "r191",
      "r237",
      "r242",
      "r243",
      "r244",
      "r248",
      "r249",
      "r423",
      "r494",
      "r513"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "NON-CONTROLLING INTERESTS",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders.",
        "label": "Noncontrolling interest, description"
       }
      }
     },
     "localname": "MinorityInterestDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "NON-CONTROLLING INTEREST"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/Non-controllingInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r98",
      "r100",
      "r103"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r67",
      "r69",
      "r76",
      "r79",
      "r103",
      "r116",
      "r127",
      "r129",
      "r130",
      "r131",
      "r132",
      "r134",
      "r135",
      "r139",
      "r163",
      "r165",
      "r168",
      "r171",
      "r173",
      "r191",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r417",
      "r423",
      "r500",
      "r518"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "totalLabel": "NET (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r67",
      "r69",
      "r76",
      "r134",
      "r135",
      "r394",
      "r407"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r137",
      "r138",
      "r140",
      "r142",
      "r163",
      "r165",
      "r168",
      "r171",
      "r173"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "NET (LOSS) INCOME",
        "terseLabel": "Net (loss) income",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL NON-CASH FLOWS INFORMATION"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r291",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "TOTAL OTHER (EXPENSES) INCOME, NET"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER (EXPENSES) INCOME"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesReceivableRelatedPartiesCurrent": {
     "auth_ref": [
      "r53",
      "r121",
      "r450"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle).",
        "label": "Amount due from related parties"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "TOTAL OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r163",
      "r165",
      "r168",
      "r171",
      "r173"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "LOSS FROM OPERATIONS",
        "verboseLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating lease, rent expenses"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Present value of lease liabilities",
        "verboseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Amortization of operating right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r444",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating lease effective interest rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r443",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating lease, weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r349"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Net operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "Other payables and accrued liabilities ($1,548 and $1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2021 and 2020, respectively.)"
       }
      }
     },
     "localname": "OtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r21",
      "r492",
      "r509"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "totalLabel": "Total other assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r387",
      "r388",
      "r396"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER COMPREHENSIVE (LOSS) INCOME"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "OTHER PAYABLES AND ACCRUED LIABILITIES"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other (Expenses) Income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of interest-bearing domestic time deposit liabilities to total deposit liabilities.",
        "label": "Percentage of Interest rate for time deposits"
       }
      }
     },
     "localname": "PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24",
      "r459"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r8",
      "r37",
      "r38"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepayments and deposits",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r7",
      "r9",
      "r203",
      "r204"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid taxes (Included $1,357 and $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)",
        "verboseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.",
        "label": "(Advances to) Repayments from related parties"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfInvestmentProjects": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of investment projects held by an entity in hopes of getting a future return or interest from it.",
        "label": "Proceeds from sale of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfInvestmentProjects",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r67",
      "r69",
      "r76",
      "r97",
      "r116",
      "r127",
      "r134",
      "r135",
      "r163",
      "r165",
      "r168",
      "r171",
      "r173",
      "r191",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r387",
      "r393",
      "r395",
      "r407",
      "r408",
      "r417",
      "r423",
      "r504"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "NET (LOSS) INCOME"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r43",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r224",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "PROPERTY AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/PropertyAndEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Estimated Useful Lives of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r42",
      "r220"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Subtotal"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r222",
      "r459",
      "r506",
      "r515"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      },
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r41",
      "r222",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r19",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/PropertyAndEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r19",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Estimated Useful Life of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r83",
      "r195"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Provision for doubtful accounts",
        "negatedLabel": "PROVISION FOR DOUBTFUL ACCOUNTS"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r314",
      "r449",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Purchase"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r314",
      "r449",
      "r453",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r447",
      "r448",
      "r450",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY BALANCES AND TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/RelatedPartyBalancesAndTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r291",
      "r329",
      "r459",
      "r512",
      "r534",
      "r536"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r124",
      "r125",
      "r126",
      "r128",
      "r133",
      "r135",
      "r192",
      "r326",
      "r327",
      "r328",
      "r356",
      "r357",
      "r416",
      "r531",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r160",
      "r161",
      "r164",
      "r169",
      "r170",
      "r174",
      "r175",
      "r177",
      "r303",
      "r304",
      "r476"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "REVENUE",
        "terseLabel": "Operating revenues",
        "verboseLabel": "Revenue from sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r153",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "verboseLabel": "Customer deposits"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r86",
      "r240",
      "r242",
      "r243",
      "r247",
      "r248",
      "r249",
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r77",
      "r116",
      "r160",
      "r161",
      "r164",
      "r169",
      "r170",
      "r174",
      "r175",
      "r177",
      "r191",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r423",
      "r504"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Total revenues",
        "totalLabel": "TOTAL REVENUE"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesCommissionsAndFees": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).",
        "label": "Sales Commissions and Fees",
        "negatedLabel": "COMMISSION"
       }
      }
     },
     "localname": "SalesCommissionsAndFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/AccountsReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "SCHEDULE OF PROVISION FOR INCOME TAX"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "SCHEDULE OF DEFERRED TAX ASSETS"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "SCHEDULE OF EFFECTIVE INCOME TAX RATE"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r208",
      "r211",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r208",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "SCHEDULE OF INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.",
        "label": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES"
       }
      }
     },
     "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "SCHEDULE OF LEASE COMMITMENTS"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r13",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "SCHEDULE OF INVENTORIES"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r43",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r451",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "SCHEDULE OF RELATED PARTIES"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership.",
        "label": "SCHEDULE OF SUBSIDIARIES AND ASSOCIATES"
       }
      }
     },
     "localname": "ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r401",
      "r402",
      "r403",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "SCHEDULE OF VARIABLE INTEREST ENTITY"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/VariableInterestEntityVieTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services.",
        "label": "Selling expenses",
        "negatedLabel": "SELLING"
       }
      }
     },
     "localname": "SellingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r320",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Purchased price per shares",
        "verboseLabel": "Shares Issued, Price Per Share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Shares, Outstanding, Beginning Balance"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r108",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r52",
      "r74",
      "r75",
      "r76",
      "r124",
      "r125",
      "r126",
      "r128",
      "r133",
      "r135",
      "r146",
      "r192",
      "r286",
      "r291",
      "r326",
      "r327",
      "r328",
      "r356",
      "r357",
      "r416",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r531",
      "r532",
      "r533",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r146",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited": {
     "auth_ref": [
      "r324"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Company share forfeiture"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r24",
      "r25",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock issued during period acquisitions, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r24",
      "r25",
      "r286",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited",
        "negatedLabel": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r52",
      "r286",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock issued during period, value, acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r24",
      "r25",
      "r286",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "auth_ref": [
      "r323"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Forfeiture of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r30",
      "r31",
      "r116",
      "r187",
      "r191",
      "r423",
      "r459"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Net deficit",
        "totalLabel": "TOTAL AGAPE CORPORATION STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r75",
      "r116",
      "r124",
      "r125",
      "r126",
      "r128",
      "r133",
      "r191",
      "r192",
      "r291",
      "r326",
      "r327",
      "r328",
      "r356",
      "r357",
      "r385",
      "r386",
      "r406",
      "r416",
      "r423",
      "r425",
      "r426",
      "r430",
      "r532",
      "r533",
      "r583"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "TOTAL EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r431",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r431",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r431",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r431",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r460",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASH FLOWS INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription": {
     "auth_ref": [
      "r64",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of other income tax effect related to application of Tax Cuts and Jobs Act that are reclassified from accumulated other comprehensive income to retained earnings.",
        "label": "Tax rate description"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017OtherTaxEffectDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Income tax payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TimeDeposits": {
     "auth_ref": [
      "r497",
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of time deposit liabilities, including certificates of deposit.",
        "label": "Time deposits"
       }
      }
     },
     "localname": "TimeDeposits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradingActivitiesGainLossByTypeTable": {
     "auth_ref": [
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance by statement location, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit).",
        "label": "Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table]"
       }
      }
     },
     "localname": "TradingActivitiesGainLossByTypeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingActivityByTypeAxis": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of trading activity.",
        "label": "Trading Activity [Axis]"
       }
      }
     },
     "localname": "TradingActivityByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingActivityByTypeDomain": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit)."
       }
      }
     },
     "localname": "TradingActivityByTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingActivityGainsAndLossesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Trading Activity, Gains and Losses, Net [Line Items]"
       }
      }
     },
     "localname": "TradingActivityGainsAndLossesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusinessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.",
        "label": "Unusual Risk or Uncertainty, Nature [Axis]"
       }
      }
     },
     "localname": "UnusualRiskOrUncertaintyByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualRiskOrUncertaintyImpact": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the potential impact of the occurrence of the defined risk or adverse resolution of an uncertainty on the entity's financial statements, including a range of potential loss if reasonably estimable.",
        "label": "COVID-19 impact description"
       }
      }
     },
     "localname": "UnusualRiskOrUncertaintyImpact",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualRiskOrUncertaintyNatureDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost."
       }
      }
     },
     "localname": "UnusualRiskOrUncertaintyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r150",
      "r156",
      "r157",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableIncomeInterestRateMember": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading in derivative and nonderivative instrument that provides fluctuating return in form of periodic payment of interest based on movement of benchmark rate and return of principal at maturity.",
        "label": "Variable Income Interest Rate [Member]"
       }
      }
     },
     "localname": "VariableIncomeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d)"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/VariableInterestEntityVie"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "verboseLabel": "Basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123364984&loc=d3e1205-110223"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121825205&loc=d3e27249-109313"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "184",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5634876-113961"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10(3))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.12)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r563": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r564": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r565": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r566": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r567": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r568": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r569": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r571": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r572": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r573": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r574": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r575": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r576": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r577": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r578": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r579": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r581": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r582": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL116659650-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659663-227067"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>118
<FILENAME>0001493152-22-007862-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-007862-xbrl.zip
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MKM^4IX]I=WCI"".OZ[KVU&VSFN_!6!9]U@FN$?N"0['&N=B+&+PX.U5KJ?0
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M.@RR_,P9FYM=#[86#,]@DY%QZ4-9M,*S_(#;HZ(>T)*+)SMIQL8IS)>P#YF
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MZZ$K>34*FZCJC.Q68Z77>6$-:TJL1ZKDKFB"SF%]VYIP30.E^X9$WV@=$H?
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MD!V+AD33)Z*=,PU3=37EWWRO+B*SJMF3E+!A)\E62?^0ZM@9&<["/4!):\6
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M3N#EV2X_-H%9U^Y.L;>\A8<1P[RL;1V!"0+<!"*+B=WCF6JJJ2PU@?7QDN*
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M @RIGG]-N0GL3QFT Q91O,,IQF"592:PW1O=.OTA"7"(<># [%;,6],1F"!
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M96'2JGY*+XA+OY[9A799QBII3H^27ZG,NV]@8PKA3('5_EEL, 7#4_P8GON
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MNP&=H1)N@F74C=9KGV1NSU&5&"I%(0@H+=="/E6QS%!)FGD8LQY5>S['VY3
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M<D;P]\((]!0C?X'V9\0(TZ('3F,<DX>S,\!G1H\<&-X2)<,?LR=;XX1^JK3
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M-/X_CE=4K9!$^?]JB#Y$X(5=G.BL&N#B4ZH7FZ/1HPFM'S35O;C]-8FF_N:
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MVG/#!-[G?QAO_O'=3^?G[S[?6F;RI[//;7XM;6=0@V!]!TM*H1Z8%^#LW:$
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MP5= WC1FG3DXL=**D)?[4 IK9(HLBGP=O?+"0OA#*=PI0%Q=A.D S<HZDAB
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M.K14KSRUX*ZO-*U6F6H?S%EA2OO&' ?<_>+";GAGKC3,_CNA[G<=EAV:V./
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M81J@W0I7%QY\$!)WH5,]=(V#I>6[?R9 (AS/X]#U01B>6_:/90!CWV'1R#U
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M'SLF_22X/DB&JVC#0#/-BYWD2420R#>* O<N3J)79K"<49I:5L?X\\]RIH"
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M<:LG&6#*7W&K\3QM)X.)AW-D9 11F!G%:<[35^I*?L:?2"G+ \T]@C*^:7Y
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M4]VCE2C%NL^J[S#VEQ=(WXH]BRK-8L/YJ>I'%8EFHG1K/ZN2I-(VHB-:]:T
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M> =.LD'B #EBQFUR:VGNZ>;!@QSLMV-<KHPH+5$TK7W[.;N9(J:CH6+B[OH
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MM9E_ZHRHRVDG2?:3JO?#I#10A;M$TF]^*NE=<&6ECH<?17U8FFW'ZSBQW [
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M.*XQW/WG9Y)2?/ !(<@'$9^:*[^\^N0 =1B4Q',(2'BP=LPAP$#LF$/@F$-
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M',C'DZ):>QF]^,<  %;P(T=7.>&J+ S8B)5*0+U0U2;!4])YT S [0>QY@.
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MW;UL"4,>PE5R[M8%AZH.VUH@:R%9V*ZFO(TO8\%3"MSV'PEN"6+;7\ROOY?
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M#T/-1I>+,(6%ZAXD=I!FH*L"#N3C2='K<1F]^,< ,%U0'%WE^ U9&+ 1*Y6
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MZQ;0D: @QB>/QL\M9<%4\DQK#O!6_:#7P15\^ 9_]%<0,B)FRYI*J(Y0=?E
M-B?M;)K"=PI\$H\76A!8_C*9EG0%B]!<Z8.,3KJBMOP,G=@%,8*^]?*;&?HI
MM.QD4C*S+XH.)$<1HZ,##V-)5>5,%LA*'GK-3X16#[]=SH4%<)/XI64 $K*H
MQR"]DR3=K>IR@R)\*;H-)[DR+A&/$7 &B8]C@M_#.+B@+$BXNK-"'&RZQIZG
MY)JP9;.T[/+NU#I@5%E1TZ+6YT-9)$V(=VS/S_;W^'_P1]!O_C]02P,$%
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M"E8(6ZML+>"JXJ62,$B@@]<F1"F/"@5$-;Z^-C]&JT]!FI(QNIP5G(@U+DC
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M_-_!7CE)%PL[H8@0L) H#4EX=!'!TY$FUT%$R=6DNZ MW0 1'E=K/;=WY%@
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M@(5N:A9Y?/.]32 .Z[0DF:[C)::<"$+<L)H8>Q&7=IU7V71ZU_Q8]39SC?>
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M _*>8;B QSU*@T;I_B:HV)TO&ZZ(ZT6#Z73^\V V'-/!-!K-'^_6=..J'$P
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M#UO) OWI2H-V\4*G[F;ER<PH\>*26A<.;[L!%O6D5.D&,376;5:*Z.],]?\
M(:O4P&D0X4F&=S(/:Z((XM009XC1J:%*"PPIC:%VI"-51TP?/"?+9)1;F>\T
MT@3!2MX4(UJ>U.#SDL/*73U5)AE%N2BBLG3J41;9I"IT=HIRIG;]9N(R0#!6
M99X1=T4%P&>Q K4!GXDP>$*;G]S3;[=I"X!Y*E.S):K1!D/BSI"Y"5=1 .5L
M7L0M*P.="D%Y*<"&L0I[=0-9,U6KEUYU,*9QYY6!'ABN=@#+W7BE82:\$:W<
M6.V0UDP5!CW5@UH3O3= SP[#VD,^# C+84!PXJK'N J$GHWU#O^PR>KY!DV7
MJL1ZSM:H5&9(%Z=$2F H:8I4U:D7FJBF"JPGYVTS6(F2:UB>.NF@MR9*,G$P
MG--C%*PV\0PS[)&O6#?E;0ZBBBB?6=[L4WUW#E+[,Z_CS M14H@!:;LC_)2=
MKBU5]1Q"29MM50&U3@V!&!B.R+&I>H!I'#W?9CC9(:J/:K?, NL(FN;I.@&I
MM#M2*9V_1!0HN71.OT4ED%.PY@WRY:4D]-10[?KX=[+I@*FVU8E8-Y,:<S$S
M53!T[(:76S#(M5&ICDI]1 NX0;4BKA2)J< _>,4)'UMGK&4M3M/<A"IL4Z_B
MG&#=<,J(M2F)A4MB)302O(Q5R<L X@A565)/6=6+3-62YMBQ#)M.L9=Y==?8
MJ0#G_#T'=9O-I3R95I0*-\@K"T9D/H<V"?:##(5QJIQS7+%^JUSJ/R=!AD?Q
MITA4B;P4O$A.!<9VS92B 4[1)RI]ZQ/Q*_559E1*Q1ZB5PG6^K!^IE7]63=U
MY[ZA/V;.,S2<@%\4@[RB'" ]VV2W]X(DOUB03G/9ZGVQZ1G?X5&0[DF3].=;
M68,TU[?9HW4VJ^$(396=L[4O8LY75OITN2.DRQTAVRF\S):+?("_Q<0Q^\/X
ML(^C/"N%9*PI$K0YC)<#K8_<>2GG%-%"$XS/<UFT8<+L8*;Z[.[UUZ#OR1_+
MNU!_#K*7X2'-"*B$3#O"@Q]$SY3LY'\TO8-BN;I+,? &/^<8T:[EHBQ$OS9*
MO5"]'G[%"A[&*7%:[^/8IQDY5CAY#38X7<6A+ZI'N32\ZC+ VJX5JD(]<+%'
MX:A*5IAE6"P290DW@!L2@/: ),"XQ?U<#.'B2A\@@[&!3VB5!2G_\=LS5X&@
MU04#*=#&J@ G!:V)2A%R@_F3(.D6TZL-B5;4$P_CW2Y(4WI,BR9RQ#AM+[%K
M9.WEH]7 /66>E0A"(80)2-Y9EY+0_,@(;X.(#O;(("%X.K!;40GT\6X?QD><
MD.G )L'LU')RK L-=G1J*MW=.J]0NYN*E_@ S;W'<TH$TS]>Q Q^)Y,52ASC
M20'MB4C9+J[G+ E,::H%B8Q-YRB$5W>*#0'G+%&AXH903.R"I^ EE?Q 2/42
M'O/7B?"V!*Q5KQ!85;>-IS J5@2I7:N%#)T1$B$@W5DM=:^W"Z(BI.Y7' 8O
M9'(UWSY&6^\U3O)[9;(LQ#OY+ES/LJRN79YC;G-#IT=!SKEZ"?3\7A M"V7>
M9](E5:7=H+ JC\ZZ#Z<245H5";@1+'#DA30I$AFIEO<AJ">.G4MQ37P#$W64
M5Q0!FNQZW*8TWY<EL;.450:;"XW.+G4S8!#%29 =2U-'F(Q%@[T@BZ.1AM5;
M ?70&W<"RL7!$%*/L4V^&?E.I^M9*I;=(/^D"H1J@R@+_" \T%SHIYOH\O5S
M[.?KZ[O](6/-9[X=>TE$3$K)F)BEX5%.DR]4MM75O$M^CL8"X"4*!M,D+FD-
M=P(DSLA0(_!",O8NWT'&(.5+4'S(THPX;U(@D#:T3CRVUU0E9GSO!=$T3M.[
MXYJ\7'60P4S59@OH8DR=X"9Z8/C; 2QW<B9712?=&T2UV7B"%D'_\'1$M!SV
M0S$269'&P ;11&@#\>1<\YL<J4WL8@!FTE1S?L)4V1V3=0;)N2S3!,IF#5P-
MGX\YF],&G6?8_$S&-3MG%H&CBKVM"P#:BA7C$I_)RV/!,X-PHRM^Z=IM((K/
MS4O9^N8_Y-\\PL_TH+QJ6U.!D=O$*KY\>%)Q%75 $U>^Q*&/DS1/V"J,/."D
M %%> 8Z;+1'OXN-ML F4"TS7#+SQTA?B,.D_%.NK%](#C8-LZ"7)D3C'CUYX
M$ YZC!0!AN-T@LVU$Z+FJ*(6"=Y[ 8WFDB4/.SV']]F%Z/@#\$R(KER!V40O
M [Z+2[X)==B=W_Q%WYIC/YV+L3KU[VED8P#2L0PP[KHG<.D1H'U>#OKC'_[R
MW;MW/^9+8,7]-U?:'6U<0U^_IUMQTD2O8VT/U11^M:VJ4X#B_;J Y7+-4[62
M3/F<Q,LI"6"4UGN0_#V89J\ IYZ=N/_Z#J/A[=8?<9R7CX67U7)UI9U1;I@K
M5N_[)$[311)O V&KJCT&-.D1H6I_82:#]DS(T;>M*CE?FJ2K/*)O+!"#-Z96
M@6Q_>OHP/^41YUIQY(K>9,ZK_O@- 4 4%^,23>EUA[PMSE^(6TSC,/#SP!GB
M!-<O7O3S2QR&1WJ;C7^ZHY&,2>K7X52Q!NRZZ'2^';+T#"FQ3[6K<\7WV9P1
M7?VS-8\S7>EE8)K.M2WD@_)K[[M!](TH(YHH?R=B+T6GM]Z@_+WH=,/3I(I<
M*-Y-8\.*MQ?; J#VL*[QB:>:K:\KO_.M-WCN\UV[T4_![<_9L-)-XY^"R]-V
M=T@)II2>77HJ@OZ6>!,_1\$_L3_Q:63)-O"J7.'L%K$$^W2[]#2E)<\..^P7
MR^2U)7))!5_[I39]@)T/6'<"UWTC&"]@Q<RN>S5OM67FRU"Y9"T-C8U/+WWU
MFVVEFH]YM;8J>>_OL\6JC14O?)\2J5WKD+4-$VO+_9(;Q%V@L+:QX^X35UM%
M]B$X;\-N[=8V9W1+?F.*:)]K_@Y[Z2I#H07_6GO76^V'N<]UK8ZW>A&TQ?QK
M&JG(B?G6^E91%)05M]=\\=OO067A9/;>"J4%6K?X+82]7?M[%"=8JV K]LSV
M7$2-Y:WVI9T_MY5)K@J(\Q$S!.N%7N&87R]#@[]B-HX&=?G=U3Z7[>KYG31V
MJPT:2O=MR]!SCRR]T78IO=W;0C4HWOU6VZOV<UZK[4I?_'MNQSJC!3<PGBZ;
MQZ7P#8HPE/P_EUTF:%X>S<8D='^>)BO^%(1VEBJT&-YJ4S?^O-=;Z]( ^#TW
M?5/C^;6QUD73O]?6/\);3,8N=&7"VJ!;\,ZWVKJEG^]:K9E[X>]RUBRS4I!L
MELGEBV9Y4_V]ME2:4LOR[)A_Y5MMI[*/=ZUFVG[?[[*52HP43Y%_YPM7UMKD
M6V^)=MK?[[C5&;2UWVTK*U;DZ@^:Q_;MK0JJ,+S5MFG\>:^\M"P'\+MLT:96
M:W---$.JH&1LO^ZG*J< Q1EP)]7%8?C]. #)Y[7G %H ?L^+5:;&\VG;\CP'
MR,?[. W^F_3\;"G/2:T4;_[]-/+&I[37M-EK_WLUZ+K)ET_U\[MIVT[JYO?4
MHNTWYO]>[?B2*:+>:*NUVUQ_%^W48@-UU3)MS9E-V^+ONPW.L(T +/:6M]KF
M:I_H:IL]&$X:T^O8)6Y;$2XC'LE -2\'6!MCYI$9,<USMDCB^SC9>68+14I-
M%VW!P!01OQ5JX#BKQ]KF8?'TRL?71+B&<9K-MV(N=56V?HS,V"#N*)A6$\HT
MH!=J/H50FM&4/XDSF@F2@)H:V% %03%)1M,N>F^&7CSFOFE0K\2L*FUH<1I)
M>8[6L  0+),:9L0U3MMY+]D;LB0.I\IO7-SX"6U>)#+QE'"US/$<1 =BP[S*
M8GN'MW&"B]QLDZC8&J4YGR-__#E+O#CQ WJ1/<O51D:V\VTM'W:' <GUH$ 9
M55[[8YL.4Z^%PWF+!F!\VS?\\0_O_NW;'[NFA[Y6UT0W0EIIK0O?QB]XG%T:
MC$[+R&2S'DQ9E'/R7P:_>.\LR"^:_++HV;ZZ2"AX#P*?&F_>2*L+O;N/LI1%
M@:"N@;%&O%64 Y^T>O"2Z]F?F'C)W(OD_NA-6';C/&LY=SC"/::<TF( $55J
M9 >2<F6\%8+*@ M.P+Z2$N(($79>E)P6)@O"FR4Z#+U:^E"&Y=H+,XR5G;.U
M+V+1)1LY.>WYS!)?^T;W.R\--B-Z6SOV#1NG65$N?6<78U7^TZ0<YZR\ '@Y
M01$9T"+RPX[XU)1JHUOT1 M@<5Y^7HI]%O^,@^<7\N;!*QEO/^/98?=$!M_;
M(0/*K$SGARS-"$AB.K.83"_[T?S,=T%H!Q?Y7"8-Y:P7@6])E["NW=3*,I&7
M%XHB5BK=OJDWNQ3%IY*OT08O-,!9;5ZP?P@Q_2HA 1/3Z? K'B0)7>]A^<#(
M)Z$G,"6/U^2GU-NP/E5U4],U7F1SR'2]#]6X:?SB;W'>2*]N&K^;6M-'M0)8
M\ZO_GJ_FL,M:FDK0[EHZ^WM- ]W52I=\A=V;E"[_<9H7)UVN?#!M\0I&7:,5
MTG? NO2H&#ID\>;76;SPDH]>* WQDLC:;1P*N$V6"P0!T56.CENA+W:CRF%8
M%--#JNB5J@ AD2!VDEXB%OC%7AAK9OF!O'?FX9>*(AS'U&J-TP3,2O7!$+0'
M:&XIE.!Y\5),9A$UQ;?*VUJ0[R1/WM*>Q5^J4*#<5GR GFP7E/@6^2\W@[]$
MFHP(BF.*CBZ/KG4\I-N9)ZN,9CU@W4^Y.J?I365J\.[W[@*:'^SE*Q]4^7+=
MK629D:#9D'&C]XRKI1SZWDF:'M@!@]J2CFB]J).ZM<7 'D95ZWL==)U[C)Z
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MCI/M4! 8QW@.>E4T::&#F!*JE\="/YN/8<5S2C[$5!.%J5>S26]3(^I,UNF
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MQ:(VR:4"6Z>42 X,D13@VO0YB2(F"RR6NV7)5!/)+1=WR"$.M()'4W QW!J
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M(N&:47N3MSQG-Y?7EW,9,Y1>"&TVXGG<"?VH# Y&<G^TNT\0%U,3*$>_3;_
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MR/&@<Z3>@"MG]IU<G)P,9<J27'E-'>2FQU^B:+Z#W0D%9%R$H;6X$6K:F>Q
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M^@/IC9>+W)AS)G!8PL$A$S67WY^FM1/'=+F*AXO[*"- L?VIN^$E,C?F&0@
M2Y@EJD4^"/R93M70]<-+@&[,+A@$I_*K7/&RW9Z.?@>4AE>R@P]B. 9>SG0X
M:RJ09=6RVM403K,?\%"2(!(^1\O;2YKC95TW7D1*@BUA2H$:D!:.F8C=_- I
M$W?QYI..5Z9L:MC[ #)QKX8Y?>H^4B_=AIE%D09IK0*/ 1UQZR+>Z@U>^ AX
M^>%/O]$UQ<F2S;(P;?"%KZH/7C[YJGR0LM'N6^'=?=K(W7)EB>=9(>#K1&$G
MO"ST<.S%=XH*#"SA5B?P4T)^H_&JDT1QL";ACMRMEFVPWGBI[*ORSP052QAY
M:/3#6:CKAY<,ORKS8$C8PK94;3[<+MCQP'X3)DPAV].NLQA 0^"EV*_,3%-\
M+.%K>@N;SU>[!H6-\?+Q5^65@F9+N-)-R#0P#)M1]<'+WU^51WH$+&%5F3(3
MO1\SQ7]5UL@IOB9;?>\R-;+G1-WP*@S4;M+)4;%D.4J4*LA5#: K7ED#(U:
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MR\]E6)4ZJ=P4VX-JQE(IK:?R<6J) O5*8-DWIV!GL3&Z=[4B1P7.2#N\ H/
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M038,4;-DN</IKV-OAS.\,1]>;0PW1^[B%0)GL6!VRW#AO,S2^G!C)ME#GZ/
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M C.S_/S7&"H+%N1QUBGI8OQ;6;6;M@<?>_R&H3V9.-,)^CKDQ6:?J>>U>87
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M_&^FZLR9J# S??<^*YUTR/[E%RO.L+\E:S(WUQ-J^A#ROE!-6*0;0*WH6Z*
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MH0.:W7LZV"6RSX7W]#DPP[O0 8AW_7GG3\>[1/;9\&;-#27\H L0\_JSD=>
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M#?N]U-7Q5I7O+9+^+9+^+9+^+9+^XMCR%DG_=4;2E^[.=C,PNSP\[G4Q <A
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MI2_\)VTY$%4?[!<3%;@&H,HJEO6Y<VL5>//>>A,&3UE"#AW/E)VP\XI59QH
MBX9<00]D16>>_)4V;W34!CM14\4=34BI)6M!2I(L"$,'A5E$QMDY5;)*H(J
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M\5:F^U<=#3NZ2<_ED\C#9W]=#TD3PHG/2L*&T3!,Y9U7KF3_ZN@22<)Z8T=
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MB+IC^S7K8HX<&DPUK"IWT[<Z?'\/R8II NP(D+Y0 D$B'P_;,]H _W7@78Q
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MAP;HO"K'&GL-"!JY9/._\/_A([/?_/]02P,$%     @ )'=\5,.;#:>G"0
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MLCQQ&N1Q0U \>CA#0;_1%KWBIM^$^P=02P,$%     @ )'=\5(>.N^U2@@(
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MLO*!K+QH,19/F<73RVHU%AAY ,8RM)RG_?_]Q6*OP^YY^%I!,F$^['XT;2S
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M#6L$L+' C@ORN+Q7WB"A,-\)$?HB9/C]_M[&X<=W _=/_=#M13QT=Q$/W5_
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M+BLOLT'V66-]#1[%S!H1@S@C#-$PT_*43/+[HRM'.7! ;*(Q")95%&CM&4;
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M7!1Q 1M^G1E#_#6.Y)Y*KL=H>@8&;'U-#P-_#C@L,)4X&?#(0%T7"L)=F"$
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M4YC1',!!6K5L7C*Y SM'?7CG^-4!+2']II9RZ^#X8C\B1@#[POUVP;*Q8-=
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M7;PJILH-+YEZFXV7&P#FCU]R0VO^IM:Z/.QTV^G.)/TYF^Z<D6L=>B^NAN7
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M4 )UW%-\V)LLAW9 ^_+@G<S(7)\]I)<IB.H!=SE*(.IYX@%VY/3Z E9@71O
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M-N;U6XU!F#;<RCI,[6<P&"Y=Y:CH&C/J:3+!['X ,;M;_"W>R=G?D788 D7
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M!:OA'%YM1W=Y@J-[JYQR=>_M;>WN6%?W9#DR5<;&GLW8F&O&QI[-V,@)>]C
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M<7))VYUE.].S4<QLWZ;&SC4U=M^FQKXV']@LP:#M];6K-FM2X"/FNS80M.Q
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MXC_K4^M57QP=P@V2BGRQ?U!'%@95<+RM+D00IB]+G*$]O;S?+6<3%K),:XY
M'0J3<N.C SE@PQ",W>I)EHT*BX'!+"1Y<WU4?:L[9?7,SZ;7=?2A3<P>$V"=
MFO9-:&[&!Q6&WF/ZZAF\6Z3G 3RY1'K:OR*9PN(#!0-C,PX4!SVH&P>L:?(<
M#'9YWDQW*-=.&MU_5#GP>5V*.EZK E>##S4E.%3R98 ):7A@!U^E"K;VL^!
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MIT/KEQ_':;!>4E^H*UP25U#7Y9EUXUR'HA8;=A& JKY'H24\%;"AGB<>AJM
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M-[G0+01\8&54W_W]M-[<F)IL#H7D;RNWO^M:J5M,>(T[=O/45PG^'C+>6(<
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M1&-#DW&B!.O!XN2W^1[![<3%8=*@"P:I75_-V8\OAV]S-OC]?S<N36^148A
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M63A1TM13C)I(QQJ.FF'BKS#P&>>@\)S^6Q.,7J07:14L\$V:IYQL3S_+6@*
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MO*@$\<<#G^ BE6GU27-K+X WE*7L1RIRS1O\K2@EBQ;E,A;@0[//.Y)74B:
M=<'H)P@:%Y.8I;6AZP_!%X>OSY*K#D*CQ[!LX2TI! IGYN.;UI&QM2:F^YOV
MJZ*4HJ_K@#%95]'<7/K[7P9'\?'!,1_@7P:'\>'VH2HGEX6EGC:)T01*H[HK
MU,$6FNO>X=;N]U(0N+>_-?@^#DH0H"?IB-*VR,ZBVHK>!<04!Q4"=!/&OG)
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MC)#;W,<P>$?_W22,[LA#V%(7M6!96N--0(FU;B<,LAHVV59TAJ((NS8L!I/
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M39]T@-8)XJ-9AO^V^L*Q0L<'YWA+T;7:+5ORV$G^80>+V^IVOT90>#"XE1Z
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M PR;P.<(@P2-9NRF^-\%V]/ZW) .$[*LFB*4DB(63)/+"X6*B19Y2JH9H N
M3YKW,0EX4L_K7984<X^;=-308K.K%NB_R6W5X9(]D3[CP9Y<2O8>*]"!)MGG
M(O(\;<48PXKR,Y)6;>##3O,HFY ]%A<I(&;5B3$V,"G>E Q83NSE4_2<[! -
MO>)0/YDK#R!CDZ3%'@04,"C(-HF74V=12;8/T,\YR=:,4\ZF45#9=?_M;]U9
M++7T@5-IYK>D$89]?"G5(._IJ#FY(.XA'69@)>Q*&AFF*:>WUXS1G <T&CC3
M+I$9KL[ H(UDBUPPJM9_VH+Y?Q!MODER5R:?.Q2;0CI(:):$A:I6[&K,H@/-
MK C0G%>N=0 <6["H+]64=;MQ:A3XC0YJS=WN"V)BLKFQ2&961G+95ZL:&IXV
M)+C1>9,D+#E_4D-.XX*,\+CU=%_3S13ND8QC^F![K5:EC"Z6"X& <K),/3"M
M3(B6&TA8H?8Q[[#!A3J&P(C(G?'@K D;.\TUF=]W,[&H0$%$P_?%HRD&93G0
MV*(+ ;<+>H5V=\6B7M,E*!NKB7).'.EB2)@3)YXO:V%<"'0;,M*F="%E8M+#
M+J+?BC2O%GIDL!['G  Q("*<Q.^9#>PEI79FE]>XPM1E,CYO]8NQNQVF*?1T
M>UG?Z?L42-I[LJ?C9:<LQ#8C$]^C;W'*N:NXY<_H>LQ@[4PF<H&SK!42K,UH
MFA=9<4[TP%[1V#NM8TUPL9VCG,_5 :IYV9-$Y^C%) VED-7IIU'3L/@4:L[:
M;=;:795U+>R;EY*Q.)!YL<6.MWB$4CZ9&9\4.W8HS#KPFFB_2=0RA!BPN7MA
M=9NGR_.RN 17XF0MR).X;2=RF1U2K@2Q,@_YEX_IK[OS?GNGD>2!=BNV.=><
MHRIYT7#8SO7'74X#[+^ ]\;]1BJPAYP*R D5,XA'ZTM"_D0L'HD@%5R55AT]
M:.ZMN1PTH =9')<H [&XGA(=\JD^@GSHNY%P,HY'S_8#<H4KZE#36F KV='%
M\]38G*32=E$_3/ Q2;!4)!;^W"S]K"X=:'9,\$4'F-*5W1 /SNAD^I;A@#?Z
M/]%&KPRO[75'M7*T>H]7[ >BV-$GVK,F'R,B591_ ZW4Y@_HN,$@1XCD5J[:
M$X7'TIO S,DDG:4CT*QHW)=HCZ,E-*E7L>5&%4W-8:-[=$3<RU8]MJ,'P" 0
M5(B+ ,1$9&=I@MIH=Y+L*[94 #EJ>WPX5WWH?K>N]JWH P\/"T6&OI2B-#NN
M8)_E)-<Y65ZJ@C@CFPR;B[2D#SQY_NZ?IR^>[1P_M9QWBMRU>8G(?IG0G+@:
M71EL4GI8WLNBS,;]TSI%BY&2QAIL#[9%9?@53VLSCLV-$*B)4]D33KJ&&:?3
M0254DO.&2!J$W1Z>GQB'XHA&Y1Y211A4G]:(:B_D;A,3#3+G61LUZ'K!J9Z"
M&\=Y'$CX-[: 8!2$25R7E(ED08+//K),[QM2!O;7*0-WFS*P_^=+&<"W5O-R
MK+#H.0O;10.W(O.]ZB0*R/HP*L@,,L^5E7H._IP8)U,G"Y>E54FBU*KG$'Y(
MFYD5:\9<)]4TMIG9J(#3FG/@W8>-!IT$L/T-6>D)V#\0<AD!*NQF>YX50R1B
MTY**&<.EJ_6P%:%UB]??Q6'&&8[ALG@A+C4QEB(K$DOG=H*QYK);EX<O.T/F
M8]A:0Y!#$96?F?(\Q%''K,>-S\HGH0Q]S[=W#,2?RBR+92\ 0F0 "?2,8+P'
M?0N]>HAU\J]JWS:JNZ\U^X)0E2W;@7/)9NB8JZ3B;::AN2H4QEAKQ+:B]YW=
MM&F;1IQ(UL<0@A>U8-G^]GAN6C_G\ (N%&A=@??%:V[)NZ5R\3MFZX'TN_T'
M>N3D=U9(>-GXQ1/>WAK<>7GU\<'AL=]W$IZ_8YI_J'2YA@QK._\[VQ>KX<IF
MJ)K+/)N#@\LT9!^-L6&:23O'F+.XFPH9-"DW!>5^MXHTM>C>BT/4))Y)X8'5
M%IX7[B#9R@N-OUMGS K2 Z'N/Y"+/&!J[IOKXSV5Q\!DV/'*=]#&B23EA4,R
M8==@1(EMN_N&;[PMJ-??2-"XW9$LJ'+C*B>M$V'59<9(N1YFOI)Y<!^<"]>@
MS,ZD49!%8 Z$TTJ@-"1<U #>,"Z:88V(E!W4%7';J*_%[VQ!HK"O-65U%XY1
MF8GJ@&2J&K\[86FH^E'"GGL>S]QGDO6UX5M6E+40X?Z37*4U@WN(I_(8&%QR
MYUI4KOI3T'K=EHY!\;D"X'Y*PV0%H+#@LG6XZUS-[;0FX9&>/P0  JU"WB60
M'\ZWJ@P\:;3>+7)Q=-;#!+!DQ)R7UM>@F$ZXV(0;KHC3DFU,\/BB#+G7V&1<
ME9>A^/C*\D2WAH#WR2PX"<4"D=A,RM8KW%OLSW%_UESM(9[*8^!J=V\; F49
MVZ"N,L'54?@AQ8ER<,YC[\ +3;=6<^I6)RE!(W*@/=[99$-1UJ$E'Y3P.V:C
M32)2T\&LDKP2\4NZ3))KE"Z!D[=:FN5/X20%N-=FJK!#BGZ667!&2P R:7-:
M;!7-'>M\6_WW4#W_*QM.>NC3ON:Z:4F2:TH3]$0G*5OR*]8L6"#NN-..4L5\
M$.D/K0E)G!K;[K[&_CT(RVYN:([P,.C->87\G70FW3/@*P?,6^IZKFOJ\+F$
M0XW'&J7Q:RYM4<\_N[J1*B(9X3,&6Q'?N\U7%<Q,1*UI0Y".SETX[*U)*W1W
MX5\-M@>#!0-,;;AQ<9E?)FS,X20=:DO_/?1)9>'M:WUR<\-]DU-R@^R(=G^E
MCE$J& CC,$[0P_SP-F9^P>7JS,DT>J_<[;$$?5?6VW[-)Y!KH0&?3MZTDQV+
M L/FDTD57SL)(U"^^[LQA(R A.5%RKF0$Z+A_'^26",[B-\T7)!8S=-2,.JJ
MJWQ<(C7MR=G)A[.G,I)[,SJ)F /$T<MAD27VA^5Y0;8'V"3CQFDE$?/_T*5#
M\@A+MWF198TB0I4+&41(U0CY$% ;=0NN^6C?4'$K,N63E8),CTJQN\;%O+:H
M?2ZWR;5."Y"OG!37.@1OCJF5(KT(>TVFQ6R/=IV,XE3(+'WBATUNU$\&&^T;
MV#65ME<61W52UKF:8#/T\O#-(#S?"R?6H2:$(F,W6ZP'\\6#8* !J 4_+P,H
M;4^!6!8KE$=M%0SGU^<B.G'WZWS1-H.#G?64OI(Z!<>N00!_$YOM(AUR M-Q
M*_JG)B:IB*.?*H?6F"SL6K!IOL+/G6(<5#@%H&,(1FKUB'Y%3_N+<([6S/K^
M<LL_(+%Q<^.#UW=P7*?Y&'7B5^M4[V]83ROWPZ("VHR,4 +:'&.'7.AQ"ATF
M7NS=XPSM#;T8-=HVX3J9@4] 5$X@A:ID8FH+ZE[)+Y\-BQ)XM5DFA5"QS7ZM
MITA&H)\M)I*%HN7LE#)GG=$R!,E8QU,A'F,;-.E]=T$H[+79V*$?+]58B/2P
MN3#"S_T^^+ZZV550-+>FY_N;]NOTD[$@X$"*:&:F]%GQSM7)?DK$>.SY.I@K
M1;6LI%1ERFC\#E*K]>30B,.TD392C$4Y0>.HPGYZKJT@2PL7+;3L*,YAZY4H
M4885T3N";65;)I=.YEF 4EX79^W,7(=LU!.*;BM74; P1F*KDJ)6%D.,$&,^
MC$;IKF,4PI3156]RVX:2LVW34B1_:@(@3WI^F 'OP8KV(!YFLY*K.CDW80OD
M8M246K"FWY.Z3"!R /PB<;(:V;;(,'1-;26[MQ@I7D,+'E0FT@8(ZV5$$\[^
M144GZ5UV/8L\PSK0*R/K:!>V!FP2,QV6C!\7@(4LYY0!!JJ#<!7]TCK(K?6]
M%?W"K:IMG<TH+4?-K.*6NY7#OU^ HAYQ7E:+S;W4UA_H_:#(&J0Q&FF0(<4B
M*4!4N N,SEP&BH/>71ZH0Q3O96OL(+UZH-JP\3GJ9A@;W4)Q-)64[,KQ;6UN
M+/#FZ"Y9L^^GYM_S[VCE;5KA;-#Y6C\X-I,$Q&4MJ5E:36F@C.49]YNV1-M2
M._^JN+W!3=5:H?#& 7W=[T <)8L[', (_]:,S\6 <AO(MM;B"7X)9%,/+EZP
ME,(E04J?@\>F0=^0XWZPSG&_VQSW@S]?CON?74MKFQPIG%(5^LBG%I:B1__O
M1XMR,2#N)*JOA["O\U+ 3\#M208YZ"PW+ESG3>4!1T,<V@5VW9:HKYH27'C&
MP%RB$0#C;&0$C<CW?K?,V(??9X9[B3+2E5LLV1TR*SA_&'4F<$>V9^E'(L$$
MA!H75+<YUS@-MT@%TA58X [4ND#+R\; T;.YP85+0((;RL*UALEF)T BAEZW
M<VG"+ Y!+_T3UBZ=8PDBC6:6"%:N]*:,/D@/>3LE[NDD+GW5<%C$])$#>RY;
M!N&"@F[K 6S7><'Y(DY:HK6HW]S T9MW$]02BY=O88!CWP\VC!7:'%4/6[*\
M"$)15-BH8%SERK5E2VLIC89?!(H&JG13;E(]M4AQED2ZZV>0M$1[9K,ZTTO6
MCT1(/_QI(\(0M Q8L"V2(51*/4(F/':"."\&-SMG)8^,0AB9TO:)3C:6VXR6
MMHU5,]G0U18SP^;*8DJY4]_<\.K_$I4=?+C) P@/BRYD^P+/F[)JC$)D.X+W
M*PK#GKAXHMV["A?.*W674ZE3('40 LU_:\JK@#,O7DX?-^]87L+W7-<@:XO1
M7:3=X:X5?H=PO;B89TF[)GFS[05;[#CE2^@!88Z=I8405831/SNB1P_OXP9T
M,A];N:]N8W-S6<6MW#!KOTJRO##:P'(*$7\X-0O(1,K5A&*N:6)#Q'I-\P@_
MW96[ARO*/H# 8MME27-'!7Z2PT_F+816GR@C_1W5VFO*=N[@VA5YC]/^..7>
M0XR'?RG5]A:$C',O !^FK2_Y:"^D1:;\K!WTK",3 #DNUNG&R*,9HF'S#- G
MQ7F9S*?HK@JB"?U0FQLY>)_  [1&$J1<8I,<1D2C5N;%:&A3C)@I!S>?^]0&
M4%7GVNO!]7U@T']VQVGR?$"6L@.,*&2GS[J8<Q'*!VV"A?JT;/P\\ E)>8!H
ME4._>]P>0-H3C0OUYO@T- \%*U*H>WU\6P?)WLJ+B\2&C7U;"R<=LN**I+9E
MK+[A 9(+,CYF$EC. C&?Y]J(H_ N4VD'-:)]."\$KJ$_":$?"FG%;L**7N"E
M@<KGQ6Q&Q'&&G* U1[W7 PF9:D_K2O!5K2Z7D(PRV8L"P3\M( IZF%_"<NY"
M38?Y+;;-C/IZ__:(CGM=<_R'UQS?8;;_NC(:DX6V8%/#,$<5RXCI:J-#4BY0
M+6AZDJCCR  S3JM8;)12DV(%F;F5K6OQA "/"0M.'2U_DIJ(.Z/=/^6TUG2Q
MLB4\=SDO^'!L$;,%=6&'C=A8XLB>=&$3K&M_>!64[@66SIK2UM-:<Z"'=@ K
MS8'0_,3#VZ\9S\,[R)69UIHNUHR'YF4APKF<16;$4++.V]T"QHO)AOMWDVH;
M E:#&&;P' [M3+(J7$0MU4*!-9]ZD/2X(M-:T\6:3]&\I(N@]R>A6R8Z$+CB
M:68PP^;JKQ7"::CXG1'+&B<N!N639),\R:ZJ-433>EIK_O/P#N!A\I^@GP=F
MXVOHUL2RGM::B3RT UBA8%EM 9S2F>N9B&QJ3DY$^: K?BO;^0V<H]V36[:8
MQB1-,-(,V?@,'SX#VAVG+B7P8H\XQEPVF56P) W2(3FL:7D]K36/>V@'\# 5
M)87KD;DH0PK@5EQ-9+O?@I0"M4 PK?MH#3NYGM:: 3W$ UA%)<NG&RELP>B3
M9BC2'[C9BZU9;^=T6S  Y4J=WBP7%@3/)B+VM%=98T-^FVFW*[P8#M%CD[:@
M @7FE$9[5A?/\-\0.;551^A;>5X463/K)*>ZI'W!'K1*NQ0&>@+L$!Q#=HP:
MX#0ZJK.P92I'6U]Q=40A?&G>4XH56 8\;P>&*<FX=YZH?L>YQ);L%C)Z;T
M.%PC -PM L#A&@'@#Z'CA\]"M=NM= 4"^LK05_'/I601Y9ECD8G@?$WN\_O'
M!=VG=4W;?=:TD:P9DU2('>PV)-$\2<<Q_0O-5O ' %H**-9<&Z!P,S? 4!D^
M70L]X(]7Z^5'4EG#VE/LJN(OT55N! A4WXL;%<T:J6-LWR1'#\%2).M(G5G
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M4_\F.L-2(JA("G^2ME62ILBU<VCQ!AV 63)WI +;07D=\ZB86T[-:UO"1ZO
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MOR="Q'&6+XH2Q=(Z$MZNX"C5$P?MGK4CVM\R/ M2Y'K:3,/<H(EH$9)&;61
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ML:J/.C:[IS,D@(-*(EID7LRN.I-QF0^<T$ 6DI,Q$ ')F*Y[!7,SX<3:MFG
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M+N'EHGVA_KJ=6  692>YZ76KT42/N2P:J1[ZA"^"+H0[*L+Z9A#'[H46!AV
MH2EJ&NJBA.;).$X-&W"H+0>TF#33]#L7'0LCY'2L,2!./!>1RQ[098IHAB'A
MQ"$+NMM3FK,8A\"-5L0Q#\TV9^!A,8CI[ERBTR5Q'U6^V; *A!_2C:-THK>7
M)50+-T[HAT05,]K#HX 'ZGI=@EO "8G%T8;T[I]EB,XFWCO8ZF&*W!@4QMVT
MJ!^) ?#0IWV-)G;6#($86'-3T\T-J N*YF,AA1A'CY0=B \)E[5<2\0P*];
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ME=OHZC''H7Q\[+)P[VZD2F(T; T<;)>,S*C5-(9FPE"%(<!KE7L)\U4^K%P
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MY"S"^8+;&FY<A"EBURE$P103596YBQ@*I$$D6*4?=S_+M=Q[8\=$Q+ 1+,'
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MR_IA*=<;J[WFP#3E:LI2]JU2.](/$\64SV(H?4XFX;$'S"7)1D?9\-V=1([
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M?L1K]RKWES?+67PR$/2V?>4,#O^!/.4G$$N.<\22Q2*6'.>()3]@J"=5:YK
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MQ7/-4@M*15]).P<-1FP9@-@V]A#T=?AM$4LE7AS;\Y;".G?@HO8\'#*+A6G
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M]Z#*6H8Z0&@TD^+SV1#V$D2Y_(<Q3T29)W#>":/'*8>=H$+,.&:G 6*W@O:
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M*^ $YP[8M+"HB*UCF1:V5_EP@" SF83/ULHQ[G^;W!]UY@]C &$^B;W=XQA
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MV;,.7CD5J&8URPO/CGY>1MDV\X2LKVR>(>271+=[TNX5 M[WN,<"06RS>XW
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M#1Y84/"/'H)?R]( $7394A"J7T!\3F$9'EV,!Y_3D?8H]9%^>F*,!)"-,#L
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MR$_#>A(MH7-_^5CD9.3!+IV>@/J"2A_%2H[,2SV11-(U=BF#DYIP=I'3*5Q
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M(R$*)Z" 11^I=\<FBZ (M T$),L82C6=:Z:ED;INCB?4]0+!A44,:>RR*IQ
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MB4RXAD3>M2MGG],Y/I5)KAH22<CN!<X*?G#F6!\.WBP[Y"+]J,ZTGV-Y(FS
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M2/W^WBL4G"R'8U)S%&HBI<&^:[IG\3BO._-?ES'W&VSPNZN@Q\!V%V!=R'I
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M-WBYM4K4&GL$ZR 7P@'OR>CX/AU# ^M'25!=T+0IH(,.D(4 M$(_CU\WM98
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M60OT!/MO?6$\(8$:> MU<59_R^5;P?=LX*S==%:6GGIE.H)9JL;*JA/Z*OR
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M3\UZFQJW5DBV)Y>7=W?/@\&C]#0(_:@T_UEVLQO<W&P[F\:*JF[4>TV<>]X
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M?3_V19!-I@&H>$;Q>7R$L//V#M61I.#WK$,H&-)LFVQK0RR[EZ4G%,9P+F"
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M+*.[RH2*YPYQ9+8XK1K<;=B5G3IC+X?49:E'['$X;IDH>[-'C+)J4#HB5*.
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M43:&1BHX/BA8/(@#VG8,%]R!O2'+B[#)WA<"ML?C(S:1:D#<=!=H'C"DT31
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M8Q5?BFEU_J&5%=(0?1U[QZQPQ_O6'P+\7AMS<?JV)#>3K(;W80D%\ZI9:50
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MO[,Q;Z4R62Z DAO:[]),B-M*).#/J&T8<"'HTR3N-A]+:'8'1#1E4N_Y1@1
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MYI"9^A@RK6LSE4&\WL_E4CH.T-P?,M\?K0M 9I)/Q[/85CL(F3S>IAR1+MX
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MP1I1T/Y/Y:MT:);7#U,><\F8G^F%M>"JG^657M7R8BHCFXQ]0'N+^[6TLB<
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MJ?GU9E=^[8GY&]G<E4B^I/_?O>J.)(069V65M^QM\;;,OR>%*]9E'* 4@CC
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M2XX/4\H <;@3!$4/):2:--1WS,I:KME__5^$-JCJXJM%XZLX:4=/1:/Z2/E
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MQF9-HO='7?.5/3%KR\U!HS1L&#!SAF'>XOP"/8AC'[IIT1SP<8F>< K-X]*
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M&LD**0J=(('FL2C[ ;#(8$>):B&H@IB1@.W TQ/,S(JL=L(>(UJ>2HA\92J
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M! @9:"(52Z56@PKX?MX?NE"S&_"Q,63_L"@@@ 3_R+9B0 [,.5;X.*4"CPX
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MRL4FSW'C9QZ!%!? OB*7R'T$)M,[DHVK9UC4GGI)/ Q>/.*&(UUXODU!^"M
MRO S[$D\/<%8X80I$<MC$3:%(R^P+"?ISWR(DC+B!"1'M6EAT*/X5&UUJ>BD
M(6&E"?FJ0UV-I>V5B;Z050F3X*GY%1SPNF)DJ9HKYSB9I"@HM [DF%.X(>D>
M!F2.'Q*%H8A;FFGKH<58E(DD G^HT3\)\;0J?"EY!&1(VC8A1H5&0=)XN6>7
M"(!CIAHB 4GDS1)ZFW(24AL^*?A#M2+/:$Q@76'1DPWO7T!Z(H=I7 OY '>L
M5 93WBC<D[5&:],)[&$ [(_Y"-B8=('3F[>9L8>;IH!NP?;. I@8<"O\*.$^
M4Y0B@1>L(D*$I['P4^44;/^<NC*^"*I)]9P=.Z'U:1:$2U_!;>#LC^SX6/N_
MOL'=JYT]W#8G2T?-R;QN3I:,FI-YVIPLT Y141NR,&RF$;4AB]J0N=!RQZ"C
M2>\NA]Y<U'?X0U<+FY:]/;7(PU@?(44_3D\JG\R(%D 7@H&/@@N4VG7I6M,S
M^2C/*H#]N&TSS= "<8FFM 3^&$*+I'6&"&$%BU(3'7QP/&Y',\;]D64%T2P^
M,)Q@@ZVQF/HC]O!HW#E9YDC3_-EJ)CQX&#Q[>@+?43^7P5"DZ#'Q.T!2@YLW
MT&(ZN.21]$&1B-4\@=V*FM_31PP]E8W6.0-^RBC83P1_R@HTC3_'_AYY'PYY
M8(4@4>"SX2"P]C8639#JC9%+&?,"\(;V+7GGU<U?V/'%%C4>0")2H';4_MFP
M0Q:^JWJ,UL?);@WXD/5-ZA=E[,P#?'C& ';O\+L0O$@<@P>(A'=.$@75S\<A
M27&J8!^.8X[0-3M<[\SQF".U%G)18$LDLC4$*X,CUX,;NF@6+;?$VRS4FW.O
M%X^5)R;7EI)'T4^S8--/,]V;OU6OIA]2_NWIB<;]-&]O:UUB9%+%1AF;HMU:
MX[("%FBE8YQM0!H[4@]^3HVH(UI&.!1L4'TT+R)0L)L"N*X3B>.I11\ <U$9
M*TZP+BIV2E0^G21*L]BI&_D&XF  >H+"H25$\?@PB7)1\V3P3XH$RIR$6XF#
M@NO2\/KJ5TDO,H$AUPNG)UC!J4%,_ V:>9MRVB *T)#P4FNXU#1405W,-*MK
MM:ALY8*H9)*YBWGW>"%]&L\,WQ*IJ3CIN#D!YV(JDSN)X@)":[9+<0AZHC,E
MUH14Y]YA93W=11DGYJ_32>[YH6]<,AFO7]K(;-.UI@/<#O=-\31H-#UUQ1'$
M72<,I0OQ6-PYI3JF7G;2 )J$;S9%U4(ADY;.Q,'9%$L!W=EN-^]U9QM/_T"D
M?G'9D+,,%]%J7\F(\X7)-E7P9)$QT-]X.J:PO8DK#^F9:NIHWR(XCU'X3(=
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M2F)R_.;.9<F<I>+&3TNI!5BYCN&I$4O/\*Z1\,V<MF #]K=?)JRF5GPH+;V
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M'GQK?/#=IM#<RMVE7ZAHB0^S8C&G#_\"4$L#!!0    ( "1W?%1O.\GO\U(
M /I6   -    :6UA9V5?,# Q+FIP9YRY=50<7?<N6'B"0R X),$AD. 2/$&#
MNP9+D,;= HU+!_?@+@T-P=W=W2$AC;L[-)?W6S-S__G>W\R=TVNO/KU.=:W:
M_CR['N<?5P%\.2E9*0 )"0DP>OH CTO 1^ 9.CH&.MHS# R,Y\^?86(3X6!C
M86&3$;[ (Z(BIZ&F(J>D?$7'SOCJS5M:2DHF/N:W[SFXN;EI& 6$^3F%V+FX
M.?^Y"=+SY\^QL;!)<7!(.5]3ON;\/UZ/[0#!,^272$XH2&\ 9 (D% *DQVZ
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MR3#E&_%8,M-ZM8YEUYBCE+<DPE3W;DQFA@Q$?:X.(^K@4*Z;;U76L(>5[D=
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MQLQM>0\(=:1VU83G&U_:9='N*=;6-3;_U*CV>&>T[/J9TD<F-;-YK#JSR[X
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M7TCDBOHM+U33<<AG2KN3(I ZGVD##J(.*[TWK8MR]N3-./W5?U86.3-6I#)
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M0 >O="!<I!5/@G,+HV-C7/ 19'@CCX W.-+*P243:Z^;/=\Z>M@>2XXW\^[
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M3#N;_]D4=/<MYC/-81KD.%= U;:/->**G\O*"04N,^\M*:P2UKYGT++_X6!
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M^QOZ*1GXFH:;M\4#$DF(79X@R;%-FZD?:U&)JM&/K N3&9ZSSF^H/8/%<Y^
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M-3E8W&@V5QZP9V.-TY[]&8'DSC+J+E8&<CG#E!'RAXPJ>R(NK-U&)F_=/H(
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ME1D97*49>9U)3&<EC_\>HT=O09^$$/TI#FV )R88$$6RK/^_G2<*+P&$%^0
MOQ%+;SS/\<XEH +F94#M>F29C:,AGUT"MD;S1\UXYBU=>/XI4BW%T@M3JIX)
M7F.9@% Y$(F D/ "*\GAISX**GO2%]4>:$ <;Z3<;!)?KD$>9_(?;6;^!Y+1
M -C_R27T_P?6?V\/49=3_P)02P,$%     @ )'=\5.Y77^&I+@  H#$   T
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MK>V=W[M[IV?G%Y=7US>W=W_%A0 @(?S'^)=QX3W%A8B,C(2,]E=<"(B>?TW
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M7Q67%W]EA^W?LK--=F$[=G/6  ?*[>]+1W.RGL5>E3I/R_W1:/@#(=162 ^
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M,KIN+[;*0O\QY @'1&C_FB8'J 8"5%,U_^FJ_G\!&GS^?P!02P,$%     @
M)'=\5%*6P(LD1   1D8   T   !I;6%G95\P,#,N:G!GG'L%4!S1MFWC#H%
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M'04I0D -'E^>+T;F O@/[QZ=%*0 JG!"-7$4>*![E4\G_$]W+_8LF)]E=V#
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MN%/UIXW;4N5T+^ZGXS.PN-PS&* ) Q">I',BC\KO"Q_VHIVV'K5A@ 3/S<A
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M9@IE5+E/^7XB/JMLJ0L-BE]3;.1XTX' E6YAW_ 3M&#>8[UYH_-L407SMHZ
M3PB5?M4+\T*?:>:/R,.*P/WB.62Y\EJ=4$PXICETRGGYINB\ 2N^\Q'46_*K
M:()=0@"U0HLO8D>P4-P\-"I!D&AP7H$]LG1A^97,4/5.0-K<U<AYV;XL$H%3
MCXM7V<]Z(;-RK[U\JTQ-HY#\A<7<H1*77E\9U2Y>+2UNA0H_TJW/C"5ULT-A
M4-PV5ZIC=ZI(X^'&>X&("58W4=8$1\?X'V%&*3U?$ 4Z(6;))+7)X4GX/4JA
MU%&714>>Q:^#&_%Z?VSB;B<-V.L;$8X\T&NUG<"'<P5'U[G+7_ZJU!@3[Z;
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MG-G!0RLX5V K.-G2^WW4Z5P4WZ&T1$5ZL_8DI742$ES3PMCM!VX(^7,E7\;
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M3S6[6.J88"6[EU;?5A[(IS->VY4=.D2YXB3-/I%'3C<4KR#>I*L(_)1N,#G
MO,V& 11#/NS,[5J0ZFAYN]M7MIZE.<PBZN\VBAJC9%9M@DI]G$]D6 AC>-U$
M);&#=#5N0%UUXK>-# &,A2_V\;91P5.^NV6NG]O(Q[O]W.GR[TND= R5'U4&
MO1U!AX7EF?0WAFL8<HQRF"IN:1)W#CU62B>V75RUZ@HW(5F*<&:$QDU<C>T'
M)3.&EK44E7'Z<-[5^J72)V]GLV,MQLCX%#\1_1DZ49&@VVR;3-S?];N2#VA%
MMPDYVI\QVX> 6THPU4,W=G0GT3OJ!6" FU]GKLJS_3$!UQ8WD]%@<M_X ]!)
MMAUHE]L%!O@FY$>N^D: IL&)0T^[$H\XE-,(0\_[C+N3)].]-1JHCOJT;]^_
M*0:KA\D5&-9?V"3! +VK[AN&M5'GF?F?WI[1D8\QU6RM^![*"*%L#NRBFZDA
M3T$0HVG$[8#S#LM/@P30R61.8V6]!^&3U!^_]1BJ_&8,Q_UVWTT/I7W/W=OA
M\W++;;C\2J2RR>SM-H96;8B7^/I!M&2?FDR4Y<P-U$..+;,3IJV0_\!P:GB.
MQS=-QB-R5)_DQ]!?GHT(,7@O=+;+J'J&P[WJ2F<+;JQJ(X?:$QL_>%:E#S09
MTJVM?.6Q+T7]05@9\%2[<1U^N>/OZZ^M*:?;T'_4YVQGFE6 ( ZX(@8IYR7'
M2">'%FD5)(VBV+3NE94U%-"=?Z2))$'IE;@@3Q]OU+-69/JO&RJSB_<."O<J
M%\C1Z#@KGEY0X-W^43+*\A?I%!WX'9%K+LVR[XW?063#FG'Z*I3^R(V,9XF)
M.)E:, IW8S)2>6,O:/CM_CYFE$3.@&)U#=<D"]AB3Q9#*X>PI_"%/R6+A"+A
MJ3@NX>G?W6B8* +JF&[4A.H0">4,E-R<W R4+(C>/_?.YF;Y$\0D0 ![FER>
M<1O_+C5>^=ZL]YY;^-)<0W=X>D!#3D>C=DK$RRWC<K_S8[U+<L[7STKDKM_[
MNC&HT?S=PV,5Q6R3\WGUGNKOUC/(_QATS'_GV?3#RR)G??;GVK3-9\(7OEKW
MA7_YMUN^>+& WZ;/?\;BU<HK#ROS"-0>C7(3O9IEY;IL">-,KU-L8BD/&[Z<
M+[S>_#KF[K6)]<L_!;\UK#_O$?+\8]SB#V>U>0V"@]8&=95,=%9F"[XCM6F=
M)L\&S4<+PU:&-#L(<14L8_8787A5L$1D48.,9B:K50-7E ;$NTS3NKP<=$5F
M+IB5(-)RP==@PP)6M1EG6-T^-=3^#KEP(R9&(*;2\#_#UN_]#V]_7'3 P?RL
M0I>JSO,OWTTWIJ9MFSBOW.-^Y?X%*W7?+MK:G^+='U0U?ZUOB':K2*!#$\S'
M:)C+?);KU-?&)SDB_?]L]9^Z*WGR_8]G4WT?WNXXE[M.R/7\W2FY"K7N+/^8
M=EEI,/=-NO?N]M_:+2L,)SG<65#KYK#(<FJ;(TNUU)LLR;6ZZZ1++KB][<E+
ME61^[=I>/"M2*[3J:JW0V0;.9^Y]KW[^JUP1[?)S?WF1TR^CE/\,AEX'BV84
M^O,&S55Z8G[JH^ K3_E+BW/MOD8SZ1Z^8O!O2X2>1E:!J>36/8[3&O\S\,@_
M]>6V__/[+# +W_ZCL>'D9^]9S3G_&3X?RO_]K?[0W&WU/Q^:__UMLH;EYN)2
M)Y8GC]]\KK^_V?^W[4-) ?-G[%^7)\CO",H7T>U]_;4W^.]WH(&7+WOM3/W[
MY./"_PPI8O\9N'2T)\YD=;O,>.7JDTM*+))J4S]>!5;?U[^N#HR,=G+T"%=X
M8OBD_\AGUZ9G5I67_S.L[+Q3]9CYLTWHBB\[XV<^Y;+?-6?^F6MK10X],;AU
M./_?.@/^[[OFGUNVJ(M%!&E#JTC@O$)D'F58_:/P6V_//^XOO<$S]>PF[>5)
M[%> $LSE1?:,L%,RVFT;_KR0?,?^',@N!@D&"0/CG<' Y+!1<X^4Q@+VU6R2
M(EN0]IKBP>PU%UU%&/_?! !02P,$%     @ )'=\5+%7O"(W0   0T,   T
M  !I;6%G95\P,#0N:G!GQ;MU5%Q/MS;8! L$0M#@[A:LL2 !@C4T[AJ"NWMP
M30=M-!W<W1O7X.X2+'CC3I @P_O._=WOFYEOS;TS:\V:.FO_<;KJU.KGU*YG
M/_M4U=/"TQK@#4A&7@: A(0$^/1\ 9Z6 %* EVAHZ&BH+]'1T3$P7F)B$6!C
MO7J%18*'CT- 04I%24%*3DY-S\E$3<M.1T[.+,#"SL7-Q\='Q20D*L@CPLG+
MQ_.O3I P,#"P7F$18V,3\]"0T_#\/RY/G0#<ER\4D)"1D6@!+W"1D'&1GGH
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MQ &S)B-4(U$%??21<\J^[DCIF'E03".J<=R 7!O9Y:STS2WE=P/$>:7DV?9
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M03Z!LB!);F4E:\ /:5:(QR+W!U3A!(+& B0E@L2<0'IU+5J@IHW5<TJBD&M
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MB:/R#]98*3AIX8D(QREXSJ>:-"QF"FZ]OF_U97WN*;]DZ1_1XD$\AK=R+QD
M*W?SI@566F>T*18NHF#%U'BO3]ZE<Y.\52H+E 5U3F"=[6(UM=F:0Y6?@2A1
MFMFX?3Z8-B_7#-XQ-64-Z!=GR[P12LNG=BD1/- H("N9UE#,@GW9EI42W=R7
MUF:5MF[&S&?NY3NV)XGO<[*M/.U:*93S,W^.!(1\.<S?:P_9:D[CQZ"(1QC5
M%EO-M[D^PLW\T7WFG.;7*O]C?>_W.=OJP]LG@"3AAEZS0VV @^U2J_YSC&@[
MF0RXI#'B]6E9C_?3F-/T>,\5,]6DW&U+L575<XX*6Y2B]WYDH(N_O=#F6Q'S
MHQVV'RH9!@XLYB%R,A_;3/;NQ')=<5MKB+GKD;"#E>'"[X=OKTJMX *)=O2
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MJ.AZZJ/7^+I*&J-O0A3K-%CG>,/7FY!\"W^&,@#3UUMUV:P1F_$ET\).4[F
M1K*3U@85QS<S<M,HQ-F6>WF!1E-8^.P@NO4QCJE.,QOL[(=LNC!/^$[L DKR
M-I[;5C5*A7-\R&K%TEY/5<*H<4<+F5\I3+X@?%\NCT'^\_"X"MBMV2!JKI\^
MPW?.C4%3<SLQRO:G2MBQ@F-!)$,\[(.4*<!?Y!'NQ"Z_8)'SOMGB^WBY1TM:
MS/ELS>_%X#7<_G*6N Q94'&#2YR-+="^CQ\]XWM)E(,42#CQRNU=X7#,1BT?
M6Q'?@2U4Y_8<BQE9M#1KAD:S-L&)'FFQZ<QJ'AF7L>O P LRE:TI[VA:'\$!
MXL3S,4@>UH#],I>_$/C1/^*C4>SR$X?E*RY"E!77FJ)F1VM96LK9>8<&PT 9
M7\LV^<[^&@:*HC]!40 >RHG=W!^@J\\&2A)6O<_4"[_;GJ:S'#4X6CXTYG19
M29FJRY?]OI(1@_.*1%26/]>98)Q=C><]YW),EJ8;PP]7/'DA^AD2^JV9;]1&
M:;#+C;KJO=FM@LJ9Y:J4H4[T'>#)G9ZW#SCG3K)CJ-VM.D& N\!EI%-[BG\R
MU=XD\NJCIGA@I2P.F0RBWR*)8%\G&<)<$3+\GYLQ;P\VX-6U9^DC$.433;/Q
M&>T)^.83@,QMLP4\0\"-5?Z*W.FE$%6&\O:':>L52EF*Q0&/A/!'=^MW!=$H
MOL/4U$>B@A7^7YZU/%$NO8XVV?Q5!2C5LQ7'&">U;QF>,G+)!G:94WN%CY+Q
M@+.I?VHHY9:E4'<G/)\BY8?2B@ZXHV23)/OZ^38G/F77%JJM)T\9W#U=TE0\
M<%EK21M]6G_UYT!-JDC9\;Q=[A+X<]$K4[6>#J$+..R^9W/ (5T:>K'ZB_P)
MX/W:AH\G@ZA$K_\[Z:N-%9'584>7<EQMMF02M,J7;BL?;N.!+0\K6;Z6E3NV
M7SO@4_!7Q0X<CB,,"^D)-/T(#?':BC6A8+.$B5[F\>VYQK9@-9="QN^_R"E(
M&(:9WN[XB/_Y6(H5++2<;(#4\MZKG^0YX*FG@)JPFR2QXL/VZI"- HBJRQ;6
MO"\J:Z.> ,+3]6=]A90HP4)BI2'@,D6? J%/W%06\NGF?=]%:B17U:MU>7H\
MD:=%Q>]FLTU1ED@DY:']"4G(]Y"=HR]>H['\"SC9%=W2<SDSY8J05*1JO0EW
M!G%OG8LSC6J"[)-^"<:8=4M!75T7Y>&]H,< 4IK@S?&O]1W):"-<8NE@:[+$
M%4A >C]HS_[0J00*FJ/3]Z ,+G^E<E:A3!=G4YWV5]VB';<_.5[#-TUSZK<Z
M?S[M=D^\E,,H#3$R#,$)%R2/Q\7T*\EH*-=/%W:+.6:,JP0(,C;VM':-S.M0
M0O+FB/-*W@-=9SO7A'(0C&[S DKR[QLP*QA<!$RMCL&FZ?ZK2-]\M>+/KG<<
MG@ 2NO,^Y2N3PP,$/LR=%52E!P41^:3XO]C>\>IKM$=]5)7C>-A<;++.-_PU
M: K.D'09^_T5F")6Z(C1:8^8M*V))K,F=-G6$O1:5:O.,6-:T/1VA/+"7^\\
M:G[CSV6_1ZX6117^G4RXJ][M'K_QN=;(ML38>_%&##F@\M?'K<=S-S7_/.UI
M][4.C&<E6^>50P(*KJ*3<[WL?)"K]*GH*?."VK=4Y4!8H/_L8R(<^*(X]=ST
M'L<[;"2YQX!)?&7M";"97UI9=$RM\,/Z4YPYO5J4:&0OX(NM1ZJK[IA016[/
MH@%,!NYMRKJ>E91P.HY^7F$CO36!:MH+QC[J(:<OI(R(5^4J&F4BF/VNDI9U
M\M;"IK>\^0E0%B70N%$A6Z[7+N H=<QK<$086C7S6ZH]P_IKA/Y=^A?/^BE3
MN[W+,6P=+?6)D)MY7)C+P*Z_MLDE\%L79]11N/>[!IRF]"DA(XWX2R#CCND%
MWF\CVTB%@[R_M1T(=<;*+QWG*[%SV6N(R73<<>:K;_>O1_C?OWLX9SVJJ PP
M"^.H(.5C$E3A-J">?]=_7T=U/5 8X/@[P"_@)%[]"E1J87.11C^;E[GR!$ Y
M>0*LT\U^'5_*&Y\("*.S72R]FN$,0*>[U49^:/L2$/W\B.R?HR? _97QWRW5
M*]#*P.-L9WGV#5V3O>2C1$1;H\FNN>F##9Z"BSS3S#S!8N]?JIL;D\N-7#_)
M8^4V5YHG0)#J%6NL!]52JM?]FX#@]]%#N<G(^S9U=TEIK K+LGM=X^<5#-N>
M0IX68@@@B5 Y79"AF:FZ>,(-S75M44H/4<GO%NV$T\Z2MY0T&8J1DRK^%M7-
MF-8VJX)ZSKO>5ZYVFF"A\EUET>5K=)ZAT4.P)$OZWL%<@SP'+F+():$U_9>(
M*;#0(K2J[$9;L")$ML[W6^2F-/M()P"=?IK^FBI46#=$H;G#O"L^U$;N4$A\
MK(VUYOY]/O9;B;JJSM_DIB-T+1G*!WJ)_^<334@;3P#2>X%Z+^ NW:W9"[)@
M]#.<YOY]P7M4KZB]8-O#-@4P?/9RK\SQ,][22(NN\@5E>+O]V1.@>^D$8X5O
M@'13P:-'&^#2<=B1?7T"1D(XP'$);:1+#ELG4-P2"^(F/^%%34H3(;F"L/F#
MY-!WHJ9=9:R09BP)ON<$OG4GVZM30;Y6T?O^_%O/S@^8XM3$"\AW=" >!(YG
M!@' [2GE*C_=R*^[^A4_ :Q'2?CG(K;IG:8\J"*,AQHK4;S$_O;JP;ILPCBF
MT7S#J=AM'Y2S*@OJ_!BGI:;6IP]S?V%)(<_&NOB- HS^EP?J*NRS6NNAJSOT
MS_0[']TGA2/)JL>,W'WO>*K9/1RPGM"&P3ZGY&U\C>-\&,!K],[7U-74E:%M
M!D^*SQ*''**9^#?$V$Z+*K*5)L>K .>=9HT\.1;]\/E R*^.0I G\J:%7A3D
MSPG>%_2VB"^+J,N>\H-$%^FQE]@3CX*5;+/W[TIW$XCA%,([OSKV\LR0EZ@O
MZ995T!A96+6^IL"Y0O:D.Q4GI1D ' 3?LT@![AP"?!:!1! 6%H"::LB>$F[3
M;D$@7AHZ,+_@QE-K-E_GT(Z3D_@25T;_5CO?RW=-J\FWWE!+I^ZFH[G_2\0I
M.4X/8C%0I(0X0P:)(,$H::TCC+0C$LM3 #+G@8Z](]=:]00P\[R[K#0[1713
M8=\XY17;_FE)VE)POOAT%[9GF ZPV(419:X? =G==E%4WZG?*_G)']N"_LLC
MB\%DJ2.N/= ^G]*B3P'(:JH?R/V+3SM^"M?OI(#DS(1NCQ;Z7'S7G )P#8P*
M_XKOG>,M.M3R29$SC$@J9EXG5HC3&0U* [YL^YZ2]:@$VN_4-(U?,[#%_MW%
M_-E\([YQ8,T?8"[2:LDM7/7H?J5)@'2.W=\=2Z!/+I]K^(B;<%^2?2H;*=$U
M6=EQ2M'QLWTP)U!,@/+E&8;X.7K[$Z#3XSFO:+ _1?1<@^LY2$_$SI*>>SEZ
M[F4ELZN2:.6%4@8-\J//0&GF7,-A.^" )]2V]*\@TM]N]A%QFI#;^8DZ%?3X
MO=\ -QW>A^P2P^6,51"[U-G8X6/2_-YOK'NZ O+NW&XZ)T\EQ0BZ@ZGF1>87
M@AQK];'##>&""7^KBU1O,:'_C?.U_S\:\M.O_PU02P,$%     @ )'=\5$P%
M#$-420  94P   T   !I;6%G95\P,#4N:G!GM+ME5!Q=M"U:C8<@(:$)3K#@
M)+C3$(([C6N"T[B[!(*D@[N[->Y. D&#N[M+<"?(XSOGWOO._<[]\=X;X^T>
MJZMWU>[J/4?-M>9:NZH?9QY7@!<R$M(2  @$ CX]O8#'>4 ,P$!#0T=#Q4!'
M1W_V# ,3"Q\;Z_ES+**7KW#QR8@IR,F(24G?T+#2O:%BIB8EI>=A8'[/QLG)
M24'')\3++LC*P<G^STE SYX]PWJ.18B-3<A.24K)_O^Z/;8!>!A(ZB!N9! 5
M@(0'0L8#/78"%   0@7]1P/^1P,A(:.@HJ%C/,-\_C2@]@6 !$)&1D)!1D5%
M07DZZOUT'$#!0WU)R2:*]DKY,SJ5/3[[EZ@L#.H/E>U@E=%C&@Y#!_]GF 2O
M"8F(:=_2T3,P<G)Q\_#R\8M]%)>0E)*6@:JJJ6MH:FD;&9N8FIE;P!R=G%U<
MW=P] KX&!@6'?(-'Q\3&Q2<D)B5GY^3FY1<4(HJJJFMJZ^H;&IM^=71V=??T
M_NX;&Y^8G)J>F9U;75O?V-S:WMG=.SD].[^XO+J^N?T'%PA !OW/]G_$A?>$
M"PD%!1D%_1]<("37?P;@H:!2LJ&]%%5&_VS_BHK]"P;^AZBLRO9GU!PJQV!#
MAU%, AK.5=J3?Z#]![+_9\#\_S\A^U_ _F]<<P 6,NCIXB'C 1#@ZI8^VP_S
M_S<K<N6O#<QBXIKX_*5=32#1!_FM'ZNRYBNW_!<8];7)*CCL&U09/MOG12IN
M"4JNPJH$)P4Y)B%W;@^JH"EE75E8<F=F@,L*CXDX150WK)ID2U?6VTXR1\&W
M.Z['Z&?1&(Q F4V+]6 TV#02^6[?C[L"^6P@:5AHQW]LR971!@EUF\8Y>]6H
MQ=I 03G&U_I:!EOD@7(,6KI&<:6:L<$4\S \/GVT9'8_*AF56Z!E#&,EX,^X
MEJ[QO?G["/0J/N#[_I+-]1U>?OC@>US&[UXRIBN&MMDM;*3\/+&=L$X!C;Y!
M\^#G*NT8[R,@N_\(R&7<T9/3CF&L'<W?0Q^!0'ND78D%G8)^D2;E^JMG7:^?
MD_7<T7@H0G8E(VZ-'X%5R:>>NOUESB/@DW''%/+:Z,L&G>[8]]I'(/WY-%TR
M*X& [;74>0GR9<[P/;OO<1XY]5ABU&6)T10WQ5A#E$O:VM',>->&T+J0>8/F
M88SFN$'>1<,CX"$"29,%7^0>59$4TMA^C'QUJX'"6CJL)GBQEDI3[67\;NUI
MVN?\3'[?K*,"/CSHX.QT*>YJ?&YJ#MEB^>"@2"%P=$_"J8<:W@??HIKBHF_#
M.A[@Z.?_E-'[Y59MYNX#9+,U]_N.T:>G2=HKK'$7%E7 N%WIK* (JQ4FK]Q[
MT%:I$D@<__]LFM--=\HF+/@*C\#R<"^$_+[)QQFJV11]^"!+:_CF*_8>)"QD
M6+C-*$+WK[HEO5AX; IH^C5/0N[W[T&,CG]K!:#DB62^I!-(BZI.:DCY?XMT
MP]&YHAP=SH39/XP1.<BFF#=L#M=J6(LW21(7WNVETW<ATWHBEDO"S@N_L?Q^
M&ZH,!^CQ:PS],!48)I20[>@+5)20#.$.99K(?L_VH8L=3_$'ZX?A.EUX+,@@
M=!2N+0.\9V"3%0?>,K -"B33@QC:%]VQQ-\RF",9M\3A+G&9"DD'XV0^Q&6D
MON#;GDN# W/PK6?7*,:7L!'_T[5Y)#Z<]B^5C83GEW=,\3VD4_DI''UD-'ST
M]C%+D9I[I;4A>;^&!.LN]@KN(,-<N1AO7CC@BNE^ [ F6_DO-<VD)NL_=B+E
M'@MUJ749Y63#&4+HLY_F_[\LJZD1/C2ED[3 K%RV]=:/E\%F\$>K3YF4L&=4
MNMN@>:5.( F&%ELJ^2,@LUU>/@V=I&V5&I"EQF+@XVVC&.=BJ1F3P$?KI4'"
MA2Q2]!+'<_@(<EH3_5TOY$K@3MU,[ KJ43MD['1=,O3?3P=1J-@!0KYIVEK*
MO3=5#B)"N&2^O[M>$PU7@6E>B)*%\8!'^7,S7ZO9BGT9/H>DJ7L+HT'H380#
M[G Y01%P-FW<_(K?DM#PQO6[!Z[G,W*X;(? 2?@Y1C&<#5J#TZKT)=4I_R#3
M6#,'_'9<8@Z((!V%QUB3F",)*O^S=<O$.)%@E/\Q8?V?'V*M.$'D#/8J7S-I
M 7&X4BUO2+K?^-1BQ"?A&I".-;UV4UWQ0L:O$AKZ@J]$N:B$I?KZDGT_EX28
M)*90O[#S.S-[3NS:,D6=IGH>0Q@KZHS/J,U"1U"MDAJA7R^$]@9D-^-X^8;<
MBY^_S"(DW2:"Z$+)@L86CR$]MR/HXN+X:M'XRN+ _S1PQ%JBOB^.7LFG:, 0
M/?.3X@['M7H7)>@+"A(N"C%P<BVL'*'@5GS"K8GKN[>\JF;[2V?OJNZD;"+<
M3%SWG.B-3QPG*^$A^C)%@&^8J/@,#I;1$MNM:4'83Y<"P9"TGQQ*']_O]TA2
M9*M&/0*%D(NCNT% F[67%/&F!!-TCNB/V@K/HD;!F2WZ(ZSU""R*WA59H-]Y
M/0)-V9&_@]\%S EM7#T"^TI%!OUD&T3M.Y#NR$>@-&$.3_'[O77%N9C<1T]I
MO1M>[!J/[5L5KF8"IDII@\1;W!,NQD>@I^IO_SW,]\8:\K<&E&Q=!3K]AN6C
MO#A\CM]A>?5%[M/F#,[K&?6BB.CE?170(T"!#_IJ/1]-_:8>X^=4LO7QX&E:
MH;!1>'X3EB^BP)KB!R$^:/ &-^0!VA@AYY+[_@>-@ +^15D"\HOT\^, IP!D
M?%#_=W>>PCF?SSWXS]TQXV>6&3KL]424JSC"SX]S/+%<,G%TM10TZ<-N-NP5
M"5ZCNKK+AZ[G.65B?[\H )U1Y &._7D+!.TBO$/2"*A,"J;"Z/ZPS *%LX5O
MJP@14VX]7R2.6QLB03;4V92ZUMQ#^>ZM'Q-+*%-&@J!1C$I(%&@NTWY7A?S\
M'U\!Q*9/\,='[K%YK^X8,#;N%4\ST>JA%X\ LI*4@,O^#0@J !30E5^KD23)
M,CQ?\N,O8JA,&T5< .-%O_\M?H(I!E]Y0MX%R=2G=KX_B%%[&W5^J>R0B[:S
MP\XDJ0]J@;H3[IF0>HL@N!*G^[Z^P*585>G[2##]98+3@0G7*+DEVC]/JEOI
MW0AR<H<4U3>EK\B"T;Q<"'#C')9C5(\DT;T%J&"+Z9N=SPUTN%9AF7T!;VBM
MX0J<6KE0)BQNOY>?JR7C?>Y\"Q>QX+GM#WB2IT"IC/T5BO.!2<)#_'-[=16C
M2%$B9*0OT?2/@*3B[>Z39/5+/\1A-LR]1@:V\G">.4;\>&_^8G/7]J(@/&9<
M-6+Q$:A41/$YNV\"#&[6%2@\M$4C8C*:%0G[4^_W/O%0,$LNWZH&W!O=,S20
M*)D=CE\O]4RH@'+NM;TMUN\_WZH W/3#8@KK]IS Z$.I3\WJU?"8'R^R$(/;
MD#D(?1'_1XT+4@)GFQ!]#UJ,,Z7]P@ARR,8] ^\]8_72KX CFVU")>E[1KEF
M)SG/9!&AE'*R(@::E;/0L<29^^V>L1C#=U894#D,HN_'F1F.2C)9("&=J5(!
M8@1DD1,TKA5M9?U[S\A@$SI! #G%K7L$RF3O A75I93%\8'_8J#-!QIQ888F
M/L:^/3&<S ,P>"1^;9*[(6I<>'87ZE9HU'F5>*%X#[(49B!21)FH4:'"DBG\
M[,];:NZS=\_8#$ZRVQ\V4J?:07W#0DG=JB6M,PW1+HEC/\]E]Y)X4F8:X0WH
M5X+M:\PG)Y5G@ZEEHK.T^';0!)P4A! ZI3Y0!1; 4>CA!C=[!<<%(5L/ITH,
M:WY ]2W=ML)SGBN-LTQH.V>;G/S]Z,W8FNUAQ%#JLXL\E-LQ)&Z.HHV/N'6P
MU^F[[^4KNCT.=S54,[2EO]&+[HH'?2S;P%I+<$R.@GY1>";WT8#O2&)*:%"^
M*JP&A--GP)K_3$8##@1&@=$F@8 NP=2QJFC_9'-0?J+%5N($B$1-^I:XYD+=
M)LB/7P=ML6 ^X]8TY[P8+"MM/:>+/A,Q,3E7]0%.GXGT7PSW_<E3.(+GGWM8
M/0(C!-6O2LVOZQ\DBH=^MC\"F2RFW;@VXF]56'H&M4/5>&\OBNUCX)$LM JU
M2,1IYD3L$\7*+#(U?G$6:XG9N4A?</%/Y)#24=^3,OQ*1N5%%L')R\7/]B-/
M379"--KQC_/E;?G1*2%AC=W]R,[<2L '<6M,Q3A,N.7@ Z=KR?HQ^$I(!)S!
M;^,C1Y"E\HG=N4A>H$FO^5%[%/.\F8SG(R(3@I7T .MGF=CW) ^B[Q^!MI_G
MU!I[06&/P)M$R(K!+5[QA7$@OK((ZG\Q<IVUU4< K+9]A_P(B&CWAT9::G0]
M J><>MZOGG: G[PV5O<#H5>'\/TCP%_S_7ZZ9\(4T:.>DXM:NP3QX\D??^!%
M3(G@8%#O85"DJ8L=J2OW'DD9GS15]$5*%G+Q3]K7GC2"?^1PT:ORKD3DX(D0
MH$HQ J"=0\B[8P0@E$L!W[X=H?JL"'X9=-CGBP4-3MK)N)I^!+3]WJ*E8DOP
M>. .I?+XNE[@MT6J;.6@_FSP95/XCW<1W$%6BP#7*U]EV;.G07[DV/1<%$<"
M*(_ CY^W$ZO-C<K76WYDR0P9W#ZWZ_?+#ZTHQO>7=T]?R^'\A9^Z^O.HB)<T
M4/=VS0^735$LHX#SY?)B3R,G 5TKYP@2Z95M7Z(4&;IP?JI%F A>(UVI:DI6
ML;S:VQUSY+PQB476!=_JC*FR26M>ZW'KX'L.Z*U:\G]G#L.)]X#U.LF\]TR4
M"G?[(6:XN)GD5)4/:TW\$M_9FD.T=SJWNGY.X4-<1*[;W.*,:.&7Y^=GD@L0
M \5-L>^U Y/F9P[5C>$E/:JE-I0-829!XE&$)EH*HF 70>( PS[5725:A9H@
MN5KV"::Q/&T4N5JJB0^YVD LL1L780$<<"M EL-?E4/?BD]F^.5')BN/7P/L
M,3"8@\S_1](E(R8K]9^ND6.(K@L2P6LUW=.PUYR3M>?X3*W2LU31(G9"(C8:
MMP;_[.G22*Z*_H;<Y\R)-,+Q0%_+?:U5I_.V4];^[8QL6/R)7<ZX<,'^K1H]
MMPG_Z/=ZZ&XICJ/SZCWW2MDX2XF"A(<)J/@B;?4Z5)AD;,W*A(4*&F$,SI&K
MR(;3 __%D-L?N-XN$\QG'&E1/HGV@J_,J73/$7&KY[K979A+QL5*QBV[S*E
MU-E675!/BL&ZT1]GV0-V^4M7]@^*2@4!%^@!>OH9)V]OES=;:N#.*R:$65=T
MA9 \E;%S)GE)R2!ID);"GR92BA8820:Z7KY\S>_W?T@V.3.8%L;82E%2703N
M(6NL@8Z=8[*PV;97DM,GNA'#X/&9?6+G&R8S;UL^9!K)-X;"#>7(#6.US^5N
MIJ(+*3I?4Y^!I9LH8 G23B;,JN,U4>=S[X6PY6K/A.I^EF@%ZEBKG-+HAU2_
M5[XV ]?;GE!W$1SFU:(F21Y+8WYZ$*&8RAHW[7]%7GC[#":J3VU[XJLC0>Z<
M%OI]@;$JYOH0TE=K>#W2@22/Y1G7])#"X""5IY_A."TNJ)'4=9(@Q9#D]'?3
MRTDD%"+4<:/6Z_/>S;T7&_76M_7E(R#!V6A@V%HCD/Z5X5?#ONTW'Y)&:X0C
MO:W8<]] ?7*^$13/P774)]E@]8TL^,W:V2)/V,Q7WK(KSM_H<O((!.7H_L@4
MN:I/> 2^%>JLN7Y]85)KY3O?\O-.GE6]"4Q<LWG\&Y(T#7=A@D/ =P2MSA%W
M<2F/0$@NA*"% ++%JGC?-/@(=(Z:&K ?NDQD-Q#YO+^6@#0ZV[_[&_\'DL[X
MZB2B8].1+#_[$9 :\>7)$K^D4OM,-KO3D-U2MKVN5L6Z;TUL\?HA>>C%PY=B
MJJMUF]P^XF&IVN"'9JFQ1X"E5G](+^1VD'6[=NR5@<#2W:<3DQDDHE*K8X]V
M@._)_:_431Z!4"]IKWZ:V\5#S4\A>6R(1\"O#'U77B7J5=<ONC&>IKCP-(SD
MR]/GYM_FR"V06+W9+9,F?KR]-E!\6;3,-5&Y?N4R&K]X;A0(N9KT>AC0C#>4
M?14MO3'9+/1:=:+R4N#YM[AP9&8SV_MSMWO8)'@R4= J+Y?*XVWQ2;KI0K)"
M_/<S[*I%80>!S=>$D&-J78+*M7M/O87ZV]C!5W:?Q2HQANS4['#78W2:?#O(
M##>"6N))/@I)>/50^*U?E#7+7KMF[W89IQ%?*H>;0EB]8^TCRLROJ+A(Q>7/
M)>-WB7%R2J7KAA:3.(+B&L1O,W;XRJ5&[EZ;9:,VQH5UK5!X'1?YSE),WVCH
M4H73=]IG%]&WJ1$"JJ]90KZ1!=)Q#\$UW3KT9G=N->Z^_/FYOP2Y1U%KRLLU
M^TO0(>0S3.Y[%*4!P_;_=RQ[?OT4DZG5"N[="AY"HUNB]PO+=:\G2I88:ZFS
M9R@ABFS[OUD]ID9FSBJ?+PN\PWX$>E\N/SPQ+(MX*;SQ$<"FN(YNO["]QY@6
MI9 9/'0=N\8S 80:\A7S9O21+[]+&?-V:X$@:>Q[CM8%"PHY+*16*YY^\GK^
MXO$TT1R-I&A8 @$2=8T*PQ*?Y5>L7SI3?HHF>#AW('V0I*K>OK:PZKFG4$J"
M[&>C/6B6S<),<I*B=T7/!>=L@SS\,Q;TYWLA\U@9_5PRML%S=Y*;<**?"PEW
M]OH-!? HAK,J<G*L$[-CC9"<C=TRW\4HW%,NK1:^TFZ[.?GMU><4F_J'#0@
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M\^AMSK1=N(/%!' WH@@FO] UOJ<W=<!0:[O@[.:-1*<#(\LWAR3X_M7[R6_
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M57<DN5L11Z-YKU0>5"V .):M-],B7FFBN:BJGHNJEGV<%@K7G?@T7BW3E2_
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ME]V<-\:\63^SVTS6I-)E9 NZ7X UG./'1L_L:!+=YSO,F89QUI-;?#U ]E]
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MT321Y8<YZ#A5G_8')105.?@2MU=,E#GM:FO>539\"A94;6CL#.F)SOGC? 3
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M;D-%$@"2AULF0YG\%$(?SSHAYMO=9!A]Q#!>O0Y&&VLFO,/N.[B-:MP9U9$
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M\A#Z+"10_,'SA /?/V"Z )KWJV)WJFL!..&JZ\_;[20+\6/X9R=R HCD)4&
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MVH/U?'VHO!/(T*O2OY&/^UV*T_L%%9R[.L/^_$C\M7L(PN6Q4H%K+6+C7)9
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M$OV32N WOE67S.&2F@VYG^A]?.UHXY64"5#)^3,&)%XA:Z6T(J;T4./'<=P
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MA"DX"(UD'RP[GZJ; )HN=WYK'-EPR5VT>IZN.?H$3)C!3:HLB:*CG;0>N)\
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M08H=<VQ[I:!T9GPDQNYAAM=5881GD<Y<&O?NW[_X&70MJ>,$B,7Y.XM_>.@
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M.4]V.UN!-PO>?([:C&(^IEH(Y.A)NS/6CU<]:XW.S(F$\6I22N,H*X4"6M!
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MAP8R^RMM"N B615_$60Q)Y[7.E@BH='^$WSO 'WC"<'Z\7(M5@.V)%F:SS0
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M 52&@$*U$VJ8VDMIDH2\01>T^&UCP=Q.C3)$GK[3M,>&?]=MX,EQ]SSAOQ\
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MNJZ"X_#M*HD\=02RV=)+[G#RY483<LOM^!GIJ,1EW\8O]:^HHHX$:Q6AN60
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MEC;? 5GL_R"1NC OD.:CI(!DR&%>%BY&((K^_^LS]_^'P;TO_1]02P,$%
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ML9(.#,9WD&_$'0^N4E%[T%7_,1*9,E/EB,,/=!#>;J-P[283/L]7@PM;?8\
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MOHAX1P"2B1J[NL ,_K<&DF\V&>H"06>@4;/,[7T3I^!6[R*3?:5"VX'088O
M>@=+QXY'@+.GC8$_V%8[^[7AR^(V\JIRZH^!!7 =-?X1>ZXI!VU^^2760-0$
MNS<T)WS,B)0,V](S SZ-&PR:*UPN$1&6G+S_R)-9/_X1-O,?8:<NT([NO4P@
MLTP(^0 Q[*YQAT9K2G1&\-@L^Z?4+'!FHRQDO0-BM/=9M6M9,93RV1_51^"V
M-+[1GL[<K/TI'2&9$OI0]U"L\.;MY2Y.6@)(06E1"OD2'^;W+X0*^@RP [^
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M#E3J/W(-5<=P;>Y#T'V)LGTNM] C8/ED5#\8OPF4?AK*HJ3T?[+[2I.(@[I
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ML.3+3/6ZL7T?2_AHR"MW=G=./L(#F-1&U", HQG)U'4[8QGA2!.-L;1 ']-
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MW='.>!W6,- 5^*>NP0@91L@D[P-[.B"?%PM0V>G\;-CU+A^H2LN1][[8U4V
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MW$.< R9M;& [613ULZBGL&@2=RJ;N#^:KMCV#_&H8(G&1G7]/*.N3 U1>V(
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MD)RFO%W_$])DL6@H"]LNZ)GP;X\_TQD)^'X4M)UP"^#[#9J?UMP"N2[/]HX
MW_R7^4>C"06Q&I?MW\%%K$V5BTH\JJR9$(T;LL5%);H]/E6_W+OG#)KMFD;J
MS+.P.&6Y4Y%;?,%8GCXP5GSCT.7$LQNYVMJ>R\ P]N&J&O;GQUK!#_ER1U"R
MSCUJ4!&]K^WPNL<>QI!P6=8;?]79^E[A'C7>UNY2N3Q]N?:V5C3,[,G21>=;
MNBR,S(Q?:*4*B@WA?6.#:0,N!XH1T':%UA)[4C;[!8&FGC^O[RL/$7ZR6/8?
MM+RG8'(6"EVU_MG6*SSGJ^UB@&A\4:MBN^31TLL7KARY)I\#:LSDFO%KH$HA
M5%[,+_/5SG1VZ1$3N/</'E@]O6*N$+[>&848-U"7D-B(^LA=2UG<C S8:LS4
M:"W4O1"M?EN%:\^-'G_,DTU\JH6?"1I%*M98-] HC\CPX#\?#9+.PLJ%DF+S
M>ZB181C86&X_6)Y&?6^(E?51^)-86Y"<O:N1)(%MI0("NZC*4R-&GS:$4:A0
M)@7([IV\BI"J&TG0U0B:0B;1N1<Y:H0C/D9]SW*-Y=B=#'W@.W=OFREJ$F7J
M_8I,0^H=\F[)_9^ERD<]PSK876/3CME/4>T8C?A^ +D*HZF_]AJX!;)H,""B
M3F^7$M30S$Z=^-KEDOGK.6IFRU0# I$RPD3'?7QVZ:D$5%>(B?*+ZB%_@Y*,
M"<34]4LZ%\3FWHM3QC0,#LF:H-'\)BK.7WDO1+6T=%YU_<18&)GV)*-[J]X@
M  )-QA_(J<KH583,OZU*TJ2RF);W"1R4*V>H66:P-G59U;5$22Q-(VP?9VY-
MDYF+M+&)7'.N%6%1>%9LJ2N6T\7B\7P^)%(38+MBMF-_:N<3F5[5>"U]DV#P
MD@A!$@L77H'L2,(RN')BLZ.XR\R&P$\L=XRF:GZ461MNRU]MK$HW?UM9GSKL
M,K@$?<OY863,Q3U.U, ]7K;X]8J+;\;73I$!_O5AN)M.>%74)\BRTI/&MUZ/
M>50J=0?@_<6R7O2N6JO87M"]"SQ9;QF!5^/;B6G$+;(B9#N322)R2J+/0=^X
MWK^ ?^_) J%6Q(70/4(?:]G?IR 7OW6J^7[VR[+^C78D48&<.@>NW2]=M_OB
M''H+A!TO;\EXH2>S8NQ<YFP)>K.?:81V_S*!,62DVXU_5==^R/+'YJC2/8V-
MHHFASGV UZA[)KC0.5JKOQ&\B0I]DZ3L9<#E-? ];,)^)+=GO)#13V!])BG8
M@?OX=(+A0BS>E(4-6\E!POEL0@7RO'&2H 1A@<.(1^2<=N&\:_ <6[IK*%.F
M,>T@(><1@XK^ULA+-;ZZ6:'PR S70O#-^6/;/F>_GK5WXT33Z5$W?2:OYXFG
MF/UCL5][*I#Y\W%L9YUEL_3WN"!AS4ZM(T6^\+ SQ-/M-1A:>UOE%GC)/!KT
M*Q'RJ&[^%A"!C5;-G07=D&KAVG<GU5"8XXE0]^X.P53!?ER)OPL^/F6:8*IJ
M02DLIM19P968/5:.=DVBB>Q2213UO%SZV%P+B'4$EK^7R1/)P=#8!]VV@2V;
M59+S_J)++J+Q<OM7FZN-5,SD^E15)T.+\/+O$_BZ'-V=S4UC]7Y667P^TQ+-
MHWLY:2(*7WL*EE7!DA. P]O1/?"G8DU*#F%F"=LW+#3OA:"[$T;MJZR].4S9
MA*J$,5UP\TI&QM&U%)31Y5A#J1C4604G";KWT"8WAZP-KR>/OO"1G,_(9XM
M96FD$2"2G\2*,@@+R>9=C\2&1@KG04/"@D,3>7(;OUJ,HP(UOROH17U16]4Q
M2B\@:VM6QYA);^_4<,9_YTT KU]4"L#AR!WFX]^$ZP$SZ.1;('_S%OB$'U&L
M KMY-OGRY"?L^*'6^R'Y;"1'Z'^A9:%.HS-KG5N@7*3U&&2@G5Y>Y$^$"!6M
MS<VY!>B@&$<QE^M0(G9SH0P.Z3+\U(SW@@S\D;ZVD6]N:BXB+@Z,=GX07G'^
MK+@>_;./+,K(]2BI"&=:KBC)5YZN?G(V*.:J-7X\\-)!EO.C$2^X,D_;'=\Q
MBT;**X_Y*/^06+&W<O>//XV4JRIU-[]\PY#B\T?O1/(;]7834$:D@FEN?THR
M[29*JX_FLNA7X%*WP)=JK84,0_W1-R_MRN3*[WBR9^GM75UJB*4*^]$+FZPK
M^&9OJ-Q?('"LD"W\6<VG >LY([U+ =M)D?4!>#;&?B#YF:4RC\_R&GVECJ;1
MV),4OQ^69!FEO73$/>6;LB5V>;/=$02&;!XZX66[!3&9#@DE+JOVJAN#XI_[
MA/53@]*T/"G59PQ;.O>*: @J)8J^]98][>$J3'6/<Z'E^:K#PE)=7T15%BXA
M $=P3R^CA52)%(P&/!H.,D,[Y4W$Y+OU;@$7\;OUD\J-MTY2>,V;U\>7'-SF
M>DL?_ACJ5HA'3<'2'=^\E+GI'M41 NWRW1Q:W0(VIQ=$":Y&53<C(V7V%4I\
MI '^;UQ@ZESUVPB!Y6^Y%@7G::TZ+CE/')%R#^T*KTO:=.M*?TDT@C+W$K'\
M-<ZT,S\,?"P/E-"&H5V*ZQ-YA\BB56B^I](;X^YGKL'2W6Z H9ER[^NN&ZL6
M A4!?'(C#^\;N<QG#MI%!4UC1\0D;YIN)%0-#?&P>-MGE5YC5=)[G]XQ]G=)
M]@.<897Q9.:HN0+8V>YS=L*E=:)&G985#\;6P[(C]0.)R!@_[G(FE,"YOV^M
M(N'7WOW,!;/1RA)X(L-]DP&Q' /UDM"T7V(ZU@\7[9GV+O7?[2Z[OV,[,I %
MKS''!,VMM4@)4M(W:2O1%NZ_9FP.Y8E\,RE#( *$A]^X<\2!OJAXZ7VW*.>J
MM6-(I,0O[.Z;7\D[6XI)HPM?)S?.DTPA>U\MZ22W;/*ZA+X8%)3 "/#> I,E
M"L) K-RZMH84V$O<C2J;@K0OQ/CS),)%Q2NBBT]-S)G[S *ZR+.PE+XJVQ;,
MO$I?1&!ZNJ]R].=>)T%;+(_<:-JCY>W)N'X03KRLZ'*F0>[:4S>G>*(4U@P6
MG!R\P;=C[ZT#1$I4GR%8FMN@BZQ@<@P,^2=;K9HJ1SGKIC%#A53DV:D/<PV)
MVPJ*+&8*/ZZSK;Z0CCQGC:>T2$H8*B,";QIPAC4^>?S9^,&^:"3[@X>7R($+
M_+)/6DY $<B#/+NPZ4%OGV?C'N7FP$/J+84+E-45C<=6F;F7G%4L4GFL0<]H
M](&L+;\4CBV'V+ *\'!3A34>95;@5!&28Z&*,!/7;""I-TA2@QT(5=T"90=W
M4?CLDX6F[=S6Z;^A@\Y'Z]P1&?)G_^4;A'?GXC\EUV#[+[Z=!VF.6=)FNY]@
MJ8._VW?0J#NK.'EFEJ,YET<;.!V\R4Y9=MX49E*SU2JA/E;),YP$UPIN0%W/
M)]\1@9]KGV)^"_R%JJ@MM;!@W9,7(8<O.C\4/]()!&V?%);IKA+(0?/+/E!:
M:<,4'7ALQ^==]XW6<L-BV4%@G 1O5RFP2!>@9'OJ^I9RIMY+^&'H4 $]E^,E
MI4H3V\[4M$.'TVL_>CM\7,O&1GDS=4N_%&'0ML%Z!^5;\#XC6\.*O^)\K+V/
M$&_AJ#_Y!X5%NPSQDN0T[PJN&X$B=VOR@@^)>*E>8=B&7W9.2S7R$*<!I4J,
M&K> >-[RX0"\T? P[#3&M88DZ,D>3+3^$=9U]_OXW*G/'J\ZG9/8 ((X/8\O
MC'7-(0\]'9Y_3IZM?RABG!LT=/!TV= 4Q^@^+C-5<9*W"GHG1CPFO/MK")EK
MN 4;]8ZH3LTJ8;Z+EN8ED\P2(9_L3#WC+5#[CLPU4I5'I.2CK\,F;<X'?5I$
MS):8O^B@).U8^.SW%ZS#7_1<R"YC?AV4J&^J2]O2U^A'DKW>51>YAIG4:*^L
M7L^O],R\G*_T(7/BK5FQAA9\,VIL UQ<]<OSWFGA$<U9L&#*F05-7PZ[S>'A
M)M$&81Q>7!P-<B5,H#9LR\VW]?05V%-V/_$%1:_BN&ZC]-%H-OLCPRYFYV]9
M;.&!=V0B='WLBTBN2[ F7*\T7D1^$ ]L+E^#<=K4?F;9/>R>](#3_6$)#_=+
M*4ID<LP:MT>''>Q$"B!92+()BW," 'I@5Q5?8:WH4<(<G((4E,9O>@)C']KX
ME5QT/.;6K59#P1S UW#>O!S8H]CGJC C4S2K1#'Y,"W:58TWYH^K&I"A986R
MU&)S!?QJ2\+-:^_5/3M_'C0^;K.E '<:5W!U,,)Q O]IUO9HK"?=C7@>-^<"
MX^URFHAM63H61'J,UQ(IK4P,M$$4<]FL#P\Q.>A6CJ^*J4_?T;^:4Y.A+^HN
MJ JK^]3W?4"#Y:V+$88<ZCTIAF.>^;Y8P];;\8.YBN4R"1N]U0E0UL #EO=7
MQ<42Y[DLE>?I417"I0<N*PPJ#*]3/3&E!OG5MDNRB<T'@%"B9T>JR^12RFWN
M RKT;?O:=%JO&M(%PY[3JU#1+:."AG2$Z;2R#E"3 @^F,W2"A)>A):R$/(>^
MFP6,VIQU1(:)"4>3N81:VN<E>&RC3;;CC6D+^F"D\I'RSV[V 8>4A ]KT2CE
M%0UM9S#9^P-IZ/L1IXKW8ZZ**M Q##3*@L;5O7 F@$H-K3^*L^OPW7],W9^S
M&''ZCK_<@/@TZE @5\'ZTUVF6P;_PQ85"$]?[(KS9(P+<:VD*HNI;4X95TC9
MNJ_$!QRJ[?,QN2>\BK(<S&NJ08%ZZ '#X9CD#T;.QR6<B/B((TL/ 1?^!/ !
M^L%X2 T+*(/CE?I(- =X,I?AF)>ZH<>! STE -VN>R:Q]6"T$54M^)/8Z#?O
MD#(^G/CYUPM-M-S^$OARHLY<=C%!;5R;_2=>?[=QQ$C5%Z3_H@F5=]"-C.W6
MD8GO)P>F#+/7;63LBH$[_A #]UKT9^_@SZ4![*['=)!M0TK* ;(ULD ]C#ZK
MGN.R4+DYVV:J09,+6Z.UY2D!JFDKWRVPK+K_Q<FC[E975\O?*F0OA0Y8946.
MU^KT=ZQ$,M6H)?0X,Z?0\"^5HRII(3^,7X%6(4)LDB?<*FRV$<*N7)W3JD%C
MY(S"^4P\H"!DC(7KL)\;RW?C8'"@(L<FWGZ@*A>-R\!H:AA;RGV*697S%6&-
M-,V,TQ$BO@*RL:(R9U)K<2(NF/7 >)F=VV.9U]=GY*;/L@B_8YR63C1^3LI^
M#]EU'Y (BO7IBQ3#Z((6=3B;P)^FF$;M"P\U=FEE:B))7SC'.O^P3?QEV?O(
M18YS2'VNG\6EWVNSR\*0!%OUP#L)W_[;/+/0GS(<P4]_7M\"G/(Q^<RN_ RJ
MHL0'^5_F!Z+?,C1V/7O%3*N$^78EDJL_W?:E9A5TH@;"YZ6JVD4$"Q.Y1LC:
MI1P\#I;%(8N\!8*UO:@*VZBV,R:LZ,2)=IP -G"+-<4Z&_GX2 G7NYP%%U71
MS)M:%:C22DG<$1'N@ 9E<6M7]QO,'+MJ_N4TZP!.306^!!%!?2(7G#=[A(J?
MWAT*=\G0!.1X]=UHG;[FP*B"I<N4$KC4F_AS$D2$$[T?4P_XX> K(Q[8D 'L
M<" HZ,JDUE&>F8?D;>LM0C:'7ZE8CD\+TY%U5 3K,=H>P99]D\H,/TJB3>B_
MTF+;"7-5.^#[!:$2N-<=0OUI9M**9>;9/[9S(VQJ?KB&FT<+R@C.SVM1V]<Z
MFX-+_+1_XFIEH/56X\+=9,PR\S@K"2?+2SD"<-FVY>*HEVW*>H=CMZRVLLG,
M96W/_Q2)YW5C"^0P%RAN*>2PL72"T5@'*F"DR!5'/M<]%"&K+P=>@3.&2+XU
M6>Z!"AO2\QXAM$/50J-R*;W-;*GFL]A0*#>XV7^#M9I8<\#VS#&3Q. 6:+L%
MCG'03$H2.$AV-.X_;8"3M/H,KX][2B<"0<M,;>O6CA_6[CX3]_WVD?+00DO.
MA-!I8FX__QCSC01[^+*K5<S!-A*Q(NL[9- OAE(R99M'SU;RE@LH"2"&5WC^
MY($+5VJXBP08APH+I_+D6YHFWY,[C$5WE'L7__@J4."4NBB9DV>5D?ZFU*KV
MR5/ITYYK5G'_-\Z&F\-TD^2Y?-#"KT088(E*PWX<SJP:LF Q)=E7QKVT:PS9
MY>NJ:8RD-<HY-A8)PE?>DU[L:&KW>?(O>_S-5VOYS3QM']WQA0,#";^>JXW5
MVM_[,3VH,^:R->V(D=6LJSE7""MD2A&H[22IB2S4\'IDR':NPS7/80Y_1"#*
MN\41N/^$V692(87V7?-'"%J7T\[.I^]SW-SVP'=YG$U  +3E'/0>_JN_1#J_
M=YI/4B+8.+*?*N39'G/&V\GY+1%JHY]S@\XTIF_Q;<8*&F MOED97@.*2?SW
MW-+.65F9V;/>9:6Y#QVCH1O$:.OO>57<W1H<SW.ED$(4KPGH)G*K(OD/ <EW
MI1@HDR#J3UWN;"G1$@VST=.G7=:UI1_>+1^B*;X)8N3;"Y<ICG^2#/F=*ONF
M)AI3Z [PXG\,I+T"NCD/EI+8)%L-UB]J^5_:,7.4/L$3+Y @\H9'2$P+'@UE
MH8T\\CB:\[U.\TX4?4E,YN4D)RD?]6$#?]9R4I5:&#%8WC#DWJ6@6X8\?5'I
M9ZUK19R8+OEU0Z4&9I%PZU_'FW!]FZJ0QWO))@"U0)VI\*"SCD64#4"@+0?&
M.9%1HH26A@?E*J^L^6#"FM6BY-_<'*\&[B*G+*EZQ<>2P&B;"BW=Y^"/A1<I
M)=:D+EU5B%<U@<W6,^5D6&[4A09S>_UU8&?M$STYFVS?ZK=5L*KV!C'I:P0T
M$L:3($-U6I0'#Y7J@TY3XJLP#+!9AN3NOHT$Y0G[U619A5N@?'+GC B<;, X
MT0^B$&+#7!062<XKFO4$$S(L=!/O[2=JV%PY9#L;H=;AHZ[;LG9NWWOSE%U$
MM4PGPE\Y:R?;FQ,2-#2'H6RA<)K4\&>^F[FCE;WY#S*PQ8+?LR;[?1ZMS*<Q
M,RLH0L,(_7L[[&X!T"TP3%,U@#BSSKP_ZPNY!:0%2G%C-J :,@BK_[HG40;P
MV5Z*.J>I=7Q9-W!7U:#ZZ70*D/XK=A.MVX>.UP23ZN)3Y/:#6X8/Z4:=:_#M
M&%2>:G:950G^_!B.RIA>4O8>I[/*).D,&V#?$ZR!3F6L;ZH9>=]HTZQCYH(W
M4=.]T8 L[E(J?8W\;-W*!2I2Z7VXBXMOR9-;0#TS.'SG^>9DI&[#RT^UC\;O
MF^G_[LG:5U<HY!4.-WT[)8;YN1XO/"UFT"X_2)7>DN42WWEUBX-M..3>QZ[V
M_O?51;U8EKHR."5.ZEZGE<MTBQ<WY*KLE#[.LIA)]HV@@O,N6P7ZX R2Q2-+
M9C9FYVO$F*-V-I."36Y9;^N2/B^K(6M$T\K3EY=KB6[5D90V#M3T6C$/2(86
M9!%J9TD*W9/!+5X:-V0_=C.F+=,/&*(V3_*X:GVI9/MFM>S8?D(4WVRW%2Y=
MYHR1K?T,K%E8SQ!%YJ!FXA]&%+BE]=@,I:6!8LXN)JLFGR4KMWVH=LU8MAVJ
M-YBFY]54'BV7OL9^L1N$A+<Q>&NQ_%E+4+ U9R95F7ZY+@_)'U-OWH5<>T<-
MS+BBOO;^D&K09?;P'I-:2XXK\2R*+U!'C"K3#Q>G#\@#9 ,_AJ#=\7)],+1)
M#.M ;,P ZQP1@L23>NN8-KD/\IFL,5OW<3/Q:Y(N^;Q 6F\MB&T]75*!C"M9
M'+;.@*+SE^75A#KN^[B]POD+1<L%M3"0^+ F/39B!&5>#HUHVT2!>^7R1!H-
M@(\]O;;(5*VWX]/G7H4KC$0(FBVXHRG$#4ZB*IU G>N8=(4P&#9W :/9CO*^
M9KF7[FAW!P4-*-":'HSF2/@62\E^]X2^4*Y,*\]C4S07E&/*<+++?K)&J&<0
MXI UGITB?(YM.$VQ0F_[I09NE34NFT_CG/] ILU!8?-NK49C"QTC#X&@7Y_I
M6;\,O6"&C%9&F=2V+&(/UO1<5E1>RSBJN8KL>&K]MY&]N1031;XUW_HZZ19X
M+A"M*JHKO?SF*I-J*RRRFN+J_*9V,"[2+K)LW9T[ND?\9%^5GI/_FU9HR/-9
M4(OIQ$!<Q2KV()F?@ .[CJ1SW+8"37$XP)%$J3$KE[C:C-_0W2EB5#/(3,UB
M7JSTYKN\*L:^UI?1*9#S_@S:< ;ZGF+QK4XQ!U>UX*S',UDTEW.LKXR:8!H-
M]RB#G#!.#>-'9F5VT$D1%<XS(F+TB[7Y4(0@;P*%.#953YX1<DNK9U!5 O$9
M2;:P<%IDGZ/O8/KQ3#?ZKL9:U6V)^%EJ\D&+5^5!DR67=93J28NXO\VKYCHF
M+7<@P.L"^76BU*(BA8))L6*(;3Z[HN'+.UD[GA4"!_7F#TM<-GU=#6J:;.0L
M!2#[=*U=4ZWE' *=X-Q7-7VQVDQ\N.IS9LYZFTM>[P).>P?F5J)&B[9H3B96
M"&F"/^*N/-74*5 5+7 QLN;FMBBK9YGM5H-GYW?+%W+3NI<^5E60\E=T[XSM
MN2?.>QX)^R!<LN$JL*]7XOA0BJ3,?GQ]C[SGKAB9TN@1B$SB'W(F,W%3:'X4
M$+YB48E3&Q9,AV*<0!:GCY!]AD$&<P;W,#;AE;K,:=JV1C+?[N?,5Q1>''/>
MR^JY6Q@,E%YS*,?(YWZD9'0=T+5+'E[V7M_6$WFRKJS)RJLH@N^ZJW*X]^&G
M7$&'=]JK#^NZ.HOZ;TS]:1H*E0I%5"7PAU68*![(/#QFU/[P3B3)*29I>NP0
MLB^T0*A LP>BEZPM1LZZ<J@9H@FZJSK,E 1%X]J*T&BM\*;)F)D<$-;%.%?_
MB@"; BO,GK64:;833(*6,)/J0 "NXW#'KQ(<!,U4#ZZVRLG4/G]+[E\8+?.F
MD8FA?LY%]'9D[>%6>_UP]W=G4!Y/^F?XOO1(402G&QO;)GP'FGSEQ*\AB=LE
M-;517E,T1R12["GZ*>(W,Y4$7IEW,M+9,/59^.P(3<D?67938NHN*\-?"H]-
MK[*61U,%.IO]#H9JE3H[$C?*S;A^H)3[Q<8(#LIINZP8G/M$[E97_1DBI8\^
M)KUX66FL7UA:WA]SIJ&O+C_R+7;.6Z=>0UNVO,;$4NO#0_$WLVK03@A[ 6HO
ML@=:CS&9(G11W27NJIPJ1F@XG="H*PZG,>% Z]/BCG\_(5M6A@)CRFQ,:<['
M^9!VE&FGA-VGWXY7(:S_L0%^W76F"8)S"_1:.5[\<;S&L\M.B3\50[%GU_']
M4V4G_F")L2?BA.1F%'(54ML?=UQ6O23'(#+.>PLHMQX;3#T</RU3;"7YH;1(
M=S\F4U,G1STL4$4Z&#-ML# O%41.46D?WMAH^.8BXF>PV3>N[YV5+&-[#C1>
M'R7XNU3L'7CH+R[@#KTU82CC!JXD$'.60$T.U8J?=@KBZR.Z$_)\8F4X?.T9
MXGN\Q1@JGNC'TB?-#$YUKP%&_GWFF?,=WZ(Z.<K3GAL4VN"+RL@>56_I<707
MI^@"'X\9JF^3"\5M[G 63N(*(MX;_T*Y6M9SV3J9$]6)6.">**XXA0U/;$L8
M*CZ;U[M/T;U8#;E&;*H2E8O&?#]/D)2-=-A9.G2^F?47+>U999YI^@B-$+W0
M3;SWM;&/C0"WK]C3CP;%;ADK%OI36X$QG$Z'+T?"8'Q2P"S;6L%<;CJKY^KH
MY:KF>1A-DD=[I$)Q'>20N/[._G97Q5L8R!D)(@6'_EUG"U<&X^77+B)?(9,%
M;!);R-Y13*RZK!!F,^7E3+0)B"N2'S[[JD_/EE;&<IO_W&/AG6M3G5% %BA.
MKVE^#!$8#TF=(A\(U0D2[+ 3<$TU-NH0U,,L>(>M\O9U4MV\I?Y7:G +/%/M
MP8.51G"% &%-TLR+<",\[J%YV@K)[,_C<3\RUEG\V"644Z-$9Y[EIGD(V"FV
M^M=WYO6:7%W@_XBQ%TCU>$.DYLZ\1CZD8G-**=W(E6;I@8Y3T=]S;W<N3+,L
M'<P?,R;DO4,!B'3?XU\+7 [<"(YXW%]X&X1>KB)$7A((K:986,-:D:SSF7[:
MX9F:EG=%\URK=T/RE8J[A=O7T!BA^QL*ZQD3J43-[E3 %UDN0;DG.S^V7&S+
M/ ]P(, G=PE-"9I?AC5?@GS@/M.K"E\A!M\:#R@3.+1W["(B?E*1F1-7HG>%
M7B1NE$Y9YGHMOD4-.M6AXW^[V<S#O1D^9+_T;555\-B%J;N>ZP0!;Q<F*6)C
M?NR$,)%XVY^@#Q<B93P7UPH(O2$2H<@(N6\5PXJ_O>'US!=P,[W?MN)9(@/V
M5A:?5 ]H\0_"JV)BMK@$__"1 E^WN!!ZO2N\R_.5)UBOOA5NSGR^TC(IW>WH
M,W[H5F^!H;,8OX16^GHJ$)-GM-?XBNHK-?J=IWS ,6ME_OX]&IVHQU^#J'FG
MO<=.=_O(<B$"S?C.U%CXLTFN&:NO?=K6ZL@_RK 0R;S:/0]&L+<7'I/G4PB^
M'JSKK80P:D8I6OJ@Q5''%#T/YJ00(D-[6\I+60WB&"HMF%QPAOCW:W'B=*AG
M;TH=[$U9O,>M4:[W97@R..9P*J]LP]_DL29[Y0>HAC0]Q?[WQ(==D$Z)9-CE
M_M8;1/-[2\G=B->.R'=;N\J0Z:Q)_\,V=G"0CR+DP @!OFGTWZ@M4X6EM VX
MWP(/DAPCG@S]B>6_!2+Q5Q:-PE%KA2W+9:E_%#Z 1@L1_ DO'S.T((X$NUB.
MR8/%4@HDU[)&B&L_?/?M$9.Q62"2D"@65G^1#-J&TZW/-!9P5;N5?NCN,E9]
M>V10^*97?%)8H,1A-EM3E2"%J?_BII9]68#4K4OQLW85I@SA V*-T4K+<[V5
MR8T5'9D=*Y'9H"&!!S(RT2"UW2X9!H,7JJFAU,<#]K /Y>H.S^D"+NAH0MOA
M/\C6R9OY[IB9[Z<1RRL*+\QE6D\Z/VT6E/N.W'IMM"^.?X*4UE&T*U)%D;%T
M<%E-9 P]_2?"/\$D"C4TIG:E9/_!D=L_P2!]@INN[J9C15AD%[D5-KP8^[E4
M*U:?C%_9O%L5U+/AK1/H1.+<0PYG7TFK.A_KWGZGT9[!.<9&)< M\2W.D%#8
M0:'4WDMO)O_7_BV@.,6"_VW*F**3G^"JO7';AV"6V-^6EJ[D&Y3JX;VWR]#6
M&;%E#B93-Y9(CG*7EE^8A=\\<M-(;@16NUY:S(>+U,O$/:8HGN+YMEKOFV;]
M>P/Q7;.CY.OJ8!C=KS;_UAM?+AS;D6Y,=H;QKB9W*G"@(;L8[25MR0EMH;Z"
MK9-V_')EEPY[1^%2$ZW=F<-N)^6&)2@W8*7\;%0IVT0.I&+3YPJ(LZ]6;B,G
M^=[2=-<_;=:4.Z,[Y=BD%:$B?YI1+&]#QK-<P!2MC-&K>3YAG"YD-9]@;>_0
MKH_\G-E.+&5GMUM8\N=<@BO2,!OB1 4S<#5NQAA2;-=:9?,8-$CVA.O&B6$4
MRI'HT\CTIRV+E%6K?C'<-EVE]I^G]]WN-?!\!52VH??OO0FLN<RL'ES>&64H
M\]M$V[ IZG[YP/#TZ5K! +V!!!LMD2XT6[TM,J3*T?V25GCJR2LK:JVP-;;#
M4MIRLI\BOW!2.;-NV!9NM"=$^\48M!_3&Z03M<NRW*>I+I_Z7G>WE/]4YO2F
MFR<3"N?RUHZ :25I(A>*[^<4B*]O&DUP-G+I;402H9]Z*YFY)1,(Q36*: 8:
MCJ0-9NEX9%J[,#U:MO_^@YH*_=9.P>>JHH>A-H+&U=Y&E377*/6U2IO(>HNP
MM<..JP[SV(W]J- "9UN]S'KY9'/.,T=?(C8="7R>%R8JWX7)/869TL,?()5]
M)DHY"KF8.912YE"2\6OBZCF8J(DFGK<!F]H%KUM'2Q/;X[3HJSHO4*C8JDHG
M@SD-!13&4NK8MM[<^#,%<1JS@KAMC<H")YKN9!4.1AK;8F5E_K@!=Q,\H[F?
M0MGL5T.W@$$C[V33/LCE3\$/V"EB*]M"TZ(R&\GE>O\??O0,ZI3DS!^BY+VY
MPOWUW5]Q>9E*-;EL>VF4^$S1WDGT1_E-R$EG8'"7F<0@RA]/]<(X>A>,->E;
MY>#[,UC)_Z&71^3XV0-S_/:<*E'&,*ZQ+QQX(@.8T8=V":GX1**3P6$/&'XI
M#FXBZ\VGHZ,TM,&%>97%F7F*$@CR!1=.LW"=TMXW DIPY4XZH@0W(MOJGK7V
M;[L*)9_0U,$$YDK).6P8<YB^?'8E$T_R1NT70V89>2X'^J[MXAA#EM\1H]T$
M42TM$Q5UXTG,U2>WP D\CR5.MYI<ZV=Z6>BG _H=.3ZL&%_<K^@Q?\*N@":*
MC-<^YV&!":6+G_14/:7?'F;\P"E/K!HY[F,B#6%AP%O]B%[<)3_/"-$\=9@K
M@7<UO-MZ9&<^+/9D%2[,O#EV6*3A-^$PTDN-*RPL_HY0>U1(!;L1P/J(P2;A
M(JIU0(9:VW"M3",BX@_@='Q3))G;9Z#B\<A0(5:3R5AP"3B/9XC?'N*1OJQZ
M[D ;2LUHG89?$(?K_M3I$=:N1B*6QU>1DBESW=I'()R%]()H_@$:Z X%0J%:
MXI%G#&:E^]>?,>]$EHKL#I2>I-=2/J;3;N]9Y_TF.:'26?7G>$5;Q3[9MH<Y
M5HZ\3W/1VIB;4[:'T-/>)8C[P>Z>5&]Q],PW)_IXIQR!8D=C!>Q0B$'<+K(N
MEM_"0X+KHZJ"0<^7 I8ZD7G7<*UB@)F9[;BPCZ#SKBQA-PN*!#L;$VQOV!BP
MO.Y@%SV5X+*5G+!"ONZ-?5).LEB]16@Z"XUU$I:>.T4KV8K74WN811GAKZ:/
MB2"ZJNP*2QT]:T=%W3#=7V;PWTSO26SCKRNA0,G):@Q"X*B8*'_%K?L]HCSA
M 6=MC_DX'A]O?WL;,1E:W+-??E7E.)104J#10K YY59>WI>F-^17BYAIW]J_
M5B;J$!X4OMH>L?@]G^3*CC)T4\I8AG' 5$/*"'ES[+.*"S=[R*=Z=UVL41TV
M:)]!BE_M22ZF TRR8H%') ;WSQ1_^D^I,$-.I2#+QDA;T^M-X=-]G>7*^G"?
M;PV7J#R%ZLA\6\FH/9%M8\YYW'=RM!"?6R!8V<TF]Q9(,O]EA-J(?Q&PH_T_
MNONNH":@KML@"H(442(HU8!2 DB+]";2>PL0>N^]@X!TB/0JH1,@)#3I3:1(
M[RT(H4COH"!(A]_[>N?[Y_[WZ<[<A_5R'L[,/C-[K;4?]CHF^<6\;BIFR_4V
M-+W:SMM=*@3BY'.%)N</1PS@_09OI0"7K&5C;X!&>JV6MW4+Y@TLN.F\[B$*
M;*EN,E:'[QQ;MTJQZV!O Y%:CM4.=+?SWJH@G*RSEK<B&M)RY_NER=K++IRJ
MH+SKBWH*C\ER5CB RD0?TD;,YZI QRAK%#:%^(>/#"?S^(29:%YV;V8AC*?#
M)YNZ6>!Q"92K?B4\:\54>%$5K^W4^(>Q+_E9*[]WW &.;_:NVF\035C1U=8W
M^#94=X"__TC"NA+'(B9=]=_R0M\W<.QYX?2E/LL_"NCJ]RZ +%WK,!QI&03_
M0-P!MEV, [T[S1Q]@+%GPFS[E@RY'J=E#K'F99)?4Z $'H9I]"C+9^%AV>I!
MH2$JHI=0@M"$F9)&I]J"@VQM)CJVO7E<^'[W1!,*5*S)_I#&TSY01EF\J6(X
M!II+(&=O>HW>N_0N8J+?O??F'BM^ (#OT"'?Z9%J8X3XA @3_<91BCXLV\9>
ML=U/C: >\HAFZ(K:*-%OXK<V/<V"5BALQ[5T,;V!29P^U 2!.WD<_*)*(,K%
MXD%J[S+)^HMA6RZG/$Z:WJ4F4(F*XM]7[%S,S^F(1J33Q*NK%?EVP#GB&<X&
MJN$7R8R6ZI*"!_"FI")J'0 K!O=6-<-98<NTK+(@! H(FZ: IJW&^PW\J=.^
M655XC?7Q)B0CDS,63RL0[I_Y>$^:UH8TH9+4*EH4"0K,3N=0K+,!^/M4*"67
MV<0(T(=MK&]B<D=7Q-;,L]T42*X>IH:2*=$FV)=5?M_<B4?]@!0XZZ61'=-U
MK.B1]4UK^RQ#F@UM('%Z.)+)I_:%-I^_<DWM ]9SV6!S_>Q"@&-P27H7)%6!
MFN:+G%@9Q_L!OH>1?PFS?V2,!I* T8YFAG.I)CQ"JK>%R,;,@B!PA?R'GGFQ
M9LWO]^&;$!J6ZE;;63I4FGAA(TK<RMI3L[SD0K^ /,W[H=7L$L8-NO8E4_?C
M:_PO@CWF<_)0J=S,RD@<U.,8/VRINC3;) GHAZQV47LRY)KX<#CX-ZVN$3&S
MV\.N#;>P7SHGLZ*EE%]H/EN>E440^*X!?[S+8-_<'2.G,,B%OBLGE@7<RP(I
MW4M?(KY\H6-CZ'.I77P6R\T@;23,[V%4HD4%EV-$_T5==,=&DIY/.7.NX/2R
M \$22=E!P!0G9T]9BO32B2L%_"0YG#M[8D[U0'_^M\ '*G/& T\'A,QBL=%^
M^#^ N61JQNS[A""$/]Q-P=9$*N->E0 U?2@&QK7C,>L!5?)ZW<JV7>FJO=2A
M]KQT1/!I&"+Z"R><>4">\HF'UAO5U'&^'K"@I+MD41W--/6RNYLVE\V"]QNI
M'8V%):I7ZK]%IED]QOPWT$8*Q]TXRHHR9CJV[B.5_AZZ72U^B]J>E_RT%@CG
M0/9*^:?*_"BXW< )RI7:;X0[>RH!9K:G^TP)Z O!^3(<_@R>E_C7G 5&[2%]
MARY$A__TK2%D1'N/M1"^S?,?QW7D:KGO3'GQ[>FWA1OJ.T"<7]R5N2AY;YO!
MZO(CKM2;P4$)4/N:L=('G[=XY26>6K.A7)3612.R@O=RQ=IS7)4\&IC^],&4
MET^+1H!9',%"M%,9#>RB)Z@P>5*'UXL/[Y\(EGU,BK4!9J+:N;X5UF4(C14[
MT<46U;\"LI^L%AHC"8&L)2\S'FU*?L>5%1^BK0&+C!KCPCI=K4@F%'5QH'.
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M(.3@IS2F+[\NH:&ANP6K'&+V\OEZU&G*W0N/ Z#3E?7;,/30JU<MH@.\Y(3
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MJQKPPZ[(%_:(FSG;);EQN3YTACN)45WL@5C6O=:=\5BO@.PT<+-MI)F&:SY
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M1J_32@[-C-KI'=3^U(<J#2GYOL4!%(C(_PWP:>-(MM;DFJ,E 0#B=Z32]BG
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M ;PDT?_/O\GX_P,2=W/_!5!+ P04    "  D=WQ4"?@'5U<(  #J"   #0
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M4 ( , @P_VN _]-@8.'@$1"!2,@HJ/\%M& !8&'@X&#AX1 0X.'_\P;]YP?
M8R/@4'-*(N*JFP-IW/"X0A,*D&B_-/3A:\Q=TG%;N(<AHQ 0$A&3T']B8&1B
MYN'EXQ<0%)*2EI$%R<DK:&IIZ^CJZ1M86EG;V-K9.WAX>GG[^/KYAW^/B(SZ
M$0U.3$I.24U+S\@L+"HN*2TKKZAL;&IN:6UK[^CL'Q@<&AX9'1N?7UA<6EY9
M_;.VLPO=VS\X/#H^N;J^N;V[?WA\>OX?+A@ ',S_9?\?N;#_XX*%AX>#!_X/
M%PRLS_\$8,,C4',BXDBJ \W=<&FX0I'POB04-/0ATW)K7.);N,^A$-#Q[-!?
M_0_:_Y+]OP,+^_^)[/\&^W^XU@!H<##_%0\.&R .>'AF+ Q!^=]]Q.7(=:$O
M=T->&%3HDDW&^)QWF8\NQ))HL[*?4<*_*Y)+*TT*.N!6"JC# R61#U7GALD%
M#^!'M2UOU)U_ ,* YC)N T97TJ:GK*S6'P#/Q@^ I@H%ZU+1&L.LQQN4[ ,P
MBJU]5K3\ ?" JROLD+GJK'L-M%NYNGFEU@OFU*R+Y8$D4'7]^ "TN8P\V>2U
MEFVP>R;KT/C^EG0'WD/LY&:FJW]/:I>WG-$$^OGG%-GFWZ2].B3OWIO9S:F#
M/."+.*=(X[3-' SR4?YOHO]_[>K3,X?Y8748F]3]2!VDR,/G/,ESNY;>N>K3
M&@LD.HY^]$%H)6@N>$L4>%/]$/ &$K</;I((WH> $L77OEX.*>*I]Q;00)CC
M)+7-BWF'I@[Y-9RE/@"L21&O00Y:T;1&S"%,;^6"(^1VC B\.2"$D-*SM)?^
M2%D& 4T)]-7BRP] S>=440]EQE[<?=B@&)G]<15O;)F0E&TT@2&9>P[0Y(]@
ME #67+UAR7.FC(3@;DRH3!(VZK'.]#='O9D=;?K+\SPFX7_SS:G>PX)TSU<J
M"7_A#K8?RCW-'L"HM'G!R/965RYC,^H:GR-?LYL-(O;\R$N_7M4,9K2:E4VM
MY5H_:9UM+XJ(BO7ORU(MW,FE/0AMSHY0<A\^+: ^Y@)$>HSI !^ ";GDP]N:
M 6:NMS7P+D(B!_[X8;Q$R9UGJW-@_^BXLN60&UR'D\WMI%7PIPK=(:%_M@^=
M(ACBJ\EQ1PYK4G2VL-#]6Q:)V#-5KD'9@%J!HM4I9_Y'!/ 'X#)K8UA+-7\#
M\X)H#TB9CD_C>S]I.[W@133SYJ'SKBQEN"$"^=O%4!BRA-W6Q=92,RS>$V^W
M5]V:^/)[&SPT^NJ7WT%]T!X%]VY@*'Z+6#.T^P' G&ASJ7$JZ00Z1UT+#%FS
MA8V]MVZ"7N&U"(7(T+CBAV*?#$Q_&>=M$=BJ$S253',3E-B]_=)/_@ 8M"?2
MY;DM_8KB/;@^:H7?5;1[NOO"5#:@(T]PIQV35;J\G@#BM>X6QVH2Y0+?T,^7
MM5F_B!7Y44R'NAC"74XIDYZZL<O6!9U.L!S>(";5T'=3[KR;5QS=ZF+BST0K
M(/Y4QTR8U\.#7@^)G&PQA]MQZD_%=D2GB2=I/ _ZE_Y2PE@&[Z8-&;R:GC;K
M4>96L'R^0:S^'&.CS<87[9H?["[S]1 <K%>R] $P=:WU:M;E^,7?"!-X2GH4
M??I2O_H:HTH)N;6EY&D"S5SU?@!FM9EO<^=-?<\]\724OC',T5D@EL#&<]^T
MSAR".PC*S#DT\>^:SH];M07?'&7H[LW=E_# )U#FOJB&*3:._S>OABM0BO7*
M_@KIDR\D#;NHT=4[:138MERUMJZ_5J%'*STV)KKZG+28F3<8_D[_(XB=YK\C
M15ATUW1#;DO!BHI96?&W-&FQPQW*!J_']^B>7 H4&969NN"BWPGF](F:ZRT,
M=#GI?$D-ZU"P1,O/^XZTHDS7W^E>#E48PR/P;NK)60P8O[^P"/(RX8HS#LEU
M%E#Z,:(2:BEA3C7'.3C*,^?=(40UE"-6$)\4:_TL[_<_O,Z7+I1=TR\TC]WT
MD&M#FFISA/M+$^H'%XQ5AKSMXL,&X)E!=-7#+"_#1>ZE]SM"%VAFY5"(MR<1
M**;DJLB'QY:)!8RT,/R!_A.G5=S[HNO2US9?^,*(YIT(=.+<3<=PM*;:2=?X
MZ1;>\1.C-S89B=2B/%,R=$5PBB%)P#1U^_"M!#&$]H41#E!!J6#>EH$YKE7+
M"<EL(1DO?HH0QSA(GW$E;AVN!1;D(_K1CY^KM5-FE >V,13%O@E4#*AVI[8(
MP%%=(!;?/"."9<3/9^$I!5C:Z]''1*Z4N3B<7*!_\5E4$CFT,XJ<H C^<P=P
MO9TQ/T[C&6')UR-)'<-ORT)JB?Q86C X9$27T@"HP4Y7BGOG^P7$IRDNI2%4
MUFTBW4A!)SQ1JC=]V(7C0N[,_8A:UAQ*1:(^+CR)DLBC[B, W Z8D6,)#$W"
M231KI/M3%0HYC8*KF1I9$MX-L=GNM[,!Q,P$/GYB6JJKG.$0AM5\Z)3@[:=0
M+%KXBN=0=:*]5)EQM[?MWE ECM%:V=Y1P1U790)8V6:I)=JOE8N?S8%27XD9
M9C6'U:@'HLAC)7C\8E6T9[ZH3LU^HRE8"-_\W(YR5K0F]YNW?":?5[];L&PL
M>STA3HWYU6/FU?DOF5G<<.D-_?5/O@VXV.\Z7]'E+_!8:+%\32:M0#UBX43%
M)#R7J1P.:79R([@"[RT-F"F18W_"8\GF"5=?/!A'7B3FGVO8P7_YW\VMK'\J
M>Z.7LCFX""$3\05S./@>7C';\B>,S6CBY.V#.^G)$./K;^T^ /W)"1 X)& ;
M"VBI2_YM9UR'I.R')9H!B[XH,'7@B43U4=[+M^'@6%W@HE&6<E)[$D=R%>DX
M)3'%AWIZ3([V?(],XQZ?8(ER(VQ(^NIG&($SS;Z*'^-)[S??BA%(\Z5<*FK[
MU2F!QQ.N!E+&BF_\V:TGWA@.#T!US\4EP\@FSE;?F?XAN \_>F'(7QC*CY9!
M_+1K_L8\Z?^>1 WCA<3ECQA(N=PHDB4/>NZR_0!X5=25K/$15S>J:I0)%"ZM
MV#[$3AY!>UJRQ+0G/\=V60'Q!02)\4?XHLK$/Q'CBE4ID_#6BW=V^<XH1;(H
M9C9N47K@9_R9,_JQ4%=D;>?%U!H+IA<H1JX;R&F[%F 0Y]!\8Z:@47^L^-T7
M$?L+O!=;5M?O+NV.>0\]?K(H%J-=M%S_-<\ /5A/>'.@$ ,_UO9HHI(KXT_4
M_;1";_@G>^T*3)<-5FCXNNM!/R[#E^6&TS"23JX/ZC@4+[$GLT:VGP1*RM#4
M6Z,58_EC*QI3F3_63/ISU7\ \M*#;SGUG#X />87AB8<5+[^LJ($=JKOT@;]
M'M'H/$;>C*?0R=G:Y'NE%82=X]&E@I-OYB91Y9\S2C>81CCS]DWTB^4LEVF)
M>S$$JSG9EVUXQ>C\%^2)TA-5M@5O*^#@YLM-#10]&YHU4GJ/5Y>RK*TBU/]Z
M,/;QS@4I/^,>I/'T^YOMIM^P.DSN(9C(3W'06U26I&]CR/.F^-2MK7/HW7 .
M?Y/2>\YM_^HC W<67@K2J?4Z8"1B3OF'7,?U2_1O:MJ6)7/KZBT;MWJ<>O0F
M)M7U[\TJ>5H!<18F("6ONQ@B Z%1TLS676U'TZI-%\=-\G$9V\3WCB)O\4DJ
MZ*><@XFX5%E\>#E:"(!S W*09YBLPGYH^F1G+UL@E(L!\J^[*P(#.GD%W9%'
MYBOR\ J-I@B3I^>@^R:E6=K?^H#K$5N3\A K"B;>5?S.+/NJ,+U_,_GD,OK&
M&C2([N@6Z 4_ &_V]J'=GW?$1YX6AA:5D'#0,@\K!>@2BN.Y=F#Z,Q$L*W"&
M06IVJ 0"*-S_6'*XN&YY_.KB?2B$U( 2LWW4&^K(=T.\-;36O;:J#T3@(<,.
M+3-!V&(2"/2Q',Y^=Y-B*2$Y-$2R?)G8[7JC 5JAOMR8IIWN!7A#D./5/0\+
MX4'3;#2?5/HSP]*+-RP?36'=S;8>>?RLK5[%:*9 DN E9TK=%"Z!RV-7"6B=
MEAS58"*0CLAZT P;$0F3*%9\<7HMQC1(.W/-QJ8:^68'D^OD1SN3@*D"4BW#
MX["F)SG# ,$LVE0C[[K$,K+@A>PQ30%TKR<(UJC,9 4O[H8$"[C(QE#V[ICO
M/B=@4[K)RF(@\$B2[*%!<@=G$;ZR,A+%[L"<8]C/LW+MVF(4BDWF.-A&3"0V
M=1ZV.;B/4+DJ%=<]R.6C*.(%CI#5I]ZRQ.VK<G+#AB;O0:/$5;(7:\B7=S7'
MA@/J>)B%;-\H1)XKA@!?M%N1 B/7LX'"*J)72IR-M=[Q\E06W'EUB&785()\
MU]0"T\-EY/7UEG3YV! *63O81D$E.&IRF*?1=\^?/-.^FRO$9M68UQ6OO;(R
MLU0? #\92FY\8?.$8%H)?'HLD1\+Z_UG"P>0\/!C'8U^V"R(#8/3'EU4W$UF
MKD#4^&26'IH9/T K'P'/"*7B*QWW5_T#SW.(Y.&I6C%_0?K3#Y"((N7*[)LX
M<Q=_NN571J9 MZY2A]:7P>E'2[=8%#%Q*3DKI<]$"(G##!*2B()NTT&<QU-L
M4_/2H,PT;,!O/T0MMS,-^AL"YOLV)(F]L]'7(1'3=03ZDC^0MTN0:@T'"_V>
M*3/;<^1IJW:?V-_R*L9=CW$9&N?I?<&Q9\VYLW-"?Z)B\A]]Y;^;SB;#5!EI
MP[.'Y68:[B@6<W(AP"P6/RU*%GOQ4/PO]W^<L7[):_;60"+(EDTJ R>8@CKP
M!\ #&BF"O/@!&(P].X4'PQK3^H$SR;@+H8;:T3M..4QQ;[SBHSJ;.JAO6Q3?
M)[S-?!=M^].^S6#_)V6J]%@EXT/<00;K5PM.E\XO_D0S_]-=H&'"L2W+>9(C
M%BPU4XX<<%0%==2-R:!JFMQYM!</DP'!#P HZ6W!A.&_'-$'\ML3;XYH7SIE
MM7U [=+K-;.QZ7A%L0ZHWLB.!!RR<_.E-OT'G812ZB,E;EN?EM BG)WE;]U9
M O07=88GXX/]H2@L$3;L0^G6T;O=K]]HTQ[4G]*7*B8*B2 3(5%Q4O)NU)R)
M10=G=Q5A"2M@.1K'KE6J&.2G4($ZYL_&&%I9WL+BJ'I9;&R*:")YG#6%0<P"
M\5(XY?\ 11Z!O12.1\<#?Q;4A7>KJ\43,= !N5$U' U/<K1;L;T)H[>51->N
M&*IXA5GMMN13 .S<@18.\MY\LML^O &21.03##MRWV'N*8  +%'.'V!;"8C^
M=Q:5M_?V)0STJD*&&OY6X)6Q'BT&S0ZKPS)[[ZX":,)4RLL5C30!$ZJR@<"!
M=@BVJ ?:7.JAY1FHN4Z-'J0/#88[F3VWNLDA,R$]5#X0XDB*2$VPX69S8^Y4
M"<(':,*(=FH<Q#9[/JO1"":/=FF/4ZHKA7V"F.>DQT)4/Y5.P8:TPXP(\!3G
M+F8<9&ZGF)&Z@$P5 -^NN\_%<P1=R-"B>)&H\@71.%>6D_8!OU0XL]40DG]E
MP4>37E40:K4#S-Z]5%VI*(9#9& _\S4(L7LCBBU]OI\S<I&,J['!/9W/](Z'
M.?@)TYBYX>06MUQ*TLQ0*^.Q[>X.>"@99JPGQSE)'>H_/\N&@I.->_\.%^NR
M#M0*%L.'MC&(-5=S5^%(^'-ESQ.$N@[6 >-JW%7TL2PLLN\J9!9_<%7+/<^9
M"6UQCBA@TA+7*KZ8>+F'C,H1'^O0+K&K!4YELB)>) F]K4/B[I,U39B*GZSD
M]DP#P>/OJ^GLWN$:(]5B,%Y#!*BI[^.T\8T#-'M[R?$WDO%[X709#*%T?GBK
M=S^R<60Y%Y=*>B(E)? +FQ6+-UE=.[$'J)CE:V BMKW/E'!'9CGPR1IW0BD5
M4L<5=L?WHXQTG*=WK)F;7)R+DW1*XYEQ5/%U]CX A1/OQ]6'U?IV"Y<5TS^B
MWEK?O5KTM@B-.]$87B9'/@ 4O$WZYOCE4G-$$]X>IEA8OT-YS81^A']3PKRM
M594WK*,3N4'&3\;O'4;PSN4!/'+K LO^9+9O?M(.$A/Q)JH1K-$'=5I&>[O+
M-.>=9UYV6-%J.\'D<7P A!X$,<]-*2*[V9UR'#1 KZVTE#%$,0GX0A1-!6N;
MA2">1,289/(>1V_[P!)V5VQ9O<RZTJO27E$L'=5H7DQV^A:I&W$V!2]\$I&#
MQ-0TFT\E_@\KD+W7G)X(#0#!- ;"I^T?'JJ:$+>AP-OBO8T\S>B7Z7_RR$2D
M*ICXOW<,J4P,"\7_:!K=0H:^F2 +X&_9\_VU7K"(@T _=7'@=9R4WAMD:H#=
M._)59/C); 7*0Q-R4I(1_DE6"*Z'FIP?RE7C,8T^Y-=KL\H!/)) !DX)U0U$
M&]9R?0_Y0):J$.W09W5(SI]#(GR%^3XV%PH9[W4(P@R^^'I-]PY1^X^V!Q^/
M3(///R6L3N3)FS;4O&.Y8+XNQQ3HU8^(VKF  +@7VF9D10X1,P?V'LH7"U?%
MUALE'I#81<!V+P1L*8?ZCS:,2QD[$@D_/5%@[$+A2RH9&AA@#/:CPCUQ8,#Y
M1*R?OF?MRG0:>KT-UAF!R@&]\G>KFI/HKH8;+J1RIE45\@1+J8[EY.#H0IB9
MS'&Y^!Z,HP3(C_>B6,,3A2F2 5V=AV66<K6& F3^<U233MSAL44M,HA0E\J9
M;FCJD3) &=+JH3SQ3SBD=)A8O\WCR'[D/!Z3!T;E2&4RVI%F)#P1:3NNQA@0
M&N:A]@2C.0'P"^H36=!AP+VXP>CEP-,@IJW0* "2'69&6.3H;^X;478"CC69
MZZ</IMC=W?H,+'#X[.$0C=L%3A76(V=#*/QF2A@!:"@ U#Q_ (B=LT'*8X:G
MFA_##CT^0$ONFCB#&$ERKFDY'7.:4'#TOOK)2UK.RHTLRK[WR7]IS'0\.H_6
M(4Q9QI'5)[5A&L_9K5W=UC',SA^;CHD:6.IJIP_'A^<:\+RX"EW+"NT*!<-+
M42.,4U.8$?=5X!.%_JYK81>&P)U^D:M5V=H@ <2S2=];F+?D-&1?NFD$8S$0
M5= F&%FK^ T!!,VEE=M'Q5J81_',O,_4!05'7RL@KL6W/)$RH@L_?WJSRQYS
M@H_('XU6J .]445P5*Z7EF3[=K\$P53O=Q1[$WO^;;?P+36FO)4/WN Q\8!S
M]8^-VLKP^]Z8E;?#F_U.H-ZU4Q"'N?82*?YX5>,P>?GP&L+Z =AX+VT^<3U9
M+.Q.VS-GFU0E# FDK();^#?S6C7C&=Z2@T= !4&[Q3_*9=5XQUG2\N+[SS'5
M_"02(\WT3C]D:6+4<OQ;O09]^0.@ 148%74<8%\<JE;ZGM/O,0,U.5FU/HYW
M'.J6AY/9[2A0?]B'A[DPYEW^ :ZR7.5Y LSG6_A>]\WL&#G?+1B;*-+R;6/
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M2E^_Z*67[CLE"D/C:E2[R<Q>5DCS?0_63:_@_LC Y6.G@A@NS)YUS39J.5?
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M<R>K<*_OJP,N4M'@>MU,V!#LT\<VEN:SWQ+\JFKW&V);THH%KQ5R91UU74<
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M&J6I:J-$J@LJ>FO]>P:+*0I?XH,P0Q?$[+T9EP;_LB):^&BQ+IM2RS_AY3V
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MJ,OMR:^$IZM:$W<[++8TY?Q9T.'&ZG? )P_57:N$6@YFBX[^YSD2:)(!7V;
MAL5_ HZ%F$T>8FCM6YCH?0TU"MUJ=6HVSA?9>-%^";!SQ@81WU44MVM!>9(@
M@7\62.P=1F(2/BT1#4FR@LL\LJ'YE6DDX/+^N^HG=NOD??=@E&B5Y^3]U1;1
M=<+[$L.8"7!Q@]'H*C8GQ9T%N=AE]G= 0.;00O;F/[H_UI]0W.8S'VC=4#6"
M;8P:3@KSWE+X_8"_\141]-]2M?^ 9O825I8SZ%8?Q%**>608/K-0EAC\5 FC
MT$8,4G9&ZZSRKT+5I$!EJC5D1U/_5F/HO=PP0*1E7/5ZHBU1E*LLD!3+LCBP
MPS2[Y-!KW(N&$BMC,[S,+#F#5ZG"9>^18,RV =?"@S4I=SJ?EK.UB&83C[J>
M),>7,EI:09<-P5C\70(0:KS#Q+3WC_XL6OGT_7!2-:7I#K\DD<M#<5&--#O]
MTK%[3['FKVAK\.+Y"$5&S28_J''>W.[?-G+[?GIV4Y#\09UGT8'@/\;Z1#G^
MD'55 Z7 P0^ @:,T!"7[L,Y #>/<WW(Y?=2JJ2U1WLJNSUYSPCV@KNS$D>M4
M2E;&;@N4HL#<U>K-G!W"XK2;:0>'^H(BMW=CV;7)Q-7$7:;Q>!BGA-)@72I:
MLC;6H>2V3H<:VP&?&)SB0&+):,:]NJ?9#LDBLEY@Z/B^/L$UQ:W0R 2D>GZV
M:"AK7TST*]&S:;.GMD:!PR*K1QV#AL[@KX3UFG>^J,G*(L$'S )96$X4RWD[
MDJ;T4.#UK0#CF*QR(Z*](TK:3\9U7GIL1O+HO^.ML ]=#J8YW(Z$ Y87$%B1
MU>2.W.8+VMO"MIDGP8-D%4>@^1#.S^>[\Y_-)Q.;.63GN2X8Z']HD[T<U-3V
MP!DH"D9?H3HGF:,!B:<#(%H7Q?JCM36$6VH=8Z. O6^@S(K@?!D_HK]>C-3$
MJ!SH\<$8OVY[\UXL1LYH*#E#J3'.RNPV'R1%FS1YWWZM<(XV<G%H5 Y4"%QH
M_6Z(2]U63GQ YG8Q*9" "9;4SI+K1 GW_&:Z]GV8GBZBEP'RW(K90L4/_V,O
MPE4UD$0"B>Y0+*Q#OWDBAZ_/JD^_.UIDC);VDRXMW UOP,#)%^/Q=XO1:OP=
MI_<+%"%W_[O=4!)-([KM0B/91-K <23+$2?M>#A\RUA90;(5?%NNXLM-'K W
M<IE[ UG_?^6FK#-!<# \3;L&1JC399TAH]E($ H:#\8C'S$2SP/*"R1ZR6#D
MSIJR<94B)N<J6-83A6R*:45!>#!PX[C$,Y.N0 -=;Z' ?-L,/.V@.IYKYU%&
MMQMVX+;#1%@J4-1 ?>%8DPULF/F+DJC%K<L-/2S(GE7KV[L,=7Q3=N6VK<_7
M\>(YB1>F0 CN6@%X9XUX+U5]WXF>B'T64=EFRK*>>7=+,U%2R>-4NQL6_ '
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M'QP>'9^<GEW(1020$/W[^3_*=9D@%S$I*0DIZ$(N(F+_"X++I&1<XN175$U
M]EY7N27"*,!J\>^JOE+R2)KN,#ST'J!BY)6:Y=N]$.VO9/_/! O__R39?P3[
M'[G& !H2(H+Q2"X#4.#X3/"]F)A(S;E%4W.V+*=1"^^;4 7ZX5"!O"JMUS[D
MJZ76>&#:9W:NA?3@MSMB>Z9DR1;UHP<IS(.[\H8&#_RZ.X+#407L<D0;DA>[
MX0&$AO*CB1L]NL**;F/J;+2&@S@\('8RV%I7TWI&:8V87L0#+*+AOUHT3'!C
MZ#[,=W?H]AX>>"-VU)F&!U2I[<XQK?,:_58I+A_LQLX\L:0BB.VUO^-U67@
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MB6J5_1-0J9G$L S85JM,+==<]0W[KGS.P5[:FR4@Y .NKDY!)NXD&0=5*@U
MAFDN,=T4=%PB>\@?>NW=NLIR53Y3;E;+"I&!5(R<5.0K6?"#[ .@ 1RI*0B$
M#4?$3QASMM-I>*R>4>D5LVOB$-7C"#IRJR]OD<+%N^;/84VVGP,N,T5X#<J6
M<[[-"*%9D_%E&/J><RZBLZ<QPDXYWG/GVQ;0ZA%0<K!._7K]G:='1H&2SDK^
MT(B^(GGGC9;M[9 4I&OF\H?;/\J$5OGA3Q"/PFE6O:<:..\F-9'*!,&G5BUH
MKQ>+78V60!9^<!E<30RT@'0<\T%\2_6^>LN[PM50QYZ7I^@-A3J")SZI9;;T
M!DBFGT9"WN@\ 4_\K"_:CS6L:1.^ZON!)L@D@A +IH[97BI$)E.)+CVD$&LY
MIJ50\#F+9$0/P42RG,;$+(9)#\)A?W))V%>^YG,D$3+(S>Z\L)%$71"X#=02
M3-_&AOBF7H('@C?R\8 :PWP[L-3R8H9RLG(-<;@!/>!2B4407/CYOY,?' _8
M.N!\IT>(=N.<9Q?[\4#1O[(?:P+<)--LFK7D>;FJ_<E HFHG3+('8&9?-S,8
M+!=]7%%1L90L.",(]6L4\.IX%-_Q&#:/$\HRWS]^AP?ZWY@S%A@>]</J^B7$
M0WSQP+-(XFDUR-ZY#W0SKBS[P*^X9X$MMEDZFH5#]DL3 ;UQ9QS97L(#/P_[
MYAD>.:3;!<E]CGA[[/2N;D R+,2+,!\6-:[9AT%,(*;3>Y1KIG3R,[KD[/Q@
MV$0M 1QT"[K=(S4& X6%0.?I"3F^&E>3%^/)N1""FM"ZHGN7TEH;I6D?[N:U
M*/\B,A\E:26CZ&U\7$9BD=>0J/\%>,]E?N.EO"P/'JB\?7\NTR/%QQ]!=["2
M8Y2^.I#IJ7 4G:-"YOMIO)V4IIS.1KEM/):'N2?P2U@9*M]PA<_+X8EW#/VD
M<E33;,F8=L:7\<MFO?KA325KY?"HN@2/D89IEC%+G=F?A92O\MKY*:%93ZS-
M"/&R4I]2@-OS6OA.T1MB\#@@POJ%J5W5/;WS.'\CZ .09]"2J*?&Y"^OO,N>
M3'OSL4HMSVJ3QDR;_&4*,MZD5S$4UGZ>C3YV(P*%FF?^3AXLD^PLAV#/I5/;
MW1B45#L8$F ^\FQV<'U8$"+DOMCY$0RE]Y'GC1/]^='O%*3@DFWDC_-TNS^W
ME!!U]@35.V5*O8'B(FXBILD_?:GY[).?YD=G,3&"Z_XHBP=>#4&0+.H%EB2Q
MFZ6(\]G2ZPDQCT;E[. /7(Y$?Y26C2<8@KK<;IV-;_@GWJLF%V^TB9%$ZMF=
MG+W 'N)\G:U11[^7L;Z>R^K5;S:HUNXVJK/YYH-#!%G?Z#B\T(4I)S5T,!&'
M I+W.W8 ^LU-,_;R%[CGPBAO(]TCL3\$R.]_!W+PUV<YL(2"32$<=H+*.;%(
M(?"5?>&DVZ6A)]UX@'=O&=>$PJQ<57[XZ)200^F&;NDH)UT!WM]0FS@H6G"(
MU[VG)$2WK0N8C"#'JU 8'I9*DI07A."0?I&@<+<GC)#6'.XRS3^%_OJMY2U0
M/^$PWP).^KQ4\#$7G9V4]9Y(TJ!#02IKA4B#;5\'G<*1!#C5B(J,'?$VU9].
M )]RS]MB3@X^:#*;YR4]< 1R45,@=&$V^MCHT?[F<KW3^9>'8('5=%C"B/W'
M;F[&ET)/)B0<*@D^FG/T2.[!B;'D1^R:0?VGWH\;:46*U\D48OM]B[L+7<5_
MLN@X^,0*?2./#'/81$EMA?]"PNPXC-79'BQ[(CJ+JVNOTTZV"9$Z<&939[>9
M=DD;2+YZV%@W/?A+K1'3H;8:Z,\CS(MNVM-$:[\3ESH23FS\R;',GW10HI$U
M$)=;G_HI^NVH-YGFRJZXSN7X%\;MY(GZ!?W]!N#(]P7$Y_U*[_O6M73)B2/B
M]= )85?&X($@K(_=\EW?"NGF*0+&]5R^LX$Z<V\M3FWM+7.SVV-M(2""'LS:
MEV[(XWPDE(5H+F*$/#[706XI2:R<GXR-H+/&CF#(!A[  UPMA+9MD!#S*W?F
M,RT^/>O#K)T1C%E$3:BOQCQ3*WG(=V1/H(1:LY ]<18X\-?,!+M?F'G]WV:&
M]X%_.9<KQL -9/NDR5ZH:QLP'Q></JL!GB@,][SJBSST0,1 L!3#0L"!=/5#
M8&?X \C_PN ?HA;,Q[?$JPS[:IED<WU*;JBC0[U=4%+&Q)>$A$8+<HG+5G>_
M2F.$X#>CB-N#ZYZ 9GON=A"'RJ_6*NA4#,,J9J^JC',E<&I;=K6MD>ONGJ9'
MWOVA[NSN7V+]Z4;SHD^"!0VPW?# N0BHN)_",51V37Z@9%RYRCG$UY\^AUI"
M4JLA/,-PPFN\\ ZZ=J5G,TDB;_Q[PC68M99#5B2\6Q8CG%'0::! UM-(>G5J
MG+(XTL$DV5ZX@3=H:S7']=[K]V-;P[,55WLLJ 62#:DBOF) #)D^S8>UYV:6
M$Z^?.O>(W_H5XH4L-2]\])"/M3G=R[8S_#3K]7;\$Y)+EH[''_SK[=PR90U"
M!8TELT&-[X4H^J3D;I5)@[.^;^LA02U"G=<U^<5U!?/9C(EC#$!(E9 2 Q+^
MZB7<.*ZI<I]!N39V\^<48K$:(1_UW=FXCH =DTLQ:R$N])O-TV<;T[VE&_%'
M2#9CP?%M=*)R7D&5 :0#G>0#=L@6!&:01W:$:,:IC=5CG]AAJ3[#XX<LJG $
MPX\1D&01!71WS46KQ42#08V* #!W=XX6" [B0FA:_7__5Y'ZIWNIMX;QM C[
M%H7#T;D?N^8!-+%X5^%$B. %%&0R0]?=(%>4_+"/>7+A7M'FON1U4GC@E-'7
M&-%Z#??<-;^1X=9Y=,521H>8JVY"VV'!8>&V!L O5\@=EV[2 _ +*96,'A<<
MYM)6UF@4Z=;Y!3V5M&%_5]3T4NZABBS%!%%?4<AZ8=2Z94M3_6!1X\[^#VT3
M&-]'13S@\S8ZMFM$I.@$N6^4+B#D*1M+]/3DBB;U2EE;_(EY?5!H$TRC\*0V
MW"Y;6_^^Z?+'4W+6]3!M.O1\>_*U6_77Y(O"J\@2?^X?R.E'Q)XY=YTEQA8Z
MTU(6&IWD>VR*,M&GZ>QM[>,!8JS?C(58\9IP09/-N)TM-M=9^/)>&W3;,8'>
M*^S>F_F&6MZ VA9NYGEXCL2?7Q(DT?2IOJ@6EEAUI0W1FN:NN2&6 ]L?H]H6
M@C(<<DYL^R,DNWGW]&!;8U-,/HL-T3/?^5*.B_L9E1!BKBMYNZ201X^J=B45
M0:[86*NZ?=D#FG<?H41W*BIJ-!NMMMT/B%]WVRI.".?DSL(/N5^'_;(9^PIW
M5IIL::P-]J>68GUEDJ BG!W,%F&EE3[RN[:VE9S53?#&YNMDX4MR\-$JWD1,
M*7=JJ&FZJMY8Z%6V?4,E<B%)I"  L::W,8VF4E=AO '"Z(M4#_;8+5VW]<2I
M^S<0DCXAQ8A <6JW6A C OL,M^KHCQ:/L7Z>RQ9'^KCIKMYN<"-YBNQ<HD<@
M ]D+W2<\*S#R8/2."Q'! 8U"(7O@W]AW1LOW)8##2F=L3J<O^X.CO<33=/GH
MXR#!O+(X0J_#V=?^,^=LDP!=<0WTT3D$Z(I8)S0^89)+_+0-^P;M9IGLD[#/
MR/#OW7T\87I?"VC7]>H;<DDYD6-5<CN$$-A%$+R.-9KEST="E;&N/]]%2-ZA
M[<J>]HK50I2#IA)R/_:U" 0)?BTB4@%3T0+@)+A6$""N%R./%.]@/LHE[0"W
MK *Y9*!L6G 6J 4,%"5RS"'E60!CP5RT,1'R_@0:CGR2JQ8BN&TV/M[M*__U
M<K3"CF(W VCNEPK#C73;!1.IGDOB@C_EFSZ%);2H'I*'10^V+@BX$<(G\129
M:-TU(H98)X2P4PXA#PL;G6WD_#)/[^YM#"809)S^QB8H3W>]>]->*?4@=B<?
M-!R='AXY 2*/$6KL<WW">U1$O'M_X!R*0&U5XP&;>9S3YP<T([7/^O# [F'9
MP2P/SBFN#T[ EMU4_]-)#\S_H\M\*/W_Z%*D.=W@6^::=V"1?=5X^J^/G!!7
M%>UU=)+7U^*9AZDT/VH?CXHJBI=RM"I">ZN.PH6=OAIA>.0KSW<NHMIDXM7F
M,=.,8W0FO9FM/X:[>C6(V]6")2I&1&SP9Q3L=H5YMB$0/3-S.>='(]<@PRJ.
M]U;I3G7[M&N,LP&&(E,(1+M&JRZE1>2?_]H$QKW&F*CN_:M42LW@@P5S[P*H
M8876=A<440NE&[MG:RMU]9Y-J*DE,S(Z.GJ!6/;H@W5<Q&9\!E^:SW[]CWT)
MS<W25M+C/KMOS0V?=6#DS8&YZ_&G8TIS:I2*J78_]6_B@77X5-0&B!*+1'QL
MK7US6)FR%'C?9'K)H]/KV*L_:/A-982HZ%,E;#.VN+CC87G5F+KHG18*BA M
M_>'6UXI*8E&86\/14X[T[T'A]ET^@J-0:S3Z<^R)Z0C"99\&X29W.8[^SF'N
MC2<IZ5)^1VIK(H:]:U IS:<Y-QEXG>-6/GN-2Y?*A//7#=XX%'[CH(=$;\PQ
M,_5T'W!JH>:M9/# GU;G>ES?-5:<IT(O9^9N3.;#%I&:4A'GMOM7JUI:W;AX
MG_.<WOL*E0'%1Y_MJY,&?JF?Q:JK-%EZ/C3FM1W0C6;FM;NC_-89=UFO0>K$
MLU:XU."6T&FD1]IQEY):7A7)&IF/\JW?'OR[=#GY-G]8[]DJH:6NQ'5J=+%V
M=]Y4V>P0Z( +8/@NA35OA/]1C*9/9#\Z.BA\4O5K(L OX*"Q5I"0^A[//=),
MO@8-.!IKNXE1@5C_'L (^$@E[0J,2U4_8E9(7M!ND]&7>"Z'D1#JGLWPW5%,
MWUL[%B;IX@ZV?ZSL#(K.D21U;EVUY8]?R D_5IOIJCK=3&0B/61_!=YBE*6>
MY'M8[;;B*\Q:(_'8WH/7M&#_V.I:;.'C40ST\Q!?-FO(/7U8^=R5'HY5.$M\
MME%*]#F)9?V\X;U[]D7="@GE1['2?IG+BS-7Y"T\=^JTTHTNZ0A7-U8OIBYD
MMZPT?^3UDK&^/J;SF-7\4X '-9$\Y:VBP8@&,.TIR5V,^JQP#FT'B>VTE?;^
M^P3960G&1X>+ !9NB4YX9)]X'&M]$/LRG*?LY($-P]ZS'J9$?X/F*/@FDAC%
M\N5:HX$\]?IYLZT\)1X8PA9\606]-[\K>RS[OE:,=FIU^.8:T $O_O4DY>Z&
M%>6!'%!RQ&EALNO<BP>>Q_QYHOQ#)&7C9+6^==TL($ 2P[-+$>=QYZU^<".
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MK]E?,-QZ>G:QF69+,V1O7P:+D;[<S2Z(,M,8M;H2\FD##_P<FC[^4RCCKX)
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MQD\&"N"OE^Y]Y<49<*W)/]RH-7]+'_\--H33&\*3TN^6TL<'NX0IM^WRP??
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M282%<W@H-YG6K)^:, X"G*^V-!<U%9$T9['2,! *IS2$N\5-C6\3(.9L=%B
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M*;>T+-49$+7AZ++"G)&Q<-:H/N:<J,F4I!V]?&/5R]K=HG3TX%*N8!-/$09
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M\CK0H@7.UMY153K0FPWGS#%.FLW-FJE^8U"_>[#!ZL_KGC@3Q!<TR$,^<$0
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MZ(+#3-D5_.8N3O[&<_(W?$TX$+[U!1XO<33VD0"H<?Z;S^C>L'JA&QQ+UT0
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M-12@0&^A,2]SOW5*N/J]93CM?]QPR+._ 5!+ P04    "  D=WQ4)(1<V,1
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M<TD2_8L.W'_I8E'P5_#DW_JCU =Y6/XEMD$!:\6<*!V1%7E@32N/*)^?G8]
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M!KIC367=U=-4)?]*'NM3M]*P-ZVBU"-LJ?FGHVF<0>ZW:)5C;SAGN >;S5?
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MU8B#_#&1X>0UU5!Y=FAH)-;07P</%$SWCXRH'RECFI6V):#;J0ZF_B<M8)<
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M;.T-T1:V9MEQ,$=+ZUY#2IJ+\AI>VPUJ3AHTI LSF6V4I#=_&='FO2?3LA6
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M4AT2HT/#$[1,,&,==E#PVQ_SFQ+0">+KX5$NYQ<7$HV3ITHEA;/>^U*9]_4
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M=I628X6?GNM?,C<S_D!;>1D'\$FE^P4"@W7C8OE#YVF#]H27DV,22S>&ZXB
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MJ*LFK5^3-U^>(P)T[Q%J^!"?DZ04 @1 (G^0?;JJ:Q?]A'(-X.G^[0L&W>J
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M7%P)-)H F5R]M'\+;4/=S8T1'E*^^[_RQZAO)[D16X]HWY)Y@V,6T*9[#T5
M+G3N2R2BO)IVR3H&^V.Z9U08@_M')P9XB(!VX^TL(]SD=>7(?2HB@/I"15P;
M*TM'!$CB,BYO1Y1/'2./4(/ VX/O[JQ];W0P?.LYM9_LQW&-8_TRAE224F(B
ML1Y+^Y$!;-,6@RDM5D&M]4K8]2;5YU7(-/W)N_49,;*)4CTY47-A7<(3(<P6
MHI'MVF9B?N))@VL17<]L&V-P^^ ;D7OI?PM+]GU3*^]4-$$$W.7+A&^+BJUO
M51^:!>KT(P=N!8_(8B?&LWHYUBR]JKCTG-<^(W+6LTPJ>>-*$>?..+VCXO*
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M?XYX10I3O[FA?,)@BXZ.@>RD6$SQX8<:4)DWO&9V8@)4Y1>=07G9\S+*;>/
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M(;=0=K:!OHX8V?KZ"+T42\Z #X6HD](2.X8_=^:3[C,^[NFZJ"8!2#0&G=P
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M&,1A6.I[:7PD=*DTM,-"KPM]33;>EFNKE3M1J7!6ROM>([11ST82%H0+H+"
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M.M:B2*4:Q90A8!5P3D)&AR%HVR <K3D^2U2OQ7?F/"A/#E&96'%/M2(R6[R
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M5XX_@;YB3W?54%)]@C^>6,7<)(<%QW=:QD>B>5>L:5%,TXCI8^E'(:K=4SZ
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M>!'15Q6R+PS<62(_-#?CU[GZNGNY9JL:N993%1IR9M <<%T+N"N(JP\(X[@
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M""9TD8C:(MV-%H8SSNO[0S+6;N:Q6$C;;P<_$)'SQ,X3W:=/25XUNHP-KW*
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M9+^D;_C6,Y^:7E]6A5PL;(#C[2)E.=94J(?2/0-Z6?;(.!F#+K*(]LAK?-Z
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MDC%+Z"C,X$L8J4VK;#\FA.5/]^(W5P>CI3?XLC'@9>W#,6$AT;3SU;M5P_!
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M\[FDN7I84_'8?9=AJVC.>:LR]$8G)SOJ?OA#B^BK/M'!/]_KUS ^AG4&:1Q
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MANX3UO.NT3#2K/K[]<AH<+E2: N#[UY[%O41(NI\+VRZ3'Z8M'/@PUL=YSM
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M3P#D_(ZY->K#(@H]'WI5$]Z8R&PB(L(\C_RK[SM&8Q:*E;B%[53^J2A<$D\
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M:SSSLF9*_+B=WK6\G59?>Y](4TBGA(WQ .%.YTR6H6=YMW3F:AGU:4S7H]!
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MD+5.YM:M*T]"U[('5J5DT7S(0R]!MR=6X4_[Y4CFP22SF,'XK3L0L$E"9),
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M-R"XD(--=Y(F%0'ET^18AS*0Q9$:\,0HC2H'K_L-H]]K\+.W*U+G .=TI':
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M!O0VR+,7I0,9P#?B<ZN:&05E#'$<#]WZF,X)R<Y>PO^&]B>R_QFPH/\3LG\
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M,8NV*LN6((4^&%7Q>:ITFMV_D'>_XV-M=.?2W]W. I?;AM1DGP0X0/Z6WH/
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MLV4D4#Y;&/;%4<#*Z'\^]I6K,*LKB5.#NSLNZ.W)AX8M.MU3P+,KTV;>IK?
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M836YA49_FN5;6+1-)A+4Y]B"OI4UT^;S;D]]V34LG8!2ENJASE#,.OC8I,7
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MQ;N& 8S2-D6]7J-^<B/]D[; !&]>/A4/_7<+5<$M,\7"FHL?1C!S-IF^5T?
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MJ\<=>7XLH#9Z=;<)<+(:IXV%IXG0YX"NN!N)(SE]4S8EDLTJ,"]0@1[W6Y?
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M(9O).(@B'R!.=F7CMQ M5R? UJQ97C)Q=%RY^;U!R4</H^!*K-$:PC:U<*K
M8$F8V)A68Z]49*>Y3'"UA29ZR*HBQ:FL&0]I%SBCO(_,BDZQW0.\7$>_S!IS
M<HKP%< L/HJTITG$^X+&U)Q_ZCI'''\PO&#E[>*U7_4(N^O_ S#I)->=,)MA
MB-Z1BMRB"5KSO%B8QZDO$W"O6GK"$0.5Z=[@,7WYL0!GQ_FT4^)BR%2-HSQ7
M9+'@,'=''%4R)C;NETD2N=&U(GIDWIX[#=D1+FL<BO<&=:@4J53LGSDC(= (
M!XD^5T2=-P<W8CKCRI3:H]7*.2G1GKZJ#PSW\HON>IU2;@@?$U.(>!>S(?8R
M6ZN!UJWE'KWKE,FDE5&.P9I<]<GC1$PI%H$E&B?07H5-)U2WGACW(II238?O
M\Y3(<J>*[];H\$RGC/6J?1_NVM]5:+_F [N+.-G(Y"<SY_)#E#XE[^;,/5N+
M6->E(R5X3T;RIJ=I#IN-DHQ>6T?TK*Q.8=R/8U=HO1Y.S2>)F0:VG>@]:5#O
M<IFOH-E)-&OF%+HVU%M814[SBW*X59IQ*)<$GIL"GY+YAT,78U]\9OFT0)^6
M(YVJZJHGJ[REE<61VQU+[ DB.<KR0P71HFNBZ96T]/<6\;DV0%CDWN[\1MNQ
MYY2K2\>[F>"W">^GO40K=P7J%&0&D/AJL?)]Z)+<@#-<XWF5$0TIX.DEXDMZ
M3?Q"UNBT*I\WN(;]:()H>6[^Z[JI:G;#9XZ._,^(-1Q=G3,!W':::"8&Y/8T
MPP0+VDFC]XMGY!+\_*Q=MEU)CCJIYQEM.0-Z'W56HKUTT@5U#3L_^^XU-#?9
MQ)G2FVLTN 7@D-1@M,]6>V9]=GB,6'$5"0K>YYG0J[Q_>=F2.2_J+'CC$+3_
MJJ"P\.U(;V"4SUBZ<GJ(> I=N*"8_F[G1]:ZW< IKARMAH9T03[#Y,B6JXO^
M.MW.L J[_&7C)D%N>?<;@6I#":T=^:=MWICQSTG^O?-KYI..#0MC#$F2L7XX
M+ZTU4H84_'>5T5*X-BTV3DH@QK85_ $G+#_(7L,^IL!6@O%IBN-.=^ZLG/QR
M>=U^%',L$*GH0PA%YFYN. K"K]$/X:J ,Z-9^O<:(A:8_4!6Z):H72D7")(F
MMV%49UWJ8Q0,B=-;0PDS058N%V4C&L6G),O$^%ZPPP0OD"F[?3GYD12V&E$K
MBS[(:YX5;0MSS4("R7*Y:N(I0"1XJ&:T:F_R@P@(UQL9X2Z2$@.W,TV_"3@X
M?QVH1KJR/MM5]=[2F>KC1<M(]:!4"XSYP/1L^P1K5-DW;:M[*+%E7=M#M;[_
MA+W7HZP%%UL/;&M-E0M1@W_(#2_,8&7>5ID/VH[%J:6=J ^$>IK$(8C<E$>W
MCM_KO3?(D!.L CM'9;Y5W*@Q@_?3=HI=BEYP;PE2'H7..D*$L73'5R,]K&PL
MU'K ,?#K:2N6D:9*^AC1&4^@:%,X45&@<#LU)_-7.,[:7LR>4762!]RKYM7Z
M1;L#CKH/W\*WLV/AN1PG,ZT(ZN.</P#]LF\=8$Z'9#UC57?)^A!LO]5=_Q['
MVF%.%#2K@_FY3K='K=:6>]_2Y4.BB1Z1X.XOY)^. ^:H[E]TMEY8(C,TW^$I
MQAL:X=$"_P P;CK?P<@\LDFFJQJ5K+T,N3?.J9&)KP6JL=X[-42/'!3?J-17
MG^_6.%3;\C<W125:8D@>5J*@\548?>C^7;5['N3@,_063C\@MD=W#?-JW)G5
MS9"36MCK,#:_\U.])@51]N(H[GUB*9,K62/9"RAC7DI8N*V1,B65I\'UH9D7
M+?61&CJ!RQODNKD'#SQ5C)7)NE:<F+K-%7!Z:I)GH=% 0]!$00KTD?C$7A@%
MK=762SWPSI)!HN_#U,4\,6--'!ZU>#CN(BF:T>YOU@.0/5A4KFL;;-YU?#0,
MT4W#3&0M?,J]@?G>Q?"!1 \7V3[%!1S[S?N6KA1%A<V_=L%3H 9?5F *?I*N
M>46? [H3O";=;:W%'E*,%[QP]]*>.S[N0"UZ3E#R[S=2</EL% T1TM-A_X:E
M0I?)"DUX#Z+'+=0(*H4 )8[9,B^RBVZ-A8\G<[)-?G0W5_#)9D? -8KV7=*3
M9OLJ-L/39ZCYBA%%?_1U?J*,0XD-DMJ)<C5!G@S"*5?M @W!<F;FYB&-;[\?
M1/"*=Z0$7U?F/D>]MC:37BX^'"[K<4C1//I,R^*<S-#KBG$CH%V(5T&1I(Y>
M3?<+K);F]I YW/VI=F^^M7KN<(/#T3)K#$C,>WX4GY'9=J@+Y"/6-%:5[FM+
MWFQB]J'FV9JK]!%6R>*]BS?59/GZT=MLZ;S:#T[*=X:+NQQ)S2YG5:,<1<0\
MBVNF#4!MM(F(:4BHH&5^ZZ QZX^[/$J9E!G?!*33=#71*1@4'?^VD;W*0_>[
MZ%SXM:_8[-S]F=8EN^80S]7P< !+-F"JXQL+'SHQ#@B>=IQ?]G+9F#S@&>AO
M(.DA-&"*]^G86W'-=_SW@8G6A85&=( L',8%1F;OG\B>/?2+.O;[G".Z7(*)
MG[S;(:U2F],G]K8WC84^0B'CL51\C,WW< ;/)](VM]FF\(E_NO#[>:(*\YMJ
MBN'0!0_JH>9&#K(UK606AGAMGU\8Y@$EZ9T4KDO=M;GH%/8 RB"@[I#O6T;_
M(,4EG.0WSW\ N@]^.D.@^!W;PQ(FU2'A>'U]6 F8H0$9:I?I)"@RFPYFC5<P
M(%QR.E:\6J,\%/KFDR(S55EU5]X%'U@E'-!^G@@<!U^37=50FWRP?6&=\+3M
MYD@G((P7&$".$7P23W*6]-]6LJ#;I"IOXZ\J,1ZD""^L_]5H3O)F/'#D16?0
M1VJ.;<6>Q0+41Z,RAGIA7?/TWC MO#"]>;14(0L:E0BR@>H)%]O;%1[PP#Z&
M.UL'<F1UA?GKU<@(P.B2_8KG]C1%PF=WY+79V7LSO8Q.Q:=:5A1O&D7!AA$B
M1-TQ$D)ZF@..U^3#N3_CB'X=#<+<^%U/7?OYYCG LKQSQ_N\2J93+*(5C4W*
M3,#PO"5 4-Q<FS[*+!Q9*'JHCV,E.5<CKO] ST)"\$Q]*??GF/TFU*N:=&"*
MV2TZB14*U0(,'-S/U,;\U,6W_II$O(R1Y4-2S SDKK)@M(VC=PABN70GMYB8
M*OU9F/+5D.H?M2[MA0FC9#5!]5B^+VN:%\+(;1'9_2<U'6_S@^@Q3U0Q56',
MA%A.+-IFX<*$%NFVTJF6F3K>I!2S^;DV5Z5&EGJ?J+ZPQZE7@5)*-XOC LH9
M4?G:K)7#-M3F4K<$3S23-E.'X0W*(06Y@GRZDOW##W.AI33K.H()P Y2;,)B
MB0&?7]5*Q@WB/,AW?(ORW"V5[4<?!(!]WH@@8ZX M,7E*_*P14;_:(>F6;T3
M$^KF3+<Z:>CCUA] E8';@:Q_1BB[,E KQMVP65WI]2C/CJT)U\3Q'B6*6(/;
M8L:0H@)/3-NT9? )'<=N1VQ4R\?@!)@_\=<& ]ZU"#<#@_!H?P>K%292L]F?
MXEF^R;4%*[9G3DP4)SJK0HBO)6HT+ZJ+,'V\AA5LH?,/Z?E2:7TDP5?4Q0[C
ML _I+([NQ0EMK:WK U4;YY^3.9)T^9MU!4Y[W0*%5BM'B::PR17KIL*&3-!"
MMD1RM,">.]IS*EF8IOG)_QQ;FX^CTQS[I>U)/X?\4N,:T#8M%UGDWJ,RJ7=1
M>:BM<17P-7-&MY@:VFC3D<4[+/4!=1=S^4'W+OP:KV#1-QZZHHS@_CQYH)1W
M;X\-BNKM'VMW4LI>4URMW)]T=7)?29TJ7.XLO,.X"B1J'ZT6^;C\=HAMBBW]
M C6"6JN%F'^J7&GYG;06I(2E:'@R@A4_DX/ NIOYV*.4;D [&A3_.7,><]-A
MT/E,FE>%D.;SF?<%#OB(_3IC+X)WYK2W-I<D"@6AO^Q,=9Z783;/.)HN#@6!
M#NJGO<DR5@A,7D&O0!_+BJ]U4 H1IJ1%^X5 Q*7P8MWZ%L_AY-.X@Q/&4ME.
MS,5CC/UR_42-2%C(RW-Q,,HK>2Z<F3N@U%EWLUY*A&X\/33NLMJ'*HEOUJ"(
MI J]O%PQ':H3^41>XDOD[',4D;CA_@P_& =,TX33!--"S?"D@M6J6R2E1$KW
MBY#1F N&;@A;YI[43>GCISY2=7>*P5<X. J:OYK1J>?J.A:'(E<WB^4+VA%C
MB+?YSW5:?2G<H/3FR5/XU:KDY?L'T+NB*%]E^EU*:O"JJZM(Y7Q8.7I--D6=
MAM2)HCH &/CPNVH<_]Y\K5?WL.8-Q/(Q'B%G[/MU#:(]/XBO(?UZV+*? PO)
MZ:R_4:!/T;&.@K'"';Z_O]/R,M_JS^;U!R #W=S4F(RY0WCQK"PO#28$E',!
M3M07%W^9V2?/37[=E Q"UJ^*%\IOZ^S-A[ D,KCD $-R,*3BV4C@IUQ+?L'I
MIT>H.DK&?DOJDZ<%K/@T.U=W:N>Q_KBR#HJJ4VJUW *!D?Q-*6+HTXUH87&_
ME>.ZJUO>R&]3#^AEP>FQ+5SJ^DRT>!W);<C=UZZK2W1GSSS7(C)JHF_K?N"A
MU\: ) 3$P:'=0HY)SV'Q*US6''$YZW1%_B2.=#5*F8W&H>KO_P#"%.7-3>>Q
MO["LV1X&@O<:*HA]T_0=F;DEJ\M9V(^9.I-/9GLCMWO+/^^SS>#X?><-(Q8+
M3'5O8%$7VNKT8DQL%#RS7<A0@?;C0W5'T%. FB1-KM%)>4ZM8JF5AXJ[KAS]
MXT K?VV%<)B^SJ%\M6"]I:@>A79DYDVA9/8L=PTPU*I0ON)R]NL,620*H )#
M8+,V@1]"F?XQYS#C0+70];%IO,B*XYNL"9Q_9H>%?UZP]O7?TA+SHCQ:DX:6
M.03@2-A2\,_1ZEP-B*E2\TVI49#0UI$NX+>LGWG+!V+[%/ZV7OZB$:ZZ"#FD
M+S>D-S72.*^]\MUFO-J%FDEW\YRG\J<M?2OCEJGD=EF]C'/GJMS:29VJI?32
M+5XWOBG.Q@;3!"=ZEM?3,$%::<;Y7E7\W<_7&>30QO7OZ!A9U6>:-]!+!@4F
M:;^BSXV+?>UJC.='6B_DX*LY.<6+##FG[/1[9A-:'=><.MG*/M5&)O:P= ]1
M<P=?C238?QR">9?!OTSSR5XJ/=[31Y/()1$&*]E4"_+9/T:)LEL?G1^E=V:J
MT&-\E?<T=<V\'G/0TYC9GO4X$1DD9VS.YXY7W['4@+Z$\KV-Y!-PYI6]+))?
M4?\$6=[V*E_%FMIIGS&=)EL^,S(R5EWSU;XDOMAL+2^]O%+*FY7IC#MRU9=C
M./:+M38P8= S.I?3N+\" \'PC=UDVQ$<_-XE2;,>' U=^0':#L'FF6,IM@I\
M8/#-KT*7$:Z:AH<MOIZ#!Z)6*T^1IG7948(\&[/!M3BH=[^[[EC.)MY;^+O_
M%;XW0<A(["*2.-&F *Y(V[B.">M9L=CH7TJ&9MUR\DWL[<?E5N*.*) L2JJC
MH%'%<I9Z?XF:!#<W3+)&. ''S'?GGU^7BK$%AKL-PC.^^,;MJK+M"DL3EACG
M@BDDD]$)02U1TY8 @$@$]!48N(6E,0E0R#JFX9_*N8TC2]>2]BEU*8.D<YD4
M>9NVJ5(('XU6D\-:F/$4M];LB9G:59&8$ %,8QC.<^^*J[&=K17'VVB^)4L
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M4NVDV4P'KC8!5&_T^UOU"74"2JIR-PZ&KZ@;0.]1R"NNDVDFC":*OEK'&(T
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MSIUE>'-Q:Q2G&,N@-0\*K&4L'%_">%1WZRMAT(/J*[CP3XC,=TNG3REHY/\
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M" D\G))/4U8C&.E28K*I4<FS6$;(!4L?WJCJ2+[U<\]C2.Y-1117.:A1110
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M20SJH&.]=4='84I70MO$GDJV.1TK8N;54TV"=G)E/;VK)B^7:.@JPTS2X!/
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MCJ*YWQ)+?BV9[1S$D:Y=QU/M74G?8R6YUDL['RT"!T;AR>PK#TJ_BL?%$^G
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MBF]:0PS?WJE^TI[_ )4?:4]&_*G[07*B'R)?[U'V>3UJ4W:>C?E2?:T_NO\
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M^VC=_#Z^?:LU+L!].E!RL,P$U5WDX"6VVU)]1XV%0V4NAH<?-\$B='&HE3S
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M#*U7JH(6'$=XV>/69180;IE[];5Y9=]ZV.4W9ZWS%[CYRR3]6 ?QO!'F]>Q
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M<"TR,#(Q,3(S,2YX<V102P$"% ,4    "  D=WQ49$E^LE8:  !@3@$ %0
M            @ $2&0  86%T<"TR,#(Q,3(S,5]C86PN>&UL4$L! A0#%
M  @ )'=\5-&E!0/;.0  CVL# !4              ( !FS,  &%A=' M,C R
M,3$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( "1W?%2NW!09$H\   7,!P 5
M          "  :EM  !A871P+3(P,C$Q,C,Q7VQA8BYX;6Q02P$"% ,4
M"  D=WQ4!JCKMA!@  #Y_@4 %0              @ 'N_   86%T<"TR,#(Q
M,3(S,5]P<F4N>&UL4$L! A0#%     @ )'=\5,.;#:>G"0  IX(   H
M         ( !,5T! &5X,S$M,2YH=&U02P$"% ,4    "  D=WQ4UD]Z.P@&
M   0-P  "@              @ $ 9P$ 97@S,BTQ+FAT;5!+ 0(4 Q0    (
M "1W?%2'CKOM4H(" !ZX&P ,              "  3!M 0!F;W)M,3 M:RYH
M=&U02P$"% ,4    "  D=WQ4;SO)[_-2  #Z5@  #0              @ &L
M[P, :6UA9V5?,# Q+FIP9U!+ 0(4 Q0    ( "1W?%3N5U_AJ2X  * Q   -
M              "  <I"! !I;6%G95\P,#(N:G!G4$L! A0#%     @ )'=\
M5%*6P(LD1   1D8   T              ( !GG$$ &EM86=E7S P,RYJ<&=0
M2P$"% ,4    "  D=WQ4L5>\(C=   !#0P  #0              @ 'MM00
M:6UA9V5?,# T+FIP9U!+ 0(4 Q0    ( "1W?%1,!0Q#5$D  &5,   -
M          "  4_V! !I;6%G95\P,#4N:G!G4$L! A0#%     @ )'=\5."?
M]K=I?@  DH(   T              ( !SC\% &EM86=E7S P-BYJ<&=02P$"
M% ,4    "  D=WQ4?XT+!5XU  !'.0  #0              @ %BO@4 :6UA
M9V5?,# W+FIP9U!+ 0(4 Q0    ( "1W?%2*@2 2VV   )9G   -
M      "  >OS!0!I;6%G95\P,#@N:G!G4$L! A0#%     @ )'=\5 GX!U=7
M"   Z@@   T              ( !\50& &EM86=E7S P.2YJ<&=02P$"% ,4
M    "  D=WQ4]M/QX9--  #W3@  #0              @ %S708 :6UA9V5?
M,#$P+FIP9U!+ 0(4 Q0    ( "1W?%2UBZ0F738  %TY   -
M  "  3&K!@!I;6%G95\P,3$N:G!G4$L! A0#%     @ )'=\5#E4>%!!1P
MNTH   T              ( !N>$& &EM86=E7S Q,BYJ<&=02P$"% ,4
M"  D=WQ4)(1<V,1   #-1   #0              @ $E*0< :6UA9V5?,#$S
M+FIP9U!+ 0(4 Q0    ( "1W?%3<:#XV>R,! %PQ 0 -              "
M 11J!P!I;6%G95\P,30N:G!G4$L! A0#%     @ )'=\5 >Z9C;R%@  QQ@
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(   *4@D    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
